MIME-Version: 1.0
Content-Type: multipart/related; boundary="----=_NextPart_01D75918.E6EFEE90"

This document is a Single File Web Page, also known as a Web Archive file.  If you are seeing this message, your browser or editor doesn't support Web Archive files.  Please download a browser that supports Web Archive.

------=_NextPart_01D75918.E6EFEE90
Content-Location: file:///C:/8467A08E/Stalevo_clean.htm
Content-Transfer-Encoding: quoted-printable
Content-Type: text/html; charset="windows-1252"

<html xmlns:v=3D"urn:schemas-microsoft-com:vml"
xmlns:o=3D"urn:schemas-microsoft-com:office:office"
xmlns:w=3D"urn:schemas-microsoft-com:office:word"
xmlns:dt=3D"uuid:C2F41010-65B3-11d1-A29F-00AA00C14882"
xmlns:m=3D"http://schemas.microsoft.com/office/2004/12/omml"
xmlns:st1=3D"urn:schemas-microsoft-com:office:smarttags"
xmlns=3D"http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=3DContent-Type content=3D"text/html; charset=3Dwindows-125=
2">
<meta name=3DProgId content=3DWord.Document>
<meta name=3DGenerator content=3D"Microsoft Word 15">
<meta name=3DOriginator content=3D"Microsoft Word 15">
<link rel=3DFile-List href=3D"Stalevo_clean_files/filelist.xml">
<link rel=3DEdit-Time-Data href=3D"Stalevo_clean_files/editdata.mso">
<!--[if !mso]>
<style>
v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style>
<![endif]-->
<title>Stalevo, INN-levodopa, carbidopa, entacapone</title>
<o:SmartTagType namespaceuri=3D"urn:schemas-microsoft-com:office:smarttags"
 name=3D"PersonName"/>
<o:SmartTagType namespaceuri=3D"urn:schemas-microsoft-com:office:smarttags"
 name=3D"stockticker"/>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Subject>EPAR</o:Subject>
  <o:Author>CHMP</o:Author>
  <o:Keywords>Stalevo, INN-levodopa, carbidopa, entacapone</o:Keywords>
  <o:Template>Normal</o:Template>
  <o:LastAuthor>Manish Kumar</o:LastAuthor>
  <o:Revision>2</o:Revision>
  <o:TotalTime>0</o:TotalTime>
  <o:Created>2021-06-04T02:39:00Z</o:Created>
  <o:LastSaved>2021-06-04T02:39:00Z</o:LastSaved>
  <o:Pages>1</o:Pages>
  <o:Words>26123</o:Words>
  <o:Characters>148902</o:Characters>
  <o:Company>EMEA</o:Company>
  <o:Bytes>Document</o:Bytes>
  <o:Lines>1240</o:Lines>
  <o:Paragraphs>349</o:Paragraphs>
  <o:CharactersWithSpaces>174676</o:CharactersWithSpaces>
  <o:Version>16.00</o:Version>
 </o:DocumentProperties>
 <o:CustomDocumentProperties>
  <o:ContentTypeId dt:dt=3D"string">0x010100D23763CA1DA6044B88B8569D128159F=
3</o:ContentTypeId>
  <o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_Enabled dt:dt=3D"strin=
g">true</o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_Enabled>
  <o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_SetDate dt:dt=3D"strin=
g">2021-05-25T14:13:12Z</o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_=
SetDate>
  <o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_Method dt:dt=3D"string=
">Standard</o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_Method>
  <o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_Name dt:dt=3D"string">=
0eea11ca-d417-4147-80ed-01a58412c458</o:MSIP_Label_0eea11ca-d417-4147-80ed-=
01a58412c458_Name>
  <o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_SiteId dt:dt=3D"string=
">bc9dc15c-61bc-4f03-b60b-e5b6d8922839</o:MSIP_Label_0eea11ca-d417-4147-80e=
d-01a58412c458_SiteId>
  <o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_ActionId dt:dt=3D"stri=
ng">12fa1d23-9c93-4bb9-a8b8-3df784635539</o:MSIP_Label_0eea11ca-d417-4147-8=
0ed-01a58412c458_ActionId>
  <o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_ContentBits dt:dt=3D"s=
tring">2</o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_ContentBits>
 </o:CustomDocumentProperties>
 <o:OfficeDocumentSettings>
  <o:AllowPNG/>
  <o:TargetScreenSize>800x600</o:TargetScreenSize>
 </o:OfficeDocumentSettings>
</xml><![endif]-->
<link rel=3DdataStoreItem href=3D"Stalevo_clean_files/item0001.xml"
target=3D"Stalevo_clean_files/props002.xml">
<link rel=3DdataStoreItem href=3D"Stalevo_clean_files/item0003.xml"
target=3D"Stalevo_clean_files/props004.xml">
<link rel=3DdataStoreItem href=3D"Stalevo_clean_files/item0005.xml"
target=3D"Stalevo_clean_files/props006.xml">
<link rel=3DdataStoreItem href=3D"Stalevo_clean_files/item0007.xml"
target=3D"Stalevo_clean_files/props008.xml">
<link rel=3DthemeData href=3D"Stalevo_clean_files/themedata.thmx">
<link rel=3DcolorSchemeMapping href=3D"Stalevo_clean_files/colorschememappi=
ng.xml">
<!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:HideSpellingErrors/>
  <w:ActiveWritingStyle Lang=3D"FR" VendorID=3D"64" DLLVersion=3D"131078" N=
LCheck=3D"1">0</w:ActiveWritingStyle>
  <w:ActiveWritingStyle Lang=3D"EN-GB" VendorID=3D"64" DLLVersion=3D"131078"
   NLCheck=3D"1">1</w:ActiveWritingStyle>
  <w:ActiveWritingStyle Lang=3D"IT" VendorID=3D"64" DLLVersion=3D"131078" N=
LCheck=3D"1">0</w:ActiveWritingStyle>
  <w:ActiveWritingStyle Lang=3D"EN-US" VendorID=3D"64" DLLVersion=3D"131078"
   NLCheck=3D"1">1</w:ActiveWritingStyle>
  <w:ActiveWritingStyle Lang=3D"FI" VendorID=3D"64" DLLVersion=3D"131078" N=
LCheck=3D"1">0</w:ActiveWritingStyle>
  <w:ActiveWritingStyle Lang=3D"DE" VendorID=3D"64" DLLVersion=3D"131078" N=
LCheck=3D"1">0</w:ActiveWritingStyle>
  <w:ActiveWritingStyle Lang=3D"EN-GB" VendorID=3D"64" DLLVersion=3D"0" NLC=
heck=3D"1">0</w:ActiveWritingStyle>
  <w:ActiveWritingStyle Lang=3D"EN-US" VendorID=3D"64" DLLVersion=3D"0" NLC=
heck=3D"1">0</w:ActiveWritingStyle>
  <w:ActiveWritingStyle Lang=3D"FR" VendorID=3D"64" DLLVersion=3D"0" NLChec=
k=3D"1">0</w:ActiveWritingStyle>
  <w:SpellingState>Clean</w:SpellingState>
  <w:TrackMoves>false</w:TrackMoves>
  <w:TrackFormatting/>
  <w:DoNotHyphenateCaps/>
  <w:DrawingGridHorizontalSpacing>8.55 pt</w:DrawingGridHorizontalSpacing>
  <w:DrawingGridVerticalSpacing>11.65 pt</w:DrawingGridVerticalSpacing>
  <w:DisplayHorizontalDrawingGridEvery>0</w:DisplayHorizontalDrawingGridEve=
ry>
  <w:DisplayVerticalDrawingGridEvery>0</w:DisplayVerticalDrawingGridEvery>
  <w:ValidateAgainstSchemas/>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotPromoteQF/>
  <w:LidThemeOther>EN-US</w:LidThemeOther>
  <w:LidThemeAsian>X-NONE</w:LidThemeAsian>
  <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>
  <w:Compatibility>
   <w:UsePrinterMetrics/>
   <w:WW6BorderRules/>
   <w:FootnoteLayoutLikeWW8/>
   <w:ShapeLayoutLikeWW8/>
   <w:AlignTablesRowByRow/>
   <w:ForgetLastTabAlignment/>
   <w:DoNotUseHTMLParagraphAutoSpacing/>
   <w:LayoutRawTableWidth/>
   <w:LayoutTableRowsApart/>
   <w:UseWord97LineBreakingRules/>
   <w:SelectEntireFieldWithStartOrEnd/>
   <w:UseWord2002TableStyleRules/>
   <w:UseWord2010TableStyleRules/>
   <w:DontUseIndentAsNumberingTabStop/>
   <w:FELineBreak11/>
   <w:WW11IndentRules/>
   <w:DontAutofitConstrainedTables/>
   <w:AutofitLikeWW11/>
   <w:HangulWidthLikeWW11/>
   <w:UseNormalStyleForList/>
   <w:DontVertAlignCellWithSp/>
   <w:DontBreakConstrainedForcedTables/>
   <w:DontVertAlignInTxbx/>
   <w:Word11KerningPairs/>
   <w:CachedColBalance/>
  </w:Compatibility>
  <w:DocumentVariables>
   <w:o_extra_attribute>CTD Variation</w:o_extra_attribute>
   <w:o_title>25 November 2004</w:o_title>
   <w:Registered>-1</w:Registered>
   <w:Version>0</w:Version>
  </w:DocumentVariables>
  <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel>
  <m:mathPr>
   <m:mathFont m:val=3D"Cambria Math"/>
   <m:brkBin m:val=3D"before"/>
   <m:brkBinSub m:val=3D"&#45;-"/>
   <m:smallFrac m:val=3D"off"/>
   <m:dispDef/>
   <m:lMargin m:val=3D"0"/>
   <m:rMargin m:val=3D"0"/>
   <m:defJc m:val=3D"centerGroup"/>
   <m:wrapIndent m:val=3D"1440"/>
   <m:intLim m:val=3D"subSup"/>
   <m:naryLim m:val=3D"undOvr"/>
  </m:mathPr></w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState=3D"false" DefUnhideWhenUsed=3D"false"
  DefSemiHidden=3D"false" DefQFormat=3D"false" DefPriority=3D"99"
  LatentStyleCount=3D"376">
  <w:LsdException Locked=3D"false" Priority=3D"0" QFormat=3D"true" Name=3D"=
Normal"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"0" QFormat=3D"true" Name=3D"=
heading 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"0" QFormat=3D"true" Name=3D"=
heading 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 7"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 8"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 9"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 5"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 6"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 7"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 8"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 9"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"toc 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"toc 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"toc 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"toc 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"toc 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"toc 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"toc 7"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"toc 8"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"toc 9"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Normal Indent"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"footnote text"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"annotation text"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"header"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"footer"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index heading"/>
  <w:LsdException Locked=3D"false" Priority=3D"35" QFormat=3D"true" Name=3D=
"caption"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"table of figures"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"envelope address"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"envelope return"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"footnote reference"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"annotation reference"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"line number"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"page number"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"endnote reference"/>
  <w:LsdException Locked=3D"false" Priority=3D"0" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"endnote text"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"table of authorities"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"macro"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"toa heading"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Bullet"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Number"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List 5"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Bullet 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Bullet 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Bullet 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Bullet 5"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Number 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Number 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Number 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Number 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"10" QFormat=3D"true" Name=3D=
"Title"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Closing"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Signature"/>
  <w:LsdException Locked=3D"false" Priority=3D"0" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"Default Paragraph Font"/>
  <w:LsdException Locked=3D"false" Priority=3D"0" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"Body Text"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Body Text Indent"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Continue"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Continue 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Continue 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Continue 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Continue 5"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Message Header"/>
  <w:LsdException Locked=3D"false" Priority=3D"11" QFormat=3D"true" Name=3D=
"Subtitle"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Salutation"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Date"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Body Text First Indent"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Body Text First Indent 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Note Heading"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Body Text 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"0" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"Body Text 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Body Text Indent 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Body Text Indent 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Block Text"/>
  <w:LsdException Locked=3D"false" Priority=3D"0" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"Hyperlink"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"FollowedHyperlink"/>
  <w:LsdException Locked=3D"false" Priority=3D"0" QFormat=3D"true" Name=3D"=
Strong"/>
  <w:LsdException Locked=3D"false" Priority=3D"20" QFormat=3D"true" Name=3D=
"Emphasis"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Document Map"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Plain Text"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"E-mail Signature"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Top of Form"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Bottom of Form"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Normal (Web)"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Acronym"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Address"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Cite"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Code"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Definition"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Keyboard"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Preformatted"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Sample"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Typewriter"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Variable"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Normal Table"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"annotation subject"/>
  <w:LsdException Locked=3D"false" Priority=3D"0" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"No List"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Outline List 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Outline List 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Outline List 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Simple 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Simple 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Simple 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Classic 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Classic 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Classic 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Classic 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Colorful 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Colorful 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Colorful 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Columns 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Columns 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Columns 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Columns 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Columns 5"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 5"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 6"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 7"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 8"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 5"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 6"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 7"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 8"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table 3D effects 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table 3D effects 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table 3D effects 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Contemporary"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Elegant"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Professional"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Subtle 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Subtle 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Web 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Web 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Web 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Balloon Text"/>
  <w:LsdException Locked=3D"false" Priority=3D"59" Name=3D"Table Grid"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Theme"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" Name=3D"Placeholder =
Text"/>
  <w:LsdException Locked=3D"false" Priority=3D"1" QFormat=3D"true" Name=3D"=
No Spacing"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" Name=3D"Revision"/>
  <w:LsdException Locked=3D"false" Priority=3D"34" QFormat=3D"true"
   Name=3D"List Paragraph"/>
  <w:LsdException Locked=3D"false" Priority=3D"29" QFormat=3D"true" Name=3D=
"Quote"/>
  <w:LsdException Locked=3D"false" Priority=3D"30" QFormat=3D"true"
   Name=3D"Intense Quote"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"19" QFormat=3D"true"
   Name=3D"Subtle Emphasis"/>
  <w:LsdException Locked=3D"false" Priority=3D"21" QFormat=3D"true"
   Name=3D"Intense Emphasis"/>
  <w:LsdException Locked=3D"false" Priority=3D"31" QFormat=3D"true"
   Name=3D"Subtle Reference"/>
  <w:LsdException Locked=3D"false" Priority=3D"32" QFormat=3D"true"
   Name=3D"Intense Reference"/>
  <w:LsdException Locked=3D"false" Priority=3D"33" QFormat=3D"true" Name=3D=
"Book Title"/>
  <w:LsdException Locked=3D"false" Priority=3D"37" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"Bibliography"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" QFormat=3D"true" Name=3D"TOC Heading"/>
  <w:LsdException Locked=3D"false" Priority=3D"41" Name=3D"Plain Table 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"42" Name=3D"Plain Table 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"43" Name=3D"Plain Table 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"44" Name=3D"Plain Table 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"45" Name=3D"Plain Table 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"40" Name=3D"Grid Table Light=
"/>
  <w:LsdException Locked=3D"false" Priority=3D"46" Name=3D"Grid Table 1 Lig=
ht"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"Grid Table 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"Grid Table 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"Grid Table 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"Grid Table 5 Dar=
k"/>
  <w:LsdException Locked=3D"false" Priority=3D"51" Name=3D"Grid Table 6 Col=
orful"/>
  <w:LsdException Locked=3D"false" Priority=3D"52" Name=3D"Grid Table 7 Col=
orful"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"Grid Table 1 Light Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"Grid Table 2 Acc=
ent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"Grid Table 3 Acc=
ent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"Grid Table 4 Acc=
ent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"Grid Table 5 Dar=
k Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"Grid Table 6 Colorful Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"Grid Table 7 Colorful Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"Grid Table 1 Light Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"Grid Table 2 Acc=
ent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"Grid Table 3 Acc=
ent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"Grid Table 4 Acc=
ent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"Grid Table 5 Dar=
k Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"Grid Table 6 Colorful Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"Grid Table 7 Colorful Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"Grid Table 1 Light Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"Grid Table 2 Acc=
ent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"Grid Table 3 Acc=
ent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"Grid Table 4 Acc=
ent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"Grid Table 5 Dar=
k Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"Grid Table 6 Colorful Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"Grid Table 7 Colorful Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"Grid Table 1 Light Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"Grid Table 2 Acc=
ent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"Grid Table 3 Acc=
ent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"Grid Table 4 Acc=
ent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"Grid Table 5 Dar=
k Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"Grid Table 6 Colorful Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"Grid Table 7 Colorful Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"Grid Table 1 Light Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"Grid Table 2 Acc=
ent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"Grid Table 3 Acc=
ent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"Grid Table 4 Acc=
ent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"Grid Table 5 Dar=
k Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"Grid Table 6 Colorful Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"Grid Table 7 Colorful Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"Grid Table 1 Light Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"Grid Table 2 Acc=
ent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"Grid Table 3 Acc=
ent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"Grid Table 4 Acc=
ent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"Grid Table 5 Dar=
k Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"Grid Table 6 Colorful Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"Grid Table 7 Colorful Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"46" Name=3D"List Table 1 Lig=
ht"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"List Table 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"List Table 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"List Table 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"List Table 5 Dar=
k"/>
  <w:LsdException Locked=3D"false" Priority=3D"51" Name=3D"List Table 6 Col=
orful"/>
  <w:LsdException Locked=3D"false" Priority=3D"52" Name=3D"List Table 7 Col=
orful"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"List Table 1 Light Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"List Table 2 Acc=
ent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"List Table 3 Acc=
ent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"List Table 4 Acc=
ent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"List Table 5 Dar=
k Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"List Table 6 Colorful Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"List Table 7 Colorful Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"List Table 1 Light Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"List Table 2 Acc=
ent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"List Table 3 Acc=
ent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"List Table 4 Acc=
ent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"List Table 5 Dar=
k Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"List Table 6 Colorful Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"List Table 7 Colorful Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"List Table 1 Light Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"List Table 2 Acc=
ent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"List Table 3 Acc=
ent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"List Table 4 Acc=
ent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"List Table 5 Dar=
k Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"List Table 6 Colorful Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"List Table 7 Colorful Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"List Table 1 Light Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"List Table 2 Acc=
ent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"List Table 3 Acc=
ent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"List Table 4 Acc=
ent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"List Table 5 Dar=
k Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"List Table 6 Colorful Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"List Table 7 Colorful Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"List Table 1 Light Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"List Table 2 Acc=
ent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"List Table 3 Acc=
ent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"List Table 4 Acc=
ent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"List Table 5 Dar=
k Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"List Table 6 Colorful Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"List Table 7 Colorful Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"List Table 1 Light Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"List Table 2 Acc=
ent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"List Table 3 Acc=
ent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"List Table 4 Acc=
ent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"List Table 5 Dar=
k Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"List Table 6 Colorful Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"List Table 7 Colorful Accent 6"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Mention"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Smart Hyperlink"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Hashtag"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Unresolved Mention"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Smart Link"/>
 </w:LatentStyles>
</xml><![endif]--><!--[if !mso]><object
 classid=3D"clsid:38481807-CA0E-42D2-BF39-B33AF135CC4D" id=3Dieooui></objec=
t>
<style>
st1\:*{behavior:url(#ieooui) }
</style>
<![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Helvetica;
	panose-1:2 11 6 4 2 2 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536858881 -1073711013 9 0 511 0;}
@font-face
	{font-family:Courier;
	panose-1:2 7 4 9 2 2 5 2 4 4;
	mso-font-charset:0;
	mso-generic-font-family:modern;
	mso-font-format:other;
	mso-font-pitch:fixed;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Tms Rmn";
	panose-1:2 2 6 3 4 5 5 2 3 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-format:other;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Helv;
	panose-1:2 11 6 4 2 2 2 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-format:other;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"New York";
	panose-1:2 4 5 3 6 5 6 2 3 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:System;
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-format:other;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:"MS Mincho";
	panose-1:2 2 6 9 4 2 5 8 3 4;
	mso-font-alt:"\FF2D\FF33 \660E\671D";
	mso-font-charset:128;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:-536870145 1791491579 134217746 0 131231 0;}
@font-face
	{font-family:Batang;
	panose-1:2 3 6 0 0 1 1 1 1 1;
	mso-font-alt:\BC14\D0D5;
	mso-font-charset:129;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-1342176593 1775729915 48 0 524447 0;}
@font-face
	{font-family:SimSun;
	panose-1:2 1 6 0 3 1 1 1 1 1;
	mso-font-alt:\5B8B\4F53;
	mso-font-charset:134;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:3 680460288 22 0 262145 0;}
@font-face
	{font-family:PMingLiU;
	panose-1:2 1 6 1 0 1 1 1 1 1;
	mso-font-alt:\65B0\7D30\660E\9AD4;
	mso-font-charset:136;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-1610611969 684719354 22 0 1048577 0;}
@font-face
	{font-family:"MS Gothic";
	panose-1:2 11 6 9 7 2 5 8 2 4;
	mso-font-alt:"\FF2D\FF33 \30B4\30B7\30C3\30AF";
	mso-font-charset:128;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:-536870145 1791491579 134217746 0 131231 0;}
@font-face
	{font-family:Dotum;
	panose-1:2 11 6 0 0 1 1 1 1 1;
	mso-font-alt:\B3CB\C6C0;
	mso-font-charset:129;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1342176593 1775729915 48 0 524447 0;}
@font-face
	{font-family:SimHei;
	panose-1:2 1 6 0 3 1 1 1 1 1;
	mso-font-alt:\9ED1\4F53;
	mso-font-charset:134;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:-2147482945 953122042 22 0 262145 0;}
@font-face
	{font-family:MingLiU;
	panose-1:2 1 6 9 0 1 1 1 1 1;
	mso-font-alt:\7D30\660E\9AD4;
	mso-font-charset:136;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:-1610611969 684719354 22 0 1048577 0;}
@font-face
	{font-family:Mincho;
	panose-1:2 2 6 9 4 3 5 8 3 5;
	mso-font-alt:\660E\671D;
	mso-font-charset:128;
	mso-generic-font-family:roman;
	mso-font-pitch:fixed;
	mso-font-signature:1 134676480 16 0 131072 0;}
@font-face
	{font-family:Gulim;
	panose-1:2 11 6 0 0 1 1 1 1 1;
	mso-font-alt:\AD74\B9BC;
	mso-font-charset:129;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1342176593 1775729915 48 0 524447 0;}
@font-face
	{font-family:Century;
	panose-1:2 4 6 4 5 5 5 2 3 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:647 0 0 0 159 0;}
@font-face
	{font-family:"Angsana New";
	panose-1:2 2 6 3 5 4 5 2 3 4;
	mso-font-charset:222;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2130706429 0 0 0 65537 0;}
@font-face
	{font-family:"Cordia New";
	panose-1:2 11 3 4 2 2 2 2 2 4;
	mso-font-charset:222;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2130706429 0 0 0 65537 0;}
@font-face
	{font-family:Mangal;
	panose-1:0 0 4 0 0 0 0 0 0 0;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:32771 0 0 0 1 0;}
@font-face
	{font-family:Latha;
	panose-1:2 0 4 0 0 0 0 0 0 0;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:1048579 0 0 0 1 0;}
@font-face
	{font-family:Sylfaen;
	panose-1:1 10 5 2 5 3 6 3 3 3;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:67110535 0 0 0 159 0;}
@font-face
	{font-family:Vrinda;
	panose-1:0 0 4 0 0 0 0 0 0 0;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:65539 0 0 0 1 0;}
@font-face
	{font-family:Raavi;
	panose-1:2 0 5 0 0 0 0 0 0 0;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:131075 0 0 0 1 0;}
@font-face
	{font-family:Shruti;
	panose-1:2 0 5 0 0 0 0 0 0 0;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:262147 0 0 0 1 0;}
@font-face
	{font-family:Sendnya;
	panose-1:0 0 4 0 0 0 0 0 0 0;
	mso-font-charset:1;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:0 0 0 0 0 0;}
@font-face
	{font-family:Gautami;
	panose-1:2 0 5 0 0 0 0 0 0 0;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:2097155 0 0 0 1 0;}
@font-face
	{font-family:Tunga;
	panose-1:0 0 4 0 0 0 0 0 0 0;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:4194307 0 0 0 1 0;}
@font-face
	{font-family:"Estrangelo Edessa";
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-charset:1;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:0 0 0 0 0 0;}
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-536869121 1107305727 33554432 0 415 0;}
@font-face
	{font-family:"Yu Gothic";
	panose-1:2 11 4 0 0 0 0 0 0 0;
	mso-font-alt:\6E38\30B4\30B7\30C3\30AF;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 717749759 22 0 131231 0;}
@font-face
	{font-family:DengXian;
	panose-1:2 1 6 0 3 1 1 1 1 1;
	mso-font-alt:\7B49\7EBF;
	mso-font-charset:134;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610612033 953122042 22 0 262159 0;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-469750017 -1073732485 9 0 511 0;}
@font-face
	{font-family:"Calibri Light";
	panose-1:2 15 3 2 2 2 4 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-469750017 -1073732485 9 0 511 0;}
@font-face
	{font-family:"Palatino Linotype";
	panose-1:2 4 5 2 5 5 5 3 3 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-536870265 1073741843 0 0 415 0;}
@font-face
	{font-family:Verdana;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610610945 1073750107 16 0 415 0;}
@font-face
	{font-family:"Arial Unicode MS";
	panose-1:2 11 6 4 2 2 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Segoe UI Emoji";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 33554432 0 0 1 0;}
@font-face
	{font-family:TimesNewRomanPS-BoldMT;
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-alt:"Times New Roman";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-format:other;
	mso-font-pitch:auto;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-520081665 -1073717157 41 0 66047 0;}
@font-face
	{font-family:Marlett;
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:"Arial Black";
	panose-1:2 11 10 4 2 1 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610612049 1073772795 0 0 159 0;}
@font-face
	{font-family:"Bahnschrift Light";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610612025 2 0 0 415 0;}
@font-face
	{font-family:"Bahnschrift SemiLight";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610612025 2 0 0 415 0;}
@font-face
	{font-family:Bahnschrift;
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610612025 2 0 0 415 0;}
@font-face
	{font-family:"Bahnschrift SemiBold";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610612025 2 0 0 415 0;}
@font-face
	{font-family:"Bahnschrift Light SemiCondensed";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610612025 2 0 0 415 0;}
@font-face
	{font-family:"Bahnschrift SemiLight SemiConde";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610612025 2 0 0 415 0;}
@font-face
	{font-family:"Bahnschrift SemiCondensed";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610612025 2 0 0 415 0;}
@font-face
	{font-family:"Bahnschrift SemiBold SemiConden";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610612025 2 0 0 415 0;}
@font-face
	{font-family:"Bahnschrift Light Condensed";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610612025 2 0 0 415 0;}
@font-face
	{font-family:"Bahnschrift SemiLight Condensed";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610612025 2 0 0 415 0;}
@font-face
	{font-family:"Bahnschrift Condensed";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610612025 2 0 0 415 0;}
@font-face
	{font-family:"Bahnschrift SemiBold Condensed";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610612025 2 0 0 415 0;}
@font-face
	{font-family:Cambria;
	panose-1:2 4 5 3 5 4 6 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-536869121 1107305727 33554432 0 415 0;}
@font-face
	{font-family:Candara;
	panose-1:2 14 5 2 3 3 3 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610611985 1073783883 0 0 415 0;}
@font-face
	{font-family:"Candara Light";
	panose-1:2 14 5 2 3 3 3 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610611969 2 0 0 415 0;}
@font-face
	{font-family:"Comic Sans MS";
	panose-1:3 15 7 2 3 3 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:647 19 0 0 159 0;}
@font-face
	{font-family:Consolas;
	panose-1:2 11 6 9 2 2 4 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:-536869121 64767 1 0 415 0;}
@font-face
	{font-family:Constantia;
	panose-1:2 3 6 2 5 3 6 3 3 3;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-1610611985 1073750091 0 0 415 0;}
@font-face
	{font-family:Corbel;
	panose-1:2 11 5 3 2 2 4 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610611985 1073783883 0 0 415 0;}
@font-face
	{font-family:"Corbel Light";
	panose-1:2 11 3 3 2 2 4 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610611985 1073783883 0 0 415 0;}
@font-face
	{font-family:Ebrima;
	panose-1:2 0 0 0 0 0 0 0 0 0;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610612641 33554497 2048 0 147 0;}
@font-face
	{font-family:"Franklin Gothic Medium";
	panose-1:2 11 6 3 2 1 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:647 0 0 0 159 0;}
@font-face
	{font-family:Gabriola;
	panose-1:4 4 6 5 5 16 2 2 13 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:-536870161 1342185547 0 0 159 0;}
@font-face
	{font-family:Gadugi;
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483645 33554432 12288 0 1 0;}
@font-face
	{font-family:Georgia;
	panose-1:2 4 5 2 5 4 5 2 3 3;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:647 0 0 0 159 0;}
@font-face
	{font-family:Impact;
	panose-1:2 11 8 6 3 9 2 5 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:647 0 0 0 159 0;}
@font-face
	{font-family:"Ink Free";
	panose-1:3 8 4 2 0 5 0 0 0 0;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:-2147483645 0 0 0 1 0;}
@font-face
	{font-family:"Javanese Text";
	panose-1:2 0 0 0 0 0 0 0 0 0;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-2147483645 8192 0 0 1 0;}
@font-face
	{font-family:"Leelawadee UI";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1560281085 0 65536 0 65793 0;}
@font-face
	{font-family:"Leelawadee UI Semilight";
	panose-1:2 11 4 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1560281085 0 65536 0 65793 0;}
@font-face
	{font-family:"Lucida Console";
	panose-1:2 11 6 9 4 5 4 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:-2147482993 6144 0 0 31 0;}
@font-face
	{font-family:"Lucida Sans Unicode";
	panose-1:2 11 6 2 3 5 4 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147480833 14699 0 0 191 0;}
@font-face
	{font-family:"Malgun Gothic";
	panose-1:2 11 5 3 2 0 0 2 0 4;
	mso-font-charset:129;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1879048145 701988091 18 0 524289 0;}
@font-face
	{font-family:"\@Malgun Gothic";
	mso-font-charset:129;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1879048145 701988091 18 0 524289 0;}
@font-face
	{font-family:"Malgun Gothic Semilight";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1342174545 165641467 18 0 4063677 0;}
@font-face
	{font-family:"\@Malgun Gothic Semilight";
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1342174545 165641467 18 0 4063677 0;}
@font-face
	{font-family:"Microsoft Himalaya";
	panose-1:1 1 1 0 1 1 1 1 1 1;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-2147483645 65536 64 0 1 0;}
@font-face
	{font-family:"Microsoft JhengHei";
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:136;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:679 684672000 22 0 1048585 0;}
@font-face
	{font-family:"\@Microsoft JhengHei";
	mso-font-charset:136;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:679 684672000 22 0 1048585 0;}
@font-face
	{font-family:"Microsoft JhengHei UI";
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:136;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:679 684672000 22 0 1048585 0;}
@font-face
	{font-family:"\@Microsoft JhengHei UI";
	mso-font-charset:136;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:679 684672000 22 0 1048585 0;}
@font-face
	{font-family:"Microsoft JhengHei Light";
	panose-1:2 11 3 4 3 5 4 4 2 4;
	mso-font-charset:136;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147482969 684672000 22 0 1048585 0;}
@font-face
	{font-family:"\@Microsoft JhengHei Light";
	mso-font-charset:136;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147482969 684672000 22 0 1048585 0;}
@font-face
	{font-family:"Microsoft JhengHei UI Light";
	panose-1:2 11 3 4 3 5 4 4 2 4;
	mso-font-charset:136;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147482969 684672000 22 0 1048585 0;}
@font-face
	{font-family:"\@Microsoft JhengHei UI Light";
	mso-font-charset:136;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147482969 684672000 22 0 1048585 0;}
@font-face
	{font-family:"Microsoft New Tai Lue";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 0 -2147483648 0 1 0;}
@font-face
	{font-family:"Microsoft PhagsPa";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 0 134217728 0 1 0;}
@font-face
	{font-family:"Microsoft Sans Serif";
	panose-1:2 11 6 4 2 2 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-452972801 -1073717157 41 0 66047 0;}
@font-face
	{font-family:"Microsoft Tai Le";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 0 1073741824 0 1 0;}
@font-face
	{font-family:"Microsoft YaHei";
	panose-1:2 11 5 3 2 2 4 2 2 4;
	mso-font-charset:134;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 718224464 22 0 262175 0;}
@font-face
	{font-family:"\@Microsoft YaHei";
	mso-font-charset:134;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 718224464 22 0 262175 0;}
@font-face
	{font-family:"Microsoft YaHei UI";
	panose-1:2 11 5 3 2 2 4 2 2 4;
	mso-font-charset:134;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 718224464 22 0 262175 0;}
@font-face
	{font-family:"\@Microsoft YaHei UI";
	mso-font-charset:134;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 718224464 22 0 262175 0;}
@font-face
	{font-family:"Microsoft YaHei Light";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:134;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 718209040 22 0 262175 0;}
@font-face
	{font-family:"\@Microsoft YaHei Light";
	mso-font-charset:134;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 718209040 22 0 262175 0;}
@font-face
	{font-family:"Microsoft YaHei UI Light";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:134;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 718209040 22 0 262175 0;}
@font-face
	{font-family:"\@Microsoft YaHei UI Light";
	mso-font-charset:134;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 718209040 22 0 262175 0;}
@font-face
	{font-family:"Microsoft Yi Baiti";
	panose-1:3 0 5 0 0 0 0 0 0 0;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:-2147483645 66562 524290 0 1 0;}
@font-face
	{font-family:MingLiU-ExtB;
	panose-1:2 2 5 0 0 0 0 0 0 0;
	mso-font-charset:136;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 168296456 16 0 1048577 0;}
@font-face
	{font-family:"\@MingLiU-ExtB";
	mso-font-charset:136;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 168296456 16 0 1048577 0;}
@font-face
	{font-family:PMingLiU-ExtB;
	panose-1:2 2 5 0 0 0 0 0 0 0;
	mso-font-charset:136;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 168296456 16 0 1048577 0;}
@font-face
	{font-family:"\@PMingLiU-ExtB";
	mso-font-charset:136;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 168296456 16 0 1048577 0;}
@font-face
	{font-family:MingLiU_HKSCS-ExtB;
	panose-1:2 2 5 0 0 0 0 0 0 0;
	mso-font-charset:136;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 168296456 16 0 1048577 0;}
@font-face
	{font-family:"\@MingLiU_HKSCS-ExtB";
	mso-font-charset:136;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 168296456 16 0 1048577 0;}
@font-face
	{font-family:"Mongolian Baiti";
	panose-1:3 0 5 0 0 0 0 0 0 0;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:-2147483613 0 131072 0 1 0;}
@font-face
	{font-family:"\@MS Gothic";
	panose-1:2 11 6 9 7 2 5 8 2 4;
	mso-font-charset:128;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:-536870145 1791491579 134217746 0 131231 0;}
@font-face
	{font-family:"MS UI Gothic";
	panose-1:2 11 6 0 7 2 5 8 2 4;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1791491579 134217746 0 131231 0;}
@font-face
	{font-family:"\@MS UI Gothic";
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1791491579 134217746 0 131231 0;}
@font-face
	{font-family:"MS PGothic";
	panose-1:2 11 6 0 7 2 5 8 2 4;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1791491579 134217746 0 131231 0;}
@font-face
	{font-family:"\@MS PGothic";
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1791491579 134217746 0 131231 0;}
@font-face
	{font-family:"MV Boli";
	panose-1:2 0 5 0 3 2 0 9 0 0;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:3 0 256 0 1 0;}
@font-face
	{font-family:"Myanmar Text";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483645 0 1024 0 1 0;}
@font-face
	{font-family:"Nirmala UI";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2130739165 33554506 512 0 1 0;}
@font-face
	{font-family:"Nirmala UI Semilight";
	panose-1:2 11 4 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2130739165 33554506 512 0 1 0;}
@font-face
	{font-family:"Segoe MDL2 Assets";
	panose-1:5 10 1 2 1 1 1 1 1 1;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 268435456 0 0 1 0;}
@font-face
	{font-family:"Segoe Print";
	panose-1:2 0 6 0 0 0 0 0 0 0;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:655 0 0 0 159 0;}
@font-face
	{font-family:"Segoe Script";
	panose-1:3 11 5 4 2 0 0 0 0 3;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:655 0 0 0 159 0;}
@font-face
	{font-family:"Segoe UI";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-469750017 -1073683329 9 0 511 0;}
@font-face
	{font-family:"Segoe UI Black";
	panose-1:2 11 10 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1073800319 33 0 415 0;}
@font-face
	{font-family:"Segoe UI Historic";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483153 33554434 6340736 0 1 0;}
@font-face
	{font-family:"Segoe UI Light";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-469750017 -1073683329 9 0 511 0;}
@font-face
	{font-family:"Segoe UI Semibold";
	panose-1:2 11 7 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-469750017 -1073683329 9 0 511 0;}
@font-face
	{font-family:"Segoe UI Semilight";
	panose-1:2 11 4 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-469750017 -1073683329 9 0 511 0;}
@font-face
	{font-family:"Segoe UI Symbol";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483165 302055407 262144 0 1 0;}
@font-face
	{font-family:"\@SimSun";
	panose-1:2 1 6 0 3 1 1 1 1 1;
	mso-font-charset:134;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:3 680460288 22 0 262145 0;}
@font-face
	{font-family:NSimSun;
	panose-1:2 1 6 9 3 1 1 1 1 1;
	mso-font-charset:134;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:643 680460288 22 0 262145 0;}
@font-face
	{font-family:"\@NSimSun";
	mso-font-charset:134;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:643 680460288 22 0 262145 0;}
@font-face
	{font-family:SimSun-ExtB;
	panose-1:2 1 6 9 6 1 1 1 1 1;
	mso-font-charset:134;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:3 168689664 16 0 262145 0;}
@font-face
	{font-family:"\@SimSun-ExtB";
	mso-font-charset:134;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:3 168689664 16 0 262145 0;}
@font-face
	{font-family:"Sitka Small";
	panose-1:2 0 5 5 0 0 0 2 0 4;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610611985 1073750091 0 0 415 0;}
@font-face
	{font-family:"Sitka Text";
	panose-1:2 0 5 5 0 0 0 2 0 4;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610611985 1073750091 0 0 415 0;}
@font-face
	{font-family:"Sitka Subheading";
	panose-1:2 0 5 5 0 0 0 2 0 4;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610611985 1073750091 0 0 415 0;}
@font-face
	{font-family:"Sitka Heading";
	panose-1:2 0 5 5 0 0 0 2 0 4;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610611985 1073750091 0 0 415 0;}
@font-face
	{font-family:"Sitka Display";
	panose-1:2 0 5 5 0 0 0 2 0 4;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610611985 1073750091 0 0 415 0;}
@font-face
	{font-family:"Sitka Banner";
	panose-1:2 0 5 5 0 0 0 2 0 4;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610611985 1073750091 0 0 415 0;}
@font-face
	{font-family:"Trebuchet MS";
	panose-1:2 11 6 3 2 2 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:1671 0 0 0 159 0;}
@font-face
	{font-family:Webdings;
	panose-1:5 3 1 2 1 5 9 6 7 3;
	mso-font-charset:2;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:"\@Yu Gothic";
	panose-1:2 11 4 0 0 0 0 0 0 0;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 717749759 22 0 131231 0;}
@font-face
	{font-family:"Yu Gothic UI";
	panose-1:2 11 5 0 0 0 0 0 0 0;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 717749759 22 0 131231 0;}
@font-face
	{font-family:"\@Yu Gothic UI";
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 717749759 22 0 131231 0;}
@font-face
	{font-family:"Yu Gothic UI Semibold";
	panose-1:2 11 7 0 0 0 0 0 0 0;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 717749759 22 0 131231 0;}
@font-face
	{font-family:"\@Yu Gothic UI Semibold";
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 717749759 22 0 131231 0;}
@font-face
	{font-family:"Yu Gothic Light";
	panose-1:2 11 3 0 0 0 0 0 0 0;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 717749759 22 0 131231 0;}
@font-face
	{font-family:"\@Yu Gothic Light";
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 717749759 22 0 131231 0;}
@font-face
	{font-family:"Yu Gothic UI Light";
	panose-1:2 11 3 0 0 0 0 0 0 0;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 717749759 22 0 131231 0;}
@font-face
	{font-family:"\@Yu Gothic UI Light";
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 717749759 22 0 131231 0;}
@font-face
	{font-family:"Yu Gothic Medium";
	panose-1:2 11 5 0 0 0 0 0 0 0;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 717749759 22 0 131231 0;}
@font-face
	{font-family:"\@Yu Gothic Medium";
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 717749759 22 0 131231 0;}
@font-face
	{font-family:"Yu Gothic UI Semilight";
	panose-1:2 11 4 0 0 0 0 0 0 0;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 717749759 22 0 131231 0;}
@font-face
	{font-family:"\@Yu Gothic UI Semilight";
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 717749759 22 0 131231 0;}
@font-face
	{font-family:"HoloLens MDL2 Assets";
	panose-1:5 10 1 2 1 1 1 1 1 1;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 268435456 0 0 1 0;}
@font-face
	{font-family:"Agency FB";
	panose-1:2 11 5 3 2 2 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Algerian;
	panose-1:4 2 7 5 4 10 2 6 7 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Book Antiqua";
	panose-1:2 4 6 2 5 3 5 3 3 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:647 0 0 0 159 0;}
@font-face
	{font-family:"Arial Narrow";
	panose-1:2 11 6 6 2 2 2 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:647 2048 0 0 159 0;}
@font-face
	{font-family:"Arial Rounded MT Bold";
	panose-1:2 15 7 4 3 5 4 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Baskerville Old Face";
	panose-1:2 2 6 2 8 5 5 2 3 3;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Bauhaus 93";
	panose-1:4 3 9 5 2 11 2 2 12 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Bell MT";
	panose-1:2 2 5 3 6 3 5 2 3 3;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Bernard MT Condensed";
	panose-1:2 5 8 6 6 9 5 2 4 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Bodoni MT";
	panose-1:2 7 6 3 8 6 6 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Bodoni MT Black";
	panose-1:2 7 10 3 8 6 6 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Bodoni MT Condensed";
	panose-1:2 7 6 6 8 6 6 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Bodoni MT Poster Compressed";
	panose-1:2 7 7 6 8 6 1 5 2 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:7 0 0 0 17 0;}
@font-face
	{font-family:"Bookman Old Style";
	panose-1:2 5 6 4 5 5 5 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:647 0 0 0 159 0;}
@font-face
	{font-family:"Bradley Hand ITC";
	panose-1:3 7 4 2 5 3 2 3 2 3;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Britannic Bold";
	panose-1:2 11 9 3 6 7 3 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Berlin Sans FB";
	panose-1:2 14 6 2 2 5 2 2 3 6;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Berlin Sans FB Demi";
	panose-1:2 14 8 2 2 5 2 2 3 6;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Broadway;
	panose-1:4 4 9 5 8 11 2 2 5 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Brush Script MT";
	panose-1:3 6 8 2 4 4 6 7 3 4;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Bookshelf Symbol 7";
	panose-1:5 1 1 1 1 1 1 1 1 1;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:"Californian FB";
	panose-1:2 7 4 3 6 8 11 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Calisto MT";
	panose-1:2 4 6 3 5 5 5 3 3 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Castellar;
	panose-1:2 10 4 2 6 4 6 1 3 1;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Century Schoolbook";
	panose-1:2 4 6 4 5 5 5 2 3 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:647 0 0 0 159 0;}
@font-face
	{font-family:Centaur;
	panose-1:2 3 5 4 5 2 5 2 3 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Chiller;
	panose-1:4 2 4 4 3 16 7 2 6 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Colonna MT";
	panose-1:4 2 8 5 6 2 2 3 2 3;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Cooper Black";
	panose-1:2 8 9 4 4 3 11 2 4 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Copperplate Gothic Bold";
	panose-1:2 14 7 5 2 2 6 2 4 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Copperplate Gothic Light";
	panose-1:2 14 5 7 2 2 6 2 4 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Curlz MT";
	panose-1:4 4 4 4 5 7 2 2 2 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Dubai;
	panose-1:2 11 5 3 3 4 3 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147475353 -2147483648 8 0 65 0;}
@font-face
	{font-family:"Dubai Light";
	panose-1:2 11 3 3 3 4 3 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147475353 -2147483648 8 0 65 0;}
@font-face
	{font-family:"Dubai Medium";
	panose-1:2 11 6 3 3 4 3 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147475353 -2147483648 8 0 65 0;}
@font-face
	{font-family:Elephant;
	panose-1:2 2 9 4 9 5 5 2 3 3;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Engravers MT";
	panose-1:2 9 7 7 8 5 5 2 3 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Eras Bold ITC";
	panose-1:2 11 9 7 3 5 4 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Eras Demi ITC";
	panose-1:2 11 8 5 3 5 4 2 8 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Eras Light ITC";
	panose-1:2 11 4 2 3 5 4 2 8 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Eras Medium ITC";
	panose-1:2 11 6 2 3 5 4 2 8 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Felix Titling";
	panose-1:4 6 5 5 6 2 2 2 10 4;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Forte;
	panose-1:3 6 9 2 4 5 2 7 2 3;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Franklin Gothic Book";
	panose-1:2 11 5 3 2 1 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:647 0 0 0 159 0;}
@font-face
	{font-family:"Franklin Gothic Demi";
	panose-1:2 11 7 3 2 1 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:647 0 0 0 159 0;}
@font-face
	{font-family:"Franklin Gothic Demi Cond";
	panose-1:2 11 7 6 3 4 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:647 0 0 0 159 0;}
@font-face
	{font-family:"Franklin Gothic Heavy";
	panose-1:2 11 9 3 2 1 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:647 0 0 0 159 0;}
@font-face
	{font-family:"Franklin Gothic Medium Cond";
	panose-1:2 11 6 6 3 4 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:647 0 0 0 159 0;}
@font-face
	{font-family:"Freestyle Script";
	panose-1:3 8 4 2 3 2 5 11 4 4;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"French Script MT";
	panose-1:3 2 4 2 4 6 7 4 6 5;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Footlight MT Light";
	panose-1:2 4 6 2 6 3 10 2 3 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Garamond;
	panose-1:2 2 4 4 3 3 1 1 8 3;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:647 0 0 0 159 0;}
@font-face
	{font-family:Gigi;
	panose-1:4 4 5 4 6 16 7 2 13 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Gill Sans MT";
	panose-1:2 11 5 2 2 1 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:7 0 0 0 3 0;}
@font-face
	{font-family:"Gill Sans MT Condensed";
	panose-1:2 11 5 6 2 1 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:7 0 0 0 3 0;}
@font-face
	{font-family:"Gill Sans Ultra Bold Condensed";
	panose-1:2 11 10 6 2 1 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:7 0 0 0 3 0;}
@font-face
	{font-family:"Gill Sans Ultra Bold";
	panose-1:2 11 10 2 2 1 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:7 0 0 0 3 0;}
@font-face
	{font-family:"Gloucester MT Extra Condensed";
	panose-1:2 3 8 8 2 6 1 1 1 1;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Gill Sans MT Ext Condensed Bold";
	panose-1:2 11 9 2 2 1 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:7 0 0 0 3 0;}
@font-face
	{font-family:"Century Gothic";
	panose-1:2 11 5 2 2 2 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:647 0 0 0 159 0;}
@font-face
	{font-family:"Goudy Old Style";
	panose-1:2 2 5 2 5 3 5 2 3 3;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Goudy Stout";
	panose-1:2 2 9 4 7 3 11 2 4 1;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Harlow Solid Italic";
	panose-1:4 3 6 4 2 15 2 2 13 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Harrington;
	panose-1:4 4 5 5 5 10 2 2 7 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Haettenschweiler;
	panose-1:2 11 7 6 4 9 2 6 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:647 0 0 0 159 0;}
@font-face
	{font-family:"High Tower Text";
	panose-1:2 4 5 2 5 5 6 3 3 3;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Imprint MT Shadow";
	panose-1:4 2 6 5 6 3 3 3 2 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Informal Roman";
	panose-1:3 6 4 2 3 4 6 11 2 4;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Blackadder ITC";
	panose-1:4 2 5 5 5 16 7 2 13 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Edwardian Script ITC";
	panose-1:3 3 3 2 4 7 7 13 8 4;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Kristen ITC";
	panose-1:3 5 5 2 4 2 2 3 2 2;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Jokerman;
	panose-1:4 9 6 5 6 13 6 2 7 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Juice ITC";
	panose-1:4 4 4 3 4 10 2 2 2 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Kunstler Script";
	panose-1:3 3 4 2 2 6 7 13 13 6;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Wide Latin";
	panose-1:2 10 10 7 5 5 5 2 4 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Lucida Bright";
	panose-1:2 4 6 2 5 5 5 2 3 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Lucida Calligraphy";
	panose-1:3 1 1 1 1 1 1 1 1 1;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Lucida Fax";
	panose-1:2 6 6 2 5 5 5 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Lucida Handwriting";
	panose-1:3 1 1 1 1 1 1 1 1 1;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Lucida Sans";
	panose-1:2 11 6 2 3 5 4 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Lucida Sans Typewriter";
	panose-1:2 11 5 9 3 5 4 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Magneto;
	panose-1:4 3 8 5 5 8 2 2 13 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Maiandra GD";
	panose-1:2 14 5 2 3 3 8 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Matura MT Script Capitals";
	panose-1:3 2 8 2 6 6 2 7 2 2;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Mistral;
	panose-1:3 9 7 2 3 4 7 2 4 3;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:647 0 0 0 159 0;}
@font-face
	{font-family:"Modern No\. 20";
	panose-1:2 7 7 4 7 5 5 2 3 3;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Monotype Corsiva";
	panose-1:3 1 1 1 1 2 1 1 1 1;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:647 0 0 0 159 0;}
@font-face
	{font-family:"MT Extra";
	panose-1:5 5 1 2 1 2 5 2 2 2;
	mso-font-charset:2;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:"Niagara Engraved";
	panose-1:4 2 5 2 7 7 3 3 2 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Niagara Solid";
	panose-1:4 2 5 2 7 7 2 2 2 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"OCR A Extended";
	panose-1:2 1 5 9 2 1 2 1 3 3;
	mso-font-charset:0;
	mso-generic-font-family:modern;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Old English Text MT";
	panose-1:3 4 9 2 4 5 8 3 8 6;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Onyx;
	panose-1:4 5 6 2 8 7 2 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"MS Outlook";
	panose-1:5 1 1 0 1 0 0 0 0 0;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:"Palace Script MT";
	panose-1:3 3 3 2 2 6 7 12 11 5;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Papyrus;
	panose-1:3 7 5 2 6 5 2 3 2 5;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Parchment;
	panose-1:3 4 6 2 4 7 8 4 8 4;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Perpetua;
	panose-1:2 2 5 2 6 4 1 2 3 3;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Perpetua Titling MT";
	panose-1:2 2 5 2 6 5 5 2 8 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Playbill;
	panose-1:4 5 6 3 10 6 2 2 2 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Poor Richard";
	panose-1:2 8 5 2 5 5 5 2 7 2;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Pristina;
	panose-1:3 6 4 2 4 4 6 8 2 4;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Rage Italic";
	panose-1:3 7 5 2 4 5 7 7 3 4;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Ravie;
	panose-1:4 4 8 5 5 8 9 2 6 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"MS Reference Sans Serif";
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:536871559 0 0 0 415 0;}
@font-face
	{font-family:"MS Reference Specialty";
	panose-1:5 0 5 0 0 0 0 0 0 0;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:"Rockwell Condensed";
	panose-1:2 6 6 3 5 4 5 2 1 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Rockwell;
	panose-1:2 6 6 3 2 2 5 2 4 3;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Rockwell Extra Bold";
	panose-1:2 6 9 3 4 5 5 2 4 3;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Script MT Bold";
	panose-1:3 4 6 2 4 6 7 8 9 4;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Showcard Gothic";
	panose-1:4 2 9 4 2 1 2 2 6 4;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Snap ITC";
	panose-1:4 4 10 7 6 10 2 2 2 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Stencil;
	panose-1:4 4 9 5 13 8 2 2 4 4;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Tw Cen MT";
	panose-1:2 11 6 2 2 1 4 2 6 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:7 0 0 0 3 0;}
@font-face
	{font-family:"Tw Cen MT Condensed";
	panose-1:2 11 6 6 2 1 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:7 0 0 0 3 0;}
@font-face
	{font-family:"Tw Cen MT Condensed Extra Bold";
	panose-1:2 11 8 3 2 2 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:7 0 0 0 3 0;}
@font-face
	{font-family:"Tempus Sans ITC";
	panose-1:4 2 4 4 3 13 7 2 2 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Viner Hand ITC";
	panose-1:3 7 5 2 3 5 2 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Vivaldi;
	panose-1:3 2 6 2 5 5 6 9 8 4;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Vladimir Script";
	panose-1:3 5 4 2 4 4 7 7 3 5;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Wingdings 2";
	panose-1:5 2 1 2 1 5 7 7 7 7;
	mso-font-charset:2;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:"Wingdings 3";
	panose-1:5 4 1 2 1 8 7 7 7 7;
	mso-font-charset:2;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:Abadi;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483645 0 0 0 1 0;}
@font-face
	{font-family:"Abadi Extra Light";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483645 0 0 0 1 0;}
@font-face
	{font-family:Aharoni;
	mso-font-charset:177;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:2051 0 0 0 33 0;}
@font-face
	{font-family:Aldhabi;
	mso-font-charset:178;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-2147475449 -2147483648 8 0 65 0;}
@font-face
	{font-family:Alef;
	mso-font-charset:177;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:2055 1073741824 0 0 179 0;}
@font-face
	{font-family:"Amasis MT Pro";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-1610612561 1073750107 0 0 147 0;}
@font-face
	{font-family:"Amasis MT Pro Black";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-1610612561 1073750107 0 0 147 0;}
@font-face
	{font-family:"Amasis MT Pro Light";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-1610612561 1073750107 0 0 147 0;}
@font-face
	{font-family:"Amasis MT Pro Medium";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-1610612561 1073750107 0 0 147 0;}
@font-face
	{font-family:"Amatic SC";
	mso-font-charset:177;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:536873487 1073741826 0 0 439 0;}
@font-face
	{font-family:AngsanaUPC;
	mso-font-charset:222;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2130706429 0 0 0 65537 0;}
@font-face
	{font-family:Aparajita;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:32771 0 0 0 1 0;}
@font-face
	{font-family:"Arabic Typesetting";
	mso-font-charset:178;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:-2147475449 -2147483648 8 0 211 0;}
@font-face
	{font-family:"Aref Ruqaa";
	mso-font-charset:178;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-2147475345 -2147483573 0 0 65 0;}
@font-face
	{font-family:"Arial Nova";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:655 2 0 0 415 0;}
@font-face
	{font-family:"Arial Nova Cond";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:655 2 0 0 415 0;}
@font-face
	{font-family:"Arial Nova Cond Light";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:655 2 0 0 415 0;}
@font-face
	{font-family:"Arial Nova Light";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:655 2 0 0 415 0;}
@font-face
	{font-family:Assistant;
	mso-font-charset:177;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610610433 1073750091 0 0 33 0;}
@font-face
	{font-family:"Assistant ExtraBold";
	mso-font-charset:177;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610610433 1073750091 0 0 33 0;}
@font-face
	{font-family:"Assistant ExtraLight";
	mso-font-charset:177;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610610433 1073750091 0 0 33 0;}
@font-face
	{font-family:"Assistant Light";
	mso-font-charset:177;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610610433 1073750091 0 0 33 0;}
@font-face
	{font-family:"Assistant SemiBold";
	mso-font-charset:177;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610610433 1073750091 0 0 33 0;}
@font-face
	{font-family:Athiti;
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Athiti ExtraLight";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Athiti Light";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Athiti Medium";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Athiti SemiBold";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Avenir Next LT Pro";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483409 1342185546 0 0 147 0;}
@font-face
	{font-family:"Avenir Next LT Pro Demi";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483409 1342185546 0 0 147 0;}
@font-face
	{font-family:"Avenir Next LT Pro Light";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610612497 1342185547 0 0 147 0;}
@font-face
	{font-family:BatangChe;
	mso-font-charset:129;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:-1342176593 1775729915 48 0 524447 0;}
@font-face
	{font-family:Bembo;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483645 0 0 0 1 0;}
@font-face
	{font-family:Bierstadt;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483645 1 0 0 1 0;}
@font-face
	{font-family:"Bierstadt Display";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483645 1 0 0 1 0;}
@font-face
	{font-family:Biome;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1592449281 -2147483638 65536 0 415 0;}
@font-face
	{font-family:"Biome Light";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1592449281 -2147483638 65536 0 415 0;}
@font-face
	{font-family:"Browallia New";
	mso-font-charset:222;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2130706429 0 0 0 65537 0;}
@font-face
	{font-family:BrowalliaUPC;
	mso-font-charset:222;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2130706429 0 0 0 65537 0;}
@font-face
	{font-family:Cavolini;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:-1592449281 -2147483638 65536 0 415 0;}
@font-face
	{font-family:Charmonman;
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:Chonburi;
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:CordiaUPC;
	mso-font-charset:222;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2130706429 0 0 0 65537 0;}
@font-face
	{font-family:Dante;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483645 0 0 0 1 0;}
@font-face
	{font-family:DaunPenh;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-2147483645 0 65536 0 1 0;}
@font-face
	{font-family:David;
	mso-font-charset:177;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:2051 0 0 0 33 0;}
@font-face
	{font-family:Daytona;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147482897 10 0 0 415 0;}
@font-face
	{font-family:"Daytona Condensed";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"Daytona Condensed Light";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"Daytona Light";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"DengXian Light";
	mso-font-charset:134;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610612033 953122042 22 0 262159 0;}
@font-face
	{font-family:DilleniaUPC;
	mso-font-charset:222;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2130706429 0 0 0 65537 0;}
@font-face
	{font-family:DokChampa;
	mso-font-charset:222;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2097151997 0 0 0 65537 0;}
@font-face
	{font-family:DotumChe;
	mso-font-charset:129;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:-1342176593 1775729915 48 0 524447 0;}
@font-face
	{font-family:"EB Garamond";
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 33555475 0 0 415 0;}
@font-face
	{font-family:"EB Garamond ExtraBold";
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 33555475 0 0 415 0;}
@font-face
	{font-family:"EB Garamond Medium";
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 33555475 0 0 415 0;}
@font-face
	{font-family:"EB Garamond SemiBold";
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 33555475 0 0 415 0;}
@font-face
	{font-family:"Elephant Pro";
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:536871559 2 0 0 415 0;}
@font-face
	{font-family:EucrosiaUPC;
	mso-font-charset:222;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2130706429 0 0 0 65537 0;}
@font-face
	{font-family:Euphemia;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483537 74 8192 0 1 0;}
@font-face
	{font-family:Fahkwang;
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Fahkwang ExtraLight";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Fahkwang Light";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Fahkwang Medium";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Fahkwang SemiBold";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:FangSong;
	mso-font-charset:134;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:-2147482945 953122042 22 0 262145 0;}
@font-face
	{font-family:"Frank Ruhl Libre";
	mso-font-charset:177;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:2055 1073741825 0 0 163 0;}
@font-face
	{font-family:"Frank Ruhl Libre Black";
	mso-font-charset:177;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:2055 1073741825 0 0 163 0;}
@font-face
	{font-family:"Frank Ruhl Libre Light";
	mso-font-charset:177;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:2055 1073741825 0 0 163 0;}
@font-face
	{font-family:"Frank Ruhl Libre Medium";
	mso-font-charset:177;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:2055 1073741825 0 0 163 0;}
@font-face
	{font-family:FrankRuehl;
	mso-font-charset:177;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:2051 0 0 0 33 0;}
@font-face
	{font-family:FreesiaUPC;
	mso-font-charset:222;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2130706429 0 0 0 65537 0;}
@font-face
	{font-family:"Georgia Pro";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 67 0 0 159 0;}
@font-face
	{font-family:"Georgia Pro Black";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 67 0 0 159 0;}
@font-face
	{font-family:"Georgia Pro Cond";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 67 0 0 159 0;}
@font-face
	{font-family:"Georgia Pro Cond Black";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 67 0 0 159 0;}
@font-face
	{font-family:"Georgia Pro Cond Light";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 67 0 0 159 0;}
@font-face
	{font-family:"Georgia Pro Cond Semibold";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 67 0 0 159 0;}
@font-face
	{font-family:"Georgia Pro Light";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 67 0 0 159 0;}
@font-face
	{font-family:"Georgia Pro Semibold";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 67 0 0 159 0;}
@font-face
	{font-family:"Gill Sans Nova";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 2 0 0 159 0;}
@font-face
	{font-family:"Gill Sans Nova Cond";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 2 0 0 159 0;}
@font-face
	{font-family:"Gill Sans Nova Cond Lt";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 2 0 0 159 0;}
@font-face
	{font-family:"Gill Sans Nova Cond Ultra Bold";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 2 0 0 159 0;}
@font-face
	{font-family:"Gill Sans Nova Cond XBd";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 2 0 0 159 0;}
@font-face
	{font-family:"Gill Sans Nova Light";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 2 0 0 159 0;}
@font-face
	{font-family:"Gill Sans Nova Ultra Bold";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 2 0 0 159 0;}
@font-face
	{font-family:Gisha;
	mso-font-charset:177;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147481593 1073741890 0 0 33 0;}
@font-face
	{font-family:"Goudy Type";
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:7 1 0 0 147 0;}
@font-face
	{font-family:Grandview;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610612025 2 0 0 415 0;}
@font-face
	{font-family:"Grandview Display";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610612025 2 0 0 415 0;}
@font-face
	{font-family:Grotesque;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483645 0 0 0 1 0;}
@font-face
	{font-family:"Grotesque Light";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483645 0 0 0 1 0;}
@font-face
	{font-family:GulimChe;
	mso-font-charset:129;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:-1342176593 1775729915 48 0 524447 0;}
@font-face
	{font-family:Gungsuh;
	mso-font-charset:129;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-1342176593 1775729915 48 0 524447 0;}
@font-face
	{font-family:GungsuhChe;
	mso-font-charset:129;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:-1342176593 1775729915 48 0 524447 0;}
@font-face
	{font-family:"Hadassah Friedlaender";
	mso-font-charset:177;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:2051 0 0 0 33 0;}
@font-face
	{font-family:Heebo;
	mso-font-charset:177;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610610457 1073741891 0 0 33 0;}
@font-face
	{font-family:"Heebo Black";
	mso-font-charset:177;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610610457 1073741891 0 0 33 0;}
@font-face
	{font-family:"Heebo ExtraBold";
	mso-font-charset:177;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610610457 1073741891 0 0 33 0;}
@font-face
	{font-family:"Heebo Light";
	mso-font-charset:177;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610610457 1073741891 0 0 33 0;}
@font-face
	{font-family:"Heebo Medium";
	mso-font-charset:177;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610610457 1073741891 0 0 33 0;}
@font-face
	{font-family:"Heebo Thin";
	mso-font-charset:177;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610610457 1073741891 0 0 33 0;}
@font-face
	{font-family:HGGothicE;
	mso-font-charset:128;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:-536870145 717745662 18 0 131073 0;}
@font-face
	{font-family:HGMaruGothicMPRO;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 717745662 18 0 131073 0;}
@font-face
	{font-family:HGMinchoE;
	mso-font-charset:128;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:-536870145 717745662 18 0 131073 0;}
@font-face
	{font-family:HGPGothicE;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 717745662 18 0 131073 0;}
@font-face
	{font-family:HGPMinchoE;
	mso-font-charset:128;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 717745662 18 0 131073 0;}
@font-face
	{font-family:HGPSoeiKakugothicUB;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 717745662 18 0 131073 0;}
@font-face
	{font-family:HGSGothicE;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 717745662 18 0 131073 0;}
@font-face
	{font-family:HGSMinchoE;
	mso-font-charset:128;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 717745662 18 0 131073 0;}
@font-face
	{font-family:HGSoeiKakugothicUB;
	mso-font-charset:128;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:-536870145 717745662 18 0 131073 0;}
@font-face
	{font-family:HGSSoeiKakugothicUB;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 717745662 18 0 131073 0;}
@font-face
	{font-family:IrisUPC;
	mso-font-charset:222;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2130706429 0 0 0 65537 0;}
@font-face
	{font-family:"Iskoola Pota";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 0 512 0 1 0;}
@font-face
	{font-family:JasmineUPC;
	mso-font-charset:222;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2130706429 0 0 0 65537 0;}
@font-face
	{font-family:KaiTi;
	mso-font-charset:134;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:-2147482945 953122042 22 0 262145 0;}
@font-face
	{font-family:Kalinga;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:524291 0 0 0 1 0;}
@font-face
	{font-family:Kartika;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:8388611 0 0 0 1 0;}
@font-face
	{font-family:"Khmer UI";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483645 0 65536 0 1 0;}
@font-face
	{font-family:Kigelia;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1609226497 -1040187317 67584 0 415 0;}
@font-face
	{font-family:"Kigelia Arabic";
	mso-font-charset:178;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610603905 -2147483645 8 0 471 0;}
@font-face
	{font-family:"Kigelia Arabic Light";
	mso-font-charset:178;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610603905 -2147483645 8 0 471 0;}
@font-face
	{font-family:"Kigelia Light";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1609226497 -1040187317 67584 0 415 0;}
@font-face
	{font-family:KodchiangUPC;
	mso-font-charset:222;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2130706429 0 0 0 65537 0;}
@font-face
	{font-family:Kokila;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:32771 0 0 0 1 0;}
@font-face
	{font-family:Krub;
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Krub ExtraLight";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Krub Light";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Krub Medium";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Krub SemiBold";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:Lalezar;
	mso-font-charset:178;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:536879111 0 8 0 467 0;}
@font-face
	{font-family:"Lao UI";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2113929213 0 0 0 1 0;}
@font-face
	{font-family:Leelawadee;
	mso-font-charset:222;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2130706429 0 0 0 65537 0;}
@font-face
	{font-family:"Levenim MT";
	mso-font-charset:177;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:2051 0 0 0 33 0;}
@font-face
	{font-family:LilyUPC;
	mso-font-charset:222;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2130706429 0 0 0 65537 0;}
@font-face
	{font-family:"Mangal Pro";
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-2147483645 1 0 0 1 0;}
@font-face
	{font-family:Meiryo;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1791492095 134217746 0 131231 0;}
@font-face
	{font-family:"Meiryo UI";
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1791492095 134217746 0 131231 0;}
@font-face
	{font-family:"Microsoft GothicNeo";
	mso-font-charset:129;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147482945 701998203 16 0 2687135 0;}
@font-face
	{font-family:"Microsoft GothicNeo Light";
	mso-font-charset:129;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147482945 701998203 16 0 2687135 0;}
@font-face
	{font-family:"Microsoft Uighur";
	mso-font-charset:178;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-2147475453 -2147483648 8 0 65 0;}
@font-face
	{font-family:MingLiU_HKSCS;
	mso-font-charset:136;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-1610611969 684719354 22 0 1048577 0;}
@font-face
	{font-family:Miriam;
	mso-font-charset:177;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:2051 0 0 0 33 0;}
@font-face
	{font-family:"Miriam Fixed";
	mso-font-charset:177;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:2051 0 0 0 33 0;}
@font-face
	{font-family:"Miriam Libre";
	mso-font-charset:177;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:2055 1073741824 0 0 179 0;}
@font-face
	{font-family:Mitr;
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Mitr ExtraLight";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Mitr Light";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Mitr Medium";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Mitr SemiBold";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Modern Love";
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"Modern Love Caps";
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"Modern Love Grunge";
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:MoolBoran;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483645 0 65536 0 1 0;}
@font-face
	{font-family:"MS PMincho";
	mso-font-charset:128;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1791491579 134217746 0 131231 0;}
@font-face
	{font-family:Narkisim;
	mso-font-charset:177;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:2051 0 0 0 33 0;}
@font-face
	{font-family:"Neue Haas Grotesk Text Pro";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:7 0 0 0 147 0;}
@font-face
	{font-family:"News Gothic MT";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Nyala;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610612625 0 2048 0 147 0;}
@font-face
	{font-family:OCRB;
	mso-font-charset:0;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Open Sans";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870161 1073750107 40 0 415 0;}
@font-face
	{font-family:"Open Sans ExtraBold";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870161 1073750107 40 0 415 0;}
@font-face
	{font-family:"Open Sans Light";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870161 1073750107 40 0 415 0;}
@font-face
	{font-family:"Open Sans SemiBold";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870161 1073750107 40 0 415 0;}
@font-face
	{font-family:"Plantagenet Cherokee";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 4096 0 1 0;}
@font-face
	{font-family:Posterama;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1592449281 -805298101 65536 0 415 0;}
@font-face
	{font-family:Pridi;
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Pridi ExtraLight";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Pridi Light";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Pridi Medium";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Pridi SemiBold";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:Prompt;
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Prompt Black";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Prompt ExtraBold";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Prompt ExtraLight";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Prompt Light";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Prompt Medium";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Prompt SemiBold";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Prompt Thin";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Quire Sans";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1592449281 -2147483638 65536 0 415 0;}
@font-face
	{font-family:"Quire Sans Light";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"Quire Sans Pro Light";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"Reem Kufi";
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Roboto;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1342185563 32 0 415 0;}
@font-face
	{font-family:"Roboto Black";
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1342185563 32 0 415 0;}
@font-face
	{font-family:"Roboto Condensed";
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1342185563 32 0 415 0;}
@font-face
	{font-family:"Roboto Condensed Light";
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1342185563 32 0 415 0;}
@font-face
	{font-family:"Roboto Condensed Medium";
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1342185563 32 0 415 0;}
@font-face
	{font-family:"Roboto Light";
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1342185563 32 0 415 0;}
@font-face
	{font-family:"Roboto Medium";
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1342185563 32 0 415 0;}
@font-face
	{font-family:"Roboto Thin";
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1342185563 32 0 415 0;}
@font-face
	{font-family:"Rockwell Light";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 0 0 0 15 0;}
@font-face
	{font-family:"Rockwell Nova";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 2 0 0 159 0;}
@font-face
	{font-family:"Rockwell Nova Cond";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 2 0 0 159 0;}
@font-face
	{font-family:"Rockwell Nova Cond Light";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 2 0 0 159 0;}
@font-face
	{font-family:"Rockwell Nova Extra Bold";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 2 0 0 159 0;}
@font-face
	{font-family:"Rockwell Nova Light";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 2 0 0 159 0;}
@font-face
	{font-family:Rod;
	mso-font-charset:177;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:2051 0 0 0 33 0;}
@font-face
	{font-family:"Sabon Next LT";
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1592449281 -805306357 65536 0 415 0;}
@font-face
	{font-family:"Sagona Book";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"Sagona ExtraLight";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"Sakkal Majalla";
	mso-font-charset:178;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-2147475449 -2147483648 8 0 211 0;}
@font-face
	{font-family:"Sanskrit Text";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-1610579897 0 0 0 1 0;}
@font-face
	{font-family:Seaford;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483645 1 0 0 1 0;}
@font-face
	{font-family:"Seaford Display";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483645 1 0 0 1 0;}
@font-face
	{font-family:"Secular One";
	mso-font-charset:177;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:2055 1073741824 0 0 179 0;}
@font-face
	{font-family:Selawik;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:7 0 0 0 147 0;}
@font-face
	{font-family:"Selawik Light";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:7 0 0 0 147 0;}
@font-face
	{font-family:"Selawik Semibold";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:7 0 0 0 147 0;}
@font-face
	{font-family:"Shonar Bangla";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:65539 0 0 0 1 0;}
@font-face
	{font-family:"Simplified Arabic";
	mso-font-charset:178;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:8195 -2147483648 8 0 65 0;}
@font-face
	{font-family:"Simplified Arabic Fixed";
	mso-font-charset:178;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:8195 0 8 0 65 0;}
@font-face
	{font-family:"Sitka Banner Semibold";
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610611985 1073750091 0 0 415 0;}
@font-face
	{font-family:"Sitka Display Semibold";
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610611985 1073750091 0 0 415 0;}
@font-face
	{font-family:"Sitka Heading Semibold";
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610611985 1073750091 0 0 415 0;}
@font-face
	{font-family:"Sitka Small Semibold";
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610611985 1073750091 0 0 415 0;}
@font-face
	{font-family:"Sitka Subheading Semibold";
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610611985 1073750091 0 0 415 0;}
@font-face
	{font-family:"Sitka Text Semibold";
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610611985 1073750091 0 0 415 0;}
@font-face
	{font-family:Skeena;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-2147483645 1 0 0 1 0;}
@font-face
	{font-family:"Skeena Display";
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-2147483645 1 0 0 1 0;}
@font-face
	{font-family:"Source Code Pro";
	mso-font-charset:0;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:536871671 33568771 0 0 415 0;}
@font-face
	{font-family:"Source Code Pro Black";
	mso-font-charset:0;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:536871671 33568771 0 0 415 0;}
@font-face
	{font-family:"Source Code Pro ExtraLight";
	mso-font-charset:0;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:536871671 33568771 0 0 415 0;}
@font-face
	{font-family:"Source Code Pro Light";
	mso-font-charset:0;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:536871671 33568771 0 0 415 0;}
@font-face
	{font-family:"Source Code Pro Medium";
	mso-font-charset:0;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:536871671 33568771 0 0 415 0;}
@font-face
	{font-family:"Source Code Pro Semibold";
	mso-font-charset:0;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:536871671 33568771 0 0 415 0;}
@font-face
	{font-family:"Source Sans Pro";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:1610613495 33554433 0 0 415 0;}
@font-face
	{font-family:"Source Sans Pro Black";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:1610613495 33554433 0 0 415 0;}
@font-face
	{font-family:"Source Sans Pro ExtraLight";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:1610613495 33554433 0 0 415 0;}
@font-face
	{font-family:"Source Sans Pro Light";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:1610613495 33554433 0 0 415 0;}
@font-face
	{font-family:"Source Sans Pro SemiBold";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:1610613495 33554433 0 0 415 0;}
@font-face
	{font-family:"Source Serif Pro";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:536871559 33554435 0 0 415 0;}
@font-face
	{font-family:"Source Serif Pro Black";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:536871559 33554435 0 0 415 0;}
@font-face
	{font-family:"Source Serif Pro ExtraLight";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:536871559 33554435 0 0 415 0;}
@font-face
	{font-family:"Source Serif Pro Light";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:536871559 33554435 0 0 415 0;}
@font-face
	{font-family:"Source Serif Pro SemiBold";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:536871559 33554435 0 0 415 0;}
@font-face
	{font-family:"Speak Pro";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"Speak Pro Light";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:STCaiyun;
	mso-font-charset:134;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:1 953090296 22 0 262145 0;}
@font-face
	{font-family:STFangsong;
	mso-font-charset:134;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:647 135200768 16 0 262303 0;}
@font-face
	{font-family:STHupo;
	mso-font-charset:134;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:1 135200768 16 0 262144 0;}
@font-face
	{font-family:STKaiti;
	mso-font-charset:134;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:647 135200768 16 0 262303 0;}
@font-face
	{font-family:STXihei;
	mso-font-charset:134;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:647 135200768 16 0 262303 0;}
@font-face
	{font-family:STXingkai;
	mso-font-charset:134;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:1 135200768 16 0 262144 0;}
@font-face
	{font-family:STXinwei;
	mso-font-charset:134;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:1 135200768 16 0 262144 0;}
@font-face
	{font-family:STZhongsong;
	mso-font-charset:134;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:647 135200768 16 0 262303 0;}
@font-face
	{font-family:"Suez One";
	mso-font-charset:177;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:2055 1073741824 0 0 179 0;}
@font-face
	{font-family:Tenorite;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-2147483645 1 0 0 1 0;}
@font-face
	{font-family:"Tenorite Display";
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-2147483645 1 0 0 1 0;}
@font-face
	{font-family:"TH SarabunPSK";
	mso-font-charset:222;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:16777219 0 0 0 65809 0;}
@font-face
	{font-family:"The Hand";
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"The Hand Black";
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"The Hand Extrablack";
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"The Hand Light";
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"The Serif Hand";
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"The Serif Hand Black";
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"The Serif Hand Extrablack";
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"The Serif Hand Light";
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"Tisa Offc Serif Pro";
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-2147482905 2 0 0 415 0;}
@font-face
	{font-family:"Tisa Offc Serif Pro Thin";
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-2147482905 2 0 0 415 0;}
@font-face
	{font-family:"Trade Gothic Next";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"Trade Gothic Next Cond";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"Trade Gothic Next Cond Hv";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"Trade Gothic Next Heavy";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"Trade Gothic Next Light";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"Traditional Arabic";
	mso-font-charset:178;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:8195 -2147483648 8 0 65 0;}
@font-face
	{font-family:Trirong;
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Trirong Black";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Trirong ExtraBold";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Trirong ExtraLight";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Trirong Light";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Trirong Medium";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Trirong SemiBold";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Trirong Thin";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"UD Digi Kyokasho N-B";
	mso-font-charset:128;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147482973 717745402 16 0 131072 0;}
@font-face
	{font-family:"UD Digi Kyokasho N-R";
	mso-font-charset:128;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147482973 717745402 16 0 131072 0;}
@font-face
	{font-family:"UD Digi Kyokasho NK-B";
	mso-font-charset:128;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147482973 717745402 16 0 131072 0;}
@font-face
	{font-family:"UD Digi Kyokasho NK-R";
	mso-font-charset:128;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147482973 717745402 16 0 131072 0;}
@font-face
	{font-family:"UD Digi Kyokasho NP-B";
	mso-font-charset:128;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147482973 717745402 16 0 131072 0;}
@font-face
	{font-family:"UD Digi Kyokasho NP-R";
	mso-font-charset:128;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147482973 717745402 16 0 131072 0;}
@font-face
	{font-family:Univers;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 0 0 0 15 0;}
@font-face
	{font-family:"Univers Condensed";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 0 0 0 15 0;}
@font-face
	{font-family:"Univers Condensed Light";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 0 0 0 15 0;}
@font-face
	{font-family:"Univers Light";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 0 0 0 15 0;}
@font-face
	{font-family:"Urdu Typesetting";
	mso-font-charset:178;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:8195 -2147483648 8 0 65 0;}
@font-face
	{font-family:Utsaah;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:32771 0 0 0 1 0;}
@font-face
	{font-family:Vani;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:2097155 0 0 0 1 0;}
@font-face
	{font-family:"Verdana Pro";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 67 0 0 159 0;}
@font-face
	{font-family:"Verdana Pro Black";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 67 0 0 159 0;}
@font-face
	{font-family:"Verdana Pro Cond";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 67 0 0 159 0;}
@font-face
	{font-family:"Verdana Pro Cond Black";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 67 0 0 159 0;}
@font-face
	{font-family:"Verdana Pro Cond Light";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 67 0 0 159 0;}
@font-face
	{font-family:"Verdana Pro Cond SemiBold";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 67 0 0 159 0;}
@font-face
	{font-family:"Verdana Pro Light";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 67 0 0 159 0;}
@font-face
	{font-family:"Verdana Pro SemiBold";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 67 0 0 159 0;}
@font-face
	{font-family:Vijaya;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:1048579 0 0 0 1 0;}
@font-face
	{font-family:"Walbaum Display";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"Walbaum Display Heavy";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"Walbaum Display Light";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"Walbaum Display SemiBold";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"Walbaum Heading";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"Walbaum Text";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"Yu Mincho";
	mso-font-charset:128;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147482905 717749503 18 0 131231 0;}
@font-face
	{font-family:"Yu Mincho Demibold";
	mso-font-charset:128;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147482905 717749503 18 0 131231 0;}
@font-face
	{font-family:"Yu Mincho Light";
	mso-font-charset:128;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147482905 717749503 18 0 131231 0;}
@font-face
	{font-family:"\@MS Mincho";
	panose-1:2 2 6 9 4 2 5 8 3 4;
	mso-font-charset:128;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:-536870145 1791491579 134217746 0 131231 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	margin:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
h1
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-next:Normal;
	margin:0in;
	text-align:center;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:none;
	mso-outline-level:1;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-font-kerning:0pt;
	mso-ansi-language:EN-GB;
	mso-bidi-font-weight:normal;}
h2
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:3.0pt;
	margin-left:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	tab-stops:28.35pt;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Helvetica",sans-serif;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;
	mso-bidi-font-weight:normal;
	font-style:italic;
	mso-bidi-font-style:normal;}
h3
	{mso-style-name:"Heading 3\,D70AR3\,titel 3\,OLD Heading 3";
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-next:Normal;
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:4.0pt;
	margin-left:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:3;
	tab-stops:28.35pt;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-font-kerning:14.0pt;
	mso-bidi-font-weight:normal;}
h4
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Heading 4 Char";
	mso-style-next:Normal;
	margin:0in;
	text-align:justify;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:4;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-ansi-language:EN-GB;
	mso-bidi-font-weight:normal;
	mso-no-proof:yes;}
h5
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-next:Normal;
	margin:0in;
	text-align:justify;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:5;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-ansi-language:EN-GB;
	font-weight:normal;
	mso-no-proof:yes;}
h6
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-next:Normal;
	margin:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:6;
	mso-hyphenate:none;
	tab-stops:-.5in 28.35pt 3.15in;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-ansi-language:EN-GB;
	font-weight:normal;
	font-style:italic;
	mso-bidi-font-style:normal;}
p.MsoHeading7, li.MsoHeading7, div.MsoHeading7
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-next:Normal;
	margin:0in;
	text-align:justify;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:7;
	mso-hyphenate:none;
	tab-stops:-.5in 28.35pt 3.15in;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;
	font-style:italic;
	mso-bidi-font-style:normal;}
p.MsoHeading8, li.MsoHeading8, div.MsoHeading8
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:28.35pt;
	text-align:justify;
	text-indent:-28.35pt;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:8;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;
	font-weight:bold;
	mso-bidi-font-weight:normal;
	font-style:italic;
	mso-bidi-font-style:normal;}
p.MsoHeading9, li.MsoHeading9, div.MsoHeading9
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-next:Normal;
	margin:0in;
	text-align:justify;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:9;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;
	font-weight:bold;
	mso-bidi-font-weight:normal;
	font-style:italic;
	mso-bidi-font-style:normal;}
p.MsoFootnoteText, li.MsoFootnoteText, div.MsoFootnoteText
	{mso-style-noshow:yes;
	mso-style-unhide:no;
	margin:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoCommentText, li.MsoCommentText, div.MsoCommentText
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-link:"Comment Text Char";
	margin:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{mso-style-unhide:no;
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt center 207.65pt right 415.3pt;
	font-size:10.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{mso-style-unhide:no;
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt center 3.15in 446.5pt;
	font-size:8.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoCaption, li.MsoCaption, div.MsoCaption
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-next:Normal;
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:56.7pt;
	text-indent:-56.7pt;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
span.MsoFootnoteReference
	{mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-parent:"";
	vertical-align:super;}
span.MsoCommentReference
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-parent:"";
	mso-ansi-font-size:8.0pt;}
span.MsoEndnoteReference
	{mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-parent:"";
	vertical-align:super;}
p.MsoEndnoteText, li.MsoEndnoteText, div.MsoEndnoteText
	{mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-link:"Endnote Text Char";
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{mso-style-unhide:no;
	margin:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;
	font-weight:bold;
	mso-bidi-font-weight:normal;
	font-style:italic;
	mso-bidi-font-style:normal;}
p.MsoBodyTextIndent, li.MsoBodyTextIndent, div.MsoBodyTextIndent
	{mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:28.35pt;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoBodyText2, li.MsoBodyText2, div.MsoBodyText2
	{mso-style-unhide:no;
	margin:0in;
	text-align:justify;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt 3.15in;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.MsoBodyText3, li.MsoBodyText3, div.MsoBodyText3
	{mso-style-unhide:no;
	mso-style-link:"Body Text 3 Char";
	margin:0in;
	text-align:justify;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;
	font-weight:bold;
	mso-bidi-font-weight:normal;
	font-style:italic;
	mso-bidi-font-style:normal;}
p.MsoBodyTextIndent2, li.MsoBodyTextIndent2, div.MsoBodyTextIndent2
	{mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:28.35pt;
	text-align:justify;
	text-indent:-28.35pt;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.MsoBodyTextIndent3, li.MsoBodyTextIndent3, div.MsoBodyTextIndent3
	{mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:28.35pt;
	text-indent:-28.35pt;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	color:green;
	mso-ansi-language:EN-GB;
	font-style:italic;
	mso-bidi-font-style:normal;}
p.MsoBlockText, li.MsoBlockText, div.MsoBlockText
	{mso-style-unhide:no;
	margin-top:0in;
	margin-right:-.05pt;
	margin-bottom:0in;
	margin-left:56.7pt;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
a:link, span.MsoHyperlink
	{mso-style-unhide:no;
	mso-style-parent:"";
	color:blue;
	text-decoration:underline;
	text-underline:single;}
a:visited, span.MsoHyperlinkFollowed
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	color:purple;
	text-decoration:underline;
	text-underline:single;}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{mso-style-noshow:yes;
	mso-style-unhide:no;
	margin:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	background:navy;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Tahoma",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoCommentSubject, li.MsoCommentSubject, div.MsoCommentSubject
	{mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-parent:"Comment Text";
	mso-style-next:"Comment Text";
	margin:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;
	font-weight:bold;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-noshow:yes;
	mso-style-unhide:no;
	margin:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:8.0pt;
	font-family:"Tahoma",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoRMPane, li.MsoRMPane, div.MsoRMPane
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-parent:"";
	margin:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.Normal11, li.Normal11, div.Normal11
	{mso-style-name:Normal11;
	mso-style-unhide:no;
	margin:0in;
	text-align:justify;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:FR;}
p.Text, li.Text, div.Text
	{mso-style-name:Text;
	mso-style-unhide:no;
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	text-align:justify;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";}
p.Inforubrik2, li.Inforubrik2, div.Inforubrik2
	{mso-style-name:"Info rubrik 2";
	mso-style-unhide:no;
	mso-style-parent:"Heading 1";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	text-align:center;
	text-indent:0in;
	page-break-before:always;
	mso-pagination:none;
	page-break-after:avoid;
	mso-outline-level:1;
	mso-list:l0 level1 lfo2;
	font-size:12.0pt;
	mso-bidi-font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	text-transform:uppercase;
	mso-ansi-language:EN-GB;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.Figure, li.Figure, div.Figure
	{mso-style-name:Figure;
	mso-style-unhide:no;
	mso-style-next:Caption;
	margin-top:16.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.Reference, li.Reference, div.Reference
	{mso-style-name:Reference;
	mso-style-unhide:no;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:3.0pt;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"MS Mincho";}
span.EndnoteTextChar
	{mso-style-name:"Endnote Text Char";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Endnote Text";
	mso-ansi-font-size:11.0pt;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
span.BodyText3Char
	{mso-style-name:"Body Text 3 Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Body Text 3";
	mso-ansi-font-size:11.0pt;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;
	font-weight:bold;
	mso-bidi-font-weight:normal;
	font-style:italic;
	mso-bidi-font-style:normal;}
span.CommentTextChar
	{mso-style-name:"Comment Text Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Comment Text";
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.Default, li.Default, div.Default
	{mso-style-name:Default;
	mso-style-unhide:no;
	mso-style-parent:"";
	margin:0in;
	mso-pagination:widow-orphan;
	mso-layout-grid-align:none;
	text-autospace:none;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	color:black;}
p.BodytextAgency, li.BodytextAgency, div.BodytextAgency
	{mso-style-name:"Body text \(Agency\)";
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Body text \(Agency\) Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:7.0pt;
	margin-left:0in;
	line-height:14.0pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:Verdana;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:X-NONE;
	mso-fareast-language:X-NONE;}
span.BodytextAgencyChar
	{mso-style-name:"Body text \(Agency\) Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Body text \(Agency\)";
	mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-ascii-font-family:Verdana;
	mso-fareast-font-family:Verdana;
	mso-hansi-font-family:Verdana;
	mso-ansi-language:X-NONE;
	mso-fareast-language:X-NONE;}
span.Heading4Char
	{mso-style-name:"Heading 4 Char";
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Heading 4";
	mso-ansi-font-size:11.0pt;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;
	font-weight:bold;
	mso-bidi-font-weight:normal;
	mso-no-proof:yes;}
span.msoIns
	{mso-style-type:export-only;
	mso-style-name:"";
	text-decoration:underline;
	text-underline:single;
	color:teal;}
span.msoDel
	{mso-style-type:export-only;
	mso-style-name:"";
	text-decoration:line-through;
	color:red;}
span.msoChangeProp
	{mso-style-type:export-only;
	mso-style-name:"";}
span.SpellE
	{mso-style-name:"";
	mso-spl-e:yes;}
.MsoChpDefault
	{mso-style-type:export-only;
	mso-default-props:yes;}
 /* Page Definitions */
 @page
	{mso-footnote-separator:url("Stalevo_clean_files/header.htm") fs;
	mso-footnote-continuation-separator:url("Stalevo_clean_files/header.htm") =
fcs;
	mso-endnote-separator:url("Stalevo_clean_files/header.htm") es;
	mso-endnote-continuation-separator:url("Stalevo_clean_files/header.htm") e=
cs;
	mso-endnote-numbering-style:arabic;}
@page WordSection1
	{size:595.35pt 842.0pt;
	margin:56.7pt 70.9pt 56.7pt 70.9pt;
	mso-header-margin:36.85pt;
	mso-footer-margin:36.85pt;
	mso-page-numbers:1;
	mso-footer:url("Stalevo_clean_files/header.htm") f1;
	mso-paper-source:0;}
div.WordSection1
	{page:WordSection1;
	mso-endnote-numbering-style:arabic;}
 /* List Definitions */
 @list l0
	{mso-list-id:-5;
	mso-list-template-ids:96917604;}
@list l0:level1
	{mso-level-number-format:none;
	mso-level-style-link:"Info rubrik 2";
	mso-level-suffix:none;
	mso-level-text:"";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0in;
	text-indent:0in;}
@list l0:level2
	{mso-level-text:%2;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	mso-level-legacy:yes;
	mso-level-legacy-indent:0in;
	mso-level-legacy-space:17.0pt;
	margin-left:42.55pt;
	text-indent:0in;}
@list l0:level3
	{mso-level-text:"%2\.%3";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	mso-level-legacy:yes;
	mso-level-legacy-indent:0in;
	mso-level-legacy-space:8.5pt;
	margin-left:42.55pt;
	text-indent:0in;}
@list l0:level4
	{mso-level-text:"%2\.%3\.%4";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	mso-level-legacy:yes;
	mso-level-legacy-indent:0in;
	mso-level-legacy-space:11.35pt;
	margin-left:42.55pt;
	text-indent:0in;}
@list l0:level5
	{mso-level-text:"%2\.%3\.%4\.%5";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	mso-level-legacy:yes;
	mso-level-legacy-indent:35.4pt;
	mso-level-legacy-space:0in;
	margin-left:42.55pt;
	text-indent:-35.4pt;}
@list l0:level6
	{mso-level-text:"%2\.%3\.%4\.%5\.%6";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	mso-level-legacy:yes;
	mso-level-legacy-indent:35.4pt;
	mso-level-legacy-space:0in;
	margin-left:92.15pt;
	text-indent:-35.4pt;}
@list l0:level7
	{mso-level-text:"%2\.%3\.%4\.%5\.%6\.%7";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	mso-level-legacy:yes;
	mso-level-legacy-indent:35.4pt;
	mso-level-legacy-space:0in;
	margin-left:106.2pt;
	text-indent:-35.4pt;}
@list l0:level8
	{mso-level-text:"%2\.%3\.%4\.%5\.%6\.%7\.%8";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	mso-level-legacy:yes;
	mso-level-legacy-indent:35.4pt;
	mso-level-legacy-space:0in;
	margin-left:141.6pt;
	text-indent:-35.4pt;}
@list l0:level9
	{mso-level-text:"%2\.%3\.%4\.%5\.%6\.%7\.%8\.%9";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	mso-level-legacy:yes;
	mso-level-legacy-indent:35.4pt;
	mso-level-legacy-space:0in;
	margin-left:177.0pt;
	text-indent:-35.4pt;}
@list l1
	{mso-list-id:-2;
	mso-list-type:simple;
	mso-list-template-ids:-1;}
@list l1:level1
	{mso-level-start-at:0;
	mso-level-text:*;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0in;
	text-indent:0in;}
@list l2
	{mso-list-id:15469623;
	mso-list-type:hybrid;
	mso-list-template-ids:-1833121242 -215964322 67698691 67698693 67698689 67=
698691 67698693 67698689 67698691 67698693;}
@list l2:level1
	{mso-level-number-format:bullet;
	mso-level-reset-level:level1;
	mso-level-text:\F0B7;
	mso-level-tab-stop:28.35pt;
	mso-level-number-position:left;
	margin-left:28.35pt;
	text-indent:-28.35pt;
	font-family:Symbol;}
@list l2:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l2:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l2:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l2:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l2:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l2:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l2:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l2:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l3
	{mso-list-id:69696243;
	mso-list-type:simple;
	mso-list-template-ids:802829288;}
@list l3:level1
	{mso-level-number-format:alpha-upper;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	mso-level-legacy:yes;
	mso-level-legacy-indent:.25in;
	mso-level-legacy-space:0in;
	margin-left:74.7pt;
	text-indent:-.25in;}
@list l4
	{mso-list-id:130756052;
	mso-list-type:hybrid;
	mso-list-template-ids:-1183422490 2124968322 67829763 67829765 67829761 67=
829763 67829765 67829761 67829763 67829765;}
@list l4:level1
	{mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:28.35pt;
	mso-level-number-position:left;
	margin-left:28.35pt;
	text-indent:-28.35pt;
	font-family:"Times New Roman",serif;}
@list l4:level2
	{mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l4:level3
	{mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l4:level4
	{mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l4:level5
	{mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l4:level6
	{mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l4:level7
	{mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l4:level8
	{mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l4:level9
	{mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l5
	{mso-list-id:132987398;
	mso-list-type:hybrid;
	mso-list-template-ids:892925354 1395716254 -321646000 67829765 67829761 67=
829763 67829765 67829761 67829763 67829765;}
@list l5:level1
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";}
@list l5:level2
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:"Times New Roman";}
@list l5:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.25in;
	mso-level-number-position:left;
	margin-left:1.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l5:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:1.75in;
	mso-level-number-position:left;
	margin-left:1.75in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l5:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:2.25in;
	mso-level-number-position:left;
	margin-left:2.25in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l5:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.75in;
	mso-level-number-position:left;
	margin-left:2.75in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l5:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.25in;
	mso-level-number-position:left;
	margin-left:3.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l5:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:3.75in;
	mso-level-number-position:left;
	margin-left:3.75in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l5:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.25in;
	mso-level-number-position:left;
	margin-left:4.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l6
	{mso-list-id:206988092;
	mso-list-type:hybrid;
	mso-list-template-ids:1320078142 134807577 134807577 134807579 134807567 1=
34807577 134807579 134807567 134807577 134807579;}
@list l6:level1
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l6:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l6:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l6:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l6:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l6:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l6:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l6:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l6:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l7
	{mso-list-id:213198861;
	mso-list-type:hybrid;
	mso-list-template-ids:-2082968236 67698689 67698691 67698693 67698689 6769=
8691 67698693 67698689 67698691 67698693;}
@list l7:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l7:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l7:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l7:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l7:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l7:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l7:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l7:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l7:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l8
	{mso-list-id:227808825;
	mso-list-type:hybrid;
	mso-list-template-ids:2123416134 -997314390 67829763 67829765 67829761 678=
29763 67829765 67829761 67829763 67829765;}
@list l8:level1
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";}
@list l8:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l8:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l8:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l8:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l8:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l8:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l8:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l8:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l9
	{mso-list-id:279845754;
	mso-list-type:hybrid;
	mso-list-template-ids:2087746756 -1 -321646000 67698693 67698689 67698691 =
67698693 67698689 67698691 67698693;}
@list l9:level1
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;
	font-family:"Times New Roman",serif;}
@list l9:level2
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:"Times New Roman";}
@list l9:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.25in;
	mso-level-number-position:left;
	margin-left:1.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l9:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:1.75in;
	mso-level-number-position:left;
	margin-left:1.75in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l9:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:2.25in;
	mso-level-number-position:left;
	margin-left:2.25in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l9:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.75in;
	mso-level-number-position:left;
	margin-left:2.75in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l9:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.25in;
	mso-level-number-position:left;
	margin-left:3.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l9:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:3.75in;
	mso-level-number-position:left;
	margin-left:3.75in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l9:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.25in;
	mso-level-number-position:left;
	margin-left:4.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l10
	{mso-list-id:285934943;
	mso-list-type:hybrid;
	mso-list-template-ids:2001769630 -321646000 67698691 67698693 67698689 676=
98691 67698693 67698689 67698691 67698693;}
@list l10:level1
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:"Times New Roman";}
@list l10:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l10:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.25in;
	mso-level-number-position:left;
	margin-left:1.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l10:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:1.75in;
	mso-level-number-position:left;
	margin-left:1.75in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l10:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:2.25in;
	mso-level-number-position:left;
	margin-left:2.25in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l10:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.75in;
	mso-level-number-position:left;
	margin-left:2.75in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l10:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.25in;
	mso-level-number-position:left;
	margin-left:3.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l10:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:3.75in;
	mso-level-number-position:left;
	margin-left:3.75in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l10:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.25in;
	mso-level-number-position:left;
	margin-left:4.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l11
	{mso-list-id:312417872;
	mso-list-type:hybrid;
	mso-list-template-ids:-14615870 -321646000 -321646000 67829765 67829761 67=
829763 67829765 67829761 67829763 67829765;}
@list l11:level1
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:"Times New Roman";}
@list l11:level2
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:"Times New Roman";}
@list l11:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l11:level4
	{mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l11:level5
	{mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l11:level6
	{mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l11:level7
	{mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l11:level8
	{mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l11:level9
	{mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l12
	{mso-list-id:326175766;
	mso-list-type:hybrid;
	mso-list-template-ids:1320078142 134807577 134807577 134807579 134807567 1=
34807577 134807579 134807567 134807577 134807579;}
@list l12:level1
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l12:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l12:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l12:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l12:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l12:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l12:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l12:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l12:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l13
	{mso-list-id:335769633;
	mso-list-type:hybrid;
	mso-list-template-ids:1320078142 134807577 134807577 134807579 134807567 1=
34807577 134807579 134807567 134807577 134807579;}
@list l13:level1
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l13:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l13:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l13:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l13:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l13:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l13:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l13:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l13:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l14
	{mso-list-id:372076727;
	mso-list-type:hybrid;
	mso-list-template-ids:-1434954324 1290559784 -321646000 67698693 67698689 =
67698691 67698693 67698689 67698691 67698693;}
@list l14:level1
	{mso-level-start-at:7;
	mso-level-number-format:bullet;
	mso-level-reset-level:level1;
	mso-level-text:-;
	mso-level-tab-stop:28.35pt;
	mso-level-number-position:left;
	margin-left:28.35pt;
	text-indent:-28.35pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";}
@list l14:level2
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:"Times New Roman";}
@list l14:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l14:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l14:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l14:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l14:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l14:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l14:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l15
	{mso-list-id:449207604;
	mso-list-type:hybrid;
	mso-list-template-ids:1171849162 1395716254 67829763 67829765 67829761 678=
29763 67829765 67829761 67829763 67829765;}
@list l15:level1
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";}
@list l15:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l15:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.25in;
	mso-level-number-position:left;
	margin-left:1.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l15:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:1.75in;
	mso-level-number-position:left;
	margin-left:1.75in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l15:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:2.25in;
	mso-level-number-position:left;
	margin-left:2.25in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l15:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.75in;
	mso-level-number-position:left;
	margin-left:2.75in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l15:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.25in;
	mso-level-number-position:left;
	margin-left:3.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l15:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:3.75in;
	mso-level-number-position:left;
	margin-left:3.75in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l15:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.25in;
	mso-level-number-position:left;
	margin-left:4.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l16
	{mso-list-id:489103594;
	mso-list-type:hybrid;
	mso-list-template-ids:-203931840 -997314390 67829763 67829765 67829761 678=
29763 67829765 67829761 67829763 67829765;}
@list l16:level1
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";}
@list l16:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l16:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l16:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l16:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l16:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l16:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l16:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l16:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l17
	{mso-list-id:496848363;
	mso-list-type:hybrid;
	mso-list-template-ids:1303965198 -1712793546 67829785 67829787 67829775 67=
829785 67829787 67829775 67829785 67829787;}
@list l17:level1
	{mso-level-start-at:7;
	mso-level-tab-stop:26.55pt;
	mso-level-number-position:left;
	margin-left:26.55pt;
	text-indent:-.25in;}
@list l17:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:62.55pt;
	mso-level-number-position:left;
	margin-left:62.55pt;
	text-indent:-.25in;}
@list l17:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:98.55pt;
	mso-level-number-position:right;
	margin-left:98.55pt;
	text-indent:-9.0pt;}
@list l17:level4
	{mso-level-tab-stop:134.55pt;
	mso-level-number-position:left;
	margin-left:134.55pt;
	text-indent:-.25in;}
@list l17:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:170.55pt;
	mso-level-number-position:left;
	margin-left:170.55pt;
	text-indent:-.25in;}
@list l17:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:206.55pt;
	mso-level-number-position:right;
	margin-left:206.55pt;
	text-indent:-9.0pt;}
@list l17:level7
	{mso-level-tab-stop:242.55pt;
	mso-level-number-position:left;
	margin-left:242.55pt;
	text-indent:-.25in;}
@list l17:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:278.55pt;
	mso-level-number-position:left;
	margin-left:278.55pt;
	text-indent:-.25in;}
@list l17:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:314.55pt;
	mso-level-number-position:right;
	margin-left:314.55pt;
	text-indent:-9.0pt;}
@list l18
	{mso-list-id:504903942;
	mso-list-type:hybrid;
	mso-list-template-ids:-1553047310 -1 67698691 67698693 67698689 67698691 6=
7698693 67698689 67698691 67698693;}
@list l18:level1
	{mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l18:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l18:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l18:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l18:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l18:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l18:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l18:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l18:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l19
	{mso-list-id:552929047;
	mso-list-type:hybrid;
	mso-list-template-ids:1955903020 -2107480466 67698691 67698693 67698689 67=
698691 67698693 67698689 67698691 67698693;}
@list l19:level1
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;
	font-family:"Times New Roman",serif;}
@list l19:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l19:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l19:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l19:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l19:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l19:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l19:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l19:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l20
	{mso-list-id:556090109;
	mso-list-type:hybrid;
	mso-list-template-ids:934811976 -1 67829763 67829765 67829761 67829763 678=
29765 67829761 67829763 67829765;}
@list l20:level1
	{mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	mso-level-legacy:yes;
	mso-level-legacy-indent:.25in;
	mso-level-legacy-space:0in;
	margin-left:.25in;
	text-indent:-.25in;}
@list l20:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l20:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l20:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l20:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l20:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l20:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l20:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l20:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l21
	{mso-list-id:723412971;
	mso-list-type:simple;
	mso-list-template-ids:-869120406;}
@list l21:level1
	{mso-level-start-at:7;
	mso-level-tab-stop:37.05pt;
	mso-level-number-position:left;
	margin-left:37.05pt;
	text-indent:-28.5pt;}
@list l22
	{mso-list-id:753555065;
	mso-list-type:hybrid;
	mso-list-template-ids:1318089826 -1 67698691 67698693 67698689 67698691 67=
698693 67698689 67698691 67698693;}
@list l22:level1
	{mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:64.15pt;
	text-indent:-.25in;}
@list l22:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:100.15pt;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l22:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:136.15pt;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l22:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:172.15pt;
	text-indent:-.25in;
	font-family:Symbol;}
@list l22:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:208.15pt;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l22:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:244.15pt;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l22:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:280.15pt;
	text-indent:-.25in;
	font-family:Symbol;}
@list l22:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:316.15pt;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l22:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:352.15pt;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l23
	{mso-list-id:898900346;
	mso-list-type:hybrid;
	mso-list-template-ids:306450798 -321646000 -321646000 67698693 67698689 67=
698691 67698693 67698689 67698691 67698693;}
@list l23:level1
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:"Times New Roman";}
@list l23:level2
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:"Times New Roman";}
@list l23:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l23:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l23:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l23:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l23:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l23:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l23:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l24
	{mso-list-id:913003271;
	mso-list-type:hybrid;
	mso-list-template-ids:-833820976 455240198 67829785 67829787 67829775 6782=
9785 67829787 67829775 67829785 67829787;}
@list l24:level1
	{mso-level-start-at:7;
	mso-level-tab-stop:35.1pt;
	mso-level-number-position:left;
	margin-left:35.1pt;
	text-indent:-.25in;}
@list l24:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:71.1pt;
	mso-level-number-position:left;
	margin-left:71.1pt;
	text-indent:-.25in;}
@list l24:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:107.1pt;
	mso-level-number-position:right;
	margin-left:107.1pt;
	text-indent:-9.0pt;}
@list l24:level4
	{mso-level-tab-stop:143.1pt;
	mso-level-number-position:left;
	margin-left:143.1pt;
	text-indent:-.25in;}
@list l24:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:179.1pt;
	mso-level-number-position:left;
	margin-left:179.1pt;
	text-indent:-.25in;}
@list l24:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:215.1pt;
	mso-level-number-position:right;
	margin-left:215.1pt;
	text-indent:-9.0pt;}
@list l24:level7
	{mso-level-tab-stop:251.1pt;
	mso-level-number-position:left;
	margin-left:251.1pt;
	text-indent:-.25in;}
@list l24:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:287.1pt;
	mso-level-number-position:left;
	margin-left:287.1pt;
	text-indent:-.25in;}
@list l24:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:323.1pt;
	mso-level-number-position:right;
	margin-left:323.1pt;
	text-indent:-9.0pt;}
@list l25
	{mso-list-id:916940391;
	mso-list-type:hybrid;
	mso-list-template-ids:1320078142 134807577 134807577 134807579 134807567 1=
34807577 134807579 134807567 134807577 134807579;}
@list l25:level1
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l25:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l25:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l25:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l25:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l25:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l25:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l25:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l25:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l26
	{mso-list-id:1034304924;
	mso-list-type:hybrid;
	mso-list-template-ids:1320078142 134807577 134807577 134807579 134807567 1=
34807577 134807579 134807567 134807577 134807579;}
@list l26:level1
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l26:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l26:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l26:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l26:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l26:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l26:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l26:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l26:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l27
	{mso-list-id:1046683230;
	mso-list-type:hybrid;
	mso-list-template-ids:1734127596 -1415535018 67829763 67829765 67829761 67=
829763 67829765 67829761 67829763 67829765;}
@list l27:level1
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:27.0pt;
	mso-level-number-position:left;
	margin-left:27.0pt;
	text-indent:-27.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";}
@list l27:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l27:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.25in;
	mso-level-number-position:left;
	margin-left:1.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l27:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:1.75in;
	mso-level-number-position:left;
	margin-left:1.75in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l27:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:2.25in;
	mso-level-number-position:left;
	margin-left:2.25in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l27:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.75in;
	mso-level-number-position:left;
	margin-left:2.75in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l27:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.25in;
	mso-level-number-position:left;
	margin-left:3.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l27:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:3.75in;
	mso-level-number-position:left;
	margin-left:3.75in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l27:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.25in;
	mso-level-number-position:left;
	margin-left:4.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l28
	{mso-list-id:1056665304;
	mso-list-type:hybrid;
	mso-list-template-ids:1320078142 134807577 134807577 134807579 134807567 1=
34807577 134807579 134807567 134807577 134807579;}
@list l28:level1
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l28:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l28:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l28:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l28:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l28:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l28:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l28:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l28:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l29
	{mso-list-id:1225218046;
	mso-list-type:hybrid;
	mso-list-template-ids:-628463876 -1 -1 67698693 67698689 67698691 67698693=
 67698689 67698691 67698693;}
@list l29:level1
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;
	font-family:"Times New Roman",serif;}
@list l29:level2
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;
	font-family:"Times New Roman",serif;}
@list l29:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.25in;
	mso-level-number-position:left;
	margin-left:1.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l29:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:1.75in;
	mso-level-number-position:left;
	margin-left:1.75in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l29:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:2.25in;
	mso-level-number-position:left;
	margin-left:2.25in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l29:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.75in;
	mso-level-number-position:left;
	margin-left:2.75in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l29:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.25in;
	mso-level-number-position:left;
	margin-left:3.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l29:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:3.75in;
	mso-level-number-position:left;
	margin-left:3.75in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l29:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.25in;
	mso-level-number-position:left;
	margin-left:4.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l30
	{mso-list-id:1237784016;
	mso-list-type:hybrid;
	mso-list-template-ids:262815664 -997314390 67829763 67829765 67829761 6782=
9763 67829765 67829761 67829763 67829765;}
@list l30:level1
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";}
@list l30:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l30:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l30:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l30:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l30:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l30:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l30:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l30:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l31
	{mso-list-id:1245796735;
	mso-list-type:hybrid;
	mso-list-template-ids:1320078142 134807577 134807577 134807579 134807567 1=
34807577 134807579 134807567 134807577 134807579;}
@list l31:level1
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l31:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l31:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l31:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l31:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l31:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l31:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l31:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l31:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l32
	{mso-list-id:1256400952;
	mso-list-type:hybrid;
	mso-list-template-ids:5261786 -321646000 67829763 67829765 67829761 678297=
63 67829765 67829761 67829763 67829765;}
@list l32:level1
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:"Times New Roman";}
@list l32:level2
	{mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l32:level3
	{mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l32:level4
	{mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l32:level5
	{mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l32:level6
	{mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l32:level7
	{mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l32:level8
	{mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l32:level9
	{mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l33
	{mso-list-id:1303921832;
	mso-list-type:hybrid;
	mso-list-template-ids:1320078142 134807577 134807577 134807579 134807567 1=
34807577 134807579 134807567 134807577 134807579;}
@list l33:level1
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l33:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l33:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l33:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l33:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l33:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l33:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l33:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l33:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l34
	{mso-list-id:1328510744;
	mso-list-type:hybrid;
	mso-list-template-ids:-225830710 2070852408 67698713 67698715 67698703 676=
98713 67698715 67698703 67698713 67698715;}
@list l34:level1
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:49.5pt;
	text-indent:-31.5pt;}
@list l34:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l34:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l34:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l34:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l34:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l34:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l34:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l34:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l35
	{mso-list-id:1352993298;
	mso-list-type:hybrid;
	mso-list-template-ids:2146618048 -1415535018 67829763 67829765 67829761 67=
829763 67829765 67829761 67829763 67829765;}
@list l35:level1
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:45.0pt;
	mso-level-number-position:left;
	margin-left:45.0pt;
	text-indent:-27.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";}
@list l35:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l35:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l35:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l35:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l35:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l35:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l35:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l35:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l36
	{mso-list-id:1362514150;
	mso-list-type:hybrid;
	mso-list-template-ids:-1462083976 -997314390 67829763 67829765 67829761 67=
829763 67829765 67829761 67829763 67829765;}
@list l36:level1
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";}
@list l36:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l36:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l36:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l36:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l36:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l36:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l36:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l36:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l37
	{mso-list-id:1401439182;
	mso-list-type:hybrid;
	mso-list-template-ids:2018123238 -997314390 67829763 67829765 67829761 678=
29763 67829765 67829761 67829763 67829765;}
@list l37:level1
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";}
@list l37:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l37:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l37:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l37:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l37:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l37:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l37:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l37:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l38
	{mso-list-id:1408528685;
	mso-list-type:hybrid;
	mso-list-template-ids:1058449450 67698689 67698691 67698693 67698689 67698=
691 67698693 67698689 67698691 67698693;}
@list l38:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:32.2pt;
	text-indent:-.25in;
	font-family:Symbol;}
@list l38:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l38:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l38:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l38:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l38:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l38:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l38:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l38:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l39
	{mso-list-id:1421215986;
	mso-list-type:hybrid;
	mso-list-template-ids:-578272078 -1 67698691 67698693 67698689 67698691 67=
698693 67698689 67698691 67698693;}
@list l39:level1
	{mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l39:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l39:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l39:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l39:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l39:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l39:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l39:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l39:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l40
	{mso-list-id:1470853980;
	mso-list-type:hybrid;
	mso-list-template-ids:1320078142 134807577 134807577 134807579 134807567 1=
34807577 134807579 134807567 134807577 134807579;}
@list l40:level1
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l40:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l40:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l40:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l40:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l40:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l40:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l40:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l40:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l41
	{mso-list-id:1534347802;
	mso-list-type:hybrid;
	mso-list-template-ids:-170781144 -1415535018 67829763 67829765 67829761 67=
829763 67829765 67829761 67829763 67829765;}
@list l41:level1
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:27.0pt;
	mso-level-number-position:left;
	margin-left:27.0pt;
	text-indent:-27.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";}
@list l41:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l41:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.25in;
	mso-level-number-position:left;
	margin-left:1.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l41:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:1.75in;
	mso-level-number-position:left;
	margin-left:1.75in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l41:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:2.25in;
	mso-level-number-position:left;
	margin-left:2.25in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l41:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.75in;
	mso-level-number-position:left;
	margin-left:2.75in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l41:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.25in;
	mso-level-number-position:left;
	margin-left:3.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l41:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:3.75in;
	mso-level-number-position:left;
	margin-left:3.75in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l41:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.25in;
	mso-level-number-position:left;
	margin-left:4.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l42
	{mso-list-id:1557276456;
	mso-list-type:hybrid;
	mso-list-template-ids:-788498564 -1 -1 -1 -1 -1 -1 -1 -1 -1;}
@list l42:level1
	{mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	mso-level-legacy:yes;
	mso-level-legacy-indent:.25in;
	mso-level-legacy-space:0in;
	margin-left:.25in;
	text-indent:-.25in;}
@list l42:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l42:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l42:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l42:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l42:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l42:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l42:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l42:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l43
	{mso-list-id:1624074487;
	mso-list-type:hybrid;
	mso-list-template-ids:1368813112 -955615924 67829763 67829765 67829761 678=
29763 67829765 67829761 67829763 67829765;}
@list l43:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:28.35pt;
	mso-level-number-position:left;
	margin-left:28.35pt;
	text-indent:-28.35pt;
	font-family:Symbol;}
@list l43:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	margin-left:.5in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l43:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	margin-left:1.0in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l43:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	margin-left:1.5in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l43:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	margin-left:2.0in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l43:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	margin-left:2.5in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l43:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	margin-left:3.0in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l43:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	margin-left:3.5in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l43:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	margin-left:4.0in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l44
	{mso-list-id:1690597962;
	mso-list-type:hybrid;
	mso-list-template-ids:1320078142 134807577 134807577 134807579 134807567 1=
34807577 134807579 134807567 134807577 134807579;}
@list l44:level1
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l44:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l44:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l44:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l44:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l44:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l44:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l44:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l44:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l45
	{mso-list-id:1757167993;
	mso-list-type:hybrid;
	mso-list-template-ids:27688574 -215964322 67698691 67698693 67698689 67698=
691 67698693 67698689 67698691 67698693;}
@list l45:level1
	{mso-level-number-format:bullet;
	mso-level-reset-level:level1;
	mso-level-text:\F0B7;
	mso-level-tab-stop:28.35pt;
	mso-level-number-position:left;
	margin-left:28.35pt;
	text-indent:-28.35pt;
	font-family:Symbol;}
@list l45:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l45:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l45:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l45:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l45:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l45:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l45:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l45:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l46
	{mso-list-id:1775857624;
	mso-list-type:hybrid;
	mso-list-template-ids:1320078142 134807577 134807577 134807579 134807567 1=
34807577 134807579 134807567 134807577 134807579;}
@list l46:level1
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l46:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l46:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l46:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l46:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l46:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l46:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l46:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l46:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l47
	{mso-list-id:1814450009;
	mso-list-type:hybrid;
	mso-list-template-ids:1320078142 134807577 134807577 134807579 134807567 1=
34807577 134807579 134807567 134807577 134807579;}
@list l47:level1
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l47:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l47:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l47:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l47:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l47:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l47:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l47:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l47:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l48
	{mso-list-id:1871919056;
	mso-list-type:hybrid;
	mso-list-template-ids:-1228372506 67698689 67698691 67698693 67698689 6769=
8691 67698693 67698689 67698691 67698693;}
@list l48:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l48:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l48:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l48:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l48:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l48:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l48:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l48:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l48:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l49
	{mso-list-id:1884630668;
	mso-list-type:hybrid;
	mso-list-template-ids:-484138898;}
@list l49:level1
	{mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;
	font-family:"Times New Roman",serif;}
@list l49:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l49:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.25in;
	mso-level-number-position:left;
	margin-left:1.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l49:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:1.75in;
	mso-level-number-position:left;
	margin-left:1.75in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l49:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:2.25in;
	mso-level-number-position:left;
	margin-left:2.25in;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l49:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.75in;
	mso-level-number-position:left;
	margin-left:2.75in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l49:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.25in;
	mso-level-number-position:left;
	margin-left:3.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l49:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:3.75in;
	mso-level-number-position:left;
	margin-left:3.75in;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l49:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.25in;
	mso-level-number-position:left;
	margin-left:4.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l50
	{mso-list-id:1969699639;
	mso-list-type:hybrid;
	mso-list-template-ids:-1323112954 -997314390 67829763 67829765 67829761 67=
829763 67829765 67829761 67829763 67829765;}
@list l50:level1
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";}
@list l50:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l50:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l50:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l50:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l50:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l50:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l50:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l50:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l51
	{mso-list-id:2141530913;
	mso-list-type:hybrid;
	mso-list-template-ids:-1580334806 66779938 67698713 67698715 67698703 6769=
8713 67698715 67698703 67698713 67698715;}
@list l51:level1
	{mso-level-tab-stop:37.05pt;
	mso-level-number-position:left;
	margin-left:37.05pt;
	text-indent:-28.5pt;}
@list l51:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l51:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l51:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l51:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l51:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l51:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l51:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l51:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l1:level1 lfo3
	{mso-level-start-at:1;
	mso-level-number-format:bullet;
	mso-level-numbering:continue;
	mso-level-text:-;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	mso-level-legacy:yes;
	mso-level-legacy-indent:.25in;
	mso-level-legacy-space:0in;
	margin-left:.25in;
	text-indent:-.25in;}
@list l1:level1 lfo53
	{mso-level-start-at:1;
	mso-level-number-format:bullet;
	mso-level-numbering:continue;
	mso-level-text:-;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	mso-level-legacy:yes;
	mso-level-legacy-indent:.25in;
	mso-level-legacy-space:0in;
	margin-left:.25in;
	text-indent:-.25in;}
ol
	{margin-bottom:0in;}
ul
	{margin-bottom:0in;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
table.MsoTableGrid
	{mso-style-name:"Table Grid";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-priority:59;
	mso-style-unhide:no;
	border:solid windowtext 1.0pt;
	mso-border-alt:solid windowtext .5pt;
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-border-insideh:.5pt solid windowtext;
	mso-border-insidev:.5pt solid windowtext;
	mso-para-margin:0in;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext=3D"edit" spidmax=3D"3074"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext=3D"edit">
  <o:idmap v:ext=3D"edit" data=3D"1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=3DEN-US link=3Dblue vlink=3Dpurple style=3D'tab-interval:28.35pt=
;word-wrap:
break-word'>

<div class=3DWordSection1>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-paginati=
on:none'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt'>ANNEX I<o:p></o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-paginati=
on:none'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<h1><span lang=3DEN-GB>SUMMARY OF PRODUCT CHARACTERISTICS</span></h1>

<b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-s=
ize:11.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-ansi-language:EN-GB;mso-fareast-language:EN-US;mso-bidi-language:AR-SA'=
><br
clear=3Dall style=3D'page-break-before:always'>
</span></b>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-align:left;text-indent:-2=
7.0pt;
mso-pagination:none;tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:nor=
mal'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>1.<span
style=3D'mso-tab-count:1'> </span>NAME OF THE MEDICINAL PRODUCT<o:p></=
o:p></span></b></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'>Stalevo 50&nbsp;mg/12.5&nbsp;mg/200&nbsp;mg film-coated tablets<o:p>=
</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB;mso-fareast-language:FI'>Stalevo 75&nbsp;mg/18.75&nbsp;mg/200&nbsp;mg
film-coated tablets</span><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-=
ansi-language:
EN-GB'><o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'>Stalevo 100&nbsp;mg/25&nbsp;mg/200&nbsp;mg film-coated tablets<o:p><=
/o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'>Stalevo 125</span><span style=3D'font-size:11.0pt'>&nbsp;</span><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>mg/31.25</s=
pan><span
style=3D'font-size:11.0pt'>&nbsp;</span><span lang=3DEN-GB style=3D'font-si=
ze:11.0pt;
mso-ansi-language:EN-GB'>mg/200</span><span style=3D'font-size:11.0pt'>&nbs=
p;</span><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>mg film-coa=
ted
tablets<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'>Stalevo 150&nbsp;mg/37.5&nbsp;mg/200&nbsp;mg film-coated tablets<o:p=
></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB;mso-fareast-language:FI'>Stalevo 175&nbsp;mg/43.75&nbsp;mg/200&nbsp;mg
film-coated tablets</span><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-=
ansi-language:
EN-GB'><o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'>Stalevo 200&nbsp;mg/50&nbsp;mg/200&nbsp;mg film-coated tablets <o:p>=
</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;text-t=
ransform:
uppercase;mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;text-t=
ransform:
uppercase;mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-align:left;text-indent:-2=
7.0pt;
mso-pagination:none;tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:nor=
mal'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>2.<span
style=3D'mso-tab-count:1'> </span>QUALITATIVE <st1:stockticker w:st=3D=
"on">AND</st1:stockticker>
QUANTITATIVE COMPOSITION<o:p></o:p></span></b></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p>&nbsp;=
</o:p></span></b></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><u><span lang=3DEN-GB style=3D'font-size:11.0pt;mso=
-ansi-language:
EN-GB'>50&nbsp;mg/12.5&nbsp;mg/200&nbsp;mg<o:p></o:p></span></u></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'>Each tablet contains 50&nbsp;mg of levodopa, 12.5&nbsp;mg of carbido=
pa
and 200&nbsp;mg of entacapone.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'>Excipient with known effect:</span><span style=3D'font-size:11.0pt;
mso-fareast-font-family:"MS Mincho"'> <o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span style=3D'font-size:11.0pt;mso-fareast-font-fa=
mily:
"MS Mincho"'>Each tablet contains 1.2&nbsp;mg of sucrose</span><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>.<o:p></o:p=
></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><u><span lang=3DEN-GB style=3D'font-size:11.0pt;mso=
-ansi-language:
EN-GB;mso-fareast-language:FI'>75&nbsp;mg/18.75&nbsp;mg/200&nbsp;mg</span><=
/u><u><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p></o:p>=
</span></u></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB;mso-fareast-language:FI'>Each tablet contains 75&nbsp;mg of levodopa,
18.75&nbsp;mg of carbidopa and 200&nbsp;mg of entacapone.</span><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p></o:p>=
</span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'>Excipient with known effect: <o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span style=3D'font-size:11.0pt;mso-fareast-font-fa=
mily:
"MS Mincho"'>Each tablet contains </span><span lang=3DEN-GB style=3D'font-s=
ize:
11.0pt;mso-ansi-language:EN-GB;mso-fareast-language:FI'>1.4&nbsp;</span><sp=
an
style=3D'font-size:11.0pt;mso-fareast-font-family:"MS Mincho"'>mg of sucros=
e</span><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>.<o:p></o:p=
></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><u><span lang=3DEN-GB style=3D'font-size:11.0pt;mso=
-ansi-language:
EN-GB'>100&nbsp;mg/25&nbsp;mg/200&nbsp;mg <o:p></o:p></span></u></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'>Each tablet contains 100&nbsp;mg of levodopa, 25&nbsp;mg of carbidopa
and 200&nbsp;mg of entacapone.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'>Excipient with known effect: <o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span style=3D'font-size:11.0pt;mso-fareast-font-fa=
mily:
"MS Mincho"'>Each tablet contains </span><span lang=3DEN-GB style=3D'font-s=
ize:
11.0pt;mso-ansi-language:EN-GB'>1.6&nbsp;mg</span><span style=3D'font-size:=
11.0pt;
mso-fareast-font-family:"MS Mincho"'> of sucrose</span><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><u><span lang=3DEN-GB style=3D'font-size:11.0pt;mso=
-ansi-language:
EN-GB'>125</span></u><u><span style=3D'font-size:11.0pt'>&nbsp;</span></u><=
u><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>mg/31.25</s=
pan></u><u><span
style=3D'font-size:11.0pt'>&nbsp;</span></u><u><span lang=3DEN-GB style=3D'=
font-size:
11.0pt;mso-ansi-language:EN-GB'>mg/200</span></u><u><span style=3D'font-siz=
e:
11.0pt'>&nbsp;</span></u><u><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>mg<o:p></o:p></span></u></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB;mso-fareast-language:FI'>Each tablet contains 125&nbsp;mg of levodopa,
31.25&nbsp;mg of carbidopa and 200&nbsp;mg of entacapone.</span><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p></o:p>=
</span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'>Excipient with known effect: <o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span style=3D'font-size:11.0pt;mso-fareast-font-fa=
mily:
"MS Mincho"'>Each tablet contains </span><span style=3D'font-size:11.0pt'>1=
.6&nbsp;</span><span
style=3D'font-size:11.0pt;mso-fareast-font-family:"MS Mincho"'>mg of sucros=
e</span><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>.<o:p></o:p=
></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><u><span lang=3DEN-GB style=3D'font-size:11.0pt;mso=
-ansi-language:
EN-GB'>150&nbsp;mg/37.5&nbsp;mg/200&nbsp;mg<o:p></o:p></span></u></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'>Each tablet contains 150&nbsp;mg of levodopa, 37.5&nbsp;mg of carbid=
opa
and 200&nbsp;mg of entacapone.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'>Excipient with known effect: <o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span style=3D'font-size:11.0pt;mso-fareast-font-fa=
mily:
"MS Mincho"'>Each tablet contains </span><span lang=3DEN-GB style=3D'font-s=
ize:
11.0pt;mso-ansi-language:EN-GB'>1.9&nbsp;mg</span><span style=3D'font-size:=
11.0pt;
mso-fareast-font-family:"MS Mincho"'> of sucrose</span><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><u><span lang=3DEN-GB style=3D'font-size:11.0pt;mso=
-ansi-language:
EN-GB;mso-fareast-language:FI'>175&nbsp;mg/43.75&nbsp;mg/200&nbsp;mg</span>=
</u><u><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p></o:p>=
</span></u></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB;mso-fareast-language:FI'>Each tablet contains 175&nbsp;mg of levodopa,
43.75&nbsp;mg of carbidopa and 200&nbsp;mg of entacapone.</span><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p></o:p>=
</span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'>Excipient with known effect: <o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span style=3D'font-size:11.0pt;mso-fareast-font-fa=
mily:
"MS Mincho"'>Each tablet contains </span><span lang=3DEN-GB style=3D'font-s=
ize:
11.0pt;mso-ansi-language:EN-GB;mso-fareast-language:FI'>1.89&nbsp;</span><s=
pan
style=3D'font-size:11.0pt;mso-fareast-font-family:"MS Mincho"'>mg of sucros=
e</span><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>.<o:p></o:p=
></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><u><span lang=3DEN-GB style=3D'font-size:11.0pt;mso=
-ansi-language:
EN-GB'>200&nbsp;mg/50&nbsp;mg/200&nbsp;mg<o:p></o:p></span></u></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'>Each tablet contains 200&nbsp;mg of levodopa, 50&nbsp;mg of carbidopa
and 200&nbsp;mg of entacapone.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'>Excipient with known effect: <o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span style=3D'font-size:11.0pt;mso-fareast-font-fa=
mily:
"MS Mincho"'>Each tablet contains </span><span lang=3DEN-GB style=3D'font-s=
ize:
11.0pt;mso-ansi-language:EN-GB'>2.3&nbsp;mg</span><span style=3D'font-size:=
11.0pt;
mso-fareast-font-family:"MS Mincho"'> of sucrose</span><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'>For the full list of excipients, see section 6.1.<o:p></o:p></span><=
/p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;text-t=
ransform:
uppercase;mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;text-t=
ransform:
uppercase;mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-align:left;text-indent:-2=
7.0pt;
mso-pagination:none;tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:nor=
mal'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>3.<span
style=3D'mso-tab-count:1'> </span>PHARMACEUTICAL <st1:stockticker w:st=
=3D"on">FORM</st1:stockticker><o:p></o:p></span></b></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p>&nbsp;=
</o:p></span></b></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'>Film-coated tablet (tablet)<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><u><span lang=3DEN-GB style=3D'font-size:11.0pt;mso=
-ansi-language:
EN-GB'>50&nbsp;mg/12.5&nbsp;mg/200&nbsp;mg<o:p></o:p></span></u></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'>Brownish or greyish red, round, convex, unscored film-coated tablets
marked with LCE 50 on one side.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB;mso-fareast-language:FI'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><u><span lang=3DEN-GB style=3D'font-size:11.0pt;mso=
-ansi-language:
EN-GB;mso-fareast-language:FI'>75&nbsp;mg/18.75&nbsp;mg/200&nbsp;mg<o:p></o=
:p></span></u></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB;mso-fareast-language:FI'>Light b</span><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'>rownish red, </span><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB;mso-fareast-language:FI'>=
oval</span><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'> film-coated
tablets marked with </span><span lang=3DEN-GB style=3D'font-size:11.0pt;mso=
-ansi-language:
EN-GB;mso-fareast-language:FI'>LCE 75 </span><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>on one side.<o:p></o:p><=
/span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><u><span lang=3DEN-GB style=3D'font-size:11.0pt;mso=
-ansi-language:
EN-GB'>100&nbsp;mg/25&nbsp;mg/200&nbsp;mg<o:p></o:p></span></u></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'>Brownish or greyish red, oval, unscored film-coated tablets marked w=
ith
LCE 100 on one side.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><u><span lang=3DEN-GB style=3D'font-size:11.0pt;mso=
-ansi-language:
EN-GB'>125</span></u><u><span style=3D'font-size:11.0pt'>&nbsp;</span></u><=
u><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>mg/31.25</s=
pan></u><u><span
style=3D'font-size:11.0pt'>&nbsp;</span></u><u><span lang=3DEN-GB style=3D'=
font-size:
11.0pt;mso-ansi-language:EN-GB'>mg/200</span></u><u><span style=3D'font-siz=
e:
11.0pt'>&nbsp;</span></u><u><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>mg<o:p></o:p></span></u></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB;mso-fareast-language:FI'>Light b</span><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'>rownish red, </span><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB;mso-fareast-language:FI'>=
oval</span><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'> film-coated
tablets marked with </span><span lang=3DEN-GB style=3D'font-size:11.0pt;mso=
-ansi-language:
EN-GB;mso-fareast-language:FI'>LCE 125 </span><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>on one side.<o:p></o:p><=
/span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><u><span lang=3DEN-GB style=3D'font-size:11.0pt;mso=
-ansi-language:
EN-GB'>150&nbsp;mg/37.5&nbsp;mg/200&nbsp;mg<o:p></o:p></span></u></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'>Brownish or greyish red, elongated-ellipse shaped, unscored film-coa=
ted
tablets marked with LCE 150 on one side.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><u><span lang=3DEN-GB style=3D'font-size:11.0pt;mso=
-ansi-language:
EN-GB;mso-fareast-language:FI'>175&nbsp;mg/43.75&nbsp;mg/200&nbsp;mg</span>=
</u><u><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p></o:p>=
</span></u></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB;mso-fareast-language:FI'>Light b</span><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'>rownish red, </span><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB;mso-fareast-language:FI'>=
oval, </span><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>unscored
film-coated tablets marked with </span><span lang=3DEN-GB style=3D'font-siz=
e:11.0pt;
mso-ansi-language:EN-GB;mso-fareast-language:FI'>LCE 175 </span><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>on one side=
.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><u><span lang=3DEN-GB style=3D'font-size:11.0pt;mso=
-ansi-language:
EN-GB'>200&nbsp;mg/50&nbsp;mg/200&nbsp;mg<o:p></o:p></span></u></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'>Dark brownish red, oval, unscored film-coated tablets marked with L=
CE
200 on one side.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;text-t=
ransform:
uppercase;mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;text-t=
ransform:
uppercase;mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-align:left;text-indent:-2=
7.0pt;
mso-pagination:none;tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:nor=
mal'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>4.<span
style=3D'mso-tab-count:1'> </span><span style=3D'text-transform:upperc=
ase'>Clinical
particulars<o:p></o:p></span></span></b></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p>&nbsp;=
</o:p></span></b></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;mso-pagination:
none;tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>4.1<span
style=3D'mso-tab-count:1'> </span>Therapeutic indications</span></b><span
lang=3DEN-GB style=3D'font-size:11.0pt;text-transform:uppercase;mso-ansi-la=
nguage:
EN-GB'><o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'>Stalevo is indicated for the treatment of adult patients with
Parkinsons disease and end-of-dose motor fluctuations not stabilised on
levodopa/dopa decarboxylase (DDC) inhibitor treatment.<span style=3D'text-t=
ransform:
uppercase'><o:p></o:p></span></span></p>

<p class=3DMsoEndnoteText style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-align:left;text-indent:-2=
7.0pt;
mso-pagination:none;tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:nor=
mal'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>4.2<span
style=3D'mso-tab-count:1'> </span>Posology and method of administration<=
o:p></o:p></span></b></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><i style=3D'mso-bidi-font-style:normal'><span lang=
=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span>=
</i></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><u><span lang=3DEN-GB style=3D'font-size:11.0pt;mso=
-ansi-language:
EN-GB'>Posology<o:p></o:p></span></u></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>The
optimum daily dose must be determined by careful titration of levodopa in e=
ach
patient. The daily dose should be preferably optimised using one of the sev=
en available
tablet strengths (50&nbsp;mg/12.5&nbsp;mg/200&nbsp;mg,
75&nbsp;mg/18.75&nbsp;mg/200&nbsp;mg, 100&nbsp;mg/25&nbsp;mg/200&nbsp;mg,
125&nbsp;mg/31.25&nbsp;mg/200&nbsp;mg, 150&nbsp;mg/37.5&nbsp;mg/200&nbsp;mg,
175&nbsp;mg/43.75&nbsp;mg/200&nbsp;mg or 200&nbsp;mg/50&nbsp;mg/200&nbsp;mg=
 levodopa/carbidopa/entacapone).
<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Patients
should be instructed to take only one Stalevo tablet per dose administratio=
n.
Patients receiving less than 70-100&nbsp;mg carbidopa a day are more likely=
 to
experience nausea and vomiting. While the experience with total daily dose
greater than 200&nbsp;mg carbidopa is limited, the maximum recommended daily
dose of entacapone is 2,000&nbsp;mg and therefore the maximum dose is 10
tablets per day for the Stalevo strengths of
50&nbsp;mg/12.5&nbsp;mg/200&nbsp;mg, 75&nbsp;mg/18.75&nbsp;mg/200&nbsp;mg
100&nbsp;mg/25&nbsp;mg/200&nbsp;mg, 125&nbsp;mg/31.25&nbsp;mg/200&nbsp;mg a=
nd
150&nbsp;mg/37.5&nbsp;mg/200&nbsp;mg. Ten tablets of Stalevo
150&nbsp;mg/37.5&nbsp;mg/200&nbsp;mg equals 375&nbsp;mg of carbidopa a day.
According to this daily carbidopa dose, the maximum recommended daily dose =
of
Stalevo 175&nbsp;mg/43.75&nbsp;mg/200&nbsp;mg is 8 tablets per day and Stal=
evo
200&nbsp;mg/50&nbsp;mg/200&nbsp;mg dose is 7 tablets per day.<o:p></o:p></s=
pan></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'>Usually Stalevo is to be used in patients who are currently treated =
with
corresponding doses of standard release levodopa/DDC inhibitor and entacapo=
ne. <o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;text-t=
ransform:
uppercase;mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><i style=3D'mso-bidi-font-style:normal'><span lang=
=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>How to transfer patients
taking levodopa/DDC inhibitor (carbidopa or <span class=3DSpellE>benserazid=
e</span>)
preparations and entacapone tablets to Stalevo <o:p></o:p></span></i></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><i style=3D'mso-bidi-font-style:normal'><span lang=
=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span>=
</i></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><i style=3D'mso-bidi-font-style:normal'><span lang=
=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>a</span></i><span lang=
=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>. Patients who are curre=
ntly
treated with entacapone and with standard release levodopa/carbidopa in dos=
es
equal to Stalevo tablet<b style=3D'mso-bidi-font-weight:normal'> </b>streng=
ths
can be directly transferred to corresponding Stalevo tablets. <o:p></o:p></=
span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'>For example, a patient taking one tablet of 50&nbsp;mg/12.5&nbsp;mg =
of
levodopa/carbidopa with one tablet of entacapone 200&nbsp;mg four times dai=
ly
can take one 50&nbsp;mg/12.5&nbsp;mg/200&nbsp;mg Stalevo tablet four times
daily in place of their usual levodopa/carbidopa and entacapone doses. <o:p=
></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DE=
N-GB
style=3D'mso-bidi-font-size:11.0pt'>b. </span></i><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>When initiating Stalevo therapy for pat=
ients
currently treated with entacapone and levodopa/carbidopa in doses not equal=
 to
Stalevo tablets (50&nbsp;mg/12.5&nbsp;mg/200&nbsp;mg or
75&nbsp;mg/18.75&nbsp;mg/200&nbsp;mg or 100&nbsp;mg/25&nbsp;mg/200&nbsp;mg =
or
125&nbsp;mg/31.25&nbsp;mg/200&nbsp;mg or 150&nbsp;mg/37.5&nbsp;mg/200&nbsp;=
mg
or 175&nbsp;mg/43.75&nbsp;mg/200&nbsp;mg or 200&nbsp;mg/50&nbsp;mg/200&nbsp=
;mg),
Stalevo dosing should be carefully titrated for optimal clinical response. =
At
the initiation, Stalevo should be adjusted to correspond as closely as poss=
ible
to the total daily dose of levodopa currently used. <o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><i style=3D'mso-bidi-font-style:normal'><span lang=
=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>c.</span></i><span lang=
=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'> When initiating Stalevo=
 in
patients currently treated with entacapone and levodopa/<span class=3DSpell=
E>benserazide</span>
in a standard release formulation, </span><span style=3D'font-size:11.0pt'>=
the</span><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'> dosing of
levodopa/<span class=3DSpellE>benserazide</span> should be discontinued in =
the
previous night, and Stalevo should be started in the next morning. The star=
ting
dose of Stalevo should provide either the same amount of levodopa or slight=
ly
(5-10%) more. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:6.8pt;mso-pagination:none'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'mso-bidi-f=
ont-size:
11.0pt;text-transform:uppercase'><o:p>&nbsp;</o:p></span></i></p>

<p class=3DText style=3D'margin-top:0in;mso-pagination:none;tab-stops:28.35=
pt'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'font-size:=
11.0pt;
mso-ansi-language:EN-GB'>How to transfer patients not currently treated with
entacapone to Stalevo<o:p></o:p></span></i></p>

<p class=3DText style=3D'margin-top:0in;mso-pagination:none;tab-stops:28.35=
pt'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'font-size:=
11.0pt;
mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></i></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'>Initiation of Stalevo may be considered at corresponding doses to
current treatment in some patients with Parkinson's disease and end-of-dose
motor fluctuations, who are not stabilised on their current standard release
levodopa/DDC inhibitor treatment. However, a direct switch from levodopa/DDC
inhibitor to Stalevo is not recommended for patients who have dyskinesias or
whose daily levodopa dose is above 800&nbsp;mg. In such patients it is
advisable to introduce entacapone treatment as a separate treatment (entaca=
pone
tablets) and adjust the levodopa dose if necessary, before switching to
Stalevo.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Entacapone enhances the
effects of levodopa. It may therefore be necessary, particularly in patients
with dyskinesia, to reduce levodopa dose by 10-30% within the first days to
first weeks after initiating Stalevo treatment. The daily dose of levodopa =
can
be reduced by extending the dosing intervals and/or by reducing the amount =
of
levodopa per dose, according to the clinical condition of the patient. <o:p=
></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText style=3D'margin-top:0in;mso-pagination:none;tab-stops:28.35=
pt'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'font-size:=
11.0pt;
mso-ansi-language:EN-GB'>Dose adjustment during the course of the treatment=
<o:p></o:p></span></i></p>

<p class=3DText style=3D'margin-top:0in;mso-pagination:none;tab-stops:28.35=
pt'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'font-size:=
11.0pt;
mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></i></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'>When more levodopa is required, an increase in the frequency of doses
and/or the use of an alternative strength of Stalevo should be considered,
within the dose recommendations. <o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'>When less levodopa is required, the total daily dose of Stalevo shou=
ld
be reduced either by decreasing the frequency of administration by extending
the time between doses, or by decreasing the strength of Stalevo at an
administration.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'>If other levodopa products are used concomitantly with a Stalevo tab=
let,
the maximum dose recommendations should be followed.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><i style=3D'mso-bidi-font-style:normal'><u><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></i></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><i style=3D'mso-bidi-font-style:normal'><u><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>Discontinua=
tion of
Stalevo therapy</span></u></i><i style=3D'mso-bidi-font-style:normal'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>: </span></=
i><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>If Stalevo
treatment (levodopa/carbidopa/entacapone) is discontinued and the patient is
transferred to levodopa/DDC inhibitor therapy without entacapone, it is
necessary to adjust the dosing of other antiparkinsonian treatments, especi=
ally
levodopa, to achieve a sufficient level of control of the parkinsonian
symptoms.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><i style=3D'mso-bidi-font-style:normal'><u><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></i></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span class=3DSpellE><i style=3D'mso-bidi-font-styl=
e:normal'><u><span
style=3D'font-size:11.0pt'>Paediatric</span></u></i></span><i style=3D'mso-=
bidi-font-style:
normal'><u><span style=3D'font-size:11.0pt'> population</span></u></i><i
style=3D'mso-bidi-font-style:normal'><span style=3D'font-size:11.0pt'>:</sp=
an></i><span
style=3D'font-size:11.0pt'> The safety and efficacy of Stalevo in children =
aged
below 18 years have not been established. No data are available.<o:p></o:p>=
</span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><i style=3D'mso-bidi-font-style:normal'><u><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>Elderly</sp=
an></u></i><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'font-size:=
11.0pt;
mso-ansi-language:EN-GB'>:</span></i><span lang=3DEN-GB style=3D'font-size:=
11.0pt;
mso-ansi-language:EN-GB'> No dose adjustment of Stalevo is required for eld=
erly.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><i style=3D'mso-bidi-font-style:normal'><u><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></i></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><i style=3D'mso-bidi-font-style:normal'><u><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>Hepatic imp=
airment</span></u></i><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'font-size:=
11.0pt;
mso-ansi-language:EN-GB'>: </span></i><span lang=3DEN-GB style=3D'font-size=
:11.0pt;
mso-ansi-language:EN-GB'>It is advised that Stalevo should be administered
cautiously to patients with mild to moderate hepatic impairment. Dose reduc=
tion
may be needed (see section 5.2). </span><span style=3D'font-size:11.0pt'>For
severe hepatic impairment see section 4.3.</span><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><i style=3D'mso-bidi-font-style:normal'><u><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>Renal impai=
rment</span></u></i><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'font-size:=
11.0pt;
mso-ansi-language:EN-GB'>:</span></i><span lang=3DEN-GB style=3D'font-size:=
11.0pt;
mso-ansi-language:EN-GB'> Renal </span><span style=3D'font-size:11.0pt'>imp=
airment</span><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'> does not a=
ffect
the pharmacokinetics of entacapone. No particular studies are reported on t=
he
pharmacokinetics of levodopa and carbidopa in patients with renal
insufficiency, therefore Stalevo therapy should be administered cautiously =
to
patients in severe renal impairment including those receiving dialysis ther=
apy
(see section 5.2). <o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><u><span lang=3DEN-GB style=3D'font-size:11.0pt;mso=
-ansi-language:
EN-GB'>Method of administration<o:p></o:p></span></u></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'>Each tablet is to be taken orally either with or without food (see
section 5.2). One tablet contains one treatment dose and the tablet may onl=
y be
administered as whole tablets.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;text-t=
ransform:
uppercase;mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:27.0pt;text-indent:-27.0pt;mso-pa=
gination:
none'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'=
mso-bidi-font-size:
11.0pt'>4.3<span style=3D'mso-tab-count:1'> </span>Contraindications</sp=
an></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-pagination:none;mso-list:l27 level1 lfo11;tab-stops:list 27.0pt left 28=
.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>Hypersensitivity to the active substances or to an=
y of
the excipients </span><span style=3D'font-size:11.0pt;mso-no-proof:yes'>lis=
ted in
section 6.1</span><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-lan=
guage:
EN-GB'>.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-pagination:none;mso-list:l27 level1 lfo11;tab-stops:list 27.0pt left 28=
.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>Severe hepatic impairment.<i style=3D'mso-bidi-fon=
t-style:
normal'><o:p></o:p></i></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-pagination:none;mso-list:l27 level1 lfo11;tab-stops:list 27.0pt left 28=
.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>Narrow-angle glaucoma.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-pagination:none;mso-list:l27 level1 lfo11;tab-stops:list 27.0pt left 28=
.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>Pheochromocytoma.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-pagination:none;mso-list:l27 level1 lfo11;tab-stops:list 27.0pt left 28=
.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>Coadministration of Stalevo with non-selective
monoamine oxidase (MAO-A and MAO-B) inhibitors (e.g. phenelzine,
tranylcypromine). <o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-pagination:none;mso-list:l27 level1 lfo11;tab-stops:list 27.0pt left 28=
.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>Coadministration with a selective MAO-A inhibitor =
and
a selective MAO-B inhibitor (see section 4.5). <o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-pagination:none;mso-list:l27 level1 lfo11;tab-stops:list 27.0pt left 28=
.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>A previous history of Neuroleptic Malignant Syndro=
me
(NMS) and/or non-traumatic rhabdomyolysis.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-pagination:none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-siz=
e:11.0pt;
text-transform:uppercase;mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span><=
/p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-pagination:none;tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:nor=
mal'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>4.4<span
style=3D'mso-tab-count:1'> </span>Special warnings and precautions for =
use </span></b><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p></o:p>=
</span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-pagination:none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-siz=
e:11.0pt;
mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-pagination:none;mso-list:l35 level1 lfo10;tab-stops:list 27.0pt left 28=
.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>Stalevo is not recommended for the treatment of
drug-induced extrapyramidal reactions. <o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-pagination:none;mso-list:l35 level1 lfo10;tab-stops:list 28.35pt'><![if=
 !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;text-transform:uppercase;mso-ansi-la=
nguage:
EN-GB'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times Ne=
w Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp=
;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>Stalevo therapy should be administered cautiously =
to
patients with ischemic heart disease, severe cardiovascular or pulmonary
disease, bronchial asthma, renal or endocrine disease, history of peptic ul=
cer
disease or history of convulsions. <span style=3D'text-transform:uppercase'=
><o:p></o:p></span></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-pagination:none;mso-list:l35 level1 lfo10;tab-stops:list 27.0pt left 28=
.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>In patients with a history of myocardial infarction
who have residual atrial nodal or ventricular arrhythmias; cardiac function
should be monitored with particular care during the period of initial dose
adjustments.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-pagination:none;mso-list:l35 level1 lfo10;tab-stops:list 27.0pt left 28=
.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>All patients treated with Stalevo should be monito=
red
carefully for the development of mental changes, depression with suicidal
tendencies, and other serious antisocial behaviour. Patients with past or
current psychosis should be treated with caution.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-pagination:none;mso-list:l35 level1 lfo10;tab-stops:list 27.0pt left 28=
.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>Concomitant administration of antipsychotics with
dopamine receptor-blocking properties, particularly D<sub>2</sub> receptor
antagonists should be carried out with caution, and the patient carefully
observed for loss of antiparkinsonian effect or worsening of parkinsonian s=
ymptoms.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-pagination:none;mso-list:l35 level1 lfo10;tab-stops:list 27.0pt left 28=
.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>Patients with chronic wide-angle glaucoma may be
treated with Stalevo with caution, provided the intra-ocular pressure is we=
ll
controlled and the patient is monitored carefully for changes in intra-ocul=
ar
pressure.<b style=3D'mso-bidi-font-weight:normal'><o:p></o:p></b></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-pagination:none;mso-list:l35 level1 lfo10;tab-stops:list 27.0pt left 28=
.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>Stalevo may induce orthostatic hypotension. Theref=
ore
Stalevo should be given cautiously to patients who are taking other medicin=
al
products which may cause orthostatic hypotension.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-pagination:none;mso-list:l35 level1 lfo10;tab-stops:list 27.0pt left 28=
.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>Entacapone in association with levodopa has been
associated with somnolence and episodes of sudden sleep onset in patients w=
ith
Parkinsons disease and caution should therefore be exercised when driving =
or
operating machines (see section 4.7).<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-pagination:none;mso-list:l35 level1 lfo10;tab-stops:list 27.0pt left 28=
.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>In clinical studies, </span><span style=3D'font-si=
ze:
11.0pt'>dopaminergic adverse reactions</span><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'>, e.g. dyskinesia, were more common in pati=
ents
who received entacapone and dopamine agonists (such as bromocriptine),
selegiline or amantadine compared to those who received placebo with this
combination. The doses of other antiparkinsonian medicinal products may nee=
d to
be adjusted when Stalevo treatment is substituted for a patient currently n=
ot
treated with entacapone.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-pagination:none;mso-list:l35 level1 lfo10;tab-stops:list 27.0pt left 28=
.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>Rhabdomyolysis secondary to severe dyskinesias or
neuroleptic malignant syndrome (NMS) has been observed rarely in patients w=
ith
Parkinsons disease. Therefore, any abrupt dose reduction or withdrawal of =
levodopa
should be carefully observed, particularly in patients who are also receivi=
ng
neuroleptics. NMS, including rhabdomyolysis and hyperthermia, is characteri=
sed
by motor symptoms (rigidity, myoclonus, tremor), mental status changes (e.g=
.,
agitation, confusion, coma), hyperthermia, autonomic dysfunction (tachycard=
ia,
labile blood pressure) and elevated serum creatine phosphokinase. In indivi=
dual
cases, only some of these symptoms and/or findings may be evident. The early
diagnosis is important for the appropriate management of NMS. A syndrome
resembling the neuroleptic malignant syndrome including muscular rigidity,
elevated body temperature, mental changes and increased serum creatine
phosphokinase has been reported with the abrupt withdrawal of antiparkinson=
ian
agents. Neither NMS nor rhabdomyolysis have been reported in association wi=
th
entacapone treatment from controlled trials in which entacapone was
discontinued abruptly. Since the introduction of entacapone into the market,
isolated cases of NMS have been reported, especially following abrupt reduc=
tion
or discontinuation of entacapone and other concomitant dopaminergic medicin=
al
products. When considered necessary, the replacement of Stalevo with levodo=
pa
and DDC inhibitor without entacapone or other dopaminergic treatment should
proceed slowly and an increase in levodopa dose may be necessary.<o:p></o:p=
></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-pagination:none;mso-list:l35 level1 lfo10;tab-stops:list 27.0pt left 28=
.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>If general anaesthesia is required, therapy with
Stalevo may be continued for as long as the patient is permitted to take fl=
uids
and medicinal products by mouth. If therapy has to be stopped temporarily,
Stalevo may be restarted as soon as oral medicinal products can be taken at=
 the
same daily dose as before. <o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-pagination:none;mso-list:l35 level1 lfo10;tab-stops:list 27.0pt left 28=
.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>Periodic evaluation of hepatic, haematopoietic,
cardiovascular and renal function is recommended during extended therapy wi=
th
Stalevo.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-pagination:none;mso-list:l35 level1 lfo10;tab-stops:list 27.0pt left 28=
.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>For patients experiencing diarrhoea, a follow-up of
weight is recommended in order to avoid potential excessive weight decrease.
Prolonged or persistent diarrhoea appearing during use of entacapone may be=
 a
sign of colitis. In the event of prolonged or persistent diarrhoea, the drug
should be discontinued and appropriate medical therapy and investigations
considered.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-pagination:none;mso-list:l35 level1 lfo10;tab-stops:list 27.0pt left 28=
.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>Patients should be regularly monitored for the
development of impulse control disorders. Patients and carers should be made
aware that behavioural symptoms of impulse control disorders including
pathological gambling, increased libido, hypersexuality, compulsive spendin=
g or
buying, binge eating and compulsive eating can occur in patients treated wi=
th
dopamine agonists and/or other dopaminergic treatments containing levodopa
including Stalevo. Review of treatment is recommended if such symptoms deve=
lop.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-pagination:none;mso-list:l35 level1 lfo10;tab-stops:list 28.35pt'><![if=
 !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>Dopamine Dysregulation Syndrome (DDS) is an addict=
ive
disorder resulting in excessive use of the product seen in some patients
treated with carbidopa/levodopa. Before initiation of treatment, patients a=
nd
caregivers should be warned of the potential risk of developing DDS (see al=
so
section 4.8).<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-pagination:none;mso-list:l35 level1 lfo10;tab-stops:list 27.0pt left 28=
.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>For patients who experience progressive anorexia,
asthenia and weight decrease within a relatively short period of time, a
general medical evaluation including liver function should be considered.<o=
:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-pagination:none;mso-list:l35 level1 lfo10;tab-stops:list 27.0pt left 28=
.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>Levodopa/carbidopa may cause false positive result
when a dipstick is used to test for urinary ketone and this reaction is not
altered by boiling the urine sample. The use of glucose oxidase methods may
give false negative results for glycosuria.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-pagination:none;mso-list:l35 level1 lfo10;tab-stops:list 27.0pt left 28=
.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>Stalevo contains sucrose, and therefore patients w=
ith
rare hereditary problems of fructose intolerance, glucose-galactose
malabsorption or sucrase-<span class=3DSpellE>isomaltase</span> insufficien=
cy
should not take this medicine.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-align:left;text-indent:-2=
7.0pt;
mso-pagination:none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-siz=
e:11.0pt;
mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;mso-pagination:
none;tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>4.5<span
style=3D'mso-tab-count:1'> </span>Interaction with other medicinal produ=
cts
and other forms of interaction <o:p></o:p></span></b></p>

<p class=3DText style=3D'margin-top:0in;mso-pagination:none;tab-stops:28.35=
pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-size=
:11.0pt;
mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><i style=3D'mso-bidi-font-style:normal'><span lang=
=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>Other antiparkinsonian
medicinal products</span></i><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>: To date there has been no indication of interact=
ions
that would preclude concurrent use of standard antiparkinsonian medicinal
products with Stalevo therapy. Entacapone in high doses may affect the
absorption of carbidopa. However, no interaction with carbidopa has been
observed with the recommended treatment schedule (200&nbsp;mg of entacapone=
 up
to 10 times daily). Interactions between entacapone and selegiline have been
investigated in repeated dose studies in Parkinson's disease patients treat=
ed
with levodopa/DDC inhibitor and no interaction was observed. When used with
Stalevo, the daily dose of selegiline should not exceed 10&nbsp;mg.<o:p></o=
:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><s><span lang=3DEN-GB style=3D'font-size:11.0pt;mso=
-ansi-language:
EN-GB'><o:p><span style=3D'text-decoration:none'>&nbsp;</span></o:p></span>=
</s></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'>Caution should be exercised when the following active substances are
administered concomitantly with levodopa therapy.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p>&nbsp;=
</o:p></span></b></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><i style=3D'mso-bidi-font-style:normal'><span lang=
=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>Antihypertensives</span>=
</i><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>: Symptomat=
ic
postural hypotension may occur when levodopa is added to the treatment of
patients already receiving antihypertensives. Dose adjustment of the
antihypertensive agent may be required. <i style=3D'mso-bidi-font-style:nor=
mal'><o:p></o:p></i></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><i style=3D'mso-bidi-font-style:normal'><span lang=
=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span>=
</i></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><i style=3D'mso-bidi-font-style:normal'><span lang=
=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>Antidepressants: </span>=
</i><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>Rarely, rea=
ctions
including hypertension and dyskinesia have been reported with the concomita=
nt
use of tricyclic antidepressants and levodopa/carbidopa. Interactions betwe=
en
entacapone and imipramine and between entacapone and moclobemide have been
investigated in single dose studies in healthy volunteers. No pharmacodynam=
ic
interactions were observed. A significant number of Parkinson's disease
patients have been treated with the combination of levodopa, carbidopa and
entacapone with several active substances including MAO-A inhibitors, tricy=
clic
antidepressants, noradrenaline reuptake inhibitors such as desipramine,
maprotiline and venlafaxine and medicinal products that are metabolised by =
<st1:stockticker
w:st=3D"on">COMT</st1:stockticker> (e.g. catechol-structured compounds,
paroxetine). No pharmacodynamic interactions have been observed. However,
caution should be exercised when these medicinal products are used
concomitantly with Stalevo (see sections 4.3 and 4.4).<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><i style=3D'mso-bidi-font-style:normal'><span lang=
=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span>=
</i></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><i style=3D'mso-bidi-font-style:normal'><span lang=
=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>Other active substances:=
 </span></i><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>Dopamine re=
ceptor
antagonists (e.g. some antipsychotics and antiemetics), phenytoin and
papaverine may reduce the therapeutic effect of levodopa. Patients taking t=
hese
medicinal products with Stalevo should be carefully observed for loss of
therapeutic response.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'>Due to entacapone's affinity to cytochrome P450 2C9 <i style=3D'mso-=
bidi-font-style:
normal'>in vitro</i> (see section&nbsp;5.2), Stalevo may potentially interf=
ere
with active substances whose metabolism is dependent on this isoenzyme, suc=
h as
S-warfarin. However, in an interaction study with healthy volunteers,
entacapone did not change the plasma levels of S-warfarin, while the AUC for
R-warfarin increased on average by 18% [CI<sub>90</sub> 11-26%]. The INR va=
lues
increased on average by 13% [CI<sub>90</sub> 6-19%]. Thus, a control of INR=
 is
recommended when Stalevo is initiated for patients receiving warfarin.<o:p>=
</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><i style=3D'mso-bidi-font-style:normal'><span lang=
=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>Other forms of interacti=
ons:</span></i><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'> Since levo=
dopa
competes with certain amino acids, the absorption of Stalevo may be impaire=
d in
some patients on high protein diet.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'>Levodopa and entacapone may form chelates with iron in the
gastrointestinal tract. Therefore, Stalevo and iron preparations should be
taken at least 2-3 hours apart (see section 4.8).<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><i style=3D'mso-bidi-font-style:normal'><span lang=
=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>In vitro data:</span></i=
><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'> Entacapone=
 binds
to human albumin binding site II which also binds several other medicinal
products, including diazepam and ibuprofen. According to <i style=3D'mso-bi=
di-font-style:
normal'>in vitro</i> studies, significant displacement is not anticipated at
therapeutic concentrations of the medicinal products. Accordingly, to date
there has been no indication of such interactions.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;text-t=
ransform:
uppercase;mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText style=3D'margin-top:0in;mso-pagination:none;tab-stops:28.35=
pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-size=
:11.0pt;
mso-ansi-language:EN-GB'>4.6<span style=3D'mso-tab-count:1'> </span>Fer=
tility,
pregnancy and lactation<o:p></o:p></span></b></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><u><span lang=3DEN-GB style=3D'font-size:11.0pt;mso=
-ansi-language:
EN-GB'>Pregnancy<o:p></o:p></span></u></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'>There are no adequate data from the use of the combination of
levodopa/carbidopa/entacapone in pregnant women. Studies in animals have sh=
own
reproductive toxicity of the separate compounds (see section 5.3). The
potential risk for humans is unknown. Stalevo should not be used during
pregnancy unless the benefits for the mother outweigh the possible risks to=
 the
foetus.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><u><span lang=3DEN-GB style=3D'font-size:11.0pt;mso=
-ansi-language:
EN-GB'>Breast-feeding<o:p></o:p></span></u></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'>Levodopa is excreted in human breast milk. There is evidence that br=
east-feeding
is suppressed during treatment with levodopa. Carbidopa and entacapone were
excreted in milk in animals but is not known whether they are excreted in h=
uman
breast milk. The safety of levodopa, carbidopa or entacapone in the infant =
is
not known. Women should not breast-feed during treatment with Stalevo.<o:p>=
</o:p></span></p>

<p class=3DText style=3D'mso-pagination:none'><u><span lang=3DEN-GB style=
=3D'font-size:
11.0pt;mso-ansi-language:EN-GB'>Fertility <o:p></o:p></span></u></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'>No adverse reactions on fertility were observed in preclinical studi=
es
with entacapone, carbidopa or levodopa alone. Fertility studies in animals =
have
not been conducted with the combination of entacapone, levodopa and carbido=
pa.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;text-t=
ransform:
uppercase;mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText style=3D'margin-top:0in;mso-pagination:none;tab-stops:28.35=
pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-size=
:11.0pt;
mso-ansi-language:EN-GB'>4.7<span style=3D'mso-tab-count:1'> </span>Eff=
ects
on ability to drive and use machines<o:p></o:p></span></b></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'>Stalevo may have a major influence on the ability to drive and use
machines. Levodopa, carbidopa and entacapone together may cause dizziness a=
nd
symptomatic orthostatism. Therefore, caution should be exercised when drivi=
ng
or using machines.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'>Patients being treated with Stalevo and presenting with somnolence
and/or sudden sleep onset episodes must be instructed to refrain from drivi=
ng
or engaging in activities where impaired alertness may put themselves or ot=
hers
at risk of serious injury or death (e.g. operating machines) until such
recurrent episodes have resolved (see section&nbsp;4.4).<o:p></o:p></span><=
/p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;text-t=
ransform:
uppercase;mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText style=3D'margin-top:0in;mso-pagination:none;tab-stops:28.35=
pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-size=
:11.0pt;
mso-ansi-language:EN-GB'>4.8<span style=3D'mso-tab-count:1'> </span>Und=
esirable
effects<o:p></o:p></span></b></p>

<p class=3DText style=3D'margin-top:0in;mso-pagination:none;tab-stops:28.35=
pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-size=
:11.0pt;
mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-left:0in;text-indent:0in;line-height:n=
ormal;
mso-list:l46 level1 lfo31;tab-stops:28.35pt'><![if !supportLists]><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt'><span style=3D'mso-list:Ignore'>a.<span style=3D'font:7.0pt "Times =
New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></b><![endif]><b style=3D'mso-bidi-font-weight:normal'=
><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Summary of the safety prof=
ile<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>The most frequently reported adverse
reactions with Stalevo are dyskinesias occurring in approximately 19% of
patients; gastrointestinal symptoms including nausea and diarrhoea occurrin=
g in
approximately 15% and 12% of patients, respectively; muscle, musculoskeletal
and connective tissue pain occurring in approximately 12% of patients; and
harmless reddish-brown discolouration of urine (chromaturia) occurring in
approximately 10% of patients. Serious events of gastrointestinal haemorrha=
ge
(uncommon) and angioedema (rare) have been identified from the clinical tri=
als
with Stalevo or entacapone combined with levodopa/DDC inhibitor. Serious
hepatitis with mainly cholestatic features, rhabdomyolysis and neuroleptic
malignant syndrome may occur with Stalevo although no cases have been
identified from the clinical trial data. <o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:0in;text-indent:0in;line-height:n=
ormal;
mso-list:l46 level1 lfo31;tab-stops:28.35pt'><![if !supportLists]><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt'><span style=3D'mso-list:Ignore'>b.<span style=3D'font:7.0pt "Times =
New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></b><![endif]><b style=3D'mso-bidi-font-weight:normal'=
><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Tabulated list of adverse
reactions<o:p></o:p></span></b></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>The
following adverse reactions, listed in Table 1, have been accumulated both =
from
a pooled data of eleven double-blind clinical trials consisting of 3230
patients (1810 treated with Stalevo or entacapone combined with levodopa/DDC
inhibitor, and 1420 treated with placebo combined with levodopa/DDC inhibit=
or
or cabergoline combined with levodopa/ DDC inhibitor), and from the
post-marketing data since the introduction of entacapone into the market for
the combination use of entacapone with levodopa/DDC inhibitor. <o:p></o:p><=
/span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>Adverse reactions are ranked under head=
ings
of frequency, the most frequent first, using the following convention: Very
common (&#8805;1/10); common (&#8805;1/100 to &lt;1/10); uncommon
(&#8805;1/1,000 to &lt;1/100); rare (&#8805;1/10,000 to &lt;1/1,000), very =
rare
(&lt;1/10,000), not known (cannot be estimated from the available data, sin=
ce
no valid estimate can be derived from clinical trials or epidemiological
studies).<u><o:p></o:p></u></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'mso-bidi-font-size:11.0pt'>Table 1.</span></b><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'> Adverse reactions<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><i style=3D'm=
so-bidi-font-style:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Blood and ly=
mphatic
system disorders<o:p></o:p></span></i></b></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Common:<span
style=3D'mso-tab-count:2'> </span>Anaemia<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Uncommon:<span
style=3D'mso-tab-count:2'> </span>Thrombocytopenia<o:p></o:p></spa=
n></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><i style=3D'm=
so-bidi-font-style:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;<=
/o:p></span></i></b></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><i style=3D'm=
so-bidi-font-style:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Metabolism a=
nd
nutrition disorders<o:p></o:p></span></i></b></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Common:<span
style=3D'mso-tab-count:2'> </span>Weight decreased*, decreased
appetite*<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span class=3DSpellE><b style=3D'mso-bidi-font-weight:=
normal'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DFR style=3D'mso-bidi-font=
-size:
11.0pt;mso-ansi-language:FR'>Psychiatric</span></i></b></span><b
style=3D'mso-bidi-font-weight:normal'><i style=3D'mso-bidi-font-style:norma=
l'><span
lang=3DFR style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FR'> <span
class=3DSpellE>disorders</span></span></i></b><b style=3D'mso-bidi-font-wei=
ght:
normal'><span lang=3DFR style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:FR'><o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-left:85.05pt;text-indent:-85.05pt'><sp=
an
lang=3DFR style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FR'>Common: =
<span
style=3D'mso-tab-count:1'> </span><span class=3DSpellE>Depressi=
on</span>,
hallucination, <span class=3DSpellE>confusional</span> state*, <span
class=3DSpellE>abnormal</span> <span class=3DSpellE>dreams</span>*, <span
class=3DSpellE>anxiety</span>, <span class=3DSpellE>insomnia</span><o:p></o=
:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:85.05pt;text-indent:-85.05pt'><sp=
an
class=3DSpellE><span lang=3DFR style=3D'mso-bidi-font-size:11.0pt;mso-ansi-=
language:
FR'>Uncommon</span></span><span lang=3DFR style=3D'mso-bidi-font-size:11.0p=
t;
mso-ansi-language:FR'>:<span style=3D'mso-tab-count:1'> </span>P</=
span><span
class=3DSpellE><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>sycho=
sis</span></span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>,</span><span lang=3DFR
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FR'> agitation* </span=
><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:85.05pt;text-indent:-85.05pt'><sp=
an
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Not known:<span style=3D'm=
so-tab-count:
1'> </span>Suicidal behaviour, Dopamine dysregulation syndrome</s=
pan><span
lang=3DFR style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FR'><o:p></o=
:p></span></p>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DFR
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FR'><o:p>&nbsp;</o:p><=
/span></i></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><i style=3D'm=
so-bidi-font-style:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Nervous syst=
em
disorders<o:p></o:p></span></i></b></p>

<p class=3DMsoNormal style=3D'margin-left:85.05pt;text-indent:-85.05pt'><sp=
an
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Very common:<span
style=3D'mso-tab-count:1'> </span>Dyskinesia*<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:85.05pt;text-indent:-85.05pt'><sp=
an
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Common: <span style=3D'mso=
-tab-count:
1'> </span>Parkinsonism aggravated (e.g. bradykinesia)*, tremor=
, on
and off phenomenon, dystonia, mental impairment (e.g. memory impairment,
dementia), somnolence, dizziness*, headache<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:85.05pt;text-indent:-85.05pt'><sp=
an
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Not known:<span style=3D'm=
so-tab-count:
1'> </span>Neuroleptic malignant syndrome*<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:85.05pt;text-indent:-85.05pt'><b
style=3D'mso-bidi-font-weight:normal'><i style=3D'mso-bidi-font-style:norma=
l'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
i></b></p>

<p class=3DMsoNormal style=3D'margin-left:85.05pt;text-indent:-85.05pt'><b
style=3D'mso-bidi-font-weight:normal'><i style=3D'mso-bidi-font-style:norma=
l'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Eye disorders<o:p></o:p></=
span></i></b></p>

<p class=3DMsoNormal style=3D'margin-left:85.05pt;text-indent:-85.05pt'><sp=
an
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Common:<span style=3D'mso-=
tab-count:
1'> </span>Blurred vision<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:85.05pt;text-indent:-85.05pt'><sp=
an
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-left:85.05pt;text-indent:-85.05pt'><b
style=3D'mso-bidi-font-weight:normal'><i style=3D'mso-bidi-font-style:norma=
l'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Cardiac disorders<o:p></o:=
p></span></i></b></p>

<p class=3DMsoNormal style=3D'margin-left:85.05pt;text-indent:-85.05pt'><sp=
an
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:FI;mso=
-bidi-language:
NE'>Common: <span style=3D'mso-tab-count:1'> </span>Ischemic he=
art
disease events other than myocardial infarction (e.g. angina pectoris)**,
irregular heart rhythm <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:85.05pt;text-indent:-85.05pt'><sp=
an
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Uncommon:<span style=3D'ms=
o-tab-count:
1'> </span>Myocardial infarction**<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><i style=3D'm=
so-bidi-font-style:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Vascular dis=
orders<o:p></o:p></span></i></b></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Common:<span
style=3D'mso-tab-count:2'> </span>Orthostatic hypotension,
hypertension<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Uncommon:<span
style=3D'mso-tab-count:2'> </span>Gastrointestinal haemorrhage<o:p=
></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><i style=3D'm=
so-bidi-font-style:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Respiratory,
thoracic and mediastinal disorders<o:p></o:p></span></i></b></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Common:<span
style=3D'mso-tab-count:2'> </span>Dyspnoea<o:p></o:p></span></=
p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><i style=3D'm=
so-bidi-font-style:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Gastrointest=
inal
disorders</span></i></b><i style=3D'mso-bidi-font-style:normal'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></i></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Very
common:<span style=3D'mso-tab-count:1'> </span>Diarrhoea*, nausea*<o:p=
></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:85.05pt;text-indent:-85.05pt'><sp=
an
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Common:<span
style=3D'mso-spacerun:yes'> </span><span style=3D'mso-tab-count:1'>=
 </span>Constipation*,
vomiting*, dyspepsia, abdominal pain and discomfort*, dry mouth*<o:p></o:p>=
</span></p>

<p class=3DMsoNormal style=3D'margin-left:85.05pt;text-indent:-85.05pt'><sp=
an
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Uncommon:<span style=3D'ms=
o-tab-count:
1'> </span>Colitis*, dysphagia<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><i style=3D'm=
so-bidi-font-style:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Hepatobiliary
disorders<o:p></o:p></span></i></b></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Uncommon:<span
style=3D'mso-tab-count:2'> </span>Hepatic function test abnormal*<=
o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Not
known:<span style=3D'mso-tab-count:2'> </span>Hepatitis with main=
ly
cholestatic features (see section 4.4)*<o:p></o:p></span></p>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DE=
N-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><i style=3D'm=
so-bidi-font-style:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Skin and
subcutaneous tissue disorders<o:p></o:p></span></i></b></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Common:<span
style=3D'mso-tab-count:2'> </span>Rash*, hyperhidrosis<o:p></o=
:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Uncommon:<span
style=3D'mso-tab-count:2'> </span><span class=3DSpellE>Discolourat=
ions</span>
other than urine (e.g. skin, nail, hair, sweat)*<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Rare:<span
style=3D'mso-tab-count:3'> </span>Angioedema<o:p></o:p><=
/span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Not
known:<span style=3D'mso-tab-count:2'> </span>Urticaria*<o:p></o:=
p></span></p>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DE=
N-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><i style=3D'm=
so-bidi-font-style:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Musculoskele=
tal and
connective tissue disorders<o:p></o:p></span></i></b></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Very
common:<span style=3D'mso-tab-count:1'> </span>Muscle, musculoskeletal=
 and
connective tissue pain*<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Common:<span
style=3D'mso-tab-count:2'> </span>Muscle spasms, arthralgia<o:=
p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Not
known:<span style=3D'mso-tab-count:2'> </span>Rhabdomyolysis*<o:p=
></o:p></span></p>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DE=
N-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><i style=3D'm=
so-bidi-font-style:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Renal and ur=
inary
disorders<o:p></o:p></span></i></b></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Very
common: <span style=3D'mso-tab-count:1'> </span>Chromaturia*<o:p></o:p>=
</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Common:<span
style=3D'mso-tab-count:2'> </span>Urinary tract infection<o:p>=
</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Uncommon:<span
style=3D'mso-tab-count:2'> </span>Urinary retention<o:p></o:p></sp=
an></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><i style=3D'm=
so-bidi-font-style:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;<=
/o:p></span></i></b></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><i style=3D'm=
so-bidi-font-style:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>General diso=
rders
and administration site conditions<o:p></o:p></span></i></b></p>

<p class=3DMsoNormal style=3D'margin-left:85.05pt;text-indent:-85.05pt'><sp=
an
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Common:<span
style=3D'mso-spacerun:yes'> </span><span style=3D'mso-tab-count:1'>=
 </span>Chest
pain, peripheral oedema, fall, gait disturbance, asthenia, fatigue<o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'margin-left:85.05pt;text-indent:-85.05pt'><sp=
an
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Uncommon:<span style=3D'ms=
o-tab-count:
1'> </span>Malaise<o:p></o:p></span></p>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DE=
N-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>*Adverse reactions that are mainly
attributable to entacapone or are more frequent (by the frequency differenc=
e of
at least 1% in the clinical trial data) with entacapone than levodopa/DDC
inhibitor alone. See section c.<o:p></o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:FI;mso-bidi-languag=
e:
NE'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:FI;mso-bidi-languag=
e:
NE'>**The incidence rates of myocardial infarction and other ischemic heart
disease events&nbsp;(0.43% and 1.54%, respectively) are derived from an
analysis of 13 double-blind studies involving 2082 patients with end-of-dose
motor fluctuations receiving entacapone</span><span lang=3DEN style=3D'mso-=
bidi-font-size:
11.0pt;mso-ansi-language:EN;mso-fareast-language:FI'>.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:0in;text-indent:0in;line-height:n=
ormal;
mso-list:l46 level1 lfo31;tab-stops:28.35pt'><![if !supportLists]><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt'><span style=3D'mso-list:Ignore'>c.<span style=3D'font:7.0pt "Times =
New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></b><![endif]><b style=3D'mso-bidi-font-weight:normal'=
><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Description of selected ad=
verse
reactions<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>Adverse reactions that are mainly
attributable to entacapone or are more frequent with entacapone than
levodopa/DDC inhibitor alone are indicated with an asterisk in Table 1, sec=
tion
4.8b. Some of these adverse reactions relate to the increased dopaminergic
activity (e.g. dyskinesia, nausea and vomiting) and occur most commonly at =
the
beginning of the treatment. Reduction of levodopa dose decreases the severi=
ty
and frequency of these dopaminergic reactions. Few adverse reactions are kn=
own
to be directly attributable to the active substance entacapone including
diarrhoea and reddish-brown discolouration of urine. Entacapone may in some
cases cause also discolouration of e.g. skin, nail, hair and sweat. Other
adverse reactions with an asterisk in Table 1, section 4.8b are marked base=
d on
either their more frequent occurring (by the frequency difference of at lea=
st
1%) in the clinical trial data with entacapone than levodopa/DDCI alone or =
the
individual case safety reports received after the introduction of entacapone
into the market.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'>Convulsions have occurred rarely with levodopa/carbidopa; however a
causal relationship to levodopa/carbidopa therapy has not been established.=
<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'>Impulse control disorders: Pathological gambling, increased libido,
hypersexuality, compulsive spending or buying, binge eating and compulsive
eating can occur in patients treated with dopamine agonists and/or other
dopaminergic treatments containing levodopa including Stalevo (see section =
4.4).<o:p></o:p></span></p>

<p class=3DText style=3D'mso-pagination:none'><span lang=3DEN-GB style=3D'f=
ont-size:
11.0pt;mso-ansi-language:EN-GB'>Dopamine Dysregulation Syndrome (DDS) is an
addictive disorder seen in some patients treated with carbidopa/levodopa.
Affected patients show a compulsive pattern of dopaminergic drug misuse abo=
ve<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'>doses adequate to control motor symptoms, which may in some cases re=
sult
in severe dyskinesias (see also section 4.4).<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:FI'>Entacapone in
association with levodopa has been associated with isolated cases of excess=
ive
daytime somnolence and sudden sleep onset episodes.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><u><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:FI'><o:p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'text-align:justify'><u><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>Reporting of suspected adverse reaction=
s<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>Reporting suspected adverse reactions a=
fter
authorisation of the medicinal product is important. It allows continued
monitoring of the benefit/risk balance of the medicinal product. Healthcare
professionals are asked to report any suspected adverse reactions via <span
style=3D'background:silver;mso-highlight:silver'>the national reporting sys=
tem
listed in <a
href=3D"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_fo=
rm/2013/03/WC500139752.doc">Appendix
V</a></span>.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText style=3D'margin-top:0in;mso-pagination:none;tab-stops:28.35=
pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-size=
:11.0pt;
mso-ansi-language:EN-GB'>4.9<span style=3D'mso-tab-count:1'> </span>Ove=
rdose<o:p></o:p></span></b></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'>The post-marketing data includes isolated cases of overdose in which=
 the
reported highest daily doses of levodopa and entacapone have been at least
10,000&nbsp;mg and 40,000&nbsp;mg, respectively. The acute symptoms and sig=
ns
in these cases of overdose included agitation, <span class=3DSpellE>confusi=
onal</span>
state, coma, bradycardia, ventricular tachycardia, Cheyne-Stokes respiratio=
n, <span
class=3DSpellE>discolourations</span> of skin, tongue and conjunctiva, and
chromaturia. Management of acute overdose with Stalevo therapy is similar to
acute overdose with levodopa. Pyridoxine, however, is not effective in
reversing the actions of Stalevo. Hospitalisation is advised and general
supportive measures should be employed with immediate gastric lavage and
repeated doses of charcoal over time. This may hasten the elimination of
entacapone in particular by decreasing its absorption/reabsorption from the=
 GI
tract. The adequacy of the respiratory, circulatory and renal systems shoul=
d be
carefully monitored and appropriate supportive measures employed. ECG
monitoring should be started and the patient carefully monitored for the
possible development of arrhythmias. If required, appropriate anti-arrhythm=
ic
therapy should be given. The possibility that the patient has taken other
active substances in addition to Stalevo should be taken into consideration.
The value of dialysis in the treatment of overdose is not known.<o:p></o:p>=
</span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;text-t=
ransform:
uppercase;mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;text-t=
ransform:
uppercase;mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;mso-pagination:
none;tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>5.<span
style=3D'mso-tab-count:1'> </span>PHARMACOLOGICAL PROPERTIES</span></b=
><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p></o:p>=
</span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;text-t=
ransform:
uppercase;mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;mso-pagination:
none;tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>5.1 <span
style=3D'mso-tab-count:1'> </span>Pharmacodynamic properties<o:p></o:p><=
/span></b></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;mso-pagination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'>Pharmacotherapeutic group: anti-<span class=3DSpellE>parkinson</span>
drugs, dopa and dopa derivatives, ATC code:<b style=3D'mso-bidi-font-weight=
:normal'>
</b>N04BA03<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'>According to the current understanding, the symptoms of Parkinsons
disease are related to depletion of dopamine in the corpus striatum. Dopami=
ne
does not cross the blood-brain barrier. Levodopa, the precursor of dopamine,
crosses the blood brain barrier and relieves the symptoms of the disease. As
levodopa is extensively metabolised in the periphery, only a small portion =
of a
given dose reaches the central nervous system when levodopa is administered
without metabolic enzyme inhibitors. <o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'>Carbidopa and <span class=3DSpellE>benserazide</span> are peripheral=
 DDC
inhibitors which reduce the peripheral metabolism of levodopa to dopamine, =
and
thus, more levodopa is available to the brain. When decarboxylation of levo=
dopa
is reduced with the co-administration of a DDC inhibitor, a lower dose of
levodopa can be used and the incidence of adverse reactions such as nausea =
is
reduced. <o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt;background:white'><span lang=3DEN-GB style=3D'font-s=
ize:
11.0pt;color:black;mso-color-alt:windowtext;mso-ansi-language:EN-GB'>With
inhibition of the decarboxylase by a DDC inhibitor, catechol-<i
style=3D'mso-bidi-font-style:normal'>O</i>-methyltransferase (<st1:stocktic=
ker
w:st=3D"on">COMT</st1:stockticker>) becomes the major peripheral metabolic
pathway <span class=3DSpellE>catalyzing</span> the conversion of levodopa to
3-O-methyldopa (3-OMD), a potentially harmful metabolite of levodopa. Entac=
apone
is a reversible, specific and mainly peripherally acting <st1:stockticker
w:st=3D"on">COMT</st1:stockticker> inhibitor designed for concomitant
administration with levodopa. Entacapone slows the clearance of levodopa fr=
om
the bloodstream resulting in an increased area under the curve (AUC) in the
pharmacokinetic profile of levodopa. Consequently the clinical response to =
each
dose of levodopa is enhanced and prolonged.</span><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt;background:white'><span lang=3DEN-GB style=3D'font-s=
ize:
11.0pt;mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>The evidence of the therapeutic effects=
 of
Stalevo is based on two phase <st1:stockticker w:st=3D"on">III</st1:stockti=
cker>
double-blind studies, in which 376 Parkinsons disease patients with
end-of-dose motor fluctuations received either entacapone or placebo with e=
ach
levodopa/DDC inhibitor dose. Daily ON time with and without entacapone was
recorded in home-diaries by patients. In the first study, entacapone increa=
sed
the mean daily ON time by 1&nbsp;h&nbsp;20&nbsp;min (CI <sub>95%</sub>
45&nbsp;min, 1&nbsp;h&nbsp;56&nbsp;min) from baseline. This corresponded to=
 an
8.3% increase in the proportion of daily ON time. Correspondingly, the decr=
ease
in daily OFF time was 24% in the entacapone group and 0% in the placebo gro=
up.
In the second study, the mean proportion of daily ON time increased by 4.5%=
 (CI<sub>95%</sub>
0.93%, 7.97%) from baseline. This is translated to a mean increase of
35&nbsp;min in the daily ON time. Correspondingly, the daily OFF time decre=
ased
by 18% on entacapone and by 5% on placebo. Because the effects of Stalevo
tablets are equivalent with entacapone 200&nbsp;mg tablet administered
concomitantly with the commercially available standard release
carbidopa/levodopa preparations in corresponding doses these results are ap=
plicable
to describe the effects of Stalevo as well.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;text-transform:uppercase'><o:p>&nbsp;</o=
:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;mso-pagination:
none;tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>5.2<span
style=3D'mso-tab-count:1'> </span>Pharmacokinetic properties<o:p></o:p><=
/span></b></p>

<p class=3DText style=3D'margin-top:0in;mso-pagination:none;tab-stops:28.35=
pt'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p>&nbsp;=
</o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;mso-pagination:
none;tab-stops:28.35pt'><i style=3D'mso-bidi-font-style:normal'><u><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>General
characteristics of the active substances<o:p></o:p></span></u></i></p>

<p class=3DText style=3D'margin-top:0in;mso-pagination:none;tab-stops:28.35=
pt'><b
style=3D'mso-bidi-font-weight:normal'><i style=3D'mso-bidi-font-style:norma=
l'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p>&nbsp;=
</o:p></span></i></b></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><i style=3D'mso-bidi-font-style:normal'><u><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>Absorption/=
distribution</span></u></i><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'font-size:=
11.0pt;
mso-ansi-language:EN-GB'>:</span></i><span lang=3DEN-GB style=3D'font-size:=
11.0pt;
mso-ansi-language:EN-GB'> There are substantial inter- and intra-individual
variations in the absorption of levodopa, carbidopa<sup> </sup>and entacapo=
ne.
Both levodopa and entacapone are rapidly absorbed and eliminated. Carbidopa=
 is
absorbed and eliminated slightly slower compared with levodopa. When given
separately without the two other active substances, the bioavailability for
levodopa is 15-33%, for carbidopa 40-70% and for entacapone 35% after a
200&nbsp;mg oral dose. Meals rich in large neutral amino acids may delay and
reduce the absorption of levodopa. Food does not significantly affect the
absorption of entacapone. The distribution volume of both levodopa (<span
class=3DSpellE>Vd</span> 0.36-1.6&nbsp;l/kg) and entacapone (<span class=3D=
SpellE>Vd<sub>ss</sub></span>
0.27&nbsp;l/kg) is moderately small while no data for carbidopa are availab=
le.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-2.25pt;mso-pagination:none'><sp=
an
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Levodopa is bound to plasma
protein only to a minor extent of about 10-30% and c<span style=3D'layout-g=
rid-mode:
line'>arbidopa </span>is bound <span style=3D'layout-grid-mode:line'>approx=
imately
36%</span>, <span style=3D'layout-grid-mode:line'>while e</span>ntacapone is
extensively bound to plasma proteins (about 98%) mainly to serum albumin. =
At
therapeutic concentrations, entacapone does not displace other extensively
bound active substances (e.g. warfarin, salicylic acid, phenylbutazone, or
diazepam), nor is it displaced to any significant extent by any of these
substances at therapeutic or higher concentrations.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><i style=3D'mso-bidi-font-style:normal'><u><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></i></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><i style=3D'mso-bidi-font-style:normal'><u><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>Biotransfor=
mation
and elimination</span></u></i><i style=3D'mso-bidi-font-style:normal'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>:</span></i=
><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'> Levodopa is
extensively metabolised to various metabolites: decarboxylation by dopa
decarboxylase (DDC) and O-methylation by catechol-O-methyltransferase (<st1=
:stockticker
w:st=3D"on">COMT</st1:stockticker>) being the most important pathways.<sup>=
<o:p></o:p></sup></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'>Carbidopa is metabolized to two main metabolites which are excreted =
in
the urine as glucuronides and unconjugated compounds. Unchanged carbidopa
accounts for 30% of the total urinary excretion.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'>Entacapone is almost completely metabolized prior to excretion via u=
rine
(10 to 20%) and bile/faeces<u> </u>(80 to 90%). The main metabolic pathway =
is
glucuronidation of entacapone and its active metabolite, the cis-isomer, wh=
ich
accounts for about 5% of plasma total amount.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><s><span lang=3DEN-GB style=3D'font-size:11.0pt;mso=
-ansi-language:
EN-GB'><o:p><span style=3D'text-decoration:none'>&nbsp;</span></o:p></span>=
</s></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'>Total clearance for levodopa is in the range of 0.55-1.38&nbsp;l/kg/h
and for entacapone is in the range of 0.70&nbsp;l/kg/h. The elimination-half
life is (t<sub>1/2</sub>) is 0.6-1.3 hours for levodopa, 2-3 hours for
carbidopa and 0.4-0.7 hours for entacapone, each given separately.<o:p></o:=
p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'>Due to short elimination half-lives, no true accumulation of levodop=
a or
entacapone occurs on repeated administration.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'>Data from <i style=3D'mso-bidi-font-style:normal'>in vitro</i> studi=
es
using human liver microsomal preparations indicate that entacapone inhibits
cytochrome P450 2C9 (IC50 ~ 4&nbsp;M). Entacapone showed little or no
inhibition of other types of P450 isoenzymes (CYP1A2, CYP2A6, CYP2D6, CYP2E=
1,
CYP3A and CYP2C19); see section 4.5.<s><o:p></o:p></s></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;text-t=
ransform:
uppercase;mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText style=3D'margin-top:0in;mso-pagination:none;tab-stops:28.35=
pt'><i
style=3D'mso-bidi-font-style:normal'><u><span lang=3DEN-GB style=3D'font-si=
ze:11.0pt;
mso-ansi-language:EN-GB'>Characteristics in patients<o:p></o:p></span></u><=
/i></p>

<p class=3DText style=3D'margin-top:0in;mso-pagination:none;tab-stops:28.35=
pt'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'font-size:=
11.0pt;
mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></i></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><i style=3D'mso-bidi-font-style:normal'><u><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>Elderly</sp=
an></u></i><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>: When give=
n without
carbidopa and entacapone, the absorption of levodopa is greater and elimina=
tion
is slower in elderly than in young people. However, after combination of
carbidopa with levodopa, the absorption of levodopa is similar between the =
elderly
and the young people, but the AUC is still 1.5 fold greater in the elderly =
due
to decreased DDC activity and lower clearance by aging. There are no
significant differences in the AUC of carbidopa or entacapone between young=
er
(4564 years) and elderly (6575 years).<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><i style=3D'mso-bidi-font-style:normal'><u><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>Gender</spa=
n></u></i><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'font-size:=
11.0pt;
mso-ansi-language:EN-GB'>: </span></i><span lang=3DEN-GB style=3D'font-size=
:11.0pt;
mso-ansi-language:EN-GB'>Bioavailability of levodopa is significantly highe=
r in
women than in men. In the pharmacokinetic studies with Stalevo<sup> </sup>t=
he
bioavailability of levodopa is higher in women than in men, primarily due to
the difference in body weight, while there is no gender difference with
carbidopa and entacapone.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><i style=3D'mso-bidi-font-style:normal'><u><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>Hepatic imp=
airment</span></u></i><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'font-size:=
11.0pt;
mso-ansi-language:EN-GB'>: </span></i><span lang=3DEN-GB style=3D'font-size=
:11.0pt;
mso-ansi-language:EN-GB'>The metabolism of entacapone is slowed in patients
with mild to moderate hepatic impairment (Child-Pugh Class A and B) leading=
 to
an increased plasma concentration of entacapone both in the absorption and
elimination phases (see sections 4.2 and 4.3). No particular studies on the
pharmacokinetics of carbidopa and levodopa in patients with hepatic impairm=
ent
are reported, however, it is advised that Stalevo<sup> </sup>should be
administered cautiously to patients with mild or moderate hepatic impairmen=
t. <o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><i style=3D'mso-bidi-font-style:normal'><u><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>Renal impai=
rment</span></u></i><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>: Renal imp=
airment
does not affect the pharmacokinetics of entacapone. No particular studies a=
re
reported on the pharmacokinetics of levodopa and carbidopa in patients with
renal impairment. However, a longer dosing interval of Stalevo may be
considered for patients who are receiving dialysis therapy (see section 4.2=
).<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;text-t=
ransform:
uppercase;mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;mso-pagination:
none;tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>5.3<span
style=3D'mso-tab-count:1'> </span>Preclinical safety data<o:p></o:p></sp=
an></b></p>

<p class=3DText style=3D'margin-top:0in;mso-pagination:none;tab-stops:28.35=
pt'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p>&nbsp;=
</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'>Preclinical data of levodopa, carbidopa and entacapone, tested alone=
 or
in combination, revealed no special hazard for humans based on conventional
studies of safety pharmacology, repeated dose toxicity, genotoxicity, and
carcinogenic potential. In repeated dose toxicity studies with entacapone,
anaemia most likely due to iron chelating properties of entacapone was
observed. Regarding reproduction toxicity of entacapone, decreased foetal
weight and a slightly delayed bone development were noticed in rabbits trea=
ted
at systemic exposure levels in the therapeutic range. Both levodopa and com=
binations
of carbidopa and levodopa have caused visceral and skeletal malformations in
rabbits. <o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;text-t=
ransform:
uppercase;mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;text-t=
ransform:
uppercase;mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:27.0pt;text-indent:-27.0pt;mso-pa=
gination:
none'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'=
mso-bidi-font-size:
11.0pt'>6.<span style=3D'mso-tab-count:1'> </span>PHARMACEUTICAL PARTI=
CULARS<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><b style=3D'mso-bidi-fon=
t-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;<=
/o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-left:27.0pt;text-indent:-27.0pt;mso-pa=
gination:
none'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'=
mso-bidi-font-size:
11.0pt'>6.1<span style=3D'mso-tab-count:1'> </span>List of excipients</s=
pan></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><u><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>Tablet core</span></u><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DIT style=3D=
'mso-bidi-font-size:
11.0pt;mso-ansi-language:IT'>Croscarmellose sodium<br>
Magnesium stearate<br>
Maize starch<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DIT style=3D=
'mso-bidi-font-size:
11.0pt;mso-ansi-language:IT'>Mannitol (E421)<br>
Povidone K 30 (E1201) <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DIT style=3D=
'mso-bidi-font-size:
11.0pt;mso-ansi-language:IT'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><u><span lang=3DIT
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'>Film-coating of </=
span></u><u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>50/12.5/200&nbsp;mg, 100/2=
5/200&nbsp;mg
and 150</span><span lang=3DEN-GB>/37.5/200&nbsp;mg</span></u><span lang=3DIT
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'>:<o:p></o:p></span=
></p>

<p class=3DMsoBodyText3 align=3Dleft style=3D'text-align:left'><span lang=
=3DIT
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT;font-weight:normal;
font-style:normal'>Glycerol (85 per cent) (E422)<o:p></o:p></span></p>

<p class=3DMsoBodyText3 align=3Dleft style=3D'text-align:left'><span lang=
=3DIT
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT;font-weight:normal;
font-style:normal'>Hypromellose<o:p></o:p></span></p>

<p class=3DMsoBodyText3 align=3Dleft style=3D'text-align:left'><span lang=
=3DIT
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT;font-weight:normal;
font-style:normal'>Magnesium stearate<o:p></o:p></span></p>

<p class=3DMsoBodyText3 align=3Dleft style=3D'text-align:left'><span lang=
=3DIT
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT;font-weight:normal;
font-style:normal'>Polysorbate 80<o:p></o:p></span></p>

<p class=3DMsoBodyText3 align=3Dleft style=3D'text-align:left'><span lang=
=3DIT
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT;font-weight:normal;
font-style:normal'>Red iron oxide (E172)<o:p></o:p></span></p>

<p class=3DMsoBodyText3 align=3Dleft style=3D'text-align:left'><span lang=
=3DIT
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT;font-weight:normal;
font-style:normal'>Sucrose<o:p></o:p></span></p>

<p class=3DMsoBodyText3 align=3Dleft style=3D'text-align:left'><span lang=
=3DIT
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT;font-weight:normal;
font-style:normal'>Titanium dioxide (E171)<o:p></o:p></span></p>

<p class=3DMsoBodyText3 align=3Dleft style=3D'text-align:left'><span lang=
=3DIT
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT;font-weight:normal;
font-style:normal'>Yellow iron oxide (E172)<o:p></o:p></span></p>

<p class=3DMsoBodyText3 align=3Dleft style=3D'text-align:left'><span lang=
=3DIT
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT;font-weight:normal;
font-style:normal'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><u><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>Film-coating of 75/18.75/200&nbsp;mg, 1=
25/31.25/200&nbsp;mg,
175/43.75/200&nbsp;mg and 200/50/200&nbsp;mg</span></u><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>:<u><o:p></o:p></u></span></p>

<p class=3DMsoBodyText3 align=3Dleft style=3D'text-align:left'><span lang=
=3DIT
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT;font-weight:normal;
font-style:normal'>Glycerol (85 per cent) (E422)<o:p></o:p></span></p>

<p class=3DMsoBodyText3 align=3Dleft style=3D'text-align:left'><span lang=
=3DIT
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT;font-weight:normal;
font-style:normal'>Hypromellose<o:p></o:p></span></p>

<p class=3DMsoBodyText3 align=3Dleft style=3D'text-align:left'><span lang=
=3DIT
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT;font-weight:normal;
font-style:normal'>Magnesium stearate<o:p></o:p></span></p>

<p class=3DMsoBodyText3 align=3Dleft style=3D'text-align:left'><span lang=
=3DIT
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT;font-weight:normal;
font-style:normal'>Polysorbate 80<o:p></o:p></span></p>

<p class=3DMsoBodyText3 align=3Dleft style=3D'text-align:left'><span lang=
=3DIT
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT;font-weight:normal;
font-style:normal'>Red iron oxide (E172)<o:p></o:p></span></p>

<p class=3DMsoBodyText3 align=3Dleft style=3D'text-align:left'><span lang=
=3DIT
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT;font-weight:normal;
font-style:normal'>Sucrose<o:p></o:p></span></p>

<p class=3DMsoBodyText3 align=3Dleft style=3D'text-align:left'><span lang=
=3DIT
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT;font-weight:normal;
font-style:normal'>Titanium dioxide (E171)<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DIT style=3D=
'mso-bidi-font-size:
11.0pt;mso-ansi-language:IT'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:27.0pt;text-indent:-27.0pt;mso-pa=
gination:
none'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'=
mso-bidi-font-size:
11.0pt'>6.2<span style=3D'mso-tab-count:1'> </span>Incompatibilities</sp=
an></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>Not applicable.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:27.0pt;text-indent:-27.0pt;mso-pa=
gination:
none'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'=
mso-bidi-font-size:
11.0pt'>6.3<span style=3D'mso-tab-count:1'> </span>Shelf life</span></b>=
<span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>3 years.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:27.0pt;text-indent:-27.0pt;mso-pa=
gination:
none'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'=
mso-bidi-font-size:
11.0pt'>6.4<span style=3D'mso-tab-count:1'> </span>Special precautions f=
or
storage</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o=
:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>This medicinal product does not require=
 any
special storage conditions.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:27.0pt;text-indent:-27.0pt;mso-pa=
gination:
none'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'=
mso-bidi-font-size:
11.0pt'>6.5<span style=3D'mso-tab-count:1'> </span>Nature and contents of
container</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>=
<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>HDPE bottle with a child resistant
PP-closure.<o:p></o:p></span></p>

<p class=3DMsoEndnoteText style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>Pack sizes of 50/12.5/200&nbsp;mg,
100/25/200&nbsp;mg and 150</span><span lang=3DEN-GB>/37.5/200&nbsp;mg</span=
><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>10, 30, 100, 130, 175 and 250 tablets.<=
o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>Pack sizes of 75/18.75/200&nbsp;mg,
125/31.25/200&nbsp;mg,&nbsp;175/43.75/200&nbsp;mg and 200/50/200&nbsp;mg:<o=
:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>10, 30, 100, 130 and 175 tablets.<o:p><=
/o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>Not all pack sizes may be marketed.<o:p=
></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:27.0pt;text-indent:-27.0pt;mso-pa=
gination:
none'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'=
mso-bidi-font-size:
11.0pt'>6.6<span style=3D'mso-tab-count:1'> </span>Special precautions f=
or
disposal</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><=
o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>Any unused medicinal product or waste
material should be disposed of in accordance with local requirements.<o:p><=
/o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;text-t=
ransform:
uppercase;mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:27.0pt;text-indent:-27.0pt;mso-pa=
gination:
none;mso-list:l21 level1 lfo4;tab-stops:28.35pt list 37.05pt'><![if !suppor=
tLists]><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt'><span style=3D'mso-list:Ignore'>7.<span style=3D'font:7.0pt "Times =
New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></b><![endif]><b style=3D'mso-bidi-font-weight:normal'=
><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>MARKETING AUTHORISATION HO=
LDER<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>Orion Corporation<o:p></o:p></span></p>

<p class=3DFigure style=3D'margin-top:0in;mso-pagination:none;page-break-af=
ter:
auto;tab-stops:28.35pt'><span class=3DSpellE><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt'>Orionintie</span></span><span lang=3DEN-GB style=3D'font-size:11.0p=
t'> 1<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>FI-02200 Espoo<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>Finland<o:p></o:p></span></p>

<p class=3DMsoEndnoteText style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:27.0pt;text-indent:-27.0pt;mso-pa=
gination:
none'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'=
mso-bidi-font-size:
11.0pt'>8.<span style=3D'mso-tab-count:1'> </span>MARKETING AUTHORISAT=
ION
NUMBERS <o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><u><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>50&nbsp;mg/12.5&nbsp;mg/200&nbsp;mg<o:p=
></o:p></span></u></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>EU/1/03/260/001-004<o:p></o:p></span></=
p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>EU/1/03/260/013<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>EU/1/03/260/016<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><u><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>75&nbsp;mg/18.75&nbsp;mg/200&nbsp;mg<o:=
p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>EU/1/03/260/024-028<o:p></o:p></span></=
p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><u><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>100&nbsp;mg/25&nbsp;mg/200&nbsp;mg<o:p>=
</o:p></span></u></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>EU/1/03/260/005-008<o:p></o:p></span></=
p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>EU/1/03/260/014<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>EU/1/03/260/017<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><u><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>125&nbsp;mg/31.25&nbsp;mg/200&nbsp;mg<o=
:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>EU/1/03/260/029-033<o:p></o:p></span></=
p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><u><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>150&nbsp;mg/37.5&nbsp;mg/200&nbsp;mg<o:=
p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>EU/1/03/260/009-012<o:p></o:p></span></=
p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>EU/1/03/260/015<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>EU/1/03/260/018<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><u><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>175&nbsp;mg/43.75&nbsp;mg/200&nbsp;mg<o=
:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>EU/1/03/260/034-038<o:p></o:p></span></=
p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><u><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>200&nbsp;mg/50&nbsp;mg/200&nbsp;mg<o:p>=
</o:p></span></u></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>EU/1/03/260/019-023<o:p></o:p></span></=
p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:27.0pt;text-indent:-27.0pt;mso-pa=
gination:
none'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'=
mso-bidi-font-size:
11.0pt'>9.<span style=3D'mso-tab-count:1'> </span>DATE OF FIRST
AUTHORISATION/RENEWAL OF THE AUTHORISATION<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>Date of first authorisation: 17 October=
 2003<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>Date of latest renewal: 17 October 2008=
<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:27.0pt;text-indent:-27.0pt;mso-pa=
gination:
none'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'=
mso-bidi-font-size:
11.0pt'>10.<span style=3D'mso-tab-count:1'> </span>DATE OF REVISION OF T=
HE
TEXT<o:p></o:p></span></b></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;mso-pa=
gination:
none;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Detailed
information on this <span style=3D'mso-bidi-font-style:italic;mso-no-proof:=
yes'>medicinal
product</span> is available on the <span style=3D'mso-no-proof:yes'>website=
 of </span>European
Medicines Agency <a href=3D"http://www.ema.europa.eu">http://www.ema.europa=
.eu</a>.<o:p></o:p></span></p>

<b style=3D'mso-bidi-font-weight:normal'><span style=3D'font-size:11.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-ansi-language:EN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA'=
><br
clear=3Dall style=3D'mso-special-character:line-break;page-break-before:alw=
ays'>
</span></b>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:27.0pt;margin-bottom:.0001pt;text-align:left;text-indent:-2=
7.0pt;
mso-pagination:none;tab-stops:28.35pt'><span style=3D'mso-bidi-font-size:11=
.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-left:28.35pt;text-align=
:center;
text-indent:-28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt=
'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-left:28.35pt;text-align=
:center;
text-indent:-28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt=
'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-left:28.35pt;text-align=
:center;
text-indent:-28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt=
'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-left:28.35pt;text-align=
:center;
text-indent:-28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt=
'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-left:28.35pt;text-align=
:center;
text-indent:-28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt=
'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-left:28.35pt;text-align=
:center;
text-indent:-28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt=
'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-left:28.35pt;text-align=
:center;
text-indent:-28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt=
'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-left:28.35pt;text-align=
:center;
text-indent:-28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt=
'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-left:28.35pt;text-align=
:center;
text-indent:-28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt=
'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-left:28.35pt;text-align=
:center;
text-indent:-28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt=
'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-left:28.35pt;text-align=
:center;
text-indent:-28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt=
'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-left:28.35pt;text-align=
:center;
text-indent:-28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt=
'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-left:28.35pt;text-align=
:center;
text-indent:-28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt=
'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-left:28.35pt;text-align=
:center;
text-indent:-28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt=
'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-left:28.35pt;text-align=
:center;
text-indent:-28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt=
'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-left:28.35pt;text-align=
:center;
text-indent:-28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt=
'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-left:28.35pt;text-align=
:center;
text-indent:-28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt=
'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-left:28.35pt;text-align=
:center;
text-indent:-28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt=
'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-left:28.35pt;text-align=
:center;
text-indent:-28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt=
'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-left:28.35pt;text-align=
:center;
text-indent:-28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt=
'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-left:28.35pt;text-align=
:center;
text-indent:-28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt=
'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-left:28.35pt;text-align=
:center;
text-indent:-28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt=
'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-left:28.35pt;text-align=
:center;
text-indent:-28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt=
'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-left:28.35pt;text-align=
:center;
text-indent:-28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt=
'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'mso-bidi-font-size:11.0pt'>ANNEX II<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:70.8pt;margin-bot=
tom:
0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-hei=
ght:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;<=
/o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:70.8pt;margin-bot=
tom:
0in;margin-left:74.7pt;margin-bottom:.0001pt;text-indent:-.25in;mso-paginat=
ion:
widow-orphan no-line-numbers;mso-list:l3 level1 lfo1'><![if !supportLists]>=
<b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'><span style=3D'mso-list:Ignore'>A.<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp; </span></span></s=
pan></b><![endif]><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>MANUFACTURERS R<st1:PersonName w:st=3D"on">ES</st1=
:PersonName>PON<st1:PersonName
w:st=3D"on">SI</st1:PersonName>BLE FOR BATCH R<st1:PersonName w:st=3D"on">E=
L</st1:PersonName>EA<st1:PersonName
w:st=3D"on">SE</st1:PersonName><o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-left:74.7pt;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:70.8pt;margin-bot=
tom:
0in;margin-left:74.7pt;margin-bottom:.0001pt;text-indent:-.25in;mso-paginat=
ion:
widow-orphan no-line-numbers;mso-list:l3 level1 lfo1'><![if !supportLists]>=
<b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'><span style=3D'mso-list:Ignore'>B.<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp; </span></span></s=
pan></b><![endif]><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>CONDITIONS OR R<st1:PersonName w:st=3D"on">ES</st1=
:PersonName>TRICTIONS
REGARDING SUP<st1:PersonName w:st=3D"on">PL</st1:PersonName>Y AND USE<o:p><=
/o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-left:74.7pt;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:77.9pt;margin-bot=
tom:
0in;margin-left:74.7pt;margin-bottom:.0001pt;text-indent:-.25in;mso-paginat=
ion:
widow-orphan no-line-numbers;mso-list:l3 level1 lfo1'><![if !supportLists]>=
<b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'><span style=3D'mso-list:Ignore'>C.<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp; </span></span></s=
pan></b><![endif]><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING
AUTHOR<st1:PersonName w:st=3D"on">IS</st1:PersonName>ATION<o:p></o:p></span=
></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.05pt;margin-bot=
tom:
0in;margin-left:74.7pt;margin-bottom:.0001pt;mso-pagination:widow-orphan no=
-line-numbers'><u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-style:italic;
mso-no-proof:yes'><o:p><span style=3D'text-decoration:none'>&nbsp;</span></=
o:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-left:74.7pt;text-indent:-.25in;mso-pag=
ination:
widow-orphan no-line-numbers;mso-list:l3 level1 lfo1'><![if !supportLists]>=
<b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ig=
nore'>D.<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp; </span></span></s=
pan></b><![endif]><b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>CONDITIONS OR RESTRICTIONS=
 WITH
REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT <o:p></o:p></=
span></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:70.8pt;margin-bot=
tom:
0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-hei=
ght:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;<=
/o:p></span></p>

<b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-s=
ize:11.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-ansi-language:EN-GB;mso-fareast-language:EN-US;mso-bidi-language:AR-SA'=
><br
clear=3Dall style=3D'page-break-before:always'>
</span></b>

<h1 align=3Dleft style=3D'text-align:left'><span lang=3DEN-GB>A<span
style=3D'mso-tab-count:1'> </span>MANUFACTURERS RESPONSIBLE FOR BATCH
RELEASE</span></h1>

<p class=3DMsoNormal style=3D'margin-right:70.8pt;line-height:normal;mso-li=
st:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;mso-li=
st:skip;
tab-stops:28.35pt'><u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt=
'>Name
and address of the manufacturers responsible for batch release<o:p></o:p></=
span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'tab-stops:28.35pt 141.75pt 3.25in'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>Orion Corporation Orion Pharma<o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:28.35pt 141.75pt 3.25in'><span
class=3DSpellE><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Joens=
uunkatu</span></span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>&nbsp;7<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'tab-stops:28.35pt 141.75pt 3.25in'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>FI-24100&nbsp;Salo<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Finland<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'>Orion
Corporation </span><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>O=
rion
Pharma</span><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-la=
nguage:
IT'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'>Orionint=
ie&nbsp;1<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'>FI-02200=
&nbsp;Espoo<o:p></o:p></span></p>

<p class=3DMsoEndnoteText style=3D'mso-list:skip;tab-stops:28.35pt'><span l=
ang=3DIT
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'>Finland<o:p></o:p>=
</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span lang=
=3DIT
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'><o:p>&nbsp;</o:p><=
/span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span lang=
=3DIT
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'>The printed packag=
e leaflet
of the medicinal product must state the name and address of the manufacturer
responsible for the release of the concerned batch.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span lang=
=3DIT
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'><o:p>&nbsp;</o:p><=
/span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span lang=
=3DIT
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'><o:p>&nbsp;</o:p><=
/span></p>

<h1 align=3Dleft style=3D'text-align:left'><span lang=3DEN-GB>B<span
style=3D'mso-tab-count:1'> </span>CONDITIONS OR RESTRICTIONS REGARDING
SUPPLY <st1:stockticker w:st=3D"on">AND</st1:stockticker> USE</span></h1>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;mso-li=
st:skip'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoEndnoteText style=3D'mso-list:skip'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>Medicinal product subject to medical
prescription.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<h1 align=3Dleft style=3D'margin-left:28.35pt;text-align:left;text-indent:-=
28.35pt'><span
lang=3DEN-GB>C<span style=3D'mso-tab-count:1'> </span>OTHER CONDITION=
S AND
REQUIREMENTS OF THE MARKETING AUTHORISATION </span></h1>

<p class=3DMsoNormal style=3D'margin-right:28.35pt;text-align:justify;line-=
height:
normal;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:28.35pt;margin-bo=
ttom:
0in;margin-left:0in;margin-bottom:.0001pt;text-indent:0in;mso-list:l7 level=
1 lfo54;
tab-stops:0in'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi-fo=
nt-size:
11.0pt;font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fami=
ly:
Symbol;mso-bidi-font-style:italic'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><b style=3D'mso-bidi-font-weight:normal'><sp=
an
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-style:italic'=
>Periodic
safety update reports (PSURs)<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:28.35pt;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:28.35pt;tab-stops:28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>The requirements for submi=
ssion of
PSURs for this medicinal product are set out in the list of Union reference
dates (EURD list) provided for under Article 107c(7) of Directive 2001/83/EC
and any subsequent updates published on the European medicines web portal.<=
o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:28.35pt;text-align:justify;line-=
height:
normal;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:28.35pt;text-align:justify;line-=
height:
normal;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'><o:p>&nbsp;</o:p></span></p>

<h1 align=3Dleft style=3D'margin-left:28.35pt;text-align:left;text-indent:-=
28.35pt'><span
lang=3DEN-GB>D.<span style=3D'mso-tab-count:1'> </span>CONDITIONS OR
RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRO=
DUCT
</span></h1>

<p class=3DMsoNormal style=3D'margin-right:28.35pt;line-height:normal;tab-s=
tops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:28.35pt;margin-bo=
ttom:
0in;margin-left:0in;margin-bottom:.0001pt;text-indent:0in;line-height:norma=
l;
mso-list:l7 level1 lfo54;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;font-family:Symbol;mso-fare=
ast-font-family:
Symbol;mso-bidi-font-family:Symbol'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><b style=3D'mso-bidi-font-weight:normal'><sp=
an
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-style:italic'=
>Risk management
plan (RMP)</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:28.35pt;line-height:normal;tab-s=
tops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:28.35pt;line-height:normal;tab-s=
tops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Not applica=
ble.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:28.35pt;text-align:justify;line-=
height:
normal;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'><o:p>&nbsp;</o:p></span></p>

<b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-s=
ize:11.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-ansi-language:EN-GB;mso-fareast-language:EN-US;mso-bidi-language:AR-SA'=
><br
clear=3Dall style=3D'mso-special-character:line-break;page-break-before:alw=
ays'>
</span></b>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-left:28.35pt;text-align=
:center;
text-indent:-28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-left:28.35pt;text-align=
:center;
text-indent:-28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-left:28.35pt;text-align=
:center;
text-indent:-28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-left:28.35pt;text-align=
:center;
text-indent:-28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-left:28.35pt;text-align=
:center;
text-indent:-28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-left:28.35pt;text-align=
:center;
text-indent:-28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-left:28.35pt;text-align=
:center;
text-indent:-28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-left:28.35pt;text-align=
:center;
text-indent:-28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-left:28.35pt;text-align=
:center;
text-indent:-28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-left:28.35pt;text-align=
:center;
text-indent:-28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-left:28.35pt;text-align=
:center;
text-indent:-28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-left:28.35pt;text-align=
:center;
text-indent:-28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-left:28.35pt;text-align=
:center;
text-indent:-28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-left:28.35pt;text-align=
:center;
text-indent:-28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-left:28.35pt;text-align=
:center;
text-indent:-28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-left:28.35pt;text-align=
:center;
text-indent:-28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-left:28.35pt;text-align=
:center;
text-indent:-28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-left:28.35pt;text-align=
:center;
text-indent:-28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-left:28.35pt;text-align=
:center;
text-indent:-28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-left:28.35pt;text-align=
:center;
text-indent:-28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-left:28.35pt;text-align=
:center;
text-indent:-28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-left:28.35pt;text-align=
:center;
text-indent:-28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-left:28.35pt;text-align=
:center;
text-indent:-28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>ANNEX <st1:stockticker w:st=3D"on">III<=
/st1:stockticker><o:p></o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-left:28.35pt;text-align=
:center;
text-indent:-28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-left:28.35pt;text-align=
:center;
text-indent:-28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>LABELLING <st1:stockticker w:st=3D"on">=
AND</st1:stockticker>
PACKAGE LEAFLET<o:p></o:p></span></b></p>

<span lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",=
serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB;mso-farea=
st-language:
EN-US;mso-bidi-language:AR-SA'><br clear=3Dall style=3D'mso-special-charact=
er:line-break;
page-break-before:always'>
</span>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><sp=
an
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:28.3pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<h1><span lang=3DEN-GB>A. LABELLING</span></h1>

<span lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",=
serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB;mso-farea=
st-language:
EN-US;mso-bidi-language:AR-SA'><br clear=3Dall style=3D'mso-special-charact=
er:line-break;
page-break-before:always'>
</span>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes;
  height:52.0pt'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:5=
2.0pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>PARTICULARS TO APPEAR ON THE OUTER
  PACKAGING <st1:stockticker w:st=3D"on">AND</st1:stockticker> THE IMMEDIATE
  PACKAGING<o:p></o:p></span></b></p>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>BOTTLE LABEL <st1:stockticker w:st=3D=
"on">AND</st1:stockticker>
  OUTER CARTON TEXT<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>1.<span style=3D'mso-tab-count:1'> </span>NAME OF THE MEDIC=
INAL
  PRODUCT<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span class=3DSpellE><span lang=3DEN-GB style=3D'mso-b=
idi-font-size:
11.0pt'>Stalevo</span></span><span lang=3DEN-GB style=3D'mso-bidi-font-size=
:11.0pt'>
50&nbsp;mg/12.5&nbsp;mg/200&nbsp;mg film-coated tablets <o:p></o:p></span><=
/p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>levodopa/carbidopa/entacapone<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>2.<span style=3D'mso-tab-count:1'> </span>STATEMENT OF ACTI=
VE
  SUBSTANCE(S)<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Each film-coated
tablet contains 50&nbsp;mg of levodopa, 12.5&nbsp;mg of carbidopa and
200&nbsp;mg of entacapone.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>3.<span style=3D'mso-tab-count:1'> </span>LIST OF EXCIPIENT=
S<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Contains
sucrose. <o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>4.<span style=3D'mso-tab-count:1'> </span>PHARMACEUTICAL <s=
t1:stockticker
  w:st=3D"on">FORM</st1:stockticker> <st1:stockticker w:st=3D"on">AND</st1:=
stockticker>
  CONTENTS<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DE=
N-GB
style=3D'mso-bidi-font-size:11.0pt;background:silver;mso-highlight:silver'>=
Carton<o:p></o:p></span></i></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>10
film-coated tablets<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>30 film-coated tablets<o:p></o:p></=
span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>100 film-coated tablets<o:p></o:p><=
/span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>130 film-coated tablets<o:p></o:p><=
/span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>175 film-coated tablets<o:p></o:p><=
/span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>250 film-coated tablets</span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DE=
N-GB
style=3D'mso-bidi-font-size:11.0pt;background:silver;mso-highlight:silver'>=
Label</span></i><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>10
tablets<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>30 tablets<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>100 tablets<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>130 tablets<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>175 tablets<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>250 tablets</span><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>5.<span style=3D'mso-tab-count:1'> </span>METHOD <st1:stock=
ticker
  w:st=3D"on">AND</st1:stockticker> ROUTE(S) OF ADMINISTRATION<o:p></o:p></=
span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Read the
package leaflet before use.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Oral use.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>6.<span style=3D'mso-tab-count:1'> </span>SPECIAL WARNING T=
HAT
  THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDR=
EN<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Keep out
of the sight and reach of children.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>7.<span style=3D'mso-tab-count:1'> </span>OTHER SPECIAL
  WARNING(S), IF NECESSARY<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>8.<span style=3D'mso-tab-count:1'> </span>EXPIRY DATE<o:p><=
/o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>EXP<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>9.<span style=3D'mso-tab-count:1'> </span>SPECIAL STORAGE
  CONDITIONS</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'><o:p></o:p></span></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>10.<span style=3D'mso-tab-count:1'> </span>SPECIAL PRECAUTION=
S FOR
  DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH
  MEDICINAL PRODUCTS, IF APPROPRIATE<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>11.<span style=3D'mso-tab-count:1'> </span>NAME <st1:stocktic=
ker
  w:st=3D"on">AND</st1:stockticker> ADDRESS OF THE MARKETING AUTHORISATION =
HOLDER<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DE=
N-GB
style=3D'mso-bidi-font-size:11.0pt;background:silver;mso-highlight:silver'>=
Carton</span></i><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'mso-bidi-f=
ont-size:
11.0pt'><o:p></o:p></span></i></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
IT'>Orion Corporation<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
IT'>Orionintie 1<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
IT'>FI-02200 Espoo<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
IT'>Finland<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
IT'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DIT
style=3D'mso-bidi-font-size:11.0pt;background:silver;mso-highlight:silver;
mso-ansi-language:IT'>Label</span></i><i style=3D'mso-bidi-font-style:norma=
l'><span
lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'><o:p></o=
:p></span></i></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
IT'>Orion Corporation<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
IT'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
IT'><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>12.<span style=3D'mso-tab-count:1'> </span>MARKETING AUTHORIS=
ATION
  NUMBER(S)<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>EU/1/03/260/001<span
style=3D'mso-spacerun:yes'> </span><span style=3D'color:black;mso-color-al=
t:windowtext;
background:silver;mso-highlight:silver;mso-shading:#CCCCCC'>10 film-coated
tablets</span><span style=3D'background:gray;mso-highlight:gray'><o:p></o:p=
></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;background:silver;mso-highlight:silver'>=
EU/1/03/260/002<span
style=3D'mso-spacerun:yes'> </span><span style=3D'color:black;mso-color-al=
t:windowtext;
mso-shading:#CCCCCC'>30 film-coated tablets</span><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;background:silver;mso-highlight:silver'>=
EU/1/03/260/003<span
style=3D'mso-spacerun:yes'> </span><span style=3D'color:black;mso-color-al=
t:windowtext;
mso-shading:#CCCCCC'>100 film-coated tablets</span><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;background:silver;mso-highlight:silver'>=
EU/1/03/260/004<span
style=3D'mso-spacerun:yes'> </span><span style=3D'color:black;mso-color-al=
t:windowtext;
mso-shading:#CCCCCC'>250 film-coated tablets</span><span style=3D'mso-shadi=
ng:
#CCCCCC'><o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;background:silver;mso-highlight:silver'>=
EU/1/03/260/013<span
style=3D'mso-spacerun:yes'> </span>175<span style=3D'color:black;mso-color=
-alt:
windowtext;mso-shading:#CCCCCC'> film-coated tablets</span></span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>EU/1/03/260/016<span
style=3D'mso-spacerun:yes'> </span>130 film-coated tablets</span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>13.<span style=3D'mso-tab-count:1'> </span>BATCH NUMBER<o:p><=
/o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Batch<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>14.<span style=3D'mso-tab-count:1'> </span>GENERAL CLASSIFICA=
TION
  FOR SUPPLY<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>15.<span style=3D'mso-tab-count:1'> </span>INSTRUCTIONS ON US=
E<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>16.<span style=3D'mso-tab-count:1'> </span>INFORMATION IN BRA=
ILLE<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span class=3DSpellE><span lang=3DEN-GB style=3D'mso-b=
idi-font-size:
11.0pt'>stalevo</span></span><span lang=3DEN-GB style=3D'mso-bidi-font-size=
:11.0pt'>
50/12.5/200&nbsp;mg <i style=3D'mso-bidi-font-style:normal'><span
style=3D'background:silver;mso-highlight:silver'>[carton only]</span></i><o=
:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><u><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black'><o:p><span style=3D'text-de=
coration:
 none'>&nbsp;</span></o:p></span></u></b></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=3DMsoNormal style=3D'border:none;mso-border-alt:solid windowtext .=
5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 0in 4.0pt'><b style=3D'mso-bidi-fon=
t-weight:
normal'><span lang=3DEN-GB style=3D'mso-no-proof:yes'>17.<span style=3D'mso=
-tab-count:
1'> </span>UNIQUE IDENTIFIER  2D BARCODE</span></b><i style=3D'mso-bid=
i-font-style:
normal'><span lang=3DEN-GB style=3D'mso-no-proof:yes'><o:p></o:p></span></i=
></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black;background:silver;mso-highlight:silver'>2D barcode carrying the
unique identifier included</span><span lang=3DEN-GB style=3D'mso-bidi-font-=
size:
11.0pt;color:black'> <i style=3D'mso-bidi-font-style:normal'><span
style=3D'background:#D9D9D9'>[carton only]</span></i><span style=3D'backgro=
und:
#D9D9D9'><o:p></o:p></span></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black;background:#D9D9D9'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black;background:#D9D9D9'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=3DMsoNormal style=3D'border:none;mso-border-alt:solid windowtext .=
5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 0in 4.0pt'><b style=3D'mso-bidi-fon=
t-weight:
normal'><span lang=3DEN-GB style=3D'mso-no-proof:yes'>18.<span style=3D'mso=
-tab-count:
1'> </span>UNIQUE IDENTIFIER - HUMAN READABLE DATA</span></b><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'mso-no-pro=
of:yes'><o:p></o:p></span></i></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DE=
N-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;background:#D9D9D9'>[carton =
only]:<o:p></o:p></span></i></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>PC <span
style=3D'background:silver;mso-highlight:silver'>{number}</span> <o:p></o:p=
></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>SN <span
style=3D'background:silver;mso-highlight:silver'>{number}</span> <o:p></o:p=
></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>&lt;NN <span
style=3D'background:silver;mso-highlight:silver'>{number}</span>&gt;<span
style=3D'color:black'><o:p></o:p></span></span></p>

<span lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",=
serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB;mso-farea=
st-language:
EN-US;mso-bidi-language:AR-SA'><br clear=3Dall style=3D'mso-special-charact=
er:line-break;
page-break-before:always'>
</span>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes;
  height:52.0pt'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:5=
2.0pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>PARTICULARS TO APPEAR ON THE OUTER
  PACKAGING <st1:stockticker w:st=3D"on">AND</st1:stockticker> THE IMMEDIATE
  PACKAGING<o:p></o:p></span></b></p>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>BOTTLE LABEL <st1:stockticker w:st=3D=
"on">AND</st1:stockticker>
  OUTER CARTON TEXT<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>1.<span style=3D'mso-tab-count:1'> </span>NAME OF THE MEDIC=
INAL
  PRODUCT<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span class=3DSpellE><span lang=3DEN-GB style=3D'mso-b=
idi-font-size:
11.0pt'>Stalevo</span></span><span lang=3DEN-GB style=3D'mso-bidi-font-size=
:11.0pt'>
75&nbsp;mg/18.75&nbsp;mg/200&nbsp;mg film-coated tablets<o:p></o:p></span><=
/p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>levodopa/carbidopa/entacapone<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>2.<span style=3D'mso-tab-count:1'> </span>STATEMENT OF ACTI=
VE
  SUBSTANCE(S)<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Each film-coated
tablet contains 75&nbsp;mg of levodopa, 18.75&nbsp;mg of carbidopa and
200&nbsp;mg of entacapone.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>3.<span style=3D'mso-tab-count:1'> </span>LIST OF EXCIPIENT=
S<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Contains
sucrose. <o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>4.<span style=3D'mso-tab-count:1'> </span>PHARMACEUTICAL <s=
t1:stockticker
  w:st=3D"on">FORM</st1:stockticker> <st1:stockticker w:st=3D"on">AND</st1:=
stockticker>
  CONTENTS<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DE=
N-GB
style=3D'mso-bidi-font-size:11.0pt;background:silver;mso-highlight:silver'>=
Carton</span></i><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'mso-bidi-f=
ont-size:
11.0pt'><o:p></o:p></span></i></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>10
film-coated tablets<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>30 film-coated tablets<o:p></o:p></=
span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>100 film-coated tablets<o:p></o:p><=
/span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>130 film-coated tablets<o:p></o:p><=
/span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>175 film-coated tablets<o:p></o:p><=
/span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DE=
N-GB
style=3D'mso-bidi-font-size:11.0pt;background:silver;mso-highlight:silver'>=
Label</span></i><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'mso-bidi-f=
ont-size:
11.0pt'><o:p></o:p></span></i></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>10
tablets<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>30 tablets<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>100 tablets<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>130 tablets<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>175 tablets<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>5.<span style=3D'mso-tab-count:1'> </span>METHOD <st1:stock=
ticker
  w:st=3D"on">AND</st1:stockticker> ROUTE(S) OF ADMINISTRATION<o:p></o:p></=
span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Read the
package leaflet before use.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Oral use.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>6.<span style=3D'mso-tab-count:1'> </span>SPECIAL WARNING T=
HAT
  THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDR=
EN<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Keep out
of the sight and reach of children.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>7.<span style=3D'mso-tab-count:1'> </span>OTHER SPECIAL
  WARNING(S), IF NECESSARY<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>8.<span style=3D'mso-tab-count:1'> </span>EXPIRY DATE<o:p><=
/o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>EXP<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>9.<span style=3D'mso-tab-count:1'> </span>SPECIAL STORAGE
  CONDITIONS</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'><o:p></o:p></span></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>10.<span style=3D'mso-tab-count:1'> </span>SPECIAL PRECAUTION=
S FOR
  DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH
  MEDICINAL PRODUCTS, IF APPROPRIATE<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>11.<span style=3D'mso-tab-count:1'> </span>NAME <st1:stocktic=
ker
  w:st=3D"on">AND</st1:stockticker> ADDRESS OF THE MARKETING AUTHORISATION =
HOLDER<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DIT
style=3D'mso-bidi-font-size:11.0pt;background:silver;mso-highlight:silver;
mso-ansi-language:IT'>Carton</span></i><i style=3D'mso-bidi-font-style:norm=
al'><span
lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'><o:p></o=
:p></span></i></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
IT'>Orion Corporation<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
IT'>Orionintie 1<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
IT'>FI-02200 Espoo<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
IT'>Finland<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
IT'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DIT
style=3D'mso-bidi-font-size:11.0pt;background:silver;mso-highlight:silver;
mso-ansi-language:IT'>Label</span></i><i style=3D'mso-bidi-font-style:norma=
l'><span
lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'><o:p></o=
:p></span></i></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
IT'>Orion Corporation<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
IT'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
IT'><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>12.<span style=3D'mso-tab-count:1'> </span>MARKETING AUTHORIS=
ATION
  NUMBER(S)<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>EU/1/03/260/024<span
style=3D'mso-spacerun:yes'> </span><span style=3D'color:black;mso-color-al=
t:windowtext;
background:silver;mso-highlight:silver;mso-shading:#CCCCCC'>10 film-coated
tablets</span><span style=3D'background:gray;mso-highlight:gray'><o:p></o:p=
></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;background:silver;mso-highlight:silver'>=
EU/1/03/260/025<span
style=3D'mso-spacerun:yes'> </span><span style=3D'color:black;mso-color-al=
t:windowtext;
mso-shading:#CCCCCC'>30 film-coated tablets</span><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;background:silver;mso-highlight:silver'>=
EU/1/03/260/026<span
style=3D'mso-spacerun:yes'> </span><span style=3D'color:black;mso-color-al=
t:windowtext;
mso-shading:#CCCCCC'>100 film-coated tablets</span><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;background:silver;mso-highlight:silver'>=
EU/1/03/260/027<span
style=3D'mso-spacerun:yes'> </span><span style=3D'color:black;mso-color-al=
t:windowtext;
mso-shading:#CCCCCC'>130 film-coated tablets</span><span style=3D'mso-shadi=
ng:
#CCCCCC'><o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;background:silver;mso-highlight:silver'>=
EU/1/03/260/028<span
style=3D'mso-spacerun:yes'> </span>175<span style=3D'color:black;mso-color=
-alt:
windowtext;mso-shading:#CCCCCC'> film-coated tablets</span></span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>13.<span style=3D'mso-tab-count:1'> </span>BATCH NUMBER<o:p><=
/o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Batch<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>14.<span style=3D'mso-tab-count:1'> </span>GENERAL CLASSIFICA=
TION
  FOR SUPPLY<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>15.<span style=3D'mso-tab-count:1'> </span>INSTRUCTIONS ON US=
E<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>16.<span style=3D'mso-tab-count:1'> </span>INFORMATION IN BRA=
ILLE<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span class=3DSpellE><span lang=3DEN-GB style=3D'mso-b=
idi-font-size:
11.0pt'>stalevo</span></span><span lang=3DEN-GB style=3D'mso-bidi-font-size=
:11.0pt'>
75/18.75/200&nbsp;mg <i style=3D'mso-bidi-font-style:normal'><span
style=3D'background:silver;mso-highlight:silver'>[carton only]</span></i><o=
:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><u><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black'><o:p><span style=3D'text-de=
coration:
 none'>&nbsp;</span></o:p></span></u></b></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=3DMsoNormal style=3D'border:none;mso-border-alt:solid windowtext .=
5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 0in 4.0pt'><b style=3D'mso-bidi-fon=
t-weight:
normal'><span lang=3DEN-GB style=3D'mso-no-proof:yes'>17.<span style=3D'mso=
-tab-count:
1'> </span>UNIQUE IDENTIFIER  2D BARCODE</span></b><i style=3D'mso-bid=
i-font-style:
normal'><span lang=3DEN-GB style=3D'mso-no-proof:yes'><o:p></o:p></span></i=
></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black;background:silver;mso-highlight:silver'>2D barcode carrying the
unique identifier included</span><span lang=3DEN-GB style=3D'mso-bidi-font-=
size:
11.0pt;color:black'> <i style=3D'mso-bidi-font-style:normal'><span
style=3D'background:#D9D9D9'>[carton only]</span></i><span style=3D'backgro=
und:
#D9D9D9'><o:p></o:p></span></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black;background:#D9D9D9'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black;background:#D9D9D9'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=3DMsoNormal style=3D'border:none;mso-border-alt:solid windowtext .=
5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 0in 4.0pt'><b style=3D'mso-bidi-fon=
t-weight:
normal'><span lang=3DEN-GB style=3D'mso-no-proof:yes'>18.<span style=3D'mso=
-tab-count:
1'> </span>UNIQUE IDENTIFIER - HUMAN READABLE DATA</span></b><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'mso-no-pro=
of:yes'><o:p></o:p></span></i></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DE=
N-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;background:#D9D9D9'>[carton =
only]:<o:p></o:p></span></i></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>PC <span
style=3D'background:silver;mso-highlight:silver'>{number}</span> <o:p></o:p=
></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>SN <span
style=3D'background:silver;mso-highlight:silver'>{number}</span> <o:p></o:p=
></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>&lt;NN <span
style=3D'background:silver;mso-highlight:silver'>{number}</span>&gt;<span
style=3D'color:black'><o:p></o:p></span></span></p>

<span lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",=
serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB;mso-farea=
st-language:
EN-US;mso-bidi-language:AR-SA'><br clear=3Dall style=3D'mso-special-charact=
er:line-break;
page-break-before:always'>
</span>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes;
  height:52.0pt'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:5=
2.0pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>PARTICULARS TO APPEAR ON THE OUTER
  PACKAGING <st1:stockticker w:st=3D"on">AND</st1:stockticker> THE IMMEDIATE
  PACKAGING<o:p></o:p></span></b></p>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>BOTTLE LABEL <st1:stockticker w:st=3D=
"on">AND</st1:stockticker>
  OUTER CARTON TEXT<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>1.<span style=3D'mso-tab-count:1'> </span>NAME OF THE MEDIC=
INAL
  PRODUCT<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span class=3DSpellE><span lang=3DEN-GB style=3D'mso-b=
idi-font-size:
11.0pt'>Stalevo</span></span><span lang=3DEN-GB style=3D'mso-bidi-font-size=
:11.0pt'>
100&nbsp;mg/25&nbsp;mg/200&nbsp;mg film-coated tablets <o:p></o:p></span></=
p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>levodopa/carbidopa/entacapone<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>2.<span style=3D'mso-tab-count:1'> </span>STATEMENT OF ACTI=
VE
  SUBSTANCE(S)<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Each film-coated
tablet contains 100&nbsp;mg of levodopa, 25&nbsp;mg of carbidopa and 200&nb=
sp;mg
of entacapone.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>3.<span style=3D'mso-tab-count:1'> </span>LIST OF EXCIPIENT=
S<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Contains
sucrose.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>4.<span style=3D'mso-tab-count:1'> </span>PHARMACEUTICAL <s=
t1:stockticker
  w:st=3D"on">FORM</st1:stockticker> <st1:stockticker w:st=3D"on">AND</st1:=
stockticker>
  CONTENTS<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DE=
N-GB
style=3D'mso-bidi-font-size:11.0pt;background:silver;mso-highlight:silver'>=
Carton</span></i><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'mso-bidi-f=
ont-size:
11.0pt'><o:p></o:p></span></i></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>10
film-coated tablets<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>30 film-coated tablets<o:p></o:p></=
span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>100 film-coated tablets<o:p></o:p><=
/span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>130 film-coated tablets<o:p></o:p><=
/span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>175 film-coated tablets<o:p></o:p><=
/span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>250 film-coated tablets</span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DE=
N-GB
style=3D'mso-bidi-font-size:11.0pt;background:silver;mso-highlight:silver'>=
Label</span></i><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'mso-bidi-f=
ont-size:
11.0pt'><o:p></o:p></span></i></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>10
tablets<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>30 tablets<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>100 tablets<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>130 tablets<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>175 tablets<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>250 tablets</span><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>5.<span style=3D'mso-tab-count:1'> </span>METHOD <st1:stock=
ticker
  w:st=3D"on">AND</st1:stockticker> ROUTE(S) OF ADMINISTRATION<o:p></o:p></=
span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Read the
package leaflet before use.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Oral use.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>6.<span style=3D'mso-tab-count:1'> </span>SPECIAL WARNING T=
HAT
  THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDR=
EN<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Keep out
of the sight and reach of children.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>7.<span style=3D'mso-tab-count:1'> </span>OTHER SPECIAL
  WARNING(S), IF NECESSARY<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>8.<span style=3D'mso-tab-count:1'> </span>EXPIRY DATE<o:p><=
/o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>EXP<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>9.<span style=3D'mso-tab-count:1'> </span>SPECIAL STORAGE
  CONDITIONS</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'><o:p></o:p></span></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>10.<span style=3D'mso-tab-count:1'> </span>SPECIAL PRECAUTION=
S FOR
  DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH
  MEDICINAL PRODUCTS, IF APPROPRIATE<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>11.<span style=3D'mso-tab-count:1'> </span>NAME <st1:stocktic=
ker
  w:st=3D"on">AND</st1:stockticker> ADDRESS OF THE MARKETING AUTHORISATION =
HOLDER<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DE=
N-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DIT
style=3D'mso-bidi-font-size:11.0pt;background:silver;mso-highlight:silver;
mso-ansi-language:IT'>Carton</span></i><i style=3D'mso-bidi-font-style:norm=
al'><span
lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'><o:p></o=
:p></span></i></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
IT'>Orion Corporation<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
IT'>Orionintie 1<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
IT'>FI-02200 Espoo<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
IT'>Finland<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
IT'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DIT
style=3D'mso-bidi-font-size:11.0pt;background:silver;mso-highlight:silver;
mso-ansi-language:IT'>Label</span></i><i style=3D'mso-bidi-font-style:norma=
l'><span
lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'><o:p></o=
:p></span></i></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
IT'>Orion Corporation<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
IT'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
IT'><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>12.<span style=3D'mso-tab-count:1'> </span>MARKETING AUTHORIS=
ATION
  NUMBER(S)<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>EU/1/03/260/005<span
style=3D'mso-spacerun:yes'> </span><span style=3D'color:black;mso-color-al=
t:windowtext;
background:silver;mso-highlight:silver;mso-shading:#CCCCCC'>10 film-coated
tablets</span><span style=3D'background:gray;mso-highlight:gray'><o:p></o:p=
></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;background:silver;mso-highlight:silver'>=
EU/1/03/260/006<span
style=3D'mso-spacerun:yes'> </span><span style=3D'color:black;mso-color-al=
t:windowtext;
mso-shading:#CCCCCC'>30 film-coated tablets</span><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;background:silver;mso-highlight:silver'>=
EU/1/03/260/007<span
style=3D'mso-spacerun:yes'> </span><span style=3D'color:black;mso-color-al=
t:windowtext;
mso-shading:#CCCCCC'>100 film-coated tablets</span><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;background:silver;mso-highlight:silver'>=
EU/1/03/260/008<span
style=3D'mso-spacerun:yes'> </span><span style=3D'color:black;mso-color-al=
t:windowtext;
mso-shading:#CCCCCC'>250 film-coated tablets</span><span style=3D'mso-shadi=
ng:
#CCCCCC'><o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;background:silver;mso-highlight:silver'>=
EU/1/03/260/014<span
style=3D'mso-spacerun:yes'> </span>175 film-coated tablets<o:p></o:p></spa=
n></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>EU/1/03/260/017<span
style=3D'mso-spacerun:yes'> </span>130 film-coated tablets</span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>13.<span style=3D'mso-tab-count:1'> </span>BATCH NUMBER<o:p><=
/o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Batch<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>14.<span style=3D'mso-tab-count:1'> </span>GENERAL CLASSIFICA=
TION
  FOR SUPPLY<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>15.<span style=3D'mso-tab-count:1'> </span>INSTRUCTIONS ON US=
E<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>16.<span style=3D'mso-tab-count:1'> </span>INFORMATION IN BRA=
ILLE<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span class=3DSpellE><span lang=3DEN-GB style=3D'mso-b=
idi-font-size:
11.0pt'>stalevo</span></span><span lang=3DEN-GB style=3D'mso-bidi-font-size=
:11.0pt'>
100/25/200&nbsp;mg <i style=3D'mso-bidi-font-style:normal'><span
style=3D'background:silver;mso-highlight:silver'>[carton only]</span></i><o=
:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><u><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black'><o:p><span style=3D'text-de=
coration:
 none'>&nbsp;</span></o:p></span></u></b></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=3DMsoNormal style=3D'border:none;mso-border-alt:solid windowtext .=
5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 0in 4.0pt'><b style=3D'mso-bidi-fon=
t-weight:
normal'><span lang=3DEN-GB style=3D'mso-no-proof:yes'>17.<span style=3D'mso=
-tab-count:
1'> </span>UNIQUE IDENTIFIER  2D BARCODE</span></b><i style=3D'mso-bid=
i-font-style:
normal'><span lang=3DEN-GB style=3D'mso-no-proof:yes'><o:p></o:p></span></i=
></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black;background:silver;mso-highlight:silver'>2D barcode carrying the
unique identifier included</span><span lang=3DEN-GB style=3D'mso-bidi-font-=
size:
11.0pt;color:black'> <i style=3D'mso-bidi-font-style:normal'><span
style=3D'background:#D9D9D9'>[carton only]</span></i><span style=3D'backgro=
und:
#D9D9D9'><o:p></o:p></span></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black;background:#D9D9D9'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black;background:#D9D9D9'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=3DMsoNormal style=3D'border:none;mso-border-alt:solid windowtext .=
5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 0in 4.0pt'><b style=3D'mso-bidi-fon=
t-weight:
normal'><span lang=3DEN-GB style=3D'mso-no-proof:yes'>18.<span style=3D'mso=
-tab-count:
1'> </span>UNIQUE IDENTIFIER - HUMAN READABLE DATA</span></b><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'mso-no-pro=
of:yes'><o:p></o:p></span></i></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DE=
N-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;background:#D9D9D9'>[carton =
only]:<o:p></o:p></span></i></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>PC: <span
style=3D'background:silver;mso-highlight:silver'>{number}</span> <o:p></o:p=
></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>SN <span
style=3D'background:silver;mso-highlight:silver'>{number}</span> <o:p></o:p=
></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>&lt;NN <span
style=3D'background:silver;mso-highlight:silver'>{number}</span>&gt;<span
style=3D'color:black'><o:p></o:p></span></span></p>

<span lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",=
serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB;mso-farea=
st-language:
EN-US;mso-bidi-language:AR-SA'><br clear=3Dall style=3D'mso-special-charact=
er:line-break;
page-break-before:always'>
</span>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes;
  height:52.0pt'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:5=
2.0pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>PARTICULARS TO APPEAR ON THE OUTER
  PACKAGING <st1:stockticker w:st=3D"on">AND</st1:stockticker> THE IMMEDIATE
  PACKAGING<o:p></o:p></span></b></p>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>BOTTLE LABEL <st1:stockticker w:st=3D=
"on">AND</st1:stockticker>
  OUTER CARTON TEXT<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>1.<span style=3D'mso-tab-count:1'> </span>NAME OF THE MEDIC=
INAL
  PRODUCT<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span class=3DSpellE><span lang=3DEN-GB style=3D'mso-b=
idi-font-size:
11.0pt'>Stalevo</span></span><span lang=3DEN-GB style=3D'mso-bidi-font-size=
:11.0pt'>
125&nbsp;mg/31.25&nbsp;mg/200&nbsp;mg film-coated tablets <o:p></o:p></span=
></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>levodopa/carbidopa/entacapone<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>2.<span style=3D'mso-tab-count:1'> </span>STATEMENT OF ACTI=
VE
  SUBSTANCE(S)<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Each film-coated
tablet contains 125&nbsp;mg of levodopa, 31.25&nbsp;mg of carbidopa and
200&nbsp;mg of entacapone.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>3.<span style=3D'mso-tab-count:1'> </span>LIST OF EXCIPIENT=
S<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Contains
sucrose.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>4.<span style=3D'mso-tab-count:1'> </span>PHARMACEUTICAL <s=
t1:stockticker
  w:st=3D"on">FORM</st1:stockticker> <st1:stockticker w:st=3D"on">AND</st1:=
stockticker>
  CONTENTS<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DE=
N-GB
style=3D'mso-bidi-font-size:11.0pt;background:silver;mso-highlight:silver'>=
Carton</span></i><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'mso-bidi-f=
ont-size:
11.0pt'><o:p></o:p></span></i></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>10
film-coated tablets<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>30 film-coated tablets<o:p></o:p></=
span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>100 film-coated tablets<o:p></o:p><=
/span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>130 film-coated tablets<o:p></o:p><=
/span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>175 film-coated tablets<o:p></o:p><=
/span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DE=
N-GB
style=3D'mso-bidi-font-size:11.0pt;background:silver;mso-highlight:silver'>=
Label</span></i><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'mso-bidi-f=
ont-size:
11.0pt'><o:p></o:p></span></i></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>10
tablets<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>30 tablets<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>100 tablets<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>130 tablets<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>175 tablets<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>5.<span style=3D'mso-tab-count:1'> </span>METHOD <st1:stock=
ticker
  w:st=3D"on">AND</st1:stockticker> ROUTE(S) OF ADMINISTRATION<o:p></o:p></=
span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Read the
package leaflet before use.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Oral use.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>6.<span style=3D'mso-tab-count:1'> </span>SPECIAL WARNING T=
HAT
  THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDR=
EN<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Keep out
of the sight and reach of children.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>7.<span style=3D'mso-tab-count:1'> </span>OTHER SPECIAL
  WARNING(S), IF NECESSARY<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>8.<span style=3D'mso-tab-count:1'> </span>EXPIRY DATE<o:p><=
/o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>EXP<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>9.<span style=3D'mso-tab-count:1'> </span>SPECIAL STORAGE
  CONDITIONS</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'><o:p></o:p></span></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>10.<span style=3D'mso-tab-count:1'> </span>SPECIAL PRECAUTION=
S FOR
  DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH
  MEDICINAL PRODUCTS, IF APPROPRIATE<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>11.<span style=3D'mso-tab-count:1'> </span>NAME <st1:stocktic=
ker
  w:st=3D"on">AND</st1:stockticker> ADDRESS OF THE MARKETING AUTHORISATION =
HOLDER<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DIT
style=3D'mso-bidi-font-size:11.0pt;background:silver;mso-highlight:silver;
mso-ansi-language:IT'>Carton</span></i><i style=3D'mso-bidi-font-style:norm=
al'><span
lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'><o:p></o=
:p></span></i></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
IT'>Orion Corporation<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
IT'>Orionintie 1<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
IT'>FI-02200 Espoo<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
IT'>Finland<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
IT'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DIT
style=3D'mso-bidi-font-size:11.0pt;background:silver;mso-highlight:silver;
mso-ansi-language:IT'>Label</span></i><i style=3D'mso-bidi-font-style:norma=
l'><span
lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'><o:p></o=
:p></span></i></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
IT'>Orion Corporation<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
IT'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
IT'><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>12.<span style=3D'mso-tab-count:1'> </span>MARKETING AUTHORIS=
ATION
  NUMBER(S)<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>EU/1/03/260/029 <span style=3D'color:bl=
ack;
mso-color-alt:windowtext;background:silver;mso-highlight:silver;mso-shading:
#CCCCCC'>10 film-coated tablets</span><span style=3D'background:gray;mso-hi=
ghlight:
gray'><o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;background:silver;mso-highlight:silver'>=
EU/1/03/260/030
<span style=3D'color:black;mso-color-alt:windowtext;mso-shading:#CCCCCC'>30
film-coated tablets</span><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;background:silver;mso-highlight:silver'>=
EU/1/03/260/031
<span style=3D'color:black;mso-color-alt:windowtext;mso-shading:#CCCCCC'>100
film-coated tablets</span><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;background:silver;mso-highlight:silver'>=
EU/1/03/260/032
<span style=3D'color:black;mso-color-alt:windowtext;mso-shading:#CCCCCC'>130
film-coated tablets</span><span style=3D'mso-shading:#CCCCCC'><o:p></o:p></=
span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;background:silver;mso-highlight:silver'>=
EU/1/03/260/033
175<span style=3D'color:black;mso-color-alt:windowtext;mso-shading:#CCCCCC'>
film-coated tablets</span></span><span lang=3DEN-GB style=3D'mso-bidi-font-=
size:
11.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>13.<span style=3D'mso-tab-count:1'> </span>BATCH NUMBER<o:p><=
/o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Batch<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>14.<span style=3D'mso-tab-count:1'> </span>GENERAL CLASSIFICA=
TION
  FOR SUPPLY<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>15.<span style=3D'mso-tab-count:1'> </span>INSTRUCTIONS ON US=
E<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>16.<span style=3D'mso-tab-count:1'> </span>INFORMATION IN BRA=
ILLE<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span class=3DSpellE><span lang=3DEN-GB style=3D'mso-b=
idi-font-size:
11.0pt'>stalevo</span></span><span lang=3DEN-GB style=3D'mso-bidi-font-size=
:11.0pt'>
125/31.25/200&nbsp;mg <i style=3D'mso-bidi-font-style:normal'><span
style=3D'background:silver;mso-highlight:silver'>[carton only]</span></i><o=
:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><u><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black'><o:p><span style=3D'text-de=
coration:
 none'>&nbsp;</span></o:p></span></u></b></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=3DMsoNormal style=3D'border:none;mso-border-alt:solid windowtext .=
5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 0in 4.0pt'><b style=3D'mso-bidi-fon=
t-weight:
normal'><span lang=3DEN-GB style=3D'mso-no-proof:yes'>17.<span style=3D'mso=
-tab-count:
1'> </span>UNIQUE IDENTIFIER  2D BARCODE</span></b><i style=3D'mso-bid=
i-font-style:
normal'><span lang=3DEN-GB style=3D'mso-no-proof:yes'><o:p></o:p></span></i=
></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black;background:silver;mso-highlight:silver'>2D barcode carrying the
unique identifier included</span><span lang=3DEN-GB style=3D'mso-bidi-font-=
size:
11.0pt;color:black'> <i style=3D'mso-bidi-font-style:normal'><span
style=3D'background:#D9D9D9'>[carton only]</span></i><span style=3D'backgro=
und:
#D9D9D9'><o:p></o:p></span></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black;background:#D9D9D9'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black;background:#D9D9D9'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=3DMsoNormal style=3D'border:none;mso-border-alt:solid windowtext .=
5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 0in 4.0pt'><b style=3D'mso-bidi-fon=
t-weight:
normal'><span lang=3DEN-GB style=3D'mso-no-proof:yes'>18.<span style=3D'mso=
-tab-count:
1'> </span>UNIQUE IDENTIFIER - HUMAN READABLE DATA</span></b><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'mso-no-pro=
of:yes'><o:p></o:p></span></i></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DE=
N-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;background:#D9D9D9'>[carton =
only]:<o:p></o:p></span></i></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>PC <span
style=3D'background:silver;mso-highlight:silver'>{number}</span> <o:p></o:p=
></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>SN <span
style=3D'background:silver;mso-highlight:silver'>{number}</span> <o:p></o:p=
></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>&lt;NN <span
style=3D'background:silver;mso-highlight:silver'>{number}</span>&gt;<span
style=3D'color:black'><o:p></o:p></span></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<span lang=3DEN-GB style=3D'font-size:11.0pt;mso-bidi-font-size:10.0pt;font=
-family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-ansi-=
language:
EN-GB;mso-fareast-language:EN-US;mso-bidi-language:AR-SA'><br clear=3Dall
style=3D'mso-special-character:line-break;page-break-before:always'>
</span>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes;
  height:52.0pt'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:5=
2.0pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>PARTICULARS TO APPEAR ON THE OUTER
  PACKAGING <st1:stockticker w:st=3D"on">AND</st1:stockticker> THE IMMEDIATE
  PACKAGING<o:p></o:p></span></b></p>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>BOTTLE LABEL <st1:stockticker w:st=3D=
"on">AND</st1:stockticker>
  OUTER CARTON TEXT<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>1.<span style=3D'mso-tab-count:1'> </span>NAME OF THE MEDIC=
INAL
  PRODUCT<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span class=3DSpellE><span lang=3DEN-GB style=3D'mso-b=
idi-font-size:
11.0pt'>Stalevo</span></span><span lang=3DEN-GB style=3D'mso-bidi-font-size=
:11.0pt'>
150&nbsp;mg/37.5&nbsp;mg/200&nbsp;mg film-coated tablets <o:p></o:p></span>=
</p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>levodopa/carbidopa/entacapone<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>2.<span style=3D'mso-tab-count:1'> </span>STATEMENT OF ACTI=
VE
  SUBSTANCE(S)<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Each film-coated
tablet contains 150&nbsp;mg of levodopa, 37.5&nbsp;mg of carbidopa and
200&nbsp;mg of entacapone.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>3.<span style=3D'mso-tab-count:1'> </span>LIST OF EXCIPIENT=
S<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Contains
sucrose. <o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>4.<span style=3D'mso-tab-count:1'> </span>PHARMACEUTICAL <s=
t1:stockticker
  w:st=3D"on">FORM</st1:stockticker> <st1:stockticker w:st=3D"on">AND</st1:=
stockticker>
  CONTENTS<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DE=
N-GB
style=3D'mso-bidi-font-size:11.0pt;background:silver;mso-highlight:silver'>=
Carton</span></i><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'mso-bidi-f=
ont-size:
11.0pt'><o:p></o:p></span></i></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>10
film-coated tablets<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>30 film-coated tablets<o:p></o:p></=
span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>100 film-coated tablets<o:p></o:p><=
/span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>130 film-coated tablets<o:p></o:p><=
/span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>175 film-coated tablets<o:p></o:p><=
/span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>250 film-coated tablets</span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DE=
N-GB
style=3D'mso-bidi-font-size:11.0pt;background:silver;mso-highlight:silver'>=
Label</span></i><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'mso-bidi-f=
ont-size:
11.0pt'><o:p></o:p></span></i></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>10
tablets<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>30 tablets<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>100 tablets<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>130 tablets<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>175 tablets<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>250 tablets</span><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>5.<span style=3D'mso-tab-count:1'> </span>METHOD <st1:stock=
ticker
  w:st=3D"on">AND</st1:stockticker> ROUTE(S) OF ADMINISTRATION<o:p></o:p></=
span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Read the
package leaflet before use.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Oral use.
<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>6.<span style=3D'mso-tab-count:1'> </span>SPECIAL WARNING T=
HAT
  THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDR=
EN<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Keep out
of the sight and reach of children.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>7.<span style=3D'mso-tab-count:1'> </span>OTHER SPECIAL
  WARNING(S), IF NECESSARY<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>8.<span style=3D'mso-tab-count:1'> </span>EXPIRY DATE<o:p><=
/o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>EXP<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>9.<span style=3D'mso-tab-count:1'> </span>SPECIAL STORAGE
  CONDITIONS</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'><o:p></o:p></span></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>10.<span style=3D'mso-tab-count:1'> </span>SPECIAL PRECAUTION=
S FOR
  DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH
  MEDICINAL PRODUCTS, IF APPROPRIATE<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>11.<span style=3D'mso-tab-count:1'> </span>NAME <st1:stocktic=
ker
  w:st=3D"on">AND</st1:stockticker> ADDRESS OF THE MARKETING AUTHORISATION =
HOLDER<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DIT
style=3D'mso-bidi-font-size:11.0pt;background:silver;mso-highlight:silver;
mso-ansi-language:IT'>Carton</span></i><i style=3D'mso-bidi-font-style:norm=
al'><span
lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'><o:p></o=
:p></span></i></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
IT'>Orion Corporation<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
IT'>Orionintie 1<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
IT'>FI-02200 Espoo<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
IT'>Finland<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
IT'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DIT
style=3D'mso-bidi-font-size:11.0pt;background:silver;mso-highlight:silver;
mso-ansi-language:IT'>Label</span></i><i style=3D'mso-bidi-font-style:norma=
l'><span
lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'><o:p></o=
:p></span></i></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
IT'>Orion Corporation<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
IT'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
IT'><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>12.<span style=3D'mso-tab-count:1'> </span>MARKETING AUTHORIS=
ATION
  NUMBER(S)<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>EU/1/03/260/009<span
style=3D'mso-spacerun:yes'> </span><span style=3D'color:black;mso-color-al=
t:windowtext;
background:silver;mso-highlight:silver;mso-shading:#CCCCCC'>10 film-coated
tablets</span><span style=3D'background:gray;mso-highlight:gray'><o:p></o:p=
></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;background:silver;mso-highlight:silver'>=
EU/1/03/260/010<span
style=3D'mso-spacerun:yes'> </span><span style=3D'color:black;mso-color-al=
t:windowtext;
mso-shading:#CCCCCC'>30 film-coated tablets</span><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;background:silver;mso-highlight:silver'>=
EU/1/03/260/011<span
style=3D'mso-spacerun:yes'> </span><span style=3D'color:black;mso-color-al=
t:windowtext;
mso-shading:#CCCCCC'>100 film-coated tablets</span><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;background:silver;mso-highlight:silver'>=
EU/1/03/260/012<span
style=3D'mso-spacerun:yes'> </span><span style=3D'color:black;mso-color-al=
t:windowtext;
mso-shading:#CCCCCC'>250 film-coated tablets</span><span style=3D'mso-shadi=
ng:
#CCCCCC'><o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-color-alt:windowtext;
background:silver;mso-highlight:silver;mso-shading:#CCCCCC'>EU/1/03/260/015=
<span
style=3D'mso-spacerun:yes'> </span>175 film-coated tablets</span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;background:silver;mso-highl=
ight:
silver'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>EU/1/03/260/018<span
style=3D'mso-spacerun:yes'> </span>130 film-coated tablets</span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>13.<span style=3D'mso-tab-count:1'> </span>BATCH NUMBER<o:p><=
/o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Batch<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>14.<span style=3D'mso-tab-count:1'> </span>GENERAL CLASSIFICA=
TION
  FOR SUPPLY<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>15.<span style=3D'mso-tab-count:1'> </span>INSTRUCTIONS ON US=
E<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>16.<span style=3D'mso-tab-count:1'> </span>INFORMATION IN BRA=
ILLE<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span class=3DSpellE><span lang=3DEN-GB style=3D'mso-b=
idi-font-size:
11.0pt'>stalevo</span></span><span lang=3DEN-GB style=3D'mso-bidi-font-size=
:11.0pt'>
150/37.5/200&nbsp;mg <i style=3D'mso-bidi-font-style:normal'><span
style=3D'background:silver;mso-highlight:silver'>[carton only]</span></i><o=
:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><u><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black'><o:p><span style=3D'text-de=
coration:
 none'>&nbsp;</span></o:p></span></u></b></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=3DMsoNormal style=3D'border:none;mso-border-alt:solid windowtext .=
5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 0in 4.0pt'><b style=3D'mso-bidi-fon=
t-weight:
normal'><span lang=3DEN-GB style=3D'mso-no-proof:yes'>17.<span style=3D'mso=
-tab-count:
1'> </span>UNIQUE IDENTIFIER  2D BARCODE</span></b><i style=3D'mso-bid=
i-font-style:
normal'><span lang=3DEN-GB style=3D'mso-no-proof:yes'><o:p></o:p></span></i=
></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black;background:silver;mso-highlight:silver'>2D barcode carrying the
unique identifier included</span><span lang=3DEN-GB style=3D'mso-bidi-font-=
size:
11.0pt;color:black'> <i style=3D'mso-bidi-font-style:normal'><span
style=3D'background:#D9D9D9'>[carton only]</span></i><span style=3D'backgro=
und:
#D9D9D9'><o:p></o:p></span></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black;background:#D9D9D9'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black;background:#D9D9D9'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=3DMsoNormal style=3D'border:none;mso-border-alt:solid windowtext .=
5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 0in 4.0pt'><b style=3D'mso-bidi-fon=
t-weight:
normal'><span lang=3DEN-GB style=3D'mso-no-proof:yes'>18.<span style=3D'mso=
-tab-count:
1'> </span>UNIQUE IDENTIFIER - HUMAN READABLE DATA</span></b><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'mso-no-pro=
of:yes'><o:p></o:p></span></i></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DE=
N-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;background:#D9D9D9'>[carton =
only]:<o:p></o:p></span></i></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>PC <span
style=3D'background:silver;mso-highlight:silver'>{number}</span> <o:p></o:p=
></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>SN <span
style=3D'background:silver;mso-highlight:silver'>{number}</span> <o:p></o:p=
></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>&lt;NN <span
style=3D'background:silver;mso-highlight:silver'>{number}</span>&gt;<span
style=3D'color:black'><o:p></o:p></span></span></p>

<span lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",=
serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB;mso-farea=
st-language:
EN-US;mso-bidi-language:AR-SA'><br clear=3Dall style=3D'mso-special-charact=
er:line-break;
page-break-before:always'>
</span>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes;
  height:52.0pt'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:5=
2.0pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>PARTICULARS TO APPEAR ON THE OUTER
  PACKAGING <st1:stockticker w:st=3D"on">AND</st1:stockticker> THE IMMEDIATE
  PACKAGING<o:p></o:p></span></b></p>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>BOTTLE LABEL <st1:stockticker w:st=3D=
"on">AND</st1:stockticker>
  OUTER CARTON TEXT<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>1.<span style=3D'mso-tab-count:1'> </span>NAME OF THE MEDIC=
INAL
  PRODUCT<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span class=3DSpellE><span lang=3DEN-GB style=3D'mso-b=
idi-font-size:
11.0pt'>Stalevo</span></span><span lang=3DEN-GB style=3D'mso-bidi-font-size=
:11.0pt'>
175&nbsp;mg/43.75&nbsp;mg/200&nbsp;mg film-coated tablets<o:p></o:p></span>=
</p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>levodopa/carbidopa/entacapone<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>2.<span style=3D'mso-tab-count:1'> </span>STATEMENT OF ACTI=
VE
  SUBSTANCE(S)<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Each
film-coated tablet contains 175&nbsp;mg of levodopa, 43.75&nbsp;mg of carbi=
dopa
and 200&nbsp;mg of entacapone.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>3.<span style=3D'mso-tab-count:1'> </span>LIST OF EXCIPIENT=
S<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Contains
sucrose. <o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>4.<span style=3D'mso-tab-count:1'> </span>PHARMACEUTICAL <s=
t1:stockticker
  w:st=3D"on">FORM</st1:stockticker> <st1:stockticker w:st=3D"on">AND</st1:=
stockticker>
  CONTENTS<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DE=
N-GB
style=3D'mso-bidi-font-size:11.0pt;background:silver;mso-highlight:silver'>=
Carton</span></i><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'mso-bidi-f=
ont-size:
11.0pt'><o:p></o:p></span></i></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>10
film-coated tablets<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>30 film-coated tablets<o:p></o:p></=
span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>100 film-coated tablets<o:p></o:p><=
/span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>130 film-coated tablets<o:p></o:p><=
/span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>175 film-coated tablets<o:p></o:p><=
/span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DE=
N-GB
style=3D'mso-bidi-font-size:11.0pt;background:silver;mso-highlight:silver'>=
Label</span></i><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'mso-bidi-f=
ont-size:
11.0pt'><o:p></o:p></span></i></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>10
tablets<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>30 tablets<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>100 tablets<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>130 tablets<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>175 tablets<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>5.<span style=3D'mso-tab-count:1'> </span>METHOD <st1:stock=
ticker
  w:st=3D"on">AND</st1:stockticker> ROUTE(S) OF ADMINISTRATION<o:p></o:p></=
span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Read the
package leaflet before use.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Oral use.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>6.<span style=3D'mso-tab-count:1'> </span>SPECIAL WARNING T=
HAT
  THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDR=
EN<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Keep out
of the sight and reach of children.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>7.<span style=3D'mso-tab-count:1'> </span>OTHER SPECIAL WAR=
NING(S),
  IF NECESSARY<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>8.<span style=3D'mso-tab-count:1'> </span>EXPIRY DATE<o:p><=
/o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>EXP<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>9.<span style=3D'mso-tab-count:1'> </span>SPECIAL STORAGE
  CONDITIONS</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'><o:p></o:p></span></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>10.<span style=3D'mso-tab-count:1'> </span>SPECIAL PRECAUTION=
S FOR
  DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH
  MEDICINAL PRODUCTS, IF APPROPRIATE<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>11.<span style=3D'mso-tab-count:1'> </span>NAME <st1:stocktic=
ker
  w:st=3D"on">AND</st1:stockticker> ADDRESS OF THE MARKETING AUTHORISATION =
HOLDER<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DIT
style=3D'mso-bidi-font-size:11.0pt;background:silver;mso-highlight:silver;
mso-ansi-language:IT'>Carton</span></i><i style=3D'mso-bidi-font-style:norm=
al'><span
lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'><o:p></o=
:p></span></i></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
IT'>Orion Corporation<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
IT'>Orionintie 1<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
IT'>FI-02200 Espoo<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
IT'>Finland<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
IT'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DIT
style=3D'mso-bidi-font-size:11.0pt;background:silver;mso-highlight:silver;
mso-ansi-language:IT'>Label</span></i><i style=3D'mso-bidi-font-style:norma=
l'><span
lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'><o:p></o=
:p></span></i></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
IT'>Orion Corporation<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
IT'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
IT'><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>12.<span style=3D'mso-tab-count:1'> </span>MARKETING AUTHORIS=
ATION
  NUMBER(S)<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>EU/1/03/260/034 <span style=3D'color:bl=
ack;
mso-color-alt:windowtext;background:#CCCCCC'>10 film-coated tablets</span><=
o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;background:silver;mso-highlight:silver'>=
EU/1/03/260/035
<span style=3D'color:black;mso-color-alt:windowtext;mso-shading:#CCCCCC'>30
film-coated tablets</span><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;background:silver;mso-highlight:silver'>=
EU/1/03/260/036
<span style=3D'color:black;mso-color-alt:windowtext;mso-shading:#CCCCCC'>100
film-coated tablets</span><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;background:silver;mso-highlight:silver'>=
EU/1/03/260/037
<span style=3D'color:black;mso-color-alt:windowtext;mso-shading:#CCCCCC'>130
film-coated tablets</span><span style=3D'mso-shading:#CCCCCC'><o:p></o:p></=
span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;background:silver;mso-highlight:silver'>=
EU/1/03/260/038
175</span><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;
mso-color-alt:windowtext;background:#CCCCCC'> film-coated tablets</span><sp=
an
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>13.<span style=3D'mso-tab-count:1'> </span>BATCH NUMBER<o:p><=
/o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Batch<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>14.<span style=3D'mso-tab-count:1'> </span>GENERAL CLASSIFICA=
TION
  FOR SUPPLY<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>15.<span style=3D'mso-tab-count:1'> </span>INSTRUCTIONS ON US=
E<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>16.<span style=3D'mso-tab-count:1'> </span>INFORMATION IN BRA=
ILLE<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span class=3DSpellE><span lang=3DEN-GB style=3D'mso-b=
idi-font-size:
11.0pt'>stalevo</span></span><span lang=3DEN-GB style=3D'mso-bidi-font-size=
:11.0pt'>
175/43.75/200&nbsp;mg <i style=3D'mso-bidi-font-style:normal'><span
style=3D'background:silver;mso-highlight:silver'>[carton only]</span></i><o=
:p></o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><u><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black'><o:p><span style=3D'text-de=
coration:
 none'>&nbsp;</span></o:p></span></u></b></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><u><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black'><o:p><span style=3D'text-de=
coration:
 none'>&nbsp;</span></o:p></span></u></b></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=3DMsoNormal style=3D'border:none;mso-border-alt:solid windowtext .=
5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 0in 4.0pt'><b style=3D'mso-bidi-fon=
t-weight:
normal'><span lang=3DEN-GB style=3D'mso-no-proof:yes'>17.<span style=3D'mso=
-tab-count:
1'> </span>UNIQUE IDENTIFIER  2D BARCODE</span></b><i style=3D'mso-bid=
i-font-style:
normal'><span lang=3DEN-GB style=3D'mso-no-proof:yes'><o:p></o:p></span></i=
></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black;background:silver;mso-highlight:silver'>2D barcode carrying the
unique identifier included</span><span lang=3DEN-GB style=3D'mso-bidi-font-=
size:
11.0pt;color:black'> <span style=3D'background:#D9D9D9'>[<i style=3D'mso-bi=
di-font-style:
normal'>carton only</i>]<o:p></o:p></span></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black;background:#D9D9D9'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black;background:#D9D9D9'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=3DMsoNormal style=3D'border:none;mso-border-alt:solid windowtext .=
5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 0in 4.0pt'><b style=3D'mso-bidi-fon=
t-weight:
normal'><span lang=3DEN-GB style=3D'mso-no-proof:yes'>18.<span style=3D'mso=
-tab-count:
1'> </span>UNIQUE IDENTIFIER - HUMAN READABLE DATA</span></b><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'mso-no-pro=
of:yes'><o:p></o:p></span></i></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black;background:#D9D9D9'>[<i style=3D'mso-bidi-font-style:normal'>ca=
rton
only</i>]:<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>PC <span
style=3D'background:silver;mso-highlight:silver'>{number}</span> <o:p></o:p=
></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>SN <span
style=3D'background:silver;mso-highlight:silver'>{number}</span> <o:p></o:p=
></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>&lt;NN <span
style=3D'background:silver;mso-highlight:silver'>{number}</span>&gt;<span
style=3D'color:black'><o:p></o:p></span></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<span lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",=
serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB;mso-farea=
st-language:
EN-US;mso-bidi-language:AR-SA'><br clear=3Dall style=3D'mso-special-charact=
er:line-break;
page-break-before:always'>
</span>

<p class=3DMsoNormal><span style=3D'mso-bidi-font-size:11.0pt;mso-ansi-lang=
uage:
EN-US'><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes;
  height:52.0pt'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:5=
2.0pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>PARTICULARS TO APPEAR ON THE OUTER PA=
CKAGING
  <st1:stockticker w:st=3D"on">AND</st1:stockticker> THE IMMEDIATE PACKAGIN=
G<o:p></o:p></span></b></p>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>BOTTLE LABEL <st1:stockticker w:st=3D=
"on">AND</st1:stockticker>
  OUTER CARTON TEXT<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>1.<span style=3D'mso-tab-count:1'> </span>NAME OF THE MEDIC=
INAL
  PRODUCT<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span class=3DSpellE><span lang=3DEN-GB style=3D'mso-b=
idi-font-size:
11.0pt'>Stalevo</span></span><span lang=3DEN-GB style=3D'mso-bidi-font-size=
:11.0pt'>
200&nbsp;mg/50&nbsp;mg/200&nbsp;mg film-coated tablets<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>levodopa/carbidopa/entacapone<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>2.<span style=3D'mso-tab-count:1'> </span>STATEMENT OF ACTI=
VE
  SUBSTANCE(S)<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Each film-coated
tablet contains 200&nbsp;mg of levodopa, 50&nbsp;mg of carbidopa and
200&nbsp;mg of entacapone.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>3.<span style=3D'mso-tab-count:1'> </span>LIST OF EXCIPIENT=
S<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Contains
sucrose. <o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>4.<span style=3D'mso-tab-count:1'> </span>PHARMACEUTICAL <s=
t1:stockticker
  w:st=3D"on">FORM</st1:stockticker> <st1:stockticker w:st=3D"on">AND</st1:=
stockticker>
  CONTENTS<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DE=
N-GB
style=3D'mso-bidi-font-size:11.0pt;background:silver;mso-highlight:silver'>=
Carton</span></i><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'mso-bidi-f=
ont-size:
11.0pt'><o:p></o:p></span></i></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>10
film-coated tablets<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>30 film-coated tablets<o:p></o:p></=
span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>100 film-coated tablets<o:p></o:p><=
/span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>130 film-coated tablets<o:p></o:p><=
/span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>175 film-coated tablets<o:p></o:p><=
/span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DE=
N-GB
style=3D'mso-bidi-font-size:11.0pt;background:silver;mso-highlight:silver'>=
Label<o:p></o:p></span></i></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>10
tablets<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>30 tablets<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>100 tablets<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>130 tablets<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:silver;mso-highlight:silver'>175 tablets<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>5.<span style=3D'mso-tab-count:1'> </span>METHOD <st1:stock=
ticker
  w:st=3D"on">AND</st1:stockticker> ROUTE(S) OF ADMINISTRATION<o:p></o:p></=
span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Read the
package leaflet before use.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Oral use.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>6.<span style=3D'mso-tab-count:1'> </span>SPECIAL WARNING T=
HAT
  THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDR=
EN<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><span
style=3D'mso-spacerun:yes'></span><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Keep out
of the sight and reach of children.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>7.<span style=3D'mso-tab-count:1'> </span>OTHER SPECIAL
  WARNING(S), IF NECESSARY<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>8.<span style=3D'mso-tab-count:1'> </span>EXPIRY DATE<o:p><=
/o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>EXP<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>9.<span style=3D'mso-tab-count:1'> </span>SPECIAL STORAGE
  CONDITIONS</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'><o:p></o:p></span></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>10.<span style=3D'mso-tab-count:1'> </span>SPECIAL PRECAUTION=
S FOR
  DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH
  MEDICINAL PRODUCTS, IF APPROPRIATE<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>11.<span style=3D'mso-tab-count:1'> </span>NAME <st1:stocktic=
ker
  w:st=3D"on">AND</st1:stockticker> ADDRESS OF THE MARKETING AUTHORISATION =
HOLDER<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DIT
style=3D'mso-bidi-font-size:11.0pt;background:silver;mso-highlight:silver;
mso-ansi-language:IT'>Carton</span></i><i style=3D'mso-bidi-font-style:norm=
al'><span
lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'><o:p></o=
:p></span></i></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
IT'>Orion Corporation<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
IT'>Orionintie 1<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
IT'>FI-02200 Espoo<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
IT'>Finland<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
IT'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DIT
style=3D'mso-bidi-font-size:11.0pt;background:silver;mso-highlight:silver;
mso-ansi-language:IT'>Label</span></i><i style=3D'mso-bidi-font-style:norma=
l'><span
lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'><o:p></o=
:p></span></i></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
IT'>Orion Corporation<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
IT'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
IT'><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>12.<span style=3D'mso-tab-count:1'> </span>MARKETING AUTHORIS=
ATION
  NUMBER(S)<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>EU/1/03/260/019<span
style=3D'mso-spacerun:yes'> </span><span style=3D'color:black;mso-color-al=
t:windowtext;
background:silver;mso-highlight:silver;mso-shading:#CCCCCC'>10 film-coated
tablets</span><span style=3D'background:gray;mso-highlight:gray'><o:p></o:p=
></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;background:silver;mso-highlight:silver'>=
EU/1/03/260/020<span
style=3D'mso-spacerun:yes'> </span><span style=3D'color:black;mso-color-al=
t:windowtext;
mso-shading:#CCCCCC'>30 film-coated tablets</span><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;background:silver;mso-highlight:silver'>=
EU/1/03/260/021<span
style=3D'mso-spacerun:yes'> </span><span style=3D'color:black;mso-color-al=
t:windowtext;
mso-shading:#CCCCCC'>100 film-coated tablets</span><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;background:silver;mso-highlight:silver'>=
EU/1/03/260/022<span
style=3D'mso-spacerun:yes'> </span><span style=3D'color:black;mso-color-al=
t:windowtext;
mso-shading:#CCCCCC'>130 film-coated tablets</span><span style=3D'mso-shadi=
ng:
#CCCCCC'><o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;background:silver;mso-highlight:silver'>=
EU/1/03/260/023<span
style=3D'mso-spacerun:yes'> </span>175<span style=3D'color:black;mso-color=
-alt:
windowtext;mso-shading:#CCCCCC'> film-coated tablets</span></span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>13.<span style=3D'mso-tab-count:1'> </span>BATCH NUMBER<o:p><=
/o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Batch<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>14.<span style=3D'mso-tab-count:1'> </span>GENERAL CLASSIFICA=
TION
  FOR SUPPLY<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>15.<span style=3D'mso-tab-count:1'> </span>INSTRUCTIONS ON US=
E<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D619 valign=3Dtop style=3D'width:464.35pt;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>16.<span style=3D'mso-tab-count:1'> </span>INFORMATION IN BRA=
ILLE<o:p></o:p></span></b></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span class=3DSpellE><span lang=3DEN-GB style=3D'mso-b=
idi-font-size:
11.0pt'>stalevo</span></span><span lang=3DEN-GB style=3D'mso-bidi-font-size=
:11.0pt'>
200/50/200&nbsp;mg <i style=3D'mso-bidi-font-style:normal'><span
style=3D'background:silver;mso-highlight:silver'>[carton only]</span></i><o=
:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=3DMsoNormal style=3D'border:none;mso-border-alt:solid windowtext .=
5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 0in 4.0pt'><b style=3D'mso-bidi-fon=
t-weight:
normal'><span lang=3DEN-GB style=3D'mso-no-proof:yes'>17.<span style=3D'mso=
-tab-count:
1'> </span>UNIQUE IDENTIFIER  2D BARCODE</span></b><i style=3D'mso-bid=
i-font-style:
normal'><span lang=3DEN-GB style=3D'mso-no-proof:yes'><o:p></o:p></span></i=
></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black;background:silver;mso-highlight:silver'>2D barcode carrying the
unique identifier included</span><span lang=3DEN-GB style=3D'mso-bidi-font-=
size:
11.0pt;color:black'> <span style=3D'background:#D9D9D9'>[<i style=3D'mso-bi=
di-font-style:
normal'>carton only</i>]<o:p></o:p></span></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black;background:#D9D9D9'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black;background:#D9D9D9'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=3DMsoNormal style=3D'border:none;mso-border-alt:solid windowtext .=
5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 0in 4.0pt'><b style=3D'mso-bidi-fon=
t-weight:
normal'><span lang=3DEN-GB style=3D'mso-no-proof:yes'>18.<span style=3D'mso=
-tab-count:
1'> </span>UNIQUE IDENTIFIER - HUMAN READABLE DATA</span></b><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'mso-no-pro=
of:yes'><o:p></o:p></span></i></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DE=
N-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;background:#D9D9D9'>[carton =
only</span></i><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;background:#D9D=
9D9'>]:<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>PC <span
style=3D'background:silver;mso-highlight:silver'>{number}</span> <o:p></o:p=
></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>SN <span
style=3D'background:silver;mso-highlight:silver'>{number}</span> <o:p></o:p=
></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>&lt;NN <span
style=3D'background:silver;mso-highlight:silver'>{number}</span>&gt;<span
style=3D'color:black'><o:p></o:p></span></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<span lang=3DEN-GB style=3D'font-size:11.0pt;mso-bidi-font-size:10.0pt;font=
-family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-ansi-=
language:
EN-GB;mso-fareast-language:EN-US;mso-bidi-language:AR-SA'><br clear=3Dall
style=3D'mso-special-character:line-break;page-break-before:always'>
</span>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<h1><span lang=3DEN-GB>B. PACKAGE LEAFLET</span></h1>

<span lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",=
serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB;mso-farea=
st-language:
EN-US;mso-bidi-language:AR-SA'><br clear=3Dall style=3D'page-break-before:a=
lways'>
</span>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><b style=3D=
'mso-bidi-font-weight:
normal'><span lang=3DEN-GB style=3D'color:black'>Package leaflet: Informati=
on for
the user</span></b><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN=
-GB
style=3D'mso-bidi-font-size:11.0pt'> </span></b><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><b style=3D=
'mso-bidi-font-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;text-transfor=
m:uppercase'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span class=
=3DSpellE><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;text-transform:uppercase'>s</span></b><b style=3D'mso-bidi-font-weig=
ht:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>talevo</span=
></b></span><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt'> 50&nbsp;mg/12.5&nbsp;mg/200&nbsp;mg film-coated tablets<o:p></o:p>=
</span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DIT
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'>levodopa/carbidopa=
/entacapone<b
style=3D'mso-bidi-font-weight:normal'><span style=3D'text-transform:upperca=
se'><o:p></o:p></span></b></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DIT
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'><o:p>&nbsp;</o:p><=
/span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-hyphenate:none;tab-sto=
ps:28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-no-pr=
oof:yes'>Read
all of this leaflet carefully before you start taking this medicine because=
 it
contains important information for you.</span></b><span lang=3DEN-GB
style=3D'mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-list:l1 level1 lfo3;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ig=
nore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>Keep
this leaflet. You may need to read it again.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-list:l1 level1 lfo3;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ig=
nore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>If
you have any further questions, ask your doctor or pharmacist.<o:p></o:p></=
span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'>-<span
style=3D'mso-tab-count:1'> </span>This medicine has been prescribed =
for you
only. Do not pass it on to others. It may harm them, even if their signs of
illness are the same as yours.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l1 level1 lfo53'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-no-pr=
oof:
yes'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New =
Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&=
nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-no-proof:yes=
'>If you
get any side effects, talk to your doctor or pharmacist.</span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:red'> </span><span
lang=3DEN-GB style=3D'mso-no-proof:yes'>This includes any possible side eff=
ects not
listed in this leaflet. See section 4.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DNormal11><span class=3DSpellE><b style=3D'mso-bidi-font-weight:n=
ormal'><span
lang=3DFR>What</span></b></span><b style=3D'mso-bidi-font-weight:normal'><s=
pan
lang=3DFR> <span class=3DSpellE>is</span> in <span class=3DSpellE>this</spa=
n> <span
class=3DSpellE>leaflet</span>:<o:p></o:p></span></b></p>

<p class=3DMsoNormal><span lang=3DEN-GB>1.<span style=3D'mso-tab-count:1'>=
 </span>What
<span class=3DSpellE>Stalevo</span> is and what it is used for</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>2.<span style=3D'mso-tab-count:1'>=
 </span><span
style=3D'mso-no-proof:yes'>What you need to know </span>before you take <sp=
an
class=3DSpellE>Stalevo</span></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>3.<span style=3D'mso-tab-count:1'>=
 </span>How
to take <span class=3DSpellE>Stalevo</span></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>4.<span style=3D'mso-tab-count:1'>=
 </span>Possible
side effects</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>5<span style=3D'mso-tab-count:1'>=
 </span>How
to store <span class=3DSpellE>Stalevo</span></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>6.<span style=3D'mso-tab-count:1'>=
 </span><span
style=3D'mso-no-proof:yes'>Contents of the pack and other information</span=
></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-left:37.05pt;text-indent:-37.05pt;mso-=
list:
l51 level1 lfo56;tab-stops:28.35pt list 35.45pt'><![if !supportLists]><b><s=
pan
lang=3DEN-GB style=3D'text-transform:uppercase'><span style=3D'mso-list:Ign=
ore'>1.<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;
</span></span></span></b><![endif]><b style=3D'mso-bidi-font-weight:normal'=
><span
lang=3DEN-GB>What <span class=3DSpellE>Stalevo</span> is and what it is use=
d for<span
style=3D'text-transform:uppercase;mso-bidi-font-weight:bold'><o:p></o:p></s=
pan></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><b style=3D'mso-bidi-font=
-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;<=
/o:p></span></b></p>

<p class=3DMsoBodyText3 align=3Dleft style=3D'text-align:left;line-height:n=
ormal'><span
class=3DSpellE><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;font-w=
eight:
normal;font-style:normal'>Stalevo</span></span><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-style:normal'>
contains three active substances (levodopa, carbidopa and entacapone) in one
film-coated tablet. <span class=3DSpellE>Stalevo</span> is used for the tre=
atment
of Parkinsons disease. <o:p></o:p></span></p>

<p class=3DMsoBodyText3 align=3Dleft style=3D'text-align:left;line-height:n=
ormal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-sty=
le:normal'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Parkinsons disease is cau=
sed by
low levels of a substance called dopamine in the brain. Levodopa increases =
the
amount of dopamine and hence reduces the symptoms of Parkinsons disease.
Carbidopa and entacapone improve the <span class=3DSpellE>antiparkinson</sp=
an>
effects of levodopa. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>2.<span
style=3D'mso-tab-count:1'> </span>What you need to know before you ta=
ke <span
class=3DSpellE>Stalevo</span><span style=3D'text-transform:uppercase'><o:p>=
</o:p></span></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>Do
not take <span class=3DSpellE>Stalevo</span> if you:<o:p></o:p></span></b><=
/p>

<p class=3DMsoNormal><span style=3D'mso-ansi-language:EN-US'><o:p>&nbsp;</o=
:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l42 level1 lfo17;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>are allergic to levodopa, carbidopa or entacapone,=
 or
any of the other ingredients of this medicine </span><span style=3D'font-si=
ze:
11.0pt;mso-no-proof:yes'>(listed in section 6)</span><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l42 level1 lfo17;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>have narrow-angle glaucoma (an eye disorder)<o:p><=
/o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l42 level1 lfo17;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>have a tumour of the adrenal gland<o:p></o:p></spa=
n></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l42 level1 lfo17;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>are taking certain medicines for treating depressi=
on (</span><span
style=3D'font-size:11.0pt'>combinations of </span><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>selective MAO-A and MAO-B
inhibitors, or non-selective MAO-inhibitors)<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l42 level1 lfo17;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>have ever had neuroleptic malignant syndrome (NMS 
this is a rare reaction to medicines used to treat severe mental disorders)=
<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l42 level1 lfo17;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>have ever had non-traumatic rhabdomyolysis (a rare
muscle disorder)<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l42 level1 lfo17;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>have a severe liver disease. <o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-la=
nguage:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;mso-li=
st:skip;
tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN=
-GB
style=3D'mso-no-proof:yes'>Warnings and precautions <o:p></o:p></span></b><=
/p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;mso-li=
st:skip;
tab-stops:28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN=
-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></b></p>

<p class=3DMsoNormal><u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0=
pt'>Talk
to your doctor or pharmacist before taking <span class=3DSpellE>Stalevo</sp=
an> if
you have or have ever had</span></u><span lang=3DEN-GB style=3D'mso-bidi-fo=
nt-size:
11.0pt'>:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>a
heart attack or any other diseases of the heart including cardiac arrhythmi=
as,
or of the blood vessels<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>asthma
or any other disease of the lungs<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>a
liver problem, because your dose may need to be adjusted<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>kidney
or hormone-related diseases<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>stomach
ulcers or convulsions<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>if
you experience prolonged diarrhoea consult your doctor as it may be a sign =
of
inflammation of the colon<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>any
form of severe mental disorder like psychosis<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>chronic
wide-angle glaucoma, because your dose may need to be adjusted and the pres=
sure
in your eyes may need to be monitored.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0=
pt'>Consult
your doctor if you are currently taking</span></u><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>antipsychotics
(medicines used to treat psychosis)<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>a
medicine which may cause low blood pressure when rising from a chair or bed.
You should be aware that <span class=3DSpellE>Stalevo</span> may make these
reactions worse.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0=
pt'>Consult
your doctor if during the treatment with <span class=3DSpellE>Stalevo</span=
> you</span></u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>notice
that your muscles get very rigid or jerk violently, or if you get tremors,
agitation, confusion, fever, rapid pulse, or wide fluctuations in your blood
pressure. If any of this happens, <b style=3D'mso-bidi-font-weight:normal'>=
contact
your doctor immediately</b><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>feel
depressed, have suicidal thoughts, or notice unusual changes in your behavi=
our<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>find
yourself suddenly falling asleep, or if you feel very drowsy. If this happe=
ns,
you should not drive or use any tools or machines (see also section 'Driving
and using machines')<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>notice
that uncontrolled movements begin or get worse after you started to take <s=
pan
class=3DSpellE>Stalevo</span>. If this happens, your doctor may need to cha=
nge
the dose of your <span class=3DSpellE>antiparkinson</span> medicine <o:p></=
o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>experience
diarrhoea: monitoring of your weight is recommended in order to avoid poten=
tially
excessive weight loss<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>experience
progressive anorexia, asthenia (weakness, exhaustion) and weight decrease
within a relatively short period of time. If this happens, a general medical
evaluation including liver function should be considered<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>feel
the need to stop using <span class=3DSpellE>Stalevo</span>, see section 'If=
 you
stop taking <span class=3DSpellE>Stalevo</span>'.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Tell your
doctor if you or your family/carer notices you are developing addiction-like
symptoms leading to craving for large doses of <span class=3DSpellE>Stalevo=
</span>
and other medicines used to treat Parkinsons disease.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span style=3D'mso-bidi-font-size:11.0pt;mso-ansi-lang=
uage:
EN-US'>Tell your doctor if you or your family/<span class=3DSpellE>carer</s=
pan>
notices you are developing urges or cravings to behave in ways that are unu=
sual
for you or you cannot resist the impulse, drive or temptation to carry out
certain activities that could harm yourself or others. These <span
class=3DSpellE>behaviours</span> are called impulse control disorders and c=
an
include addictive gambling, excessive eating or spending, an abnormally high
sex drive or a preoccupation with an increase in sexual thoughts or feeling=
s. <u>Your
doctor may need to review your treatments.</u> <o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Your
doctor may take some regular laboratory tests during a long term treatment =
with
<span class=3DSpellE>Stalevo</span>.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>If you
must undergo surgery, please tell your doctor that you are using <span
class=3DSpellE>Stalevo</span>.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span class=3DSpellE><span lang=3DEN-GB style=3D'mso-b=
idi-font-size:
11.0pt'>Stalevo</span></span><span lang=3DEN-GB style=3D'mso-bidi-font-size=
:11.0pt'>
is not recommended to be used for treatment of extrapyramidal symptoms (e.g.
involuntary movements, shaking, muscle rigidity and muscle contractions</sp=
an><span
lang=3DEN style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EN'>)</span>=
<span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'> caused by other medicines=
.<o:p></o:p></span></p>

<p class=3DMsoNormal><u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0=
pt'><o:p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'mso-bidi-font-size:11.0pt'>Children</span><span lang=3DEN-GB
style=3D'color:black'> and adolescents<o:p></o:p></span></b></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Experience
with <span class=3DSpellE>Stalevo</span> in patients under 18 years is limi=
ted.
Therefore, the use of <span class=3DSpellE>Stalevo</span> in children or
adolescents is not recommended.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-la=
nguage:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>Other
medicines and <span class=3DSpellE>Stalevo</span><o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoBodyText style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-style:normal'>Te=
ll
your doctor or pharmacist if you are taking, have recently taken or might t=
ake any
other medicines.<o:p></o:p></span></p>

<p class=3DMsoBodyText style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-style:normal'><o=
:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Do not take <span class=3D=
SpellE>Stalevo</span>
if you are taking certain medicines for treating depression (combinations of
selective MAO-A and MAO-B inhibitors, or non-selective MAO inhibitors).<o:p=
></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal'><span
class=3DSpellE><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Stale=
vo</span></span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'> may increase the effects =
and side
effects of certain medicines. These include: <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>medicines
used to treat depression such as moclobemide, amitriptyline, desipramine,
maprotiline, venlafaxine and paroxetine <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l11 level2 lfo20'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-family:"Arial",sans-serif;mso-farea=
st-font-family:
Arial'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times Ne=
w Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp=
;&nbsp;
</span></span></span><![endif]><span class=3DSpellE><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>rimiterole</span></span><span lang=3DEN=
-GB
style=3D'mso-bidi-font-size:11.0pt'> and isoprenaline, used to treat respir=
atory
diseases<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>adrenaline,
used </span><span lang=3DPT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-lan=
guage:
PT'>for severe allergic reactions</span><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
11.0pt'> <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>noradrenaline,
dopamine and dobutamine, used to treat heart diseases and low blood pressur=
e<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l22 level1 lfo60'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>alpha-methyldopa,
used to treat high blood pressure <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>-<span
style=3D'mso-tab-count:1'> </span>apomorphine, which is used to treat
Parkinsons disease.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;tab-sto=
ps:17.1pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;tab-st=
ops:28.35pt'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>The effects=
 of <span
class=3DSpellE>Stalevo</span> may be weakened by certain medicines. These
include: <o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-la=
nguage:
EN-GB'>-<span style=3D'mso-tab-count:1'> </span>dopamine antagonists=
 used
to treat mental disorders</span><span style=3D'font-size:11.0pt'>, nausea a=
nd
vomiting</span><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-langua=
ge:EN-GB'><o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l49 level1 lfo18;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>phenytoin, used to prevent convulsions <o:p></o:p>=
</span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l49 level1 lfo18;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>papaverine used to relax the muscles.<o:p></o:p></=
span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;tab-st=
ops:28.35pt'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p>&nbsp;=
</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;tab-st=
ops:28.35pt'><span
class=3DSpellE><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-langua=
ge:EN-GB'>Stalevo</span></span><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'> may make i=
t harder
for you to digest iron. Therefore, do not take <span class=3DSpellE>Stalevo=
</span>
and iron supplements at the same time. After taking one of them, wait at le=
ast
2 to 3 hours before taking the other.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;tab-st=
ops:28.35pt'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal><span class=3DSpellE><b style=3D'mso-bidi-font-weight:=
normal'><span
lang=3DEN-GB>Stalevo</span></b></span><b style=3D'mso-bidi-font-weight:norm=
al'><span
lang=3DEN-GB> with food and drink<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoBodyText style=3D'text-align:justify;line-height:normal;tab-s=
tops:
28.35pt'><span class=3DSpellE><span lang=3DEN-GB style=3D'mso-bidi-font-siz=
e:11.0pt;
font-weight:normal;font-style:normal'>Stalevo</span></span><span lang=3DEN-=
GB
style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-style:normal'> m=
ay be
taken with or without food. For some patients, <span class=3DSpellE>Stalevo=
</span>
may not be well absorbed if it is taken with, or shortly after eating
protein-rich food (such as meats, fish, dairy products, seeds and nuts).
Consult your doctor if you think this applies to you.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;tab-st=
ops:28.35pt'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>Pregnancy,
breast-feeding and fertility<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoBodyText style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-style:normal'>If=
 you
are pregnant</span><span lang=3DEN-GB> </span><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;font-weight:normal;font-style:normal'>or breast-feeding, think you m=
ay
be pregnant or are planning to have a baby, ask your doctor or pharmacist f=
or
advice before taking this medicine. <o:p></o:p></span></p>

<p class=3DMsoBodyText style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-style:normal'><o=
:p>&nbsp;</o:p></span></p>

<p class=3DMsoBodyText style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-style:normal'>You
should not breast-feed during treatment with <span class=3DSpellE>Stalevo</=
span>.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>Driving
and using machines<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span class=
=3DSpellE><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Stalevo</span></span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'> may lower your blood pres=
sure,
which may make you feel light-headed or dizzy. Therefore, be particularly
careful when you drive or when you use any tools or machines.<o:p></o:p></s=
pan></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>If you feel very drowsy, or if you some=
times
find yourself suddenly falling asleep, wait until you feel fully awake again
before driving or doing anything else that requires you to be alert. Otherw=
ise,
you may put yourself and others at risk of serious injury or death.<o:p></o=
:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span class=
=3DSpellE><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt'>Stalevo</span></b></span><b style=3D'mso-bidi-font-weight:normal'><=
span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'> contains sucrose<o:p></o:=
p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span class=
=3DSpellE><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Stalevo</span></span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'> contains sucrose
(1.2&nbsp;mg/tablet). If you have been told by your doctor that you have
intolerance to some sugars, contact your doctor before taking this medicinal
product.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'text-transform:uppercase'>3.<span style=3D'mso-tab-count:1'>=
 </span></span><span
lang=3DEN-GB>How to take <span class=3DSpellE>Stalevo</span><span style=3D'=
text-transform:
uppercase'><o:p></o:p></span></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Always take this medicine =
exactly
as your doctor or pharmacist has told you. Check with your doctor or pharma=
cist
if you are not sure.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>For adults and elderly</sp=
an></u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt=
'>-<span
style=3D'mso-tab-count:1'> </span>Your doctor will tell you exactly =
how
many tablets of <span class=3DSpellE>Stalevo</span> to take each day. <o:p>=
</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l32 level1 lfo21'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-family:"Arial",sans-serif;mso-farea=
st-font-family:
Arial'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times Ne=
w Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp=
;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>The
tablets are not intended to be split or broken into smaller pieces.<o:p></o=
:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l32 level1 lfo21'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-family:"Arial",sans-serif;mso-farea=
st-font-family:
Arial'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times Ne=
w Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp=
;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>You
should take only one tablet each time.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l32 level1 lfo21'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-family:"Arial",sans-serif;mso-farea=
st-font-family:
Arial'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times Ne=
w Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp=
;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>Depending
on how you respond to treatment, your doctor may suggest a higher or lower
dose. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l32 level1 lfo21'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt;font-family:"Arial",sans-serif;mso-fareast-font-family:Arial'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>If
you are taking <span class=3DSpellE>Stalevo</span> 50&nbsp;mg/12.5&nbsp;mg/=
200&nbsp;mg,
75&nbsp;mg/18.75&nbsp;mg/200&nbsp;mg, 100&nbsp;mg/25&nbsp;mg/200&nbsp;mg, 1=
25
mg/31.25 mg/200 mg or 150&nbsp;mg/37.5&nbsp;mg/200&nbsp;mg tablets, do not =
take
more than 10 tablets per day.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;text-align:justify;line-he=
ight:
normal;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt=
'>Talk
to your doctor or pharmacist if you think the effect of <span class=3DSpell=
E>Stalevo</span>
is too strong or too weak, or if you experience possible side effects.<o:p>=
</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;text-align:justify;line-he=
ight:
12.0pt;mso-list:skip'><span lang=3DEN-GB><!--[if gte vml 1]><v:shapetype id=
=3D"_x0000_t75"
 coordsize=3D"21600,21600" o:spt=3D"75" o:preferrelative=3D"t" path=3D"m@4@=
5l@4@11@9@11@9@5xe"
 filled=3D"f" stroked=3D"f">
 <v:stroke joinstyle=3D"miter"/>
 <v:formulas>
  <v:f eqn=3D"if lineDrawn pixelLineWidth 0"/>
  <v:f eqn=3D"sum @0 1 0"/>
  <v:f eqn=3D"sum 0 0 @1"/>
  <v:f eqn=3D"prod @2 1 2"/>
  <v:f eqn=3D"prod @3 21600 pixelWidth"/>
  <v:f eqn=3D"prod @3 21600 pixelHeight"/>
  <v:f eqn=3D"sum @0 0 1"/>
  <v:f eqn=3D"prod @6 1 2"/>
  <v:f eqn=3D"prod @7 21600 pixelWidth"/>
  <v:f eqn=3D"sum @8 21600 0"/>
  <v:f eqn=3D"prod @7 21600 pixelHeight"/>
  <v:f eqn=3D"sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok=3D"f" gradientshapeok=3D"t" o:connecttype=3D"rect"/>
 <o:lock v:ext=3D"edit" aspectratio=3D"t"/>
</v:shapetype><v:shape id=3D"_x0000_i1045" type=3D"#_x0000_t75" style=3D'wi=
dth:468pt;
 height:91.5pt'>
 <v:imagedata src=3D"Stalevo_clean_files/image001.emz" o:title=3D""/>
</v:shape><![endif]--><![if !vml]><img border=3D0 width=3D624 height=3D122
src=3D"Stalevo_clean_files/image002.png" v:shapes=3D"_x0000_i1045"><![endif=
]></span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>

<p class=3DNormal11><b style=3D'mso-bidi-font-weight:normal'><span lang=3DF=
R>If <span
class=3DSpellE>you</span> <span class=3DSpellE>take</span> more <span class=
=3DSpellE>Stalevo</span>
<span class=3DSpellE>than</span> <span class=3DSpellE>you</span> <span
class=3DSpellE>should</span><o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>If you have accidentally taken more <sp=
an
class=3DSpellE>Stalevo</span> tablets than you should, talk to your doctor =
or pharmacist
immediately. In case of an overdose you may feel confused or agitated, your
heart rate may be slower or faster than normal or the colour of your skin,
tongue, eyes or urine may change.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>If
you forget to take <span class=3DSpellE>Stalevo</span><o:p></o:p></span></b=
></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>Do not take a double dose to make up fo=
r a
forgotten tablet.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p><span style=3D'text-d=
ecoration:
 none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>If it is more than 1 hour =
until
your next dose</span></u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.=
0pt'>: <o:p></o:p></span></p>

<p class=3DMsoBodyText style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-style:normal'>Ta=
ke one
tablet as soon as you remember, and the next tablet at the normal time. <o:=
p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>If it is less than 1 hour =
until
your next dose</span></u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.=
0pt'>: <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Take a tablet as soon as y=
ou
remember, wait 1 hour, then take another tablet. After that carry on as nor=
mal.
<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Always leave at least an h=
our
between <span class=3DSpellE>Stalevo</span> tablets, to avoid possible side
effects.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>If
you stop taking <span class=3DSpellE>Stalevo</span> <o:p></o:p></span></b><=
/p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Do not stop taking <span
class=3DSpellE>Stalevo</span> unless your doctor tells you to. In such a ca=
se
your doctor may need to adjust your other <span class=3DSpellE>antiparkinso=
n</span>
medicines, especially levodopa, to give sufficient control of your symptoms=
. If
you suddenly stop taking <span class=3DSpellE>Stalevo</span> and other
antiparkinsonian medicines it may result in unwanted side effects. <o:p></o=
:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>If you have any further qu=
estions
on the use of this medicine, ask your doctor or pharmacist.<o:p></o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>4.<span
style=3D'mso-tab-count:1'> </span>Possible side effects<span
style=3D'text-transform:uppercase'><o:p></o:p></span></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-1.4pt;line-height:normal;mso-ou=
tline-level:
1;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:=
p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:28=
.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Like all medicines, this m=
edicine can
cause side effects, although not everybody gets them. Many of the side effe=
cts
can be relieved by adjusting the dose. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.4pt;line-height:normal;mso-ou=
tline-level:
1;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:=
p>&nbsp;</o:p></span></p>

<p class=3DText style=3D'margin-top:0in'><span style=3D'font-size:11.0pt'>I=
f you
during the treatment with <span class=3DSpellE>Stalevo</span> experience the
following symptoms, <b style=3D'mso-bidi-font-weight:normal'>contact your d=
octor
immediately</b>: <o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l50=
 level1 lfo26'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-size:11.0pt'>Your muscle=
s get
very rigid or jerk violently, you get tremors, agitation, confusion, fever,
rapid pulse, or wide fluctuations in your blood pressure. These can be symp=
toms
</span><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB=
'>of
neuroleptic malignant syndrome (NMS, a rare severe reaction to medicines us=
ed
to treat disorders of the central nervous system) or rhabdomyolysis (a rare
severe muscle disorder).<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l37=
 level1 lfo27'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>Allergic reaction, the signs may include hives (ne=
ttle
rash), itching, rash, swelling of your face, lips, tongue or throat. This m=
ay
cause difficulties in breathing or swallowing.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.4pt;line-height:normal;mso-ou=
tline-level:
1;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:=
p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><u><span lang=3DEN-GB>Very common (may affect more tha=
n 1 in
10 people)<o:p></o:p></span></u></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>uncontrolled movements (dyskinesias)<o:p></o:p></s=
pan></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>feeling sick (nausea)<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>harmless reddish-brown discolouration of urine<o:p=
></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>muscle pain<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span class=3DSpellE><span style=3D'font-siz=
e:11.0pt'>diarrhoea</span></span><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p></o:p>=
</span></p>

<p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><span lang=3DEN-=
GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span>=
</p>

<p class=3DMsoNormal><u><span lang=3DEN-GB>Common (may affect up to 1 in 10=
 people)<o:p></o:p></span></u></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>light-headedness or fainting due to low blood pres=
sure,
high blood pressure<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>worsening of Parkinson`s symptoms, dizziness,
drowsiness<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>vomiting, abdominal pain and discomfort, heartburn,
dry mouth, constipation<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>inability to sleep, hallucinations, confusion,
abnormal dreams (including nightmares), tiredness<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>mental changes  including problems with memory, a=
nxiety
and depression (possibly with thoughts of suicide) <o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-size:11.0pt'>heart or ar=
tery
disease events (e.g. chest pain), irregular heart rate or rhythm </span><sp=
an
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p></o:p>=
</span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>more frequent falling <o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>shortness of breath <o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>increased sweating, rashes<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>muscle cramps, swelling of legs<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span lang=3D=
EN-GB
style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>blurred
vision<span style=3D'mso-spacerun:yes'> </span><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span lang=3D=
EN-GB
style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>anaemia<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span lang=3D=
EN-GB
style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>decreased
appetite, decreased weight<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span lang=3D=
EN-GB
style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>headache,
joint pain<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span lang=3D=
EN-GB
style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>urinary
tract infection<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;tab-st=
ops:28.35pt'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p>&nbsp;=
</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;tab-st=
ops:28.35pt'><u><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>Uncommon </=
span></u><u><span
style=3D'font-size:11.0pt;color:black'>(may affect up to 1 in 100&nbsp;peop=
le)</span></u><u><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p></o:p>=
</span></u></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>heart attack<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>bleeding in the gut<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>changes in the blood cell count which may result in
bleeding, abnormal liver function tests<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>convulsions<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo7;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>feeling agitated<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l4 =
level1 lfo22;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>psychotic symptoms <o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l4 =
level1 lfo22;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>colitis (inflammation of the colon) <o:p></o:p></s=
pan></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l4 =
level1 lfo22;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span class=3DSpellE><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>discolourations</span></=
span><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'> other than=
 urine
(e.g. skin, nail, hair, sweat)<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo7;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>swallowing difficulties<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo7;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-size:11.0pt'>inability to
urinate</span><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-languag=
e:EN-GB'><o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p>&nbsp;=
</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left'><u><s=
pan
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>Not known (=
cannot
be estimated from the available data)<o:p></o:p></span></u></p>

<p class=3DText style=3D'margin-top:0in'><span lang=3DEN-GB style=3D'font-s=
ize:11.0pt;
mso-ansi-language:EN-GB'>Craving for large doses of <span class=3DSpellE>St=
alevo</span>
in excess of that required to control motor symptoms, known as dopamine
dysregulation syndrome. Some patients experience severe abnormal involuntary
movements (dyskinesias), mood swings or other side effects after taking lar=
ge
doses of <span class=3DSpellE>Stalevo</span>.<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in'><span lang=3DEN-GB style=3D'font-s=
ize:11.0pt;
mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText style=3D'margin-top:0in'><u><span lang=3DEN-GB style=3D'fon=
t-size:11.0pt;
mso-ansi-language:EN-GB'>The following side effects have also been reported=
</span></u><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>:<o:p></o:p=
></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l4 =
level1 lfo22;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>hepatitis </span><span style=3D'font-size:11.0pt'>=
(inflammation
of the liver)</span><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-l=
anguage:
EN-GB'> <o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l4 =
level1 lfo22;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>itching<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in'><span lang=3DEN-GB style=3D'font-s=
ize:11.0pt;
mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:4.8pt;mso-pagination:none'><u><s=
pan
lang=3DEN-GB style=3D'color:black'>You may experience the following side ef=
fects: <o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:4.8pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-pagination:none;mso-list:l10 level1 lfo49;tab-stops:28.35pt'><![=
if !supportLists]><span
lang=3DEN-GB style=3D'font-family:"Arial",sans-serif;mso-fareast-font-famil=
y:Arial;
color:black'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Ti=
mes New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp=
;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
color:black'>Inability to resist the impulse to perform an action that coul=
d be
harmful, which may include:</span><span lang=3DEN-GB style=3D'color:black'>=
<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:4.8pt;margin-bott=
om:0in;
margin-left:42.55pt;margin-bottom:.0001pt;text-indent:-14.2pt;line-height:n=
ormal;
mso-pagination:none;mso-list:l9 level2 lfo51;tab-stops:list 42.55pt'><![if =
!supportLists]><span
lang=3DEN-GB style=3D'font-family:"Arial",sans-serif;mso-fareast-font-famil=
y:Arial;
color:black'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Ti=
mes New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
color:black'>strong impulse to gamble excessively despite serious personal =
or family
consequences</span><span lang=3DEN-GB style=3D'color:black'><o:p></o:p></sp=
an></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:4.8pt;margin-bott=
om:0in;
margin-left:42.55pt;margin-bottom:.0001pt;text-indent:-14.2pt;line-height:n=
ormal;
mso-pagination:none;mso-list:l9 level2 lfo51;tab-stops:list 42.55pt'><![if =
!supportLists]><span
lang=3DEN-GB style=3D'font-family:"Arial",sans-serif;mso-fareast-font-famil=
y:Arial;
color:black'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Ti=
mes New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
color:black'>altered or increased sexual interest and behaviour of signific=
ant
concern to you or to others, for example, an increased sexual drive</span><=
span
lang=3DEN-GB style=3D'color:black'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:4.8pt;margin-bott=
om:0in;
margin-left:42.55pt;margin-bottom:.0001pt;text-indent:-14.2pt;line-height:n=
ormal;
mso-pagination:none;mso-list:l9 level2 lfo51;tab-stops:list 42.55pt'><![if =
!supportLists]><span
lang=3DEN-GB style=3D'font-family:"Arial",sans-serif;mso-fareast-font-famil=
y:Arial;
color:black'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Ti=
mes New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
color:black'>uncontrollable excessive shopping or spending</span><span
lang=3DEN-GB style=3D'color:black'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:4.8pt;margin-bott=
om:0in;
margin-left:42.55pt;margin-bottom:.0001pt;text-indent:-14.2pt;line-height:n=
ormal;
mso-pagination:none;mso-list:l9 level2 lfo51;tab-stops:list 42.55pt'><![if =
!supportLists]><span
lang=3DEN-GB style=3D'font-family:"Arial",sans-serif;mso-fareast-font-famil=
y:Arial;
color:black'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Ti=
mes New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
color:black'>binge eating (eating large amounts of food in a short time per=
iod)
or compulsive eating (eating more food than normal and more than is needed =
to
satisfy your hunger).</span><span lang=3DEN-GB style=3D'color:black'><o:p><=
/o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:4.8pt;mso-pagination:none'><span
lang=3DEN-GB style=3D'color:black'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:4.8pt;mso-pagination:none;tab-st=
ops:
0in'><span lang=3DEN-GB style=3D'color:black'>Tell your doctor if you exper=
ience
any of these behaviours; they will discuss ways of managing or reducing the
symptoms.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-out=
line-level:
1;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:=
p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-out=
line-level:
1;mso-list:skip'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>Reporting of side effects<o:p></o:p></s=
pan></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-out=
line-level:
1;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>If =
you get
any side effects, talk to your doctor or pharmacist. This includes any poss=
ible
side effects not listed in this leaflet. You can also report side effects
directly via <span style=3D'background:silver;mso-highlight:silver'>the nat=
ional
reporting system listed in <a
href=3D"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_fo=
rm/2013/03/WC500139752.doc">Appendix
V</a></span>. By reporting side <span class=3DSpellE>effects you</span> can=
 help
provide more information on the safety of this medicine.<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DNormal11><b style=3D'mso-bidi-font-weight:normal'><span lang=3DF=
R>5.<span
style=3D'mso-tab-count:1'> </span> How to store <span class=3DSpellE>=
Stalevo</span><span
style=3D'text-transform:uppercase'><o:p></o:p></span></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-out=
line-level:
1;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Kee=
p this
medicine out of the sight and reach of children.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Do not use this medicine a=
fter the
expiry date which is stated on the bottle and the carton after EXP. The exp=
iry
date refers to the last day of that month.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>This medicinal product doe=
s not
require any special storage conditions.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Do not </=
span><span
lang=3DEN-GB style=3D'mso-no-proof:yes'>throw away any medicines </span><sp=
an
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>via wastewater or househol=
d waste.
Ask your pharmacist how to </span><span lang=3DEN-GB style=3D'mso-no-proof:=
yes'>throw
away </span><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>medicine=
s you no
longer use. These measures will help to protect the environment.<o:p></o:p>=
</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>6.<span
style=3D'mso-tab-count:1'> </span>Contents of the pack and other
information<span style=3D'text-transform:uppercase'><o:p></o:p></span></spa=
n></b></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><b style=3D'mso-bidi-font=
-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>What <span
class=3DSpellE>Stalevo</span> contains<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:no=
rmal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-list:l14 level1 lfo7;tab-stops:list 28.35pt'><![if !supportLists=
]><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ig=
nore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>The
active substances of <span class=3DSpellE>Stalevo</span> are levodopa, carb=
idopa
and entacapone.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo7;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>Each <span class=3DSpellE>Stalevo</span>
50&nbsp;mg/12.5&nbsp;mg/200&nbsp;mg tablet contains 50&nbsp;mg of levodopa,=
 12.5&nbsp;mg
of carbidopa and 200&nbsp;mg of entacapone.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-list:l14 level1 lfo7;tab-stops:list 28.35pt'><![if !supportLists=
]><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ig=
nore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>The
other ingredients in the tablet core are croscarmellose sodium, magnesium
stearate, maize starch, mannitol (E421) and povidone (E1201)<o:p></o:p></sp=
an></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-list:l14 level1 lfo7;tab-stops:list 28.35pt'><![if !supportLists=
]><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ig=
nore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>The
ingredients in the film-coating are glycerol (85 per cent) (E422), <span
class=3DSpellE>hypromellose</span>, magnesium stearate, polysorbate 80, red=
 iron
oxide (E172), sucrose, titanium dioxide (E171), and yellow iron oxide (E172=
).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:27.0pt;text-indent:-27.0pt;line-h=
eight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;<=
/o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:27.0pt;text-indent:-27.0pt;line-h=
eight:
normal'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>What <span class=3DSpellE>Stalevo</span=
> looks
like and contents of the pack<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-left:27.0pt;text-indent:-27.0pt;line-h=
eight:
normal'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoEndnoteText><span class=3DSpellE><span lang=3DEN-GB style=3D'=
mso-bidi-font-size:
11.0pt'>Stalevo</span></span><span lang=3DEN-GB style=3D'mso-bidi-font-size=
:11.0pt'>
50&nbsp;mg/12.5&nbsp;mg/200&nbsp;mg: brownish or greyish red, round, convex
unscored film-coated tablets marked with LCE 50 on one side.<o:p></o:p></=
span></p>

<p class=3DMsoEndnoteText><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoEndnoteText><span class=3DSpellE><span lang=3DEN-GB style=3D'=
mso-bidi-font-size:
11.0pt'>Stalevo</span></span><span lang=3DEN-GB style=3D'mso-bidi-font-size=
:11.0pt'>
comes in six different pack sizes (10, 30, 100, 130, 175 or 250 tablets). N=
ot
all pack sizes may be marketed.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:27.0pt;text-indent:-27.0pt;line-h=
eight:
normal'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>Marketing
Authorisation Holder</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoEndnoteText><span lang=3DIT style=3D'mso-bidi-font-size:11.0p=
t;
mso-ansi-language:IT'>Orion Corporation<o:p></o:p></span></p>

<p class=3DMsoEndnoteText><span lang=3DIT style=3D'mso-bidi-font-size:11.0p=
t;
mso-ansi-language:IT'>Orionintie 1<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DIT style=3D'=
mso-bidi-font-size:
11.0pt;mso-ansi-language:IT'>FI-02200 Espoo<o:p></o:p></span></p>

<p class=3DMsoEndnoteText><span lang=3DIT style=3D'mso-bidi-font-size:11.0p=
t;
mso-ansi-language:IT'>Finland<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DIT style=3D'=
mso-bidi-font-size:
11.0pt;mso-ansi-language:IT'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-2.25pt'><b style=3D'mso-bidi-fo=
nt-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Manufacturer=
<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-2.25pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>Orion Corporation Orion Pharma<o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-2.25pt'><span class=3DSpellE><s=
pan
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Joensuunkatu</span></span>=
<span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>&nbsp;7<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'margin-right:-2.25pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>FI-24100&nbsp;Salo<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>Finland<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DIT style=3D'=
mso-bidi-font-size:
11.0pt;mso-ansi-language:IT'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoEndnoteText><span lang=3DIT style=3D'mso-bidi-font-size:11.0p=
t;
mso-ansi-language:IT'>Orion Corporation </span><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>Orion Pharma</span><span lang=3DIT
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'><o:p></o:p></span>=
</p>

<p class=3DMsoEndnoteText><span lang=3DIT style=3D'mso-bidi-font-size:11.0p=
t;
mso-ansi-language:IT'>Orionintie&nbsp;1<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DIT style=3D'=
mso-bidi-font-size:
11.0pt;mso-ansi-language:IT'>FI-02200&nbsp;Espoo<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DIT style=3D'=
mso-bidi-font-size:
11.0pt;mso-ansi-language:IT'>Finland<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DIT style=3D'=
mso-bidi-font-size:
11.0pt;mso-ansi-language:IT'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>For any information about =
this
medicine, please contact the local representative of the Marketing
Authorisation Holder.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<table class=3DMsoNormalTable border=3D0 cellspacing=3D0 cellpadding=3D0 wi=
dth=3D628
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;mso-yfti-tbll=
ook:
 1184;mso-padding-alt:0in 5.4pt 0in 5.4pt'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;page-break-inside:avoid=
'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DFR
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FR;mso-no-proof:yes'=
>Belgi/Belgique/Belgien</span></b><span
  lang=3DFR style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FR'><br>
  </span><strong><span lang=3DEN-GB style=3D'font-weight:normal;mso-bidi-fo=
nt-weight:
  bold'>Orion Pharma BVBA/SPRL</span></strong><strong><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt;font-weight:normal'><o:p></o:p></span>=
</strong></p>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><span class=3D=
SpellE><span
  style=3D'font-size:11.0pt'>Tl</span></span><span style=3D'font-size:11.0=
pt'>/Tel:
  +32 (0)15 64 10 20</span><span lang=3DFR style=3D'font-size:11.0pt;mso-an=
si-language:
  FR'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt'><b style=3D'mso-bidi-=
font-weight:
  normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast=
-language:
  CS'><o:p>&nbsp;</o:p></span></b></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DFI
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI'>Lietuva</span></=
b><span
  lang=3DFI style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI;mso-far=
east-language:
  CS'><o:p></o:p></span></p>
  <p class=3DMsoNormal><span lang=3DFI style=3D'mso-bidi-font-size:11.0pt;m=
so-ansi-language:
  FI'>UAB Orion Pharma<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none'><span lang=3DFI style=
=3D'mso-bidi-font-size:
  11.0pt;mso-ansi-language:FI'>Tel. +370 5&nbsp;276 9499</span><span lang=
=3DFI
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI;mso-fareast-langu=
age:
  CS'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:1;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal><span class=3DSpellE><b style=3D'mso-bidi-font-weigh=
t:normal'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black'>&#1041;&#109=
8;&#1083;&#1075;&#1072;&#1088;&#1080;&#1103;</span></b></span><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DFR style=3D'mso-bidi-f=
ont-size:
  11.0pt;color:black;mso-ansi-language:FR'><o:p></o:p></span></b></p>
  <p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;m=
so-ansi-language:
  IT'>Orion Pharma Poland Sp z.o.o.<o:p></o:p></span></p>
  <p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;m=
so-ansi-language:
  IT'>Tel.: + 48&nbsp;22&nbsp;8333177<o:p></o:p></span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DDE
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'>Luxembourg/Luxem=
burg</span></b><span
  lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'><br>
  </span><strong><span lang=3DEN-GB style=3D'font-weight:normal;mso-bidi-fo=
nt-weight:
  bold'>Orion Pharma BVBA/SPRL</span></strong><strong><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt;font-weight:normal'><o:p></o:p></span>=
</strong></p>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><span class=3D=
SpellE><span
  style=3D'font-size:11.0pt'>Tl</span></span><span style=3D'font-size:11.0=
pt'>/Tel:
  +32 (0)15 64 10 20</span><span lang=3DFR style=3D'font-size:11.0pt;mso-an=
si-language:
  FR'><o:p></o:p></span></p>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DSV
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:SV'><o:p>&nbsp;</o:p=
></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:2;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none'><b style=3D'mso-bidi-fo=
nt-weight:
  normal'><span lang=3DSV style=3D'mso-bidi-font-size:11.0pt;mso-ansi-langu=
age:
  SV'>&#268;esk republika</span></b><span lang=3DSV style=3D'mso-bidi-font=
-size:
  11.0pt;mso-ansi-language:SV;mso-fareast-language:CS'><o:p></o:p></span></=
p>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none'><span lang=3DFI style=
=3D'mso-ansi-language:
  FI'>Orion Pharma s.r.o.<o:p></o:p></span></p>
  <p class=3DMsoNormal><span lang=3DEN-GB>Tel: <span
  style=3D'mso-spacerun:yes'></span></span><span lang=3DSV style=3D'mso-an=
si-language:
  SV'>+420 234 703 305</span><b style=3D'mso-bidi-font-weight:normal'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:CS'>=
<o:p></o:p></span></b></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DSV
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:SV'>Magyarorszg</sp=
an></b><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DSV style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:SV;mso-fareast-language:CS'><o:p></o:p></span></=
b></p>
  <p class=3DMsoNormal style=3D'line-height:13.0pt'><strong><span lang=3DEN=
-GB
  style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;mso-bidi-font-weigh=
t:
  bold'>Orion Pharma <span class=3DSpellE>Kft</span>.</span></strong><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'><o:p></o:p></span></b></p>
  <p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>Tel.: +</span><span
  lang=3DEN-GB>36 1 239 9095</span><span lang=3DSV style=3D'mso-bidi-font-s=
ize:11.0pt;
  mso-ansi-language:SV'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:3;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>Danmark</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size:=
11.0pt'><br>
  Orion Pharma A/S<br>
  <span class=3DSpellE>Tlf</span>: +45 8614 0000</span><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:CS'><o:p></o:p></=
span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none'><b style=3D'mso-bidi-fo=
nt-weight:
  normal'><span lang=3DFR style=3D'mso-bidi-font-size:11.0pt;mso-ansi-langu=
age:
  FR'>Malta</span></b><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DFR
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FR;mso-fareast-langu=
age:
  CS'><o:p></o:p></span></b></p>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DIT style=
=3D'mso-bidi-font-size:
  11.0pt;mso-ansi-language:IT'>Salomone Pharma<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-2.25pt;margin-=
bottom:
  9.0pt;margin-left:0in'><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;
  mso-ansi-language:IT'>Tel: +356&nbsp;21220174</span><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:CS'><o:p></o:p></=
span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:4;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DDE style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:DE'>Deutschland</span></b><span lang=3DDE
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'><br>
  Orion Pharma GmbH</span><span lang=3DDE style=3D'mso-bidi-font-size:11.0p=
t;
  mso-ansi-language:DE;mso-fareast-language:CS'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><s=
pan
  lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'>Tel: +=
49 40
  899 6890</span><span lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ans=
i-language:
  DE;mso-fareast-language:CS'><o:p></o:p></span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DSV
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:SV'>Nederland</span>=
</b><span
  lang=3DSV style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:SV'><br>
  </span><strong><span lang=3DEN-GB style=3D'font-weight:normal;mso-bidi-fo=
nt-weight:
  bold'>Orion Pharma BVBA/SPRL</span></strong><strong><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt;font-weight:normal'><o:p></o:p></span>=
</strong></p>
  <p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:9.=
0pt;
  margin-left:0in;tab-stops:28.35pt'><span class=3DSpellE><span style=3D'fo=
nt-size:
  11.0pt'>Tl</span></span><span style=3D'font-size:11.0pt'>/Tel: +32 (0)15=
 64 10
  20</span><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:E=
N-GB;
  mso-fareast-language:CS'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:5;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none'><b><span lang=3DFI
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI'>Eesti</span></b>=
<b><span
  lang=3DFI style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI;mso-far=
east-language:
  CS'><o:p></o:p></span></b></p>
  <p class=3DMsoNormal><span lang=3DFI style=3D'mso-bidi-font-size:11.0pt;m=
so-ansi-language:
  FI'>Orion Pharma Eesti O<o:p></o:p></span></p>
  <p class=3DMsoNormal><span lang=3DFI style=3D'mso-bidi-font-size:11.0pt;m=
so-ansi-language:
  FI'>Tel: +372 66 44 550</span><span lang=3DFI style=3D'mso-bidi-font-size=
:11.0pt;
  mso-ansi-language:FI;mso-fareast-language:CS'><o:p></o:p></span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt'><b style=3D'mso-bidi-=
font-weight:
  normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Norge</spa=
n></b><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:CS'>=
<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-hyphenate:none'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Orion Pharma AS<o:p></o:=
p></span></p>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-2.25pt;margin-=
bottom:
  9.0pt;margin-left:0in'><span class=3DSpellE><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
  11.0pt'>Tlf</span></span><span lang=3DEN-GB style=3D'mso-bidi-font-size:1=
1.0pt'>:
  +47 40 00 42 10</span><span lang=3DDE style=3D'mso-bidi-font-size:11.0pt;
  mso-ansi-language:DE;mso-fareast-language:CS'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:6;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><span class=3D=
SpellE><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-si=
ze:11.0pt;
  mso-ansi-language:EN-GB'>&#917;&#955;&#955;&#940;&#948;</span></b></span>=
<b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-si=
ze:11.0pt;
  mso-ansi-language:EN-GB'>&#945;</span></b><span lang=3DFI style=3D'font-s=
ize:
  11.0pt;mso-ansi-language:FI'><br>
  Orion Pharma Hellas M.E.</span><span style=3D'font-size:11.0pt'>&#928;</s=
pan><span
  lang=3DFI style=3D'font-size:11.0pt;mso-ansi-language:FI'>.E<o:p></o:p></=
span></p>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><span class=3D=
SpellE><span
  style=3D'font-size:11.0pt'>&#932;&#951;&#955;</span></span><span lang=3DFI
  style=3D'font-size:11.0pt;mso-ansi-language:FI'>: + 30&nbsp;210&nbsp;980 =
3355</span><span
  lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p></o:=
p></span></p>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt'><b style=3D'mso-bidi-=
font-weight:
  normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast=
-language:
  CS'><o:p>&nbsp;</o:p></span></b></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DDE style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:DE'>sterreich</span></b><span lang=3DDE
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'><br>
  Orion Pharma GmbH</span><span lang=3DDE style=3D'mso-bidi-font-size:11.0p=
t;
  mso-ansi-language:DE;mso-fareast-language:CS'><o:p></o:p></span></p>
  <p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:9.=
0pt;
  margin-left:0in;tab-stops:28.35pt'><span lang=3DDE style=3D'font-size:11.=
0pt;
  mso-ansi-language:DE'>Tel: +49 40 899 6890</span><span lang=3DEN-GB
  style=3D'font-size:11.0pt;mso-ansi-language:EN-GB;mso-fareast-language:CS=
'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:7;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><b style=3D'ms=
o-bidi-font-weight:
  normal'><span lang=3DIT style=3D'font-size:11.0pt;mso-ansi-language:IT'>E=
spaa</span></b><span
  lang=3DIT style=3D'font-size:11.0pt;mso-ansi-language:IT'><br>
  </span><span style=3D'font-size:11.0pt'>Orion Pharma S.L.</span><span
  style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><span
  style=3D'font-size:11.0pt'>Tel: + 34 91 &nbsp;599 86 01</span><span lang=
=3DEN-GB
  style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt'><b style=3D'mso-bidi-=
font-weight:
  normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast=
-language:
  CS'><o:p>&nbsp;</o:p></span></b></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>Polska</span></b><b style=3D'mso-bidi=
-font-weight:
  normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast=
-language:
  CS'><o:p></o:p></span></b></p>
  <p class=3DMsoNormal><span lang=3DSV style=3D'mso-bidi-font-size:11.0pt;m=
so-ansi-language:
  SV'>Orion Pharma Poland Sp z.o.o.</span><span lang=3DEN-GB style=3D'mso-b=
idi-font-size:
  11.0pt'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-bottom:9.0pt'><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>Tel.: + 48 22 8333177</span><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:CS'>=
<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:8;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><b style=3D'ms=
o-bidi-font-weight:
  normal'><span lang=3DFR style=3D'font-size:11.0pt;mso-ansi-language:FR'>F=
rance</span></b><span
  lang=3DFR style=3D'font-size:11.0pt;mso-ansi-language:FR'><br>
  </span><span style=3D'font-size:11.0pt;mso-fareast-font-family:Calibri;
  mso-fareast-language:EN-GB'>Centre <span class=3DSpellE>Spcialits</span=
> <span
  class=3DSpellE>Pharmaceutiques</span></span><span lang=3DFR style=3D'font=
-size:
  11.0pt;mso-ansi-language:FR'><o:p></o:p></span></p>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><span
  style=3D'font-size:11.0pt;mso-fareast-font-family:Calibri;mso-fareast-lan=
guage:
  EN-GB'>Tel: + 33 (0) 1 47 04 80 46</span><span lang=3DFR style=3D'font-si=
ze:11.0pt;
  mso-ansi-language:FR'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt'><b style=3D'mso-bidi-=
font-weight:
  normal'><span lang=3DFR style=3D'mso-bidi-font-size:11.0pt;mso-ansi-langu=
age:
  FR;mso-fareast-language:CS'><o:p>&nbsp;</o:p></span></b></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;tab-=
stops:
  28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DIT
  style=3D'font-size:11.0pt;mso-ansi-language:IT'>Portugal</span></b><span
  lang=3DIT style=3D'font-size:11.0pt;mso-ansi-language:IT'><br>
  </span><span class=3DSpellE><span style=3D'font-size:11.0pt'>Orionfin</sp=
an></span><span
  style=3D'font-size:11.0pt'> <span class=3DSpellE>Unipessoal</span> <span
  class=3DSpellE>Lda</span></span><span lang=3DIT style=3D'font-size:11.0pt;
  mso-ansi-language:IT'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-2.25pt;margin-=
bottom:
  9.0pt;margin-left:0in'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.=
0pt'>Tel:
  + 351 21 154 68 20</span><span lang=3DFR style=3D'mso-bidi-font-size:11.0=
pt;
  mso-ansi-language:FR;mso-fareast-language:CS'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:9;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DFI style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:FI;mso-fareast-language:CS'>Hrvatska<o:p></o:p><=
/span></b></p>
  <p class=3DMsoNormal><strong><span lang=3DFI style=3D'mso-bidi-font-size:=
11.0pt;
  mso-ansi-language:FI;font-weight:normal;mso-bidi-font-weight:bold'>Orion
  Pharma d.o.o.<o:p></o:p></span></strong></p>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><s=
pan
  lang=3DFI style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI'>Tel:</=
span><span
  lang=3DFI style=3D'mso-ansi-language:FI'> +386&nbsp;(0) 1 600 8015</span>=
<span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:CS'>=
<o:p></o:p></span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:12.0pt;mso-line-height-rule:exa=
ctly;
  mso-layout-grid-align:none;text-autospace:none'><span class=3DSpellE><b><=
span
  lang=3DFR style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-languag=
e:FR'>Romnia</span></b></span><b><span
  lang=3DFR style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-languag=
e:FR'><o:p></o:p></span></b></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-layout-grid-align:no=
ne;
  text-autospace:none'><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;
  mso-ansi-language:IT'>Orion Corporation</span><span lang=3DFR style=3D'ms=
o-bidi-font-size:
  11.0pt;color:black;mso-ansi-language:FR'><o:p></o:p></span></p>
  <p class=3DMsoNormal><span lang=3DFR style=3D'mso-bidi-font-size:11.0pt;c=
olor:black;
  mso-ansi-language:FR'>Tel: +358 10 4261<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:10;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><b style=3D'mso-bidi-fo=
nt-weight:
  normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Ireland</s=
pan></b><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><br>
  Orion Pharma (Ireland) Ltd.</span><span lang=3DEN-GB style=3D'mso-bidi-fo=
nt-size:
  11.0pt;mso-fareast-language:CS'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>c/o <span class=3DSpellE>Allphar</spa=
n>
  Services Ltd.<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-hyphenate:none'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Tel: +353 1 428 7777<o:p=
></o:p></span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DIT
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'>Slovenija</span>=
</b><span
  lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT;mso-far=
east-language:
  CS'><o:p></o:p></span></p>
  <p class=3DMsoNormal><strong><span lang=3DFI style=3D'mso-bidi-font-size:=
11.0pt;
  mso-ansi-language:FI;font-weight:normal;mso-bidi-font-weight:bold'>Orion
  Pharma d.o.o.<o:p></o:p></span></strong></p>
  <p class=3DMsoNormal style=3D'margin-bottom:9.0pt'><span lang=3DFI
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI'>Tel:</span><span
  lang=3DFI style=3D'mso-ansi-language:FI'> +386&nbsp;(0) 1 600 8015</span>=
<b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt;mso-fareast-language:CS'><o:p></o:p></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:11;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt'><span class=3DSpellE>=
<b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>sland</span></b></span><b style=3D'mso-bidi-font-weight:normal'>=
<span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:CS'>=
<o:p></o:p></span></b></p>
  <p class=3DMsoNormal style=3D'line-height:normal'><span class=3DSpellE><s=
pan
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Vistor</span></span><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'> hf.<o:p></o:p></span></=
p>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><span class=3D=
SpellE><span
  style=3D'font-size:11.0pt'>Smi</span></span><span style=3D'font-size:11.=
0pt'>:
  +354 535 7000</span><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi=
-language:
  EN-GB;mso-fareast-language:CS'><o:p></o:p></span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none'><b style=3D'mso-bidi-fo=
nt-weight:
  normal'><span lang=3DSV style=3D'mso-bidi-font-size:11.0pt;mso-ansi-langu=
age:
  SV'>Slovensk republika</span></b><b style=3D'mso-bidi-font-weight:normal=
'><span
  lang=3DSV style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:SV;mso-far=
east-language:
  CS'><o:p></o:p></span></b></p>
  <p class=3DMsoNormal><strong><span lang=3DSV style=3D'mso-bidi-font-size:=
11.0pt;
  mso-ansi-language:SV;font-weight:normal;mso-bidi-font-weight:bold'>Orion
  Pharma s.r.o<o:p></o:p></span></strong></p>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-2.25pt;margin-=
bottom:
  9.0pt;margin-left:0in;line-height:normal'><span lang=3DSV style=3D'mso-an=
si-language:
  SV'>Tel: </span><span lang=3DSV><span style=3D'mso-spacerun:yes'></span>=
</span><span
  lang=3DSV style=3D'mso-ansi-language:SV'>+420 234 703 305</span><span lan=
g=3DIT
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT;mso-fareast-langu=
age:
  CS'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:12;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><b style=3D'ms=
o-bidi-font-weight:
  normal'><span lang=3DIT style=3D'font-size:11.0pt;mso-ansi-language:IT'>I=
talia</span></b><span
  lang=3DIT style=3D'font-size:11.0pt;mso-ansi-language:IT'><br>
  </span><span lang=3DFI style=3D'font-size:11.0pt;mso-ansi-language:FI'>Or=
ion
  Pharma S.r.l.<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-bottom:9.0pt;mso-hyphenate:none'><sp=
an
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Tel: + 39 02&nbsp;678761=
11</span><span
  lang=3DEL style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EL;mso-far=
east-language:
  CS'><o:p></o:p></span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DIT style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:IT'>Suomi/Finland<br>
  </span></b><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-la=
nguage:
  IT'>Orion Corporation</span><span lang=3DIT style=3D'mso-bidi-font-size:1=
1.0pt;
  mso-ansi-language:IT;mso-fareast-language:CS'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><s=
pan
  lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'>Puh./T=
el: +358
  10 4261</span><span lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ansi=
-language:
  DE;mso-fareast-language:CS'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:13;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEL
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EL'>&#922;&#973;&#96=
0;&#961;&#959;&#962;</span></b><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEL style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:EL;mso-fareast-language:CS'><o:p></o:p></span></=
b></p>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none;tab-stops:-.5in 28.35pt =
3.15in'><span
  lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'>Lifeph=
arma
  (ZAM) Ltd<o:p></o:p></span></p>
  <p class=3DMsoNormal><span class=3DSpellE><span lang=3DEN-GB style=3D'mso=
-bidi-font-size:
  11.0pt'>&#932;&#951;&#955;</span></span><span lang=3DDE style=3D'mso-bidi=
-font-size:
  11.0pt;mso-ansi-language:DE'>.: +357 22056300</span><span lang=3DDE
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE;mso-fareast-langu=
age:
  CS'><o:p></o:p></span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DDE style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:DE'>Sverige</span></b><span lang=3DDE
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'><br>
  Orion Pharma AB</span><span lang=3DDE style=3D'mso-bidi-font-size:11.0pt;
  mso-ansi-language:DE;mso-fareast-language:CS'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><s=
pan
  lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'>Tel: +=
46 8 623
  6440<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:14;mso-yfti-lastrow:yes;page-break-inside:avoid=
'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DFI
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI'>Latvija</span></=
b><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DFI style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:FI;mso-fareast-language:CS'><o:p></o:p></span></=
b></p>
  <p class=3DMsoNormal><span style=3D'mso-bidi-font-size:11.0pt;mso-ansi-la=
nguage:
  EN-US'>Orion Corporation<o:p></o:p></span></p>
  <p class=3DMsoNormal><span style=3D'mso-bidi-font-size:11.0pt;mso-ansi-la=
nguage:
  EN-US'>Orion Pharma <span class=3DSpellE>p&#257;rst&#257;vniec&#299;ba</s=
pan><o:p></o:p></span></p>
  <p class=3DMsoNormal><span style=3D'mso-bidi-font-size:11.0pt;mso-ansi-la=
nguage:
  EN-US'>Tel: +371 20028332<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none'><span style=3D'mso-bidi=
-font-size:
  11.0pt;mso-ansi-language:EN-US;mso-fareast-language:CS'><o:p>&nbsp;</o:p>=
</span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt'><b style=3D'mso-bidi-=
font-weight:
  normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>United Kin=
gdom</span></b><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:CS'>=
<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-hyphenate:none'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Orion Pharma (UK) Ltd.<o=
:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none'><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>Tel: +44 1635 520 300</span><span lan=
g=3DFI
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI;mso-fareast-langu=
age:
  CS'><o:p></o:p></span></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt'>This leaflet was last revised in.<o:p></o:p></span></b></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'mso-no-proof:yes'>Other sources of information<o:p></o:p></span></=
b></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Detailed
information on this medicine is available on the European Medicines Agency =
web
site: <a href=3D"http://www.ema.europa.eu">http://www.ema.europa.eu</a>. <o=
:p></o:p></span></p>

<b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-s=
ize:11.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-ansi-language:EN-GB;mso-fareast-language:EN-US;mso-bidi-language:AR-SA'=
><br
clear=3Dall style=3D'page-break-before:always'>
</span></b>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><b style=3D=
'mso-bidi-font-weight:
normal'><span lang=3DEN-GB style=3D'color:black'>Package leaflet: Informati=
on for
the user</span></b><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN=
-GB
style=3D'mso-bidi-font-size:11.0pt'> <span style=3D'text-transform:uppercas=
e'><o:p></o:p></span></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><b style=3D=
'mso-bidi-font-weight:
normal'><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;text-transform:u=
ppercase;
mso-ansi-language:IT'>s</span></b><b style=3D'mso-bidi-font-weight:normal'>=
<span
lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'>talevo <=
/span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt'>75&nbsp;mg/18.75&nbsp;mg/200&nbsp;mg</span></b><b style=3D'mso-bidi=
-font-weight:
normal'><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:IT'>
film-coated tablets<o:p></o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DIT
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'>levodopa/carbidopa=
/entacapone<b
style=3D'mso-bidi-font-weight:normal'><span style=3D'text-transform:upperca=
se'><o:p></o:p></span></b></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DIT
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'><o:p>&nbsp;</o:p><=
/span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>Read
all of this leaflet carefully before you start taking this medicine because=
 it
contains important information for you.<o:p></o:p></span></b></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-list:l1 level1 lfo3;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ig=
nore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>Keep
this leaflet. You may need to read it again.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-list:l1 level1 lfo3;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ig=
nore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>If
you have any further questions, ask your doctor or pharmacist.<o:p></o:p></=
span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'>-<span
style=3D'mso-tab-count:1'> </span>This medicine has been prescribed =
for
you only. Do not pass it on to others. It may harm them, even if their sign=
s of
illness are the same as yours. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l1 level1 lfo53'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-no-pr=
oof:
yes'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New =
Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&=
nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-no-proof:yes=
'>If you
get any side effects, talk to your doctor or pharmacist.</span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:red'> </span><span
lang=3DEN-GB style=3D'mso-no-proof:yes'>This includes any possible side eff=
ects not
listed in this leaflet. See section 4.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>What
is in this leaflet:<o:p></o:p></span></b></p>

<p class=3DMsoNormal><span lang=3DEN-GB>1.<span style=3D'mso-tab-count:1'>=
 </span>What
<span class=3DSpellE>Stalevo</span> is and what it is used for</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>2.<span style=3D'mso-tab-count:1'>=
 </span><span
style=3D'mso-no-proof:yes'>What you need to know</span> before you take <sp=
an
class=3DSpellE>Stalevo</span></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>3.<span style=3D'mso-tab-count:1'>=
 </span>How
to take <span class=3DSpellE>Stalevo</span></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>4.<span style=3D'mso-tab-count:1'>=
 </span>Possible
side effects</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>5<span style=3D'mso-tab-count:1'>=
 </span>How
to store <span class=3DSpellE>Stalevo</span></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'font-size:10.0pt'>6.<span
style=3D'mso-tab-count:1'> </span></span><span lang=3DEN-GB
style=3D'mso-no-proof:yes'>Contents of the pack and other information</span=
><span
lang=3DEN-GB style=3D'font-size:10.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'text-transform:uppercase'>1.<span style=3D'mso-tab-count:1'>=
 </span></span><span
lang=3DEN-GB>What <span class=3DSpellE>Stalevo</span> is and what it is use=
d for<span
style=3D'text-transform:uppercase'><o:p></o:p></span></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><b style=3D'mso-bidi-font=
-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;<=
/o:p></span></b></p>

<p class=3DMsoBodyText3 align=3Dleft style=3D'text-align:left;line-height:n=
ormal'><span
class=3DSpellE><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;font-w=
eight:
normal;font-style:normal'>Stalevo</span></span><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-style:normal'>
contains three active substances (levodopa, carbidopa and entacapone) in one
film-coated tablet. <span class=3DSpellE>Stalevo</span> is used for the tre=
atment
of Parkinsons disease. <o:p></o:p></span></p>

<p class=3DMsoBodyText3 align=3Dleft style=3D'text-align:left;line-height:n=
ormal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-sty=
le:normal'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Parkinsons disease is cau=
sed by
low levels of a substance called dopamine in the brain. Levodopa increases =
the
amount of dopamine and hence reduces the symptoms of Parkinsons disease.
Carbidopa and entacapone improve the <span class=3DSpellE>antiparkinson</sp=
an>
effects of levodopa. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'text-transform:uppercase'>2.<span style=3D'mso-tab-count:1'>=
 </span></span><span
lang=3DEN-GB>What you need to know before you take <span class=3DSpellE>Sta=
levo</span><span
style=3D'text-transform:uppercase'><o:p></o:p></span></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>Do
not take <span class=3DSpellE>Stalevo</span> if you:<o:p></o:p></span></b><=
/p>

<p class=3DMsoNormal><span style=3D'mso-ansi-language:EN-US'><o:p>&nbsp;</o=
:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l42 level1 lfo17;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>are allergic to levodopa, carbidopa or entacapone,=
 or
any of the other ingredients of this medicine </span><span style=3D'font-si=
ze:
11.0pt;mso-no-proof:yes'>(listed in section 6)</span><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l42 level1 lfo17;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>have narrow-angle glaucoma (an eye disorder)<o:p><=
/o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l42 level1 lfo17;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>have a tumour of the adrenal gland<o:p></o:p></spa=
n></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l42 level1 lfo17;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>are taking certain medicines for treating depressi=
on (</span><span
style=3D'font-size:11.0pt'>combinations of </span><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>selective MAO-A and MAO-B
inhibitors, or non-selective MAO-inhibitors)<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l42 level1 lfo17;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>have ever had neuroleptic malignant syndrome (NMS 
this is a rare reaction to medicines used to treat severe mental disorders)=
<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l42 level1 lfo17;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>have ever had non-traumatic rhabdomyolysis (a rare
muscle disorder)<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l42 level1 lfo17;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>have a severe liver disease. <o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-la=
nguage:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'mso-no-proof:yes'>Warnings and precautions <o:p></o:p></span></b><=
/p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0=
pt'>Talk
to your doctor or pharmacist before taking <span class=3DSpellE>Stalevo</sp=
an> if
you have or have ever had</span></u><span lang=3DEN-GB style=3D'mso-bidi-fo=
nt-size:
11.0pt'>:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>a
heart attack or any other diseases of the heart including cardiac arrhythmi=
as,
or of the blood vessels<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>asthma
or any other disease of the lungs<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>a
liver problem, because your dose may need to be adjusted<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>kidney
or hormone-related diseases<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>stomach
ulcers or convulsions<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>if
you experience prolonged diarrhoea consult your doctor as it may be a sign =
of
inflammation of the colon<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>any
form of severe mental disorder like psychosis<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>chronic
wide-angle glaucoma, because your dose may need to be adjusted and the pres=
sure
in your eyes may need to be monitored.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0=
pt'>Consult
your doctor if you are currently taking</span></u><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>antipsychotics
(medicines used to treat psychosis)<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>a
medicine which may cause low blood pressure when rising from a chair or bed=
. You
should be aware that <span class=3DSpellE>Stalevo</span> may make these rea=
ctions
worse.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0=
pt'>Consult
your doctor if during the treatment with <span class=3DSpellE>Stalevo</span=
> you</span></u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-list:l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>notice
that your muscles get very rigid or jerk violently, or if you get tremors,
agitation, confusion, fever, rapid pulse, or wide fluctuations in your blood
pressure. If any of this happens, <b style=3D'mso-bidi-font-weight:normal'>=
contact
your doctor immediately</b><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-list:l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>feel
depressed, have suicidal thoughts, or notice unusual changes in your behavi=
our<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-list:l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>find
yourself suddenly falling asleep, or if you feel very drowsy. If this happe=
ns,
you should not drive or use any tools or machines (see also section 'Driving
and using machines')<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-list:l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>notice
that uncontrolled movements begin or get worse after you started to take <s=
pan
class=3DSpellE>Stalevo</span>. If this happens, your doctor may need to cha=
nge
the dose of your <span class=3DSpellE>antiparkinson</span> medicine <o:p></=
o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-list:l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>experience
diarrhoea: monitoring of your weight is recommended in order to avoid poten=
tially
excessive weight loss<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-list:l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>experience
progressive anorexia, asthenia (weakness, exhaustion) and weight decrease w=
ithin
a relatively short period of time. If this happens, a general medical
evaluation including liver function should be considered<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-list:l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>feel
the need to stop using <span class=3DSpellE>Stalevo</span>, see section 'If=
 you
stop taking <span class=3DSpellE>Stalevo</span>'.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Tell your
doctor if you or your family/carer notices you are developing addiction-like
symptoms leading to craving for large doses of <span class=3DSpellE>Stalevo=
</span>
and other medicines used to treat Parkinsons disease.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span style=3D'mso-bidi-font-size:11.0pt;mso-ansi-lang=
uage:
EN-US'>Tell your doctor if you or your family/<span class=3DSpellE>carer</s=
pan>
notices you are developing urges or cravings to behave in ways that are unu=
sual
for you or you cannot resist the impulse, drive or temptation to carry out
certain activities that could harm yourself or others. These <span
class=3DSpellE>behaviours</span> are called impulse control disorders and c=
an
include addictive gambling, excessive eating or spending, an abnormally high
sex drive or a preoccupation with an increase in sexual thoughts or feeling=
s. <u>Your
doctor may need to review your treatments.</u><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Your
doctor may take some regular laboratory tests during a long term treatment =
with
<span class=3DSpellE>Stalevo</span>.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>If you
must undergo surgery, please tell your doctor that you are using <span
class=3DSpellE>Stalevo</span>.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span class=3DSpellE><span lang=3DEN-GB style=3D'mso-b=
idi-font-size:
11.0pt'>Stalevo</span></span><span lang=3DEN-GB style=3D'mso-bidi-font-size=
:11.0pt'>
is not recommended to be used for treatment of extrapyramidal symptoms (e.g.
involuntary movements, <a name=3D"OLE_LINK1">shaking</a>, muscle rigidity a=
nd
muscle contractions</span><span lang=3DEN style=3D'mso-bidi-font-size:11.0p=
t;
mso-ansi-language:EN'>)</span><span lang=3DEN-GB style=3D'mso-bidi-font-siz=
e:11.0pt'>
caused by other medicines.<o:p></o:p></span></p>

<p class=3DMsoNormal><u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0=
pt'><o:p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'mso-bidi-font-size:11.0pt'>Children </span><span lang=3DEN-GB
style=3D'color:black'>and adolescents<o:p></o:p></span></b></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Experience
with <span class=3DSpellE>Stalevo</span> in patients under 18 years is limi=
ted.
Therefore, the use of <span class=3DSpellE>Stalevo</span> in children or
adolescents is not recommended.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-la=
nguage:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>Other
medicines and <span class=3DSpellE>Stalevo</span><o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoBodyText style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-style:normal'>Te=
ll
your doctor or pharmacist if you are taking, have recently taken or might t=
ake any
other medicines.<o:p></o:p></span></p>

<p class=3DMsoBodyText style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-style:normal'><o=
:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Do not take <span class=3D=
SpellE>Stalevo</span>
if you are taking certain medicines for treating depression (combinations of
selective MAO-A and MAO-B inhibitors, or non-selective MAO inhibitors).<o:p=
></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal'><span
class=3DSpellE><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Stale=
vo</span></span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'> may increase the effects =
and side
effects of certain medicines. These include: <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>medicines
used to treat depression such as moclobemide, amitriptyline, desipramine,
maprotiline, venlafaxine and paroxetine <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l11 level2 lfo20'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-family:"Arial",sans-serif;mso-farea=
st-font-family:
Arial'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times Ne=
w Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp=
;&nbsp;
</span></span></span><![endif]><span class=3DSpellE><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>rimiterole</span></span><span lang=3DEN=
-GB
style=3D'mso-bidi-font-size:11.0pt'> and isoprenaline, used to treat respir=
atory
diseases<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>adrenaline,
used </span><span lang=3DPT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-lan=
guage:
PT'>for severe allergic reactions</span><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
11.0pt'> <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>noradrenaline,
dopamine and dobutamine, used to treat heart diseases and low blood pressur=
e<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>-<span
style=3D'mso-tab-count:1'> </span>alpha-methyldopa, used to treat hi=
gh
blood pressure <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>-<span
style=3D'mso-tab-count:1'> </span>apomorphine, which is used to treat
Parkinsons disease.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;tab-sto=
ps:17.1pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;tab-st=
ops:28.35pt'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>The effects=
 of <span
class=3DSpellE>Stalevo</span> may be weakened by certain medicines. These
include: <o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-la=
nguage:
EN-GB'>-<span style=3D'mso-tab-count:1'> </span>dopamine antagonists=
 used
to treat mental disorders</span><span style=3D'font-size:11.0pt'>, nausea a=
nd
vomiting</span><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-langua=
ge:EN-GB'><o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l49 level1 lfo18;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>phenytoin, used to prevent convulsions <o:p></o:p>=
</span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l49 level1 lfo18;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>papaverine used to relax the muscles.<o:p></o:p></=
span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;tab-st=
ops:28.35pt'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p>&nbsp;=
</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;tab-st=
ops:28.35pt'><span
class=3DSpellE><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-langua=
ge:EN-GB'>Stalevo</span></span><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'> may make i=
t harder
for you to digest iron. Therefore, do not take <span class=3DSpellE>Stalevo=
</span>
and iron supplements at the same time. After taking one of them, wait at le=
ast
2 to 3 hours before taking the other.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;tab-st=
ops:28.35pt'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal><span class=3DSpellE><b style=3D'mso-bidi-font-weight:=
normal'><span
lang=3DEN-GB>Stalevo</span></b></span><b style=3D'mso-bidi-font-weight:norm=
al'><span
lang=3DEN-GB> with food and drink<o:p></o:p></span></b></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoBodyText style=3D'text-align:justify;line-height:normal;tab-s=
tops:
28.35pt'><span class=3DSpellE><span lang=3DEN-GB style=3D'mso-bidi-font-siz=
e:11.0pt;
font-weight:normal;font-style:normal'>Stalevo</span></span><span lang=3DEN-=
GB
style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-style:normal'> m=
ay be
taken with or without food. For some patients, <span class=3DSpellE>Stalevo=
</span>
may not be well absorbed if it is taken with, or shortly after eating
protein-rich food (such as meats, fish, dairy products, seeds and nuts).
Consult your doctor if you think this applies to you.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;tab-st=
ops:28.35pt'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>Pregnancy,
breast-feeding and fertility<o:p></o:p></span></b></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoBodyText style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-style:normal'>If=
 you
are pregnant or breast-feeding, think you may be pregnant or are planning to
have a baby, ask your doctor or pharmacist for advice before taking this
medicine. <o:p></o:p></span></p>

<p class=3DMsoBodyText style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-style:normal'><o=
:p>&nbsp;</o:p></span></p>

<p class=3DMsoBodyText style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-style:normal'>You
should not breast-feed during treatment with <span class=3DSpellE>Stalevo</=
span>.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>Driving
and using machines<o:p></o:p></span></b></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span class=
=3DSpellE><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Stalevo</span></span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'> may lower your blood pres=
sure,
which may make you feel light-headed or dizzy. Therefore, be particularly
careful when you drive or when you use any tools or machines.<o:p></o:p></s=
pan></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>If you feel very drowsy, or if you some=
times
find yourself suddenly falling asleep, wait until you feel fully awake again
before driving or doing anything else that requires you to be alert. Otherw=
ise,
you may put yourself and others at risk of serious injury or death.<o:p></o=
:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span class=
=3DSpellE><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt'>Stalevo</span></b></span><b style=3D'mso-bidi-font-weight:normal'><=
span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'> contains sucrose<o:p></o:=
p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span class=
=3DSpellE><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Stalevo</span></span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'> contains sucrose
(1.4&nbsp;mg/tablet). If you have been told by your doctor that you have
intolerance to some sugars, contact your doctor before taking this medicinal
product.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'text-transform:uppercase'>3.<span style=3D'mso-tab-count:1'>=
 </span></span><span
lang=3DEN-GB>How to take <span class=3DSpellE>Stalevo</span><span style=3D'=
text-transform:
uppercase'><o:p></o:p></span></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Always take this medicine =
exactly
as your doctor or pharmacist has told you. Check with your doctor or pharma=
cist
if you are not sure.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>For adults and elderly</sp=
an></u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt=
'>-<span
style=3D'mso-tab-count:1'> </span>Your doctor will tell you exactly =
how
many tablets of <span class=3DSpellE>Stalevo</span> to take each day. <o:p>=
</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l32 level1 lfo21'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-family:"Arial",sans-serif;mso-farea=
st-font-family:
Arial'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times Ne=
w Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp=
;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>The
tablets are not intended to be split or broken into smaller pieces.<o:p></o=
:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l32 level1 lfo21'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-family:"Arial",sans-serif;mso-farea=
st-font-family:
Arial'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times Ne=
w Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp=
;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>You
should take only one tablet each time.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l32 level1 lfo21'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-family:"Arial",sans-serif;mso-farea=
st-font-family:
Arial'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times Ne=
w Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp=
;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>Depending
on how you respond to treatment, your doctor may suggest a higher or lower
dose. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l32 level1 lfo21'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-family:"Arial",sans-serif;mso-farea=
st-font-family:
Arial'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times Ne=
w Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp=
;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>If
you are taking <span class=3DSpellE>Stalevo</span>
50&nbsp;mg/12.5&nbsp;mg/200&nbsp;mg, 75&nbsp;mg/18.75&nbsp;mg/200&nbsp;mg,
100&nbsp;mg/25&nbsp;mg/200&nbsp;mg, 125&nbsp;mg/31.25&nbsp;mg/200&nbsp;mg or
150&nbsp;mg/37.5&nbsp;mg/200&nbsp;mg tablets, do not take more than 10 tabl=
ets
per day.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;text-align:justify;line-he=
ight:
normal;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt=
'>Talk
to your doctor or pharmacist if you think the effect of <span class=3DSpell=
E>Stalevo</span>
is too strong or too weak, or if you experience possible side effects.<o:p>=
</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;text-align:justify;line-he=
ight:
12.0pt;mso-list:skip'><span lang=3DEN-GB><!--[if gte vml 1]><v:shape id=3D"=
_x0000_i1043"
 type=3D"#_x0000_t75" style=3D'width:468pt;height:91.5pt'>
 <v:imagedata src=3D"Stalevo_clean_files/image003.emz" o:title=3D""/>
</v:shape><![endif]--><![if !vml]><img border=3D0 width=3D624 height=3D122
src=3D"Stalevo_clean_files/image004.png" v:shapes=3D"_x0000_i1043"><![endif=
]></span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>If
you take more <span class=3DSpellE>Stalevo</span> than you should<o:p></o:p=
></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>If you have accidentally taken more <sp=
an
class=3DSpellE>Stalevo</span> tablets than you should, talk to your doctor =
or
pharmacist immediately. In case of an overdose you may feel confused or
agitated, your heart rate may be slower or faster than normal or the colour=
 of
your skin, tongue, eyes or urine may change.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>If
you forget to take <span class=3DSpellE>Stalevo</span><o:p></o:p></span></b=
></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>Do not take a double dose to make up fo=
r a
forgotten tablet.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p><span style=3D'text-d=
ecoration:
 none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>If it is more than 1 hour =
until
your next dose</span></u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.=
0pt'>: <o:p></o:p></span></p>

<p class=3DMsoBodyText style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-style:normal'>Ta=
ke one
tablet as soon as you remember, and the next tablet at the normal time. <o:=
p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>If it is less than 1 hour =
until
your next dose</span></u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.=
0pt'>: <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Take a tablet as soon as y=
ou
remember, wait 1 hour, then take another tablet. After that carry on as nor=
mal.
<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Always leave at least an h=
our
between <span class=3DSpellE>Stalevo</span> tablets, to avoid possible side
effects.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>If
you stop taking <span class=3DSpellE>Stalevo</span> <o:p></o:p></span></b><=
/p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Do not stop taking <span
class=3DSpellE>Stalevo</span> unless your doctor tells you to. In such a ca=
se
your doctor may need to adjust your other <span class=3DSpellE>antiparkinso=
n</span>
medicines, especially levodopa, to give sufficient control of your symptoms=
. If
you suddenly stop taking <span class=3DSpellE>Stalevo</span> and other
antiparkinsonian medicines it may result in unwanted side effects. <o:p></o=
:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>If you have any further qu=
estions
on the use of this medicine, ask your doctor or pharmacist.<o:p></o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'text-transform:uppercase'>4.<span style=3D'mso-tab-count:1'>=
 </span></span><span
lang=3DEN-GB>Possible side effects<span style=3D'text-transform:uppercase'>=
<o:p></o:p></span></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-1.4pt;line-height:normal;mso-ou=
tline-level:
1;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:=
p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.4pt;line-height:normal;mso-ou=
tline-level:
1;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Lik=
e all
medicines, this medicine can cause side effects, although not everybody gets
them. Many of the side effects can be relieved by adjusting the dose. <o:p>=
</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.4pt;line-height:normal;mso-ou=
tline-level:
1;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:=
p>&nbsp;</o:p></span></p>

<p class=3DText style=3D'margin-top:0in'><span style=3D'font-size:11.0pt'>I=
f you
during the treatment with <span class=3DSpellE>Stalevo</span> experience th=
e following
symptoms, <b style=3D'mso-bidi-font-weight:normal'>contact your doctor
immediately</b>: <o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:25.65pt;margin-bottom:.0001pt;text-indent:-25.65pt;mso-list:l50=
 level1 lfo26'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-size:11.0pt'>Your muscle=
s get
very rigid or jerk violently, you get tremors, agitation, confusion, fever,
rapid pulse, or wide fluctuations in your blood pressure. These can be symp=
toms
</span><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB=
'>of neuroleptic
malignant syndrome (NMS, a rare severe reaction to medicines used to treat
disorders of the central nervous system) or rhabdomyolysis (a rare severe
muscle disorder).<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:25.65pt;margin-bottom:.0001pt;text-indent:-25.65pt;mso-list:l37=
 level1 lfo27'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>Allergic reaction, the signs may include hives (ne=
ttle
rash), itching, rash, swelling of your face, lips, tongue or throat. This m=
ay
cause difficulties in breathing or swallowing.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.4pt;line-height:normal;mso-ou=
tline-level:
1;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:=
p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><u><span lang=3DEN-GB>Very common (may affect more tha=
n 1 in
10 people)<o:p></o:p></span></u></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>uncontrolled movements (dyskinesias)<o:p></o:p></s=
pan></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>feeling sick (nausea)<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>harmless reddish-brown discolouration of urine<o:p=
></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>muscle pain<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>diarrhoea<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><span lang=3DEN-=
GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span>=
</p>

<p class=3DMsoNormal><u><span lang=3DEN-GB>Common (may affect up to 1 in 10=
 people)<o:p></o:p></span></u></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>light-headedness or fainting due to low blood pres=
sure,
high blood pressure<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>worsening of Parkinsons symptoms, dizziness,
drowsiness<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>vomiting, abdominal pain and discomfort, heartburn,
dry mouth, constipation<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>inability to sleep, hallucinations, confusion abno=
rmal
dreams (including nightmares), tiredness<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>mental changes  including problems with memory, a=
nxiety
and depression (possibly with thoughts of suicide) <o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-size:11.0pt'>heart or ar=
tery
disease events (e.g. chest pain), irregular heart rate or rhythm </span><sp=
an
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p></o:p>=
</span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>more frequent falling <o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>shortness of breath <o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>increased sweating, rashes<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>muscle cramps, swelling of legs<o:p></o:p></span><=
/p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>blurred vision<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>anaemia<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>decreased appetite, decreased weight<o:p></o:p></s=
pan></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>headache, joint pain<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>urinary tract infection<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;tab-st=
ops:28.35pt'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p>&nbsp;=
</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;tab-st=
ops:28.35pt'><u><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>Uncommon </=
span></u><u><span
style=3D'font-size:11.0pt;color:black'>(may affect up to 1 in 100&nbsp;peop=
le)</span></u><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p></o:p>=
</span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>heart attack<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>bleeding in the gut<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>changes in the blood cell count which may result i=
n bleeding,
abnormal liver function tests<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>convulsions<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>feeling agitated<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>psychotic symptoms<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>colitis (inflammation of the colon)<o:p></o:p></sp=
an></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span class=3DSpellE><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>discolourations</span></=
span><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'> other than=
 urine
(e.g. skin, nail, hair, sweat)<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>swallowing difficulties<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-size:11.0pt'>inability to
urinate</span><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-languag=
e:EN-GB'><o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left'><u><s=
pan
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>Not known (=
cannot
be estimated from the available data)<o:p></o:p></span></u></p>

<p class=3DText style=3D'margin-top:0in'><span lang=3DEN-GB style=3D'font-s=
ize:11.0pt;
mso-ansi-language:EN-GB'>Craving for large doses of <span class=3DSpellE>St=
alevo</span>
in excess of that required to control motor symptoms, known as dopamine
dysregulation syndrome. Some patients experience severe abnormal involuntary
movements (dyskinesias), mood swings or other side effects after taking lar=
ge
doses of <span class=3DSpellE>Stalevo</span>.<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in'><span lang=3DEN-GB style=3D'font-s=
ize:11.0pt;
mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText style=3D'margin-top:0in'><u><span lang=3DEN-GB style=3D'fon=
t-size:11.0pt;
mso-ansi-language:EN-GB'>The following side effects have also been reported=
</span></u><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>:<o:p></o:p=
></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l4 =
level1 lfo22;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>hepatitis </span><span style=3D'font-size:11.0pt'>=
(inflammation
of the liver)</span><span style=3D'font-size:11.0pt;mso-ansi-language:EN-GB=
'> <span
lang=3DEN-GB><o:p></o:p></span></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l4 =
level1 lfo22;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>itching<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:25.65pt;margin-bottom:.0001pt'><span lang=3DEN-GB style=3D'font=
-size:
11.0pt;mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:4.8pt;mso-pagination:none'><u><s=
pan
lang=3DEN-GB style=3D'color:black'>You may experience the following side ef=
fects: <o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:4.8pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-pagination:none;mso-list:l10 level1 lfo49;tab-stops:28.35pt'><![=
if !supportLists]><span
lang=3DEN-GB style=3D'font-family:"Arial",sans-serif;mso-fareast-font-famil=
y:Arial;
color:black'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Ti=
mes New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp=
;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
color:black'>Inability to resist the impulse to perform an action that coul=
d be
harmful, which may include:</span><span lang=3DEN-GB style=3D'color:black'>=
<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:4.8pt;margin-bott=
om:0in;
margin-left:42.55pt;margin-bottom:.0001pt;text-indent:-14.2pt;line-height:n=
ormal;
mso-pagination:none;mso-list:l9 level2 lfo51;tab-stops:28.35pt'><![if !supp=
ortLists]><span
lang=3DEN-GB style=3D'font-family:"Arial",sans-serif;mso-fareast-font-famil=
y:Arial;
color:black'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Ti=
mes New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
color:black'>strong impulse to gamble excessively despite serious personal =
or family
consequences</span><span lang=3DEN-GB style=3D'color:black'><o:p></o:p></sp=
an></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:4.8pt;margin-bott=
om:0in;
margin-left:42.55pt;margin-bottom:.0001pt;text-indent:-14.2pt;line-height:n=
ormal;
mso-pagination:none;mso-list:l9 level2 lfo51;tab-stops:28.35pt'><![if !supp=
ortLists]><span
lang=3DEN-GB style=3D'font-family:"Arial",sans-serif;mso-fareast-font-famil=
y:Arial;
color:black'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Ti=
mes New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
color:black'>altered or increased sexual interest and behaviour of signific=
ant
concern to you or to others for example, an increased sexual drive</span><s=
pan
lang=3DEN-GB style=3D'color:black'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:4.8pt;margin-bott=
om:0in;
margin-left:42.55pt;margin-bottom:.0001pt;text-indent:-14.2pt;line-height:n=
ormal;
mso-pagination:none;mso-list:l9 level2 lfo51;tab-stops:28.35pt'><![if !supp=
ortLists]><span
lang=3DEN-GB style=3D'font-family:"Arial",sans-serif;mso-fareast-font-famil=
y:Arial;
color:black'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Ti=
mes New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
color:black'>uncontrollable excessive shopping or spending</span><span
lang=3DEN-GB style=3D'color:black'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:4.8pt;margin-bott=
om:0in;
margin-left:42.55pt;margin-bottom:.0001pt;text-indent:-14.2pt;line-height:n=
ormal;
mso-pagination:none;mso-list:l9 level2 lfo51;tab-stops:28.35pt'><![if !supp=
ortLists]><span
lang=3DEN-GB style=3D'font-family:"Arial",sans-serif;mso-fareast-font-famil=
y:Arial;
color:black'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Ti=
mes New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
color:black'>binge eating (eating large amounts of food in a short time per=
iod)
or compulsive eating (eating more food than normal and more than is needed =
to
satisfy your hunger).</span><span lang=3DEN-GB style=3D'color:black'><o:p><=
/o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:4.8pt;mso-pagination:none'><span
lang=3DEN-GB style=3D'color:black'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:4.8pt;mso-pagination:none;tab-st=
ops:
0in'><span lang=3DEN-GB style=3D'color:black'>Tell your doctor if you exper=
ience
any of these behaviours; they will discuss ways of managing or reducing the
symptoms.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-out=
line-level:
1;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:=
p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-out=
line-level:
1;mso-list:skip'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>Reporting of side effects<o:p></o:p></s=
pan></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-out=
line-level:
1;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>If =
you get any
side effects, talk to your doctor or pharmacist. This includes any possible
side effects not listed in this leaflet. You can also report side effects
directly via <span style=3D'background:silver;mso-highlight:silver'>the nat=
ional
reporting system listed in <a
href=3D"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_fo=
rm/2013/03/WC500139752.doc">Appendix
V</a></span>. By reporting side <span class=3DSpellE>effects you</span> can=
 help
provide more information on the safety of this medicine.<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'text-transform:uppercase'>5.<span style=3D'mso-tab-count:1'>=
 </span></span><span
lang=3DEN-GB>How to store <span class=3DSpellE>Stalevo</span><span
style=3D'text-transform:uppercase'><o:p></o:p></span></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-out=
line-level:
1;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Kee=
p this
medicine out of the sight and reach of children.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Do not use this medicine a=
fter the
expiry date which is stated on the bottle and the carton after EXP. The exp=
iry
date refers to the last day of that month.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>This medicinal product doe=
s not
require any special storage conditions.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Do not </=
span><span
lang=3DEN-GB style=3D'mso-no-proof:yes'>throw away any medicines</span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'> via wastewater or househo=
ld
waste. Ask your pharmacist how to </span><span lang=3DEN-GB style=3D'mso-no=
-proof:
yes'>throw away </span><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>medicines
you no longer use. These measures will help to protect the environment.<o:p=
></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'text-transform:uppercase'>6.<span style=3D'mso-tab-count:1'>=
 </span></span><span
lang=3DEN-GB>Contents of the pack and other information<span style=3D'text-=
transform:
uppercase'><o:p></o:p></span></span></b></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><b style=3D'mso-bidi-font=
-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>What <span
class=3DSpellE>Stalevo</span> contains<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:no=
rmal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-list:l14 level1 lfo7;tab-stops:list 28.35pt'><![if !supportLists=
]><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ig=
nore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>The
active substances of <span class=3DSpellE>Stalevo</span> are levodopa, carb=
idopa
and entacapone.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo7;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>Each <span class=3DSpellE>Stalevo</span>
75&nbsp;mg/18.75&nbsp;mg/200&nbsp;mg tablet contains 75&nbsp;mg of levodopa,
18.75&nbsp;mg of carbidopa and 200&nbsp;mg of entacapone.<o:p></o:p></span>=
</p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-list:l14 level1 lfo7;tab-stops:list 28.35pt'><![if !supportLists=
]><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ig=
nore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>The
other ingredients in the tablet core are croscarmellose sodium, magnesium
stearate, maize starch, mannitol (E421) and povidone (E1201)<o:p></o:p></sp=
an></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-list:l14 level1 lfo7;tab-stops:list 28.35pt'><![if !supportLists=
]><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ig=
nore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>The
ingredients in the film-coating are glycerol (85 per cent) (E422), <span
class=3DSpellE>hypromellose</span>, magnesium stearate, polysorbate 80, red=
 iron
oxide (E172), sucrose, and titanium dioxide (E171).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:27.0pt;text-indent:-27.0pt;line-h=
eight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;<=
/o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:27.0pt;text-indent:-27.0pt;line-h=
eight:
normal'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>What <span class=3DSpellE>Stalevo</span=
> looks
like and contents of the pack<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-left:27.0pt;text-indent:-27.0pt;line-h=
eight:
normal'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoEndnoteText><span class=3DSpellE><span lang=3DEN-GB style=3D'=
mso-bidi-font-size:
11.0pt'>Stalevo</span></span><span lang=3DEN-GB style=3D'mso-bidi-font-size=
:11.0pt'>
75&nbsp;mg/18.75&nbsp;mg/200&nbsp;mg: light brownish red, oval film-coated
tablets marked with LCE 75 on one side.<o:p></o:p></span></p>

<p class=3DMsoEndnoteText><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoEndnoteText><span class=3DSpellE><span lang=3DEN-GB style=3D'=
mso-bidi-font-size:
11.0pt'>Stalevo</span></span><span lang=3DEN-GB style=3D'mso-bidi-font-size=
:11.0pt'>
75&nbsp;mg/18.75&nbsp;mg/200&nbsp;mg tablet comes in five different pack si=
zes
(10, 30, 100, 130 or 175 tablets). Not all pack sizes may be marketed.<o:p>=
</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:27.0pt;text-indent:-27.0pt;line-h=
eight:
normal'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>Marketing
Authorisation Holder</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoEndnoteText><span lang=3DIT style=3D'mso-bidi-font-size:11.0p=
t;
mso-ansi-language:IT'>Orion Corporation<o:p></o:p></span></p>

<p class=3DMsoEndnoteText><span lang=3DIT style=3D'mso-bidi-font-size:11.0p=
t;
mso-ansi-language:IT'>Orionintie 1<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DIT style=3D'=
mso-bidi-font-size:
11.0pt;mso-ansi-language:IT'>FI-02200 Espoo<o:p></o:p></span></p>

<p class=3DMsoEndnoteText><span lang=3DIT style=3D'mso-bidi-font-size:11.0p=
t;
mso-ansi-language:IT'>Finland<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DIT style=3D'=
mso-bidi-font-size:
11.0pt;mso-ansi-language:IT'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-2.25pt'><b style=3D'mso-bidi-fo=
nt-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Manufacturer=
<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-2.25pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>Orion Corporation Orion Pharma<o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-2.25pt'><span class=3DSpellE><s=
pan
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Joensuunkatu</span></span>=
<span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>&nbsp;7<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'margin-right:-2.25pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>FI-24100&nbsp;Salo<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>Finland<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DIT style=3D'=
mso-bidi-font-size:
11.0pt;mso-ansi-language:IT'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-2.25pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold'>Orion Corpora=
tion Orion
Pharma<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-2.25pt'><span class=3DSpellE><s=
pan
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold'>=
Orionintie</span></span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold'>=
&nbsp;1<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-2.25pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold'>FI-02200&nbsp=
;Espoo<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold'>Finland<o:p><=
/o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DIT style=3D'=
mso-bidi-font-size:
11.0pt;mso-ansi-language:IT'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>For any information about =
this
medicine, please contact the local representative of the Marketing
Authorisation Holder.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<table class=3DMsoNormalTable border=3D0 cellspacing=3D0 cellpadding=3D0 wi=
dth=3D628
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;mso-yfti-tbll=
ook:
 1184;mso-padding-alt:0in 5.4pt 0in 5.4pt'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;page-break-inside:avoid=
'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DFR
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FR;mso-no-proof:yes'=
>Belgi/Belgique/Belgien</span></b><span
  lang=3DFR style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FR'><br>
  </span><strong><span lang=3DEN-GB style=3D'font-weight:normal;mso-bidi-fo=
nt-weight:
  bold'>Orion Pharma BVBA/SPRL</span></strong><strong><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt;font-weight:normal'><o:p></o:p></span>=
</strong></p>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><span class=3D=
SpellE><span
  style=3D'font-size:11.0pt'>Tl</span></span><span style=3D'font-size:11.0=
pt'>/Tel:
  +32 (0)15 64 10 20</span><span lang=3DFR style=3D'font-size:11.0pt;mso-an=
si-language:
  FR'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt'><b style=3D'mso-bidi-=
font-weight:
  normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast=
-language:
  CS'><o:p>&nbsp;</o:p></span></b></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DFI
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI'>Lietuva</span></=
b><span
  lang=3DFI style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI;mso-far=
east-language:
  CS'><o:p></o:p></span></p>
  <p class=3DMsoNormal><span lang=3DFI style=3D'mso-bidi-font-size:11.0pt;m=
so-ansi-language:
  FI'>UAB Orion Pharma<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none'><span lang=3DFI style=
=3D'mso-bidi-font-size:
  11.0pt;mso-ansi-language:FI'>Tel. +370 5&nbsp;276 9499</span><span lang=
=3DFI
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI;mso-fareast-langu=
age:
  CS'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:1;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal><span class=3DSpellE><b style=3D'mso-bidi-font-weigh=
t:normal'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black'>&#1041;&#109=
8;&#1083;&#1075;&#1072;&#1088;&#1080;&#1103;</span></b></span><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DFR style=3D'mso-bidi-f=
ont-size:
  11.0pt;color:black;mso-ansi-language:FR'><o:p></o:p></span></b></p>
  <p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;m=
so-ansi-language:
  IT'>Orion Pharma Poland Sp z.o.o.<o:p></o:p></span></p>
  <p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;m=
so-ansi-language:
  IT'>Tel.: + 48&nbsp;22&nbsp;833317<o:p></o:p></span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DDE
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'>Luxembourg/Luxem=
burg</span></b><span
  lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'><br>
  </span><strong><span lang=3DEN-GB style=3D'font-weight:normal;mso-bidi-fo=
nt-weight:
  bold'>Orion Pharma BVBA/SPRL</span></strong><strong><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt;font-weight:normal'><o:p></o:p></span>=
</strong></p>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><span class=3D=
SpellE><span
  style=3D'font-size:11.0pt'>Tl</span></span><span style=3D'font-size:11.0=
pt'>/Tel:
  +32 (0)15 64 10 20</span><span lang=3DFR style=3D'font-size:11.0pt;mso-an=
si-language:
  FR'><o:p></o:p></span></p>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DSV
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:SV'><o:p>&nbsp;</o:p=
></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:2;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none'><b style=3D'mso-bidi-fo=
nt-weight:
  normal'><span lang=3DSV style=3D'mso-bidi-font-size:11.0pt;mso-ansi-langu=
age:
  SV'>&#268;esk republika</span></b><span lang=3DSV style=3D'mso-bidi-font=
-size:
  11.0pt;mso-ansi-language:SV;mso-fareast-language:CS'><o:p></o:p></span></=
p>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none'><span lang=3DFI style=
=3D'mso-ansi-language:
  FI'>Orion Pharma s.r.o.<o:p></o:p></span></p>
  <p class=3DMsoNormal><span lang=3DEN-GB>Tel: <span
  style=3D'mso-spacerun:yes'></span></span><span lang=3DSV style=3D'mso-an=
si-language:
  SV'>+420 234 703 305</span><b style=3D'mso-bidi-font-weight:normal'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:CS'>=
<o:p></o:p></span></b></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DSV
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:SV'>Magyarorszg</sp=
an></b><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DSV style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:SV;mso-fareast-language:CS'><o:p></o:p></span></=
b></p>
  <p class=3DMsoNormal style=3D'line-height:13.0pt'><strong><span lang=3DEN=
-GB
  style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;mso-bidi-font-weigh=
t:
  bold'>Orion Pharma <span class=3DSpellE>Kft</span>.</span></strong><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'><o:p></o:p></span></b></p>
  <p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>Tel.: +</span><span
  lang=3DEN-GB>36 1 239 9095</span><span lang=3DSV style=3D'mso-bidi-font-s=
ize:11.0pt;
  mso-ansi-language:SV'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:3;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>Danmark</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size:=
11.0pt'><br>
  Orion Pharma A/S<br>
  <span class=3DSpellE>Tlf</span>: +45 8614 0000</span><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:CS'><o:p></o:p></=
span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none'><b style=3D'mso-bidi-fo=
nt-weight:
  normal'><span lang=3DFR style=3D'mso-bidi-font-size:11.0pt;mso-ansi-langu=
age:
  FR'>Malta</span></b><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DFR
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FR;mso-fareast-langu=
age:
  CS'><o:p></o:p></span></b></p>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DIT style=
=3D'mso-bidi-font-size:
  11.0pt;mso-ansi-language:IT'>Salomone Pharma<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-2.25pt;margin-=
bottom:
  9.0pt;margin-left:0in'><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;
  mso-ansi-language:IT'>Tel: +356&nbsp;21220174</span><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:CS'><o:p></o:p></=
span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:4;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DDE style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:DE'>Deutschland</span></b><span lang=3DDE
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'> <br>
  Orion Pharma GmbH</span><span lang=3DDE style=3D'mso-bidi-font-size:11.0p=
t;
  mso-ansi-language:DE;mso-fareast-language:CS'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><s=
pan
  lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'>Tel: +=
49 40
  899 6890</span><span lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ans=
i-language:
  DE;mso-fareast-language:CS'><o:p></o:p></span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DSV
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:SV'>Nederland</span>=
</b><span
  lang=3DSV style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:SV'><br>
  </span><strong><span lang=3DEN-GB style=3D'font-weight:normal;mso-bidi-fo=
nt-weight:
  bold'>Orion Pharma BVBA/SPRL</span></strong><strong><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt;font-weight:normal'><o:p></o:p></span>=
</strong></p>
  <p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:9.=
0pt;
  margin-left:0in;tab-stops:28.35pt'><span class=3DSpellE><span style=3D'fo=
nt-size:
  11.0pt'>Tl</span></span><span style=3D'font-size:11.0pt'>/Tel: +32 (0)15=
 64 10
  20</span><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:E=
N-GB;
  mso-fareast-language:CS'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:5;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none'><b><span lang=3DFI
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI'>Eesti</span></b>=
<b><span
  lang=3DFI style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI;mso-far=
east-language:
  CS'><o:p></o:p></span></b></p>
  <p class=3DMsoNormal><span lang=3DFI style=3D'mso-bidi-font-size:11.0pt;m=
so-ansi-language:
  FI'>Orion Pharma Eesti O<o:p></o:p></span></p>
  <p class=3DMsoNormal><span lang=3DFI style=3D'mso-bidi-font-size:11.0pt;m=
so-ansi-language:
  FI'>Tel: +372 66 44 550</span><span lang=3DFI style=3D'mso-bidi-font-size=
:11.0pt;
  mso-ansi-language:FI;mso-fareast-language:CS'><o:p></o:p></span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt'><b style=3D'mso-bidi-=
font-weight:
  normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Norge</spa=
n></b><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:CS'>=
<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-hyphenate:none'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Orion Pharma AS<o:p></o:=
p></span></p>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-2.25pt;margin-=
bottom:
  9.0pt;margin-left:0in'><span class=3DSpellE><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
  11.0pt'>Tlf</span></span><span lang=3DEN-GB style=3D'mso-bidi-font-size:1=
1.0pt'>:
  +47 40 00 42 10</span><span lang=3DDE style=3D'mso-bidi-font-size:11.0pt;
  mso-ansi-language:DE;mso-fareast-language:CS'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:6;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><span class=3D=
SpellE><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-si=
ze:11.0pt;
  mso-ansi-language:EN-GB'>&#917;&#955;&#955;&#940;&#948;</span></b></span>=
<b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-si=
ze:11.0pt;
  mso-ansi-language:EN-GB'>&#945;</span></b><span lang=3DFI style=3D'font-s=
ize:
  11.0pt;mso-ansi-language:FI'><br>
  Orion Pharma Hellas M.E.</span><span style=3D'font-size:11.0pt'>&#928;</s=
pan><span
  lang=3DFI style=3D'font-size:11.0pt;mso-ansi-language:FI'>.E<o:p></o:p></=
span></p>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><span class=3D=
SpellE><span
  style=3D'font-size:11.0pt'>&#932;&#951;&#955;</span></span><span lang=3DFI
  style=3D'font-size:11.0pt;mso-ansi-language:FI'>: + 30&nbsp;210&nbsp;980 =
3355</span><span
  lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p></o:=
p></span></p>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt'><b style=3D'mso-bidi-=
font-weight:
  normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast=
-language:
  CS'><o:p>&nbsp;</o:p></span></b></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DDE style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:DE'>sterreich</span></b><span lang=3DDE
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'><br>
  Orion Pharma GmbH</span><span lang=3DDE style=3D'mso-bidi-font-size:11.0p=
t;
  mso-ansi-language:DE;mso-fareast-language:CS'><o:p></o:p></span></p>
  <p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:9.=
0pt;
  margin-left:0in;tab-stops:28.35pt'><span lang=3DDE style=3D'font-size:11.=
0pt;
  mso-ansi-language:DE'>Tel: +49 40 899 6890</span><span lang=3DEN-GB
  style=3D'font-size:11.0pt;mso-ansi-language:EN-GB;mso-fareast-language:CS=
'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:7;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><b style=3D'ms=
o-bidi-font-weight:
  normal'><span lang=3DIT style=3D'font-size:11.0pt;mso-ansi-language:IT'>E=
spaa</span></b><span
  lang=3DIT style=3D'font-size:11.0pt;mso-ansi-language:IT'><br>
  </span><span style=3D'font-size:11.0pt'>Orion Pharma S.L.</span><span
  style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><span
  style=3D'font-size:11.0pt'>Tel: + 34 91 &nbsp;599 86 01</span><span lang=
=3DEN-GB
  style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt'><b style=3D'mso-bidi-=
font-weight:
  normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast=
-language:
  CS'><o:p>&nbsp;</o:p></span></b></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>Polska</span></b><b style=3D'mso-bidi=
-font-weight:
  normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast=
-language:
  CS'><o:p></o:p></span></b></p>
  <p class=3DMsoNormal><span lang=3DSV style=3D'mso-bidi-font-size:11.0pt;m=
so-ansi-language:
  SV'>Orion Pharma Poland Sp z.o.o.</span><span lang=3DEN-GB style=3D'mso-b=
idi-font-size:
  11.0pt'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-bottom:9.0pt'><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>Tel.: + 48 22 8333177</span><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:CS'>=
<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:8;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><b style=3D'ms=
o-bidi-font-weight:
  normal'><span lang=3DFR style=3D'font-size:11.0pt;mso-ansi-language:FR'>F=
rance</span></b><span
  lang=3DFR style=3D'font-size:11.0pt;mso-ansi-language:FR'><br>
  </span><span style=3D'font-size:11.0pt;mso-fareast-font-family:Calibri;
  mso-fareast-language:EN-GB'>Centre <span class=3DSpellE>Spcialits</span=
> <span
  class=3DSpellE>Pharmaceutiques</span></span><span lang=3DFR style=3D'font=
-size:
  11.0pt;mso-ansi-language:FR'><o:p></o:p></span></p>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><span
  style=3D'font-size:11.0pt;mso-fareast-font-family:Calibri;mso-fareast-lan=
guage:
  EN-GB'>Tel: + 33 (0) 1 47 04 80 46</span><span lang=3DFR style=3D'font-si=
ze:11.0pt;
  mso-ansi-language:FR'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt'><b style=3D'mso-bidi-=
font-weight:
  normal'><span lang=3DFR style=3D'mso-bidi-font-size:11.0pt;mso-ansi-langu=
age:
  FR;mso-fareast-language:CS'><o:p>&nbsp;</o:p></span></b></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;tab-=
stops:
  28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DIT
  style=3D'font-size:11.0pt;mso-ansi-language:IT'>Portugal</span></b><span
  lang=3DIT style=3D'font-size:11.0pt;mso-ansi-language:IT'><br>
  </span><span class=3DSpellE><span style=3D'font-size:11.0pt'>Orionfin</sp=
an></span><span
  style=3D'font-size:11.0pt'> <span class=3DSpellE>Unipessoal</span> <span
  class=3DSpellE>Lda</span></span><span lang=3DIT style=3D'font-size:11.0pt;
  mso-ansi-language:IT'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-2.25pt;margin-=
bottom:
  9.0pt;margin-left:0in'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.=
0pt'>Tel:
  + 351 21 154 68 20</span><span lang=3DFR style=3D'mso-bidi-font-size:11.0=
pt;
  mso-ansi-language:FR;mso-fareast-language:CS'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:9;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DFI style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:FI;mso-fareast-language:CS'>Hrvatska<o:p></o:p><=
/span></b></p>
  <p class=3DMsoNormal><strong><span lang=3DFI style=3D'mso-bidi-font-size:=
11.0pt;
  mso-ansi-language:FI;font-weight:normal;mso-bidi-font-weight:bold'>Orion
  Pharma d.o.o.<o:p></o:p></span></strong></p>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><s=
pan
  lang=3DFI style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI'>Tel:</=
span><span
  lang=3DFI style=3D'mso-ansi-language:FI'> +386&nbsp;(0) 1 600 8015</span>=
<span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:CS'>=
<o:p></o:p></span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:12.0pt;mso-line-height-rule:exa=
ctly;
  mso-layout-grid-align:none;text-autospace:none'><span class=3DSpellE><b><=
span
  lang=3DFR style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-languag=
e:FR'>Romnia</span></b></span><b><span
  lang=3DFR style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-languag=
e:FR'><o:p></o:p></span></b></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-layout-grid-align:no=
ne;
  text-autospace:none'><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;
  mso-ansi-language:IT'>Orion Corporation</span><span lang=3DFR style=3D'ms=
o-bidi-font-size:
  11.0pt;color:black;mso-ansi-language:FR'><o:p></o:p></span></p>
  <p class=3DMsoNormal><span lang=3DFR style=3D'mso-bidi-font-size:11.0pt;c=
olor:black;
  mso-ansi-language:FR'>Tel: +358 10 4261<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:10;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><b style=3D'mso-bidi-fo=
nt-weight:
  normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Ireland</s=
pan></b><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><br>
  Orion Pharma (Ireland) Ltd.</span><span lang=3DEN-GB style=3D'mso-bidi-fo=
nt-size:
  11.0pt;mso-fareast-language:CS'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>c/o <span class=3DSpellE>Allphar</spa=
n>
  Services Ltd.<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-hyphenate:none'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Tel: +353 1 428 7777<o:p=
></o:p></span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DIT
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'>Slovenija</span>=
</b><span
  lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT;mso-far=
east-language:
  CS'><o:p></o:p></span></p>
  <p class=3DMsoNormal><strong><span lang=3DFI style=3D'mso-bidi-font-size:=
11.0pt;
  mso-ansi-language:FI;font-weight:normal;mso-bidi-font-weight:bold'>Orion
  Pharma d.o.o.<o:p></o:p></span></strong></p>
  <p class=3DMsoNormal style=3D'margin-bottom:9.0pt'><span lang=3DFI
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI'>Tel:</span><span
  lang=3DFI style=3D'mso-ansi-language:FI'> +386&nbsp;(0) 1 600 8015</span>=
<b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt;mso-fareast-language:CS'><o:p></o:p></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:11;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt'><span class=3DSpellE>=
<b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>sland</span></b></span><b style=3D'mso-bidi-font-weight:normal'>=
<span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:CS'>=
<o:p></o:p></span></b></p>
  <p class=3DMsoNormal style=3D'line-height:normal'><span class=3DSpellE><s=
pan
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Vistor</span></span><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'> hf.<o:p></o:p></span></=
p>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><span class=3D=
SpellE><span
  style=3D'font-size:11.0pt'>Smi</span></span><span style=3D'font-size:11.=
0pt'>:
  +354 535 7000</span><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi=
-language:
  EN-GB;mso-fareast-language:CS'><o:p></o:p></span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none'><b style=3D'mso-bidi-fo=
nt-weight:
  normal'><span lang=3DSV style=3D'mso-bidi-font-size:11.0pt;mso-ansi-langu=
age:
  SV'>Slovensk republika</span></b><b style=3D'mso-bidi-font-weight:normal=
'><span
  lang=3DSV style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:SV;mso-far=
east-language:
  CS'><o:p></o:p></span></b></p>
  <p class=3DMsoNormal><strong><span lang=3DSV style=3D'mso-bidi-font-size:=
11.0pt;
  mso-ansi-language:SV;font-weight:normal;mso-bidi-font-weight:bold'>Orion
  Pharma s.r.o<o:p></o:p></span></strong></p>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-2.25pt;margin-=
bottom:
  9.0pt;margin-left:0in;line-height:normal'><span lang=3DSV style=3D'mso-an=
si-language:
  SV'>Tel: </span><span lang=3DSV><span style=3D'mso-spacerun:yes'></span>=
</span><span
  lang=3DSV style=3D'mso-ansi-language:SV'>+420 234 703 305</span><span lan=
g=3DIT
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT;mso-fareast-langu=
age:
  CS'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:12;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><b style=3D'ms=
o-bidi-font-weight:
  normal'><span lang=3DIT style=3D'font-size:11.0pt;mso-ansi-language:IT'>I=
talia</span></b><span
  lang=3DIT style=3D'font-size:11.0pt;mso-ansi-language:IT'><br>
  </span><span lang=3DFI style=3D'font-size:11.0pt;mso-ansi-language:FI'>Or=
ion
  Pharma S.r.l.<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-bottom:9.0pt;mso-hyphenate:none'><sp=
an
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Tel: + 39 02&nbsp;678761=
11</span><span
  lang=3DEL style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EL;mso-far=
east-language:
  CS'><o:p></o:p></span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DIT style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:IT'>Suomi/Finland<br>
  </span></b><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-la=
nguage:
  IT'>Orion Corporation</span><span lang=3DIT style=3D'mso-bidi-font-size:1=
1.0pt;
  mso-ansi-language:IT;mso-fareast-language:CS'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><s=
pan
  lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'>Puh./T=
el: +358
  10 4261</span><span lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ansi=
-language:
  DE;mso-fareast-language:CS'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:13;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEL
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EL'>&#922;&#973;&#96=
0;&#961;&#959;&#962;</span></b><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEL style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:EL;mso-fareast-language:CS'><o:p></o:p></span></=
b></p>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none;tab-stops:-.5in 28.35pt =
3.15in'><span
  lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'>Lifeph=
arma
  (ZAM) Ltd<o:p></o:p></span></p>
  <p class=3DMsoNormal><span class=3DSpellE><span lang=3DEN-GB style=3D'mso=
-bidi-font-size:
  11.0pt'>&#932;&#951;&#955;</span></span><span lang=3DDE style=3D'mso-bidi=
-font-size:
  11.0pt;mso-ansi-language:DE'>.: +357 22056300</span><span lang=3DDE
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE;mso-fareast-langu=
age:
  CS'><o:p></o:p></span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DDE style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:DE'>Sverige</span></b><span lang=3DDE
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'><br>
  Orion Pharma AB</span><span lang=3DDE style=3D'mso-bidi-font-size:11.0pt;
  mso-ansi-language:DE;mso-fareast-language:CS'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><s=
pan
  lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'>Tel: +=
46 8 623
  6440<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:14;mso-yfti-lastrow:yes;page-break-inside:avoid=
'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DFI
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI'>Latvija</span></=
b><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DFI style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:FI;mso-fareast-language:CS'><o:p></o:p></span></=
b></p>
  <p class=3DMsoNormal><span style=3D'mso-bidi-font-size:11.0pt;mso-ansi-la=
nguage:
  EN-US'>Orion Corporation<o:p></o:p></span></p>
  <p class=3DMsoNormal><span style=3D'mso-bidi-font-size:11.0pt;mso-ansi-la=
nguage:
  EN-US'>Orion Pharma <span class=3DSpellE>p&#257;rst&#257;vniec&#299;ba</s=
pan><o:p></o:p></span></p>
  <p class=3DMsoNormal><span style=3D'mso-bidi-font-size:11.0pt;mso-ansi-la=
nguage:
  EN-US'>Tel: +371 20028332<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none'><span style=3D'mso-bidi=
-font-size:
  11.0pt;mso-ansi-language:EN-US;mso-fareast-language:CS'><o:p>&nbsp;</o:p>=
</span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt'><b style=3D'mso-bidi-=
font-weight:
  normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>United Kin=
gdom</span></b><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:CS'>=
<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-hyphenate:none'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Orion Pharma (UK) Ltd.<o=
:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none'><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>Tel: +44 1635 520 300</span><span lan=
g=3DFI
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI;mso-fareast-langu=
age:
  CS'><o:p></o:p></span></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt'>This leaflet was last revised in.<o:p></o:p></span></b></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'mso-no-proof:yes'>Other sources of information<o:p></o:p></span></=
b></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Detailed
information on this medicine is available on the European Medicines Agency =
web
site: <a href=3D"http://www.ema.europa.eu">http://www.ema.europa.eu</a>. <o=
:p></o:p></span></p>

<span lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",=
serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB;mso-farea=
st-language:
EN-US;mso-bidi-language:AR-SA'><br clear=3Dall style=3D'page-break-before:a=
lways'>
</span>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><b style=3D=
'mso-bidi-font-weight:
normal'><span lang=3DEN-GB style=3D'color:black'>Package leaflet: Informati=
on for
the user</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><=
o:p></o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><b style=3D=
'mso-bidi-font-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;text-transfor=
m:uppercase'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-right:-.1pt;text-align:=
center;
mso-list:skip'><span class=3DSpellE><b style=3D'mso-bidi-font-weight:normal=
'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Stalevo</span></b></span><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt'> 100&nbsp;mg/25&nbsp;mg/200&nbsp;mg film-coated tablets<o:p></o:p><=
/span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DIT
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'>levodopa/carbidopa=
/entacapone<b
style=3D'mso-bidi-font-weight:normal'><span style=3D'text-transform:upperca=
se'><o:p></o:p></span></b></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DIT
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'><o:p>&nbsp;</o:p><=
/span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>Read
all of this leaflet carefully before you start taking this medicine because=
 it
contains important information for you.<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:no=
rmal;
mso-list:l1 level1 lfo3'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>Keep
this leaflet. You may need to read it again.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:no=
rmal;
mso-list:l1 level1 lfo3'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>If
you have any further questions, ask your doctor or pharmacist.<o:p></o:p></=
span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:no=
rmal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>-<span style=3D'mso-tab-co=
unt:1'> </span>This
medicine has been prescribed for you only. Do not pass it on to others. It =
may
harm them, even if their signs of illness are the same as yours.<o:p></o:p>=
</span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l1 level1 lfo53'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-no-pr=
oof:
yes'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New =
Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&=
nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-no-proof:yes=
'>If you
get any side effects, talk to your doctor or pharmacist.</span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:red'> </span><span
lang=3DEN-GB style=3D'mso-no-proof:yes'>This includes any possible side eff=
ects not
listed in this leaflet. See section 4.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;<=
/o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>What
is in this leaflet:<o:p></o:p></span></b></p>

<p class=3DMsoNormal><span lang=3DEN-GB>1.<span style=3D'mso-tab-count:1'>=
 </span>What
<span class=3DSpellE>Stalevo</span> is and what it is used for</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>2.<span style=3D'mso-tab-count:1'>=
 </span><span
style=3D'mso-no-proof:yes'>What you need to know </span>before you take <sp=
an
class=3DSpellE>Stalevo</span></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>3.<span style=3D'mso-tab-count:1'>=
 </span>How
to take <span class=3DSpellE>Stalevo</span></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>4.<span style=3D'mso-tab-count:1'>=
 </span>Possible
side effects</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>5<span style=3D'mso-tab-count:1'>=
 </span>How
to store <span class=3DSpellE>Stalevo</span></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>6.<span style=3D'mso-tab-count:1'>=
 </span><span
style=3D'mso-no-proof:yes'>Contents of the pack and other information</span=
></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'text-transform:uppercase'>1.<span style=3D'mso-tab-count:1'>=
 </span></span><span
lang=3DEN-GB>What <span class=3DSpellE>Stalevo</span> is and what it is use=
d for<span
style=3D'text-transform:uppercase'><o:p></o:p></span></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><b style=3D'mso-bidi-font=
-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;<=
/o:p></span></b></p>

<p class=3DMsoBodyText3 align=3Dleft style=3D'text-align:left;line-height:n=
ormal'><span
class=3DSpellE><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;font-w=
eight:
normal;font-style:normal'>Stalevo</span></span><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-style:normal'>
contains three active substances (levodopa, carbidopa and entacapone) in one
film-coated tablet. <span class=3DSpellE>Stalevo</span> is used for the tre=
atment
of Parkinsons disease. <o:p></o:p></span></p>

<p class=3DMsoBodyText3 align=3Dleft style=3D'text-align:left;line-height:n=
ormal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-sty=
le:normal'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Parkinsons disease is cau=
sed by
low levels of a substance called dopamine in the brain. Levodopa increases =
the
amount of dopamine and hence reduces the symptoms of Parkinsons disease.
Carbidopa and entacapone improve the <span class=3DSpellE>antiparkinson</sp=
an>
effects of levodopa. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'text-transform:uppercase'>2.<span style=3D'mso-tab-count:1'>=
 </span></span><span
lang=3DEN-GB>What you need to know before you take <span class=3DSpellE>Sta=
levo</span><span
style=3D'text-transform:uppercase'><o:p></o:p></span></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>Do
not take <span class=3DSpellE>Stalevo</span> if you:<o:p></o:p></span></b><=
/p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l42 level1 lfo17;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>are allergic to levodopa, carbidopa or entacapone,=
 or
any of the other ingredients of this medicine </span><span style=3D'font-si=
ze:
11.0pt;mso-no-proof:yes'>(listed in section 6)</span><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l42 level1 lfo17;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>have narrow-angle glaucoma (an eye disorder)<o:p><=
/o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l42 level1 lfo17;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>have a tumour of the adrenal gland<o:p></o:p></spa=
n></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l42 level1 lfo17;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>are taking certain medicines for treating depressi=
on (</span><span
style=3D'font-size:11.0pt'>combinations of </span><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>selective MAO-A and MAO-B
inhibitors, or non-selective MAO-inhibitors)<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l42 level1 lfo17;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>have ever had neuroleptic malignant syndrome (NMS 
this is a rare reaction to medicines used to treat severe mental disorders)=
<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l42 level1 lfo17;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>have ever had non-traumatic rhabdomyolysis (a rare
muscle disorder)<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l42 level1 lfo17;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>have a severe liver disease. <o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-la=
nguage:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'mso-no-proof:yes'>Warnings and precautions</span><span lang=3DEN-G=
B><o:p></o:p></span></b></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal><u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0=
pt'>Talk
to your doctor or pharmacist before taking <span class=3DSpellE>Stalevo</sp=
an> if
you have or have ever had</span></u><span lang=3DEN-GB style=3D'mso-bidi-fo=
nt-size:
11.0pt'>:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>a
heart attack or any other diseases of the heart including cardiac arrhythmi=
as,
or of the blood vessels<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>asthma
or any other disease of the lungs<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>a
liver problem, because your dose may need to be adjusted<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>kidney
or hormone-related diseases<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>stomach
ulcers or convulsions<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>if
you experience prolonged diarrhoea consult your doctor as it may be a sign =
of
inflammation of the colon<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp=
;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>any
form of severe mental disorder like psychosis<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>chronic
wide-angle glaucoma, because your dose may need to be adjusted and the pres=
sure
in your eyes may need to be monitored.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0=
pt'>Consult
your doctor if you are currently taking</span></u><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>antipsychotics
(medicines used to treat psychosis)<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>a
medicine which may cause low blood pressure when rising from a chair or bed.
You should be aware that <span class=3DSpellE>Stalevo</span> may make these
reactions worse.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0=
pt'>Consult
your doctor if during the treatment with <span class=3DSpellE>Stalevo</span=
> you</span></u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><a name=3D"OLE_LINK2"><![if !supportLists]><span lang=3DE=
N-GB
style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>notice</span></a><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'> that your muscles get ver=
y rigid
or jerk violently, or if you get tremors, agitation, confusion, fever, rapid
pulse, or wide fluctuations in your blood pressure. If any of this happens,=
 <b
style=3D'mso-bidi-font-weight:normal'>contact your doctor immediately</b><o=
:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>feel
depressed, have suicidal thoughts, or notice unusual changes in your behavi=
our<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>find
yourself suddenly falling asleep, or if you feel very drowsy. If this happe=
ns,
you should not drive or use any tools or machines (see also section 'Driving
and using machines')<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>notice
that uncontrolled movements begin or get worse after you started to take <s=
pan
class=3DSpellE>Stalevo</span>. If this happens, your doctor may need to cha=
nge
the dose of your <span class=3DSpellE>antiparkinson</span> medicine <o:p></=
o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>experience
diarrhoea: monitoring of your weight is recommended in order to avoid poten=
tially
excessive weight loss<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>experience
progressive anorexia, asthenia (weakness, exhaustion) and weight decrease
within a relatively short period of time. If this happens, a general medical
evaluation including liver function should be considered<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>feel
the need to stop using <span class=3DSpellE>Stalevo</span>, see section 'If=
 you
stop taking <span class=3DSpellE>Stalevo</span>'.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Tell your
doctor if you or your family/carer notices you are developing addiction-like
symptoms leading to craving for large doses of <span class=3DSpellE>Stalevo=
</span>
and other medicines used to treat Parkinsons disease.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span style=3D'mso-bidi-font-size:11.0pt;mso-ansi-lang=
uage:
EN-US'>Tell your doctor if you or your family/<span class=3DSpellE>carer</s=
pan>
notices you are developing urges or cravings to behave in ways that are unu=
sual
for you or you cannot resist the impulse, drive or temptation to carry out
certain activities that could harm yourself or others. These <span
class=3DSpellE>behaviours</span> are called impulse control disorders and c=
an
include addictive gambling, excessive eating or spending, an abnormally high
sex drive or a preoccupation with an increase in sexual thoughts or feeling=
s. <u>Your
doctor may need to review your treatments.</u></span><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Your
doctor may take some regular laboratory tests during a long term treatment =
with
<span class=3DSpellE>Stalevo</span>.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>If you
must undergo surgery, please tell your doctor that you are using <span
class=3DSpellE>Stalevo</span>.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span class=3DSpellE><span lang=3DEN-GB style=3D'mso-b=
idi-font-size:
11.0pt'>Stalevo</span></span><span lang=3DEN-GB style=3D'mso-bidi-font-size=
:11.0pt'>
is not recommended to be used for treatment of extrapyramidal symptoms (e.g.
involuntary movements, shaking, muscle rigidity and muscle contractions</sp=
an><span
lang=3DEN style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EN'>)</span>=
<span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'> caused by other medicines=
.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'mso-bidi-font-size:11.0pt'>Children </span><span lang=3DEN-GB
style=3D'color:black'>and adolescents<o:p></o:p></span></b></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Experience
with <span class=3DSpellE>Stalevo</span> in patients under 18 years is limi=
ted.
Therefore, the use of <span class=3DSpellE>Stalevo</span> in children or
adolescents is not recommended.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-la=
nguage:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>Other
medicines and <span class=3DSpellE>Stalevo</span><o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoBodyText style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-style:normal'>Te=
ll
your doctor or pharmacist if you are taking, have recently taken or might t=
ake any
other medicines.<o:p></o:p></span></p>

<p class=3DMsoBodyText style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-style:normal'><o=
:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Do not take <span class=3D=
SpellE>Stalevo</span>
if you are taking certain medicines for treating depression (combinations of
selective MAO-A and MAO-B inhibitors, or non-selective MAO inhibitors).<o:p=
></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal'><span
class=3DSpellE><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Stale=
vo</span></span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'> may increase the effects =
and side
effects of certain medicines. These include: <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>medicines
used to treat depression such as moclobemide, amitriptyline, desipramine,
maprotiline, venlafaxine and paroxetine<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span class=3DSpellE><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>rimiterole</span></span><span lang=3DEN=
-GB
style=3D'mso-bidi-font-size:11.0pt'> and isoprenaline, used to treat respir=
atory
diseases<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>adrenaline,
used </span><span lang=3DPT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-lan=
guage:
PT'>for severe allergic reactions</span><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
11.0pt'> <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>noradrenaline,
dopamine and dobutamine, used to treat heart diseases and low blood pressur=
e<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>-<span
style=3D'mso-tab-count:1'> </span>alpha-methyldopa, used to treat hi=
gh
blood pressure <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>-<span
style=3D'mso-tab-count:1'> </span>apomorphine, which is used to treat
Parkinsons disease.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;tab-sto=
ps:17.1pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;tab-st=
ops:28.35pt'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>The effects=
 of <span
class=3DSpellE>Stalevo</span> may be weakened by certain medicines. These
include: <o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-la=
nguage:
EN-GB'>-<span style=3D'mso-tab-count:1'> </span>dopamine antagonists=
 used
to treat mental disorders, nausea and vomiting<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-la=
nguage:
EN-GB'>-<span style=3D'mso-tab-count:1'> </span>phenytoin, used to p=
revent
convulsions<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-la=
nguage:
EN-GB'>-<span style=3D'mso-tab-count:1'> </span>papaverine used to r=
elax
the muscles.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;tab-st=
ops:28.35pt'><span
class=3DSpellE><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-langua=
ge:EN-GB'>Stalevo</span></span><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'> may make i=
t harder
for you to digest iron. Therefore, do not take <span class=3DSpellE>Stalevo=
</span>
and iron supplements at the same time. After taking one of them, wait at le=
ast
2 to 3 hours before taking the other.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;tab-st=
ops:28.35pt'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal><span class=3DSpellE><b style=3D'mso-bidi-font-weight:=
normal'><span
lang=3DEN-GB>Stalevo</span></b></span><b style=3D'mso-bidi-font-weight:norm=
al'><span
lang=3DEN-GB> with food and drink<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoBodyText style=3D'text-align:justify;line-height:normal;tab-s=
tops:
28.35pt'><span class=3DSpellE><span lang=3DEN-GB style=3D'mso-bidi-font-siz=
e:11.0pt;
font-weight:normal;font-style:normal'>Stalevo</span></span><span lang=3DEN-=
GB
style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-style:normal'> m=
ay be
taken with or without food. For some patients, <span class=3DSpellE>Stalevo=
</span>
may not be well absorbed if it is taken with, or shortly after eating
protein-rich food (such as meats, fish, dairy products, seeds and nuts).
Consult your doctor if you think this applies to you.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;tab-st=
ops:28.35pt'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>Pregnancy,
breast-feeding and fertility<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoBodyText style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-style:normal'>If=
 you are
pregnant or breast-feeding, think you may be pregnant or are planning to ha=
ve a
baby, ask your doctor or pharmacist for advice before taking this medicine.=
 <o:p></o:p></span></p>

<p class=3DMsoBodyText style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-style:normal'><o=
:p>&nbsp;</o:p></span></p>

<p class=3DMsoBodyText style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-style:normal'>You
should not breast-feed during treatment with <span class=3DSpellE>Stalevo</=
span>.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>Driving
and using machines<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span class=
=3DSpellE><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Stalevo</span></span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'> may lower your blood pres=
sure,
which may make you feel light-headed or dizzy. Therefore, be particularly
careful when you drive or when you use any tools or machines.<o:p></o:p></s=
pan></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>If you feel very drowsy, or if you some=
times
find yourself suddenly falling asleep, wait until you feel fully awake again
before driving or doing anything else that requires you to be alert. Otherw=
ise,
you may put yourself and others at risk of serious injury or death.<o:p></o=
:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span class=
=3DSpellE><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt'>Stalevo</span></b></span><b style=3D'mso-bidi-font-weight:normal'><=
span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'> contains sucrose<o:p></o:=
p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span class=
=3DSpellE><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Stalevo</span></span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'> contains sucrose
(1.6&nbsp;mg/tablet). If you have been told by your doctor that you have
intolerance to some sugars, contact your doctor before taking this medicinal
product.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'text-transform:uppercase'>3.<span style=3D'mso-tab-count:1'>=
 </span></span><span
lang=3DEN-GB>How to take <span class=3DSpellE>Stalevo</span><span style=3D'=
text-transform:
uppercase'><o:p></o:p></span></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Always take this medicine =
exactly
as your doctor or pharmacist has told you. Check with your doctor or pharma=
cist
if you are not sure.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>For adults and elderly</sp=
an></u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt=
'>-<span
style=3D'mso-tab-count:1'> </span>Your doctor will tell you exactly =
how
many tablets of <span class=3DSpellE>Stalevo</span> to take each day. <o:p>=
</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l32 level1 lfo21'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-family:"Arial",sans-serif;mso-farea=
st-font-family:
Arial'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times Ne=
w Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp=
;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>The
tablets are not intended to be split or broken into smaller pieces.<o:p></o=
:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l32 level1 lfo21'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-family:"Arial",sans-serif;mso-farea=
st-font-family:
Arial'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times Ne=
w Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp=
;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>You
should take only one tablet each time.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l32 level1 lfo21'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-family:"Arial",sans-serif;mso-farea=
st-font-family:
Arial'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times Ne=
w Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp=
;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>Depending
on how you respond to treatment, your doctor may suggest a higher or lower
dose. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l32 level1 lfo21'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt;font-family:"Arial",sans-serif;mso-fareast-font-family:Arial'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>If
you are taking <span class=3DSpellE>Stalevo</span>
50&nbsp;mg/12.5&nbsp;mg/200&nbsp;mg, 75&nbsp;mg/18.75&nbsp;mg/200&nbsp;mg,
100&nbsp;mg/25&nbsp;mg/200&nbsp;mg, 125&nbsp;mg/31.25&nbsp;mg/200&nbsp;mg or
150&nbsp;mg/37.5&nbsp;mg/200&nbsp;mg tablets, do not take more than 10 tabl=
ets
per day.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;text-align:justify;line-he=
ight:
normal;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt=
'>Talk
to your doctor or pharmacist if you think the effect of <span class=3DSpell=
E>Stalevo</span>
is too strong or too weak, or if you experience possible side effects.<o:p>=
</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;text-align:justify;line-he=
ight:
12.0pt;mso-list:skip'><span lang=3DEN-GB><!--[if gte vml 1]><v:shape id=3D"=
_x0000_i1041"
 type=3D"#_x0000_t75" style=3D'width:468pt;height:91.5pt'>
 <v:imagedata src=3D"Stalevo_clean_files/image005.emz" o:title=3D""/>
</v:shape><![endif]--><![if !vml]><img border=3D0 width=3D624 height=3D122
src=3D"Stalevo_clean_files/image006.png" v:shapes=3D"_x0000_i1041"><![endif=
]></span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>If
you take more <span class=3DSpellE>Stalevo</span> than you should<o:p></o:p=
></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>If you have accidentally taken more <sp=
an
class=3DSpellE>Stalevo</span> tablets than you should, talk to your doctor =
or
pharmacist immediately. In case of an overdose you may feel confused or
agitated, your heart rate may be slower or faster than normal or the colour=
 of
your skin, tongue, eyes or urine may change.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>If
you forget to take <span class=3DSpellE>Stalevo</span><o:p></o:p></span></b=
></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>Do not take a double dose to make up fo=
r a
forgotten tablet.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>If it is more than 1 hour =
until
your next dose</span></u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.=
0pt'>: <o:p></o:p></span></p>

<p class=3DMsoBodyText style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-style:normal'>Ta=
ke one
tablet as soon as you remember, and the next tablet at the normal time. <o:=
p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>If it is less than 1 hour =
until
your next dose</span></u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.=
0pt'>: <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Take a tablet as soon as y=
ou
remember, wait 1 hour, then take another tablet. After that carry on as nor=
mal.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Always leave at least an h=
our
between <span class=3DSpellE>Stalevo</span> tablets, to avoid possible side
effects.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>If
you stop taking <span class=3DSpellE>Stalevo</span> <o:p></o:p></span></b><=
/p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Do not stop taking <span
class=3DSpellE>Stalevo</span> unless your doctor tells you to. In such a ca=
se
your doctor may need to adjust your other <span class=3DSpellE>antiparkinso=
n</span>
medicines, especially levodopa, to give sufficient control of your symptoms=
. If
you suddenly stop taking <span class=3DSpellE>Stalevo</span> and other
antiparkinsonian medicines it may result in unwanted side effects. <o:p></o=
:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>If you have any further qu=
estions
on the use of this medicine, ask your doctor or pharmacist.<o:p></o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'text-transform:uppercase'>4.<span style=3D'mso-tab-count:1'>=
 </span></span><span
lang=3DEN-GB>Possible side effects<span style=3D'text-transform:uppercase'>=
<o:p></o:p></span></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-1.4pt;line-height:normal;mso-ou=
tline-level:
1;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:=
p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.4pt;line-height:normal;mso-ou=
tline-level:
1;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Lik=
e all
medicines, this medicine can cause side effects, although not everybody gets
them. Many of the side effects can be relieved by adjusting the dose. <o:p>=
</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.4pt;line-height:normal;mso-ou=
tline-level:
1;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:=
p>&nbsp;</o:p></span></p>

<p class=3DText style=3D'margin-top:0in'><span style=3D'font-size:11.0pt'>I=
f you
during the treatment with <span class=3DSpellE>Stalevo</span> experience the
following symptoms, <b style=3D'mso-bidi-font-weight:normal'>contact your d=
octor
immediately</b>: <o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:25.65pt;margin-bottom:.0001pt;text-indent:-25.65pt;mso-list:l50=
 level1 lfo26'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-size:11.0pt'>Your muscle=
s get
very rigid or jerk violently, you get tremors, agitation, confusion, fever,
rapid pulse, or wide fluctuations in your blood pressure. These can be symp=
toms
</span><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB=
'>of
neuroleptic malignant syndrome (NMS, a rare severe reaction to medicines us=
ed
to treat disorders of the central nervous system) or rhabdomyolysis (a rare
severe muscle disorder).<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:25.65pt;margin-bottom:.0001pt;text-indent:-25.65pt;mso-list:l37=
 level1 lfo27'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>Allergic reaction, the signs may include hives (ne=
ttle
rash), itching, rash, swelling of your face, lips, tongue or throat. This m=
ay
cause difficulties in breathing or swallowing.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.4pt;line-height:normal;mso-ou=
tline-level:
1;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:=
p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><u><span lang=3DEN-GB>Very common (may affect more tha=
n 1 in
10 people)<o:p></o:p></span></u></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>uncontrolled movements (dyskinesias)<o:p></o:p></s=
pan></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>feeling sick (nausea)<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>harmless reddish-brown discolouration of urine<o:p=
></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>muscle pain<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>diarrhoea<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><span lang=3DEN-=
GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span>=
</p>

<p class=3DNormal11><u><span lang=3DFR>Common (<span class=3DSpellE>may</sp=
an> affect
up to 1 <span class=3DSpellE>in</span> 10 people)<o:p></o:p></span></u></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>light-headedness or fainting due to low blood
pressure, high blood pressure<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>worsening of Parkinsons symptoms, dizziness,
drowsiness<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>vomiting, abdominal pain and discomfort, heartburn,
dry mouth, constipation<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>inability to sleep, hallucinations, confusion abno=
rmal
dreams (including nightmares), tiredness<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>mental changes  including problems with memory,
anxiety and depression (possibly with thoughts of suicide) <o:p></o:p></spa=
n></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-size:11.0pt'>heart or ar=
tery
disease events (e.g. chest pain), irregular heart rate or rhythm </span><sp=
an
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p></o:p>=
</span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>more frequent falling <o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>shortness of breath <o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>increased sweating, rashes<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>muscle cramps, swelling of legs<o:p></o:p></span><=
/p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>blurred vision<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>anaemia<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>decreased appetite, decreased weight<o:p></o:p></s=
pan></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>headache, joint pain<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>urinary tract infection<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;tab-st=
ops:28.35pt'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p>&nbsp;=
</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;tab-st=
ops:28.35pt'><u><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>Uncommon </=
span></u><u><span
style=3D'font-size:11.0pt;color:black'>(may affect up to 1 in 100&nbsp;peop=
le)</span></u><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p></o:p>=
</span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>heart attack<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>bleeding in the gut<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>changes in the blood cell count which may result i=
n bleeding,
abnormal liver function tests<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>convulsions<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>feeling agitated<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>psychotic symptoms<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>colitis (inflammation of the colon)<o:p></o:p></sp=
an></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span class=3DSpellE><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>discolourations</span></=
span><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'> other than=
 urine
(e.g. skin, nail, hair, sweat)<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>swallowing difficulties<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-size:11.0pt'>inability to
urinate</span><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-languag=
e:EN-GB'><o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in'><span lang=3DEN-GB style=3D'font-s=
ize:11.0pt;
mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left'><u><s=
pan
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>Not known (=
cannot
be estimated from the available data)<o:p></o:p></span></u></p>

<p class=3DText style=3D'margin-top:0in'><span lang=3DEN-GB style=3D'font-s=
ize:11.0pt;
mso-ansi-language:EN-GB'>Craving for large doses of <span class=3DSpellE>St=
alevo</span>
in excess of that required to control motor symptoms, known as dopamine
dysregulation syndrome. Some patients experience severe abnormal involuntary
movements (dyskinesias), mood swings or other side effects after taking lar=
ge
doses of <span class=3DSpellE>Stalevo</span>.<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in'><span lang=3DEN-GB style=3D'font-s=
ize:11.0pt;
mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText style=3D'margin-top:0in'><u><span lang=3DEN-GB style=3D'fon=
t-size:11.0pt;
mso-ansi-language:EN-GB'>The following side effects have also been reported=
</span></u><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>: <o:p></o:=
p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l4 =
level1 lfo22;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>hepatitis </span><span style=3D'font-size:11.0pt'>=
(inflammation
of the liver)</span><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-l=
anguage:
EN-GB'> <o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l4 =
level1 lfo22;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>itching<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in'><span lang=3DEN-GB style=3D'font-s=
ize:11.0pt;
mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:4.8pt;mso-pagination:none'><u><s=
pan
lang=3DEN-GB style=3D'color:black'>You may experience the following side ef=
fects: <o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:4.8pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-pagination:none;mso-list:l10 level1 lfo49;tab-stops:28.35pt'><![=
if !supportLists]><span
lang=3DEN-GB style=3D'font-family:"Arial",sans-serif;mso-fareast-font-famil=
y:Arial;
color:black'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Ti=
mes New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp=
;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
color:black'>Inability to resist the impulse to perform an action that coul=
d be
harmful, which may include:</span><span lang=3DEN-GB style=3D'color:black'>=
<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:4.8pt;margin-bott=
om:0in;
margin-left:42.55pt;margin-bottom:.0001pt;text-indent:-14.2pt;line-height:n=
ormal;
mso-pagination:none;mso-list:l9 level2 lfo51;tab-stops:list 42.55pt'><![if =
!supportLists]><span
lang=3DEN-GB style=3D'font-family:"Arial",sans-serif;mso-fareast-font-famil=
y:Arial;
color:black'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Ti=
mes New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
color:black'>strong impulse to gamble excessively despite serious personal =
or family
consequences</span><span lang=3DEN-GB style=3D'color:black'><o:p></o:p></sp=
an></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:4.8pt;margin-bott=
om:0in;
margin-left:42.55pt;margin-bottom:.0001pt;text-indent:-14.2pt;line-height:n=
ormal;
mso-pagination:none;mso-list:l9 level2 lfo51;tab-stops:list 42.55pt'><![if =
!supportLists]><span
lang=3DEN-GB style=3D'font-family:"Arial",sans-serif;mso-fareast-font-famil=
y:Arial;
color:black'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Ti=
mes New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
color:black'>altered or increased sexual interest and behaviour of signific=
ant
concern to you or to others, for example, an increased sexual drive</span><=
span
lang=3DEN-GB style=3D'color:black'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:4.8pt;margin-bott=
om:0in;
margin-left:42.55pt;margin-bottom:.0001pt;text-indent:-14.2pt;line-height:n=
ormal;
mso-pagination:none;mso-list:l9 level2 lfo51;tab-stops:list 42.55pt'><![if =
!supportLists]><span
lang=3DEN-GB style=3D'font-family:"Arial",sans-serif;mso-fareast-font-famil=
y:Arial;
color:black'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Ti=
mes New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
color:black'>uncontrollable excessive shopping or spending</span><span
lang=3DEN-GB style=3D'color:black'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:4.8pt;margin-bott=
om:0in;
margin-left:42.55pt;margin-bottom:.0001pt;text-indent:-14.2pt;line-height:n=
ormal;
mso-pagination:none;mso-list:l9 level2 lfo51;tab-stops:list 42.55pt'><![if =
!supportLists]><span
lang=3DEN-GB style=3D'font-family:"Arial",sans-serif;mso-fareast-font-famil=
y:Arial;
color:black'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Ti=
mes New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
color:black'>binge eating (eating large amounts of food in a short time per=
iod)
or compulsive eating (eating more food than normal and more than is needed =
to
satisfy your hunger).</span><span lang=3DEN-GB style=3D'color:black'><o:p><=
/o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:4.8pt;mso-pagination:none'><span
lang=3DEN-GB style=3D'color:black'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:4.8pt;mso-pagination:none;tab-st=
ops:
0in'><span lang=3DEN-GB style=3D'color:black'>Tell your doctor if you exper=
ience
any of these behaviours; they will discuss ways of managing or reducing the
symptoms.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-out=
line-level:
1;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:=
p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-out=
line-level:
1;mso-list:skip'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>Reporting of side effects<o:p></o:p></s=
pan></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-out=
line-level:
1;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>If =
you get
any side effects, talk to your doctor or pharmacist. This includes any poss=
ible
side effects not listed in this leaflet. You can also report side effects
directly via <span style=3D'background:silver;mso-highlight:silver'>the nat=
ional
reporting system listed in <a
href=3D"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_fo=
rm/2013/03/WC500139752.doc">Appendix
V</a></span>. By reporting side <span class=3DSpellE>effects you</span> can=
 help
provide more information on the safety of this medicine.<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'text-transform:uppercase'>5.<span style=3D'mso-tab-count:1'>=
 </span></span><span
lang=3DEN-GB>How to store <span class=3DSpellE>Stalevo</span><span
style=3D'text-transform:uppercase'><o:p></o:p></span></span></b></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-out=
line-level:
1;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Kee=
p this
medicine out of the sight and reach of children.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Do not use this medicine a=
fter the
expiry date which is stated on the bottle and the carton after EXP. The exp=
iry
date refers to the last day of that month.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>This medicinal product doe=
s not
require any special storage conditions.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Do not </=
span><span
lang=3DEN-GB style=3D'mso-no-proof:yes'>throw away any medicines</span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'> via wastewater or househo=
ld
waste. Ask your pharmacist how to </span><span lang=3DEN-GB style=3D'mso-no=
-proof:
yes'>throw away</span><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt=
'> of
medicines you no longer use. These measures will help to protect the
environment.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'text-transform:uppercase'>6.<span style=3D'mso-tab-count:1'>=
 </span></span><span
lang=3DEN-GB>Contents of the pack and other information<span style=3D'text-=
transform:
uppercase'><o:p></o:p></span></span></b></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><b style=3D'mso-bidi-font=
-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>What <span
class=3DSpellE>Stalevo</span> contains<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:no=
rmal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l14 level1 lfo7;tab-stops:list 28.35pt'><![if !supportLists=
]><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ig=
nore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>The
active substances of <span class=3DSpellE>Stalevo</span> are levodopa, carb=
idopa
and entacapone.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-pagination:none;mso-list:l14 level1 lfo7;tab-stops:list 28.35pt'><![if =
!supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>Each <span class=3DSpellE>Stalevo</span>
100&nbsp;mg/25&nbsp;mg/200&nbsp;mg tablet contains 100&nbsp;mg of levodopa,
25&nbsp;mg of carbidopa and 200&nbsp;mg of entacapone.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-list:l14 level1 lfo7;tab-stops:list 28.35pt'><![if !supportLists=
]><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ig=
nore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>The
other ingredients in the tablet core are croscarmellose sodium, magnesium
stearate, maize starch, mannitol (E421) and povidone (E1201)<o:p></o:p></sp=
an></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-list:l14 level1 lfo7;tab-stops:list 28.35pt'><![if !supportLists=
]><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ig=
nore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>The
ingredients in the film-coating are glycerol (85 per cent) (E422), <span
class=3DSpellE>hypromellose</span>, magnesium stearate, polysorbate 80, red=
 iron
oxide (E172), sucrose, titanium dioxide (E171), and yellow iron oxide (E172=
).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:27.0pt;text-indent:-27.0pt;line-h=
eight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;<=
/o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:27.0pt;text-indent:-27.0pt;line-h=
eight:
normal'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>What <span class=3DSpellE>Stalevo</span=
> looks
like and contents of the pack<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-left:27.0pt;text-indent:-27.0pt;line-h=
eight:
normal'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt'><span class=3DSpellE><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Stalevo</span></span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>
100&nbsp;mg/25&nbsp;mg/200&nbsp;mg: brownish or greyish red, oval, unscored
film-coated tablets marked with LCE 100 on one side.<o:p></o:p></span></p>

<p class=3DMsoEndnoteText><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoEndnoteText><span class=3DSpellE><span lang=3DEN-GB style=3D'=
mso-bidi-font-size:
11.0pt'>Stalevo</span></span><span lang=3DEN-GB style=3D'mso-bidi-font-size=
:11.0pt'>
comes in six different pack sizes (10, 30, 100, 130, 175 or 250 tablets). N=
ot
all pack sizes may be marketed.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:27.0pt;text-indent:-27.0pt;line-h=
eight:
normal'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>Marketing
Authorisation Holder</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoEndnoteText><span lang=3DIT style=3D'mso-bidi-font-size:11.0p=
t;
mso-ansi-language:IT'>Orion Corporation<o:p></o:p></span></p>

<p class=3DMsoEndnoteText><span lang=3DIT style=3D'mso-bidi-font-size:11.0p=
t;
mso-ansi-language:IT'>Orionintie 1<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DIT style=3D'=
mso-bidi-font-size:
11.0pt;mso-ansi-language:IT'>FI-02200 Espoo<o:p></o:p></span></p>

<p class=3DMsoEndnoteText><span lang=3DIT style=3D'mso-bidi-font-size:11.0p=
t;
mso-ansi-language:IT'>Finland<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DIT style=3D'=
mso-bidi-font-size:
11.0pt;mso-ansi-language:IT'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-2.25pt'><b style=3D'mso-bidi-fo=
nt-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Manufacturer=
<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-2.25pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>Orion Corporation Orion Pharma<o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-2.25pt'><span class=3DSpellE><s=
pan
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Joensuunkatu</span></span>=
<span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>&nbsp;7<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'margin-right:-2.25pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>FI-24100&nbsp;Salo<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>Finland<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-2.25pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold'>Orion Corpora=
tion Orion
Pharma<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-2.25pt'><span class=3DSpellE><s=
pan
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold'>=
Orionintie</span></span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold'>=
&nbsp;1<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-2.25pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold'>FI-02200&nbsp=
;Espoo<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold'>Finland</span=
><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DIT style=3D'=
mso-bidi-font-size:
11.0pt;mso-ansi-language:IT'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>For any information about =
this
medicine, please contact the local representative of the Marketing
Authorisation Holder.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<table class=3DMsoNormalTable border=3D0 cellspacing=3D0 cellpadding=3D0 wi=
dth=3D628
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;mso-yfti-tbll=
ook:
 1184;mso-padding-alt:0in 5.4pt 0in 5.4pt'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;page-break-inside:avoid=
'>
  <td width=3D313 valign=3Dtop style=3D'width:234.75pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal><span class=3DSpellE><b><span lang=3DEN-GB style=3D'=
mso-bidi-font-size:
  11.0pt;font-family:"TimesNewRomanPS-BoldMT",serif;mso-bidi-font-family:Ti=
mesNewRomanPS-BoldMT;
  mso-fareast-language:EN-GB'>Belgi</span></b></span><b><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt;font-family:"TimesNewRomanPS-BoldMT",s=
erif;
  mso-bidi-font-family:TimesNewRomanPS-BoldMT;mso-fareast-language:EN-GB'>/=
Belgique/<span
  class=3DSpellE>Belgien</span></span></b><span lang=3DFR style=3D'mso-bidi=
-font-size:
  11.0pt;mso-ansi-language:FR'><br>
  </span><strong><span lang=3DEN-GB style=3D'font-weight:normal;mso-bidi-fo=
nt-weight:
  bold'>Orion Pharma BVBA/SPRL</span></strong><strong><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt;font-weight:normal'><o:p></o:p></span>=
</strong></p>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><span class=3D=
SpellE><span
  style=3D'font-size:11.0pt'>Tl</span></span><span style=3D'font-size:11.0=
pt'>/Tel:
  +32 (0)15 64 10 20</span><span lang=3DFR style=3D'font-size:11.0pt;mso-an=
si-language:
  FR'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt'><b style=3D'mso-bidi-=
font-weight:
  normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast=
-language:
  CS'><o:p>&nbsp;</o:p></span></b></p>
  </td>
  <td width=3D315 valign=3Dtop style=3D'width:236.4pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DFI
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI'>Lietuva</span></=
b><span
  lang=3DFI style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI;mso-far=
east-language:
  CS'><o:p></o:p></span></p>
  <p class=3DMsoNormal><span lang=3DFI style=3D'mso-bidi-font-size:11.0pt;m=
so-ansi-language:
  FI'>UAB Orion Pharma<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none'><span lang=3DFI style=
=3D'mso-bidi-font-size:
  11.0pt;mso-ansi-language:FI'>Tel. +370 5&nbsp;276 9499</span><span lang=
=3DFI
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI;mso-fareast-langu=
age:
  CS'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:1;page-break-inside:avoid'>
  <td width=3D313 valign=3Dtop style=3D'width:234.75pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal><span class=3DSpellE><b style=3D'mso-bidi-font-weigh=
t:normal'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black'>&#1041;&#109=
8;&#1083;&#1075;&#1072;&#1088;&#1080;&#1103;</span></b></span><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DFR style=3D'mso-bidi-f=
ont-size:
  11.0pt;color:black;mso-ansi-language:FR'><o:p></o:p></span></b></p>
  <p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;m=
so-ansi-language:
  IT'>Orion Pharma Poland Sp z.o.o.<o:p></o:p></span></p>
  <p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;m=
so-ansi-language:
  IT'>Tel.: + 48&nbsp;22&nbsp;8333177<o:p></o:p></span></p>
  </td>
  <td width=3D315 valign=3Dtop style=3D'width:236.4pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DDE
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'>Luxembourg/Luxem=
burg</span></b><span
  lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'><br>
  </span><strong><span lang=3DEN-GB style=3D'font-weight:normal;mso-bidi-fo=
nt-weight:
  bold'>Orion Pharma BVBA/SPRL</span></strong><strong><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt;font-weight:normal'><o:p></o:p></span>=
</strong></p>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><span class=3D=
SpellE><span
  style=3D'font-size:11.0pt'>Tl</span></span><span style=3D'font-size:11.0=
pt'>/Tel:
  +32 (0)15 64 10 20</span><span lang=3DFR style=3D'font-size:11.0pt;mso-an=
si-language:
  FR'><o:p></o:p></span></p>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DSV
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:SV'><o:p>&nbsp;</o:p=
></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:2;page-break-inside:avoid'>
  <td width=3D313 valign=3Dtop style=3D'width:234.75pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none'><b style=3D'mso-bidi-fo=
nt-weight:
  normal'><span lang=3DSV style=3D'mso-bidi-font-size:11.0pt;mso-ansi-langu=
age:
  SV'>&#268;esk republika</span></b><span lang=3DSV style=3D'mso-bidi-font=
-size:
  11.0pt;mso-ansi-language:SV;mso-fareast-language:CS'><o:p></o:p></span></=
p>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none'><span lang=3DFI style=
=3D'mso-ansi-language:
  FI'>Orion Pharma s.r.o.<o:p></o:p></span></p>
  <p class=3DMsoNormal><span lang=3DEN-GB>Tel: <span
  style=3D'mso-spacerun:yes'></span></span><span lang=3DSV style=3D'mso-an=
si-language:
  SV'>+420 234 703 305</span><b style=3D'mso-bidi-font-weight:normal'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:CS'>=
<o:p></o:p></span></b></p>
  </td>
  <td width=3D315 valign=3Dtop style=3D'width:236.4pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DSV
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:SV'>Magyarorszg</sp=
an></b><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DSV style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:SV;mso-fareast-language:CS'><o:p></o:p></span></=
b></p>
  <p class=3DMsoNormal style=3D'line-height:13.0pt'><strong><span lang=3DEN=
-GB
  style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;mso-bidi-font-weigh=
t:
  bold'>Orion Pharma <span class=3DSpellE>Kft</span>.</span></strong><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'><o:p></o:p></span></b></p>
  <p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>Tel.: +</span><span
  lang=3DEN-GB>36 1 239 9095</span><span lang=3DSV style=3D'mso-bidi-font-s=
ize:11.0pt;
  mso-ansi-language:SV'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:3;page-break-inside:avoid'>
  <td width=3D313 valign=3Dtop style=3D'width:234.75pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>Danmark</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size:=
11.0pt'><br>
  Orion Pharma A/S<br>
  <span class=3DSpellE>Tlf</span>: +45 8614 0000</span><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:CS'><o:p></o:p></=
span></p>
  </td>
  <td width=3D315 valign=3Dtop style=3D'width:236.4pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none'><b style=3D'mso-bidi-fo=
nt-weight:
  normal'><span lang=3DFR style=3D'mso-bidi-font-size:11.0pt;mso-ansi-langu=
age:
  FR'>Malta</span></b><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DFR
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FR;mso-fareast-langu=
age:
  CS'><o:p></o:p></span></b></p>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DIT style=
=3D'mso-bidi-font-size:
  11.0pt;mso-ansi-language:IT'>Salomone Pharma<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-2.25pt;margin-=
bottom:
  9.0pt;margin-left:0in'><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;
  mso-ansi-language:IT'>Tel: +356&nbsp;21220174</span><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:CS'><o:p></o:p></=
span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:4;page-break-inside:avoid'>
  <td width=3D313 valign=3Dtop style=3D'width:234.75pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DDE style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:DE'>Deutschland</span></b><span lang=3DDE
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'><br>
  Orion Pharma GmbH</span><span lang=3DDE style=3D'mso-bidi-font-size:11.0p=
t;
  mso-ansi-language:DE;mso-fareast-language:CS'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><s=
pan
  lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'>Tel: +=
49 40
  899 6890</span><span lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ans=
i-language:
  DE;mso-fareast-language:CS'><o:p></o:p></span></p>
  </td>
  <td width=3D315 valign=3Dtop style=3D'width:236.4pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DSV
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:SV'>Nederland</span>=
</b><span
  lang=3DSV style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:SV'><br>
  </span><strong><span lang=3DEN-GB style=3D'font-weight:normal;mso-bidi-fo=
nt-weight:
  bold'>Orion Pharma BVBA/SPRL</span></strong><strong><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt;font-weight:normal'><o:p></o:p></span>=
</strong></p>
  <p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:9.=
0pt;
  margin-left:0in;tab-stops:28.35pt'><span class=3DSpellE><span style=3D'fo=
nt-size:
  11.0pt'>Tl</span></span><span style=3D'font-size:11.0pt'>/Tel: +32 (0)15=
 64 10
  20</span><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:E=
N-GB;
  mso-fareast-language:CS'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:5;page-break-inside:avoid'>
  <td width=3D313 valign=3Dtop style=3D'width:234.75pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none'><b><span lang=3DFI
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI'>Eesti</span></b>=
<b><span
  lang=3DFI style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI;mso-far=
east-language:
  CS'><o:p></o:p></span></b></p>
  <p class=3DMsoNormal><span lang=3DFI style=3D'mso-bidi-font-size:11.0pt;m=
so-ansi-language:
  FI'>Orion Pharma Eesti O<o:p></o:p></span></p>
  <p class=3DMsoNormal><span lang=3DFI style=3D'mso-bidi-font-size:11.0pt;m=
so-ansi-language:
  FI'>Tel: +372 66 44 550</span><span lang=3DFI style=3D'mso-bidi-font-size=
:11.0pt;
  mso-ansi-language:FI;mso-fareast-language:CS'><o:p></o:p></span></p>
  </td>
  <td width=3D315 valign=3Dtop style=3D'width:236.4pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt'><b style=3D'mso-bidi-=
font-weight:
  normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Norge</spa=
n></b><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:CS'>=
<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-hyphenate:none'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Orion Pharma AS<o:p></o:=
p></span></p>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-2.25pt;margin-=
bottom:
  9.0pt;margin-left:0in'><span class=3DSpellE><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
  11.0pt'>Tlf</span></span><span lang=3DEN-GB style=3D'mso-bidi-font-size:1=
1.0pt'>:
  +47 40 00 42 10</span><span lang=3DDE style=3D'mso-bidi-font-size:11.0pt;
  mso-ansi-language:DE;mso-fareast-language:CS'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:6;page-break-inside:avoid'>
  <td width=3D313 valign=3Dtop style=3D'width:234.75pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><span class=3D=
SpellE><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-si=
ze:11.0pt;
  mso-ansi-language:EN-GB'>&#917;&#955;&#955;&#940;&#948;</span></b></span>=
<b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-si=
ze:11.0pt;
  mso-ansi-language:EN-GB'>&#945;</span></b><span lang=3DFI style=3D'font-s=
ize:
  11.0pt;mso-ansi-language:FI'> <br>
  Orion Pharma Hellas M.E.</span><span style=3D'font-size:11.0pt'>&#928;</s=
pan><span
  lang=3DFI style=3D'font-size:11.0pt;mso-ansi-language:FI'>.E<o:p></o:p></=
span></p>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><span class=3D=
SpellE><span
  style=3D'font-size:11.0pt'>&#932;&#951;&#955;</span></span><span lang=3DFI
  style=3D'font-size:11.0pt;mso-ansi-language:FI'>: + 30&nbsp;210&nbsp;980 =
3355</span><span
  lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p></o:=
p></span></p>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt'><b style=3D'mso-bidi-=
font-weight:
  normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast=
-language:
  CS'><o:p>&nbsp;</o:p></span></b></p>
  </td>
  <td width=3D315 valign=3Dtop style=3D'width:236.4pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DDE style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:DE'>sterreich</span></b><span lang=3DDE
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'><br>
  Orion Pharma GmbH</span><span lang=3DDE style=3D'mso-bidi-font-size:11.0p=
t;
  mso-ansi-language:DE;mso-fareast-language:CS'><o:p></o:p></span></p>
  <p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:9.=
0pt;
  margin-left:0in;tab-stops:28.35pt'><span lang=3DDE style=3D'font-size:11.=
0pt;
  mso-ansi-language:DE'>Tel: +49 40 899 6890</span><span lang=3DEN-GB
  style=3D'font-size:11.0pt;mso-ansi-language:EN-GB;mso-fareast-language:CS=
'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:7;page-break-inside:avoid'>
  <td width=3D313 valign=3Dtop style=3D'width:234.75pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><b style=3D'ms=
o-bidi-font-weight:
  normal'><span lang=3DIT style=3D'font-size:11.0pt;mso-ansi-language:IT'>E=
spaa</span></b><span
  lang=3DIT style=3D'font-size:11.0pt;mso-ansi-language:IT'><br>
  </span><span style=3D'font-size:11.0pt'>Orion Pharma S.L.</span><span
  style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><span
  style=3D'font-size:11.0pt'>Tel: + 34 91 &nbsp;599 86 01</span><span lang=
=3DEN-GB
  style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt'><b style=3D'mso-bidi-=
font-weight:
  normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast=
-language:
  CS'><o:p>&nbsp;</o:p></span></b></p>
  </td>
  <td width=3D315 valign=3Dtop style=3D'width:236.4pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>Polska</span></b><b style=3D'mso-bidi=
-font-weight:
  normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast=
-language:
  CS'><o:p></o:p></span></b></p>
  <p class=3DMsoNormal><span lang=3DSV style=3D'mso-bidi-font-size:11.0pt;m=
so-ansi-language:
  SV'>Orion Pharma Poland Sp z.o.o.</span><span lang=3DEN-GB style=3D'mso-b=
idi-font-size:
  11.0pt'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-bottom:9.0pt'><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>Tel.: + 48 22 8333177</span><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:CS'>=
<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:8;page-break-inside:avoid'>
  <td width=3D313 valign=3Dtop style=3D'width:234.75pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><b style=3D'ms=
o-bidi-font-weight:
  normal'><span lang=3DFR style=3D'font-size:11.0pt;mso-ansi-language:FR'>F=
rance</span></b><span
  lang=3DFR style=3D'font-size:11.0pt;mso-ansi-language:FR'><br>
  </span><span style=3D'font-size:11.0pt;mso-fareast-font-family:Calibri;
  mso-fareast-language:EN-GB'>Centre <span class=3DSpellE>Spcialits</span=
> <span
  class=3DSpellE>Pharmaceutiques</span></span><span lang=3DFR style=3D'font=
-size:
  11.0pt;mso-ansi-language:FR'><o:p></o:p></span></p>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><span
  style=3D'font-size:11.0pt;mso-fareast-font-family:Calibri;mso-fareast-lan=
guage:
  EN-GB'>Tel: + 33 (0) 1 47 04 80 46</span><span lang=3DFR style=3D'font-si=
ze:11.0pt;
  mso-ansi-language:FR'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt'><b style=3D'mso-bidi-=
font-weight:
  normal'><span lang=3DFR style=3D'mso-bidi-font-size:11.0pt;mso-ansi-langu=
age:
  FR;mso-fareast-language:CS'><o:p>&nbsp;</o:p></span></b></p>
  </td>
  <td width=3D315 valign=3Dtop style=3D'width:236.4pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;tab-=
stops:
  28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DIT
  style=3D'font-size:11.0pt;mso-ansi-language:IT'>Portugal</span></b><span
  lang=3DIT style=3D'font-size:11.0pt;mso-ansi-language:IT'><br>
  </span><span class=3DSpellE><span style=3D'font-size:11.0pt'>Orionfin</sp=
an></span><span
  style=3D'font-size:11.0pt'> <span class=3DSpellE>Unipessoal</span> <span
  class=3DSpellE>Lda</span></span><span lang=3DIT style=3D'font-size:11.0pt;
  mso-ansi-language:IT'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-2.25pt;margin-=
bottom:
  9.0pt;margin-left:0in'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.=
0pt'>Tel:
  + 351 21 154 68 20</span><span lang=3DFR style=3D'mso-bidi-font-size:11.0=
pt;
  mso-ansi-language:FR;mso-fareast-language:CS'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:9;page-break-inside:avoid'>
  <td width=3D313 valign=3Dtop style=3D'width:234.75pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DFI style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:FI;mso-fareast-language:CS'>Hrvatska<o:p></o:p><=
/span></b></p>
  <p class=3DMsoNormal><strong><span lang=3DFI style=3D'mso-bidi-font-size:=
11.0pt;
  mso-ansi-language:FI;font-weight:normal;mso-bidi-font-weight:bold'>Orion
  Pharma d.o.o.<o:p></o:p></span></strong></p>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><s=
pan
  lang=3DFI style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI'>Tel:</=
span><span
  lang=3DFI style=3D'mso-ansi-language:FI'> +386&nbsp;(0) 1 600 8015</span>=
<span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:CS'>=
<o:p></o:p></span></p>
  </td>
  <td width=3D315 valign=3Dtop style=3D'width:236.4pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:12.0pt;mso-line-height-rule:exa=
ctly;
  mso-layout-grid-align:none;text-autospace:none'><span class=3DSpellE><b><=
span
  lang=3DFR style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-languag=
e:FR'>Romnia</span></b></span><b><span
  lang=3DFR style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-languag=
e:FR'><o:p></o:p></span></b></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-layout-grid-align:no=
ne;
  text-autospace:none'><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;
  mso-ansi-language:IT'>Orion Corporation</span><span lang=3DFR style=3D'ms=
o-bidi-font-size:
  11.0pt;color:black;mso-ansi-language:FR'><o:p></o:p></span></p>
  <p class=3DMsoNormal><span lang=3DFR style=3D'mso-bidi-font-size:11.0pt;c=
olor:black;
  mso-ansi-language:FR'>Tel: +358 10 4261<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:10;page-break-inside:avoid'>
  <td width=3D313 valign=3Dtop style=3D'width:234.75pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><b style=3D'mso-bidi-fo=
nt-weight:
  normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Ireland</s=
pan></b><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><br>
  Orion Pharma (Ireland) Ltd.</span><span lang=3DEN-GB style=3D'mso-bidi-fo=
nt-size:
  11.0pt;mso-fareast-language:CS'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>c/o <span class=3DSpellE>Allphar</spa=
n>
  Services Ltd.<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-hyphenate:none'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Tel: +353 1 428 7777<o:p=
></o:p></span></p>
  </td>
  <td width=3D315 valign=3Dtop style=3D'width:236.4pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DIT
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'>Slovenija</span>=
</b><span
  lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT;mso-far=
east-language:
  CS'><o:p></o:p></span></p>
  <p class=3DMsoNormal><strong><span lang=3DFI style=3D'mso-bidi-font-size:=
11.0pt;
  mso-ansi-language:FI;font-weight:normal;mso-bidi-font-weight:bold'>Orion
  Pharma d.o.o.<o:p></o:p></span></strong></p>
  <p class=3DMsoNormal style=3D'margin-bottom:9.0pt'><span lang=3DFI
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI'>Tel:</span><span
  lang=3DFI style=3D'mso-ansi-language:FI'> +386&nbsp;(0) 1 600 8015</span>=
<b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt;mso-fareast-language:CS'><o:p></o:p></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:11;page-break-inside:avoid'>
  <td width=3D313 valign=3Dtop style=3D'width:234.75pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt'><span class=3DSpellE>=
<b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>sland</span></b></span><b style=3D'mso-bidi-font-weight:normal'>=
<span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:CS'>=
<o:p></o:p></span></b></p>
  <p class=3DMsoNormal style=3D'line-height:normal'><span class=3DSpellE><s=
pan
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Vistor</span></span><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'> hf.<o:p></o:p></span></=
p>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><span class=3D=
SpellE><span
  style=3D'font-size:11.0pt'>Smi</span></span><span style=3D'font-size:11.=
0pt'>:
  +354 535 7000</span><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi=
-language:
  EN-GB;mso-fareast-language:CS'><o:p></o:p></span></p>
  </td>
  <td width=3D315 valign=3Dtop style=3D'width:236.4pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none'><b style=3D'mso-bidi-fo=
nt-weight:
  normal'><span lang=3DSV style=3D'mso-bidi-font-size:11.0pt;mso-ansi-langu=
age:
  SV'>Slovensk republika</span></b><b style=3D'mso-bidi-font-weight:normal=
'><span
  lang=3DSV style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:SV;mso-far=
east-language:
  CS'><o:p></o:p></span></b></p>
  <p class=3DMsoNormal><strong><span lang=3DSV style=3D'mso-bidi-font-size:=
11.0pt;
  mso-ansi-language:SV;font-weight:normal;mso-bidi-font-weight:bold'>Orion
  Pharma s.r.o<o:p></o:p></span></strong></p>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-2.25pt;margin-=
bottom:
  9.0pt;margin-left:0in;line-height:normal'><span lang=3DSV style=3D'mso-an=
si-language:
  SV'>Tel: </span><span lang=3DSV><span style=3D'mso-spacerun:yes'></span>=
</span><span
  lang=3DSV style=3D'mso-ansi-language:SV'>+420 234 703 305</span><span lan=
g=3DIT
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT;mso-fareast-langu=
age:
  CS'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:12;page-break-inside:avoid'>
  <td width=3D313 valign=3Dtop style=3D'width:234.75pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><b style=3D'ms=
o-bidi-font-weight:
  normal'><span lang=3DIT style=3D'font-size:11.0pt;mso-ansi-language:IT'>I=
talia</span></b><span
  lang=3DIT style=3D'font-size:11.0pt;mso-ansi-language:IT'><br>
  </span><span lang=3DFI style=3D'font-size:11.0pt;mso-ansi-language:FI'>Or=
ion
  Pharma S.r.l.<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-bottom:9.0pt;mso-hyphenate:none'><sp=
an
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Tel: + 39 02&nbsp;678761=
11</span><span
  lang=3DEL style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EL;mso-far=
east-language:
  CS'><o:p></o:p></span></p>
  </td>
  <td width=3D315 valign=3Dtop style=3D'width:236.4pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DIT style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:IT'>Suomi/Finland<br>
  </span></b><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-la=
nguage:
  IT'>Orion Corporation</span><span lang=3DIT style=3D'mso-bidi-font-size:1=
1.0pt;
  mso-ansi-language:IT;mso-fareast-language:CS'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><s=
pan
  lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'>Puh./T=
el: +358
  10 4261</span><span lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ansi=
-language:
  DE;mso-fareast-language:CS'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:13;page-break-inside:avoid'>
  <td width=3D313 valign=3Dtop style=3D'width:234.75pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEL
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EL'>&#922;&#973;&#96=
0;&#961;&#959;&#962;</span></b><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEL style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:EL;mso-fareast-language:CS'><o:p></o:p></span></=
b></p>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none;tab-stops:-.5in 28.35pt =
3.15in'><span
  lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'>Lifeph=
arma
  (ZAM) Ltd<o:p></o:p></span></p>
  <p class=3DMsoNormal><span class=3DSpellE><span lang=3DEN-GB style=3D'mso=
-bidi-font-size:
  11.0pt'>&#932;&#951;&#955;</span></span><span lang=3DDE style=3D'mso-bidi=
-font-size:
  11.0pt;mso-ansi-language:DE'>.: +357 22056300</span><span lang=3DDE
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE;mso-fareast-langu=
age:
  CS'><o:p></o:p></span></p>
  </td>
  <td width=3D315 valign=3Dtop style=3D'width:236.4pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DDE style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:DE'>Sverige</span></b><span lang=3DDE
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'><br>
  Orion Pharma AB</span><span lang=3DDE style=3D'mso-bidi-font-size:11.0pt;
  mso-ansi-language:DE;mso-fareast-language:CS'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><s=
pan
  lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'>Tel: +=
46 8 623
  6440<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:14;mso-yfti-lastrow:yes;page-break-inside:avoid=
'>
  <td width=3D313 valign=3Dtop style=3D'width:234.75pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DFI
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI'>Latvija</span></=
b><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DFI style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:FI;mso-fareast-language:CS'><o:p></o:p></span></=
b></p>
  <p class=3DMsoNormal><span style=3D'mso-bidi-font-size:11.0pt;mso-ansi-la=
nguage:
  EN-US'>Orion Corporation<o:p></o:p></span></p>
  <p class=3DMsoNormal><span style=3D'mso-bidi-font-size:11.0pt;mso-ansi-la=
nguage:
  EN-US'>Orion Pharma <span class=3DSpellE>p&#257;rst&#257;vniec&#299;ba</s=
pan><o:p></o:p></span></p>
  <p class=3DMsoNormal><span style=3D'mso-bidi-font-size:11.0pt;mso-ansi-la=
nguage:
  EN-US'>Tel: +371 20028332<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none'><span style=3D'mso-bidi=
-font-size:
  11.0pt;mso-ansi-language:EN-US;mso-fareast-language:CS'><o:p>&nbsp;</o:p>=
</span></p>
  </td>
  <td width=3D315 valign=3Dtop style=3D'width:236.4pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt'><b style=3D'mso-bidi-=
font-weight:
  normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>United Kin=
gdom</span></b><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:CS'>=
<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-hyphenate:none'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Orion Pharma (UK) Ltd.<o=
:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none'><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>Tel: +44 1635 520 300</span><span lan=
g=3DFI
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI;mso-fareast-langu=
age:
  CS'><o:p></o:p></span></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt'>This leaflet was last revised in.<o:p></o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><b style=3D=
'mso-bidi-font-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;<=
/o:p></span></b></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'mso-no-proof:yes'>Other sources of information</span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt'><o:p></o:p></span></b></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Detailed
information on this medicine is available on the European Medicines Agency =
web
site: <a href=3D"http://www.ema.europa.eu">http://www.ema.europa.eu</a>. <o=
:p></o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-s=
ize:11.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-ansi-language:EN-GB;mso-fareast-language:EN-US;mso-bidi-language:AR-SA'=
><br
clear=3Dall style=3D'page-break-before:always'>
</span></b>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><b style=3D=
'mso-bidi-font-weight:
normal'><span lang=3DEN-GB style=3D'color:black'>Package leaflet: Informati=
on for
the user</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><=
o:p></o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><b style=3D=
'mso-bidi-font-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;text-transfor=
m:uppercase'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><b style=3D=
'mso-bidi-font-weight:
normal'><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;text-transform:u=
ppercase;
mso-ansi-language:IT'>s</span></b><b style=3D'mso-bidi-font-weight:normal'>=
<span
lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'>talevo&n=
bsp;</span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt'>125&nbsp;mg/31.25&nbsp;mg/200&nbsp;mg</span></b><b style=3D'mso-bid=
i-font-weight:
normal'><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:IT'>
film-coated tablets<o:p></o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DIT
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'>levodopa/carbidopa=
/entacapone<b
style=3D'mso-bidi-font-weight:normal'><span style=3D'text-transform:upperca=
se'><o:p></o:p></span></b></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DIT
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'><o:p>&nbsp;</o:p><=
/span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>Read
all of this leaflet carefully before you start taking this medicine because=
 it
contains important information for you.<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-list:l1 level1 lfo3;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ig=
nore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>Keep
this leaflet. You may need to read it again.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-list:l1 level1 lfo3;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ig=
nore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>If
you have any further questions, ask your doctor or pharmacist.<o:p></o:p></=
span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'>-<span
style=3D'mso-tab-count:1'> </span>This medicine has been prescribed =
for
you only. Do not pass it on to others. It may harm them, even if their sign=
s of
illness are the same as yours.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l1 level1 lfo53'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-no-pr=
oof:
yes'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New =
Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&=
nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-no-proof:yes=
'>If you
get any side effects, talk to your doctor or pharmacist.</span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:red'> </span><span
lang=3DEN-GB style=3D'mso-no-proof:yes'>This includes any possible side eff=
ects not
listed in this leaflet. See section 4.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>What
is in this leaflet:<o:p></o:p></span></b></p>

<p class=3DMsoNormal><span lang=3DEN-GB>1.<span style=3D'mso-tab-count:1'>=
 </span>What
<span class=3DSpellE>Stalevo</span> is and what it is used for</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>2.<span style=3D'mso-tab-count:1'>=
 </span><span
style=3D'mso-no-proof:yes'>What you need to know </span>before you take <sp=
an
class=3DSpellE>Stalevo</span></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>3.<span style=3D'mso-tab-count:1'>=
 </span>How
to take <span class=3DSpellE>Stalevo</span></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>4.<span style=3D'mso-tab-count:1'>=
 </span>Possible
side effects</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>5<span style=3D'mso-tab-count:1'>=
 </span>How
to store <span class=3DSpellE>Stalevo</span></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>6.<span style=3D'mso-tab-count:1'>=
 </span><span
style=3D'mso-no-proof:yes'>Contents of the pack and other information</span=
></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'text-transform:uppercase'>1.<span style=3D'mso-tab-count:1'>=
 </span></span><span
lang=3DEN-GB>What <span class=3DSpellE>Stalevo</span> is and what it is use=
d for<span
style=3D'text-transform:uppercase'><o:p></o:p></span></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><b style=3D'mso-bidi-font=
-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;<=
/o:p></span></b></p>

<p class=3DMsoBodyText3 align=3Dleft style=3D'text-align:left;line-height:n=
ormal'><span
class=3DSpellE><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;font-w=
eight:
normal;font-style:normal'>Stalevo</span></span><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-style:normal'>
contains three active substances (levodopa, carbidopa and entacapone) in one
film-coated tablet. <span class=3DSpellE>Stalevo</span> is used for the tre=
atment
of Parkinsons disease. <o:p></o:p></span></p>

<p class=3DMsoBodyText3 align=3Dleft style=3D'text-align:left;line-height:n=
ormal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-sty=
le:normal'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Parkinsons disease is cau=
sed by
low levels of a substance called dopamine in the brain. Levodopa increases =
the
amount of dopamine and hence reduces the symptoms of Parkinsons disease.
Carbidopa and entacapone improve the <span class=3DSpellE>antiparkinson</sp=
an>
effects of levodopa. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'text-transform:uppercase'>2.<span style=3D'mso-tab-count:1'>=
 </span></span><span
lang=3DEN-GB>What you need to know before you take <span class=3DSpellE>Sta=
levo</span><span
style=3D'text-transform:uppercase'><o:p></o:p></span></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>Do
not take <span class=3DSpellE>Stalevo</span> if you:<o:p></o:p></span></b><=
/p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l42 level1 lfo17;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>are allergic to levodopa, carbidopa or entacapone,=
 or
any of the other ingredients of this medicine </span><span style=3D'font-si=
ze:
11.0pt;mso-no-proof:yes'>(listed in section 6)</span><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l42 level1 lfo17;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>have narrow-angle glaucoma (an eye disorder)<o:p><=
/o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l42 level1 lfo17;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>have a tumour of the adrenal gland<o:p></o:p></spa=
n></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l42 level1 lfo17;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>are taking certain medicines for treating depressi=
on (</span><span
style=3D'font-size:11.0pt'>combinations of </span><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>selective MAO-A and MAO-B
inhibitors, or non-selective MAO-inhibitors)<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l42 level1 lfo17;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>have ever had neuroleptic malignant syndrome (NMS 
this is a rare reaction to medicines used to treat severe mental disorders)=
<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l42 level1 lfo17;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>have ever had non-traumatic rhabdomyolysis (a rare
muscle disorder)<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l42 level1 lfo17;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>have a severe liver disease. <o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-la=
nguage:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'mso-no-proof:yes'>Warnings and precautions</span><span lang=3DEN-G=
B><o:p></o:p></span></b></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0=
pt'>Talk
to your doctor or pharmacist before taking <span class=3DSpellE>Stalevo</sp=
an> if
you have or have ever had</span></u><span lang=3DEN-GB style=3D'mso-bidi-fo=
nt-size:
11.0pt'>:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>a
heart attack or any other diseases of the heart including cardiac arrhythmi=
as,
or of the blood vessels<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>asthma
or any other disease of the lungs<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>a
liver problem, because your dose may need to be adjusted<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>kidney
or hormone-related diseases<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>stomach
ulcers or convulsions<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>if
you experience prolonged diarrhoea consult your doctor as it may be a sign =
of
inflammation of the colon<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>any
form of severe mental disorder like psychosis<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>chronic
wide-angle glaucoma, because your dose may need to be adjusted and the pres=
sure
in your eyes may need to be monitored.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0=
pt'>Consult
your doctor if you are currently taking</span></u><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>antipsychotics
(medicines used to treat psychosis)<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>a
medicine which may cause low blood pressure when rising from a chair or bed.
You should be aware that <span class=3DSpellE>Stalevo</span> may make these
reactions worse.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0=
pt'>Consult
your doctor if during the treatment with <span class=3DSpellE>Stalevo</span=
> you</span></u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>notice
that your muscles get very rigid or jerk violently, or if you get tremors,
agitation, confusion, fever, rapid pulse, or wide fluctuations in your blood
pressure. If any of this happens, <b style=3D'mso-bidi-font-weight:normal'>=
contact
your doctor immediately</b><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>feel
depressed, have suicidal thoughts, or notice unusual changes in your behavi=
our<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>find
yourself suddenly falling asleep, or if you feel very drowsy. If this happe=
ns,
you should not drive or use any tools or machines (see also section 'Driving
and using machines')<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>notice
that uncontrolled movements begin or get worse after you started to take <s=
pan
class=3DSpellE>Stalevo</span>. If this happens, your doctor may need to cha=
nge
the dose of your <span class=3DSpellE>antiparkinson</span> medicine <o:p></=
o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>experience
diarrhoea: monitoring of your weight is recommended in order to avoid poten=
tially
excessive weight loss<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>experience
progressive anorexia, asthenia (weakness, exhaustion) and weight decrease w=
ithin
a relatively short period of time. If this happens, a general medical
evaluation including liver function should be considered<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>feel
the need to stop using <span class=3DSpellE>Stalevo</span>, see section 'If=
 you
stop taking <span class=3DSpellE>Stalevo</span>'.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Tell your
doctor if you or your family/carer notices you are developing addiction-like
symptoms leading to craving for large doses of <span class=3DSpellE>Stalevo=
</span>
and other medicines used to treat Parkinsons disease.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span style=3D'mso-bidi-font-size:11.0pt;mso-ansi-lang=
uage:
EN-US'>Tell your doctor if you or your family/<span class=3DSpellE>carer</s=
pan>
notices you are developing urges or cravings to behave in ways that are unu=
sual
for you or you cannot resist the impulse, drive or temptation to carry out
certain activities that could harm yourself or others. These <span
class=3DSpellE>behaviours</span> are called impulse control disorders and c=
an
include addictive gambling, excessive eating or spending, an abnormally high
sex drive or a preoccupation with an increase in sexual thoughts or feeling=
s. <u>Your
doctor may need to review your treatments.</u> <o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Your
doctor may take some regular laboratory tests during a long term treatment =
with
<span class=3DSpellE>Stalevo</span>.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>If you
must undergo surgery, please tell your doctor that you are using <span
class=3DSpellE>Stalevo</span>.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span class=3DSpellE><span lang=3DEN-GB style=3D'mso-b=
idi-font-size:
11.0pt'>Stalevo</span></span><span lang=3DEN-GB style=3D'mso-bidi-font-size=
:11.0pt'>
is not recommended to be used for treatment of extrapyramidal symptoms (e.g.
involuntary movements, shaking, muscle rigidity and muscle contractions</sp=
an><span
lang=3DEN style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EN'>)</span>=
<span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'> caused by other medicines=
.<o:p></o:p></span></p>

<p class=3DMsoNormal><u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0=
pt'><o:p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'mso-bidi-font-size:11.0pt'>Children </span><span lang=3DEN-GB
style=3D'color:black'>and adolescents</span><span lang=3DEN-GB style=3D'mso=
-no-proof:
yes'><o:p></o:p></span></b></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Experience
with <span class=3DSpellE>Stalevo</span> in patients under 18 years is limi=
ted.
Therefore, the use of <span class=3DSpellE>Stalevo</span> in children or
adolescents is not recommended.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-la=
nguage:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>Other
medicines and <span class=3DSpellE>Stalevo</span><o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoBodyText style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-style:normal'>Te=
ll
your doctor or pharmacist if you are taking, have recently taken or might t=
ake any
other medicines.<o:p></o:p></span></p>

<p class=3DMsoBodyText style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-style:normal'><o=
:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Do not take <span class=3D=
SpellE>Stalevo</span>
if you are taking certain medicines for treating depression (combinations of
selective MAO-A and MAO-B inhibitors, or non-selective MAO inhibitors).<o:p=
></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal'><span
class=3DSpellE><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Stale=
vo</span></span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'> may increase the effects =
and side
effects of certain medicines. These include: <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>medicines
used to treat depression such as moclobemide, amitriptyline, desipramine,
maprotiline, venlafaxine and paroxetine <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l11 level2 lfo20'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-family:"Arial",sans-serif;mso-farea=
st-font-family:
Arial'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times Ne=
w Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp=
;&nbsp;
</span></span></span><![endif]><span class=3DSpellE><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>rimiterole</span></span><span lang=3DEN=
-GB
style=3D'mso-bidi-font-size:11.0pt'> and isoprenaline, used to treat respir=
atory
diseases<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>adrenaline,
used </span><span lang=3DPT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-lan=
guage:
PT'>for severe allergic reactions</span><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
11.0pt'> <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>noradrenaline,
dopamine and dobutamine, used to treat heart diseases and low blood pressur=
e<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>-<span
style=3D'mso-tab-count:1'> </span>alpha-methyldopa, used to treat hi=
gh
blood pressure <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>-<span
style=3D'mso-tab-count:1'> </span>apomorphine, which is used to treat
Parkinsons disease.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;tab-sto=
ps:17.1pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;tab-st=
ops:28.35pt'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>The effects=
 of <span
class=3DSpellE>Stalevo</span> may be weakened by certain medicines. These
include: <o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-la=
nguage:
EN-GB'>-<span style=3D'mso-tab-count:1'> </span>dopamine antagonists=
 used
to treat mental disorders</span><span style=3D'font-size:11.0pt'>, nausea a=
nd
vomiting</span><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-langua=
ge:EN-GB'><o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l49 level1 lfo18;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>phenytoin, used to prevent convulsions <o:p></o:p>=
</span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l49 level1 lfo18;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>papaverine used to relax the muscles.<o:p></o:p></=
span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;tab-st=
ops:28.35pt'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p>&nbsp;=
</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;tab-st=
ops:28.35pt'><span
class=3DSpellE><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-langua=
ge:EN-GB'>Stalevo</span></span><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'> may make i=
t harder
for you to digest iron. Therefore, do not take <span class=3DSpellE>Stalevo=
</span>
and iron supplements at the same time. After taking one of them, wait at le=
ast
2 to 3 hours before taking the other.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;tab-st=
ops:28.35pt'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal><span class=3DSpellE><b style=3D'mso-bidi-font-weight:=
normal'><span
lang=3DEN-GB>Stalevo</span></b></span><b style=3D'mso-bidi-font-weight:norm=
al'><span
lang=3DEN-GB> with food and drink<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoBodyText style=3D'text-align:justify;line-height:normal;tab-s=
tops:
28.35pt'><span class=3DSpellE><span lang=3DEN-GB style=3D'mso-bidi-font-siz=
e:11.0pt;
font-weight:normal;font-style:normal'>Stalevo</span></span><span lang=3DEN-=
GB
style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-style:normal'> m=
ay be
taken with or without food. For some patients, <span class=3DSpellE>Stalevo=
</span>
may not be well absorbed if it is taken with, or shortly after eating
protein-rich food (such as meats, fish, dairy products, seeds and nuts).
Consult your doctor if you think this applies to you.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;tab-st=
ops:28.35pt'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>Pregnancy,
breast-feeding and fertility<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoBodyText style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-style:normal'>If=
 you
are pregnant or breast-feeding, think you may be pregnant or are planning to
have a baby, ask your doctor or pharmacist for advice before taking this
medicine. <o:p></o:p></span></p>

<p class=3DMsoBodyText style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-style:normal'><o=
:p>&nbsp;</o:p></span></p>

<p class=3DMsoBodyText style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-style:normal'>You
should not breast-feed during treatment with <span class=3DSpellE>Stalevo</=
span>.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>Driving
and using machines<o:p></o:p></span></b></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span class=
=3DSpellE><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Stalevo</span></span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'> may lower your blood pres=
sure,
which may make you feel light-headed or dizzy. Therefore, be particularly
careful when you drive or when you use any tools or machines.<o:p></o:p></s=
pan></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>If you feel very drowsy, or if you some=
times
find yourself suddenly falling asleep, wait until you feel fully awake again
before driving or doing anything else that requires you to be alert. Otherw=
ise,
you may put yourself and others at risk of serious injury or death.<o:p></o=
:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span class=
=3DSpellE><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt'>Stalevo</span></b></span><b style=3D'mso-bidi-font-weight:normal'><=
span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'> contains sucrose<o:p></o:=
p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span class=
=3DSpellE><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Stalevo</span></span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'> contains sucrose
(1.6&nbsp;mg/tablet). If you have been told by your doctor that you have
intolerance to some sugars, contact your doctor before taking this medicinal
product.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'text-transform:uppercase'>3.<span style=3D'mso-tab-count:1'>=
 </span></span><span
lang=3DEN-GB>How to take <span class=3DSpellE>Stalevo</span><span style=3D'=
text-transform:
uppercase'><o:p></o:p></span></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Always take this medicine =
exactly
as your doctor or pharmacist has told you. Check with your doctor or pharma=
cist
if you are not sure.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>For adults and elderly</sp=
an></u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt=
'>-<span
style=3D'mso-tab-count:1'> </span>Your doctor will tell you exactly =
how
many tablets of <span class=3DSpellE>Stalevo</span> to take each day. <o:p>=
</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l32 level1 lfo21'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-family:"Arial",sans-serif;mso-farea=
st-font-family:
Arial'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times Ne=
w Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp=
;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>The
tablets are not intended to be split or broken into smaller pieces.<o:p></o=
:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l32 level1 lfo21'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-family:"Arial",sans-serif;mso-farea=
st-font-family:
Arial'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times Ne=
w Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp=
;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>You
should take only one tablet each time.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l32 level1 lfo21'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-family:"Arial",sans-serif;mso-farea=
st-font-family:
Arial'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times Ne=
w Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp=
;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>Depending
on how you respond to treatment, your doctor may suggest a higher or lower
dose. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l32 level1 lfo21'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-family:"Arial",sans-serif;mso-farea=
st-font-family:
Arial'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times Ne=
w Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp=
;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>If
you are taking <span class=3DSpellE>Stalevo</span>
50&nbsp;mg/12.5&nbsp;mg/200&nbsp;mg, 75&nbsp;mg/18.75&nbsp;mg/200&nbsp;mg,
100&nbsp;mg/25&nbsp;mg/200&nbsp;mg, 125&nbsp;mg/31.25&nbsp;mg/200&nbsp;mg or
150&nbsp;mg/37.5&nbsp;mg/200&nbsp;mg tablets, do not take more than 10 tabl=
ets
per day.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;text-align:justify;line-he=
ight:
normal;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt=
'>Talk
to your doctor or pharmacist if you think the effect of <span class=3DSpell=
E>Stalevo</span>
is too strong or too weak, or if you experience possible side effects.<o:p>=
</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;text-align:justify;line-he=
ight:
12.0pt;mso-list:skip'><span lang=3DEN-GB><!--[if gte vml 1]><v:shape id=3D"=
_x0000_i1039"
 type=3D"#_x0000_t75" style=3D'width:468pt;height:91.5pt'>
 <v:imagedata src=3D"Stalevo_clean_files/image007.emz" o:title=3D""/>
</v:shape><![endif]--><![if !vml]><img border=3D0 width=3D624 height=3D122
src=3D"Stalevo_clean_files/image008.png" v:shapes=3D"_x0000_i1039"><![endif=
]></span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>If
you take more <span class=3DSpellE>Stalevo</span> than you should<o:p></o:p=
></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>If you have accidentally taken more <sp=
an
class=3DSpellE>Stalevo</span> tablets than you should, talk to your doctor =
or
pharmacist immediately. In case of an overdose you may feel confused or
agitated, your heart rate may be slower or faster than normal or the colour=
 of
your skin, tongue, eyes or urine may change.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>If
you forget to take <span class=3DSpellE>Stalevo</span><o:p></o:p></span></b=
></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>Do not take a double dose to make up fo=
r a
forgotten tablet.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p><span style=3D'text-d=
ecoration:
 none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>If it is more than 1 hour =
until
your next dose</span></u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.=
0pt'>: <o:p></o:p></span></p>

<p class=3DMsoBodyText style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-style:normal'>Ta=
ke one
tablet as soon as you remember, and the next tablet at the normal time. <o:=
p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>If it is less than 1 hour =
until
your next dose</span></u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.=
0pt'>: <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Take a tablet as soon as y=
ou
remember, wait 1 hour, then take another tablet. After that carry on as nor=
mal.
<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Always leave at least an h=
our
between <span class=3DSpellE>Stalevo</span> tablets, to avoid possible side
effects.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>If
you stop taking <span class=3DSpellE>Stalevo</span> <o:p></o:p></span></b><=
/p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Do not stop taking <span
class=3DSpellE>Stalevo</span> unless your doctor tells you to. In such a ca=
se
your doctor may need to adjust your other <span class=3DSpellE>antiparkinso=
n</span>
medicines, especially levodopa, to give sufficient control of your symptoms=
. If
you suddenly stop taking <span class=3DSpellE>Stalevo</span> and other
antiparkinsonian medicines it may result in unwanted side effects. <o:p></o=
:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>If you have any further qu=
estions
on the use of this medicine, ask your doctor or pharmacist.<o:p></o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'text-transform:uppercase'>4.<span style=3D'mso-tab-count:1'>=
 </span></span><span
lang=3DEN-GB>Possible side effects<span style=3D'text-transform:uppercase'>=
<o:p></o:p></span></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-1.4pt;line-height:normal;mso-ou=
tline-level:
1;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:=
p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.4pt;line-height:normal;mso-ou=
tline-level:
1;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Lik=
e all
medicines, this medicine can cause side effects, although not everybody gets
them. Many of the side effects can be relieved by adjusting the dose. <o:p>=
</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.4pt;line-height:normal;mso-ou=
tline-level:
1;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:=
p>&nbsp;</o:p></span></p>

<p class=3DText style=3D'margin-top:0in'><span style=3D'font-size:11.0pt'>I=
f you
during the treatment with <span class=3DSpellE>Stalevo</span> experience the
following symptoms, <b style=3D'mso-bidi-font-weight:normal'>contact your d=
octor
immediately</b>: <o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-25.65pt;mso-list:l50=
 level1 lfo26'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-size:11.0pt'>Your muscle=
s get
very rigid or jerk violently, you get tremors, agitation, confusion, fever,
rapid pulse, or wide fluctuations in your blood pressure. These can be symp=
toms
</span><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB=
'>of neuroleptic
malignant syndrome (NMS, a rare severe reaction to medicines used to treat
disorders of the central nervous system) or rhabdomyolysis (a rare severe
muscle disorder).<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-25.65pt;mso-list:l37=
 level1 lfo27'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>Allergic reaction, the signs may include hives (ne=
ttle
rash), itching, rash, swelling of your face, lips, tongue or throat. This m=
ay
cause difficulties in breathing or swallowing.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.4pt;line-height:normal;mso-ou=
tline-level:
1;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:=
p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><u><span lang=3DEN-GB>Very common (may affect more tha=
n 1 in
10 people)<o:p></o:p></span></u></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>uncontrolled movements (dyskinesias)<o:p></o:p></s=
pan></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>feeling sick (nausea)<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>harmless reddish-brown discolouration of urine<o:p=
></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>muscle pain<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>diarrhoea<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><span lang=3DEN-=
GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span>=
</p>

<p class=3DMsoNormal><u><span lang=3DEN-GB>Common (may affect up to 1 in 10=
 people)<o:p></o:p></span></u></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>light-headedness or fainting due to low blood
pressure, high blood pressure<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>worsening of Parkinsons symptoms, dizziness,
drowsiness<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>vomiting, abdominal pain and discomfort, heartburn,
dry mouth, constipation<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>inability to sleep, hallucinations, confusion abno=
rmal
dreams (including nightmares), tiredness<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>mental changes  including problems with memory,
anxiety and depression (possibly with thoughts of suicide) <o:p></o:p></spa=
n></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-size:11.0pt'>heart or ar=
tery
disease events (e.g. chest pain), irregular heart rate or rhythm </span><sp=
an
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p></o:p>=
</span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>more frequent falling <o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>shortness of breath <o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>increased sweating, rashes<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>muscle cramps, swelling of legs<o:p></o:p></span><=
/p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>blurred vision <o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>anaemia<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>decreased appetite, decreased weight<o:p></o:p></s=
pan></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>headache, joint pain<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>urinary tract infection<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;tab-st=
ops:28.35pt'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p>&nbsp;=
</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;tab-st=
ops:28.35pt'><u><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>Uncommon </=
span></u><u><span
style=3D'font-size:11.0pt;color:black'>(may affect up to 1 in 100&nbsp;peop=
le)</span></u><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p></o:p>=
</span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>heart attack<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>bleeding in the gut<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>changes in the blood cell count which may result i=
n bleeding,
abnormal liver function tests<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>convulsions<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>feeling agitated<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>psychotic symptoms<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>colitis (inflammation of the colon)<o:p></o:p></sp=
an></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span class=3DSpellE><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>discolourations</span></=
span><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'> other than=
 urine
(e.g. skin, nail, hair, sweat)<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>swallowing difficulties<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-size:11.0pt'>inability to
urinate</span><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-languag=
e:EN-GB'><o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left'><u><s=
pan
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>Not known (=
cannot
be estimated from the available data)<o:p></o:p></span></u></p>

<p class=3DText style=3D'margin-top:0in'><span lang=3DEN-GB style=3D'font-s=
ize:11.0pt;
mso-ansi-language:EN-GB'>Craving for large doses of <span class=3DSpellE>St=
alevo</span>
in excess of that required to control motor symptoms, known as dopamine
dysregulation syndrome. Some patients experience severe abnormal involuntary
movements (dyskinesias), mood swings or other side effects after taking lar=
ge
doses of <span class=3DSpellE>Stalevo</span>.<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in'><span lang=3DEN-GB style=3D'font-s=
ize:11.0pt;
mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText style=3D'margin-top:0in'><u><span lang=3DEN-GB style=3D'fon=
t-size:11.0pt;
mso-ansi-language:EN-GB'>The following side effects have also been reported=
</span></u><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>: <o:p></o:=
p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l4 =
level1 lfo22;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>hepatitis </span><span style=3D'font-size:11.0pt'>=
(inflammation
of the liver)</span><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-l=
anguage:
EN-GB'> <o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l4 =
level1 lfo22;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>itching<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in'><span lang=3DEN-GB style=3D'font-s=
ize:11.0pt;
mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:4.8pt;mso-pagination:none'><u><s=
pan
lang=3DEN-GB style=3D'color:black'>You may experience the following side ef=
fects: <o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:4.8pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-pagination:none;mso-list:l10 level1 lfo49;tab-stops:28.35pt'><![=
if !supportLists]><span
lang=3DEN-GB style=3D'font-family:"Arial",sans-serif;mso-fareast-font-famil=
y:Arial;
color:black'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Ti=
mes New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp=
;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
color:black'>Inability to resist the impulse to perform an action that coul=
d be
harmful, which may include:</span><span lang=3DEN-GB style=3D'color:black'>=
<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:4.8pt;margin-bott=
om:0in;
margin-left:42.55pt;margin-bottom:.0001pt;text-indent:-14.2pt;line-height:n=
ormal;
mso-pagination:none;mso-list:l9 level2 lfo51;tab-stops:list 42.55pt'><![if =
!supportLists]><span
lang=3DEN-GB style=3D'font-family:"Arial",sans-serif;mso-fareast-font-famil=
y:Arial;
color:black'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Ti=
mes New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
color:black'>strong impulse to gamble excessively despite serious personal =
or family
consequences</span><span lang=3DEN-GB style=3D'color:black'><o:p></o:p></sp=
an></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:4.8pt;margin-bott=
om:0in;
margin-left:42.55pt;margin-bottom:.0001pt;text-indent:-14.2pt;line-height:n=
ormal;
mso-pagination:none;mso-list:l9 level2 lfo51;tab-stops:list 42.55pt'><![if =
!supportLists]><span
lang=3DEN-GB style=3D'font-family:"Arial",sans-serif;mso-fareast-font-famil=
y:Arial;
color:black'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Ti=
mes New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
color:black'>altered or increased sexual interest and behaviour of signific=
ant
concern to you or to others, for example, an increased sexual drive</span><=
span
lang=3DEN-GB style=3D'color:black'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:4.8pt;margin-bott=
om:0in;
margin-left:42.55pt;margin-bottom:.0001pt;text-indent:-14.2pt;line-height:n=
ormal;
mso-pagination:none;mso-list:l9 level2 lfo51;tab-stops:list 42.55pt'><![if =
!supportLists]><span
lang=3DEN-GB style=3D'font-family:"Arial",sans-serif;mso-fareast-font-famil=
y:Arial;
color:black'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Ti=
mes New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
color:black'>uncontrollable excessive shopping or spending</span><span
lang=3DEN-GB style=3D'color:black'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:4.8pt;margin-bott=
om:0in;
margin-left:42.55pt;margin-bottom:.0001pt;text-indent:-14.2pt;line-height:n=
ormal;
mso-pagination:none;mso-list:l9 level2 lfo51;tab-stops:list 42.55pt'><![if =
!supportLists]><span
lang=3DEN-GB style=3D'font-family:"Arial",sans-serif;mso-fareast-font-famil=
y:Arial;
color:black'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Ti=
mes New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
color:black'>binge eating (eating large amounts of food in a short time per=
iod)
or compulsive eating (eating more food than normal and more than is needed =
to
satisfy your hunger).</span><span lang=3DEN-GB style=3D'color:black'><o:p><=
/o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:4.8pt;mso-pagination:none'><span
lang=3DEN-GB style=3D'color:black'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:4.8pt;mso-pagination:none;tab-st=
ops:
0in'><span lang=3DEN-GB style=3D'color:black'>Tell your doctor if you exper=
ience
any of these behaviours; they will discuss ways of managing or reducing the
symptoms.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-out=
line-level:
1;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:=
p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-out=
line-level:
1;mso-list:skip'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>Reporting of side effects<o:p></o:p></s=
pan></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-out=
line-level:
1;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>If =
you get
any side effects, talk to your doctor or pharmacist. This includes any poss=
ible
side effects not listed in this leaflet. You can also report side effects
directly via <span style=3D'background:silver;mso-highlight:silver'>the nat=
ional
reporting system listed in <a
href=3D"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_fo=
rm/2013/03/WC500139752.doc">Appendix
V</a></span>. By reporting side <span class=3DSpellE>effects you</span> can=
 help
provide more information on the safety of this medicine.<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'text-transform:uppercase'>5.<span style=3D'mso-tab-count:1'>=
 </span></span><span
lang=3DEN-GB>How to store <span class=3DSpellE>Stalevo</span><span
style=3D'text-transform:uppercase'><o:p></o:p></span></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-out=
line-level:
1;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Kee=
p this
medicine out of the sight and reach of children.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Do not use this medicine a=
fter the
expiry date which is stated on the bottle and the carton after EXP. The exp=
iry
date refers to the last day of that month.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>This medicinal product doe=
s not
require any special storage conditions.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Do not </=
span><span
lang=3DEN-GB style=3D'mso-no-proof:yes'>throw away any medicines</span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'> via wastewater or househo=
ld
waste. Ask your pharmacist how to </span><span lang=3DEN-GB style=3D'mso-no=
-proof:
yes'>throw away</span><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt=
'>
medicines you no longer use. These measures will help to protect the
environment.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'text-transform:uppercase'>6.<span style=3D'mso-tab-count:1'>=
 </span></span><span
lang=3DEN-GB>Contents of the pack and other information<span style=3D'text-=
transform:
uppercase'><o:p></o:p></span></span></b></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><b style=3D'mso-bidi-font=
-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>What <span
class=3DSpellE>Stalevo</span> contains<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:no=
rmal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-list:l14 level1 lfo7;tab-stops:list 28.35pt'><![if !supportLists=
]><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ig=
nore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>The
active substances of <span class=3DSpellE>Stalevo</span> are levodopa, carb=
idopa
and entacapone.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo7;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>Each <span class=3DSpellE>Stalevo</span>
125&nbsp;mg/31.25&nbsp;mg/200&nbsp;mg tablet contains 125&nbsp;mg of levodo=
pa,
31.25&nbsp;mg of carbidopa and 200&nbsp;mg of entacapone.<o:p></o:p></span>=
</p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-list:l14 level1 lfo7;tab-stops:list 28.35pt'><![if !supportLists=
]><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ig=
nore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>The
other ingredients in the tablet core are croscarmellose sodium, magnesium s=
tearate,
maize starch, mannitol (E421) and povidone (E1201)<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-list:l14 level1 lfo7;tab-stops:list 28.35pt'><![if !supportLists=
]><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ig=
nore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>The
ingredients in the film-coating are glycerol (85 per cent) (E422), <span
class=3DSpellE>hypromellose</span>, magnesium stearate, polysorbate 80, red=
 iron
oxide (E172), sucrose, and titanium dioxide (E171).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:27.0pt;text-indent:-27.0pt;line-h=
eight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;<=
/o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:27.0pt;text-indent:-27.0pt;line-h=
eight:
normal'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>What <span class=3DSpellE>Stalevo</span=
> looks
like and contents of the pack<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-left:27.0pt;text-indent:-27.0pt;line-h=
eight:
normal'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoEndnoteText><span class=3DSpellE><span lang=3DEN-GB style=3D'=
mso-bidi-font-size:
11.0pt'>Stalevo</span></span><span lang=3DEN-GB style=3D'mso-bidi-font-size=
:11.0pt'>
125&nbsp;mg/31.25&nbsp;mg/200&nbsp;mg: light brownish red, oval film-coated
tablets marked with LCE 125 on one side.<o:p></o:p></span></p>

<p class=3DMsoEndnoteText><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoEndnoteText><span class=3DSpellE><span lang=3DEN-GB style=3D'=
mso-bidi-font-size:
11.0pt'>Stalevo</span></span><span lang=3DEN-GB style=3D'mso-bidi-font-size=
:11.0pt'>
125&nbsp;mg/31.25&nbsp;mg/200&nbsp;mg tablet comes in five different pack s=
izes
(10, 30, 100, 130 or 175 tablets). Not all pack sizes may be marketed.<o:p>=
</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:27.0pt;text-indent:-27.0pt;line-h=
eight:
normal'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>Marketing
Authorisation Holder</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoEndnoteText><span lang=3DIT style=3D'mso-bidi-font-size:11.0p=
t;
mso-ansi-language:IT'>Orion Corporation<o:p></o:p></span></p>

<p class=3DMsoEndnoteText><span lang=3DIT style=3D'mso-bidi-font-size:11.0p=
t;
mso-ansi-language:IT'>Orionintie 1<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DIT style=3D'=
mso-bidi-font-size:
11.0pt;mso-ansi-language:IT'>FI-02200 Espoo<o:p></o:p></span></p>

<p class=3DMsoEndnoteText><span lang=3DIT style=3D'mso-bidi-font-size:11.0p=
t;
mso-ansi-language:IT'>Finland<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DIT style=3D'=
mso-bidi-font-size:
11.0pt;mso-ansi-language:IT'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-2.25pt'><b style=3D'mso-bidi-fo=
nt-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Manufacturer=
<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-2.25pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>Orion Corporation Orion Pharma<o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-2.25pt'><span class=3DSpellE><s=
pan
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Joensuunkatu</span></span>=
<span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>&nbsp;7<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'margin-right:-2.25pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>FI-24100&nbsp;Salo<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>Finland<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DIT style=3D'=
mso-bidi-font-size:
11.0pt;mso-ansi-language:IT'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-2.25pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold'>Orion Corpora=
tion Orion
Pharma<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-2.25pt'><span class=3DSpellE><s=
pan
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold'>=
Orionintie</span></span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold'>=
&nbsp;1<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-2.25pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold'>FI-02200&nbsp=
;Espoo<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold'>Finland<o:p><=
/o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DIT style=3D'=
mso-bidi-font-size:
11.0pt;mso-ansi-language:IT'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>For any information about =
this
medicine, please contact the local representative of the Marketing
Authorisation Holder.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<table class=3DMsoNormalTable border=3D0 cellspacing=3D0 cellpadding=3D0 wi=
dth=3D628
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;mso-yfti-tbll=
ook:
 1184;mso-padding-alt:0in 5.4pt 0in 5.4pt'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;page-break-inside:avoid=
'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal><span class=3DSpellE><b><span lang=3DEN-GB style=3D'=
mso-bidi-font-size:
  11.0pt;font-family:"TimesNewRomanPS-BoldMT",serif;mso-bidi-font-family:Ti=
mesNewRomanPS-BoldMT;
  mso-fareast-language:EN-GB'>Belgi</span></b></span><b><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt;font-family:"TimesNewRomanPS-BoldMT",s=
erif;
  mso-bidi-font-family:TimesNewRomanPS-BoldMT;mso-fareast-language:EN-GB'>/B=
elgique/<span
  class=3DSpellE>Belgien</span></span></b><span lang=3DFR style=3D'mso-bidi=
-font-size:
  11.0pt;mso-ansi-language:FR'><br>
  </span><strong><span lang=3DEN-GB style=3D'font-weight:normal;mso-bidi-fo=
nt-weight:
  bold'>Orion Pharma BVBA/SPRL</span></strong><strong><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt;font-weight:normal'><o:p></o:p></span>=
</strong></p>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><span class=3D=
SpellE><span
  style=3D'font-size:11.0pt'>Tl</span></span><span style=3D'font-size:11.0=
pt'>/Tel:
  +32 (0)15 64 10 20</span><span lang=3DFR style=3D'font-size:11.0pt;mso-an=
si-language:
  FR'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt'><b style=3D'mso-bidi-=
font-weight:
  normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast=
-language:
  CS'><o:p>&nbsp;</o:p></span></b></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DFI
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI'>Lietuva</span></=
b><span
  lang=3DFI style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI;mso-far=
east-language:
  CS'><o:p></o:p></span></p>
  <p class=3DMsoNormal><span lang=3DFI style=3D'mso-bidi-font-size:11.0pt;m=
so-ansi-language:
  FI'>UAB Orion Pharma<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none'><span lang=3DFI style=
=3D'mso-bidi-font-size:
  11.0pt;mso-ansi-language:FI'>Tel. +370 5&nbsp;276 9499</span><span lang=
=3DFI
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI;mso-fareast-langu=
age:
  CS'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:1;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal><span class=3DSpellE><b style=3D'mso-bidi-font-weigh=
t:normal'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black'>&#1041;&#109=
8;&#1083;&#1075;&#1072;&#1088;&#1080;&#1103;</span></b></span><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DFR style=3D'mso-bidi-f=
ont-size:
  11.0pt;color:black;mso-ansi-language:FR'><o:p></o:p></span></b></p>
  <p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;m=
so-ansi-language:
  IT'>Orion Pharma Poland Sp z.o.o.<o:p></o:p></span></p>
  <p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;m=
so-ansi-language:
  IT'>Tel.: + 48&nbsp;22&nbsp;8333177<o:p></o:p></span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DDE
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'>Luxembourg/Luxem=
burg</span></b><span
  lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'><br>
  </span><strong><span lang=3DEN-GB style=3D'font-weight:normal;mso-bidi-fo=
nt-weight:
  bold'>Orion Pharma BVBA/SPRL</span></strong><strong><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt;font-weight:normal'><o:p></o:p></span>=
</strong></p>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><span class=3D=
SpellE><span
  style=3D'font-size:11.0pt'>Tl</span></span><span style=3D'font-size:11.0=
pt'>/Tel:
  +32 (0)15 64 10 20</span><span lang=3DFR style=3D'font-size:11.0pt;mso-an=
si-language:
  FR'><o:p></o:p></span></p>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DSV
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:SV'><o:p>&nbsp;</o:p=
></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:2;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none'><b style=3D'mso-bidi-fo=
nt-weight:
  normal'><span lang=3DSV style=3D'mso-bidi-font-size:11.0pt;mso-ansi-langu=
age:
  SV'>&#268;esk republika</span></b><span lang=3DSV style=3D'mso-bidi-font=
-size:
  11.0pt;mso-ansi-language:SV;mso-fareast-language:CS'><o:p></o:p></span></=
p>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none'><span lang=3DFI style=
=3D'mso-ansi-language:
  FI'>Orion Pharma s.r.o.<o:p></o:p></span></p>
  <p class=3DMsoNormal><span lang=3DEN-GB>Tel: <span
  style=3D'mso-spacerun:yes'></span></span><span lang=3DSV style=3D'mso-an=
si-language:
  SV'>+420 234 703 305</span><b style=3D'mso-bidi-font-weight:normal'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:CS'>=
<o:p></o:p></span></b></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DSV
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:SV'>Magyarorszg</sp=
an></b><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DSV style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:SV;mso-fareast-language:CS'><o:p></o:p></span></=
b></p>
  <p class=3DMsoNormal style=3D'line-height:13.0pt'><strong><span lang=3DEN=
-GB
  style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;mso-bidi-font-weigh=
t:
  bold'>Orion Pharma <span class=3DSpellE>Kft</span>.</span></strong><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'><o:p></o:p></span></b></p>
  <p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>Tel.: +</span><span
  lang=3DEN-GB>36 1 239 9095</span><span lang=3DSV style=3D'mso-bidi-font-s=
ize:11.0pt;
  mso-ansi-language:SV'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:3;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>Danmark</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size:=
11.0pt'><br>
  Orion Pharma A/S<br>
  <span class=3DSpellE>Tlf</span>: +45 8614 0000</span><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:CS'><o:p></o:p></=
span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none'><b style=3D'mso-bidi-fo=
nt-weight:
  normal'><span lang=3DFR style=3D'mso-bidi-font-size:11.0pt;mso-ansi-langu=
age:
  FR'>Malta</span></b><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DFR
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FR;mso-fareast-langu=
age:
  CS'><o:p></o:p></span></b></p>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DIT style=
=3D'mso-bidi-font-size:
  11.0pt;mso-ansi-language:IT'>Salomone Pharma<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-2.25pt;margin-=
bottom:
  9.0pt;margin-left:0in'><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;
  mso-ansi-language:IT'>Tel: +356&nbsp;21220174</span><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:CS'><o:p></o:p></=
span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:4;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DDE style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:DE'>Deutschland</span></b><span lang=3DDE
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'> <br>
  Orion Pharma GmbH</span><span lang=3DDE style=3D'mso-bidi-font-size:11.0p=
t;
  mso-ansi-language:DE;mso-fareast-language:CS'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><s=
pan
  lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'>Tel: +=
49 40
  899 6890</span><span lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ans=
i-language:
  DE;mso-fareast-language:CS'><o:p></o:p></span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DSV
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:SV'>Nederland</span>=
</b><span
  lang=3DSV style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:SV'><br>
  </span><strong><span lang=3DEN-GB style=3D'font-weight:normal;mso-bidi-fo=
nt-weight:
  bold'>Orion Pharma BVBA/SPRL</span></strong><strong><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt;font-weight:normal'><o:p></o:p></span>=
</strong></p>
  <p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:9.=
0pt;
  margin-left:0in;tab-stops:28.35pt'><span class=3DSpellE><span style=3D'fo=
nt-size:
  11.0pt'>Tl</span></span><span style=3D'font-size:11.0pt'>/Tel: +32 (0)15=
 64 10
  20</span><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:E=
N-GB;
  mso-fareast-language:CS'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:5;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none'><b><span lang=3DFI
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI'>Eesti</span></b>=
<b><span
  lang=3DFI style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI;mso-far=
east-language:
  CS'><o:p></o:p></span></b></p>
  <p class=3DMsoNormal><span lang=3DFI style=3D'mso-bidi-font-size:11.0pt;m=
so-ansi-language:
  FI'>Orion Pharma Eesti O<o:p></o:p></span></p>
  <p class=3DMsoNormal><span lang=3DFI style=3D'mso-bidi-font-size:11.0pt;m=
so-ansi-language:
  FI'>Tel: +372 66 44 550</span><span lang=3DFI style=3D'mso-bidi-font-size=
:11.0pt;
  mso-ansi-language:FI;mso-fareast-language:CS'><o:p></o:p></span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt'><b style=3D'mso-bidi-=
font-weight:
  normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Norge</spa=
n></b><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:CS'>=
<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-hyphenate:none'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Orion Pharma AS<o:p></o:=
p></span></p>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-2.25pt;margin-=
bottom:
  9.0pt;margin-left:0in'><span class=3DSpellE><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
  11.0pt'>Tlf</span></span><span lang=3DEN-GB style=3D'mso-bidi-font-size:1=
1.0pt'>:
  +47 40 00 42 10</span><span lang=3DDE style=3D'mso-bidi-font-size:11.0pt;
  mso-ansi-language:DE;mso-fareast-language:CS'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:6;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><span class=3D=
SpellE><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-si=
ze:11.0pt;
  mso-ansi-language:EN-GB'>&#917;&#955;&#955;&#940;&#948;</span></b></span>=
<b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-si=
ze:11.0pt;
  mso-ansi-language:EN-GB'>&#945;</span></b><span lang=3DFI style=3D'font-s=
ize:
  11.0pt;mso-ansi-language:FI'> <br>
  Orion Pharma Hellas M.E.</span><span style=3D'font-size:11.0pt'>&#928;</s=
pan><span
  lang=3DFI style=3D'font-size:11.0pt;mso-ansi-language:FI'>.E<o:p></o:p></=
span></p>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><span class=3D=
SpellE><span
  style=3D'font-size:11.0pt'>&#932;&#951;&#955;</span></span><span lang=3DFI
  style=3D'font-size:11.0pt;mso-ansi-language:FI'>: + 30&nbsp;210&nbsp;980 =
3355</span><span
  lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p></o:=
p></span></p>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt'><b style=3D'mso-bidi-=
font-weight:
  normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast=
-language:
  CS'><o:p>&nbsp;</o:p></span></b></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DDE style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:DE'>sterreich</span></b><span lang=3DDE
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'><br>
  Orion Pharma GmbH</span><span lang=3DDE style=3D'mso-bidi-font-size:11.0p=
t;
  mso-ansi-language:DE;mso-fareast-language:CS'><o:p></o:p></span></p>
  <p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:9.=
0pt;
  margin-left:0in;tab-stops:28.35pt'><span lang=3DDE style=3D'font-size:11.=
0pt;
  mso-ansi-language:DE'>Tel: +49 40 899 6890</span><span lang=3DEN-GB
  style=3D'font-size:11.0pt;mso-ansi-language:EN-GB;mso-fareast-language:CS=
'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:7;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><b style=3D'ms=
o-bidi-font-weight:
  normal'><span lang=3DIT style=3D'font-size:11.0pt;mso-ansi-language:IT'>E=
spaa</span></b><span
  lang=3DIT style=3D'font-size:11.0pt;mso-ansi-language:IT'> <br>
  </span><span style=3D'font-size:11.0pt'>Orion Pharma S.L.</span><span
  style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><span
  style=3D'font-size:11.0pt'>Tel: + 34 91 &nbsp;599 86 01</span><span lang=
=3DEN-GB
  style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt'><b style=3D'mso-bidi-=
font-weight:
  normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast=
-language:
  CS'><o:p>&nbsp;</o:p></span></b></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>Polska</span></b><b style=3D'mso-bidi=
-font-weight:
  normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast=
-language:
  CS'><o:p></o:p></span></b></p>
  <p class=3DMsoNormal><span lang=3DSV style=3D'mso-bidi-font-size:11.0pt;m=
so-ansi-language:
  SV'>Orion Pharma Poland Sp z.o.o.</span><span lang=3DEN-GB style=3D'mso-b=
idi-font-size:
  11.0pt'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-bottom:9.0pt'><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>Tel.: + 48 22 8333177</span><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:CS'>=
<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:8;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><b style=3D'ms=
o-bidi-font-weight:
  normal'><span lang=3DFR style=3D'font-size:11.0pt;mso-ansi-language:FR'>F=
rance</span></b><span
  lang=3DFR style=3D'font-size:11.0pt;mso-ansi-language:FR'> <br>
  </span><span style=3D'font-size:11.0pt;mso-fareast-font-family:Calibri;
  mso-fareast-language:EN-GB'>Centre <span class=3DSpellE>Spcialits</span=
> <span
  class=3DSpellE>Pharmaceutiques</span></span><span lang=3DFR style=3D'font=
-size:
  11.0pt;mso-ansi-language:FR'><o:p></o:p></span></p>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><span
  style=3D'font-size:11.0pt;mso-fareast-font-family:Calibri;mso-fareast-lan=
guage:
  EN-GB'>Tel: + 33 (0) 1 47 04 80 46</span><span lang=3DFR style=3D'font-si=
ze:11.0pt;
  mso-ansi-language:FR'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt'><b style=3D'mso-bidi-=
font-weight:
  normal'><span lang=3DFR style=3D'mso-bidi-font-size:11.0pt;mso-ansi-langu=
age:
  FR;mso-fareast-language:CS'><o:p>&nbsp;</o:p></span></b></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;tab-=
stops:
  28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DIT
  style=3D'font-size:11.0pt;mso-ansi-language:IT'>Portugal</span></b><span
  lang=3DIT style=3D'font-size:11.0pt;mso-ansi-language:IT'><br>
  </span><span class=3DSpellE><span style=3D'font-size:11.0pt'>Orionfin</sp=
an></span><span
  style=3D'font-size:11.0pt'> <span class=3DSpellE>Unipessoal</span> <span
  class=3DSpellE>Lda</span></span><span lang=3DIT style=3D'font-size:11.0pt;
  mso-ansi-language:IT'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-2.25pt;margin-=
bottom:
  9.0pt;margin-left:0in'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.=
0pt'>Tel:
  + 351 21 154 68 20</span><span lang=3DFR style=3D'mso-bidi-font-size:11.0=
pt;
  mso-ansi-language:FR;mso-fareast-language:CS'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:9;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DFI style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:FI;mso-fareast-language:CS'>Hrvatska<o:p></o:p><=
/span></b></p>
  <p class=3DMsoNormal><strong><span lang=3DFI style=3D'mso-bidi-font-size:=
11.0pt;
  mso-ansi-language:FI;font-weight:normal;mso-bidi-font-weight:bold'>Orion
  Pharma d.o.o.<o:p></o:p></span></strong></p>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><s=
pan
  lang=3DFI style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI'>Tel:</=
span><span
  lang=3DFI style=3D'mso-ansi-language:FI'> +386&nbsp;(0) 1 600 8015</span>=
<span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:CS'>=
<o:p></o:p></span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:12.0pt;mso-line-height-rule:exa=
ctly;
  mso-layout-grid-align:none;text-autospace:none'><span class=3DSpellE><b><=
span
  lang=3DFR style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-languag=
e:FR'>Romnia</span></b></span><b><span
  lang=3DFR style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-languag=
e:FR'><o:p></o:p></span></b></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-layout-grid-align:no=
ne;
  text-autospace:none'><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;
  mso-ansi-language:IT'>Orion Corporation</span><span lang=3DFR style=3D'ms=
o-bidi-font-size:
  11.0pt;color:black;mso-ansi-language:FR'><o:p></o:p></span></p>
  <p class=3DMsoNormal><span lang=3DFR style=3D'mso-bidi-font-size:11.0pt;c=
olor:black;
  mso-ansi-language:FR'>Tel: +358 10 4261<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:10;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><b style=3D'mso-bidi-fo=
nt-weight:
  normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Ireland</s=
pan></b><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><br>
  Orion Pharma (Ireland) Ltd.</span><span lang=3DEN-GB style=3D'mso-bidi-fo=
nt-size:
  11.0pt;mso-fareast-language:CS'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>c/o <span class=3DSpellE>Allphar</spa=
n>
  Services Ltd.<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-hyphenate:none'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Tel: +353 1 428 7777<o:p=
></o:p></span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DIT
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'>Slovenija</span>=
</b><span
  lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT;mso-far=
east-language:
  CS'><o:p></o:p></span></p>
  <p class=3DMsoNormal><strong><span lang=3DFI style=3D'mso-bidi-font-size:=
11.0pt;
  mso-ansi-language:FI;font-weight:normal;mso-bidi-font-weight:bold'>Orion
  Pharma d.o.o.<o:p></o:p></span></strong></p>
  <p class=3DMsoNormal style=3D'margin-bottom:9.0pt'><span lang=3DFI
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI'>Tel:</span><span
  lang=3DFI style=3D'mso-ansi-language:FI'> +386&nbsp;(0) 1 600 8015</span>=
<b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt;mso-fareast-language:CS'><o:p></o:p></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:11;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt'><span class=3DSpellE>=
<b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>sland</span></b></span><b style=3D'mso-bidi-font-weight:normal'>=
<span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:CS'>=
<o:p></o:p></span></b></p>
  <p class=3DMsoNormal style=3D'line-height:normal'><span class=3DSpellE><s=
pan
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Vistor</span></span><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'> hf.<o:p></o:p></span></=
p>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><span class=3D=
SpellE><span
  style=3D'font-size:11.0pt'>Smi</span></span><span style=3D'font-size:11.=
0pt'>:
  +354 535 7000</span><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi=
-language:
  EN-GB;mso-fareast-language:CS'><o:p></o:p></span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none'><b style=3D'mso-bidi-fo=
nt-weight:
  normal'><span lang=3DSV style=3D'mso-bidi-font-size:11.0pt;mso-ansi-langu=
age:
  SV'>Slovensk republika</span></b><b style=3D'mso-bidi-font-weight:normal=
'><span
  lang=3DSV style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:SV;mso-far=
east-language:
  CS'><o:p></o:p></span></b></p>
  <p class=3DMsoNormal><strong><span lang=3DSV style=3D'mso-bidi-font-size:=
11.0pt;
  mso-ansi-language:SV;font-weight:normal;mso-bidi-font-weight:bold'>Orion
  Pharma s.r.o<o:p></o:p></span></strong></p>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-2.25pt;margin-=
bottom:
  9.0pt;margin-left:0in;line-height:normal'><span lang=3DSV style=3D'mso-an=
si-language:
  SV'>Tel: </span><span lang=3DSV><span style=3D'mso-spacerun:yes'></span>=
</span><span
  lang=3DSV style=3D'mso-ansi-language:SV'>+420 234 703 305</span><span lan=
g=3DIT
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT;mso-fareast-langu=
age:
  CS'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:12;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><b style=3D'ms=
o-bidi-font-weight:
  normal'><span lang=3DIT style=3D'font-size:11.0pt;mso-ansi-language:IT'>I=
talia</span></b><span
  lang=3DIT style=3D'font-size:11.0pt;mso-ansi-language:IT'><br>
  </span><span lang=3DFI style=3D'font-size:11.0pt;mso-ansi-language:FI'>Or=
ion
  Pharma S.r.l.<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-bottom:9.0pt;mso-hyphenate:none'><sp=
an
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Tel: + 39 02&nbsp;678761=
11</span><span
  lang=3DEL style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EL;mso-far=
east-language:
  CS'><o:p></o:p></span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DIT style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:IT'>Suomi/Finland<br>
  </span></b><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-la=
nguage:
  IT'>Orion Corporation</span><span lang=3DIT style=3D'mso-bidi-font-size:1=
1.0pt;
  mso-ansi-language:IT;mso-fareast-language:CS'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><s=
pan
  lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'>Puh./T=
el: +358
  10 4261</span><span lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ansi=
-language:
  DE;mso-fareast-language:CS'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:13;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEL
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EL'>&#922;&#973;&#96=
0;&#961;&#959;&#962;</span></b><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEL style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:EL;mso-fareast-language:CS'><o:p></o:p></span></=
b></p>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none;tab-stops:-.5in 28.35pt =
3.15in'><span
  lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'>Lifeph=
arma
  (ZAM) Ltd<o:p></o:p></span></p>
  <p class=3DMsoNormal><span class=3DSpellE><span lang=3DEN-GB style=3D'mso=
-bidi-font-size:
  11.0pt'>&#932;&#951;&#955;</span></span><span lang=3DDE style=3D'mso-bidi=
-font-size:
  11.0pt;mso-ansi-language:DE'>.: +357 22056300</span><span lang=3DDE
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE;mso-fareast-langu=
age:
  CS'><o:p></o:p></span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DDE style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:DE'>Sverige</span></b><span lang=3DDE
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'><br>
  Orion Pharma AB</span><span lang=3DDE style=3D'mso-bidi-font-size:11.0pt;
  mso-ansi-language:DE;mso-fareast-language:CS'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><s=
pan
  lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'>Tel: +=
46 8 623
  6440<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:14;mso-yfti-lastrow:yes;page-break-inside:avoid=
'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DFI
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI'>Latvija</span></=
b><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DFI style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:FI;mso-fareast-language:CS'><o:p></o:p></span></=
b></p>
  <p class=3DMsoNormal><span style=3D'mso-bidi-font-size:11.0pt;mso-ansi-la=
nguage:
  EN-US'>Orion Corporation<o:p></o:p></span></p>
  <p class=3DMsoNormal><span style=3D'mso-bidi-font-size:11.0pt;mso-ansi-la=
nguage:
  EN-US'>Orion Pharma <span class=3DSpellE>p&#257;rst&#257;vniec&#299;ba</s=
pan><o:p></o:p></span></p>
  <p class=3DMsoNormal><span style=3D'mso-bidi-font-size:11.0pt;mso-ansi-la=
nguage:
  EN-US'>Tel: +371 20028332<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none'><span style=3D'mso-bidi=
-font-size:
  11.0pt;mso-ansi-language:EN-US;mso-fareast-language:CS'><o:p>&nbsp;</o:p>=
</span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt'><b style=3D'mso-bidi-=
font-weight:
  normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>United Kin=
gdom</span></b><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:CS'>=
<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-hyphenate:none'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Orion Pharma (UK) Ltd.<o=
:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none'><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>Tel: +44 1635 520 300</span><span lan=
g=3DFI
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI;mso-fareast-langu=
age:
  CS'><o:p></o:p></span></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt'>This leaflet was last revised in.<o:p></o:p></span></b></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'mso-no-proof:yes'>Other sources of information<o:p></o:p></span></=
b></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Detailed
information on this medicine is available on the European Medicines Agency =
web
site: <a href=3D"http://www.ema.europa.eu">http://www.ema.europa.eu</a>. <o=
:p></o:p></span></p>

<span lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",=
serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB;mso-farea=
st-language:
EN-US;mso-bidi-language:AR-SA'><br clear=3Dall style=3D'page-break-before:a=
lways'>
</span>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><b style=3D=
'mso-bidi-font-weight:
normal'><span lang=3DEN-GB style=3D'color:black'>Package leaflet: Informati=
on for
the user</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><=
o:p></o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><b style=3D=
'mso-bidi-font-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;text-transfor=
m:uppercase'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span class=
=3DSpellE><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt'>Stalevo</span></b></span><b style=3D'mso-bidi-font-weight:normal'><=
span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>
150&nbsp;mg/37.5&nbsp;mg/200&nbsp;mg film-coated tablets<o:p></o:p></span><=
/b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DIT
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'>levodopa/carbidopa=
/entacapone<b
style=3D'mso-bidi-font-weight:normal'><span style=3D'text-transform:upperca=
se'><o:p></o:p></span></b></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DIT
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'><o:p>&nbsp;</o:p><=
/span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>Read
all of this leaflet carefully before you start taking this medicine because=
 it
contains important information for you.<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-list:l1 level1 lfo3'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>Keep
this leaflet. You may need to read it again.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-list:l1 level1 lfo3'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>If
you have any further questions, ask your doctor or pharmacist.<o:p></o:p></=
span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>-<span
style=3D'mso-tab-count:1'> </span>This medicine has been prescribed =
for
you only. Do not pass it on to others. It may harm them, even if their sign=
s of
illness are the same as yours.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l1 level1 lfo53'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-no-pr=
oof:
yes'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New =
Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&=
nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-no-proof:yes=
'>If you
get any side effects, talk to your doctor or pharmacist.</span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:red'> </span><span
lang=3DEN-GB style=3D'mso-no-proof:yes'>This includes any possible side eff=
ects not
listed in this leaflet. See section 4.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;<=
/o:p></span></p>

<p class=3DNormal11><span class=3DSpellE><b style=3D'mso-bidi-font-weight:n=
ormal'><span
lang=3DFR>What</span></b></span><b style=3D'mso-bidi-font-weight:normal'><s=
pan
lang=3DFR> <span class=3DSpellE>is</span> in <span class=3DSpellE>this</spa=
n> <span
class=3DSpellE>leaflet</span>:<o:p></o:p></span></b></p>

<p class=3DMsoNormal><span lang=3DEN-GB>1.<span style=3D'mso-tab-count:1'>=
 </span>What
<span class=3DSpellE>Stalevo</span> is and what it is used for</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>2.<span style=3D'mso-tab-count:1'>=
 </span><span
style=3D'mso-no-proof:yes'>What you need to know</span> before you take <sp=
an
class=3DSpellE>Stalevo</span></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>3.<span style=3D'mso-tab-count:1'>=
 </span>How
to take <span class=3DSpellE>Stalevo</span></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>4.<span style=3D'mso-tab-count:1'>=
 </span>Possible
side effects</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>5<span style=3D'mso-tab-count:1'>=
 </span>How
to store <span class=3DSpellE>Stalevo</span></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>6.<span style=3D'mso-tab-count:1'>=
 </span><span
style=3D'mso-no-proof:yes'>Contents of the pack and other information</span=
></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'text-transform:uppercase'>1.<span style=3D'mso-tab-count:1'>=
 </span></span><span
lang=3DEN-GB>What <span class=3DSpellE>Stalevo</span> is and what it is use=
d for<span
style=3D'text-transform:uppercase'><o:p></o:p></span></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><b style=3D'mso-bidi-font=
-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;<=
/o:p></span></b></p>

<p class=3DMsoBodyText3 align=3Dleft style=3D'text-align:left;line-height:n=
ormal'><span
class=3DSpellE><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;font-w=
eight:
normal;font-style:normal'>Stalevo</span></span><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-style:normal'>
contains three active substances (levodopa, carbidopa and entacapone) in one
film-coated tablet. <span class=3DSpellE>Stalevo</span> is used for the tre=
atment
of Parkinsons disease. <o:p></o:p></span></p>

<p class=3DMsoBodyText3 align=3Dleft style=3D'text-align:left;line-height:n=
ormal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-sty=
le:normal'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Parkinsons disease is cau=
sed by
low levels of a substance called dopamine in the brain. Levodopa increases =
the
amount of dopamine and hence reduces the symptoms of Parkinsons disease.
Carbidopa and entacapone improve the <span class=3DSpellE>antiparkinson</sp=
an>
effects of levodopa. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'text-transform:uppercase'>2.<span style=3D'mso-tab-count:1'>=
 </span></span><span
lang=3DEN-GB>What you need to know before you take <span class=3DSpellE>Sta=
levo</span><span
style=3D'text-transform:uppercase'><o:p></o:p></span></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>Do
not take <span class=3DSpellE>Stalevo</span> if you:<o:p></o:p></span></b><=
/p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l42 level1 lfo17;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>are allergic to levodopa, carbidopa or entacapone,=
 or
any of the other ingredients of this medicine </span><span style=3D'font-si=
ze:
11.0pt;mso-no-proof:yes'>(listed in section 6)</span><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l42 level1 lfo17;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>have narrow-angle glaucoma (an eye disorder)<o:p><=
/o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l42 level1 lfo17;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>have a tumour of the adrenal gland<o:p></o:p></spa=
n></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l42 level1 lfo17;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>are taking certain medicines for treating depressi=
on (</span><span
style=3D'font-size:11.0pt'>combinations of </span><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>selective MAO-A and MAO-B
inhibitors, or non-selective MAO-inhibitors)<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l42 level1 lfo17;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>have ever had neuroleptic malignant syndrome (NMS 
this is a rare reaction to medicines used to treat severe mental disorders)=
<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l42 level1 lfo17;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>have ever had non-traumatic rhabdomyolysis (a rare
muscle disorder)<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l42 level1 lfo17;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>have a severe liver disease. <o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-la=
nguage:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'mso-no-proof:yes'>Warnings and precautions</span><span lang=3DEN-G=
B><o:p></o:p></span></b></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0=
pt'>Talk
to your doctor or pharmacist before taking <span class=3DSpellE>Stalevo</sp=
an> if
you have or have ever had</span></u><span lang=3DEN-GB style=3D'mso-bidi-fo=
nt-size:
11.0pt'>:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>a
heart attack or any other diseases of the heart including cardiac arrhythmi=
as,
or of the blood vessels<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>asthma
or any other disease of the lungs<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>a
liver problem, because your dose may need to be adjusted<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>kidney
or hormone-related diseases<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>stomach
ulcers or convulsions<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>if
you experience prolonged diarrhoea consult your doctor as it may be a sign =
of
inflammation of the colon<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>any
form of severe mental disorder like psychosis<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>chronic
wide-angle glaucoma, because your dose may need to be adjusted and the pres=
sure
in your eyes may need to be monitored.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0=
pt'>Consult
your doctor if you are currently taking</span></u><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>antipsychotics
(medicines used to treat psychosis)<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>a
medicine which may cause low blood pressure when rising from a chair or bed.
You should be aware that <span class=3DSpellE>Stalevo</span> may make these
reactions worse.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0=
pt'>Consult
your doctor if during the treatment with <span class=3DSpellE>Stalevo</span=
> you</span></u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>notice
that your muscles get very rigid or jerk violently, or if you get tremors,
agitation, confusion, fever, rapid pulse, or wide fluctuations in your blood
pressure. If any of this happens, <b style=3D'mso-bidi-font-weight:normal'>=
contact
your doctor immediately</b><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>feel
depressed, have suicidal thoughts, or notice unusual changes in your behavi=
our<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>find
yourself suddenly falling asleep, or if you feel very drowsy. If this happe=
ns,
you should not drive or use any tools or machines (see also section 'Driving
and using machines')<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>notice
that uncontrolled movements begin or get worse after you started to take <s=
pan
class=3DSpellE>Stalevo</span>. If this happens, your doctor may need to cha=
nge
the dose of your <span class=3DSpellE>antiparkinson</span> medicine <o:p></=
o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>experience
diarrhoea: monitoring of your weight is recommended in order to avoid poten=
tially
excessive weight loss<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>experience
progressive anorexia, asthenia (weakness, exhaustion) and weight decrease w=
ithin
a relatively short period of time. If this happens, a general medical
evaluation including liver function should be considered<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>feel
the need to stop using <span class=3DSpellE>Stalevo</span>, see section 'If=
 you
stop taking <span class=3DSpellE>Stalevo</span>'.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Tell your
doctor if you or your family/carer notices you are developing addiction-like
symptoms leading to craving for large doses of <span class=3DSpellE>Stalevo=
</span>
and other medicines used to treat Parkinsons disease.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span style=3D'mso-bidi-font-size:11.0pt;mso-ansi-lang=
uage:
EN-US'>Tell your doctor if you or your family/<span class=3DSpellE>carer</s=
pan>
notices you are developing urges or cravings to behave in ways that are unu=
sual
for you or you cannot resist the impulse, drive or temptation to carry out
certain activities that could harm yourself or others. These <span
class=3DSpellE>behaviours</span> are called impulse control disorders and c=
an
include addictive gambling, excessive eating or spending, an abnormally high
sex drive or a preoccupation with an increase in sexual thoughts or feeling=
s. <u>Your
doctor may need to review your treatments.</u> <o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Your
doctor may take some regular laboratory tests during a long term treatment =
with
<span class=3DSpellE>Stalevo</span>.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>If you
must undergo surgery, please tell your doctor that you are using <span
class=3DSpellE>Stalevo</span>.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span class=3DSpellE><span lang=3DEN-GB style=3D'mso-b=
idi-font-size:
11.0pt'>Stalevo</span></span><span lang=3DEN-GB style=3D'mso-bidi-font-size=
:11.0pt'>
is not recommended to be used for treatment of extrapyramidal symptoms (e.g.
involuntary movements, shaking, muscle rigidity and muscle contractions</sp=
an><span
lang=3DEN style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EN'>)</span>=
<span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'> caused by other medicines=
.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'mso-bidi-font-size:11.0pt'>Children </span><span lang=3DEN-GB
style=3D'color:black'>and adolescents<o:p></o:p></span></b></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Experience
with <span class=3DSpellE>Stalevo</span> in patients under 18 years is limi=
ted.
Therefore, the use of <span class=3DSpellE>Stalevo</span> in children or
adolescents is not recommended.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-la=
nguage:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>Other
medicines and <span class=3DSpellE>Stalevo</span><o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoBodyText style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-style:normal'>Te=
ll
your doctor or pharmacist if you are taking, have recently taken or might t=
ake any
other medicines.<o:p></o:p></span></p>

<p class=3DMsoBodyText style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-style:normal'><o=
:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Do not take <span class=3D=
SpellE>Stalevo</span>
if you are taking certain medicines for treating depression (combinations of
selective MAO-A and MAO-B inhibitors, or non-selective MAO inhibitors).<o:p=
></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal'><span
class=3DSpellE><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Stale=
vo</span></span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'> may increase the effects =
and side
effects of certain medicines. These include:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>medicines
used to treat depression such as moclobemide, amitriptyline, desipramine,
maprotiline, venlafaxine and paroxetine <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>-<span
style=3D'mso-tab-count:1'> </span><span class=3DSpellE>rimiterole</s=
pan> and
isoprenaline, used to treat respiratory diseases<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>adrenaline,
used </span><span lang=3DPT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-lan=
guage:
PT'>for severe allergic reactions</span><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
11.0pt'> <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>noradrenaline,
dopamine and dobutamine, used to treat heart diseases and low blood pressur=
e<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>-<span
style=3D'mso-tab-count:1'> </span>alpha-methyldopa, used to treat hi=
gh
blood pressure<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>-<span
style=3D'mso-tab-count:1'> </span>apomorphine, which is used to treat
Parkinsons disease. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;tab-sto=
ps:17.1pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;tab-st=
ops:28.35pt'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>The effects=
 of <span
class=3DSpellE>Stalevo</span> may be weakened by certain medicines. These
include: <o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-la=
nguage:
EN-GB'>-<span style=3D'mso-tab-count:1'> </span>dopamine antagonists=
 used
to treat mental disorders, nausea and vomiting<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l49 level1 lfo18;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>phenytoin, used to prevent convulsions <o:p></o:p>=
</span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l49 level1 lfo18;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>papaverine used to relax the muscles.<o:p></o:p></=
span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;tab-st=
ops:28.35pt'><span
class=3DSpellE><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-langua=
ge:EN-GB'>Stalevo</span></span><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'> may make i=
t harder
for you to digest iron. Therefore, do not take <span class=3DSpellE>Stalevo=
</span>
and iron supplements at the same time. After taking one of them, wait at le=
ast
2 to 3 hours before taking the other.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;tab-st=
ops:28.35pt'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal><span class=3DSpellE><b style=3D'mso-bidi-font-weight:=
normal'><span
lang=3DEN-GB>Stalevo</span></b></span><b style=3D'mso-bidi-font-weight:norm=
al'><span
lang=3DEN-GB> with food and drink<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoBodyText style=3D'text-align:justify;line-height:normal;tab-s=
tops:
28.35pt'><span class=3DSpellE><span lang=3DEN-GB style=3D'mso-bidi-font-siz=
e:11.0pt;
font-weight:normal;font-style:normal'>Stalevo</span></span><span lang=3DEN-=
GB
style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-style:normal'> m=
ay be
taken with or without food. For some patients, <span class=3DSpellE>Stalevo=
</span>
may not be well absorbed if it is taken with, or shortly after eating
protein-rich food (such as meats, fish, dairy products, seeds and nuts).
Consult your doctor if you think this applies to you.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;tab-st=
ops:28.35pt'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>Pregnancy,
breast-feeding and fertility<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoBodyText style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-style:normal'>If=
 you
are pregnant or breast-feeding, think you may be pregnant or are planning to
have a baby, ask your doctor or pharmacist for advice before taking this
medicine. <o:p></o:p></span></p>

<p class=3DMsoBodyText style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-style:normal'><o=
:p>&nbsp;</o:p></span></p>

<p class=3DMsoBodyText style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-style:normal'>You
should not breast-feed during treatment with <span class=3DSpellE>Stalevo</=
span>.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>Driving
and using machines<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span class=
=3DSpellE><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Stalevo</span></span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'> may lower your blood pres=
sure,
which may make you feel light-headed or dizzy. Therefore, be particularly
careful when you drive or when you use any tools or machines.<o:p></o:p></s=
pan></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>If you feel very drowsy, or if you some=
times
find yourself suddenly falling asleep, wait until you feel fully awake again
before driving or doing anything else that requires you to be alert. Otherw=
ise,
you may put yourself and others at risk of serious injury or death.<o:p></o=
:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span class=
=3DSpellE><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt'>Stalevo</span></b></span><b style=3D'mso-bidi-font-weight:normal'><=
span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'> contains sucrose<o:p></o:=
p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span class=
=3DSpellE><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Stalevo</span></span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'> contains sucrose
(1.9&nbsp;mg/tablet). If you have been told by your doctor that you have
intolerance to some sugars, contact your doctor before taking this medicinal
product.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'text-transform:uppercase'>3.<span style=3D'mso-tab-count:1'>=
 </span></span><span
lang=3DEN-GB>How to take <span class=3DSpellE>Stalevo</span><span style=3D'=
text-transform:
uppercase'><o:p></o:p></span></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Always take this medicine =
exactly
as your doctor or pharmacist has told you. Check with your doctor or pharma=
cist
if you are not sure.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>For adults and elderly</sp=
an></u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:skip'><b style=3D'mso-bidi-font-weight:normal'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'mso-bidi-f=
ont-size:
11.0pt'>-<span style=3D'mso-tab-count:1'> </span></span></i></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Your doctor will tell you =
exactly
how many tablets of <span class=3DSpellE>Stalevo</span> to take each day. <=
o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l32 level1 lfo21'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-family:"Arial",sans-serif;mso-farea=
st-font-family:
Arial'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times Ne=
w Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp=
;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>The
tablets are not intended to be split or broken into smaller pieces.<o:p></o=
:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l32 level1 lfo21'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-family:"Arial",sans-serif;mso-farea=
st-font-family:
Arial'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times Ne=
w Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp=
;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>You
should take only one tablet each time.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l32 level1 lfo21'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-family:"Arial",sans-serif;mso-farea=
st-font-family:
Arial'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times Ne=
w Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp=
;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>Depending
on how you respond to treatment, your doctor may suggest a higher or lower
dose. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l32 level1 lfo21'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt;font-family:"Arial",sans-serif;mso-fareast-font-family:Arial'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>If
you are taking <span class=3DSpellE>Stalevo</span>
50&nbsp;mg/12.5&nbsp;mg/200&nbsp;mg, 75&nbsp;mg/18.75&nbsp;mg/200&nbsp;mg,
100&nbsp;mg/25&nbsp;mg/200&nbsp;mg, 125&nbsp;mg/31.25&nbsp;mg/200&nbsp;mg or
150&nbsp;mg/37.5&nbsp;mg/200&nbsp;mg tablets, do not take more than 10 tabl=
ets
each day.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;text-align:justify;line-he=
ight:
normal;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt=
'>Talk
to your doctor or pharmacist if you think the effect of <span class=3DSpell=
E>Stalevo</span>
is too strong or too weak, or if you experience possible side effects.<o:p>=
</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;text-align:justify;line-he=
ight:
12.0pt;mso-list:skip'><span lang=3DEN-GB><!--[if gte vml 1]><v:shape id=3D"=
_x0000_i1037"
 type=3D"#_x0000_t75" style=3D'width:468pt;height:91.5pt'>
 <v:imagedata src=3D"Stalevo_clean_files/image009.emz" o:title=3D""/>
</v:shape><![endif]--><![if !vml]><img border=3D0 width=3D624 height=3D122
src=3D"Stalevo_clean_files/image010.png" v:shapes=3D"_x0000_i1037"><![endif=
]></span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>If
you take more <span class=3DSpellE>Stalevo</span> than you should<o:p></o:p=
></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>If you have accidentally taken more <sp=
an
class=3DSpellE>Stalevo</span> tablets than you should, talk to your doctor =
or
pharmacist immediately. In case of an overdose you may feel confused or
agitated, your heart rate may be slower or faster than normal or the colour=
 of
your skin, tongue, eyes or urine may change.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>If
you forget to take <span class=3DSpellE>Stalevo</span><o:p></o:p></span></b=
></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>Do not take a double dose to make up fo=
r a
forgotten tablet.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p><span style=3D'text-d=
ecoration:
 none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>If it is more than 1 hour =
until
your next dose</span></u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.=
0pt'>: <o:p></o:p></span></p>

<p class=3DMsoBodyText style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-style:normal'>Ta=
ke one
tablet as soon as you remember, and the next tablet at the normal time. <o:=
p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>If it is less than 1 hour =
until
your next dose</span></u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.=
0pt'>: <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Take a tablet as soon as y=
ou
remember, wait 1 hour, then take another tablet. After that carry on as nor=
mal.
<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;background:yellow;mso-highl=
ight:
yellow'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Always leave at least an h=
our
between <span class=3DSpellE>Stalevo</span> tablets, to avoid possible side
effects.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>If
you stop taking <span class=3DSpellE>Stalevo</span> <o:p></o:p></span></b><=
/p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Do not stop taking <span
class=3DSpellE>Stalevo</span> unless your doctor tells you to. In such a ca=
se
your doctor may need to adjust your other <span class=3DSpellE>antiparkinso=
n</span>
medicines, especially levodopa, to give sufficient control of your symptoms=
. If
you suddenly stop taking of <span class=3DSpellE>Stalevo</span> and other
antiparkinsonian medicines it may result in unwanted side effects. <o:p></o=
:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>If you have any further qu=
estions
on the use of this medicine, ask your doctor or pharmacist.<o:p></o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'text-transform:uppercase'>4.<span style=3D'mso-tab-count:1'>=
 </span></span><span
lang=3DEN-GB>Possible side effects<span style=3D'text-transform:uppercase'>=
<o:p></o:p></span></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-1.4pt;line-height:normal;mso-ou=
tline-level:
1;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:=
p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.4pt;line-height:normal;mso-ou=
tline-level:
1;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Lik=
e all
medicines, this medicine can cause side effects, although not everybody gets
them. Many of the side effects can be relieved by adjusting the dose. <o:p>=
</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.4pt;line-height:normal;mso-ou=
tline-level:
1;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:=
p>&nbsp;</o:p></span></p>

<p class=3DText style=3D'margin-top:0in'><span style=3D'font-size:11.0pt'>I=
f you
during the treatment with <span class=3DSpellE>Stalevo</span> experience the
following symptoms, <b style=3D'mso-bidi-font-weight:normal'>contact your d=
octor
immediately</b>: <o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:25.65pt;margin-bottom:.0001pt;text-indent:-25.65pt;mso-list:l50=
 level1 lfo26'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-size:11.0pt'>Your muscle=
s get
very rigid or jerk violently, you get tremors, agitation, confusion, fever,
rapid pulse, or wide fluctuations in your blood pressure. These can be symp=
toms
</span><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB=
'>of
neuroleptic malignant syndrome (NMS, a rare severe reaction to medicines us=
ed
to treat disorders of the central nervous system) or rhabdomyolysis (a rare
severe muscle disorder).<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:25.65pt;margin-bottom:.0001pt;text-indent:-25.65pt;mso-list:l37=
 level1 lfo27'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>Allergic reaction, the signs may include hives (ne=
ttle
rash), itching, rash, swelling of your face, lips, tongue or throat. This m=
ay
cause difficulties in breathing or swallowing.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.4pt;line-height:normal;mso-ou=
tline-level:
1;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:=
p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><u><span lang=3DEN-GB>Very common (may affect more tha=
n 1 in
10 people)<o:p></o:p></span></u></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>uncontrolled movements (dyskinesias)<o:p></o:p></s=
pan></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>feeling sick (nausea)<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>harmless reddish-brown discolouration of urine<o:p=
></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>muscle pain<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>diarrhoea<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><span lang=3DEN-=
GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span>=
</p>

<p class=3DMsoNormal><u><span lang=3DEN-GB>Common (may affect up to 1 in 10=
 people)<o:p></o:p></span></u></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>light-headedness or fainting due to low blood
pressure, high blood pressure<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>worsening of Parkinsons symptoms, dizziness,
drowsiness<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>vomiting, abdominal pain and discomfort, heartburn=
, dry
mouth, constipation<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>inability to sleep, hallucinations, confusion abno=
rmal
dreams (including nightmares), tiredness<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>mental changes  including problems with memory,
anxiety and depression (possibly with thoughts of suicide) <o:p></o:p></spa=
n></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-size:11.0pt'>heart or ar=
tery
disease events (e.g. chest pain), irregular heart rate or rhythm </span><sp=
an
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p></o:p>=
</span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>more frequent falling <o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>shortness of breath <o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>increased sweating, rashes<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>muscle cramps, swelling of legs<o:p></o:p></span><=
/p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>blurred vision<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>anaemia<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>decreased appetite, decreased weight<o:p></o:p></s=
pan></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>headache, joint pain<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>urinary tract infection<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;tab-st=
ops:28.35pt'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p>&nbsp;=
</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;tab-st=
ops:28.35pt'><u><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>Uncommon </=
span></u><u><span
style=3D'font-size:11.0pt;color:black'>(may affect up to 1 in 100&nbsp;peop=
le)</span></u><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p></o:p>=
</span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>heart attack<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>bleeding in the gut<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>changes in the blood cell count which may result i=
n bleeding,
abnormal liver function tests<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>convulsions<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>feeling agitated<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>psychotic symptoms<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>colitis (inflammation of the colon)<o:p></o:p></sp=
an></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span class=3DSpellE><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>discolourations</span></=
span><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'> other than=
 urine
(e.g. skin, nail, hair, sweat)<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>swallowing difficulties<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-size:11.0pt'>inability to
urinate</span><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-languag=
e:EN-GB'><o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left'><u><s=
pan
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>Not known (=
cannot
be estimated from the available data)<o:p></o:p></span></u></p>

<p class=3DText style=3D'margin-top:0in'><span lang=3DEN-GB style=3D'font-s=
ize:11.0pt;
mso-ansi-language:EN-GB'>Craving for large doses of <span class=3DSpellE>St=
alevo</span>
in excess of that required to control motor symptoms, known as dopamine
dysregulation syndrome. Some patients experience severe abnormal involuntary
movements (dyskinesias), mood swings or other side effects after taking lar=
ge
doses of <span class=3DSpellE>Stalevo</span>.<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in'><span lang=3DEN-GB style=3D'font-s=
ize:11.0pt;
mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText style=3D'margin-top:0in'><u><span lang=3DEN-GB style=3D'fon=
t-size:11.0pt;
mso-ansi-language:EN-GB'>The following side effects have also been reported=
</span></u><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>: <o:p></o:=
p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l4 =
level1 lfo22;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>hepatitis </span><span style=3D'font-size:11.0pt'>=
(inflammation
of the liver)</span><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-l=
anguage:
EN-GB'> <o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l4 =
level1 lfo22;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>itching<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in'><span lang=3DEN-GB style=3D'font-s=
ize:11.0pt;
mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:4.8pt;mso-pagination:none'><u><s=
pan
lang=3DEN-GB style=3D'color:black'>You may experience the following side ef=
fects: <o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:4.8pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-pagination:none;mso-list:l10 level1 lfo49;tab-stops:28.35pt'><![=
if !supportLists]><span
lang=3DEN-GB style=3D'font-family:"Arial",sans-serif;mso-fareast-font-famil=
y:Arial;
color:black'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Ti=
mes New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp=
;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
color:black'>Inability to resist the impulse to perform an action that coul=
d be
harmful, which may include:</span><span lang=3DEN-GB style=3D'color:black'>=
<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:4.8pt;margin-bott=
om:0in;
margin-left:.75in;margin-bottom:.0001pt;text-indent:-.25in;line-height:norm=
al;
mso-pagination:none;mso-list:l9 level2 lfo51;tab-stops:list .75in'><![if !s=
upportLists]><span
lang=3DEN-GB style=3D'font-family:"Arial",sans-serif;mso-fareast-font-famil=
y:Arial;
color:black'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Ti=
mes New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
color:black'>strong impulse to gamble excessively despite serious personal =
or family
consequences</span><span lang=3DEN-GB style=3D'color:black'><o:p></o:p></sp=
an></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:4.8pt;margin-bott=
om:0in;
margin-left:.75in;margin-bottom:.0001pt;text-indent:-.25in;line-height:norm=
al;
mso-pagination:none;mso-list:l9 level2 lfo51;tab-stops:list .75in'><![if !s=
upportLists]><span
lang=3DEN-GB style=3D'font-family:"Arial",sans-serif;mso-fareast-font-famil=
y:Arial;
color:black'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Ti=
mes New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
color:black'>altered or increased sexual interest and behaviour of signific=
ant
concern to you or to others, for example, an increased sexual drive</span><=
span
lang=3DEN-GB style=3D'color:black'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:4.8pt;margin-bott=
om:0in;
margin-left:.75in;margin-bottom:.0001pt;text-indent:-.25in;line-height:norm=
al;
mso-pagination:none;mso-list:l9 level2 lfo51;tab-stops:list .75in'><![if !s=
upportLists]><span
lang=3DEN-GB style=3D'font-family:"Arial",sans-serif;mso-fareast-font-famil=
y:Arial;
color:black'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Ti=
mes New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
color:black'>uncontrollable excessive shopping or spending</span><span
lang=3DEN-GB style=3D'color:black'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:4.8pt;margin-bott=
om:0in;
margin-left:.75in;margin-bottom:.0001pt;text-indent:-.25in;line-height:norm=
al;
mso-pagination:none;mso-list:l9 level2 lfo51;tab-stops:list .75in'><![if !s=
upportLists]><span
lang=3DEN-GB style=3D'font-family:"Arial",sans-serif;mso-fareast-font-famil=
y:Arial;
color:black'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Ti=
mes New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
color:black'>binge eating (eating large amounts of food in a short time per=
iod)
or compulsive eating (eating more food than normal and more than is needed =
to
satisfy your hunger).</span><span lang=3DEN-GB style=3D'color:black'><o:p><=
/o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:4.8pt;mso-pagination:none'><span
lang=3DEN-GB style=3D'color:black'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:4.8pt;mso-pagination:none;tab-st=
ops:
0in'><span lang=3DEN-GB style=3D'color:black'>Tell your doctor if you exper=
ience
any of these behaviours; they will discuss ways of managing or reducing the
symptoms.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;mso-li=
st:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-out=
line-level:
1;mso-list:skip'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>Reporting of side effects<o:p></o:p></s=
pan></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-outline-level:1;mso-li=
st:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>If you get any side effect=
s, talk
to your doctor or pharmacist. This includes any possible side effects not
listed in this leaflet. You can also report side effects directly via <span
style=3D'background:silver;mso-highlight:silver'>the national reporting sys=
tem
listed in <a
href=3D"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_fo=
rm/2013/03/WC500139752.doc">Appendix
V</a></span>. By reporting side <span class=3DSpellE>effects you</span> can=
 help
provide more information on the safety of this medicine.<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'text-transform:uppercase'>5.<span style=3D'mso-tab-count:1'>=
 </span></span><span
lang=3DEN-GB>How to store <span class=3DSpellE>Stalevo</span><span
style=3D'text-transform:uppercase'><o:p></o:p></span></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-out=
line-level:
1;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Kee=
p this
medicine out of the sight and reach of children.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Do not use this medicine a=
fter the
expiry date which is stated on the bottle and the carton after EXP. The exp=
iry
date refers to the last day of that month.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>This medicinal product doe=
s not
require any special storage conditions.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Do not </=
span><span
lang=3DEN-GB style=3D'mso-no-proof:yes'>throw away any medicines</span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'> via wastewater or househo=
ld
waste. Ask your pharmacist how to </span><span lang=3DEN-GB style=3D'mso-no=
-proof:
yes'>throw away</span><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt=
'> of
medicines you no longer use. These measures will help to protect the
environment.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'text-transform:uppercase'>6.<span style=3D'mso-tab-count:1'>=
 </span></span><span
lang=3DEN-GB>Contents of the pack and other information<span style=3D'text-=
transform:
uppercase'><o:p></o:p></span></span></b></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><b style=3D'mso-bidi-font=
-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>What <span
class=3DSpellE>Stalevo</span> contains<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:no=
rmal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-list:l14 level1 lfo7;tab-stops:list 28.35pt'><![if !supportLists=
]><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ig=
nore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>The
active substances of <span class=3DSpellE>Stalevo</span> are levodopa, carb=
idopa
and entacapone.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo7;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>Each <span class=3DSpellE>Stalevo</span>
150&nbsp;mg/37.5&nbsp;mg/200&nbsp;mg tablet contains 150&nbsp;mg of levodop=
a,
37.5&nbsp;mg of carbidopa and 200&nbsp;mg of entacapone.<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-list:l14 level1 lfo7;tab-stops:list 28.35pt'><![if !supportLists=
]><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ig=
nore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>The
other ingredients in the tablet core are croscarmellose sodium, magnesium
stearate, maize starch, mannitol (E421) and povidone (E1201).<o:p></o:p></s=
pan></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-list:l14 level1 lfo7;tab-stops:list 28.35pt'><![if !supportLists=
]><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ig=
nore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>The
ingredients in the film-coating are glycerol (85 per cent) (E422), <span
class=3DSpellE>hypromellose</span>, magnesium stearate, polysorbate 80, red=
 iron
oxide (E172), sucrose, titanium dioxide (E171), and yellow iron oxide (E172=
).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:27.0pt;text-indent:-27.0pt;line-h=
eight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;<=
/o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:27.0pt;text-indent:-27.0pt;line-h=
eight:
normal'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>What <span class=3DSpellE>Stalevo</span=
> looks
like and contents of the pack<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-left:27.0pt;text-indent:-27.0pt;line-h=
eight:
normal'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt'><span class=3DSpellE><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Stalevo</span></span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>
150&nbsp;mg/37.5&nbsp;mg/200&nbsp;mg: brownish or greyish red,
elongated-ellipse shaped, unscored film-coated tablets marked with LCE 150=
 on
one side.<o:p></o:p></span></p>

<p class=3DMsoEndnoteText><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoEndnoteText><span class=3DSpellE><span lang=3DEN-GB style=3D'=
mso-bidi-font-size:
11.0pt'>Stalevo</span></span><span lang=3DEN-GB style=3D'mso-bidi-font-size=
:11.0pt'>
comes in six different pack sizes (10, 30, 100, 130, 175 or 250 tablets). N=
ot
all pack sizes may be marketed.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:27.0pt;text-indent:-27.0pt;line-h=
eight:
normal'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>Marketing
Authorisation Holder</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoEndnoteText><span lang=3DIT style=3D'mso-bidi-font-size:11.0p=
t;
mso-ansi-language:IT'>Orion Corporation<o:p></o:p></span></p>

<p class=3DMsoEndnoteText><span lang=3DIT style=3D'mso-bidi-font-size:11.0p=
t;
mso-ansi-language:IT'>Orionintie 1<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DIT style=3D'=
mso-bidi-font-size:
11.0pt;mso-ansi-language:IT'>FI-02200 Espoo<o:p></o:p></span></p>

<p class=3DMsoEndnoteText><span lang=3DIT style=3D'mso-bidi-font-size:11.0p=
t;
mso-ansi-language:IT'>Finland<o:p></o:p></span></p>

<p class=3DMsoEndnoteText><span lang=3DIT style=3D'mso-bidi-font-size:11.0p=
t;
mso-ansi-language:IT'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-2.25pt'><b style=3D'mso-bidi-fo=
nt-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Manufacturer=
<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-2.25pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>Orion Corporation Orion Pharma<o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-2.25pt'><span class=3DSpellE><s=
pan
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Joensuunkatu</span></span>=
<span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>&nbsp;7<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'margin-right:-2.25pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>FI-24100&nbsp;Salo<o:p></o:p></span></p>

<p class=3DMsoEndnoteText><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'>Finland</span><span
lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'><o:p></o=
:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DIT style=3D'=
mso-bidi-font-size:
11.0pt;mso-ansi-language:IT'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-2.25pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold'>Orion Corpora=
tion Orion
Pharma<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-2.25pt'><span class=3DSpellE><s=
pan
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold'>=
Orionintie</span></span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold'>=
&nbsp;1<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-2.25pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold'>FI-02200&nbsp=
;Espoo<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold'>Finland<o:p><=
/o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DIT style=3D'=
mso-bidi-font-size:
11.0pt;mso-ansi-language:IT'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>For any information about =
this
medicine, please contact the local representative of the Marketing
Authorisation Holder.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<table class=3DMsoNormalTable border=3D0 cellspacing=3D0 cellpadding=3D0 wi=
dth=3D628
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;mso-yfti-tbll=
ook:
 1184;mso-padding-alt:0in 5.4pt 0in 5.4pt'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;page-break-inside:avoid=
'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal><span class=3DSpellE><b><span lang=3DEN-GB style=3D'=
mso-bidi-font-size:
  11.0pt;font-family:"TimesNewRomanPS-BoldMT",serif;mso-bidi-font-family:Ti=
mesNewRomanPS-BoldMT;
  mso-fareast-language:EN-GB'>Belgi</span></b></span><b><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt;font-family:"TimesNewRomanPS-BoldMT",s=
erif;
  mso-bidi-font-family:TimesNewRomanPS-BoldMT;mso-fareast-language:EN-GB'>/=
Belgique/<span
  class=3DSpellE>Belgien</span></span></b><span lang=3DFR style=3D'mso-bidi=
-font-size:
  11.0pt;mso-ansi-language:FR'><br>
  </span><strong><span lang=3DEN-GB style=3D'font-weight:normal;mso-bidi-fo=
nt-weight:
  bold'>Orion Pharma BVBA/SPRL</span></strong><strong><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt;font-weight:normal'><o:p></o:p></span>=
</strong></p>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><span class=3D=
SpellE><span
  style=3D'font-size:11.0pt'>Tl</span></span><span style=3D'font-size:11.0=
pt'>/Tel:
  +32 (0)15 64 10 20</span><span lang=3DFR style=3D'font-size:11.0pt;mso-an=
si-language:
  FR'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt'><b style=3D'mso-bidi-=
font-weight:
  normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast=
-language:
  CS'><o:p>&nbsp;</o:p></span></b></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DFI
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI'>Lietuva</span></=
b><span
  lang=3DFI style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI;mso-far=
east-language:
  CS'><o:p></o:p></span></p>
  <p class=3DMsoNormal><span lang=3DFI style=3D'mso-bidi-font-size:11.0pt;m=
so-ansi-language:
  FI'>UAB Orion Pharma<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none'><span lang=3DFI style=
=3D'mso-bidi-font-size:
  11.0pt;mso-ansi-language:FI'>Tel. +370 5&nbsp;276 9499</span><span lang=
=3DFI
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI;mso-fareast-langu=
age:
  CS'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:1;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal><span class=3DSpellE><b style=3D'mso-bidi-font-weigh=
t:normal'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black'>&#1041;&#109=
8;&#1083;&#1075;&#1072;&#1088;&#1080;&#1103;</span></b></span><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DFR style=3D'mso-bidi-f=
ont-size:
  11.0pt;color:black;mso-ansi-language:FR'><o:p></o:p></span></b></p>
  <p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;m=
so-ansi-language:
  IT'>Orion Pharma Poland Sp z.o.o.<o:p></o:p></span></p>
  <p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;m=
so-ansi-language:
  IT'>Tel.: + 48&nbsp;22&nbsp;8333177<o:p></o:p></span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DDE
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'>Luxembourg/Luxem=
burg</span></b><span
  lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'><br>
  </span><strong><span lang=3DEN-GB style=3D'font-weight:normal;mso-bidi-fo=
nt-weight:
  bold'>Orion Pharma BVBA/SPRL</span></strong><strong><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt;font-weight:normal'><o:p></o:p></span>=
</strong></p>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><span class=3D=
SpellE><span
  style=3D'font-size:11.0pt'>Tl</span></span><span style=3D'font-size:11.0=
pt'>/Tel:
  +32 (0)15 64 10 20</span><span lang=3DFR style=3D'font-size:11.0pt;mso-an=
si-language:
  FR'><o:p></o:p></span></p>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DSV
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:SV'><o:p>&nbsp;</o:p=
></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:2;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none'><b style=3D'mso-bidi-fo=
nt-weight:
  normal'><span lang=3DSV style=3D'mso-bidi-font-size:11.0pt;mso-ansi-langu=
age:
  SV'>&#268;esk republika</span></b><span lang=3DSV style=3D'mso-bidi-font=
-size:
  11.0pt;mso-ansi-language:SV;mso-fareast-language:CS'><o:p></o:p></span></=
p>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none'><span lang=3DFI style=
=3D'mso-ansi-language:
  FI'>Orion Pharma s.r.o.<o:p></o:p></span></p>
  <p class=3DMsoNormal><span lang=3DEN-GB>Tel: <span
  style=3D'mso-spacerun:yes'></span></span><span lang=3DSV style=3D'mso-an=
si-language:
  SV'>+420 234 703 305</span><b style=3D'mso-bidi-font-weight:normal'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:CS'>=
<o:p></o:p></span></b></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DSV
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:SV'>Magyarorszg</sp=
an></b><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DSV style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:SV;mso-fareast-language:CS'><o:p></o:p></span></=
b></p>
  <p class=3DMsoNormal style=3D'line-height:13.0pt'><strong><span lang=3DEN=
-GB
  style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;mso-bidi-font-weigh=
t:
  bold'>Orion Pharma <span class=3DSpellE>Kft</span>.</span></strong><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'><o:p></o:p></span></b></p>
  <p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>Tel.: +</span><span
  lang=3DEN-GB>36 1 239 9095</span><span lang=3DSV style=3D'mso-bidi-font-s=
ize:11.0pt;
  mso-ansi-language:SV'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:3;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>Danmark</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size:=
11.0pt'>
  <br>
  Orion Pharma A/S<br>
  <span class=3DSpellE>Tlf</span>: +45 8614 0000</span><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:CS'><o:p></o:p></=
span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none'><b style=3D'mso-bidi-fo=
nt-weight:
  normal'><span lang=3DFR style=3D'mso-bidi-font-size:11.0pt;mso-ansi-langu=
age:
  FR'>Malta</span></b><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DFR
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FR;mso-fareast-langu=
age:
  CS'><o:p></o:p></span></b></p>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DIT style=
=3D'mso-bidi-font-size:
  11.0pt;mso-ansi-language:IT'>Salomone Pharma<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-2.25pt;margin-=
bottom:
  9.0pt;margin-left:0in'><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;
  mso-ansi-language:IT'>Tel: +356&nbsp;21220174</span><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:CS'><o:p></o:p></=
span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:4;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DDE style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:DE'>Deutschland</span></b><span lang=3DDE
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'> <br>
  Orion Pharma GmbH</span><span lang=3DDE style=3D'mso-bidi-font-size:11.0p=
t;
  mso-ansi-language:DE;mso-fareast-language:CS'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><s=
pan
  lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'>Tel: +=
49 40
  899 6890</span><span lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ans=
i-language:
  DE;mso-fareast-language:CS'><o:p></o:p></span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DSV
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:SV'>Nederland</span>=
</b><span
  lang=3DSV style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:SV'><br>
  </span><strong><span lang=3DEN-GB style=3D'font-weight:normal;mso-bidi-fo=
nt-weight:
  bold'>Orion Pharma BVBA/SPRL</span></strong><strong><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt;font-weight:normal'><o:p></o:p></span>=
</strong></p>
  <p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:9.=
0pt;
  margin-left:0in;tab-stops:28.35pt'><span class=3DSpellE><span style=3D'fo=
nt-size:
  11.0pt'>Tl</span></span><span style=3D'font-size:11.0pt'>/Tel: +32 (0)15=
 64 10
  20</span><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:E=
N-GB;
  mso-fareast-language:CS'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:5;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none'><b><span lang=3DFI
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI'>Eesti</span></b>=
<b><span
  lang=3DFI style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI;mso-far=
east-language:
  CS'><o:p></o:p></span></b></p>
  <p class=3DMsoNormal><span lang=3DFI style=3D'mso-bidi-font-size:11.0pt;m=
so-ansi-language:
  FI'>Orion Pharma Eesti O<o:p></o:p></span></p>
  <p class=3DMsoNormal><span lang=3DFI style=3D'mso-bidi-font-size:11.0pt;m=
so-ansi-language:
  FI'>Tel: +372 66 44 550</span><span lang=3DFI style=3D'mso-bidi-font-size=
:11.0pt;
  mso-ansi-language:FI;mso-fareast-language:CS'><o:p></o:p></span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt'><b style=3D'mso-bidi-=
font-weight:
  normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Norge</spa=
n></b><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:CS'>=
<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-hyphenate:none'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Orion Pharma AS<o:p></o:=
p></span></p>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-2.25pt;margin-=
bottom:
  9.0pt;margin-left:0in'><span class=3DSpellE><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
  11.0pt'>Tlf</span></span><span lang=3DEN-GB style=3D'mso-bidi-font-size:1=
1.0pt'>:
  +47 40 00 42 10</span><span lang=3DDE style=3D'mso-bidi-font-size:11.0pt;
  mso-ansi-language:DE;mso-fareast-language:CS'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:6;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><span class=3D=
SpellE><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-si=
ze:11.0pt;
  mso-ansi-language:EN-GB'>&#917;&#955;&#955;&#940;&#948;</span></b></span>=
<b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-si=
ze:11.0pt;
  mso-ansi-language:EN-GB'>&#945;</span></b><span lang=3DFI style=3D'font-s=
ize:
  11.0pt;mso-ansi-language:FI'> <br>
  Orion Pharma Hellas M.E.</span><span style=3D'font-size:11.0pt'>&#928;</s=
pan><span
  lang=3DFI style=3D'font-size:11.0pt;mso-ansi-language:FI'>.E<o:p></o:p></=
span></p>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><span class=3D=
SpellE><span
  style=3D'font-size:11.0pt'>&#932;&#951;&#955;</span></span><span lang=3DFI
  style=3D'font-size:11.0pt;mso-ansi-language:FI'>: + 30&nbsp;210&nbsp;980 =
3355</span><span
  lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p></o:=
p></span></p>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt'><b style=3D'mso-bidi-=
font-weight:
  normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast=
-language:
  CS'><o:p>&nbsp;</o:p></span></b></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DDE style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:DE'>sterreich</span></b><span lang=3DDE
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'><br>
  Orion Pharma GmbH</span><span lang=3DDE style=3D'mso-bidi-font-size:11.0p=
t;
  mso-ansi-language:DE;mso-fareast-language:CS'><o:p></o:p></span></p>
  <p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:9.=
0pt;
  margin-left:0in;tab-stops:28.35pt'><span lang=3DDE style=3D'font-size:11.=
0pt;
  mso-ansi-language:DE'>Tel: +49 40 899 6890</span><span lang=3DEN-GB
  style=3D'font-size:11.0pt;mso-ansi-language:EN-GB;mso-fareast-language:CS=
'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:7;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><b style=3D'ms=
o-bidi-font-weight:
  normal'><span lang=3DIT style=3D'font-size:11.0pt;mso-ansi-language:IT'>E=
spaa</span></b><span
  lang=3DIT style=3D'font-size:11.0pt;mso-ansi-language:IT'> <br>
  </span><span style=3D'font-size:11.0pt'>Orion Pharma S.L.</span><span
  style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><span
  style=3D'font-size:11.0pt'>Tel: + 34 91 &nbsp;599 86 01</span><span lang=
=3DEN-GB
  style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt'><b style=3D'mso-bidi-=
font-weight:
  normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast=
-language:
  CS'><o:p>&nbsp;</o:p></span></b></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>Polska</span></b><b style=3D'mso-bidi=
-font-weight:
  normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast=
-language:
  CS'><o:p></o:p></span></b></p>
  <p class=3DMsoNormal><span lang=3DSV style=3D'mso-bidi-font-size:11.0pt;m=
so-ansi-language:
  SV'>Orion Pharma Poland Sp z.o.o.</span><span lang=3DEN-GB style=3D'mso-b=
idi-font-size:
  11.0pt'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-bottom:9.0pt'><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>Tel.: + 48 22 8333177</span><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:CS'>=
<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:8;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><b style=3D'ms=
o-bidi-font-weight:
  normal'><span lang=3DFR style=3D'font-size:11.0pt;mso-ansi-language:FR'>F=
rance</span></b><span
  lang=3DFR style=3D'font-size:11.0pt;mso-ansi-language:FR'> <br>
  </span><span style=3D'font-size:11.0pt;mso-fareast-font-family:Calibri;
  mso-fareast-language:EN-GB'>Centre <span class=3DSpellE>Spcialits</span=
> <span
  class=3DSpellE>Pharmaceutiques</span></span><span lang=3DFR style=3D'font=
-size:
  11.0pt;mso-ansi-language:FR'><o:p></o:p></span></p>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><span
  style=3D'font-size:11.0pt;mso-fareast-font-family:Calibri;mso-fareast-lan=
guage:
  EN-GB'>Tel: + 33 (0) 1 47 04 80 46</span><span lang=3DFR style=3D'font-si=
ze:11.0pt;
  mso-ansi-language:FR'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt'><b style=3D'mso-bidi-=
font-weight:
  normal'><span lang=3DFR style=3D'mso-bidi-font-size:11.0pt;mso-ansi-langu=
age:
  FR;mso-fareast-language:CS'><o:p>&nbsp;</o:p></span></b></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;tab-=
stops:
  28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DIT
  style=3D'font-size:11.0pt;mso-ansi-language:IT'>Portugal</span></b><span
  lang=3DIT style=3D'font-size:11.0pt;mso-ansi-language:IT'><br>
  </span><span class=3DSpellE><span style=3D'font-size:11.0pt'>Orionfin</sp=
an></span><span
  style=3D'font-size:11.0pt'> <span class=3DSpellE>Unipessoal</span> <span
  class=3DSpellE>Lda</span></span><span lang=3DIT style=3D'font-size:11.0pt;
  mso-ansi-language:IT'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-2.25pt;margin-=
bottom:
  9.0pt;margin-left:0in'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.=
0pt'>Tel:
  + 351 21 154 68 20</span><span lang=3DFR style=3D'mso-bidi-font-size:11.0=
pt;
  mso-ansi-language:FR;mso-fareast-language:CS'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:9;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DFI style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:FI;mso-fareast-language:CS'>Hrvatska<o:p></o:p><=
/span></b></p>
  <p class=3DMsoNormal><strong><span lang=3DFI style=3D'mso-bidi-font-size:=
11.0pt;
  mso-ansi-language:FI;font-weight:normal;mso-bidi-font-weight:bold'>Orion
  Pharma d.o.o.<o:p></o:p></span></strong></p>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><s=
pan
  lang=3DFI style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI'>Tel:</=
span><span
  lang=3DFI style=3D'mso-ansi-language:FI'> +386&nbsp;(0) 1 600 8015</span>=
<span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:CS'>=
<o:p></o:p></span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:12.0pt;mso-line-height-rule:exa=
ctly;
  mso-layout-grid-align:none;text-autospace:none'><span class=3DSpellE><b><=
span
  lang=3DFR style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-languag=
e:FR'>Romnia</span></b></span><b><span
  lang=3DFR style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-languag=
e:FR'><o:p></o:p></span></b></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-layout-grid-align:no=
ne;
  text-autospace:none'><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;
  mso-ansi-language:IT'>Orion Corporation</span><span lang=3DFR style=3D'ms=
o-bidi-font-size:
  11.0pt;color:black;mso-ansi-language:FR'><o:p></o:p></span></p>
  <p class=3DMsoNormal><span lang=3DFR style=3D'mso-bidi-font-size:11.0pt;c=
olor:black;
  mso-ansi-language:FR'>Tel: +358 10 4261<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:10;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><b style=3D'mso-bidi-fo=
nt-weight:
  normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Ireland</s=
pan></b><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'> <br>
  Orion Pharma (Ireland) Ltd.</span><span lang=3DEN-GB style=3D'mso-bidi-fo=
nt-size:
  11.0pt;mso-fareast-language:CS'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>c/o <span class=3DSpellE>Allphar</spa=
n>
  Services Ltd.<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-hyphenate:none'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Tel: +353 1 428 7777<o:p=
></o:p></span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DIT
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'>Slovenija</span>=
</b><span
  lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT;mso-far=
east-language:
  CS'><o:p></o:p></span></p>
  <p class=3DMsoNormal><strong><span lang=3DFI style=3D'mso-bidi-font-size:=
11.0pt;
  mso-ansi-language:FI;font-weight:normal;mso-bidi-font-weight:bold'>Orion
  Pharma d.o.o.<o:p></o:p></span></strong></p>
  <p class=3DMsoNormal style=3D'margin-bottom:9.0pt'><span lang=3DFI
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI'>Tel:</span><span
  lang=3DFI style=3D'mso-ansi-language:FI'> +386&nbsp;(0) 1 600 8015</span>=
<b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt;mso-fareast-language:CS'><o:p></o:p></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:11;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt'><span class=3DSpellE>=
<b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>sland</span></b></span><b style=3D'mso-bidi-font-weight:normal'>=
<span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:CS'>=
<o:p></o:p></span></b></p>
  <p class=3DMsoNormal style=3D'line-height:normal'><span class=3DSpellE><s=
pan
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Vistor</span></span><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'> hf.<o:p></o:p></span></=
p>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><span class=3D=
SpellE><span
  style=3D'font-size:11.0pt'>Smi</span></span><span style=3D'font-size:11.=
0pt'>:
  +354 535 7000</span><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi=
-language:
  EN-GB;mso-fareast-language:CS'><o:p></o:p></span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none'><b style=3D'mso-bidi-fo=
nt-weight:
  normal'><span lang=3DSV style=3D'mso-bidi-font-size:11.0pt;mso-ansi-langu=
age:
  SV'>Slovensk republika</span></b><b style=3D'mso-bidi-font-weight:normal=
'><span
  lang=3DSV style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:SV;mso-far=
east-language:
  CS'><o:p></o:p></span></b></p>
  <p class=3DMsoNormal><strong><span lang=3DSV style=3D'mso-bidi-font-size:=
11.0pt;
  mso-ansi-language:SV;font-weight:normal;mso-bidi-font-weight:bold'>Orion
  Pharma s.r.o<o:p></o:p></span></strong></p>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-2.25pt;margin-=
bottom:
  9.0pt;margin-left:0in;line-height:normal'><span lang=3DSV style=3D'mso-an=
si-language:
  SV'>Tel: </span><span lang=3DSV><span style=3D'mso-spacerun:yes'></span>=
</span><span
  lang=3DSV style=3D'mso-ansi-language:SV'>+420 234 703 305</span><span lan=
g=3DIT
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT;mso-fareast-langu=
age:
  CS'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:12;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><b style=3D'ms=
o-bidi-font-weight:
  normal'><span lang=3DIT style=3D'font-size:11.0pt;mso-ansi-language:IT'>I=
talia</span></b><span
  lang=3DIT style=3D'font-size:11.0pt;mso-ansi-language:IT'><br>
  </span><span lang=3DFI style=3D'font-size:11.0pt;mso-ansi-language:FI'>Or=
ion
  Pharma S.r.l.<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-bottom:9.0pt;mso-hyphenate:none'><sp=
an
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Tel: + 39 02&nbsp;678761=
11</span><span
  lang=3DEL style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EL;mso-far=
east-language:
  CS'><o:p></o:p></span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DIT style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:IT'>Suomi/Finland<br>
  </span></b><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-la=
nguage:
  IT'>Orion Corporation</span><span lang=3DIT style=3D'mso-bidi-font-size:1=
1.0pt;
  mso-ansi-language:IT;mso-fareast-language:CS'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><s=
pan
  lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'>Puh./T=
el: +358
  10 4261</span><span lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ansi=
-language:
  DE;mso-fareast-language:CS'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:13;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEL
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EL'>&#922;&#973;&#96=
0;&#961;&#959;&#962;</span></b><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEL style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:EL;mso-fareast-language:CS'><o:p></o:p></span></=
b></p>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none;tab-stops:-.5in 28.35pt =
3.15in'><span
  lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'>Lifeph=
arma
  (ZAM) Ltd<o:p></o:p></span></p>
  <p class=3DMsoNormal><span class=3DSpellE><span lang=3DEN-GB style=3D'mso=
-bidi-font-size:
  11.0pt'>&#932;&#951;&#955;</span></span><span lang=3DDE style=3D'mso-bidi=
-font-size:
  11.0pt;mso-ansi-language:DE'>.: +357 22056300</span><span lang=3DDE
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE;mso-fareast-langu=
age:
  CS'><o:p></o:p></span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DDE style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:DE'>Sverige</span></b><span lang=3DDE
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'><br>
  Orion Pharma AB</span><span lang=3DDE style=3D'mso-bidi-font-size:11.0pt;
  mso-ansi-language:DE;mso-fareast-language:CS'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><s=
pan
  lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'>Tel: +=
46 8 623
  6440<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:14;mso-yfti-lastrow:yes;page-break-inside:avoid=
'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DFI
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI'>Latvija</span></=
b><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DFI style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:FI;mso-fareast-language:CS'><o:p></o:p></span></=
b></p>
  <p class=3DMsoNormal><span style=3D'mso-bidi-font-size:11.0pt;mso-ansi-la=
nguage:
  EN-US'>Orion Corporation<o:p></o:p></span></p>
  <p class=3DMsoNormal><span style=3D'mso-bidi-font-size:11.0pt;mso-ansi-la=
nguage:
  EN-US'>Orion Pharma <span class=3DSpellE>p&#257;rst&#257;vniec&#299;ba</s=
pan><o:p></o:p></span></p>
  <p class=3DMsoNormal><span style=3D'mso-bidi-font-size:11.0pt;mso-ansi-la=
nguage:
  EN-US'>Tel: +371 20028332<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none'><span style=3D'mso-bidi=
-font-size:
  11.0pt;mso-ansi-language:EN-US;mso-fareast-language:CS'><o:p>&nbsp;</o:p>=
</span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt'><b style=3D'mso-bidi-=
font-weight:
  normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>United Kin=
gdom</span></b><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:CS'>=
<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-hyphenate:none'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Orion Pharma (UK) Ltd.<o=
:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none'><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>Tel: +44 1635 520 300</span><span lan=
g=3DFI
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI;mso-fareast-langu=
age:
  CS'><o:p></o:p></span></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt'>This leaflet was last revised in.</span></b><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'mso-no-proof:yes'>Other sources of information<o:p></o:p></span></=
b></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Detailed
information on this medicine is available on the European Medicines Agency =
web
site: <a href=3D"http://www.ema.europa.eu">http://www.ema.europa.eu</a>.<o:=
p></o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<span lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",=
serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB;mso-farea=
st-language:
EN-US;mso-bidi-language:AR-SA'><br clear=3Dall style=3D'page-break-before:a=
lways'>
</span>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><b style=3D=
'mso-bidi-font-weight:
normal'><span lang=3DEN-GB style=3D'color:black'>Package leaflet: Informati=
on for
the user</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><=
o:p></o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><b style=3D=
'mso-bidi-font-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;text-transfor=
m:uppercase'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><b style=3D=
'mso-bidi-font-weight:
normal'><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;text-transform:u=
ppercase;
mso-ansi-language:IT'>s</span></b><b style=3D'mso-bidi-font-weight:normal'>=
<span
lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'>talevo 1=
</span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt'>75&nbsp;mg/43.75&nbsp;mg/200&nbsp;mg</span></b><b style=3D'mso-bidi=
-font-weight:
normal'><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:IT'>
film-coated tablets<o:p></o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DIT
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'>levodopa/carbidopa=
/entacapone<b
style=3D'mso-bidi-font-weight:normal'><span style=3D'text-transform:upperca=
se'><o:p></o:p></span></b></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DIT
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'><o:p>&nbsp;</o:p><=
/span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>Read
all of this leaflet carefully before you start taking this medicine because=
 it
contains important information for you.<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-list:l1 level1 lfo3;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ig=
nore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>Keep
this leaflet. You may need to read it again.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-list:l1 level1 lfo3;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ig=
nore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>If
you have any further questions, ask your doctor or pharmacist.<o:p></o:p></=
span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'>-<span
style=3D'mso-tab-count:1'> </span>This medicine has been prescribed =
for
you only. Do not pass it on to others. It may harm them, even if their sign=
s of
illness are the same as yours.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'>-<span
style=3D'mso-tab-count:1'> </span></span><span lang=3DEN-GB
style=3D'mso-no-proof:yes'>If you get any side effects, talk to your doctor=
 or pharmacist.</span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:red'> </span><span
lang=3DEN-GB style=3D'mso-no-proof:yes'>This includes any possible side eff=
ects not
listed in this leaflet. See section 4.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>What
is in this leaflet:<o:p></o:p></span></b></p>

<p class=3DMsoNormal><span lang=3DEN-GB>1.<span style=3D'mso-tab-count:1'>=
 </span>What
Stalevo is and what it is used for</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>2.<span style=3D'mso-tab-count:1'>=
 </span><span
style=3D'mso-no-proof:yes'>What you need to know</span> before you take Sta=
levo</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>3.<span style=3D'mso-tab-count:1'>=
 </span>How
to take Stalevo</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>4.<span style=3D'mso-tab-count:1'>=
 </span>Possible
side effects</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>5<span style=3D'mso-tab-count:1'>=
 </span>How
to store Stalevo</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>6.<span style=3D'mso-tab-count:1'>=
 </span><span
style=3D'mso-no-proof:yes'>Contents of the pack and other information</span=
></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'text-transform:uppercase'>1.<span style=3D'mso-tab-count:1'>=
 </span></span><span
lang=3DEN-GB>What Stalevo is and what it is used for<span style=3D'text-tra=
nsform:
uppercase'><o:p></o:p></span></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><b style=3D'mso-bidi-font=
-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;<=
/o:p></span></b></p>

<p class=3DMsoBodyText3 align=3Dleft style=3D'text-align:left;line-height:n=
ormal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-sty=
le:normal'>Stalevo
contains three active substances (levodopa, carbidopa and entacapone) in one
film-coated tablet. Stalevo is used for the treatment of Parkinsons diseas=
e. <o:p></o:p></span></p>

<p class=3DMsoBodyText3 align=3Dleft style=3D'text-align:left;line-height:n=
ormal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-sty=
le:normal'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Parkinsons disease is cau=
sed by
low levels of a substance called dopamine in the brain. Levodopa increases =
the
amount of dopamine and hence reduces the symptoms of Parkinsons disease. C=
arbidopa
and entacapone improve the <span class=3DSpellE>antiparkinson</span> effect=
s of
levodopa. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'text-transform:uppercase'>2.<span style=3D'mso-tab-count:1'>=
 </span></span><span
lang=3DEN-GB>What you need to know before you take Stalevo<span style=3D'te=
xt-transform:
uppercase'><o:p></o:p></span></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>Do
not take Stalevo if you:<o:p></o:p></span></b></p>

<p class=3DMsoNormal><span style=3D'mso-ansi-language:EN-US'><o:p>&nbsp;</o=
:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l42 level1 lfo17;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>are allergic to levodopa, carbidopa or entacapone,=
 or
any of the other ingredients of this medicine </span><span style=3D'font-si=
ze:
11.0pt;mso-no-proof:yes'>(listed in section 6)</span><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l42 level1 lfo17;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>have narrow-angle glaucoma (an eye disorder)<o:p><=
/o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l42 level1 lfo17;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>have a tumour of the adrenal gland<o:p></o:p></spa=
n></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l42 level1 lfo17;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>are taking certain medicines for treating depressi=
on (</span><span
style=3D'font-size:11.0pt'>combinations of </span><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>selective MAO-A and MAO-B
inhibitors, or non-selective MAO-inhibitors)<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l42 level1 lfo17;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>have ever had neuroleptic malignant syndrome (NMS 
this is a rare reaction to medicines used to treat severe mental disorders)=
<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l42 level1 lfo17;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>have ever had non-traumatic rhabdomyolysis (a rare
muscle disorder)<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l42 level1 lfo17;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>have a severe liver disease. <o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-la=
nguage:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'mso-no-proof:yes'>Warnings and precautions</span><span lang=3DEN-G=
B><o:p></o:p></span></b></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0=
pt'>Talk
to your doctor or pharmacist before taking Stalevo if you have or have ever=
 had</span></u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>a
heart attack or any other diseases of the heart including cardiac arrhythmi=
as,
or of the blood vessels<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>asthma
or any other disease of the lungs<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>a
liver problem, because your dose may need to be adjusted<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>kidney
or hormone-related diseases<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>stomach
ulcers or convulsions<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>if
you experience prolonged diarrhoea consult your doctor as it may be a sign =
of
inflammation of the colon<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>any
form of severe mental disorder like psychosis<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>chronic
wide-angle glaucoma, because your dose may need to be adjusted and the pres=
sure
in your eyes may need to be monitored.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0=
pt'>Consult
your doctor if you are currently taking</span></u><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>antipsychotics
(medicines used to treat psychosis)<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>a
medicine which may cause low blood pressure when rising from a chair or bed.
You should be aware that Stalevo may make these reactions worse.<o:p></o:p>=
</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0=
pt'>Consult
your doctor if during the treatment with Stalevo you</span></u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>notice
that your muscles get very rigid or jerk violently, or if you get tremors,
agitation, confusion, fever, rapid pulse, or wide fluctuations in your blood
pressure. If any of this happens, <b style=3D'mso-bidi-font-weight:normal'>=
contact
your doctor immediately</b><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>feel
depressed, have suicidal thoughts, or notice unusual changes in your behavi=
our<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>find
yourself suddenly falling asleep, or if you feel very drowsy. If this happe=
ns,
you should not drive or use any tools or machines (see also section 'Driving
and using machines')<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>notice
that uncontrolled movements begin or get worse after you started to take
Stalevo. If this happens, your doctor may need to change the dose of your <=
span
class=3DSpellE>antiparkinson</span> medicine <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>experience
diarrhoea: monitoring of your weight is recommended in order to avoid
potentially excessive weight loss<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>experience
progressive anorexia, asthenia (weakness, exhaustion) and weight decrease
within a relatively short period of time. If this happens, a general medical
evaluation including liver function should be considered<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>feel
the need to stop using Stalevo, see section 'If you stop taking Stalevo'.<o=
:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Tell your
doctor if you or your family/carer notices you are developing addiction-like
symptoms leading to craving for large doses of Stalevo and other medicines =
used
to treat Parkinsons disease.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span style=3D'mso-bidi-font-size:11.0pt;mso-ansi-lang=
uage:
EN-US'>Tell your doctor if you or your family/<span class=3DSpellE>carer</s=
pan>
notices you are developing urges or cravings to behave in ways that are unu=
sual
for you or you cannot resist the impulse, drive or temptation to carry out
certain activities that could harm yourself or others. These <span
class=3DSpellE>behaviours</span> are called impulse control disorders and c=
an
include addictive gambling, excessive eating or spending, an abnormally high
sex drive or a preoccupation with an increase in sexual thoughts or feeling=
s. <u>Your
doctor may need to review your treatments.</u> <o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Your
doctor may take some regular laboratory tests during a long term treatment =
with
Stalevo.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>If you
must undergo surgery, please tell your doctor that you are using Stalevo.<o=
:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Stalevo
is not recommended to be used for treatment of extrapyramidal symptoms (e.g.
involuntary movements, shaking, muscle rigidity and muscle contractions</sp=
an><span
lang=3DEN style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EN'>)</span>=
<span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'> caused by other medicines=
.<o:p></o:p></span></p>

<p class=3DMsoNormal><u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0=
pt'><o:p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'mso-bidi-font-size:11.0pt'>Children </span><span lang=3DEN-GB
style=3D'color:black'>and adolescents<o:p></o:p></span></b></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Experience
with Stalevo in patients under 18 years is limited. Therefore, the use of
Stalevo in children or adolescents is not recommended.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-la=
nguage:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>Other
medicines and Stalevo<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoBodyText style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-style:normal'>Te=
ll
your doctor or pharmacist if you are taking, have recently taken or might t=
ake any
other medicines.<o:p></o:p></span></p>

<p class=3DMsoBodyText style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-style:normal'><o=
:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Do not take Stalevo if you=
 are
taking certain medicines for treating depression (combinations of selective
MAO-A and MAO-B inhibitors, or non-selective MAO inhibitors).<o:p></o:p></s=
pan></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Stalevo may increase the e=
ffects
and side effects of certain medicines. These include: <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>medicines
used to treat depression such as moclobemide, amitriptyline, desipramine,
maprotiline, venlafaxine and paroxetine <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l11 level2 lfo20'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-family:"Arial",sans-serif;mso-farea=
st-font-family:
Arial'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times Ne=
w Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp=
;&nbsp;
</span></span></span><![endif]><span class=3DSpellE><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>rimiterole</span></span><span lang=3DEN=
-GB
style=3D'mso-bidi-font-size:11.0pt'> and isoprenaline, used to treat respir=
atory
diseases<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>adrenaline,
used </span><span lang=3DPT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-lan=
guage:
PT'>for severe allergic reactions</span><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
11.0pt'> <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>noradrenaline,
dopamine and dobutamine, used to treat heart diseases and low blood pressur=
e<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>-<span
style=3D'mso-tab-count:1'> </span>alpha-methyldopa, used to treat hi=
gh
blood pressure <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>-<span
style=3D'mso-tab-count:1'> </span>apomorphine, which is used to treat
Parkinsons disease.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;tab-sto=
ps:17.1pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;tab-st=
ops:28.35pt'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>The effects=
 of
Stalevo may be weakened by certain medicines. These include: <o:p></o:p></s=
pan></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-la=
nguage:
EN-GB'>-<span style=3D'mso-tab-count:1'> </span>dopamine antagonists=
 used
to treat mental disorders</span><span style=3D'font-size:11.0pt'>, nausea a=
nd
vomiting</span><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-langua=
ge:EN-GB'><o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l49 level1 lfo18;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>phenytoin, used to prevent convulsions <o:p></o:p>=
</span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l49 level1 lfo18;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>papaverine used to relax the muscles.<o:p></o:p></=
span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;tab-st=
ops:28.35pt'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p>&nbsp;=
</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;tab-st=
ops:28.35pt'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>Stalevo may=
 make it
harder for you to digest iron. Therefore, do not take Stalevo and iron
supplements at the same time. After taking one of them, wait at least 2 to 3
hours before taking the other.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;tab-st=
ops:28.35pt'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>Stalevo
with food and drink<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoBodyText style=3D'text-align:justify;line-height:normal;tab-s=
tops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;font-weight:=
normal;
font-style:normal'>Stalevo may be taken with or without food. For some pati=
ents,
Stalevo may not be well absorbed if it is taken with, or shortly after eati=
ng
protein-rich food (such as meats, fish, dairy products, seeds and nuts).
Consult your doctor if you think this applies to you.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;tab-st=
ops:28.35pt'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>Pregnancy,
breast-feeding and fertility<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoBodyText style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-style:normal'>If=
 you
are pregnant or breast-feeding, think you may be pregnant or are planning to
have a baby, ask your doctor or pharmacist for advice before taking this
medicine. <o:p></o:p></span></p>

<p class=3DMsoBodyText style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-style:normal'><o=
:p>&nbsp;</o:p></span></p>

<p class=3DMsoBodyText style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-style:normal'>You
should not breast-feed during treatment with Stalevo.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>Driving
and using machines<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>Stalevo may lower your blood pressure, =
which
may make you feel light-headed or dizzy. Therefore, be particularly careful
when you drive or when you use any tools or machines.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>If you feel very drowsy, or if you some=
times
find yourself suddenly falling asleep, wait until you feel fully awake again
before driving or doing anything else that requires you to be alert. Otherw=
ise,
you may put yourself and others at risk of serious injury or death.<o:p></o=
:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt'>Stalevo contains sucrose<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>Stalevo contains sucrose (1.89&nbsp;mg/=
tablet).
If you have been told by your doctor that you have intolerance to some suga=
rs,
contact your doctor before taking this medicinal product.<o:p></o:p></span>=
</p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'text-transform:uppercase'>3.<span style=3D'mso-tab-count:1'>=
 </span></span><span
lang=3DEN-GB>How to take Stalevo<span style=3D'text-transform:uppercase'><o=
:p></o:p></span></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Always take this medicine =
exactly
as your doctor or pharmacist has told you. Check with your doctor or pharma=
cist
if you are not sure.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>For adults and elderly</sp=
an></u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt=
'>-<span
style=3D'mso-tab-count:1'> </span>Your doctor will tell you exactly =
how
many tablets of Stalevo to take each day. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l32 level1 lfo21'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-family:"Arial",sans-serif;mso-farea=
st-font-family:
Arial'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times Ne=
w Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp=
;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>The
tablets are not intended to be split or broken into smaller pieces.<o:p></o=
:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l32 level1 lfo21'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-family:"Arial",sans-serif;mso-farea=
st-font-family:
Arial'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times Ne=
w Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp=
;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>You
should take only one tablet each time.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l32 level1 lfo21'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-family:"Arial",sans-serif;mso-farea=
st-font-family:
Arial'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times Ne=
w Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp=
;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>Depending
on how you respond to treatment, your doctor may suggest a higher or lower
dose. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l32 level1 lfo21;tab-stops:list 28.35pt'><![if !supportList=
s]><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;font-family:"Arial",sans-se=
rif;
mso-fareast-font-family:Arial'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>If
you are taking Stalevo 175&nbsp;mg/43.75&nbsp;mg/200&nbsp;mg tablets, do not
take more than 8 tablets of this strength per day.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;text-align:justify;line-he=
ight:
normal;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt=
'>Talk
to your doctor or pharmacist if you think the effect of Stalevo is too stro=
ng
or too weak, or if you experience possible side effects.<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;text-align:justify;line-he=
ight:
12.0pt;mso-list:skip'><span lang=3DEN-GB><!--[if gte vml 1]><v:shape id=3D"=
_x0000_i1035"
 type=3D"#_x0000_t75" style=3D'width:468pt;height:91.5pt'>
 <v:imagedata src=3D"Stalevo_clean_files/image011.emz" o:title=3D""/>
</v:shape><![endif]--><![if !vml]><img border=3D0 width=3D624 height=3D122
src=3D"Stalevo_clean_files/image012.png" v:shapes=3D"_x0000_i1035"><![endif=
]></span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>If
you take more Stalevo than you should<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>If you have accidentally taken more Sta=
levo
tablets than you should, talk to your doctor or pharmacist immediately. In =
case
of an overdose you may feel confused or agitated, your heart rate may be sl=
ower
or faster than normal or the colour of your skin, tongue, eyes or urine may
change.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>If
you forget to take Stalevo<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>Do not take a double dose to make up fo=
r a
forgotten tablet.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p><span style=3D'text-d=
ecoration:
 none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>If it is more than 1 hour =
until
your next dose</span></u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.=
0pt'>: <o:p></o:p></span></p>

<p class=3DMsoBodyText style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-style:normal'>Ta=
ke one
tablet as soon as you remember, and the next tablet at the normal time. <o:=
p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>If it is less than 1 hour =
until
your next dose</span></u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.=
0pt'>: <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Take a tablet as soon as y=
ou
remember, wait 1 hour, then take another tablet. After that carry on as nor=
mal.
<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Always leave at least an h=
our
between Stalevo tablets, to avoid possible side effects.<o:p></o:p></span><=
/p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>If
you stop taking Stalevo <o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Do not stop taking Stalevo=
 unless
your doctor tells you to. In such a case your doctor may need to adjust your
other <span class=3DSpellE>antiparkinson</span> medicines, especially levod=
opa,
to give sufficient control of your symptoms. If you suddenly stop taking
Stalevo and other antiparkinsonian medicines it may result in unwanted side
effects. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>If you have any further qu=
estions
on the use of this medicine, ask your doctor or pharmacist.<o:p></o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'text-transform:uppercase'>4.<span style=3D'mso-tab-count:1'>=
 </span></span><span
lang=3DEN-GB>Possible side effects<span style=3D'text-transform:uppercase'>=
<o:p></o:p></span></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-1.4pt;line-height:normal;mso-ou=
tline-level:
1;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:=
p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.4pt;line-height:normal;mso-ou=
tline-level:
1;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Lik=
e all
medicines, this medicine can cause side effects, although not everybody gets
them. Many of the side effects can be relieved by adjusting the dose. <o:p>=
</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.4pt;line-height:normal;mso-ou=
tline-level:
1;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:=
p>&nbsp;</o:p></span></p>

<p class=3DText style=3D'margin-top:0in'><span style=3D'font-size:11.0pt'>I=
f you
during the treatment with Stalevo experience the following symptoms, <b
style=3D'mso-bidi-font-weight:normal'>contact your doctor immediately</b>: =
<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:25.65pt;margin-bottom:.0001pt;text-indent:-25.65pt;mso-list:l50=
 level1 lfo26'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-size:11.0pt'>Your muscle=
s get
very rigid or jerk violently, you get tremors, agitation, confusion, fever,
rapid pulse, or wide fluctuations in your blood pressure. These can be symp=
toms
</span><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB=
'>of
neuroleptic malignant syndrome (NMS, a rare severe reaction to medicines us=
ed
to treat disorders of the central nervous system) or rhabdomyolysis (a rare
severe muscle disorder).<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:25.65pt;margin-bottom:.0001pt;text-indent:-25.65pt;mso-list:l37=
 level1 lfo27'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>Allergic reaction, the signs may include hives (ne=
ttle
rash), itching, rash, swelling of your face, lips, tongue or throat. This m=
ay
cause difficulties in breathing or swallowing.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.4pt;line-height:normal;mso-ou=
tline-level:
1;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:=
p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><u><span lang=3DEN-GB>Very common (may affect more tha=
n 1 in
10 people)<o:p></o:p></span></u></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo7;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>uncontrolled movements (dyskinesias)<o:p></o:p></s=
pan></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo7;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>feeling sick (nausea)<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo7;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>harmless reddish-brown discolouration of urine<o:p=
></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo7;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>muscle pain<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo7;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>diarrhoea<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><span lang=3DEN-=
GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span>=
</p>

<p class=3DMsoNormal><u><span lang=3DEN-GB>Common (may affect up to 1 in 10=
 people)<o:p></o:p></span></u></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo7;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>light-headedness or fainting due to low blood
pressure, high blood pressure<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo7;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>worsening of Parkinsons symptoms, dizziness,
drowsiness<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo7;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>vomiting, abdominal pain and discomfort, heartburn,
dry mouth, constipation<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo7;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>inability to sleep, hallucinations, confusion abno=
rmal
dreams (including nightmares), tiredness<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo7;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>mental changes  including problems with memory,
anxiety and depression (possibly with thoughts of suicide) <o:p></o:p></spa=
n></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo7;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-size:11.0pt'>heart or ar=
tery
disease events (e.g. chest pain), irregular heart rate or rhythm </span><sp=
an
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p></o:p>=
</span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo7;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>more frequent falling <o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo7;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>shortness of breath <o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo7;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>increased sweating, rashes<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo7;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>muscle cramps, swelling of legs<o:p></o:p></span><=
/p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo7;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>blurred vision<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo7;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>anaemia<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo7;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>decreased appetite, decreased weight<o:p></o:p></s=
pan></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo7;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>headache, joint pain<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo7;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>urinary tract infection<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;tab-st=
ops:28.35pt'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p>&nbsp;=
</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;tab-st=
ops:28.35pt'><u><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>Uncommon </=
span></u><u><span
style=3D'font-size:11.0pt;color:black'>(may affect up to 1 in 100&nbsp;peop=
le)</span></u><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p></o:p>=
</span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo7;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>heart attack<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo7;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>bleeding in the gut<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo7;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>changes in the blood cell count which may result in
bleeding, abnormal liver function tests<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo7;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>convulsions<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo7;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>feeling agitated<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo7;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>psychotic symptoms<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo7;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>colitis (inflammation of the colon)<o:p></o:p></sp=
an></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo7;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span class=3DSpellE><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>discolourations</span></=
span><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'> other than=
 urine
(e.g. skin, nail, hair, sweat)<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo7;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>swallowing difficulties<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo7;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-size:11.0pt'>inability to
urinate</span><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-languag=
e:EN-GB'><o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in'><span lang=3DEN-GB style=3D'font-s=
ize:11.0pt;
mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left'><u><s=
pan
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>Not known (=
cannot
be estimated from the available data)<o:p></o:p></span></u></p>

<p class=3DText style=3D'margin-top:0in'><span lang=3DEN-GB style=3D'font-s=
ize:11.0pt;
mso-ansi-language:EN-GB'>Craving for large doses of Stalevo in excess of th=
at
required to control motor symptoms, known as dopamine dysregulation syndrom=
e.
Some patients experience severe abnormal involuntary movements (dyskinesias=
),
mood swings or other side effects after taking large doses of Stalevo.<o:p>=
</o:p></span></p>

<p class=3DText style=3D'margin-top:0in'><span lang=3DEN-GB style=3D'font-s=
ize:11.0pt;
mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText style=3D'margin-top:0in'><u><span lang=3DEN-GB style=3D'fon=
t-size:11.0pt;
mso-ansi-language:EN-GB'>The following side effects have also been reported=
</span></u><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>:<o:p></o:p=
></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l4 =
level1 lfo22;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>hepatitis </span><span style=3D'font-size:11.0pt'>=
(inflammation
of the liver)</span><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-l=
anguage:
EN-GB'> <o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l4 =
level1 lfo22;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>itching<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in'><span lang=3DEN-GB style=3D'font-s=
ize:11.0pt;
mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:4.8pt;mso-pagination:none'><u><s=
pan
lang=3DEN-GB style=3D'color:black'>You may experience the following side ef=
fects:<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:4.8pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-pagination:none;mso-list:l10 level1 lfo49;tab-stops:28.35pt'><![=
if !supportLists]><span
lang=3DEN-GB style=3D'font-family:"Arial",sans-serif;mso-fareast-font-famil=
y:Arial;
color:black'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Ti=
mes New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp=
;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
color:black'>Inability to resist the impulse to perform an action that coul=
d be
harmful, which may include:</span><span lang=3DEN-GB style=3D'color:black'>=
<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:4.8pt;margin-bott=
om:0in;
margin-left:42.55pt;margin-bottom:.0001pt;text-indent:-14.2pt;line-height:n=
ormal;
mso-pagination:none;mso-list:l9 level2 lfo51;tab-stops:list 42.55pt'><![if =
!supportLists]><span
lang=3DEN-GB style=3D'font-family:"Arial",sans-serif;mso-fareast-font-famil=
y:Arial;
color:black'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Ti=
mes New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
color:black'>strong impulse to gamble excessively despite serious personal =
or family
consequences</span><span lang=3DEN-GB style=3D'color:black'><o:p></o:p></sp=
an></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:4.8pt;margin-bott=
om:0in;
margin-left:42.55pt;margin-bottom:.0001pt;text-indent:-14.2pt;line-height:n=
ormal;
mso-pagination:none;mso-list:l9 level2 lfo51;tab-stops:list 42.55pt'><![if =
!supportLists]><span
lang=3DEN-GB style=3D'font-family:"Arial",sans-serif;mso-fareast-font-famil=
y:Arial;
color:black'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Ti=
mes New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
color:black'>altered or increased sexual interest and behaviour of signific=
ant
concern to you or to others, for example, an increased sexual drive</span><=
span
lang=3DEN-GB style=3D'color:black'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:4.8pt;margin-bott=
om:0in;
margin-left:42.55pt;margin-bottom:.0001pt;text-indent:-14.2pt;line-height:n=
ormal;
mso-pagination:none;mso-list:l9 level2 lfo51;tab-stops:list 42.55pt'><![if =
!supportLists]><span
lang=3DEN-GB style=3D'font-family:"Arial",sans-serif;mso-fareast-font-famil=
y:Arial;
color:black'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Ti=
mes New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
color:black'>uncontrollable excessive shopping or spending</span><span
lang=3DEN-GB style=3D'color:black'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:4.8pt;margin-bott=
om:0in;
margin-left:42.55pt;margin-bottom:.0001pt;text-indent:-14.2pt;line-height:n=
ormal;
mso-pagination:none;mso-list:l9 level2 lfo51;tab-stops:list 42.55pt'><![if =
!supportLists]><span
lang=3DEN-GB style=3D'font-family:"Arial",sans-serif;mso-fareast-font-famil=
y:Arial;
color:black'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Ti=
mes New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
color:black'>binge eating (eating large amounts of food in a short time per=
iod)
or compulsive eating (eating more food than normal and more than is needed =
to
satisfy your hunger).</span><span lang=3DEN-GB style=3D'color:black'><o:p><=
/o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:4.8pt;mso-pagination:none'><span
lang=3DEN-GB style=3D'color:black'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:4.8pt;mso-pagination:none;tab-st=
ops:
0in'><span lang=3DEN-GB style=3D'color:black'>Tell your doctor if you exper=
ience
any of these behaviours; they will discuss ways of managing or reducing the
symptoms.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-out=
line-level:
1;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:=
p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-out=
line-level:
1;mso-list:skip'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>Reporting of side effects<o:p></o:p></s=
pan></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-out=
line-level:
1;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>If =
you get
any side effects, talk to your doctor or pharmacist. This includes any poss=
ible
side effects not listed in this leaflet. You can also report side effects
directly via <span style=3D'background:silver;mso-highlight:silver'>the nat=
ional
reporting system listed in <a
href=3D"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_fo=
rm/2013/03/WC500139752.doc">Appendix
V</a></span>. By reporting side <span class=3DSpellE>effects you</span> can=
 help
provide more information on the safety of this medicine.<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'text-transform:uppercase'>5.<span style=3D'mso-tab-count:1'>=
 </span></span><span
lang=3DEN-GB>How to store Stalevo<span style=3D'text-transform:uppercase'><=
o:p></o:p></span></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-out=
line-level:
1;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Kee=
p this
medicine out of the sight and reach of children.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Do not use this medicine a=
fter the
expiry date which is stated on the bottle and the carton after EXP. The exp=
iry
date refers to the last day of that month.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>This medicinal product doe=
s not
require any special storage conditions.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Do not </=
span><span
lang=3DEN-GB style=3D'mso-no-proof:yes'>throw away any medicines</span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'> via wastewater or househo=
ld
waste. Ask your pharmacist how to </span><span lang=3DEN-GB style=3D'mso-no=
-proof:
yes'>throw away</span><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt=
'> of
medicines you no longer use. These measures will help to protect the
environment.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'text-transform:uppercase'>6.<span style=3D'mso-tab-count:1'>=
 </span></span><span
lang=3DEN-GB>Contents of the pack and other information<span style=3D'text-=
transform:
uppercase'><o:p></o:p></span></span></b></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><b style=3D'mso-bidi-font=
-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>What Stalevo
contains<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:no=
rmal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-list:l14 level1 lfo7;tab-stops:list 28.35pt'><![if !supportLists=
]><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ig=
nore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>The
active substances of Stalevo are levodopa, carbidopa and entacapone.<o:p></=
o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo7;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>Each Stalevo 175&nbsp;mg/43.75&nbsp;mg/200&nbsp;mg
tablet contains 175&nbsp;mg of levodopa, 43.75&nbsp;mg of carbidopa and
200&nbsp;mg of entacapone.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-list:l14 level1 lfo7;tab-stops:list 28.35pt'><![if !supportLists=
]><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ig=
nore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>The
other ingredients in the tablet core are croscarmellose sodium, magnesium
stearate, maize starch, mannitol (E421) and povidone (E1201)<o:p></o:p></sp=
an></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-list:l14 level1 lfo7;tab-stops:list 28.35pt'><![if !supportLists=
]><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ig=
nore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>The
ingredients in the film-coating are glycerol (85 per cent) (E422), <span
class=3DSpellE>hypromellose</span>, magnesium stearate, polysorbate 80, red=
 iron
oxide (E172), sucrose, and titanium dioxide (E171).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:27.0pt;text-indent:-27.0pt;line-h=
eight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;<=
/o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:27.0pt;text-indent:-27.0pt;line-h=
eight:
normal'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>What Stalevo looks like and contents of=
 the
pack<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-left:27.0pt;text-indent:-27.0pt;line-h=
eight:
normal'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoEndnoteText><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'>Stalevo
175&nbsp;mg/43.75&nbsp;mg/200&nbsp;mg: light brownish red, oval, unscored
film-coated tablets marked with LCE 175 on one side.<o:p></o:p></span></p>

<p class=3DMsoEndnoteText><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoEndnoteText><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'>Stalevo
175&nbsp;mg/43.75&nbsp;mg/200&nbsp;mg tablet comes in five different pack s=
izes
(10, 30, 100, 130 or 175 tablets). Not all pack sizes may be marketed.<o:p>=
</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:27.0pt;text-indent:-27.0pt;line-h=
eight:
normal'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>Marketing
Authorisation Holder</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoEndnoteText><span lang=3DIT style=3D'mso-bidi-font-size:11.0p=
t;
mso-ansi-language:IT'>Orion Corporation<o:p></o:p></span></p>

<p class=3DMsoEndnoteText><span lang=3DIT style=3D'mso-bidi-font-size:11.0p=
t;
mso-ansi-language:IT'>Orionintie 1<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DIT style=3D'=
mso-bidi-font-size:
11.0pt;mso-ansi-language:IT'>FI-02200 Espoo<o:p></o:p></span></p>

<p class=3DMsoEndnoteText><span lang=3DIT style=3D'mso-bidi-font-size:11.0p=
t;
mso-ansi-language:IT'>Finland<o:p></o:p></span></p>

<p class=3DMsoEndnoteText><span lang=3DIT style=3D'mso-bidi-font-size:11.0p=
t;
mso-ansi-language:IT'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-2.25pt'><b style=3D'mso-bidi-fo=
nt-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Manufacturer=
<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-2.25pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>Orion Corporation Orion Pharma<o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-2.25pt'><span class=3DSpellE><s=
pan
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Joensuunkatu</span></span>=
<span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>&nbsp;7<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'margin-right:-2.25pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>FI-24100&nbsp;Salo<o:p></o:p></span></p>

<p class=3DMsoEndnoteText><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'>Finland</span><span
lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'><o:p></o=
:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DIT style=3D'=
mso-bidi-font-size:
11.0pt;mso-ansi-language:IT'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-2.25pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold'>Orion Corpora=
tion Orion
Pharma<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-2.25pt'><span class=3DSpellE><s=
pan
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold'>=
Orionintie</span></span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold'>=
&nbsp;1<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-2.25pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold'>FI-02200&nbsp=
;Espoo<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold'>Finland<o:p><=
/o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DIT style=3D'=
mso-bidi-font-size:
11.0pt;mso-ansi-language:IT'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>For any information about =
this
medicine, please contact the local representative of the Marketing
Authorisation Holder.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<table class=3DMsoNormalTable border=3D0 cellspacing=3D0 cellpadding=3D0 wi=
dth=3D628
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;mso-yfti-tbll=
ook:
 1184;mso-padding-alt:0in 5.4pt 0in 5.4pt'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;page-break-inside:avoid=
'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal><span class=3DSpellE><b><span lang=3DEN-GB style=3D'=
mso-bidi-font-size:
  11.0pt;font-family:"TimesNewRomanPS-BoldMT",serif;mso-bidi-font-family:Ti=
mesNewRomanPS-BoldMT;
  mso-fareast-language:EN-GB'>Belgi</span></b></span><b><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt;font-family:"TimesNewRomanPS-BoldMT",s=
erif;
  mso-bidi-font-family:TimesNewRomanPS-BoldMT;mso-fareast-language:EN-GB'>/=
Belgique/<span
  class=3DSpellE>Belgien</span></span></b><span lang=3DFR style=3D'mso-bidi=
-font-size:
  11.0pt;mso-ansi-language:FR'><br>
  </span><strong><span lang=3DEN-GB style=3D'font-weight:normal;mso-bidi-fo=
nt-weight:
  bold'>Orion Pharma BVBA/SPRL</span></strong><strong><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt;font-weight:normal'><o:p></o:p></span>=
</strong></p>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><span class=3D=
SpellE><span
  style=3D'font-size:11.0pt'>Tl</span></span><span style=3D'font-size:11.0=
pt'>/Tel:
  +32 (0)15 64 10 20</span><span lang=3DFR style=3D'font-size:11.0pt;mso-an=
si-language:
  FR'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt'><b style=3D'mso-bidi-=
font-weight:
  normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast=
-language:
  CS'><o:p>&nbsp;</o:p></span></b></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DFI
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI'>Lietuva</span></=
b><span
  lang=3DFI style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI;mso-far=
east-language:
  CS'><o:p></o:p></span></p>
  <p class=3DMsoNormal><span lang=3DFI style=3D'mso-bidi-font-size:11.0pt;m=
so-ansi-language:
  FI'>UAB Orion Pharma<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none'><span lang=3DFI style=
=3D'mso-bidi-font-size:
  11.0pt;mso-ansi-language:FI'>Tel. +370 5&nbsp;276 9499</span><span lang=
=3DFI
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI;mso-fareast-langu=
age:
  CS'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:1;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal><span class=3DSpellE><b style=3D'mso-bidi-font-weigh=
t:normal'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black'>&#1041;&#109=
8;&#1083;&#1075;&#1072;&#1088;&#1080;&#1103;</span></b></span><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DFR style=3D'mso-bidi-f=
ont-size:
  11.0pt;color:black;mso-ansi-language:FR'><o:p></o:p></span></b></p>
  <p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;m=
so-ansi-language:
  IT'>Orion Pharma Poland Sp z.o.o.<o:p></o:p></span></p>
  <p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;m=
so-ansi-language:
  IT'>Tel.: + 48&nbsp;22&nbsp;8333177<o:p></o:p></span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DDE
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'>Luxembourg/Luxem=
burg</span></b><span
  lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'><br>
  </span><strong><span lang=3DEN-GB style=3D'font-weight:normal;mso-bidi-fo=
nt-weight:
  bold'>Orion Pharma BVBA/SPRL</span></strong><strong><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt;font-weight:normal'><o:p></o:p></span>=
</strong></p>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><span class=3D=
SpellE><span
  style=3D'font-size:11.0pt'>Tl</span></span><span style=3D'font-size:11.0=
pt'>/Tel:
  +32 (0)15 64 10 20</span><span lang=3DFR style=3D'font-size:11.0pt;mso-an=
si-language:
  FR'><o:p></o:p></span></p>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DSV
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:SV'><o:p>&nbsp;</o:p=
></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:2;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none'><b style=3D'mso-bidi-fo=
nt-weight:
  normal'><span lang=3DSV style=3D'mso-bidi-font-size:11.0pt;mso-ansi-langu=
age:
  SV'>&#268;esk republika</span></b><span lang=3DSV style=3D'mso-bidi-font=
-size:
  11.0pt;mso-ansi-language:SV;mso-fareast-language:CS'><o:p></o:p></span></=
p>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none'><span lang=3DFI style=
=3D'mso-ansi-language:
  FI'>Orion Pharma s.r.o.<o:p></o:p></span></p>
  <p class=3DMsoNormal><span lang=3DEN-GB>Tel: <span
  style=3D'mso-spacerun:yes'></span></span><span lang=3DSV style=3D'mso-an=
si-language:
  SV'>+420 234 703 305</span><b style=3D'mso-bidi-font-weight:normal'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:CS'>=
<o:p></o:p></span></b></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DSV
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:SV'>Magyarorszg</sp=
an></b><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DSV style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:SV;mso-fareast-language:CS'><o:p></o:p></span></=
b></p>
  <p class=3DMsoNormal style=3D'line-height:13.0pt'><strong><span lang=3DEN=
-GB
  style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;mso-bidi-font-weigh=
t:
  bold'>Orion Pharma <span class=3DSpellE>Kft</span>.</span></strong><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'><o:p></o:p></span></b></p>
  <p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>Tel.: +</span><span
  lang=3DEN-GB>36 1 239 9095</span><span lang=3DSV style=3D'mso-bidi-font-s=
ize:11.0pt;
  mso-ansi-language:SV'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:3;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>Danmark</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size:=
11.0pt'>
  <br>
  Orion Pharma A/S<br>
  <span class=3DSpellE>Tlf</span>: +45 8614 0000</span><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:CS'><o:p></o:p></=
span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none'><b style=3D'mso-bidi-fo=
nt-weight:
  normal'><span lang=3DFR style=3D'mso-bidi-font-size:11.0pt;mso-ansi-langu=
age:
  FR'>Malta</span></b><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DFR
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FR;mso-fareast-langu=
age:
  CS'><o:p></o:p></span></b></p>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DIT style=
=3D'mso-bidi-font-size:
  11.0pt;mso-ansi-language:IT'>Salomone Pharma<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-2.25pt;margin-=
bottom:
  9.0pt;margin-left:0in'><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;
  mso-ansi-language:IT'>Tel: +356&nbsp;21220174</span><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:CS'><o:p></o:p></=
span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:4;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DDE style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:DE'>Deutschland</span></b><span lang=3DDE
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'> <br>
  Orion Pharma GmbH</span><span lang=3DDE style=3D'mso-bidi-font-size:11.0p=
t;
  mso-ansi-language:DE;mso-fareast-language:CS'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><s=
pan
  lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'>Tel: +=
49 40
  899 6890</span><span lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ans=
i-language:
  DE;mso-fareast-language:CS'><o:p></o:p></span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DSV
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:SV'>Nederland</span>=
</b><span
  lang=3DSV style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:SV'><br>
  </span><strong><span lang=3DEN-GB style=3D'font-weight:normal;mso-bidi-fo=
nt-weight:
  bold'>Orion Pharma BVBA/SPRL</span></strong><strong><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt;font-weight:normal'><o:p></o:p></span>=
</strong></p>
  <p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:9.=
0pt;
  margin-left:0in;tab-stops:28.35pt'><span class=3DSpellE><span style=3D'fo=
nt-size:
  11.0pt'>Tl</span></span><span style=3D'font-size:11.0pt'>/Tel: +32 (0)15=
 64 10
  20</span><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:E=
N-GB;
  mso-fareast-language:CS'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:5;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none'><b><span lang=3DFI
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI'>Eesti</span></b>=
<b><span
  lang=3DFI style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI;mso-far=
east-language:
  CS'><o:p></o:p></span></b></p>
  <p class=3DMsoNormal><span lang=3DFI style=3D'mso-bidi-font-size:11.0pt;m=
so-ansi-language:
  FI'>Orion Pharma Eesti O<o:p></o:p></span></p>
  <p class=3DMsoNormal><span lang=3DFI style=3D'mso-bidi-font-size:11.0pt;m=
so-ansi-language:
  FI'>Tel: +372 66 44 550</span><span lang=3DFI style=3D'mso-bidi-font-size=
:11.0pt;
  mso-ansi-language:FI;mso-fareast-language:CS'><o:p></o:p></span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt'><b style=3D'mso-bidi-=
font-weight:
  normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Norge</spa=
n></b><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:CS'>=
<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-hyphenate:none'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Orion Pharma AS<o:p></o:=
p></span></p>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-2.25pt;margin-=
bottom:
  9.0pt;margin-left:0in'><span class=3DSpellE><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
  11.0pt'>Tlf</span></span><span lang=3DEN-GB style=3D'mso-bidi-font-size:1=
1.0pt'>:
  +47 40 00 42 10</span><span lang=3DDE style=3D'mso-bidi-font-size:11.0pt;
  mso-ansi-language:DE;mso-fareast-language:CS'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:6;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><span class=3D=
SpellE><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-si=
ze:11.0pt;
  mso-ansi-language:EN-GB'>&#917;&#955;&#955;&#940;&#948;</span></b></span>=
<b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-si=
ze:11.0pt;
  mso-ansi-language:EN-GB'>&#945;</span></b><span lang=3DFI style=3D'font-s=
ize:
  11.0pt;mso-ansi-language:FI'> <br>
  Orion Pharma Hellas M.E.</span><span style=3D'font-size:11.0pt'>&#928;</s=
pan><span
  lang=3DFI style=3D'font-size:11.0pt;mso-ansi-language:FI'>.E<o:p></o:p></=
span></p>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><span class=3D=
SpellE><span
  style=3D'font-size:11.0pt'>&#932;&#951;&#955;</span></span><span lang=3DFI
  style=3D'font-size:11.0pt;mso-ansi-language:FI'>: + 30&nbsp;210&nbsp;980 =
3355</span><span
  lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p></o:=
p></span></p>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt'><b style=3D'mso-bidi-=
font-weight:
  normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast=
-language:
  CS'><o:p>&nbsp;</o:p></span></b></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DDE style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:DE'>sterreich</span></b><span lang=3DDE
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'><br>
  Orion Pharma GmbH</span><span lang=3DDE style=3D'mso-bidi-font-size:11.0p=
t;
  mso-ansi-language:DE;mso-fareast-language:CS'><o:p></o:p></span></p>
  <p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:9.=
0pt;
  margin-left:0in;tab-stops:28.35pt'><span lang=3DDE style=3D'font-size:11.=
0pt;
  mso-ansi-language:DE'>Tel: +49 40 899 6890</span><span lang=3DEN-GB
  style=3D'font-size:11.0pt;mso-ansi-language:EN-GB;mso-fareast-language:CS=
'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:7;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><b style=3D'ms=
o-bidi-font-weight:
  normal'><span lang=3DIT style=3D'font-size:11.0pt;mso-ansi-language:IT'>E=
spaa</span></b><span
  lang=3DIT style=3D'font-size:11.0pt;mso-ansi-language:IT'> <br>
  </span><span style=3D'font-size:11.0pt'>Orion Pharma S.L.</span><span
  style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><span
  style=3D'font-size:11.0pt'>Tel: + 34 91 &nbsp;599 86 01</span><span lang=
=3DEN-GB
  style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt'><b style=3D'mso-bidi-=
font-weight:
  normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast=
-language:
  CS'><o:p>&nbsp;</o:p></span></b></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>Polska</span></b><b style=3D'mso-bidi=
-font-weight:
  normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast=
-language:
  CS'><o:p></o:p></span></b></p>
  <p class=3DMsoNormal><span lang=3DSV style=3D'mso-bidi-font-size:11.0pt;m=
so-ansi-language:
  SV'>Orion Pharma Poland Sp z.o.o.</span><span lang=3DEN-GB style=3D'mso-b=
idi-font-size:
  11.0pt'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-bottom:9.0pt'><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>Tel.: + 48 22 8333177</span><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:CS'>=
<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:8;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><b style=3D'ms=
o-bidi-font-weight:
  normal'><span lang=3DFR style=3D'font-size:11.0pt;mso-ansi-language:FR'>F=
rance</span></b><span
  lang=3DFR style=3D'font-size:11.0pt;mso-ansi-language:FR'> <br>
  </span><span style=3D'font-size:11.0pt;mso-fareast-font-family:Calibri;
  mso-fareast-language:EN-GB'>Centre <span class=3DSpellE>Spcialits</span=
> <span
  class=3DSpellE>Pharmaceutiques</span></span><span lang=3DFR style=3D'font=
-size:
  11.0pt;mso-ansi-language:FR'><o:p></o:p></span></p>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><span
  style=3D'font-size:11.0pt;mso-fareast-font-family:Calibri;mso-fareast-lan=
guage:
  EN-GB'>Tel: + 33 (0) 1 47 04 80 46</span><span lang=3DFR style=3D'font-si=
ze:11.0pt;
  mso-ansi-language:FR'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt'><b style=3D'mso-bidi-=
font-weight:
  normal'><span lang=3DFR style=3D'mso-bidi-font-size:11.0pt;mso-ansi-langu=
age:
  FR;mso-fareast-language:CS'><o:p>&nbsp;</o:p></span></b></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;tab-=
stops:
  28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DIT
  style=3D'font-size:11.0pt;mso-ansi-language:IT'>Portugal</span></b><span
  lang=3DIT style=3D'font-size:11.0pt;mso-ansi-language:IT'><br>
  </span><span class=3DSpellE><span style=3D'font-size:11.0pt'>Orionfin</sp=
an></span><span
  style=3D'font-size:11.0pt'> <span class=3DSpellE>Unipessoal</span> <span
  class=3DSpellE>Lda</span></span><span lang=3DIT style=3D'font-size:11.0pt;
  mso-ansi-language:IT'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-2.25pt;margin-=
bottom:
  9.0pt;margin-left:0in'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.=
0pt'>Tel:
  + 351 21 154 68 20</span><span lang=3DFR style=3D'mso-bidi-font-size:11.0=
pt;
  mso-ansi-language:FR;mso-fareast-language:CS'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:9;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DFI style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:FI;mso-fareast-language:CS'>Hrvatska<o:p></o:p><=
/span></b></p>
  <p class=3DMsoNormal><strong><span lang=3DFI style=3D'mso-bidi-font-size:=
11.0pt;
  mso-ansi-language:FI;font-weight:normal;mso-bidi-font-weight:bold'>Orion
  Pharma d.o.o.<o:p></o:p></span></strong></p>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><s=
pan
  lang=3DFI style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI'>Tel:</=
span><span
  lang=3DFI style=3D'mso-ansi-language:FI'> +386&nbsp;(0) 1 600 8015</span>=
<span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:CS'>=
<o:p></o:p></span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:12.0pt;mso-line-height-rule:exa=
ctly;
  mso-layout-grid-align:none;text-autospace:none'><span class=3DSpellE><b><=
span
  lang=3DFR style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-languag=
e:FR'>Romnia</span></b></span><b><span
  lang=3DFR style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-languag=
e:FR'><o:p></o:p></span></b></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-layout-grid-align:no=
ne;
  text-autospace:none'><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;
  mso-ansi-language:IT'>Orion Corporation</span><span lang=3DFR style=3D'ms=
o-bidi-font-size:
  11.0pt;color:black;mso-ansi-language:FR'><o:p></o:p></span></p>
  <p class=3DMsoNormal><span lang=3DFR style=3D'mso-bidi-font-size:11.0pt;c=
olor:black;
  mso-ansi-language:FR'>Tel: +358 10 4261<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:10;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><b style=3D'mso-bidi-fo=
nt-weight:
  normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Ireland</s=
pan></b><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'> <br>
  Orion Pharma (Ireland) Ltd.</span><span lang=3DEN-GB style=3D'mso-bidi-fo=
nt-size:
  11.0pt;mso-fareast-language:CS'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>c/o <span class=3DSpellE>Allphar</spa=
n>
  Services Ltd.<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-hyphenate:none'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Tel: +353 1 428 7777<o:p=
></o:p></span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DIT
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'>Slovenija</span>=
</b><span
  lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT;mso-far=
east-language:
  CS'><o:p></o:p></span></p>
  <p class=3DMsoNormal><strong><span lang=3DFI style=3D'mso-bidi-font-size:=
11.0pt;
  mso-ansi-language:FI;font-weight:normal;mso-bidi-font-weight:bold'>Orion
  Pharma d.o.o.<o:p></o:p></span></strong></p>
  <p class=3DMsoNormal style=3D'margin-bottom:9.0pt'><span lang=3DFI
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI'>Tel:</span><span
  lang=3DFI style=3D'mso-ansi-language:FI'> +386&nbsp;(0) 1 600 8015</span>=
<b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt;mso-fareast-language:CS'><o:p></o:p></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:11;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt'><span class=3DSpellE>=
<b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>sland</span></b></span><b style=3D'mso-bidi-font-weight:normal'>=
<span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:CS'>=
<o:p></o:p></span></b></p>
  <p class=3DMsoNormal style=3D'line-height:normal'><span class=3DSpellE><s=
pan
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Vistor</span></span><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'> hf.<o:p></o:p></span></=
p>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><span class=3D=
SpellE><span
  style=3D'font-size:11.0pt'>Smi</span></span><span style=3D'font-size:11.=
0pt'>:
  +354 535 7000</span><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi=
-language:
  EN-GB;mso-fareast-language:CS'><o:p></o:p></span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none'><b style=3D'mso-bidi-fo=
nt-weight:
  normal'><span lang=3DSV style=3D'mso-bidi-font-size:11.0pt;mso-ansi-langu=
age:
  SV'>Slovensk republika</span></b><b style=3D'mso-bidi-font-weight:normal=
'><span
  lang=3DSV style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:SV;mso-far=
east-language:
  CS'><o:p></o:p></span></b></p>
  <p class=3DMsoNormal><strong><span lang=3DSV style=3D'mso-bidi-font-size:=
11.0pt;
  mso-ansi-language:SV;font-weight:normal;mso-bidi-font-weight:bold'>Orion
  Pharma s.r.o<o:p></o:p></span></strong></p>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-2.25pt;margin-=
bottom:
  9.0pt;margin-left:0in;line-height:normal'><span lang=3DSV style=3D'mso-an=
si-language:
  SV'>Tel: </span><span lang=3DSV><span style=3D'mso-spacerun:yes'></span>=
</span><span
  lang=3DSV style=3D'mso-ansi-language:SV'>+420 234 703 305</span><span lan=
g=3DIT
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT;mso-fareast-langu=
age:
  CS'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:12;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><b style=3D'ms=
o-bidi-font-weight:
  normal'><span lang=3DIT style=3D'font-size:11.0pt;mso-ansi-language:IT'>I=
talia</span></b><span
  lang=3DIT style=3D'font-size:11.0pt;mso-ansi-language:IT'><br>
  </span><span lang=3DFI style=3D'font-size:11.0pt;mso-ansi-language:FI'>Or=
ion
  Pharma S.r.l.<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-bottom:9.0pt;mso-hyphenate:none'><sp=
an
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Tel: + 39 02&nbsp;678761=
11</span><span
  lang=3DEL style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EL;mso-far=
east-language:
  CS'><o:p></o:p></span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DIT style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:IT'>Suomi/Finland<br>
  </span></b><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-la=
nguage:
  IT'>Orion Corporation</span><span lang=3DIT style=3D'mso-bidi-font-size:1=
1.0pt;
  mso-ansi-language:IT;mso-fareast-language:CS'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><s=
pan
  lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'>Puh./T=
el: +358
  10 4261</span><span lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ansi=
-language:
  DE;mso-fareast-language:CS'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:13;page-break-inside:avoid'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEL
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EL'>&#922;&#973;&#96=
0;&#961;&#959;&#962;</span></b><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEL style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:EL;mso-fareast-language:CS'><o:p></o:p></span></=
b></p>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none;tab-stops:-.5in 28.35pt =
3.15in'><span
  lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'>Lifeph=
arma
  (ZAM) Ltd<o:p></o:p></span></p>
  <p class=3DMsoNormal><span class=3DSpellE><span lang=3DEN-GB style=3D'mso=
-bidi-font-size:
  11.0pt'>&#932;&#951;&#955;</span></span><span lang=3DDE style=3D'mso-bidi=
-font-size:
  11.0pt;mso-ansi-language:DE'>.: +357 22056300</span><span lang=3DDE
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE;mso-fareast-langu=
age:
  CS'><o:p></o:p></span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DDE style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:DE'>Sverige</span></b><span lang=3DDE
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'><br>
  Orion Pharma AB</span><span lang=3DDE style=3D'mso-bidi-font-size:11.0pt;
  mso-ansi-language:DE;mso-fareast-language:CS'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><s=
pan
  lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'>Tel: +=
46 8 623
  6440<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:14;mso-yfti-lastrow:yes;page-break-inside:avoid=
'>
  <td width=3D309 valign=3Dtop style=3D'width:232.05pt;padding:0in 5.4pt 0i=
n 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DFI
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI'>Latvija</span></=
b><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DFI style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:FI;mso-fareast-language:CS'><o:p></o:p></span></=
b></p>
  <p class=3DMsoNormal><span style=3D'mso-bidi-font-size:11.0pt;mso-ansi-la=
nguage:
  EN-US'>Orion Corporation<o:p></o:p></span></p>
  <p class=3DMsoNormal><span style=3D'mso-bidi-font-size:11.0pt;mso-ansi-la=
nguage:
  EN-US'>Orion Pharma <span class=3DSpellE>p&#257;rst&#257;vniec&#299;ba</s=
pan><o:p></o:p></span></p>
  <p class=3DMsoNormal><span style=3D'mso-bidi-font-size:11.0pt;mso-ansi-la=
nguage:
  EN-US'>Tel: +371 20028332<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none'><span style=3D'mso-bidi=
-font-size:
  11.0pt;mso-ansi-language:EN-US;mso-fareast-language:CS'><o:p>&nbsp;</o:p>=
</span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.7pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt'><b style=3D'mso-bidi-=
font-weight:
  normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>United Kin=
gdom</span></b><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:CS'>=
<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-hyphenate:none'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Orion Pharma (UK) Ltd.<o=
:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none'><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>Tel: +44 1635 520 300</span><span lan=
g=3DFI
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI;mso-fareast-langu=
age:
  CS'><o:p></o:p></span></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt'>This leaflet was last revised in.<o:p></o:p></span></b></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'mso-no-proof:yes'>Other sources of information<o:p></o:p></span></=
b></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Detailed
information on this medicine is available on the European Medicines Agency =
web
site: <a href=3D"http://www.ema.europa.eu">http://www.ema.europa.eu</a>. <o=
:p></o:p></span></p>

<span lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",=
serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB;mso-farea=
st-language:
EN-US;mso-bidi-language:AR-SA'><br clear=3Dall style=3D'page-break-before:a=
lways'>
</span>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><b style=3D=
'mso-bidi-font-weight:
normal'><span lang=3DEN-GB style=3D'color:black'>Package leaflet: Informati=
on for
the user</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><=
o:p></o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><b style=3D=
'mso-bidi-font-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;text-transfor=
m:uppercase'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><b style=3D=
'mso-bidi-font-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;text-transfor=
m:uppercase'>s</span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt'>talevo 200&nbsp;mg/50&nbsp;mg/200&nbsp;mg film-coated tablets<o:p><=
/o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DIT
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'>levodopa/carbidopa=
/entacapone<b
style=3D'mso-bidi-font-weight:normal'><span style=3D'text-transform:upperca=
se'><o:p></o:p></span></b></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DIT
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'><o:p>&nbsp;</o:p><=
/span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>Read
all of this leaflet carefully before you start taking this medicine because=
 it
contains important information for you.<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-list:l1 level1 lfo3;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ig=
nore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>Keep
this leaflet. You may need to read it again.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-list:l1 level1 lfo3;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ig=
nore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>If
you have any further questions, ask your doctor or pharmacist.<o:p></o:p></=
span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;tab-stops:28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'>-<span
style=3D'mso-tab-count:1'> </span>This medicine has been prescribed =
for
you only. Do not pass it on to others. It may harm them, even if their sign=
s of
illness are the same as yours.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l1 level1 lfo53'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-no-pr=
oof:
yes'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New =
Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&=
nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-no-proof:yes=
'>If you
get any side effects, talk to your doctor or pharmacist.</span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:red'> </span><span
lang=3DEN-GB style=3D'mso-no-proof:yes'>This includes any possible side eff=
ects not
listed in this leaflet. See section 4.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>What
is in this leaflet:<o:p></o:p></span></b></p>

<p class=3DMsoNormal><span lang=3DEN-GB>1.<span style=3D'mso-tab-count:1'>=
 </span>What
Stalevo is and what it is used for</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>2.<span style=3D'mso-tab-count:1'>=
 </span><span
style=3D'mso-no-proof:yes'>What you need to know</span> before you take Sta=
levo</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>3.<span style=3D'mso-tab-count:1'>=
 </span>How
to take Stalevo</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>4.<span style=3D'mso-tab-count:1'>=
 </span>Possible
side effects</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>5<span style=3D'mso-tab-count:1'>=
 </span>How
to store Stalevo</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>6.<span style=3D'mso-tab-count:1'>=
 </span><span
style=3D'mso-no-proof:yes'>Contents of the pack and other information</span=
></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'text-transform:uppercase'>1.<span style=3D'mso-tab-count:1'>=
 </span></span><span
lang=3DEN-GB>What Stalevo is and what it is used for<span style=3D'text-tra=
nsform:
uppercase'><o:p></o:p></span></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><b style=3D'mso-bidi-font=
-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;<=
/o:p></span></b></p>

<p class=3DMsoBodyText3 align=3Dleft style=3D'text-align:left;line-height:n=
ormal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-sty=
le:normal'>Stalevo
contains three active substances (levodopa, carbidopa and entacapone) in one
film-coated tablet. Stalevo is used for the treatment of Parkinsons diseas=
e. <o:p></o:p></span></p>

<p class=3DMsoBodyText3 align=3Dleft style=3D'text-align:left;line-height:n=
ormal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-sty=
le:normal'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Parkinsons disease is cau=
sed by
low levels of a substance called dopamine in the brain. Levodopa increases =
the
amount of dopamine and hence reduces the symptoms of Parkinsons disease.
Carbidopa and entacapone improve the <span class=3DSpellE>antiparkinson</sp=
an>
effects of levodopa. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'text-transform:uppercase'>2.<span style=3D'mso-tab-count:1'>=
 </span></span><span
lang=3DEN-GB>What you need to know before you take Stalevo<span style=3D'te=
xt-transform:
uppercase'><o:p></o:p></span></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>Do
not take Stalevo if you:<o:p></o:p></span></b></p>

<p class=3DMsoNormal><span style=3D'mso-ansi-language:EN-US'><o:p>&nbsp;</o=
:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l42 level1 lfo17;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>are allergic to levodopa, carbidopa or entacapone,=
 or
any of the other ingredients of this medicine </span><span style=3D'font-si=
ze:
11.0pt;mso-no-proof:yes'>(listed in section 6)</span><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l42 level1 lfo17;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>have narrow-angle glaucoma (an eye disorder)<o:p><=
/o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l42 level1 lfo17;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>have a tumour of the adrenal gland<o:p></o:p></spa=
n></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l42 level1 lfo17;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>are taking certain medicines for treating depressi=
on (</span><span
style=3D'font-size:11.0pt'>combinations of </span><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>selective MAO-A and MAO-B
inhibitors, or non-selective MAO-inhibitors)<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l42 level1 lfo17;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>have ever had neuroleptic malignant syndrome (NMS 
this is a rare reaction to medicines used to treat severe mental disorders)=
<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l42 level1 lfo17;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>have ever had non-traumatic rhabdomyolysis (a rare
muscle disorder)<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l42 level1 lfo17;tab-stops:28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>have a severe liver disease. <o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-la=
nguage:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'mso-no-proof:yes'>Warnings and precautions</span><span lang=3DEN-G=
B><o:p></o:p></span></b></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0=
pt'>Talk
to your doctor or pharmacist before taking <span class=3DSpellE>Stalevoif</=
span>
you have or have ever had</span></u><span lang=3DEN-GB style=3D'mso-bidi-fo=
nt-size:
11.0pt'>:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>a
heart attack or any other diseases of the heart including cardiac arrhythmi=
as,
or of the blood vessels<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>asthma
or any other disease of the lungs<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>a
liver problem, because your dose may need to be adjusted<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>kidney
or hormone-related diseases<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>stomach
ulcers or convulsions<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>if
you experience prolonged diarrhoea consult your doctor as it may be a sign =
of
inflammation of the colon<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>any
form of severe mental disorder like psychosis<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>chronic
wide-angle glaucoma, because your dose may need to be adjusted and the pres=
sure
in your eyes may need to be monitored.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0=
pt'>Consult
your doctor if you are currently taking</span></u><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>antipsychotics
(medicines used to treat psychosis)<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>a
medicine which may cause low blood pressure when rising from a chair or bed.
You should be aware that Stalevo may make these reactions worse.<o:p></o:p>=
</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0=
pt'>Consult
your doctor if during the treatment with Stalevo you</span></u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>notice
that your muscles get very rigid or jerk violently, or if you get tremors,
agitation, confusion, fever, rapid pulse, or wide fluctuations in your blood
pressure. If any of this happens, <b style=3D'mso-bidi-font-weight:normal'>=
contact
your doctor immediately</b><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>feel
depressed, have suicidal thoughts, or notice unusual changes in your behavi=
our<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>find
yourself suddenly falling asleep, or if you feel very drowsy. If this happe=
ns,
you should not drive or use any tools or machines (see also section 'Driving
and using machines')<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>notice
that uncontrolled movements begin or get worse after you started to take
Stalevo. If this happens, your doctor may need to change the dose of your <=
span
class=3DSpellE>antiparkinson</span> medicine <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>experience
diarrhoea: monitoring of your weight is recommended in order to avoid poten=
tially
excessive weight loss<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>experience
progressive anorexia, asthenia (weakness, exhaustion) and weight decrease w=
ithin
a relatively short period of time. If this happens, a general medical
evaluation including liver function should be considered<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>feel
the need to stop using Stalevo, see section 'If you stop taking Stalevo'.<o=
:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Tell your
doctor if you or your family/carer notices you are developing addiction-like
symptoms leading to craving for large doses of Stalevo and other medicines =
used
to treat Parkinsons disease.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span style=3D'mso-bidi-font-size:11.0pt;mso-ansi-lang=
uage:
EN-US'>Tell your doctor if you or your family/<span class=3DSpellE>carer</s=
pan>
notices you are developing urges or cravings to behave in ways that are unu=
sual
for you or you cannot resist the impulse, drive or temptation to carry out
certain activities that could harm yourself or others. These <span
class=3DSpellE>behaviours</span> are called impulse control disorders and c=
an
include addictive gambling, excessive eating or spending, an abnormally high
sex drive or a preoccupation with an increase in sexual thoughts or feeling=
s. <u>Your
doctor may need to review your treatments.</u> <o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Your
doctor may take some regular laboratory tests during a long term treatment =
with
Stalevo.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>If you
must undergo surgery, please tell your doctor that you are using Stalevo.<o=
:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Stalevo
is not recommended to be used for treatment of extrapyramidal symptoms (e.g.
involuntary movements, shaking, muscle rigidity and muscle contractions</sp=
an><span
lang=3DEN style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EN'>)</span>=
<span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'> caused by other medicines=
.<o:p></o:p></span></p>

<p class=3DMsoNormal><u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0=
pt'><o:p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'mso-bidi-font-size:11.0pt'>Children </span><span lang=3DEN-GB
style=3D'color:black'>and adolescents<o:p></o:p></span></b></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>Experience
with Stalevo in patients under 18 years is limited. Therefore, the use of
Stalevo in children or adolescents is not recommended.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
tab-stops:28.35pt'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-la=
nguage:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>Other
medicines and Stalevo<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoBodyText style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-style:normal'>Te=
ll
your doctor or pharmacist if you are taking, have recently taken or might t=
ake any
other medicines.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Do not take Stalevo if you=
 are
taking certain medicines for treating depression (combinations of selective
MAO-A and MAO-B inhibitors, or non-selective MAO inhibitors).<o:p></o:p></s=
pan></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Stalevo may increase the e=
ffects
and side effects of certain medicines. These include: <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>medicines
used to treat depression such as moclobemide, amitriptyline, desipramine,
maprotiline, venlafaxine and paroxetine <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span class=3DSpellE><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>rimiterole</span></span><span lang=3DEN=
-GB
style=3D'mso-bidi-font-size:11.0pt'> and isoprenaline, used to treat respir=
atory
diseases <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>adrenaline,
used </span><span lang=3DPT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-lan=
guage:
PT'>for severe allergic reactions</span><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
11.0pt'> <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l42 level1 lfo17'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>noradrenaline,
dopamine and dobutamine, used to treat heart diseases and low blood pressur=
e<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>-<span
style=3D'mso-tab-count:1'> </span>alpha-methyldopa, used to treat hi=
gh
blood pressure <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>-<span
style=3D'mso-tab-count:1'> </span>apomorphine, which is used to treat
Parkinsons disease.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;tab-sto=
ps:17.1pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;tab-st=
ops:28.35pt'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>The effects=
 of
Stalevo may be weakened by certain medicines. These include: <o:p></o:p></s=
pan></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l39 level1 lfo59'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>dopamine
antagonists used to treat mental disorders, nausea and vomiting<o:p></o:p><=
/span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l39 level1 lfo59'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>phenytoin,
used to prevent convulsions <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l39 level1 lfo59'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>papaverine
used to relax the muscles.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;tab-st=
ops:28.35pt'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>Stalevo may=
 make it
harder for you to digest iron. Therefore, do not take Stalevo and iron
supplements at the same time. After taking one of them, wait at least 2 to 3
hours before taking the other.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;tab-st=
ops:28.35pt'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>Stalevo
with food and drink<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoBodyText style=3D'text-align:justify;line-height:normal;tab-s=
tops:
28.35pt'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;font-weight:=
normal;
font-style:normal'>Stalevo may be taken with or without food. For some pati=
ents,
Stalevo may not be well absorbed if it is taken with, or shortly after eati=
ng
protein-rich food (such as meats, fish, dairy products, seeds and nuts).
Consult your doctor if you think this applies to you.<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;tab-st=
ops:28.35pt'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>Pregnancy,
breast-feeding and fertility<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoBodyText style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-style:normal'>If=
 you are
pregnant or breast-feeding, think you may be pregnant or are planning to ha=
ve a
baby, ask your doctor or pharmacist for advice before taking this medicine.=
 <o:p></o:p></span></p>

<p class=3DMsoBodyText style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-style:normal'><o=
:p>&nbsp;</o:p></span></p>

<p class=3DMsoBodyText style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-style:normal'>You
should not breast-feed during treatment with Stalevo.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>Driving
and using machines<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>Stalevo may lower your blood pressure, =
which
may make you feel light-headed or dizzy. Therefore, be particularly careful
when you drive or when you use any tools or machines.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>If you feel very drowsy, or if you some=
times
find yourself suddenly falling asleep, wait until you feel fully awake again
before driving or doing anything else that requires you to be alert. Otherw=
ise,
you may put yourself and others at risk of serious injury or death.<o:p></o=
:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt'>Stalevo contains sucrose<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>Stalevo contains sucrose
(2.3&nbsp;mg/tablet). If you have been told by your doctor that you have
intolerance to some sugars, contact your doctor before taking this medicinal
product.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'text-transform:uppercase'>3.<span style=3D'mso-tab-count:1'>=
 </span></span><span
lang=3DEN-GB>How to take Stalevo<span style=3D'text-transform:uppercase'><o=
:p></o:p></span></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Always take this medicine =
exactly
as your doctor or pharmacist has told you. Check with your doctor or pharma=
cist
if you are not sure.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>For adults and elderly</sp=
an></u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l49 level1 lfo18;tab-stops:list 28.35pt'><![if !supportList=
s]><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ig=
nore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>Your
doctor will tell you exactly how many tablets of Stalevo to take each day. =
<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l49 level1 lfo18;tab-stops:list 28.35pt'><![if !supportList=
s]><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ig=
nore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>The
tablets are not intended to be split or broken into smaller pieces.<o:p></o=
:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l49 level1 lfo18;tab-stops:list 28.35pt'><![if !supportList=
s]><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ig=
nore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>You
should take only one tablet each time.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l49 level1 lfo18;tab-stops:list 28.35pt'><![if !supportList=
s]><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ig=
nore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>Depending
on how you respond to treatment, your doctor may suggest a higher or lower
dose. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-list:l49 level1 lfo18;tab-stops:list 28.35pt'><![if !supportList=
s]><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ig=
nore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>If
you are taking Stalevo 200&nbsp;mg/50&nbsp;mg/200&nbsp;mg, do not take more
than 7 tablets of this strength per day.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;text-align:justify;line-he=
ight:
normal;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt=
'>Talk
to your doctor or pharmacist if you think the effect of Stalevo is too stro=
ng
or too weak, or if you experience possible side effects.<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'line-height:13.0pt'><span lang=3DEN-GB><!--[i=
f gte vml 1]><v:shape
 id=3D"_x0000_i1033" type=3D"#_x0000_t75" style=3D'width:468pt;height:91.5p=
t'>
 <v:imagedata src=3D"Stalevo_clean_files/image013.emz" o:title=3D""/>
</v:shape><![endif]--><![if !vml]><img border=3D0 width=3D624 height=3D122
src=3D"Stalevo_clean_files/image014.png" v:shapes=3D"_x0000_i1033"><![endif=
]></span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'mso-bidi-font-size:11.0pt'>If you take more Stalevo than you shoul=
d<o:p></o:p></span></b></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>If you have accidentally taken more Sta=
levo
tablets than you should, talk to your doctor or pharmacist immediately. In =
case
of an overdose you may feel confused or agitated, your heart rate may be sl=
ower
or faster than normal or the colour of your skin, tongue, eyes or urine may
change.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>If
you forget to take Stalevo<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>Do not take a double dose to make up fo=
r a
forgotten tablet.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p><span style=3D'text-d=
ecoration:
 none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>If it is more than 1 hour =
until
your next dose</span></u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.=
0pt'>: <o:p></o:p></span></p>

<p class=3DMsoBodyText style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;font-style:normal'>Ta=
ke one
tablet as soon as you remember, and the next tablet at the normal time. <o:=
p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>If it is less than 1 hour =
until
your next dose</span></u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.=
0pt'>: <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Take a tablet as soon as y=
ou
remember, wait 1 hour, then take another tablet. After that carry on as nor=
mal.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Always leave at least an h=
our
between Stalevo tablets, to avoid possible side effects.<o:p></o:p></span><=
/p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>If
you stop taking Stalevo <o:p></o:p></span></b></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Do not stop taking Stalevo=
 unless
your doctor tells you to. In such a case your doctor may need to adjust your
other <span class=3DSpellE>antiparkinson</span> medicines, especially levod=
opa,
to give sufficient control of your symptoms. If you suddenly stop taking of
Stalevo and other antiparkinsonian medicines it may result in unwanted side
effects. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>If you have any further qu=
estions
on the use of this medicine, ask your doctor or pharmacist.<o:p></o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'text-transform:uppercase'>4.<span style=3D'mso-tab-count:1'>=
 </span></span><span
lang=3DEN-GB>Possible side effects<span style=3D'text-transform:uppercase'>=
<o:p></o:p></span></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-1.4pt;line-height:normal;mso-ou=
tline-level:
1;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:=
p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.4pt;line-height:normal;mso-ou=
tline-level:
1;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Lik=
e all
medicines, this medicine can cause side effects, although not everybody gets
them. Many of the side effects can be relieved by adjusting the dose. <o:p>=
</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.4pt;line-height:normal;mso-ou=
tline-level:
1;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:=
p>&nbsp;</o:p></span></p>

<p class=3DText style=3D'margin-top:0in'><span style=3D'font-size:11.0pt'>I=
f you
during the treatment with Stalevo experience the following symptoms, <b
style=3D'mso-bidi-font-weight:normal'>contact your doctor immediately</b>: =
<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:25.65pt;margin-bottom:.0001pt;text-indent:-25.65pt;mso-list:l50=
 level1 lfo26'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-size:11.0pt'>Your muscle=
s get
very rigid or jerk violently, you get tremors, agitation, confusion, fever,
rapid pulse, or wide fluctuations in your blood pressure. These can be symp=
toms
</span><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB=
'>of
neuroleptic malignant syndrome (NMS, a rare severe reaction to medicines us=
ed
to treat disorders of the central nervous system) or rhabdomyolysis (a rare
severe muscle disorder).<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:25.65pt;margin-bottom:.0001pt;text-indent:-25.65pt;mso-list:l37=
 level1 lfo27'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>Allergic reaction, the signs may include hives (ne=
ttle
rash), itching, rash, swelling of your face, lips, tongue or throat. This m=
ay
cause difficulties in breathing or swallowing.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.4pt;line-height:normal;mso-ou=
tline-level:
1;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:=
p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><u><span lang=3DEN-GB>Very common (may affect more tha=
n 1 in
10 people)<o:p></o:p></span></u></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>uncontrolled movements (dyskinesias)<o:p></o:p></s=
pan></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>feeling sick (nausea)<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>harmless reddish-brown discolouration of urine<o:p=
></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>muscle pain<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>diarrhoea<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><span lang=3DEN-=
GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span>=
</p>

<p class=3DMsoNormal><u><span lang=3DEN-GB>Common (may affect up to 1 in 10=
 people)<o:p></o:p></span></u></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>light-headedness or fainting due to low blood
pressure, high blood pressure<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>worsening of Parkinsons symptoms, dizziness,
drowsiness<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>vomiting, abdominal pain and discomfort, heartburn,
dry mouth, constipation<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>inability to sleep, hallucinations, confusion abno=
rmal
dreams (including nightmares), tiredness<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>mental changes  including problems with memory,
anxiety and depression (possibly with thoughts of suicide) <o:p></o:p></spa=
n></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-size:11.0pt'>heart or ar=
tery
disease events (e.g. chest pain), irregular heart rate or rhythm </span><sp=
an
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p></o:p>=
</span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>more frequent falling <o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>shortness of breath <o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>increased sweating, rashes<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>muscle cramps, swelling of legs<o:p></o:p></span><=
/p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>blurred vision<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>anaemia<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>decreased appetite, decreased weight<o:p></o:p></s=
pan></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>headache, joint pain<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>urinary tract infection<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;tab-st=
ops:28.35pt'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p>&nbsp;=
</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;tab-st=
ops:28.35pt'><u><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>Uncommon </=
span></u><u><span
style=3D'font-size:11.0pt;color:black'>(may affect up to 1 in 100&nbsp;peop=
le)</span></u><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p></o:p>=
</span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l14=
 level1 lfo19;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>heart attack<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>bleeding in the gut<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>changes in the blood cell count which may result i=
n bleeding,
abnormal liver function tests<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>convulsions<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>feeling agitated<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>psychotic symptoms<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>colitis (inflammation of the colon)<o:p></o:p></sp=
an></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span class=3DSpellE><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>discolourations</span></=
span><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'> other than=
 urine
(e.g. skin, nail, hair, sweat)<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>swallowing difficulties<o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l14 level1 lfo19;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D'font-size:11.0pt'>inability to
urinate</span><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-languag=
e:EN-GB'><o:p></o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p>&nbsp;=
</o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left'><u><s=
pan
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>Not known (=
cannot
be estimated from the available data)</span></u><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in'><span lang=3DEN-GB style=3D'font-s=
ize:11.0pt;
mso-ansi-language:EN-GB'>Craving for large doses of Stalevo in excess of th=
at
required to control motor symptoms, known as dopamine dysregulation syndrom=
e.
Some patients experience severe abnormal involuntary movements (dyskinesias=
),
mood swings or other side effects after taking large doses of Stalevo.<o:p>=
</o:p></span></p>

<p class=3DText style=3D'margin-top:0in'><span lang=3DEN-GB style=3D'font-s=
ize:11.0pt;
mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DText style=3D'margin-top:0in'><u><span lang=3DEN-GB style=3D'fon=
t-size:11.0pt;
mso-ansi-language:EN-GB'>The following side effects have also been reported=
</span></u><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>: <o:p></o:=
p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l4 =
level1 lfo22;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>hepatitis </span><span style=3D'font-size:11.0pt'>=
(inflammation
of the liver)</span><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-l=
anguage:
EN-GB'> <o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l4 =
level1 lfo22;
tab-stops:list 28.35pt'><![if !supportLists]><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>itching<o:p></o:p></span></p>

<p class=3DText style=3D'margin-top:0in'><span lang=3DEN-GB style=3D'font-s=
ize:11.0pt;
mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:4.8pt;mso-pagination:none'><u><s=
pan
lang=3DEN-GB style=3D'color:black'>You may experience the following side ef=
fects: <o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:4.8pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:
normal;mso-pagination:none;mso-list:l10 level1 lfo49;tab-stops:28.35pt'><![=
if !supportLists]><span
lang=3DEN-GB style=3D'font-family:"Arial",sans-serif;mso-fareast-font-famil=
y:Arial;
color:black'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Ti=
mes New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp=
;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
color:black'>Inability to resist the impulse to perform an action that coul=
d be
harmful, which may include:</span><span lang=3DEN-GB style=3D'color:black'>=
<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:4.8pt;margin-bott=
om:0in;
margin-left:.75in;margin-bottom:.0001pt;text-indent:-.25in;line-height:norm=
al;
mso-pagination:none;mso-list:l9 level2 lfo51;tab-stops:list .75in'><![if !s=
upportLists]><span
lang=3DEN-GB style=3D'font-family:"Arial",sans-serif;mso-fareast-font-famil=
y:Arial;
color:black'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Ti=
mes New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
color:black'>strong impulse to gamble excessively despite serious personal =
or family
consequences</span><span lang=3DEN-GB style=3D'color:black'><o:p></o:p></sp=
an></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:4.8pt;margin-bott=
om:0in;
margin-left:.75in;margin-bottom:.0001pt;text-indent:-.25in;line-height:norm=
al;
mso-pagination:none;mso-list:l9 level2 lfo51;tab-stops:list .75in'><![if !s=
upportLists]><span
lang=3DEN-GB style=3D'font-family:"Arial",sans-serif;mso-fareast-font-famil=
y:Arial;
color:black'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Ti=
mes New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
color:black'>altered or increased sexual interest and behaviour of signific=
ant
concern to you or to others, for example, an increased sexual drive</span><=
span
lang=3DEN-GB style=3D'color:black'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:4.8pt;margin-bott=
om:0in;
margin-left:.75in;margin-bottom:.0001pt;text-indent:-.25in;line-height:norm=
al;
mso-pagination:none;mso-list:l9 level2 lfo51;tab-stops:list .75in'><![if !s=
upportLists]><span
lang=3DEN-GB style=3D'font-family:"Arial",sans-serif;mso-fareast-font-famil=
y:Arial;
color:black'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Ti=
mes New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
color:black'>uncontrollable excessive shopping or spending</span><span
lang=3DEN-GB style=3D'color:black'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:4.8pt;margin-bott=
om:0in;
margin-left:.75in;margin-bottom:.0001pt;text-indent:-.25in;line-height:norm=
al;
mso-pagination:none;mso-list:l9 level2 lfo51;tab-stops:list .75in'><![if !s=
upportLists]><span
lang=3DEN-GB style=3D'font-family:"Arial",sans-serif;mso-fareast-font-famil=
y:Arial;
color:black'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Ti=
mes New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
color:black'>binge eating (eating large amounts of food in a short time per=
iod)
or compulsive eating (eating more food than normal and more than is needed =
to
satisfy your hunger).</span><span lang=3DEN-GB style=3D'color:black'><o:p><=
/o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:4.8pt;mso-pagination:none'><span
lang=3DEN-GB style=3D'color:black'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:4.8pt;mso-pagination:none;tab-st=
ops:
0in'><span lang=3DEN-GB style=3D'color:black'>Tell your doctor if you exper=
ience
any of these behaviours; they will discuss ways of managing or reducing the
symptoms.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-out=
line-level:
1;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:=
p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-out=
line-level:
1;mso-list:skip'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>Reporting of side effects<o:p></o:p></s=
pan></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-out=
line-level:
1;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>If =
you get
any side effects, talk to your doctor or pharmacist. This includes any poss=
ible
side effects not listed in this leaflet. You can also report side effects
directly via <span style=3D'background:silver;mso-highlight:silver'>the nat=
ional
reporting system listed in <a
href=3D"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_fo=
rm/2013/03/WC500139752.doc">Appendix
V</a></span>. By reporting side <span class=3DSpellE>effects you</span> can=
 help
provide more information on the safety of this medicine.<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'text-transform:uppercase'>5.<span style=3D'mso-tab-count:1'>=
 </span></span><span
lang=3DEN-GB>How to store Stalevo<span style=3D'text-transform:uppercase'><=
o:p></o:p></span></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-out=
line-level:
1;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Kee=
p this
medicine out of the sight and reach of children.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Do not use this medicine a=
fter the
expiry date which is stated on the bottle and the carton after EXP. The exp=
iry
date refers to the last day of that month.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>This medicinal product doe=
s not
require any special storage conditions.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Do not </=
span><span
lang=3DEN-GB style=3D'mso-no-proof:yes'>throw away any medicines</span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'> via wastewater or househo=
ld
waste. Ask your pharmacist how to </span><span lang=3DEN-GB style=3D'mso-no=
-proof:
yes'>throw away</span><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt=
'> of
medicines you no longer use. These measures will help to protect the
environment.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB
style=3D'text-transform:uppercase'>6.<span style=3D'mso-tab-count:1'>=
 </span></span><span
lang=3DEN-GB>Contents of the pack and other information<span style=3D'text-=
transform:
uppercase'><o:p></o:p></span></span></b></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><b style=3D'mso-bidi-font=
-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>What Stalevo
contains<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:27.0pt;margin-bottom:.0001pt;text-indent:-27.0pt;line-height:no=
rmal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-list:l23 level1 lfo15;tab-stops:list 28.35pt'><![if !supportList=
s]><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;font-family:"Arial",sans-se=
rif;
mso-fareast-font-family:Arial'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>The
active substances of Stalevo are levodopa, carbidopa and entacapone.<o:p></=
o:p></span></p>

<p class=3DText align=3Dleft style=3D'margin-top:0in;margin-right:0in;margi=
n-bottom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-=
28.35pt;
mso-list:l23 level1 lfo15;tab-stops:list 28.35pt'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Arial",sans-serif;mso-f=
areast-font-family:
Arial;mso-ansi-language:EN-GB'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>Each Stalevo 200&nbsp;</span><span style=3D'font-s=
ize:
11.0pt'>mg</span><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-lang=
uage:
EN-GB'>/50&nbsp;</span><span style=3D'font-size:11.0pt'>mg</span><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>/200&nbsp;m=
g tablet
contains 200&nbsp;mg of levodopa, 50&nbsp;mg of carbidopa and 200&nbsp;mg of
entacapone.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
pagination:
none;mso-list:l19 level1 lfo9;tab-stops:25.65pt list 28.35pt'><![if !suppor=
tLists]><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ig=
nore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>The
other ingredients in the tablet core are croscarmellose sodium, magnesium
stearate, maize starch, mannitol (E421) and povidone (E1201).<o:p></o:p></s=
pan></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
pagination:
none;mso-list:l20 level1 lfo14;tab-stops:list 28.35pt'><![if !supportLists]=
><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><span style=3D'mso-list:Ig=
nore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>The
ingredients in the film-coating are glycerol (85 per cent) (E422), <span
class=3DSpellE>hypromellose</span>, magnesium stearate, polysorbate 80, red=
 iron
oxide (E172), sucrose and titanium dioxide (E171).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:27.0pt;text-indent:-27.0pt;line-h=
eight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;<=
/o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:27.0pt;text-indent:-27.0pt;line-h=
eight:
normal'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>What Stalevo looks like and contents of=
 the
pack<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-left:27.0pt;text-indent:-27.0pt;line-h=
eight:
normal'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>Stalevo 200&nbsp;mg/50&nbsp;mg/200&nbsp=
;mg:
dark brownish red, oval, unscored film-coated tablets marked with LCE 200=
 on
one side.<o:p></o:p></span></p>

<p class=3DMsoEndnoteText><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoEndnoteText><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt'>Stalevo
200&nbsp;mg/50&nbsp;mg/200&nbsp;mg tablet comes in five different pack sizes
(10, 30, 100, 130 or 175). Not all pack sizes may be marketed.<o:p></o:p></=
span></p>

<p class=3DMsoNormal style=3D'margin-left:27.0pt;text-indent:-27.0pt;line-h=
eight:
normal'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>Marketing
Authorisation Holder</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoEndnoteText><span lang=3DIT style=3D'mso-bidi-font-size:11.0p=
t;
mso-ansi-language:IT'>Orion Corporation<o:p></o:p></span></p>

<p class=3DMsoEndnoteText><span lang=3DIT style=3D'mso-bidi-font-size:11.0p=
t;
mso-ansi-language:IT'>Orionintie 1<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DIT style=3D'=
mso-bidi-font-size:
11.0pt;mso-ansi-language:IT'>FI-02200 Espoo<o:p></o:p></span></p>

<p class=3DMsoEndnoteText><span lang=3DIT style=3D'mso-bidi-font-size:11.0p=
t;
mso-ansi-language:IT'>Finland<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DIT style=3D'=
mso-bidi-font-size:
11.0pt;mso-ansi-language:IT'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-2.25pt'><b style=3D'mso-bidi-fo=
nt-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Manufacturer=
<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-2.25pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>Orion Corporation Orion Pharma<o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-2.25pt'><span class=3DSpellE><s=
pan
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Joensuunkatu</span></span>=
<span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>&nbsp;7<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'margin-right:-2.25pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>FI-24100&nbsp;Salo<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>Finland<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DIT style=3D'=
mso-bidi-font-size:
11.0pt;mso-ansi-language:IT'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-2.25pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold'>Orion Corpora=
tion Orion
Pharma<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-2.25pt'><span class=3DSpellE><s=
pan
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold'>=
Orionintie</span></span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold'>=
&nbsp;1<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-2.25pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold'>FI-02200&nbsp=
;Espoo<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold'>Finland<o:p><=
/o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DIT style=3D'=
mso-bidi-font-size:
11.0pt;mso-ansi-language:IT'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>For any information about =
this
medicine, please contact the local representative of the Marketing
Authorisation Holder.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<table class=3DMsoNormalTable border=3D0 cellspacing=3D0 cellpadding=3D0 wi=
dth=3D621
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;mso-yfti-tbll=
ook:
 1184;mso-padding-alt:0in 5.4pt 0in 5.4pt'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;page-break-inside:avoid=
'>
  <td width=3D310 valign=3Dtop style=3D'width:232.2pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal><a name=3D"_GoBack"></a><span class=3DSpellE><b><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;font-family:"TimesNewRoma=
nPS-BoldMT",serif;
  mso-bidi-font-family:TimesNewRomanPS-BoldMT;mso-fareast-language:EN-GB'>B=
elgi</span></b></span><b><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;font-family:"TimesNewRoma=
nPS-BoldMT",serif;
  mso-bidi-font-family:TimesNewRomanPS-BoldMT;mso-fareast-language:EN-GB'>/=
Belgique/<span
  class=3DSpellE>Belgien</span></span></b><span lang=3DFR style=3D'mso-bidi=
-font-size:
  11.0pt;mso-ansi-language:FR'><br>
  </span><strong><span lang=3DEN-GB style=3D'font-weight:normal;mso-bidi-fo=
nt-weight:
  bold'>Orion Pharma BVBA/SPRL</span></strong><strong><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt;font-weight:normal'><o:p></o:p></span>=
</strong></p>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><span class=3D=
SpellE><span
  style=3D'font-size:11.0pt'>Tl</span></span><span style=3D'font-size:11.0=
pt'>/Tel:
  +32 (0)15 64 10 20</span><span lang=3DFR style=3D'font-size:11.0pt;mso-an=
si-language:
  FR'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt'><b style=3D'mso-bidi-=
font-weight:
  normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast=
-language:
  CS'><o:p>&nbsp;</o:p></span></b></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.9pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DFI
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI'>Lietuva</span></=
b><span
  lang=3DFI style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI;mso-far=
east-language:
  CS'><o:p></o:p></span></p>
  <p class=3DMsoNormal><span lang=3DFI style=3D'mso-bidi-font-size:11.0pt;m=
so-ansi-language:
  FI'>UAB Orion Pharma<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none'><span lang=3DFI style=
=3D'mso-bidi-font-size:
  11.0pt;mso-ansi-language:FI'>Tel. +370 5&nbsp;276 9499</span><span lang=
=3DFI
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI;mso-fareast-langu=
age:
  CS'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:1;page-break-inside:avoid'>
  <td width=3D310 valign=3Dtop style=3D'width:232.2pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal><span class=3DSpellE><b style=3D'mso-bidi-font-weigh=
t:normal'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black'>&#1041;&#109=
8;&#1083;&#1075;&#1072;&#1088;&#1080;&#1103;</span></b></span><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DFR style=3D'mso-bidi-f=
ont-size:
  11.0pt;color:black;mso-ansi-language:FR'><o:p></o:p></span></b></p>
  <p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;m=
so-ansi-language:
  IT'>Orion Pharma Poland Sp z.o.o.<o:p></o:p></span></p>
  <p class=3DMsoNormal><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;m=
so-ansi-language:
  IT'>Tel.: + 48&nbsp;22&nbsp;8333177<o:p></o:p></span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.9pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DDE
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'>Luxembourg/Luxem=
burg</span></b><span
  lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'><br>
  </span><strong><span lang=3DEN-GB style=3D'font-weight:normal;mso-bidi-fo=
nt-weight:
  bold'>Orion Pharma BVBA/SPRL</span></strong><strong><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt;font-weight:normal'><o:p></o:p></span>=
</strong></p>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><span class=3D=
SpellE><span
  style=3D'font-size:11.0pt'>Tl</span></span><span style=3D'font-size:11.0=
pt'>/Tel:
  +32 (0)15 64 10 20</span><span lang=3DFR style=3D'font-size:11.0pt;mso-an=
si-language:
  FR'><o:p></o:p></span></p>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DSV
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:SV'><o:p>&nbsp;</o:p=
></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:2;page-break-inside:avoid'>
  <td width=3D310 valign=3Dtop style=3D'width:232.2pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none'><b style=3D'mso-bidi-fo=
nt-weight:
  normal'><span lang=3DSV style=3D'mso-bidi-font-size:11.0pt;mso-ansi-langu=
age:
  SV'>&#268;esk republika</span></b><span lang=3DSV style=3D'mso-bidi-font=
-size:
  11.0pt;mso-ansi-language:SV;mso-fareast-language:CS'><o:p></o:p></span></=
p>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none'><span lang=3DFI style=
=3D'mso-ansi-language:
  FI'>Orion Pharma s.r.o.<o:p></o:p></span></p>
  <p class=3DMsoNormal><span lang=3DEN-GB>Tel: +420 234 703 305</span><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt;mso-fareast-language:CS'><o:p></o:p></span></b></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.9pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DSV
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:SV'>Magyarorszg</sp=
an></b><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DSV style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:SV;mso-fareast-language:CS'><o:p></o:p></span></=
b></p>
  <p class=3DMsoNormal style=3D'line-height:13.0pt'><strong><span lang=3DEN=
-GB
  style=3D'mso-bidi-font-size:11.0pt;font-weight:normal;mso-bidi-font-weigh=
t:
  bold'>Orion Pharma <span class=3DSpellE>Kft</span>.</span></strong><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'><o:p></o:p></span></b></p>
  <p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0p=
t'>Tel.: +</span><span
  lang=3DEN-GB>36 1 239 9095</span><span lang=3DSV style=3D'mso-bidi-font-s=
ize:11.0pt;
  mso-ansi-language:SV'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:3;page-break-inside:avoid'>
  <td width=3D310 valign=3Dtop style=3D'width:232.2pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>Danmark</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size:=
11.0pt'>
  <br>
  Orion Pharma A/S<br>
  <span class=3DSpellE>Tlf</span>: +45 8614 0000</span><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:CS'><o:p></o:p></=
span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.9pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none'><b style=3D'mso-bidi-fo=
nt-weight:
  normal'><span lang=3DFR style=3D'mso-bidi-font-size:11.0pt;mso-ansi-langu=
age:
  FR'>Malta</span></b><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DFR
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FR;mso-fareast-langu=
age:
  CS'><o:p></o:p></span></b></p>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DIT style=
=3D'mso-bidi-font-size:
  11.0pt;mso-ansi-language:IT'>Salomone Pharma<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-2.25pt;margin-=
bottom:
  9.0pt;margin-left:0in'><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;
  mso-ansi-language:IT'>Tel: +356&nbsp;21220174</span><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:CS'><o:p></o:p></=
span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:4;page-break-inside:avoid'>
  <td width=3D310 valign=3Dtop style=3D'width:232.2pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DDE style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:DE'>Deutschland</span></b><span lang=3DDE
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'> <br>
  Orion Pharma GmbH</span><span lang=3DDE style=3D'mso-bidi-font-size:11.0p=
t;
  mso-ansi-language:DE;mso-fareast-language:CS'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><s=
pan
  lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'>Tel: +=
49 40
  899 6890</span><span lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ans=
i-language:
  DE;mso-fareast-language:CS'><o:p></o:p></span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.9pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DSV
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:SV'>Nederland</span>=
</b><span
  lang=3DSV style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:SV'><br>
  </span><strong><span lang=3DEN-GB style=3D'font-weight:normal;mso-bidi-fo=
nt-weight:
  bold'>Orion Pharma BVBA/SPRL</span></strong><strong><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt;font-weight:normal'><o:p></o:p></span>=
</strong></p>
  <p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:9.=
0pt;
  margin-left:0in;tab-stops:28.35pt'><span class=3DSpellE><span style=3D'fo=
nt-size:
  11.0pt'>Tl</span></span><span style=3D'font-size:11.0pt'>/Tel: +32 (0)15=
 64 10
  20</span><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:E=
N-GB;
  mso-fareast-language:CS'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:5;page-break-inside:avoid'>
  <td width=3D310 valign=3Dtop style=3D'width:232.2pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none'><b><span lang=3DFI
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI'>Eesti</span></b>=
<b><span
  lang=3DFI style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI;mso-far=
east-language:
  CS'><o:p></o:p></span></b></p>
  <p class=3DMsoNormal><span lang=3DFI style=3D'mso-bidi-font-size:11.0pt;m=
so-ansi-language:
  FI'>Orion Pharma Eesti O<o:p></o:p></span></p>
  <p class=3DMsoNormal><span lang=3DFI style=3D'mso-bidi-font-size:11.0pt;m=
so-ansi-language:
  FI'>Tel: +372 66 44 550</span><span lang=3DFI style=3D'mso-bidi-font-size=
:11.0pt;
  mso-ansi-language:FI;mso-fareast-language:CS'><o:p></o:p></span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.9pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt'><b style=3D'mso-bidi-=
font-weight:
  normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Norge</spa=
n></b><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:CS'>=
<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-hyphenate:none'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Orion Pharma AS<o:p></o:=
p></span></p>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-2.25pt;margin-=
bottom:
  9.0pt;margin-left:0in'><span class=3DSpellE><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
  11.0pt'>Tlf</span></span><span lang=3DEN-GB style=3D'mso-bidi-font-size:1=
1.0pt'>:
  +47 40 00 42 10</span><span lang=3DDE style=3D'mso-bidi-font-size:11.0pt;
  mso-ansi-language:DE;mso-fareast-language:CS'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:6;page-break-inside:avoid'>
  <td width=3D310 valign=3Dtop style=3D'width:232.2pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><span class=3D=
SpellE><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-si=
ze:11.0pt;
  mso-ansi-language:EN-GB'>&#917;&#955;&#955;&#940;&#948;</span></b></span>=
<b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-si=
ze:11.0pt;
  mso-ansi-language:EN-GB'>&#945;</span></b><span lang=3DFI style=3D'font-s=
ize:
  11.0pt;mso-ansi-language:FI'> <br>
  Orion Pharma Hellas M.E.</span><span style=3D'font-size:11.0pt'>&#928;</s=
pan><span
  lang=3DFI style=3D'font-size:11.0pt;mso-ansi-language:FI'>.E<o:p></o:p></=
span></p>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><span class=3D=
SpellE><span
  style=3D'font-size:11.0pt'>&#932;&#951;&#955;</span></span><span lang=3DFI
  style=3D'font-size:11.0pt;mso-ansi-language:FI'>: + 30&nbsp;210&nbsp;980 =
3355</span><span
  lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p></o:=
p></span></p>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt'><b style=3D'mso-bidi-=
font-weight:
  normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast=
-language:
  CS'><o:p>&nbsp;</o:p></span></b></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.9pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DDE style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:DE'>sterreich</span></b><span lang=3DDE
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'><br>
  Orion Pharma GmbH</span><span lang=3DDE style=3D'mso-bidi-font-size:11.0p=
t;
  mso-ansi-language:DE;mso-fareast-language:CS'><o:p></o:p></span></p>
  <p class=3DText style=3D'margin-top:0in;margin-right:0in;margin-bottom:9.=
0pt;
  margin-left:0in;tab-stops:28.35pt'><span lang=3DDE style=3D'font-size:11.=
0pt;
  mso-ansi-language:DE'>Tel: +49 40 899 6890</span><span lang=3DEN-GB
  style=3D'font-size:11.0pt;mso-ansi-language:EN-GB;mso-fareast-language:CS=
'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:7;page-break-inside:avoid'>
  <td width=3D310 valign=3Dtop style=3D'width:232.2pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><b style=3D'ms=
o-bidi-font-weight:
  normal'><span lang=3DIT style=3D'font-size:11.0pt;mso-ansi-language:IT'>E=
spaa</span></b><span
  lang=3DIT style=3D'font-size:11.0pt;mso-ansi-language:IT'> <br>
  </span><span style=3D'font-size:11.0pt'>Orion Pharma S.L.</span><span
  style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><span
  style=3D'font-size:11.0pt'>Tel: + 34 91 &nbsp;599 86 01</span><span lang=
=3DEN-GB
  style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt'><b style=3D'mso-bidi-=
font-weight:
  normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast=
-language:
  CS'><o:p>&nbsp;</o:p></span></b></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.9pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>Polska</span></b><b style=3D'mso-bidi=
-font-weight:
  normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast=
-language:
  CS'><o:p></o:p></span></b></p>
  <p class=3DMsoNormal><span lang=3DSV style=3D'mso-bidi-font-size:11.0pt;m=
so-ansi-language:
  SV'>Orion Pharma Poland Sp z.o.o.</span><span lang=3DEN-GB style=3D'mso-b=
idi-font-size:
  11.0pt'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-bottom:9.0pt'><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>Tel.: + 48 22 8333177</span><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:CS'>=
<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:8;page-break-inside:avoid'>
  <td width=3D310 valign=3Dtop style=3D'width:232.2pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><b style=3D'ms=
o-bidi-font-weight:
  normal'><span lang=3DFR style=3D'font-size:11.0pt;mso-ansi-language:FR'>F=
rance</span></b><span
  lang=3DFR style=3D'font-size:11.0pt;mso-ansi-language:FR'> <br>
  </span><span style=3D'font-size:11.0pt;mso-fareast-font-family:Calibri;
  mso-fareast-language:EN-GB'>Centre <span class=3DSpellE>Spcialits</span=
> <span
  class=3DSpellE>Pharmaceutiques</span></span><span lang=3DFR style=3D'font=
-size:
  11.0pt;mso-ansi-language:FR'><o:p></o:p></span></p>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><span
  style=3D'font-size:11.0pt;mso-fareast-font-family:Calibri;mso-fareast-lan=
guage:
  EN-GB'>Tel: + 33 (0) 1 47 04 80 46</span><span lang=3DFR style=3D'font-si=
ze:11.0pt;
  mso-ansi-language:FR'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt'><b style=3D'mso-bidi-=
font-weight:
  normal'><span lang=3DFR style=3D'mso-bidi-font-size:11.0pt;mso-ansi-langu=
age:
  FR;mso-fareast-language:CS'><o:p>&nbsp;</o:p></span></b></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.9pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DText align=3Dleft style=3D'margin-top:0in;text-align:left;tab-=
stops:
  28.35pt'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DIT
  style=3D'font-size:11.0pt;mso-ansi-language:IT'>Portugal</span></b><span
  lang=3DIT style=3D'font-size:11.0pt;mso-ansi-language:IT'><br>
  </span><span class=3DSpellE><span style=3D'font-size:11.0pt'>Orionfin</sp=
an></span><span
  style=3D'font-size:11.0pt'> <span class=3DSpellE>Unipessoal</span> <span
  class=3DSpellE>Lda</span></span><span lang=3DIT style=3D'font-size:11.0pt;
  mso-ansi-language:IT'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-2.25pt;margin-=
bottom:
  9.0pt;margin-left:0in'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.=
0pt'>Tel:
  + 351 21 154 68 20</span><span lang=3DFR style=3D'mso-bidi-font-size:11.0=
pt;
  mso-ansi-language:FR;mso-fareast-language:CS'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:9;page-break-inside:avoid'>
  <td width=3D310 valign=3Dtop style=3D'width:232.2pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DFI style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:FI;mso-fareast-language:CS'>Hrvatska<o:p></o:p><=
/span></b></p>
  <p class=3DMsoNormal><strong><span lang=3DFI style=3D'mso-bidi-font-size:=
11.0pt;
  mso-ansi-language:FI;font-weight:normal;mso-bidi-font-weight:bold'>Orion
  Pharma d.o.o.<o:p></o:p></span></strong></p>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><s=
pan
  lang=3DFI style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI'>Tel:</=
span><span
  lang=3DFI style=3D'mso-ansi-language:FI'> +386&nbsp;(0) 1 600 8015</span>=
<span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:CS'>=
<o:p></o:p></span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.9pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:12.0pt;mso-line-height-rule:exa=
ctly;
  mso-layout-grid-align:none;text-autospace:none'><span class=3DSpellE><b><=
span
  lang=3DFR style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-languag=
e:FR'>Romnia</span></b></span><b><span
  lang=3DFR style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-languag=
e:FR'><o:p></o:p></span></b></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-layout-grid-align:no=
ne;
  text-autospace:none'><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;
  mso-ansi-language:IT'>Orion Corporation</span><span lang=3DFR style=3D'ms=
o-bidi-font-size:
  11.0pt;color:black;mso-ansi-language:FR'><o:p></o:p></span></p>
  <p class=3DMsoNormal><span lang=3DFR style=3D'mso-bidi-font-size:11.0pt;c=
olor:black;
  mso-ansi-language:FR'>Tel: +358 10 4261<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:10;page-break-inside:avoid'>
  <td width=3D310 valign=3Dtop style=3D'width:232.2pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><b style=3D'mso-bidi-fo=
nt-weight:
  normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Ireland</s=
pan></b><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'> <br>
  Orion Pharma (Ireland) Ltd.</span><span lang=3DEN-GB style=3D'mso-bidi-fo=
nt-size:
  11.0pt;mso-fareast-language:CS'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>c/o <span class=3DSpellE>Allphar</spa=
n>
  Services Ltd.<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-hyphenate:none'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Tel: +353 1 428 7777<o:p=
></o:p></span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.9pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DIT
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'>Slovenija</span>=
</b><span
  lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT;mso-far=
east-language:
  CS'><o:p></o:p></span></p>
  <p class=3DMsoNormal><strong><span lang=3DFI style=3D'mso-bidi-font-size:=
11.0pt;
  mso-ansi-language:FI;font-weight:normal;mso-bidi-font-weight:bold'>Orion
  Pharma d.o.o.<o:p></o:p></span></strong></p>
  <p class=3DMsoNormal style=3D'margin-bottom:9.0pt'><span lang=3DFI
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI'>Tel:</span><span
  lang=3DFI style=3D'mso-ansi-language:FI'> +386&nbsp;(0) 1 600 8015</span>=
<b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt;mso-fareast-language:CS'><o:p></o:p></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:11;page-break-inside:avoid'>
  <td width=3D310 valign=3Dtop style=3D'width:232.2pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt'><span class=3DSpellE>=
<b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  11.0pt'>sland</span></b></span><b style=3D'mso-bidi-font-weight:normal'>=
<span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:CS'>=
<o:p></o:p></span></b></p>
  <p class=3DMsoNormal style=3D'line-height:normal'><span class=3DSpellE><s=
pan
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Vistor</span></span><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'> hf.<o:p></o:p></span></=
p>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><span class=3D=
SpellE><span
  style=3D'font-size:11.0pt'>Smi</span></span><span style=3D'font-size:11.=
0pt'>:
  +354 535 7000</span><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi=
-language:
  EN-GB;mso-fareast-language:CS'><o:p></o:p></span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.9pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none'><b style=3D'mso-bidi-fo=
nt-weight:
  normal'><span lang=3DSV style=3D'mso-bidi-font-size:11.0pt;mso-ansi-langu=
age:
  SV'>Slovensk republika</span></b><b style=3D'mso-bidi-font-weight:normal=
'><span
  lang=3DSV style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:SV;mso-far=
east-language:
  CS'><o:p></o:p></span></b></p>
  <p class=3DMsoNormal><strong><span lang=3DSV style=3D'mso-bidi-font-size:=
11.0pt;
  mso-ansi-language:SV;font-weight:normal;mso-bidi-font-weight:bold'>Orion
  Pharma s.r.o<o:p></o:p></span></strong></p>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-2.25pt;margin-=
bottom:
  9.0pt;margin-left:0in;line-height:normal'><span lang=3DSV style=3D'mso-an=
si-language:
  SV'>Tel: </span><span lang=3DSV><span style=3D'mso-spacerun:yes'></span>=
</span><span
  lang=3DSV style=3D'mso-ansi-language:SV'>+420 234 703 305</span><span lan=
g=3DIT
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT;mso-fareast-langu=
age:
  CS'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:12;page-break-inside:avoid'>
  <td width=3D310 valign=3Dtop style=3D'width:232.2pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DText style=3D'margin-top:0in;tab-stops:28.35pt'><b style=3D'ms=
o-bidi-font-weight:
  normal'><span lang=3DIT style=3D'font-size:11.0pt;mso-ansi-language:IT'>I=
talia</span></b><span
  lang=3DIT style=3D'font-size:11.0pt;mso-ansi-language:IT'><br>
  </span><span lang=3DFI style=3D'font-size:11.0pt;mso-ansi-language:FI'>Or=
ion
  Pharma S.r.l.<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-bottom:9.0pt;mso-hyphenate:none'><sp=
an
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Tel: + 39 02&nbsp;678761=
11</span><span
  lang=3DEL style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EL;mso-far=
east-language:
  CS'><o:p></o:p></span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.9pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DIT style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:IT'>Suomi/Finland<br>
  </span></b><span lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-la=
nguage:
  IT'>Orion Corporation</span><span lang=3DIT style=3D'mso-bidi-font-size:1=
1.0pt;
  mso-ansi-language:IT;mso-fareast-language:CS'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><s=
pan
  lang=3DIT style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:IT'>Puh./T=
el: +358
  10 4261</span><span lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ansi=
-language:
  DE;mso-fareast-language:CS'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:13;page-break-inside:avoid'>
  <td width=3D310 valign=3Dtop style=3D'width:232.2pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEL
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:EL'>&#922;&#973;&#96=
0;&#961;&#959;&#962;</span></b><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEL style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:EL;mso-fareast-language:CS'><o:p></o:p></span></=
b></p>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none;tab-stops:-.5in 28.35pt =
3.15in'><span
  lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'>Lifeph=
arma
  (ZAM) Ltd<o:p></o:p></span></p>
  <p class=3DMsoNormal><span class=3DSpellE><span lang=3DEN-GB style=3D'mso=
-bidi-font-size:
  11.0pt'>&#932;&#951;&#955;</span></span><span lang=3DDE style=3D'mso-bidi=
-font-size:
  11.0pt;mso-ansi-language:DE'>.: +357 22056300</span><span lang=3DDE
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE;mso-fareast-langu=
age:
  CS'><o:p></o:p></span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.9pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DDE style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:DE'>Sverige</span></b><span lang=3DDE
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'><br>
  Orion Pharma AB</span><span lang=3DDE style=3D'mso-bidi-font-size:11.0pt;
  mso-ansi-language:DE;mso-fareast-language:CS'><o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt;line-height:normal'><s=
pan
  lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE'>Tel: +=
46 8 623
  6440<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:14;mso-yfti-lastrow:yes;page-break-inside:avoid=
'>
  <td width=3D310 valign=3Dtop style=3D'width:232.2pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DFI
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI'>Latvija</span></=
b><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DFI style=3D'mso-bidi-f=
ont-size:
  11.0pt;mso-ansi-language:FI;mso-fareast-language:CS'><o:p></o:p></span></=
b></p>
  <p class=3DMsoNormal><span style=3D'mso-bidi-font-size:11.0pt;mso-ansi-la=
nguage:
  EN-US'>Orion Corporation<o:p></o:p></span></p>
  <p class=3DMsoNormal><span style=3D'mso-bidi-font-size:11.0pt;mso-ansi-la=
nguage:
  EN-US'>Orion Pharma <span class=3DSpellE>p&#257;rst&#257;vniec&#299;ba</s=
pan><o:p></o:p></span></p>
  <p class=3DMsoNormal><span style=3D'mso-bidi-font-size:11.0pt;mso-ansi-la=
nguage:
  EN-US'>Tel: +371 20028332<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none'><span style=3D'mso-bidi=
-font-size:
  11.0pt;mso-ansi-language:EN-US;mso-fareast-language:CS'><o:p>&nbsp;</o:p>=
</span></p>
  </td>
  <td width=3D312 valign=3Dtop style=3D'width:233.9pt;padding:0in 5.4pt 0in=
 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-2.25pt'><b style=3D'mso-bidi-=
font-weight:
  normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>United Kin=
gdom</span></b><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:CS'>=
<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-hyphenate:none'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Orion Pharma (UK) Ltd.<o=
:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'mso-hyphenate:none'><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'>Tel: +44 1635 520 300</span><span lan=
g=3DFI
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:FI;mso-fareast-langu=
age:
  CS'><o:p></o:p></span></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt'>This leaflet was last revised in.<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-out=
line-level:
1;mso-list:skip'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-out=
line-level:
1;mso-list:skip'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-out=
line-level:
1;mso-list:skip'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB
style=3D'mso-no-proof:yes'>Other sources of information<o:p></o:p></span></=
b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-out=
line-level:
1;mso-list:skip'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-out=
line-level:
1;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Det=
ailed
information on this medicine is available on the European Medicines Agency =
web
site: <a href=3D"http://www.ema.europa.eu">http://www.ema.europa.eu</a>.<o:=
p></o:p></span></p>

</div>

</body>

</html>

------=_NextPart_01D75918.E6EFEE90
Content-Location: file:///C:/8467A08E/Stalevo_clean_files/item0001.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"utf-8"?><ct:contentTypeSchema ct:_=3D"" m=
a:_=3D"" ma:contentTypeName=3D"Document" ma:contentTypeID=3D"0x010100726F91=
DD1AE57B44B1BCEB7F1056F5D0" ma:contentTypeVersion=3D"6" ma:contentTypeDescr=
iption=3D"Create a new document." ma:contentTypeScope=3D"" ma:versionID=3D"=
80d1dd17cb0c17b7740334051d5d16b2" xmlns:ct=3D"http://schemas.microsoft.com/=
office/2006/metadata/contentType" xmlns:ma=3D"http://schemas.microsoft.com/=
office/2006/metadata/properties/metaAttributes">
<xsd:schema targetNamespace=3D"http://schemas.microsoft.com/office/2006/met=
adata/properties" ma:root=3D"true" ma:fieldsID=3D"c170dc105f61f60cf84b7b3e6=
d807e4f" ns2:_=3D"" ns3:_=3D"" xmlns:xsd=3D"http://www.w3.org/2001/XMLSchem=
a" xmlns:xs=3D"http://www.w3.org/2001/XMLSchema" xmlns:p=3D"http://schemas.=
microsoft.com/office/2006/metadata/properties" xmlns:ns2=3D"a6a35199-84b7-4=
ca5-aa1c-39e9ca4c46ff" xmlns:ns3=3D"0ac2e3cc-46bd-4320-b2ac-d7f7d167e1a9">
<xsd:import namespace=3D"a6a35199-84b7-4ca5-aa1c-39e9ca4c46ff"/>
<xsd:import namespace=3D"0ac2e3cc-46bd-4320-b2ac-d7f7d167e1a9"/>
<xsd:element name=3D"properties">
<xsd:complexType>
<xsd:sequence>
<xsd:element name=3D"documentManagement">
<xsd:complexType>
<xsd:all>
<xsd:element ref=3D"ns2:MediaServiceMetadata" minOccurs=3D"0"/>
<xsd:element ref=3D"ns2:MediaServiceFastMetadata" minOccurs=3D"0"/>
<xsd:element ref=3D"ns2:MediaServiceAutoKeyPoints" minOccurs=3D"0"/>
<xsd:element ref=3D"ns2:MediaServiceKeyPoints" minOccurs=3D"0"/>
<xsd:element ref=3D"ns3:SharedWithUsers" minOccurs=3D"0"/>
<xsd:element ref=3D"ns3:SharedWithDetails" minOccurs=3D"0"/>
</xsd:all>
</xsd:complexType>
</xsd:element>
</xsd:sequence>
</xsd:complexType>
</xsd:element>
</xsd:schema>
<xsd:schema targetNamespace=3D"a6a35199-84b7-4ca5-aa1c-39e9ca4c46ff" elemen=
tFormDefault=3D"qualified" xmlns:xsd=3D"http://www.w3.org/2001/XMLSchema" x=
mlns:xs=3D"http://www.w3.org/2001/XMLSchema" xmlns:dms=3D"http://schemas.mi=
crosoft.com/office/2006/documentManagement/types" xmlns:pc=3D"http://schema=
s.microsoft.com/office/infopath/2007/PartnerControls">
<xsd:import namespace=3D"http://schemas.microsoft.com/office/2006/documentM=
anagement/types"/>
<xsd:import namespace=3D"http://schemas.microsoft.com/office/infopath/2007/=
PartnerControls"/>
<xsd:element name=3D"MediaServiceMetadata" ma:index=3D"8" nillable=3D"true"=
 ma:displayName=3D"MediaServiceMetadata" ma:hidden=3D"true" ma:internalName=
=3D"MediaServiceMetadata" ma:readOnly=3D"true">
<xsd:simpleType>
<xsd:restriction base=3D"dms:Note"/>
</xsd:simpleType>
</xsd:element>
<xsd:element name=3D"MediaServiceFastMetadata" ma:index=3D"9" nillable=3D"t=
rue" ma:displayName=3D"MediaServiceFastMetadata" ma:hidden=3D"true" ma:inte=
rnalName=3D"MediaServiceFastMetadata" ma:readOnly=3D"true">
<xsd:simpleType>
<xsd:restriction base=3D"dms:Note"/>
</xsd:simpleType>
</xsd:element>
<xsd:element name=3D"MediaServiceAutoKeyPoints" ma:index=3D"10" nillable=3D=
"true" ma:displayName=3D"MediaServiceAutoKeyPoints" ma:hidden=3D"true" ma:i=
nternalName=3D"MediaServiceAutoKeyPoints" ma:readOnly=3D"true">
<xsd:simpleType>
<xsd:restriction base=3D"dms:Note"/>
</xsd:simpleType>
</xsd:element>
<xsd:element name=3D"MediaServiceKeyPoints" ma:index=3D"11" nillable=3D"tru=
e" ma:displayName=3D"KeyPoints" ma:internalName=3D"MediaServiceKeyPoints" m=
a:readOnly=3D"true">
<xsd:simpleType>
<xsd:restriction base=3D"dms:Note">
<xsd:maxLength value=3D"255"/>
</xsd:restriction>
</xsd:simpleType>
</xsd:element>
</xsd:schema>
<xsd:schema targetNamespace=3D"0ac2e3cc-46bd-4320-b2ac-d7f7d167e1a9" elemen=
tFormDefault=3D"qualified" xmlns:xsd=3D"http://www.w3.org/2001/XMLSchema" x=
mlns:xs=3D"http://www.w3.org/2001/XMLSchema" xmlns:dms=3D"http://schemas.mi=
crosoft.com/office/2006/documentManagement/types" xmlns:pc=3D"http://schema=
s.microsoft.com/office/infopath/2007/PartnerControls">
<xsd:import namespace=3D"http://schemas.microsoft.com/office/2006/documentM=
anagement/types"/>
<xsd:import namespace=3D"http://schemas.microsoft.com/office/infopath/2007/=
PartnerControls"/>
<xsd:element name=3D"SharedWithUsers" ma:index=3D"12" nillable=3D"true" ma:=
displayName=3D"Shared With" ma:internalName=3D"SharedWithUsers" ma:readOnly=
=3D"true">
<xsd:complexType>
<xsd:complexContent>
<xsd:extension base=3D"dms:UserMulti">
<xsd:sequence>
<xsd:element name=3D"UserInfo" minOccurs=3D"0" maxOccurs=3D"unbounded">
<xsd:complexType>
<xsd:sequence>
<xsd:element name=3D"DisplayName" type=3D"xsd:string" minOccurs=3D"0"/>
<xsd:element name=3D"AccountId" type=3D"dms:UserId" minOccurs=3D"0" nillabl=
e=3D"true"/>
<xsd:element name=3D"AccountType" type=3D"xsd:string" minOccurs=3D"0"/>
</xsd:sequence>
</xsd:complexType>
</xsd:element>
</xsd:sequence>
</xsd:extension>
</xsd:complexContent>
</xsd:complexType>
</xsd:element>
<xsd:element name=3D"SharedWithDetails" ma:index=3D"13" nillable=3D"true" m=
a:displayName=3D"Shared With Details" ma:internalName=3D"SharedWithDetails"=
 ma:readOnly=3D"true">
<xsd:simpleType>
<xsd:restriction base=3D"dms:Note">
<xsd:maxLength value=3D"255"/>
</xsd:restriction>
</xsd:simpleType>
</xsd:element>
</xsd:schema>
<xsd:schema targetNamespace=3D"http://schemas.openxmlformats.org/package/20=
06/metadata/core-properties" elementFormDefault=3D"qualified" attributeForm=
Default=3D"unqualified" blockDefault=3D"#all" xmlns=3D"http://schemas.openx=
mlformats.org/package/2006/metadata/core-properties" xmlns:xsd=3D"http://ww=
w.w3.org/2001/XMLSchema" xmlns:xsi=3D"http://www.w3.org/2001/XMLSchema-inst=
ance" xmlns:dc=3D"http://purl.org/dc/elements/1.1/" xmlns:dcterms=3D"http:/=
/purl.org/dc/terms/" xmlns:odoc=3D"http://schemas.microsoft.com/internal/ob=
d">
<xsd:import namespace=3D"http://purl.org/dc/elements/1.1/" schemaLocation=
=3D"http://dublincore.org/schemas/xmls/qdc/2003/04/02/dc.xsd"/>
<xsd:import namespace=3D"http://purl.org/dc/terms/" schemaLocation=3D"http:=
//dublincore.org/schemas/xmls/qdc/2003/04/02/dcterms.xsd"/>
<xsd:element name=3D"coreProperties" type=3D"CT_coreProperties"/>
<xsd:complexType name=3D"CT_coreProperties">
<xsd:all>
<xsd:element ref=3D"dc:creator" minOccurs=3D"0" maxOccurs=3D"1"/>
<xsd:element ref=3D"dcterms:created" minOccurs=3D"0" maxOccurs=3D"1"/>
<xsd:element ref=3D"dc:identifier" minOccurs=3D"0" maxOccurs=3D"1"/>
<xsd:element name=3D"contentType" minOccurs=3D"0" maxOccurs=3D"1" type=3D"x=
sd:string" ma:index=3D"0" ma:displayName=3D"Content Type"/>
<xsd:element ref=3D"dc:title" minOccurs=3D"0" maxOccurs=3D"1" ma:index=3D"4=
" ma:displayName=3D"Title"/>
<xsd:element ref=3D"dc:subject" minOccurs=3D"0" maxOccurs=3D"1"/>
<xsd:element ref=3D"dc:description" minOccurs=3D"0" maxOccurs=3D"1"/>
<xsd:element name=3D"keywords" minOccurs=3D"0" maxOccurs=3D"1" type=3D"xsd:=
string"/>
<xsd:element ref=3D"dc:language" minOccurs=3D"0" maxOccurs=3D"1"/>
<xsd:element name=3D"category" minOccurs=3D"0" maxOccurs=3D"1" type=3D"xsd:=
string"/>
<xsd:element name=3D"version" minOccurs=3D"0" maxOccurs=3D"1" type=3D"xsd:s=
tring"/>
<xsd:element name=3D"revision" minOccurs=3D"0" maxOccurs=3D"1" type=3D"xsd:=
string">
<xsd:annotation>
<xsd:documentation>
                        This value indicates the number of saves or revisio=
ns. The application is responsible for updating this value after each revis=
ion.
                    </xsd:documentation>
</xsd:annotation>
</xsd:element>
<xsd:element name=3D"lastModifiedBy" minOccurs=3D"0" maxOccurs=3D"1" type=
=3D"xsd:string"/>
<xsd:element ref=3D"dcterms:modified" minOccurs=3D"0" maxOccurs=3D"1"/>
<xsd:element name=3D"contentStatus" minOccurs=3D"0" maxOccurs=3D"1" type=3D=
"xsd:string"/>
</xsd:all>
</xsd:complexType>
</xsd:schema>
<xs:schema targetNamespace=3D"http://schemas.microsoft.com/office/infopath/=
2007/PartnerControls" elementFormDefault=3D"qualified" attributeFormDefault=
=3D"unqualified" xmlns:pc=3D"http://schemas.microsoft.com/office/infopath/2=
007/PartnerControls" xmlns:xs=3D"http://www.w3.org/2001/XMLSchema">
<xs:element name=3D"Person">
<xs:complexType>
<xs:sequence>
<xs:element ref=3D"pc:DisplayName" minOccurs=3D"0"></xs:element>
<xs:element ref=3D"pc:AccountId" minOccurs=3D"0"></xs:element>
<xs:element ref=3D"pc:AccountType" minOccurs=3D"0"></xs:element>
</xs:sequence>
</xs:complexType>
</xs:element>
<xs:element name=3D"DisplayName" type=3D"xs:string"></xs:element>
<xs:element name=3D"AccountId" type=3D"xs:string"></xs:element>
<xs:element name=3D"AccountType" type=3D"xs:string"></xs:element>
<xs:element name=3D"BDCAssociatedEntity">
<xs:complexType>
<xs:sequence>
<xs:element ref=3D"pc:BDCEntity" minOccurs=3D"0" maxOccurs=3D"unbounded"></=
xs:element>
</xs:sequence>
<xs:attribute ref=3D"pc:EntityNamespace"></xs:attribute>
<xs:attribute ref=3D"pc:EntityName"></xs:attribute>
<xs:attribute ref=3D"pc:SystemInstanceName"></xs:attribute>
<xs:attribute ref=3D"pc:AssociationName"></xs:attribute>
</xs:complexType>
</xs:element>
<xs:attribute name=3D"EntityNamespace" type=3D"xs:string"></xs:attribute>
<xs:attribute name=3D"EntityName" type=3D"xs:string"></xs:attribute>
<xs:attribute name=3D"SystemInstanceName" type=3D"xs:string"></xs:attribute>
<xs:attribute name=3D"AssociationName" type=3D"xs:string"></xs:attribute>
<xs:element name=3D"BDCEntity">
<xs:complexType>
<xs:sequence>
<xs:element ref=3D"pc:EntityDisplayName" minOccurs=3D"0"></xs:element>
<xs:element ref=3D"pc:EntityInstanceReference" minOccurs=3D"0"></xs:element>
<xs:element ref=3D"pc:EntityId1" minOccurs=3D"0"></xs:element>
<xs:element ref=3D"pc:EntityId2" minOccurs=3D"0"></xs:element>
<xs:element ref=3D"pc:EntityId3" minOccurs=3D"0"></xs:element>
<xs:element ref=3D"pc:EntityId4" minOccurs=3D"0"></xs:element>
<xs:element ref=3D"pc:EntityId5" minOccurs=3D"0"></xs:element>
</xs:sequence>
</xs:complexType>
</xs:element>
<xs:element name=3D"EntityDisplayName" type=3D"xs:string"></xs:element>
<xs:element name=3D"EntityInstanceReference" type=3D"xs:string"></xs:elemen=
t>
<xs:element name=3D"EntityId1" type=3D"xs:string"></xs:element>
<xs:element name=3D"EntityId2" type=3D"xs:string"></xs:element>
<xs:element name=3D"EntityId3" type=3D"xs:string"></xs:element>
<xs:element name=3D"EntityId4" type=3D"xs:string"></xs:element>
<xs:element name=3D"EntityId5" type=3D"xs:string"></xs:element>
<xs:element name=3D"Terms">
<xs:complexType>
<xs:sequence>
<xs:element ref=3D"pc:TermInfo" minOccurs=3D"0" maxOccurs=3D"unbounded"></x=
s:element>
</xs:sequence>
</xs:complexType>
</xs:element>
<xs:element name=3D"TermInfo">
<xs:complexType>
<xs:sequence>
<xs:element ref=3D"pc:TermName" minOccurs=3D"0"></xs:element>
<xs:element ref=3D"pc:TermId" minOccurs=3D"0"></xs:element>
</xs:sequence>
</xs:complexType>
</xs:element>
<xs:element name=3D"TermName" type=3D"xs:string"></xs:element>
<xs:element name=3D"TermId" type=3D"xs:string"></xs:element>
</xs:schema>
</ct:contentTypeSchema>
------=_NextPart_01D75918.E6EFEE90
Content-Location: file:///C:/8467A08E/Stalevo_clean_files/props002.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"no"?>
<ds:datastoreItem ds:itemID=3D"{556330B4-E834-413B-AF69-D1AEF1323EFE}" xmln=
s:ds=3D"http://schemas.openxmlformats.org/officeDocument/2006/customXml"><d=
s:schemaRefs><ds:schemaRef ds:uri=3D"http://schemas.microsoft.com/office/20=
06/metadata/contentType"/><ds:schemaRef ds:uri=3D"http://schemas.microsoft.=
com/office/2006/metadata/properties/metaAttributes"/><ds:schemaRef ds:uri=
=3D"http://www.w3.org/2001/XMLSchema"/><ds:schemaRef ds:uri=3D"http://schem=
as.microsoft.com/office/2006/metadata/properties"/><ds:schemaRef ds:uri=3D"=
a6a35199-84b7-4ca5-aa1c-39e9ca4c46ff"/><ds:schemaRef ds:uri=3D"0ac2e3cc-46b=
d-4320-b2ac-d7f7d167e1a9"/><ds:schemaRef ds:uri=3D"http://schemas.microsoft=
.com/office/2006/documentManagement/types"/><ds:schemaRef ds:uri=3D"http://=
schemas.microsoft.com/office/infopath/2007/PartnerControls"/><ds:schemaRef =
ds:uri=3D"http://schemas.openxmlformats.org/package/2006/metadata/core-prop=
erties"/><ds:schemaRef ds:uri=3D"http://purl.org/dc/elements/1.1/"/><ds:sch=
emaRef ds:uri=3D"http://purl.org/dc/terms/"/><ds:schemaRef ds:uri=3D"http:/=
/schemas.microsoft.com/internal/obd"/></ds:schemaRefs></ds:datastoreItem>
------=_NextPart_01D75918.E6EFEE90
Content-Location: file:///C:/8467A08E/Stalevo_clean_files/item0003.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?mso-contentType?><FormTemplates xmlns=3D"http://schemas.microsoft.com/sha=
repoint/v3/contenttype/forms"><Display>DocumentLibraryForm</Display><Edit>D=
ocumentLibraryForm</Edit><New>DocumentLibraryForm</New></FormTemplates>
------=_NextPart_01D75918.E6EFEE90
Content-Location: file:///C:/8467A08E/Stalevo_clean_files/props004.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"no"?>
<ds:datastoreItem ds:itemID=3D"{59421E84-4EDB-4350-924A-6FE7BB6B7F2D}" xmln=
s:ds=3D"http://schemas.openxmlformats.org/officeDocument/2006/customXml"><d=
s:schemaRefs><ds:schemaRef ds:uri=3D"http://schemas.microsoft.com/sharepoin=
t/v3/contenttype/forms"/></ds:schemaRefs></ds:datastoreItem>
------=_NextPart_01D75918.E6EFEE90
Content-Location: file:///C:/8467A08E/Stalevo_clean_files/item0005.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"no"?><b:Sources Sele=
ctedStyle=3D"\APA.XSL" StyleName=3D"APA" xmlns:b=3D"http://schemas.openxmlf=
ormats.org/officeDocument/2006/bibliography" xmlns=3D"http://schemas.openxm=
lformats.org/officeDocument/2006/bibliography"></b:Sources>
------=_NextPart_01D75918.E6EFEE90
Content-Location: file:///C:/8467A08E/Stalevo_clean_files/props006.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"no"?>
<ds:datastoreItem ds:itemID=3D"{7DA2BB7D-2385-4FC0-A549-B4110DC5BE44}" xmln=
s:ds=3D"http://schemas.openxmlformats.org/officeDocument/2006/customXml"><d=
s:schemaRefs><ds:schemaRef ds:uri=3D"http://schemas.openxmlformats.org/offi=
ceDocument/2006/bibliography"/></ds:schemaRefs></ds:datastoreItem>
------=_NextPart_01D75918.E6EFEE90
Content-Location: file:///C:/8467A08E/Stalevo_clean_files/item0007.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"utf-8"?><p:properties xmlns:p=3D"http://s=
chemas.microsoft.com/office/2006/metadata/properties" xmlns:xsi=3D"http://w=
ww.w3.org/2001/XMLSchema-instance" xmlns:pc=3D"http://schemas.microsoft.com=
/office/infopath/2007/PartnerControls"><documentManagement/></p:properties>
------=_NextPart_01D75918.E6EFEE90
Content-Location: file:///C:/8467A08E/Stalevo_clean_files/props008.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"no"?>
<ds:datastoreItem ds:itemID=3D"{8C67E271-CAD5-493F-940F-C1A89C8C3E86}" xmln=
s:ds=3D"http://schemas.openxmlformats.org/officeDocument/2006/customXml"><d=
s:schemaRefs><ds:schemaRef ds:uri=3D"http://schemas.microsoft.com/office/20=
06/metadata/properties"/><ds:schemaRef ds:uri=3D"http://schemas.microsoft.c=
om/office/infopath/2007/PartnerControls"/></ds:schemaRefs></ds:datastoreIte=
m>
------=_NextPart_01D75918.E6EFEE90
Content-Location: file:///C:/8467A08E/Stalevo_clean_files/themedata.thmx
Content-Transfer-Encoding: base64
Content-Type: application/vnd.ms-officetheme
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------=_NextPart_01D75918.E6EFEE90
Content-Location: file:///C:/8467A08E/Stalevo_clean_files/colorschememapping.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"yes"?>
<a:clrMap xmlns:a=3D"http://schemas.openxmlformats.org/drawingml/2006/main"=
 bg1=3D"lt1" tx1=3D"dk1" bg2=3D"lt2" tx2=3D"dk2" accent1=3D"accent1" accent=
2=3D"accent2" accent3=3D"accent3" accent4=3D"accent4" accent5=3D"accent5" a=
ccent6=3D"accent6" hlink=3D"hlink" folHlink=3D"folHlink"/>
------=_NextPart_01D75918.E6EFEE90
Content-Location: file:///C:/8467A08E/Stalevo_clean_files/image001.emz
Content-Transfer-Encoding: base64
Content-Type: image/x-emz
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------=_NextPart_01D75918.E6EFEE90
Content-Location: file:///C:/8467A08E/Stalevo_clean_files/image002.png
Content-Transfer-Encoding: base64
Content-Type: image/png
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------=_NextPart_01D75918.E6EFEE90
Content-Location: file:///C:/8467A08E/Stalevo_clean_files/image003.emz
Content-Transfer-Encoding: base64
Content-Type: image/x-emz
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------=_NextPart_01D75918.E6EFEE90
Content-Location: file:///C:/8467A08E/Stalevo_clean_files/image004.png
Content-Transfer-Encoding: base64
Content-Type: image/png

iVBORw0KGgoAAAANSUhEUgAAA6gAAAC3CAYAAAAfKXP7AAAAAXNSR0ICQMB9xQAAAAlwSFlzAAAW
JQAAFiUBSVIk8AAAABl0RVh0U29mdHdhcmUATWljcm9zb2Z0IE9mZmljZX/tNXEAAIQUSURBVHja
7Z0LfFP1+f9Pci5JWm6hlJK2acuxRAxtoBxLLLE0lFiOGIoRjxhrBDvMWNV4YRjxRn/KsOq81Kkb
ikxlm9op80phbOq83+a8/J2iMu86L4BOh25Oz/98TntKGpI2LQUKPOfF+9WSJud8z/dcet59nu/z
Zf7v//6PIQiCIAiCIAiCIIi9DXUCQRAEQRAEQRAEQYJKEARBEARBEARBECSoBEEQBEEQBEEQBAkq
QRAEQRAEQRAEQZCgEgRBEARBEARBECSoBEEQBEEQBEEQBEGCShAEQRAEQRAEQZCgEgRBEARBEARB
EAQJKkEQBEEQBEEQBEGCShAEQRAEQRAEQRAkqARBEARBEARBEAQJKkEQBEEQBEEQBEGQoBIEQRAE
QRAEQRAkqARBEARBEARBEARBgkoQBEEQBEEQBEGQoBIEQRAEQRDEoHvQZRhTQGSGWRlHjssV46lP
CIIElSAIgiAIgiB2ibY2xuxzMLmacBZq5HWC7506DjFXjK60Jn+uRWFs9W52lVVwvumRGw/fn/so
2hK1ut1Wuz0QzaJzhiBBJQiCIAiCIIjdRLPiHlmbz9xkYU3vsgyzjWHMX5jM5nc1OX3LxJo2W4uK
nh91yMyrXR5ZVFXVZHxuZZSxzpnAXq8J6suaoFb1Z9tYnyzHLIjGDsa+iSuSLST7vVMrS1ucTuuz
zprIGa6YStFiggSVIAiCIAiCIHYHiKBKdmZo0Os+vMzMvsWb8j8XfbOO0qQxxy+JJXJZ/uU2Qfi3
yVyweby8wJ8ok1GRsTKMPVtRFLZfAtjkn+KVm44XAy3WwdYvqtpmjikVMw4qKrjTKbDv8hz3XV51
w1K5XeXovCFIUAmCIAiCIAhiN7IyHhg5PY/dYOGd70mhmLdLYBVmiDyeuYXjBNU0prpdUuJjBmJ7
zUGrPTjJeqNLXnjmYO2TVtkl2O32oUqVcwHHC9tyq8LnkaASJKgEQRAEQRAEsZtpjkij/A623cIX
vucJdh9T2iSLxwhm9hvGXPSxNxTtSudtCUhZbsZhT1ckqSUgWh0Mk98xnlXMM8ayRtz20XXlIy+x
Wvgv7eVHXGbNdY5lRHee266Pf8X7R9uljvGerbLMuRlmjPaatiom13gdtLfKgiTZR9iVuC2qtcWu
fY4RA8OZhFTkTtG07GgHk29XWmx96ZuoXHoMLwhbSVAJElSCIAiCIAiC2AMsU6RcTVDXpxTUkLdq
jIn9mGXy/ymFoodr0igEa9w+78H5q4v44ie8cvSw5PXFFXeBXC0tLuLYZ02M6S2eL3pt9Pgjfy4r
4fIZBY6fZ1nYTxnGpJo4YQtj5t/gCifcU14g3GtlTR+bzNyWvOrIGRijGlPchRWsqd1mZj4zsR2v
xzZt4qMBsbhGKrmo0Ck8XVIbXhwJek8QbZaX2NHT1rmDsTEJkjw0PKsiUsxxT5sY5i1OEN7POfiI
VndwmTPTvmkMlB5HgkqQoBIEQRAEQRDEIBDURXKJwpvZbxlz0Uc14Zg3HvZPKuZMT9k48zes2fmx
FIx2e388KBYcnj907bDJc653egJjrVZmVH1l3vm2LNu/zYfU3xpQYqMVr+Mknhe22Scdtdwqukcz
ojRckaw5wYpRFwuC8G2uL3wBZBBjZKM+sXjmweY7BIH7X071/Hg8Fhldm8/cOIQ3bzNznJrnqb0x
EotOVKTiOG+R/iz6I6WdcjqkvqrsgvGz5p0uBRREYbNDNeL8bJtti2lMFdKVHSSoBAkqQRAEQRAE
QQxaQXW+K4WauiKibVH7sMA45rccZ1FN+TX3SsqyXKTdBt25pVNz2YcErvD9RKFtjTGWeZLzvCxb
xfNOX7jceH1x2CVOKLS0s87a2wPxlSNjs0rrNUHdmlsdiSe2IyqXKqlksKE651xNXP+lvb5UaWtj
MQdr/eSRzRwvfMOWzV5tjz9va2+VOYYRs5m2NrPaxrDRes8x2RPqbmVyXZMYBtnGTJ7PnVsxOYd5
Xtv2D2Jd4/FqUjowCSpBgkoQBEEQBEEQg0VQuTEfjq8KztZsrkDyOA6ZJo36uU0Q/mPmCjd55OhU
4/0r44ERtQ52XXLENeJ3uyZZbC8I4+esZpLmT1UkxsbYpSwIZDrp017fSVDVdplr8OXGDUE13ju/
Om8JXsupCp+vqGq3SsKYpzXkYW/iLbYvNDF9E9PmGLAm5gOTmf3QUdNwaibCSYJKkKASBEEQBEEQ
xB4XVGadwPHf5DsKNxSy7DNmE7OZY9kPx+SXt/nkxkkphTZJUBsDnupi3rLZURW+0NWafs7QHgT1
uFSCGq7K7YqgogiSqjKmhNfOTRbHWEAc4y+0rLOWyWsYh7sQ0+Z0MlJjuMZQlyxbMukbElSCBJUg
CIIgCIIg9rigIoKa/4HbP3emg2HsnUI3wuXaWeR6EtRCwfoOX4YI6kbrHhLUneYnbQy4x022WF4Q
DplzK7OLUkmCSpCgErsMyo67rdaRLjlm2a3bcFvt9sCOcud7i97KvO8Km2IM31mavZARAyP21+OZ
yX5HA8wQK+PI2R39vEs3G4YxYSzOYGwb3Xf2z/sCkXjMmUFzzAliQARVH4O6YyqZ3t+fJKiyNLWI
tbzP5k19yBdrGd1X6VtQK87jOl5fuiuCGlfE0TUOboNFKH/FFVw8Pnn7bWqbWZLiNvwOJUElSFBT
EIu58DA8Sn8Y7pijydn5PeaDGpPwGihgGMcoV4weOna62bQx5kjANbbGU3KRkxdeLaudH8pk8Htf
ULUbWSzoLvZLJcucTuuzzprIGa6YuleORUx2WUJ+9+E9lXnfpQfcuJIdqq2YjxLxPMu/x41xPzre
Py+wp869PXE8M9lvdsyEh6RaefbMCext2i/iNyS50TeYznuMs6l3s6usgvNNj9y98iKx/56ne+u+
QGjHXFHYaDAwvqZc/D/tmP+/vX3MCWIg0OdBzcc8qJqgBnv/PacLaor3N8lecRLH/J0z898We8MR
NWls6CbtmTemPUckimji+NEFgVJFk84tOb7wBcbrkNEGX945kNG86vlLjPcmjktNFseVUcY6p4y9
ief4b0dOCjaLLRuzu90rG/3eqlmnKS65tdc/MCWMi11KgkocMILaGPJNKTLxr7Im83vGAG6TyfQ2
y5i2Mmbuc8Zk+kfXwG4z9yFnKnpduxl4qaNx01JNshyz4C9gzYp75IxC5uZs3vQ1y7LfuQILjxvo
hwZUpwtNZFqyBfPnZo77X15Nw7kDfbNK3KeeXm8KeStKePbpdGXed0l6AvbsWe6iy4eMPeJOUQqM
m1vjmu4UrP/g2ZL3tHOvan85npntt20TzxV8WlhgeYXnC1/yyFHvnjjemb5X/yU8gb1eE9SXNUGt
ovvC/nff6Qu7875AdD7IRyP5M4oKW7N5dttgOOYEMRDctixon57HbkCKrzcU61VQW2NBe83ozvcr
sandfyeZr7dxJpVhCz4qq5QbrFYrAi6j3SJTqNR4T25cHJ+4oG78PE0et+b4Iufh+okGAtY2FE+S
PYc7Ocv77MGz17jaVaFjndKwud68iwSe/9pePvMyRgyOwuvzOyv7JkprItG60jlWnvk3wwrf51ZO
XyH6fKVoh0vM9dRMGX+lPxytYjK4dhd1VBbeBmmmc4U4IAQVDzjRYE1NiWXyOo8nMM0YxF3jdk6Z
wFne4EdP/Yvd4zsEr2kX+KhZ3ooTRKv4eHVwoZ86+v+YeJN/ilduOl4MtFj1ubIkZlTdwcxvBYH9
qsTfOOAPDZ3plNkhr7OR44Uvdke6R+I+9fR6R5l3Z8oy77sKfkEUW61vObzzLjJeC1e5j+O5yQ9J
ge6FEvbl45n5fk962O0NVjGMPVtRFHZPHO++vDcqMtbd0TZicJ6nPT407sb7AtEBHqLjAXF4sGLk
JbzAbxP9C+aRoBL77vnMmH0OJrfWU1p3iJl5hzfzqtMTON/ukJzp0teRqSG7nVWHmPB+TnVW1Z4t
KfHhXT9XpIPK89l2K8d+bzabVe3Z6b9mM/tvR+GQF61ja28LxFpGx4KeKdrv283cuBl3ufyhiZGg
PDu+cuWwaMAzdjIvPGc1uzeXlNXW1cgBsWGWt3HKpII7WZ79gRWyt7EFgdXBgM97xDjT73me+8Hu
ka+wOoKFstza7XmsLW63zYIs8+ZvOZZVTSbTdwzDfsNasj7hJ86+1h5d2eMwLeyn5LA6Z5bbW3ie
V03jpqzP9UgeuxQdSucOsV8LamuM4Zc0+OqqQouDiSkOi0NSSQVneUlw1K5zR1tGGq+rrTH+tPqq
2TUNS+qYWOsBnebbHLTag5OsN7rkhWcmvt7gy10qCPxWPDTsrm03yaXHGOMRGFU17+59Svd6ujLv
uwr+WigIwjZH0l8lGUbKYpg28/52PHvf74B1T+7zrr6X2D/vO5myu+4LRHci1Ug57DjmJKjEPntP
U9wja/OZmyys6W0zw/xT+4X3qcnEvW9iix6TQtHJKZ+BQt6KItb0ONfx/k/MvLDZUd1wSuJzrCap
Y6YekncNa2Y+YxjTNpO5cHP+hKNaxGCsQH/+1eTvqEPylnOC9X1T4cS1gXC0HNcRhlItqhFDTpP5
ZbOZf9vsrLhDCUekSK3zNEux8xGxSj47FAqV1RaYV1tZ5kNs32SyvGcyTVrnC8aKd9q/ZYGcoNd1
RoGZed2EdrAFb5ZWykt80WW5vT7rdeznY5yJeR/bYczmj0wc/3ryvhLEfieo+Etsc1NYbDy/uQTf
G6+j+thEzvKy4PCv1y7mvMTPtCyLFivRZQcZ72+Jiph92NExRlUcY1dabH1pbCafV9vbuYBkH65H
DBSFdduZ0R3jZMXctjQXKW4+nYVmMHY2X0paLwpMSBIzwqWJdmurzHWu09Fb+7HfEZ84uq585CVW
C/+lvfyIy6y5zrGMw5e7qV0WOgbN81tLaxuVVk3oO9fbY78kt7W3NnQNmPdF4tGWlqyu/nC4c9Q0
wtpTP6fdJ9GdF5AcjrryETvtK+YRS1ekoL/7Zvy1sM5jX8HrqTRHtOjbY9xjmITzM5NzpuP42kfY
lbgtGpCy7IzWR2JgeHI6zWA4nj3uN9PR3rgi2ZKLzmSyjzva4igQA8oQ/AJWFMUWkcS8lMc1KQra
U/8YbUtVEMdom0tuFRKur3y0z3iPz221G9dxT79se+tP/AU+IDIj9EJNGY5RpvtO38/Trr4L6H3X
+TkxL/lzvd0XMv2dke7cRbSF6dj+aLvUUSgOkVt3R80ErDfXeL0v94L+9kc6Anb7iB31G8TcWMKU
F/05D1pjevuwf4XBYMQe0ce/kaAS+za4f0t2Zmjn9CvDMP0KKvfickiOSO64VmVO1N+z4/12SbGl
uGb4zp9riENcru6Blc6fD2fs4rDE+wGuJ239Q/Q22SX9Z9gmI0lZSlvHvT9g138+fEd7peHpsojU
NoXV1pfd2Y5sYx29gW12VjMe0bkdbG9kqn0liP1KUPU3d1Yj6y5A6QUV7zfGoMUVd0FdVcU5RTz3
VxNjeksQiv+eM66u1R2MFWWy7d4+rxcAUaRif0XZYk+R9c+if97Z4XDIW+E03yGw5nd5vmCzWB08
pbW9XUh6gBoanlURKea4p7XGvsUJwvs5Bx9xjVtpLuwYY+AuqZFKLiosFJ70zGo8LhYNHjapgPm9
zcJ9ONoVuCqgtGWnf7BVRtQWFFyVZWE/1bpBNXHCFsYsbGbya2+KRGN52kPDEp7ntrr8kZPiTUHv
xALmLu29n+SOq7061XrTtFXrg2XOngSV4/ktuZVzLl3QEJyjtf1Ontf6oyD/BXfNrHCstftNOH0/
x/VtNKfcJ+4NrrD8D2UFRWuyBPbj7vs6fZUUXTmiJeoe2eODaB/3zfhroY0zbTGZTN/r22P4zYl/
mYxHpPzezplwjUvUj69TeLqkNrw4EvSeINosL7Gjp63T3jdmsB3PdPvNmCY96A9FXGHZU+Ud11F0
xidHvbqs1LjG9rCP+jXbogSylUrPT4pY/jnOVPhMRU3o1Hmh6qCvbt5PpjuLr8/izf9MOq43u5Vl
OZn1z/RVgUjcofjdVUZBHKNt0aC7WGvbssIi/klP/YJjcX1NdjJ3Wnn2n8yYQx52hSITmuPRMbWe
guUCy77DsgVvir6FxytKG9uf/uwslvGAdh5uzqS4Bt13+neeGn0nV0uLUcRL7zu+6LXcg2derfWd
MxNBzfR3Rkt853NX0c7d6rq5Tf4ifo3VbPrYZOa25lVHzsDDZExxF1awpnabmfnMxHJb8Hps0yY+
GhCLM7kX9Lc/UoGH1LDf5y0rKmljWbN2/zL9w8IXvCFWzD09EI1mxSJuZ1/Pg2VRyVEnlS0t4ri/
cWb+jXGTZ10+21t0qcCzn5OgEgRBEPudoKYWoPSCahBTxEJfftY9Q0v8az01oSkYpzqrurQxKyvr
M2ZMVbtbiRf0tI3ePi9FW/NWtohDZ0w0t2oPWp+xLPvDmImVd1fOipysBIMFQb/HW5bPPWbhhS9K
/AuONyK6ce1Bo76q7ILxs+adLgUU/EU9O1Qjzs+y2T43jZn6gByNHDJjsvmaLEEvKvJ92eTAFcHw
4ppoUMydXTHy/wSrbYuzZn44MaLc7S9hmswH7PYhGAeKQev2SUctt4ruPMYuDW1vlwVUdbPw3Jfu
idOvlMOLpyk+u6PuYPMai0X4Mnm96dqabbNtMaEPlLgjVRsW1pXOZTn2a3Ox+FfP3Ma5AdE+PFTj
nlLu5B618Pw2p9Yfxh8RMjlO+tjWnfdpNCNKw0W7OEx7/eTkfcUfKnp8EO3Hvunj10TrqGDFyIsF
QfhqZEXwEn17jDQC/ZbRORMVh00vZG4ewpu3mTlOzfPU3hiJRSdqvhHnLZImG5HSwXY8U++3OBp/
kW0Meg/tVnQm1FS1slkZMSPfvCrdPrpqGsX2VoZrqC5ePGzczN85xBoX/hodDngl75AhD5VUR86L
RCI5Ia/jpJ2Oa9J5n7p/tLZp742GvNJObWvR2qZds9kC2sZ+5/EHmuXGeHXUJ+bWSznnWQTLV2yZ
f61frp8fjUbyAj7HpLIC6xOCUP6SJxAd38dzaEzHHy3EUdp5eJd2Hv4/T7DnqrF03+n/eRoPigWH
5w9dO2zynOudnsBYq5UZVV+Zd74ty/Zv8yHBW5lAS1ZPgprp74x2mRHSnbuiL7I0Egzk1VfkLNOu
lW9zfeELMA5fH4vrE4tnHmy+QxC4/+VUz4/HY5HRtfnMjb3dCzQ5HdKf/ujh92dNocWyyVp+1C25
3uDYgCdXPNzBtaMyqCcwd2HgUMsvhgimrzI9D7R72pC6g7NuHmqreNwjyVODAXexdtNfMrZw9DMs
x39VGligkKASBEEQB7ygqu3aw29VQTzbWvKGWN0wo+v1TS4+JOVcaBFsX+VUKBe4WrtHGPr++VY+
IDJ4KDuZ5S1fsxOOusWutHSlCEZkV42TEz7gHNM2iEpHPn+03nNM9oS6W5lc1ySGQSYZk+dz51ZM
zmGe53nh+5LAwuOao9KoI1zMGoFnvxZrIg1GGklULj0GFdnME+pvYZS2HlMousaBVkfiO/ZLnytL
HwtWWt1wYtd660qOhXgkrldtY9he2vqDWNd4fKoHj84U320jK0P/Z4/vaGcksKM/HJHmUXho0/r5
nN76mWlt59LtU0+vp3sQ3ZV9A/Or85Z0VMaLnNPXc0ZubeUwL2f95JHNHC98w5bNXm2PP29rb5U5
pNYwaQRgbx7PnvYbqaXJRWcgK1HJPqKnfYwFxDEzS2z3FFZiSGLCcamrmCPWRU9uV1WuaVbJnFTH
NdP+SVUQR29bwN5RwIXnvyj1R04w+q1JdrvKOOFVPt+/MTHiNq8q5wKBt3xRWrvjQbsv/YkxQ5Kd
sTGMfUhPhZrovtP/8xQVxOdJzvOybBXPO33hcuP1xWGXOKHQ0s4XTb9TDMRHddwXxJ3uC9huJn2v
nbtszOfI7e3cjcrFx6SaF7Chs6qmPnWEtq7e7gUDcd12P8e0Y1Gdd65FsG4v9i84wXh9kVyi8AL/
ZU5V+PyoIo2Z6WJuy+Q8gKjOrykNZ2WV/L3Eq9QZ62tW3GOmFbDrBI79ujTQSIJKEARBkKDGFbej
Jt/aLhT617uTfh4LebxOln+P5ya+KgWi41KtP9PPe+ToQR2/3MUQHka0X+4XJBYFao5IOTUOdoNF
KPjAHYxWbV4ZsIY87I28xfaF9pDxpjE9jj5Fjon5wGRmP9Qe/hdpv8y5iC9HLzBR6m88bsd+e6oL
Bes7rHv2mt4eFFNNnNztQTFxvbLn8OT1Yv5Ira039dRWR03Dqamq9CZs+9y2NP3hCTVVNccCeTUF
1nWZ9vOC2hIl1UNfukmi0wnqruxb8oTYxnsyP2eaRF32avJ+inXggTCTYgJ783j2tN8gXdEZQ2hT
7SMkobbQ8qCFn/BqSZnsF8VAV9U/jBVF1Lwvk3+ne2+6thkFXBL7LSJ7DuoovuZf7wh2iJ2qKmzH
XHIcqpF2icCu9ifddwb2PI343a5JFtsLwvg5q5noym5FuxSJsTH2HQXMut0XOufGXRYU83rte7PW
98H42NaY297TudvZD0qqfkiclzCT62SgzzNVbTMrAfcJPO98yi1HKzv6x26b63X+iBMsXzHuo29W
Wp63zffl/rTn86BjLCrO2WkF1ge1fltn/DHEuG7ClTkX0BhUgiAIggTV+HlQmlosWN5l8/3rJaV7
JTI8nEzLY/9oYZ0fpCuck/Hn5ejUJHHq9uDeHmMs9WXmVRae/UqUo8csiwQc0wuEB6xl8hrG4S40
ps3pHHyvD2Z3uWTLDhnoXvWyUZZ8RYL1bXZC/a27+qCYfr0dDx6IcPkLLet6bKssW/oiC0Z/CDz7
L5ccVWJKja+IF97uRz/vkqDuyr4li5rxQJnpOQNhQKGohqqcczrXkdFcsXvzePYmqKn6GUUXEt6/
0z5uanXxDb68mI3nvuDM3H9z8w550F0j+xKniBkIQe2hbTv3W4r7Sro+3tX+pPvOwJ6nkKdi3rLZ
URW+0JVQ7CcVieeEW+4YE9wY9FRlev22tbWxDVV5p/f13E2+hoz6Cj1dJ7vjPEMUX5IUmyKJIzwe
ryvkl84ca+FeM5v575myo1cF4i1DI77cxT0er84/AuC1YsvO50byuUSCShAEQRzwghoNeg4vxETG
juk7PWw0RySMB2u3cAUQ1Gmp1p/p591yxyTv6cQJv6TneXMwefLW0lkL58ZCgXGTBeF54ZA5tzI9
PHCnf6DzHL57HhQT19vxoIg+nmyxvNBbW/siC/r2vTkXYvJpXVDDvuoCVnh3V/u5r4K6K/uWTlAz
PWdccpMvSVCXDrygDuzxHABBTbmP7a2yJVwpnuLkzG9YeP4b7bz4Ntc15SYxEHPigXa+f/AK6q72
J913BvY8NaJ7fBkiqButfRXUqOzO7HeGHK3uPHeFvp67GQjqTtfJ7jjPOoW84jCPeINgHfuk5K+P
hWrE01le+Bfjnv1rXVCrOiKoaY+XIagBzzQ9qoq034R+Tz7mJKgEQRAECWpQmlrEWj5g86r/5IvE
R+/0cJKvPWwIxe9oD6xVqR8UM/u89qDoTXpQ7J76GGWsIQ9/k1V/OG6qaokHtAcdbr1FKH/FFVw8
Pnm7bWqbWZLiNkSX9vaDYlwRR9c4uA29tdUodpSJLCBd7egy/maLUPQPKRibuljxHuY0C+/1o593
SVB3Zd/SC2pm54wr2DRlbwjqruzz7hJU/X3ag6vWd2Nkr+usQrNps8AJ/zHlVd+jxFrGRGXxGJ4f
nIK6q/1J952BPU8bZb3v3mfzpj7ki7WM7rOgBj1VGf3OkBunZnLuLqwT53J892PTH0Ed6PMM22vw
u2Y4LdmvWstm3eTwhUtcsixgfCknWDRBndMnQY0ggsrjNU2g0wgq0oRJUAmCIIj9XlAj/s6xYvnT
20UlvtPDSFSWDqrg+Zc4tvAjd7Cpptsv/Ig4arpDaLcWTX9QTJrSo6+ftwc6tm38tTzHFz4/cSxY
e8xlCY7jf2OzTn7eFYiNVTcx/Jwy9ib8tX3kpGCz2LKxW7n+WKPfWznrtGNa4vFs7Zf7kp3HbGkP
A4L1H2wGxUoW1IrzuM6HV0Oi9HFBxnyEvawXD7m9tbVq1mmKS261pN12dUM88cFkWVTKnZYvbLAW
an0fbRkVV6TiSRz/Yub9vPM+pdvXbg+WvPPdxOk9dmXfksaRdaXkZXrOGGMbG3x5fRLUvXk8e9rv
dP0MCUwcb5e8jyiuIsuxrm3h/RHJ4Tx8DNsusM73fUpTdXSWS2ExXVHScc20f3pqW+K8nAmCWjpJ
v6/4u+4riamKeK9xPu9qf9J9Z2DP0ybZK07imL9zZv7bYm84oiadL5tiLj7WOQetHhHtPCcMQY0F
PWMz/Z2Bc6C3c7epfvwxPM9/rh2bC3b0gyaHndd9XvX8Jcbne7pOMu0PxtUqZHKOxTDWNs/yoJUr
f81ZE3XvOPcSBLWlLbuxOvfMno9XV8S7tEIQXuLHVP3JHW3O2yHCbeaGznlQSwOLjqMHH4IgCGK/
F9R4SBo3gbO8yudVb5SiK0cl/1yPBFTmLs6yCNuZcTNuZ6JtXRUuQ5LzUI9tyAvFvvBiJs1YpYw/
3zmZMQpi6AUmSo+4U3vQGma8V5Eckyfasl4o9s47x6hEG60rnWPlmX8zrPB9buX0FaLPV4oJ3V1i
rqdmyvir/OGmys4IG/76vC3xl/vikFRVIFjf1f9avanncVZok8AL23J8kfP0efhk2aI9NLBhX875
ma63l7Ze6Q9Hq5jUVXwVC89/NdxTv0LepFp29EfxUWNtQ15zVIXPxgO1PidoH/s5cZ+igYBVn78x
xev6w11cGVEzmt1g4fI/8Cqxqd1koJ/7potBRyXOr7C9Pp8zneuM+HB8uz+oDtbj2dN+g9ZlQXtX
P4diXX8I6Gkfo5HgqLoK35keb8iV+PoJU0Y3CxbxDV+o0bcoOH4u0sGTj3cm/ZPyHOjetvPQb2Lt
wuO77iuKd+xEzvIKn+f/oxRtzu3pvZn1Z6PenzjPAyIzwso4clydkkT3nYE9T3WRm2C+3saZVIYt
+KisUm6wWq15+JxbZAoVv/dHwejiiR3nRGCn+wIq52Z4/bLLIkF7T+euFIpWxRTv1EJWeI89ePYa
V7sqdLRRGjbXm4fU66/t5TMvY8TgqITrKu29oMf+OFTrj0i0CtXB3Q7GzliZXFcs/R9F8EeQSTz/
Om+aoLVzmV4ksFV2CeFqsZEVLF8zZXNXtbS1DamvsF+UyfFCv88+hL3JJvD/dkjKyWrnH0o2tkhZ
cyvzlnXsa92lVik6humhgjVBEARB7LOCGpNdFtFqLaj1Fp/BmzmVMedvFaXaEMO4xxil8A2aI+7R
hztMa7OzrF+OmXjkxYzVWuQVnWX+4qG/z3ZOu9Pdy9xxffm8Pu+nmd1utpS8UyGHF2gPD07JYZ1Y
XTLknuzC8nUepaPqJmiL222z8CDFm7/lWFY1mUzfMQz7DWvJ+oSfOPvaQMtGa1MgVzzMZWrneU61
TzyyhQlERikBcdgsqWARzwn/Y0Z7n8wV5bLkfe72oCh7qkqs1s3cuBl3if7QxEgwODsc9EzxukwP
Zrre3tpqj67MSrXtppBnipPj/26zFL1X7JVPR38EKsv8h2YP/UvJePlSu9IypD/9nLhPLm2f5gdn
BZtbmkdEZbe3OOH1SFCe3dwcHxVwi4cdYmLewbnirKo9W1LiwzM9Dqn2Deef7Ha4A+NMd/M8r5pK
a/+Q6/aV26Xo0Ez3BbLS6M8tnTHOtFbguR/sHvkKqyNY2NOx3NvHs6f9hoD43c6qHf0cOEsMBEZE
/bkH9bSPsaB7zIySYfcMK5l+h08Oe3GO1Hrc06cfNOJeS3n9L+xKW3ZM9hyaeLwjs2bVx2Ixe2/9
k/4c2NG2Wpfpbq1t6kjRv0p7eM6LBqSsWqnk6HwTv4U1u98TvUpQUhRb1O/Ee9ca77UHYmMYpkOO
eu3PeEeUqTOK+4CFL9ycGMmn+84An6eKdFB5Pttu5djvzWazqvXHf81m9t+OwiEv2sbW3obqvB3n
cuL5Wnu2GIgO60vfxwLuvB7O3eswtVZMcRdV8MLzVrN7c0lZbV2NHBAbZnkbp0wquJPl2R9YIXsb
WxBYHQz4vEeMM/2e7+Fe0GN/eGa3ulo3WZbFJGd5AfMIz3H/Huapv0iKp450xyPSqBptH7Ms/LfD
y2Yud/gCRYvmzZp5aFHBHYJ2LEyuwN2VlZ4wZ2K+Mmn9k1Mxa0VvxysadFcVctzrNkvhh6VS4GSH
KBVFQ1XKlLHO+ziOVbV9/dLsrP21W1mWQw9ABEEQxH4nqE0hb0URa3qUN5ve0x4KPmUY0ycmk/CO
yTRpnS8YK05+/7KIlBccn7uiSOBfMTGmt1jO+aynataZgUh8dCbby/TzSLXjeH5LQeUR19RLB12i
/XJ/3WRm/1FUNvUaKRLdSYSblwVygl7XGQVm7X2MaZuJLXiztFJe4ouvHNkclUZML2RWWVnmI20f
P2FY69vC5DlXKH7xNAtnel1/zWT5yGSauD7VPu+IKIjWow7JW84K1vcY56S2oKLUBJzszRYz82Ff
1pu2rdHuhUS6PVC1tZmjSk25z134C55n32FMpre4oqKNZYG5JwZSFDDJtJ+NfeIE6/umwolrA+Fo
OaI0rdpDZ9frBZ67Q9H4hCalZrKTNT3GMcw/sW9mXtjsqG44JTH9s6/71nn+Pa4d344+NLEfmjj+
9cT1ptsXY1xbs+IeqR3fm7Xjq6/DZLK8l+78HSzHM+V+m/nXnLULFjYqgSlOE/Oo0c8mXthUUiPH
pxcJt1rNzPvp9jGqKCNlyd+khEIzpk0svJQzm98wcc4XneX1l/hizXpfdTuuCce7p/7p6RxI2TbW
+q5QMbdlfl3lHIEzaccM7+X+aeKKH/fXzw3MKGZXae/9QH8vZ32fKQ+1JE5jkkl/xjuK7NylCer/
8wSjh9F9Z/ecp52SOmbqIXnXsGbmMwafMxduzp9wVIs70CGXXedymvtCJn2fybmLe+CiGjHkNJlf
Npv5t83OijuUcESK1DpPsxQ7HxGr5LNDoVBZbYF5dSb3gnT9IUWb9ShsLOIrnlTIrGNN5q2CUPK6
L9Q0JeUvX61ToshAcmjv5bgPGGfRBikcPToS8JeVM8xfODP7gSbA72rv+wy/Y00ZHC9ckxHZWzHB
wa7nzex7jKn4yaqayI/CfvFsS3Hhw6I3sMQXjBSkm+OZIAiCIPZpQW2VZc7BMHamg6EawzrK7Usj
lDTpQ60xFy92lOPPYRiH3Uh5y3ibGXzeKAyS5wsv1doxpHMKgJFMwjilZDBuSVtvdsd+iNlKZ9qe
qj1ASHZ934Z37uMIRlSGYK46/XvG+Jk0XOklZQpt199rF4fhvQE7M6Q/603X1t6Pl0voPFY5WhuG
J46T6+9xStynxDS/5Ndxrogd+zXM2F+7pNgyPQ7pzr/OdQ7f0V/MyOT19rQviKDudHwzOJZ783j2
tN+xjn1N6udAVm/7iAdlIwITkOxZHX0ljkgeS5fueGdybqQ+B3Zq23Ct37JlTYaZHe/VsA9H8ZhU
700uSNNbf3Ze09pxsQ9RMkxzpPvOLtx3OrY/tPNzQ1yuVj7FuZz2vtBb32d67kLctPV0HBe71HVO
MpKUZezLTn3TQ//21B9ok4thLD6HI7/eU7k01Ngo9tRHin4+4lho7e5MOw8wTFZnW+w7+i/z46XP
N6t/1mHX+lzAvUHbV1umx40gCIIg9klBHawkTMp+Lh1ggiDovkPsSSDDK6NR67LFkYk1s047JnFO
VoIgCIIgDkBBXSTrD4rbULGRDjBBEHTfIfYk8agyPCIHjw6GozPEKMkpQRAEQRywgop0raDDWjiz
3N6iF48Z513vkILu3greEARB0H2HGCgwhY0syxY6B4gDAaSXx2IxS2trqwVfdxfG+vHVYHduj+g/
LS0tVnzty9zjBLHfCmo06CuaZDKts5g6Cq4w5t6LiBAEQdB9hyAIoh8PkJqA3HzzzYc+9dRTzc8+
++yK5557bvnu4q9//evyxx57bPn8+fOXH3roocunTp26fNWqVct35zaJ/vH0009fqp0PF2zdutVG
1wlxwAsq/oondRSV6FMREYIgCLrvEARB9FlQzRs2bPjRf/7zn6/+py3ff//9d7uTf/3rX98deeSR
35nN5u+ys7O/u/feezP+rKqqO/HDDz98t7vbfCDyv47lM62PR9J1QhzwgkoQBEEQBEHsOUH985//
fIomI/9R98DyzTffqJqgYl5l1Wq1qvfff3+fPv/f//5XX4cm1Kompyotu3X5kgSVIEElCIIgCIIg
9rSgLtQEdfueMJ6vv/5alWVZF1Sbzabee++9GX3u888/V9evX6/+4he/UJcvX65eddVV6u23364+
/fTT6scff6x+8cUX6rfffktKObDLVhJUYlAIanurLLit1pGuHub9I/bKLxBTQGSGWRlHjssV4+k4
7h/ntN42t9VuD0SzqG8HFy0BKcutzz/Z+/U2WO4DmbS5r/eSfem83devJ4I4UAR15syZfRLUv/3t
b+r8+fPVH/3oR+rll1+url69WhfV8847T/3xj3+sNjY2qkuWLFFXrVqlPvfcc7rMYjvff/89KSYJ
KrEvC2pbG2OOBFxjazwlFzl54dWy2vkh7aQ0UecOkodlhbHVu9lVVsH5pkduPJyO4759Tmu/mU2x
oLvYL5UsczqtzzprIme4YuqgEaED+X4Rk12WkN99uPfg/NVFfPETXjl62GC/D/SlzZneS/al83aw
tKslwGQ5GEb7xzi1L/l2Ka4XF1FbZa6trc1Mv8sIEtS+R1DffPNNde7cueqvfvWrrigp0nyR4rt9
+3b1X//6l/raa6+pa9euVbX90YUVrFixQo+4Irr65ZdfUnSVBJXYVwQVD5Sy3FFCullxj5xRyNyc
zZu+Zln2O1dg4XEkqIOHlVHGOmcCe732UPmy9lBZRcdx3z6nW2OMJTSRackWzJ+bOe5/eTUN58rt
6qCezuJAOc+aQt6KEp592saZv2HNzo+lYPTwvd3fvd0H+tLmTO8l+9J5OxjaFQ+6nbLLeWUxz71o
YkxvsVzRsx7frLM8ktcTrJHDkVgsh36XESSofYugQixPP/10taWlRf9cT4vWfn1sKoQVUdTrr79e
Pe2009SFCxeq8Xhcj7o+++yz6meffaa/B4JLCwkqMQgFNd7kn+KVm44XAy1WRESiEjOq7mDmt4LA
flXibyRBHWRERcbKMPbs5MqidBz3vb7oTLPMDnmdjRwvfJFbFT5vsAvqgXKe6XOiup2lU3PZhwSu
8H1PsPHwvd3fvd0H+trmTO4l+9J5u7fbFQuKhVPHCA8MtVY8I3lln9aenIAkFdeXF1ySZbV+zBb4
17mDsTz6PUaQoGYeQUUBJERFI5GInrLb1wVR1q+++kqPrra1tanNzc3qokWL1Gg0qp5//vnqmjVr
9NRhrBvvg+DSQoJK7GVBbQ5a7cFJ1htd8sIzE19v8OUuFQR+q+hfMI86dvBDx3Hf7osmufQYXhC2
4oGaUdVBmwJ4oJ1nK+OBEbUOdp2FL3xvbwhquv7enW3uyzYH63mb2K49Jahqu8zN8+acq4nolpKq
SLib8EvM0Hpv8Xm2orp7HL5oPv3OIkhQM4+gbtu2TV2wYIH64IMP7vI2E6OrL7/8si6nS5cu1ceu
nnLKKeoll1yit2Pz5s36dv/973+TsJKgEntSUDEOJuITR9eVj7zEauG/tJcfcZk11zmWcfhyN7XL
Qrgq91w8cJbWNiqtrTHebWdGazeRMXalJe1Eva2yy+JgmPyOcTdMvpT0XhSukCRmhCvWyre2ylzn
Oh09rbP7A0A7F5Dsw/XIjaKwnZ8vZBgxt01V2e7bsY+wK3FbNCBl2RntfWJgOJMU2Ulub6p27HiP
o0AMKEO0C9QsJxSCSffz5NQ4RDbcDJOHPmT0r/YxeF9UsmOuxYKO17R2SsoI7V5tQmQq4GBGdb4/
3y5FhxrrSiyAoh9H98Aex47zo2v7Dr1d2Ee3MhJt0x+4FLuN6eg7rd3uPFlu7XoIbImK1h3jr8Ru
28J6fQ4mt/Ozo7X9ykronzGd28s1Xu/L8RyIc3pX2ueSW4WE8zofbTTe43Nb7ca5qiScqwaNgdLj
9AdqXyQebWnJ6jq3He4cNcMH/576fVevwT1xv8j0PpDJNZfpugN2+4jO96DPcmOt3ccrLlOkXL+D
XZ9O9vp/vvR8DHrqb+MaTFcIqbc2dztnMryXMGnmge3LeZvJdTxQx62rXZ2CirGpQTdj77yf4n7r
TLynZnof77EvFcY2p4y9TRDyP3QFFgaSf764MSweetCRlwUCEUd/roX+Xi8EMVgFFam1s2bN6hLU
devWpYyebtiwQT3ppJN0YRzo5bvvvtPHr27dulV96qmn1BtuuEGNxWK6sOIrKgRDjDH+Fds/gNOB
SVCJPSOoLVFlRG1BwVVZFvZT7XewauKELYxZ2Mzk194UicbyIr7cJTzPbXX5IyfFm4LeiQXMXdp7
P8kdV3t1QGnL3vlBRxwanlURKea4p00M8xYnCO/nHHzENW6luRAPPo2yu6RGKrmosFB40jOr8bhY
NHjYpALm9zYL9+FoV+CqVOtMfAiMKFKxv6JssafI+mfRP+/scDjkrXCa7xBY87s8W7C5pDp4ihyT
LdGAWKxvxyk8XVIbXhwJek8QbZaX2NHTkFo1ppf2trqDy5xd74kHspVKz0+KWP45zlT4TEVN6NRw
fU19pdw0j3G18tFowJru55qsdKtmGg36iipY03qbidlmYrhtJrbocVmJVjbWOn9k4c1vsAzzJcNy
X5gnhq5itAeqlYo0fHohc3MWy3xmFqzvF1TPX4gHwFCNuwoFUAr54id8wabKlub4iBkOx5UDdRy7
oiiKe2RtAbM6m2e2MibmXybB9j5TPudSRm4X8POF8viZWrs3MYzwBctW/MkXjBXr4hqR8uuqKs4p
4rm/YvyVIBT/PWdcndavcaexXm2/VtlY08cmM7c1rzpyhnbTM8UUd6HWP+02M/OZieW24PXYpk18
psdzV89psbMv+tq+WFB0au1bVljEP+mpX3AszuvJTuZOK8/+kxlzyMOuUGRCczw6ptZTsFxg2XdY
tuBN0bfweEVpY5MfqDme35JbOefSBQ3BOdq1cSfPa+d2Qf4L7ppZ4Vhra4+FXuKKuyB1v8eKjGuo
MdT/a3AP3S+6XX8p25H2mlx0vHHNZbJupLSG/T5vWVFJG8uaN5tMpn9Y+II3xIpQTInvePDvTfb6
eb6kPQbGeZi+v6evCkTiDsXfcR9IVQgpE0FNLKbU+71k+s1uZVlOOkHt7bzVxbfGNbaH6ziv47jZ
B+y4JQoqhF5VGPaYScyKLN68xcyyH5k4/jVHdcMpiPr25T7eE+0Y/1pu/pWFE75nRletdwYaRTVB
vqOBgLUhIIcikUhOX6+F/l4vBDEYBRXSCSn85JNPdoqgIsUW0mgsiGAuXrxYbW1t3elnu2NBOjC2
+d577+mFlSCoZ555pi6sGAN7yy23qO+8847efhJUgtgNgqqqjClgtw/BWB3tF/k2+6SjlltFdx5j
l4a2t8tCgy83buG5L90Tp18phxdPU3x2R93B5jUWi/Cls2Z+OLESYVz75VlfVXbB+FnzTpcCCv5C
nR2qEedn2Wyfm8ZMfUCORg6ZMdl8TZagF1L5vmxy4IpgeHFNNCjmzq4Y+X+C1bYleZ3dHgJjbvuM
ieZW7cHpM+3zP4yZWHl35azIyUowWBD0e7xlDu4xgRc+d9XUNx1RLKzO5szbzByn5nlqb4zEohM1
t43zFkkT20hp5y/7Ianam22zbTGNqWrXpHp0e6vMNVQXLx42bubvHGKNCwGOcMAreYcMebiken48
Go0O1X5+ZuqfR85jWjcJifugP1h5nKLPwW3kuTGflVbPnS23tnKagFmDPs/UMs70d97MfV9S2xjR
j4/2hKh4Ha5phVnrymrkUwLRlqymkHdSYgEUb7DJhweggTqOyX8UiAUczpkHm2+z8dz/7BPntNiV
+HAjooAH3Lk+cZHFNvmvLo9yuPYBczzoKPDlZ90ztMS/1lMTmoLxV7OqSxuzsrI+Y/R+jRfoVTZ9
VnuwYtTFgiB8m+sLX4AIhz6W0ScWa9u7QxC4/+VofRyPRUbX5jM3DuF7Pp4DeU7r+51J+3zz48uW
RXMDk5irswW0j/3O4w80y43xau19ufVSznkWwfIVW+Zf65fr50ejkbyAzzGprMD6hCCUv+QJRMcn
tn1hXelclmO/NheLf/XMbZwbEO3DQzXuKeVO7lELz29z+hccn+5YxRSxsKd+l6KteStbxKG1Fcy1
2Zb+XYN74n5hXH+SEnekjpwylvTXpHbNtbWxKwNSVs/XdnxMh8Bol5bFsslaftQtud7g2IAnVzzc
wa23aPtWGmic25cIap/PlwyOQer+Fkejv6Mhr9RTIaRMBDW5mFJv9xImzXnR23lbXNuoLFsWydGu
45vSXceumujYjS04bu4BO26JgtrWGckN1khTK0qKb6+slsNWh2OUXVJsLQHGGu7pnEq6j/dGVJam
FvPmt1gzrzJj3E96/KHjlWjLkMTfA4lR2d6uBXekefTGaM99k+56IYjBKqiIQl533XWqdj2oDodD
F1Ttnqj6fD59CplNmzZ1vfcf//iHetxxx3VNGbNlyxZdcPfEgu2grRDWDz74QI+knnPOOerxxx+v
T3GDIkskqAQxwILa9aBijNWpjsS7HkbbZS5c1TGmrLS64UQjfTNaV3Ks9hD2lXlC/S2M0tZRNr+N
YaP1nmOyJ9TdyuS6JjEMsgyZPJ87t2JyDvM8zwvflwQWHtcclUYd4WLWCDz7tVgTaehap7Z9bZ3/
SlxnyodjkcGD08ksb/manXDULXalpSt9MiK7apyc8D43Ztr6YDA4PiTZL+J44Ru2bPZqe/x5G2ST
YcRsPGRl1F45qsQjAUddsWVtYSWG1HW2A5+tq5gjyk0LQrKvpK4k9c9L66I/YtIUF2n0lxxn422f
5/oa4kpbR6onHgzDlfZl2ra/zvGGzzNSQKORgLe0VL4+GOx4OOupAMquHsf054d48ESL5QXBcTge
Ekd3PWiJTPZxFUNaS2siZ+EBEMeooaognm0teUOsbpjR1YZNLj4k5VxoEWxf5VQoFzCt7cZxV1KN
EWuozjkX54P2+lJFEw7M01g/eWRzuuO5O87pPrVPYoYGK0ZewvP8F6X+yAnGeptkt6uME17l8/0b
3cFYV5RjXlXOBQJv+aK0doGSGF3pfKDeNrIy9H/2+I52RAL6uf0B55i2wR3ZubiK2s5wmfQ7Hozj
AWaEXsyoH9fgHrxf/CDWNR6vpii0FAuIY2aW2O5JeU3WLWxUlED2omDF0T2tu7ijyjDf4Ms7xyJY
txf7F5xgrGtRXYl2DPh/5XjnXWQc80zTZTM5XyCefT0Gqfq7t0JImbS5r/eSdGRw3q4XlebRkp0Z
mu46bo25+N7OiUyPmzEONkFQz8W5FPL7JlSKVSuCQeXgTM+pnu7j6f/wq5ob/ONP0CR1E8+xqpnl
/pt38GGrpEDosEB0Zbd19XYtaH31nbtufkNU8R2bNeGIX/f1eiGIwSqoGNMJQbVarbqcJlJeXq5+
9NFH+vsQLb311lvVn/zkJ/oUMZ9++qn+tbc0W4glxpkO9NynWB8ipyiohKrAiKoimkqCShC7QVCT
x+rs9MDpbzyu672y5/BCwfoO6569xniIwribkIe9ibfYvtBuLm9qvGXAmpgPTGb2w7zqyCLtxOYi
vpxzdlpnwFOdvM7eHo5zqsIXJBbkaI5IOTUOdoPAF7zjCzdVN9YWLBZ4/kvtfecnj/fLoL0f5PkX
LIpHFceMAuF+Cz/h1ZIy2S+Kga7xSniojCvi6NpCy4Opfo7xXOnGLkVlz0ETBeFlC4SjM0UV0z3U
l5lv1vrme1PetA1SpGWU2spwjbWlZ5TWLTydSRjzmq4Ayq4ex/QPXAo7rzJ3qVWwbSmpWRDesQ75
4ArbobfLcqP+wBcPusfU5FvbhUL/+uQqlbGQx+tk+fd4buKrHjl6EF5bUFtybKr2IhJnPNAbn59f
nbcEr6U6nrvjnO5ch5Jp+yLVeTud1xHtOFdwlpcEh3+9I7gs1+jLjs9z20T/guNTCKr+QN2W4ty2
CAUfeOTG6uR9jStuR2b93iTqwlSVc+6uXIN74n7hqGk4NVVhm2WKmNvTNZfhvegnm1RVmFc7/nie
dz7llqOV+h9cJLttrtf5I06wfMVAEjtlIlNB7cv50uDLWZrpMUjV3z3dB/rS5r7cSzI4H9Ket+5g
tKrjOs5dnOo6xv1vwI6b3G7pahePsbHhpWFFnjS1dOrPAoGw1Ndzqi9jUHfcM9vMEdlbMcHBtAuc
6VvOzKomM//v3M4hL5n+LmLM7Luif95Pj5mctZoTrFv6er0QxGAVVCxIoXW5XN3klOd59ec//3lX
Gi9SeiGnN954oy6nENf3339ff72nBRHPX/7yl+pLL72029qPeViXL1+unnjiierbb79NgkoQe1pQ
E6tyNsqSr0iwvs1OqL+V6SzQgL9A+wst66xl8hrG4S5EemEnIzWQEjrU5ZItnes8t+d1ZvxwvDTx
FzLG/miCt0rg2S/K6hac0FBTfK4mqJhiYKc58DJpr2aglk2tLvy1PmbjuS84M/ff3LxDHnTXyD5j
2oWOh8/0P08HHkrq3fwqi6XwXbfcOA2vLW6USyoPKmorKhA2m4WCd6VQk7c5qoyRx4rXy+Hu8xOm
e/js/3Fs67XQRjToqSq2Cv/gDz7yN/bO9y+aWzF3yOTwNYwYz+54jzS1WLC8y+b710tKh5Altnla
HvtHC+vUJCs6tVNQlTTt7Yo4oXgKIrMJr2U0p+FA9EUP60jVvp3XG3CPm8hZXoagip3imNyGNIJ6
Xqpz25JmCpfGDPsdkqBHd6o6ZHoArsHdd7/Qrr9U2+7tmtTWnZfJvQjvRTRTkhSbIokjPB6vK+SX
zhxr4V4zm/nvmfI5v+6HoB7Xt/O5/+dhb+3KtM19uZf0Zb+Tz9viwMK5evSzCn+g3Pk6zvR3SEbH
rVNQ5/sxNtbyWcGUab/0F2Xf5/GFT04VZeztnNoVUAhqrt91YiFnfk1gTT8wrEVlxkx9QIrE8zPd
70hAKvY7rf26XghiMAsqxnpiTlKk9hqCWlRUpL7xxhtd73nrrbf09N5nnnlGl1NILQQVstpTdBRR
zgsvvFCXXURSd9cCUUbVX0RSEdklQSWIvSaonsOTHzjxID4ZKaCHzLmV6eFhJrN19v3h2Fj3PG/O
RTzPf54kqEuTH7Ayba/+kNUqW8KV4ilOzvyGhee/4Tn+21zXlJu0h/0i/GW9Pdbzz9PvR4li461b
cirD57W0rLQuCVfKnlmNZ9RXOS+2sNynYl1jQ1NjuKqkpO5XPl/3io8DI6iZ93mHVNtts938asHi
fNcdbKpaGRWHHDsx61pp7qIQ09YRNdEktrqQs7zPOqbvJErNEWmU1uZ2C1fwgVvuGC/XT0FdOvCC
mrovBoug6p/x5lwo8MK20hSCqvX74Zn0u0vWxxhqgoqI3sBeg7vjftGXa3K0q/JGd2RZQdTvOUhb
918zXXdj0FNxmEe8QbCOfVLy18dCNeLpLC/8i5kw+7bdLKi7dB7uC4KaeN4WBxqTBbXbddzXc6LH
49YpqAtqEdHmt+S7J9w31mp722ya8JLLH3P35z7fh4d7U0yTRdQW2BFNVU2xgJQ/y523wsox32iS
+n2eN3xOm3bfbAq4xN72W5PY4r6c0wSxrwgqFoin3W7X5dRkMunTvBhCiTTg22+/XU+lfffdd3Ux
RTotvsd40J6KFCHF949//KM+1ykinbtzwXQ1EO1TTz21X3O0kqASJKi76YETqa41Dm6DRSh/xRVc
PD55/W0q/uIdt+Ev1QMoqN0ecDpSxPibLKzzbV994/RITcE5SPFNJTSZtjfxASMalMbIXtdZhWbT
ZoET/mMac/h9Rjpl2p93FvVIvR/uUqT5Co6adb6gUjqvsvSCUNPiysaQz+cUhDdt7lm/DYd8C7Kn
hC9nxB1TIewtQQULA+JcG2/5zOFVLpoflmeMtUn3+/yRg3eIkjS1iLV8wOZV/8kX2TFWtavN+Zoo
CcXvaILq7YhwlBzHJR3LwSSoC2rFeX1o324TVETcjy7jb7Zait92yzvLRqb97go2TRkMgprp9deT
GKS85hw1a+Vg0NORspp+3QFMUYWqsrWuWqcl+1Vr2aybHL5wiUuWBYwD5QRLvwR1l8+X/UxQu5+3
RvQ+taBmck5kfNwSUnw5Xvjc6VMumud3N9gswlZmXOC39ujK4RmfU73cx3f6Q15AtJ4mV87T7uUV
yVNgbW4JWEOVuUusHL/dlD99gy+6cmRL1DGyp/3uaJOvuMbB/7Gnc7q364UgBqugYh7U2bNn64Ka
lZWlS6WxIE23qalJn6P0ww8/1MUUc5MinRbfQwZ7KpYEid1TY0QxRQ1SkZctW9Zr+jEJKkGCmiGJ
D1bGuCCMleua17DbmDLJVyxY/8EmFPKAHM4pY2/CX51HTgo2iy0bu00pEWv0eytnnXZMSzyera1z
SSbr7O1hKMcXPj9xDGp7zGUJjuN/Y7VKz/iDjePn1+Qt1raTUlAzaW/VrNMUzNWXON+p2qawEcnh
PHwMIlLOD7UHumlywhQEKX5+ePqIJGObM4G/SbDkv1tR5zvzoHGzrgkE46NaY2779HzLvVbLwe+N
P2T4hgplUT2TNJdgl3TwznelYKNvoI5jb8QV9+jqAuEBm8X9ZsWUcTfbDj3uaiO9VxclWTqogudf
4tjCj9zBpppun42Io6Y7hHZr0fQH7YEOiZpfW4oCOlu0Y3nBjvYyJhRBwUNsXvX8JcbnE8fxZSKo
A9EXC+oyb1/iHKCJf4SYhDGo+f52sbO4VGKaO96bKKhdba5uiCe+viwq5U7LFzag78SkaXX60u/G
ONiOvuz/+bAn7he4/lJN7wFBSXdNCqzz3er6eYG5k9gbOZb/JtW6m7Du+rNCkaCvyJ8n3G/lyl9z
1kTdO/pyZ9HRo9Aprred+qU/50sm52GK/u7pPtDbz/p7L+n1fOjhvN1x7uWlFNTezok+HTdXR9Vd
Y0xwXlXkp21t8eyjDmFuyLJavsqpCF3Qqu7Ydk/nVG/38Z3ukRJjW1TnOq0yFJvLpEgnPl+RSss4
4e+W/OntDqVlJAqc9XwtBA6tDTZGZpcLaziW297X64UgBrugQjBvu+02fezpYYcd1i3a+eWXX6oz
ZsxQp0+frr744ou6lKKiL4B0QkC//fbbtOvG5xFBff755/eIvaE98+bN08e+7qdzpZKgEns8gqog
DSvHFzkPDxhIUVLVNjbsyzlfe4jaVhpY1PUQtTgkVRUI1nfZCXNuZTbtmBg9Wlc6x8oz/2ZY4fvc
yukrRJ+vFJPWu8RcT82U8Vf5w02VnX9BX5rpOtO1VS+GUXrEndpD3DDjdUVyTJ5oy3rBWRU+G4U0
5vvsOz0Udnuo77m9VwYiUW80Gs2tq/Cd6fGGXImfbajMWyZYxTcq5LlHz6r0n+H2hsYl/vyEKaOb
LVbxLXcg4utxX+rEuVaW/SrPUfx0WfCsozsfaM0N1Zpcmy3/NfHlr/rk2EHJn2uNBe01o9kNFi7/
A68SmzqQx7EnICERX95ZFjP/nZkves8dauq2f3qEvDJ3cZZF2M6Mm3E7E23rilSEJOehHtuQF4p9
4cVGmhoiRk6kph48e42rXRU6HlSlYXO9eRcJPP+1vXzmZYwYHKXLbGcl1HTHc3ec031pX6Sj6M02
sXbh8TuE3jt2Imd5hc/z/1GKNnel3mrvPS/5vUabLTz/1XBP/Qp5k2rZcW4XHzXWNuQ1h3Zuu1p3
PlYZ93vnA/Oung974H5xpT8crUr1gB+NBEeluiZxzQkW8Q1fqNG3qN5db+WYr9Je242xKU2Kr7SC
417jTRPekELL9Ou3VXYJ4WqxkRUsXzPlR98ixluy5dZ2rnVZ6uttp37pw/nS0HkOZHQeJvU35tLU
1x1XRqRrV7p7RH/vJdhmuumHMjlvjWPZcZ2kvo57vSdneNwkTe7R5kWdVZXxBwO9vyLWUT4He0+W
xfl2qS9yRJfgKUpOncd3VqpzCvdxT6BxqqIwrNvB2BmH245q2On6s11mhEhNyRJL4eHtVrdcLndW
LDeYV10ys8g69M0C77wlXdXMe9jvad7xVyiNTVXR4Pijezqn010vBDHYBRULxBPFkn72s591m+P0
hRde0KdzCYVC6n333af+85//1NN6Mc0MPoNIak8VfZF6G4vF1KeffnqPGRxEur6+Xr3//vtJUAli
lwVV9lSVWK2buXEz7hL9oYmRYHB2OOiZ4nWZHuR5TrVPPLKFCURGKQFx2CypYBHPCf9jRnufzBXl
MmOKhLa43TZrgvl6G2/+lmNZjCX4jmHYb1hL1if8xNnXBlo2WpsCueJhLlN7putMhT7nnpndbraU
vFMhhxdoN1On5LBOrC4Zck92YfmDnkj8oMWyU6wdx9wt8NwPdo98hdURLExeZ2/tdbVvEpojjpwZ
JcPuGVYy/Q6fHPZiW7Ue93T/2BH3WDxzWmXZf1CgeOjdyT+fftCIe23l9dfZpfjQnvodka+JAv+a
RZj4mhRoKt1xPNy+EqvlPX78ztEszD0qu51Vh5iYd3gzpzqras+2Sx0pwANxHHsXP/e4iRb+RUGf
OqJ7OmlHtMk9+nCHaW12lvXLMROPvJixWou8orPMXzz099nOaXe6E+bra5S94mReeN5qdm8uKaut
q5EDYsMsb+OUSQV3sjz7Aytkb2MLAquDAZ/3iHGm3/M9HM/dcU43BvrQvoPNbdr5po4U/ausUjQP
xVFqpZKj8038Ftbsfk/0KkFJUWxRv/OgWpdprfFeeyA2BkNv9ChRyDPFyfF/t1mK3iv2yqfjfApU
lvkPzR76l5Lx8qV2Zcdciv3pd8zL2ViTO+6wg3ftGtwT9wt7dGVWqm3Hgu4xqa5J45oToxutmrAL
vV/bbnuN1l9ZFv7b4WUzlzt8gaJF82bNPLSo4A5Ba6/JVfeHcGPEF25aJvk9rurxJuZt43qTlPjw
1NdGhueL7D2sarzpgYzPw4T+dun9Lc9ubo6PCrjFwxLvA0a7IGzJ94hUbc70XqJvc9aseu1Bz55q
vzM4b7P1c8+fWzpjnH7up7yOM7sn93rc1oYbw4c31DfMnOkZ/XOO5783jfOut3tC4xWljV1QKwbz
zPwXrPmQt3CMGMY9RjunCtKdUxbcxwMrs+IRd/HEYv5hvrj8EUmJHpTu2sAfiyLVBecItqyPOeek
ddXB8LFW7VrEOv0VnhmescP/ZCms/r0j4T7Y6363bhJ6O6fTXS8EsS8IKqRz5cqV6v/7f/+vK2UX
0ol5Rs8//3z15JNPVjdu3Ng15hTFkTD/qBFJRfGkVJFURGORIvzss8/uUYvDXKlIW4askqASxC4I
6sqoaD3qkLzlrGB9j3FOagsqSk3Ayd5sMTMfajerTxjW+rYwec4Vil88zcKZXtdfM1k+MpkmrvcF
Y8VdD8nLAjlBr+uMAjPzuokxbTOxBW+WVspLfPGVI5uj0ojphcwqK8t81Jd1JtNRmZHfUlB5xDX1
0kGXcCZtW2b2H0VlU69xR5flrYwGhnduR2+7yWR5z2SatC7VOtO1V4p2pKNFFWWkLPmblFBoxrSJ
hZdyZvMbJs75orO8/pJAvGVUPKqMkKXan6T6uS/WPLq3fm+RmKyjJ9mutmmyy0gtXQ8Y0YA45gin
sFoKNh6dnN7bFPJWFLGmxzmG+Sf2z8wLmx3VDafgr+ebYi5+II5jj1ItMkOOrbD+ylUbOZuRU09g
vywi5QXH564oEvhXtH59i+Wcz3qqZp0ZSBofiYjMohox5DSZXzab+bfNzoo7lHBEitQ6T7MUOx8R
q+SzQ6FQWW2BeXUmx3Ogz2mVYUx9bh9rfVeomNsyv65yjsCZtP3HceL+aeKKH/fXzw3MKGZXWc3M
B/p7Oev7THmoxRjriP6IKjXlPnfhL3iefYcxmd7iioo2lgXmnhjQxKu3Y5Ou341xqc2Ke6R2bdy8
q9fgbr9fRLsXeup2/vVwTSZec5msOxqSxk1wMOtYjvuAcRZtkMLRoyMBX9kExvQozxW/6Jm7cG5T
OHCYkzU9xiZdb6nSXvt4Pmd8DDCuEf3NCdb3TQWeu0PR+IQmpWYy2pV4HyjwRRZqDw9sLOSdmOoe
kdzmTO4l+jYLJ64NhKPlapoIXU/nrRzrTJPece71eB0PwHF7QZpVHw2Mtd5mNZve0/vTbPmIMU16
QJYV13GS+RKL3gbzZyaToLV10oP+YGTyLG8gqoSCtSnOKX27TWGpZGKx0C4UedZ7Q41i2oi0Jv1N
cuWxfkWZqiiyNH1S0WU8Z3pDu5W8ZeaK/1pQNvtnUooxrZnsd3+uF4LYFwQVCwoiJY4nRYQU40dX
rFihnnnmmXr0NHHZtm2bPh4VggogrImfx/eIrkajUX3O0uQFAjzQc6QaC6oTI833hBNO0PeDBJUg
+imo+i9W7YFEL1lvF4chhSlgZ4Z0TbnCMCMYURmC+eb07zte034mDU9Od8L4HZFhsjveI2YrbZ1j
sbTf0JiovT/r7B6l6BiDmucLL9XeN6Sz1P5IY57QlNvpYZ3p2tt5ozYZf+EPSPasjtL+4gjG1Spk
8vNMiMmMJXGOU2O9mghaU7W5VZY5saO/hhn7Z5cU20Afx7TtVQKj68YetDKYNPVNqvNJ7Niu1icO
O5OU6tbV/9pDr/a+juNol4bh4Rj7yEhSlnEsdtqHDNs7EH3Rj/YN19abLWsPqsyO46RhH45iLknn
pv7e5OImiIBpr9n1vrOLw5P/SNHffkcUayCuwT1xv+jh4Snjay6TdSt2pqONoraOWExPqw0wjLZe
+1CX9n+kdvZ0vQ3I+ZxBXyX2t7HOdO3q7R7Rn3tJJumjPZ23Kc+9NOfZLh83WbZ09vFO/RmQ8B79
tWEdvzuk4TifejunOtufpR3TLCZNqnNivxrfSx3tzMnkd0Mm+93X64Ug9hVBTVxQHOnSSy9Vf/rT
n+rR0/Xr13eTSXwPYcUUNEYUFRV+EUWFmEIQEW3Fz1AVGF+T5RRFjSDFu3MfLrroInXBggX61Dgk
qATRT0HdVzAKX2AePTrYe6H/66XpoihfFwhE86g/CIIgCIIEdaAWCOaGDRv0saeIfmIuU1T6TZRT
VO/dtGlTN0FFpBIRU/wM0VSMP33iiSfUyspKfSxr4vrxs56KKw3Ugu1ccMEF6kknnaSPlyVBJUhQ
9+Od6yx8sc0ofEHsXhAVcXREAEa7HdZJ/uLhd1XUNc7tS1SPIAiCIAgS1J4WyOdjjz2mF0U69thj
1R//+Mf6+FJjQcQT/8dY1b///e/qm2++qaf5AggqQLTyk08+0edSveyyy9TCwkJdEhFVNaKnEN6e
pqcZaElFJPXEE0/U20mCSpCg7neiJHNBh7VwZrm9BeXIUfjCIQXdmRb3IfrHaXW+WqfZ/A8zw/zH
zGdvFQqmtblTFEciCIIgCIIEtb9yevfdd6uSJKnV1dV6ai4ipIk/xzQuiIa+9NJLuqC+9tprXZKK
CCUiqZgvFVL4yiuv6NV0ly9frs6aNUt94IEHdGnFz3Znam+qBfOiXnzxxWo4HFbfeOMNElSCBHV/
Ihr0FU0ymdZZTMz7RuGLvhT3IfpHU8g3xWli/s6a2a2jxx/xc7fSPIb6hSAIgiBIUAdqwVQwSMf1
+XxqS0uL+umnn+4ksBBSVMaFnL7++uu67EFijRRfCCzGluJ7RF9/9KMf6RV8r7rqKnXatGn6V3wO
CyKoENXdVSgpeUHUFuNqMU8q9oMElSBB3U9AgQupo8BGv4r7EP3vd3tH0ZehrlgrT31CEARBECSo
A7WgIi/ScDEPKiKgX375pZ6Ki4gnih0BFB2CjP71r3/VI6iIkL766qu67EFUEUFFNBVTvMyfP19P
EUZxJYgvuOaaa9QjjzxS1Z5p1Oeee04fp4p0YHzdU5KKfbjiiiv0NqD9JKgECSpBEARBEARBDCJB
xXhSRDaPPvpovSjS1Vdfrf8f40cRcYS0GixbtkxdsmSJes4556jxeFxdunSpDgopNTc3q4sWLVJr
amrUM844Q3300UfV559/Xn388cfVJ598Up9q5i9/+YsaiUT08aAoroSCSoi47ilBxQLZbm1tVefO
nduteBMJKkGCShAEQRAEQRB7QVAhaRBDREMhjLW1tWosFlPPOusstampST311FO7OO2009TTTz9d
B++BfCaCOVLPPvtsHbwXknvnnXfqUdZnnnlGfeqpp3RBRRT15ZdfVh966CG1rq5Oveeee/aa5SEy
/Ktf/Uo95phj9PaRoBIkqANz8zIFRGaYlXHkuFwxSvkkCIIgCIIgQU25YLwnxmAiYglRvPbaa3UR
xRhRRD1RzAgpr5gmxqjGi3lNMaYUXwHGmWJqGbwP69i4caMumb/5zW/UG264QY+6XnLJJWpDQ4Ne
GAlyCgFGOq+R5ovvkRJ83XXXqbNnz9bXtSejp4kLUphvueUWdc6cOerDDz+8x6oKk6AS+62gtiiM
rd7NrrIKzjc9cuPh+3NHRluiVrfbarcHoll0YhEEQRAEQYLa+4ICRKiYiylftPXphY8Q3QQrVqxQ
//SnP+ljTzHm1JhOBpFVvB9jSpH+ivTc9vZ29a677lLvuOMO9de//rW6cuVKnV/84he6lGJs6eWX
X66vH18bGxvVYDCop/giYgpJxfhUpPQi5RepvkgrPv/883VJXbt2rd7OvbFg6htEe9HedevW7TVZ
JkEl9gtBXRllrHMmsNdrgvqyJqhV/VmHdoKbZDlmQTR2MHZgXJFsIdnvnVpZ2uJ0Wp911kTOcMVU
ihYTBEEQBEGCmka4vvjiCz3aee+99+pjRhElRbQUQomoJgogffvtt11VdBHNPOqoo3TRvP766/Xx
mfj+5z//uV5QCF8xHhVceeWV+v8hpr/85S91EIW8/fbb1fvuu0/9/e9/r0sn5BdSChlF1BXbwfYg
wagCjOJKkOAbb7xRn4IGqcWJ863uyQVtQyQY7cA0O9999x0JKkGC2l+iImNlGHt2fyvoxpv8U7xy
0/FioMU62DpPVdvMMaVixkFFBXc6BfZdnuO+y6tuWCq3qzTfKkEQBEEQJKgJCyKQEMHbbrtNHwu6
YMECfXzo6tWr9TRazAOKlNbkBSm8mP4FVXeR9gvhxFeI6s0336xHTH/3u9/psouUXqTpYooZpAAj
+op1QugARG/Lli36OFRU54VwYhwqIrTGggglxBWRVaT6GhKLNmMs696KpEKeN2zYoEdSkbKcqq9I
UAkS1N1Mc9BqD06y3uiSF545WNvYKrsEu90+VKlyLuB4YVtuVfg8ElSCIAiCIEhQO6QKkojxk+ed
d55eGfenP/2p2tbWpqfTYkqV3qKBWAdSWxE9RBowIq+Y9sX4rAHEEvQ2ThPRW0RrMWYV3yOVF+Na
Ez+H4kyQXERRIahYkFaMYk17e+qXJ554Qg2FQnoBJfQBCSpxwAuq2t7OBST7cEQ02xSFdduZ0dpN
qpBhxNw2Vd0pStoSkLLcjMOeqkhSS0C0OhgmX/u8U/t8nl1pseH1tjbGHPGJo+vKR15itfBf2suP
uMya6xzLiO48bXt5TMdnRtuljvGerbLMuRlmjPaatjom13gdtLfKgiTZR9iVuC2qtcWufY4RA8MZ
VTUlSKZlRzuYfKMdfSEqlx7DC8JWElSCIAiCIEhQOyKmSKNFtBJiisjn5s2b9TGkiGT2Jb0VkUzM
WYpoJ+QUEU8AyUQkNBGjgBKAzCaCaCzGm2L6Fow1RRox0ngRSU0UVKQY43VEfCHYWCCDEFtU+93b
C1KQ0R9IZ0ZhKRJU4oAUVF0aFanYX1G22FNk/bPon3d2OBzyVjjNdwis+V2eL9gsVgdPaW1vFzql
Twj53Yd7D85fXcQXP+GVo4clri+uuAvkamlxEcc+a2JMbwl80Wu5B8+8WozE81dGleG1BQVXZVnY
TxnGpJo4YQtj5t/gCifcU14g3GtlTR+bzNyWvOrIGdoFYIop7sIK1tRuMzOfmdiO12ObNvHRgFhc
I5VcVOgUni6pDS+OBL0niDbLS+zoaevcwVhehyTbh4ZnVUSKOe5pE8O8xQnC+zkHH9HqDi5z9qUj
GwOlx5GgEgRBEARxoAsqhPL111/XI6Xz5s3TU3AhlRh72tcF60K01RijumrVKj1FGOsESA/uCxiL
etNNN+nrQsowUoSNVN9EaYaMQqYRPYXEGtIK2YbYDoYF0q4oii6pmJKGBJU44AS1Oea2z5hobtWk
8TOWZX8YM7Hy7spZkZOVYLAg6Pd4y/K5xyy88IWzZv48FDRqCnknlfDs0zbO/A1rdn4sBaNdVXzj
QbHg8Pyha4dNnnO90xMYa7Uyo+or8863Zdn+bT4keKs9sDIrYLcPCXmdjZr0bbNPOmq5VXSPZkRp
uCJZc4IVoy4WBOHbXF/4Asgg5DnqE4tnHqzJssD9L6d6fjwei4yuzWduHMKbt5k5Ts3z1N4YiUUn
ao4d5y3Sn1010bEbW6Ss+ir3BeNnzTtdCiiIwGaHasT52TbbFtOYqnZJiTtIUAmCIAiCIDITVIiS
UXH23HPP1cdxfvrppz1G+XqqSoto63HHHaeP/3zzzTf1NNvEaWX6Cj5rjDvFnKmnnHKK3j68lji2
FLJqRGgNsYagQmwRgR0sCyQV0WAUgBpEU9CQoBJ7RlBVVZ/TFNJ4MstbvmYnHHWLXWkZbvw8Irtq
nJzwAZc3bQOik0i7DbpzS6fmsg8JXOH7nmDHNDObYgw/T3Kel2WreN7pC5cbn18cdokTCi3tfNH0
Ox2BZv2k7kqbrY7EE9uiva6kksGG6pxzNXH9l/b6UqWtjcUcrPWTRzZzvPANWzZ7tT3+vK29VeYY
Rsxujbn4aL3nmOwJdbcyua5JDINsYybP586tmJzDPM/zwg9iXePxakIqMAkqQRAEQRBEakFFkSNU
1JVlWf3tb3/blX6LsaYY65lqwdhRCB/Sb5FKC1DECHOhQkaxDhQ/wrQwRx55pF5RN3EaGQO8ngpE
Sw3wf0RgUQHY5/Ppsom2YcG2/vnPf3aNh4XsQUghqYkR1MGS4pu4PPbYY/o8qZBuElTigBJUg6ZO
acypCl+gWavZeL05IuXUONgNFqHgA0+gsRqvtcWl4bUOdp2FL3zP3TkPaqPfXTrJYntBGD9nNRNd
2a0yryIxNsYuZTFMhxSmkz7t9Z0EVW2XuQZfbtwQVOO986vzluA1rb3nKwljZDEFTsjD3sRbbF9o
N9k3Nd4yYE3MByYz+6GjpuHUTGWTBJUgCIIgiANVUBHpvPTSS/XI6UMPPaSL3VtvvaWP4UTUMt2Y
U0QnUewHY1RR0RdTuSCNFtFNgNeWLl2qRzonTZqkyyokFp9DtBbbTQSpuenAzyGbEM0LL7xQTxuG
3EKOsT6kISdGURHZRbEkoxARfhaLxfRKwYNpLlK0HdPzYH8g9iSoxAEnqAki1m06lfYYY6kvM6+y
COxXJf7G43RpVdw5fge7vlNQfXgtIrt9xbxls6MqfKGrtef5QnsQ1ONSCWq4KrcrgooiSIj6Jrx2
buI6YgFxjL/Qss5aJq9hHO5C7Uab08lIjeEaQ12ybOlHv5CgEgRBEARxQAjqDz/8oAsqIqaIcKJa
L6KmEFNUwIWk9lZpFuKIoj+YQgXRQFTVxeeQvorxno888ohevRdTyZx00kn6/KdGyi7GiSL1F9vD
uFdU3gVYRyLGnKZoGyK0AOnHF110kV5sCFWCMW0L5DWxqjBE1JBrpCnH43F9HtXBMg8pIr2IXGOs
7KJFi/QIthHxJUElDkRB7SZiEMR53pyLNBncWuqfn1ZQGzVBLRSs7/BliKButO5BQV3afR3ucZMt
lheEQ+bcygyAUJKgEgRBEARxoAkq/BLVco866ih9bk6IEkTREEIIX6YLRBARQEgqJBRFlhBNPfXU
U/U5U9evX6+n5CLaijRipO0mFkoyCicBFD9KxHgPKgkjxfeGG27QI6GImj7wwANqfX29+tRTT+ly
h8hsqvGcRpQYnx0EEti1QFAh5UiVPuaYY3TZJkElDlRB7SZ8HSmz/E1W3vmeuzPFtzkijkoW1GjQ
U1XEWt5n86Y+5Iu1jO6P9C2oFedxSW3oq6DGFXF0jYPbYBHKX3EFF49P3nab2maWpLgNBZ9IUAmC
IAiCILoL6uOPP75Qk7btV111lT4204hiImIJYUJ6bF/SVCGgCxcu1Ln22mv1VGFERyGRjz76qC5f
kEhIKqKeEMzkFN9MQEQXbcWYVEg1BA/VfZFOjLGyiI6mElS0Ee+74IILBtXULmgv+hyp1JDT2bNn
6+Nk+zKVDwkqsV8Iao4vfH7iGNT2mMsSHMf/xmad/Lzb31iK15YpYq4/n2238M53DUGNBb1jJ3HM
3zkz/22xNxxRk+ZO3RRz8bFYx5ypiSKaOH50QaBU0aRzi9aGC4zXIaMNvrxzIKN51fOXGO9NHJea
LNRzytibeI7/duSkYLPYsjE7sR2xRr+3atZpiktutWTYL0oqcScIgiAIgtgfBVWToIWffPLJdqTd
3nHHHV1yChBJzXScpiF+oVBIT59F1BXptomSiHXddddd+lhUpOf+4Q9/UCHGkFf8HwWOwMcff6x/
RdGjxO9RqRfRWUgzJBTyhu8xRQt+Bk4++WRdfrHdVIKK1/7yl7/oqbTpij7trTRftPuFF17QBRxj
eiVJ0uUb+7gXRJUEldjjgqpwguUrpvSIOxmlbZjxuiI5Jk+0Zb1Q7J13DtO6qWMu1JjPXjOa3WDh
8j/wKrGpusjKjGXOBPP1Ns6kMmzBR2WVcoPVas3TbnSj3SJTOM/vbZSjMY92YpsX1JYcK/DCthxf
5Dzt/6ZoIGBta2szN8qew52c5X324NlrXO2q0CGc0rC53ryLBJ7/2l4+8zJGDI7C6/M7K/smSqtB
tK50jpVn/s2wwve5ldNXiD5fKdrhEnM9NVPGX+kPR6uYDKv4LuqoLLwN0pzq54qisG4HY2ccbju+
p5OPIAiCIIh9WVAffvjhhc8///x2pNw+8cQTetQU4zoB5DCTaU/wHowzPfroo9XnnnuuR6mFFKIQ
EN4HMUVhIGwTqcQYr5oIZDnx+8T/4zMQaKwPRZIgd5DiaDSqR1Z7WjDuFSKLtObBtKA/0I8QUuD3
+9Xa2lo9sr127Vr953swLZkEldizgrqwrnQua2a3my0l71TI4QXaDcopOawTq0uG3JNdWL7Oo0QP
wvtisssiu51Vh5iYd3gzpzqras8WA1FdaGOKdFB5Pttu5djvzWazqq3jv2Yz+29H4ZAXbWNr12Ca
Gl0gZfdhJVbrZm7cjLtc/tDESFCeHV+5clg04Bk7mRees5rdm0vKautq5IDYMMvbOGVSwZ0sz/7A
Ctnb2ILA6mDA5z1inOn3PM/9YPfIV1gdwUJZbu2KbrbF7bZZkGXe/C3HsqrJZPqOYdhvWEvWJ/zE
2dfaoyuzeusP7Ke2/86Z5fYWnudV07gp63M9kscuRYcmvq8p7BUnFvMP88Xlj0idfUQQBEEQBLEv
goDBxo0bF27YsGE7poCBNGLcKeT0lVde0aOWmQgqxntiXOfll1+uR017WhAdRFEjFEuCXGKcKraL
NGBIqgEkMxWQVHyFpOJ9kGik+RrT4Pz4xz/WX+9pQSVfjIlFKu1gquSLlGP0PdJ8kcKsHSN97O3d
d9+tizekGjKO/UNK826eM5UEldizgjrfX3ocx/NbCiqPuKZeOugSzsS8bjKz/ygqm3qNFIk6uoQs
5K0oYk2PcwzzT01APzHzwmZHdcMpRkquJqljph6Sdw1rZj5jGNM2k7lwc/6Eo1o0OS0w1rEyKlqP
OiRvOSdY3zcVTlwbCEfLEUnVjNa0qEYMOU3ml81m/m2zs+IOJRyRIrXO0yzFzkfEKvnsUChUVltg
Xm1lmQ+xfZPJ8p7JNGmdLxgrTtyf5mWBnKDXdUaBWdsPtIMteLO0Ul7iiy7LzaQ/OvfzMa0f3sd2
GLP5IxPHv564r7psK96xE4uFdqHIs94bahTp5CMIgiAIYl8WVBRJeuSRR7ajgNEzzzzTTVBRLTcT
gYPwnXnmmbrw9SZNRpEizGWKKOEll1yiR25RyTdRUA1JTZTVZHGF1CL9F9KGz0NQkbqL13taINEY
H3vxxRfrcj1YFrQFkWEIKiKlKBT1s5/9TBdXgPG855xzjl5gClPs/PGPf9SjquhTElRinxdUYwxq
ni+8VFGUIZ3Tsoxk5Fi3sZqtssyJDDNC+9kwTNmiMcIuKbZu74m5+M6faYhDXK7Wnaad6XzPcMYu
DktMt4Woauvv2L5d0n+GbTKSlKW0dYhhwK7/fLixfYaRhqdKr1XbFFZbV3ZnO7KNz2cCtulgGHvH
+vXtYHsjk/e1rY0xS3YmS5/nVbup08lHEARBEMQ++wDZWSRJE7/tDQ0N6p/+9CddkCCnGIOKKCUk
sjdJRTRv8eLF+pjS3gQVcggxxNhKyBWKFf3tb3/TI6CGhCbKaSppTSWomNIm0wgqFkRtMe52kMw5
qi9oP/odUWGMOW1vb9eLPqF/EwUf+40qxEiVBpBtVP/FsRpAWSVBJfa4oBrFgM6lDiQIgiAIgjgw
BRVFkjSx2f6Tn/xEvf7663W5QxTVmIsUKbUffvhhjymliPZdd911+vyiPRUeQqVarAvptZhrVZNj
vUgSop+JEdTEaGm6qCralUpQM4mgGjIIuYOU7+ZU2YwWtAGRU/xxwKicjIg2jkuqPkVRKkSu0YfL
ly9XkaKN4lOYfgdVkiHeiLruQgozCSqxZwW1t2JABEEQBEEQxP4vqI8++ujC//znP9vXrFmjRiKR
rrlPjQgqgBRCICFO6WQOPz/uuOP0OUoxdhUFiyBQkCtU6MV6UMEXKaqQKUT8rrjiCr2iLqKnkMpU
Kb2poqeGoEJKIaioeNvXCCoED2NXlyxZoo/3HCzpvdgvI+0YxwCCum3bth4/iz8QoI+R8ovotCGr
K1as0NOu33nnHX0d6eaGJUEl9qqgIpU16LAW7igG5F3vkILuxKJDBEEQBEEQxIEhqBiDisxRRNww
RykioaiOC+E0ihJB+CCQEJ2eiiAhVReCCEE699xz9fTdn/70p3pUE/OiQk5/+9vfqo899pgup7ff
frs+ztWQ01Qpvsmi2pugYluZCCoW7CekGlKeKhV5T1XMhTSisvCLL76oR1ENicS+Yn8yTUPG59Bm
9APmUEXqL6LVSGVGqjCO7SOPPKJvC8KKCCui2iSoxF4V1GjQVzTJZFpn6SoGZPnIZJq4PrnoEEEQ
BEEQBHFgCKomNvrARUTg6urq9PGNED4IHICY4v+IdPY2xhGpwBBVjEfFvKqI4KHoEqKpGHP66KOP
6oV/EE2FjGGqF8gw1t9bgaTkSOquCioiiogyNjc3dyuWBNHDerG/e2L+UfQN5BSinDjeFPsI4e/v
OFlINiQU/Xvvvffq/Q5hxR8LTj/9dLWlpUWfsxZzr3700Ud6hBzbx+e+//57ElRizwgqigtJHQWA
EooBpS46RBAEQRAEQez/gqpJ2HZDzCCpc+bM0SXmwQcf1COcEEnIGmQyUaAyiehBdiCOSOWFIF12
2WX6uEmsE/ILsYRAGVFbfE1O902OpCYK6qeffqqn6uIziAoaKb7Ydg/Rwa4F70XkGGM/ExesF2K9
u6OoEGC0AfOfQhITU3CR8gvh7i3FN5MFY1GxLxBW9PGGDRv0OWiR4mxEvQH+D+H/wx/+sHXjxo0k
qMTuF1SCIAiCIAiCSCWoxgIpXbZsmXrsscfqhYSuvvpqXdYghJAojNnEGE5gpMIisorXIbAQKgge
IoKo1osU00MPPVQf43rllVfqhXww/ykECaA4E+ZFhcQaqcRG0aTeBBXjXY25QbFdjNmETKNNL730
Uo9Fm4zxmxBnpB9j3Kyx4HOILBoFi3bXgjYb888mp09jnG66IkkDkVaM7eGYIYILGUb6NcawNjU1
qccff/xWRVFIUAkSVIIgCIIgCGLvCiqibZBUjCEdO3asGg6H9blKIZE333yzevfdd6vr16/XI6xr
165V29ra1Ntuu03/GcY5YtwpIrCQW8gp0kohpRAgvB9pv9p29bGomNvznnvu0aN2kCPMi4r/Qz4h
qukKJRljUJMFFdFASC4EDEWGkFKcKJ6pFuwrZPz+++/vqnoLcUOqMkR5d6X5oo3YR1TrRRsSo6f4
HhWGTzvttF7bP5DRXAh75x8atn7zzTckqAQJKkEQBEEQBLH3BBWSt3r1ahXzoiLdEwIJCcTrSA1F
8R2IHAoc3Xrrreqvf/1r/XvIKn6GSCsij5BIVJZFSinGd0J+ANJuDQmEhOHnGJuKlF+kuWJdEFUU
UULaLdKKU41BNaaZQaTWENTkMaiI8CI6CRHGdtKlvmK8KdqPbRspvYguYl8QxcTUOLtDUrH/EFPs
d/I4U/QT/iCwdOnSPqVVD+BCY1AJElSCIAiCIAhizwuqUSQJ0cJoNIr0Tl1CIX+I3iHNFSAVFOJm
pPYa4P8QuL7MuYl1QR4RcT377LN1sUTEFdtH5BByhvk9kXoKMU6OpBoR1ERBTRyDaiyQY8wLClIV
eDLGgGIbiYWS8Dq2AXmEpGI7u2O+VLQZIo7+SFzQlssvv1yvxJvYLhJUggSVIAiCIAiC2G8F9eGH
H9anmYHszZ07V128eLEeoURU8+OPP9ZBBBX/h6QiEtlZ5bXfxXogfJj2BOm/xlydkERIINKFMfUL
xBBpw0gNNoopJUZSE1N8b7rppq4iSamq+CJlFYWZkEqbas5TfA7bSxzrCRlF5BQSje32Vr243xao
9SnWnzz+FH8YQGo0Irv97WsSVIIElSAIgiAIgtinBFUTt4UfffTR9vnz56vnnXeeLoNIt8XYSMyX
CUmDBCIF1YigQpj6E03EZyCj9fX1emQQ60VKbaKAIRq7Zs0aXTQR0UWKK+buROGj5AiqkeILQYXk
pRNUI2KLVF+kISP1ODFlF9tHQSVEaxNfh5RiHCvevzvSe5G6i3ajH5L7E8fhhBNO0CV8Ly0kqAQJ
KkEQBEEQBLHn0ATEfNdddy1csWLF9lNOOUWXPqMwEYTQmGIGcposkv0RMqw/FArp6cMQ0XQLooeY
p/O+++5TV61apVf5NaKoqVJ8IajpUnyTJRWpvkghRtVcREwx1tNI84W8IlKcKK6QdEQ5Bzq9F/2J
vsb411T9irG3mKN0d0VuSVAJElSCIAiCIAhi0Anq8uXLFx599NHb29vbdSk1IpOGoEKgMplPtLcF
4yhR+AjT16RKs01cIIx33HGHPv0LIq4XXnihHk1Fm4w030RBhcQmRlDR/nQLIsD4OaoSA4z/xHpQ
2AlpwPiamOoLqUWa80Cn2WJ92M904ouf76XUXhJUggSVIAiCIAiC2PO0tbWZFyxYsPDUU0/dbkjf
a6+9tpOgDoQoQfQwpvKPf/xjr9FIiBumsYGYYjoapPmifZDUxHlRE8egGoLaUwQ1MZoLUUVkGJFK
7DPEFBFUSOuLL77YFTWFnOM9yWNED4CFBJUgQSUIgiAIgiD24AMkw5jnzp278LLLLtOLJEHUEgUV
YoYU33RTtPRlQdouopuIUmYSXcRcq4igokgQ5kZFe4wIqoEhqH2JoKaSVWwPAvrRRx/pogpJRdEk
/B/7DnFPngaGBJUgSFAJgiAIgiCIARZURVEWXn311dshdYmCijGfRpEkpNEiLXdXIqn4PCKhiHb2
th7I7KWXXqrefPPN6g033KALKMZrGpV8EwUVY0bxPkhkphHUnmQVhYuwrqefflqv4IsUYERUEb3d
yym3JKgECSpBEARBEASx/wuq9r0uqKlSfCGoSPOFCGJsZn9TXSF/GzduVI899lj1b3/7mx6ZRKEk
pNBinfg/BBPbxfQy4XBYvffee9Vzzz1Xl8XEuVAhp2grpDFZUNNV8e3LghRj7DuiqYikQlAhqlg/
CSpBkKASBEEQBEEQuwFNQMya0C1sbGzcjqq26QTVmGYG4zIxlrS/RZMgor/85S9VTYr1tF0UQlq7
dq0upJdddpl61llnqdFoVB97itdbWlr0iCtSjVPNg2pMM7N69eoBFVRDqDG9DKaZwbytkGps7wAa
i0qCSpCgEgRBEARBEHtWUC+//PKFoVBo+x/+8Ac9SgkJTBRUjMOEoELWIIAQVEyR0t8FUVMIX2tr
qz7vKiKkkNWVK1eqf/nLX/RoLbZ73XXXqVdffbUuponVe40IqpHiC0EdqBTfVAtSkxGpxTypiKQe
QAWTSFAJElSCIAiCIAhizwrqvffeq49BPfHEE/UoIcadQgghZYkpvoigIsUXgoq5OXd1PCYilFgP
1gn5RXQWBZkgysuXL1d/85vf6G0wUnuTBdWYZiZVim9fiiRlsiDlF1PNIMoMUcV20e6BnhuVBJUg
QSUIgiAIgiAO3AdIhjE//vjjCzU53H7mmWeqJ598clf1WsgigKBCziCoEEAUEcKcpoiE9kfQkB6M
dUBKUYTo1ltv1edGjcfjeiQV/4coow2JVXsT5TRxHlREd3dHim8qoUbxJmwTab/YHsQd/UCCShAk
qARBEARBEMQACOqf//znhZqIbId8nX322WooFFLvvPNOPZKK6CQwxp8agorIJ8QMkcXeFkRaUQAJ
n8f41ra2Nl1ITzvtNB2MOW1oaNBTcy+44AL12muv1Ysj4b1Ip01M6U0WVGMM6i233LJbI6iJC9Kb
Ic9oB9qIKPOupDyToBIkqARBEARBEASRIKiaaG6HkWC85Zo1a/QiRj/5yU/Ue+65RxdVCCmipvg5
vmIMZk9yivdDSBEBxTymKHbU1NSk/uhHP9LHnN5+++16uiwE9OWXX1bXrVunj0Ftbm5WL774Yn3+
UxRKevTRR/XtJ4qpIauGoEKgf/3rX+/2CGpyNBWijggztoUpcJD6jD6BkO8nqb8kqAQJKkEQBEEQ
BLH3BBWLMd4SwoioJsQSBY1QwAjRQiPFF0BEIa2QM4zJhCxijCaioKeeeqqeMowoqfF5RDvxGaQN
33jjjV1RVEjrihUrVK1N6kknnaQLLKakWbJkifrUU091FW9KFNTEeVD3tKAmiiqiw9gvyCpSftEG
7CMJKkGCSp1AEARBEARB7KKgJqbmQrogjk6nUy0uLlYXLlyoyyMinkjDxTQxGP/585//XE/Pveii
i/RxpFdeeaX+HkRIIXCJVW///ve/qyeccIKeTvzYY4/pYmtEZgGEFBFczEF633336dJqVPIdbIKa
KKoYW4v9QKo0vu4HUVQSVIIElSAIgiAIgtj7ggq5euWVV3SJXLBgQVdV3T/96U/q008/rYul9jn9
/48//rjOM888o6fjQs4wJjNVlV+MZZ0/f776i1/8Qhe5VAsiuBhTunTpUn19iMRi/YagJlfxxTrx
fojv3hLU5L6jFF+CIEElCIIgCIIgBkBQIVfr169XjzzySH0cKOb+RKVcpK8iooo0X0ghop19GXOJ
991///16FBYVfHtasB0UT4Kgog133XVX13QzyfOgoi233XabXlkX414xdnZ3Fkk6gBYSVIIElSAI
giAIgti7gvrwww+rRxxxhD5GFMV/jDlR8RUgpTaT6r3JC4T2qquuUq+++upuKb+pFggsxr5i+xi/
+rvf/U4XVIgnxBRfAV7D+FdEd/E6orJ7O4JKgkoQJKgEQRAEQRDELgjq999/rwsqoqOYZgZSCDmE
BGIqFQgfvsfPMdayPwsEFWNVUUCpt2lZIMKIoGI6l2uuuUa9++67dRk1ZBmRU/wf7cFrWC/GrEKe
IbYkqCSoBAkqQRAEQRAEsY8KqiYi25GmC3nEVDCGlCJtFt8bEUuk3qYaW5rJArHF/KqxWEyvBNzT
grlSf/rTn+qCisJLTz75pC6jkFKMPcV4V0yBAzHFGNk5c+aop59+uvqrX/1KTyHG+2ghQSVIUAmC
IAiCIIh9VFBRbRcFjFBwCOmymKcUhYcSI6iIVqIIUn8XiCMq9KLCL7ZnyC6+IqqKFF1ERxsbG/UC
TJiaBtWBIaWYE/Wmm27SJfqGG27Qp6CBmGKsLKazueKKK9R58+apkydP1qexoYUElSBBJQiCIAiC
IPZRQcVcnpj+ZcOGDbqcooovvkIOIahGai2imr2NIU23IEqLQklHH320+rOf/UzfFqKjf/zjH3Ux
RkEkpPZefvnl6t/+9jd17ty5eiVhra3qsmXL9Ajss88+q0dVI5FI1/QymPoGkdRf/vKX+mcg1rSQ
oBIkqARBEARBEMQ+KqiogBsOh3WBhOAhvTcxgmoUSsLYVEhqYgS0Lws+8/LLL+sSesYZZ+jTyEBC
L730Ur1aLwQU85/OnDlTra6u1udUxdQ227dv16eRwfQzSBNGO4xiTf/973/V9vZ2vUASUoN/+9vf
9luiaSFBJUhQCYIgCIIgiL0sqEixPe2003RxRDov5BQRVGMMKgQVvPvuu/p4UKTRYooXiCoEMdPp
ZowFAonCSdguxBPjW++99159mhiIJsahougR3mesF+NOESnFlDfJC9px1lln6Z+/5JJLei3ERAsJ
KkGCShAEQRAEQQxCQdUEUK/ii8hlfX29XoQI0dLkFF+8BkHF/KQQVERSkRqM6CvGj2J8KoTSmB81
kwWfwzQxDQ0N+thTVOzFa8myCwE977zz9LTeVOvGaytWrFCPOeYYPVV4V8bK0kKCSpCgEgRBEARB
EHtJUI15UCGBZ555ph6FRAQVabQomASSBRVy+vHHH+uCikgqJBWRUMxLCjlEdBSVe1PNmQqJxWcQ
EUV6L8ad/v73v9fFNJ3YYp0XX3yxev311+/0HkRwMWYWxZJOPPFEfR8eeuihfs3XSgsJKkGCShAE
QRAEQQwCQcWCyCiimUj3femll7qmd4Gg4isEFem4eB9SbT/55BN1y5YtupxCMDFWFAIKOU2OgkJa
8TmMNcVYUgAxhez2FnHFujZu3KiPk4U4GynCEN1bb71Vf3316tV6dV+kAWMsKoSbFhJUggSVIAiC
IAiC2EcFFQsEFONAMW0LxoUaUgoQNYWUYnwoxPSLL77Qo6aQQSNqiogmvoesIvKJ6CpShZHKi/Gh
KHz0wAMP6AKMCGymC9aFar6Yq3XNmjVd854iAotqwJiWBhHUc889V58jFdvfFxf0H/a1L2N6SVAJ
ElSCIAiCIAhivxRULJDO6667Tp8SBimzKFr01FNP6am0GJOKdF9EVVFACSnAqMyLaruYvxRRUcxZ
Ckk85ZRT9KlfUMAIQvnYY4/pFYJffPFFfR19lTCIMEQXEoqUX0xVAxlGm4499lh9u5DYtWvX6rK8
Ly7YR0Su93L7SVAJElSCIAiCIAhicAgqFggS5j696qqr9CglxngCI2oJ+cT3AN//+Mc/1qeNicfj
epR0/vz56pgxY9RzzjlHl1sUXULUFHOcPv/883p6bn8WjC2FlCLSiAWSjGjv6aefrkd5MYYWAryn
F8j2QEQ9ET2F/GMfSVAJElSCIAiCIAiCBDUp5fSrr77S5Q8R1L/+9a/qc889p3/F/yGISP3FGFRE
/5BaiygpKurecMMNenov/g8xfeGFF7o+j1ThXVkgqk888YReeRjjTpFyDLFDCjC+35ML9hn7g3G5
SHvelegn+hoR4b08hpYElSBBJQiCIAiCIAafoPZ1QXowJBHjTZH+C4lFxBRiCiCp+D8qBaPYUX9S
YCGi1157rTpt2jS9IBIKLWG544479EJJe1LusL+QcESHsa+QcbQPoprpdDuJUVjIPuafxXpJUAkS
VIIgCIIgCIIEtZ8LhOwPf/iDPh4UUdJkOTUE1YiiGqmsqVJj8RqipMbPEMnFFDeYniYSiaiyLKs3
33yzXkHYiGJiXOqNN97YL/HtSRrTpe5if1HdGGNwIaaJQMARdUZENHE/elqQ3ovoKQQVEWkSVIIE
lSAIgiAIgiBB7ecCwcKY05/97Gf6mFNjvCmk1BDTRJ599lld5hABRcTw22+/1YUV0UdU+MW0NJA8
SCAKIqFgU11dnR41xeeNcahGJBPFmNrb2/scuUy3YP1GO1LN04r2QiaxD9hfADEF+N4QVbQfkVHs
lzEVD6TVAP/Hz1A4Cu9HRBZiS4JKkKASBEEQBEEQJKi7kO6Kgkm33HKLHlU0pNQQ1MT/J6b7IpqK
wkb4DFJl8b0huJg3FWJ65JFH6kWYHnzwwZTjVyGQTU1NekGmgVggnygShfYAyCZEE+nDiIZCVtEO
RIkNOU2UVIirIaqGrOIr0p6xXqzLAP/H+wHkFO+BsJKgEiSoBEEQBEEQBAlqPxdE/VBF9/rrr9eF
zBDQxOhpsrRCQo2f4b34P4QV09KgavDs2bPVxYsXq/fff78ufJiDNdUCoUMlYawzk/Tc3iKn77zz
Tpc0Y18gohBVSCSioYisQiYNIU2MniYKqvE1+T3JEVcjcgo5xWcgrokRYhJUggSVIAiCIAiCIEHt
Y9Txmmuu0UURUgehy0RQEyOsEMFHHnlEPe200/RCS/ge0gaZw/jMdBVyEUFdtGiRLreGnEIkkZ6L
tNreRBU/x7ohuhgba0RNk6OjaJ9BOjntSVKNSGlixNQA+4mqyNhP/B9VgRGxRer0QKUtk6ASJKgE
QRAEQRDEASGoWCBWRx11lF5RF8KVGCFNJamIUoJE8YMYQt4ga5A6I10Yr0EiIZOQNsibIW5IL0b0
9qGHHtJ/vnXr1q4xsFgH0nEh0Hi/kaILEKXEZyGz2J4RKU0uemTIqhFNTUztTRUVTZRS4/9Gei8E
GBjfY+yp8Rq+T/w/QDR1D6f8kqASJKgEQRAEQRDEvi+oEEik5waDQXXjxo26lEHqDBE10mYNEU0E
r6NwEsaRQhLxWcgd3ovPQTiReouoqDG3KsQSC4T13HPPVdeuXasXWkIUEj/HevAVQJ6Nz6MiMMTP
mKcV78P2U1XkTSeriUJqfG9ERbF9CC8k1ACyidfw+SeffFLvHwCp/tOf/qTed9996m233aaD/cDP
8D7suzE3an9SlklQCRJUgiAIgiAI4oAUVEMWL7zwQl1Sf/e733XJqCGm+AphhIiuW7dOXb16tZ7O
G4vF1AULFqgNDQ36XKpXXHGF+vDDD3eLUCYKJ6KwWB/Se1EJ14jQQkITI5nGto3PJsqyIabJEdxk
gU6OjkKeDQlNJlFKIavYJiT01ltvVc877zy1sbFRnypn/vz5+v7iK8A+I7X59NNP14tN4Wd4H77i
Ncz9+pe//EVP/cV4390oqySoBAkqQRAEQRAEsX8IKhaM+8Q8pcccc4wajUbVyy+/XC+e1NLSoi5Z
skR/DSIKAUNq7kUXXaSuWrVKjyQinRfVe8844wx17ty5ajwe1yOKeN0QVUiiMSYUr7377rv6dDWQ
QmN6F0MsE8d6Gq8nCmkqGU0sWgQRTQavGwWNjMgvxsuimNOaNWvU1tZW9YILLtCFE/KJ/cQYWfTD
+vXrdZFF2jFARNeYhgZyb6Qv42fY1qOPPqqLPiQe/Yb1LVu2TJf3LVu27I7xqSSoBAkqQRAEQRAE
sf8IKhbM8YloJiKkSL/FdDGIIF599dXqnXfeqUdQIZUQMqTlGuNLsUC6ILmIPmJe1Xnz5ulihu8h
r/isIadGiu4zzzyjPvDAA7oII4KL7UGGL7vsMvXuu+/Wx6Ma0plYnMh4LRVYPz4HcYYkYwodyOfy
5ct1cYaALly4UD3ppJN0CUV0FMKN/bzqqqv0sbhPPPGEnlKM/USktz+RT/Ql+gjjZbGv2EdsC5HW
e+65Rx9zO4ARVRJUggSVIAiCIAiC2L8ENXFcKuQKwomvKEwE4cp0gdQhwggRO//883VRPeGEE/R5
TxF5bW5u1tODIYgAkdef//zn6q9//Wt9PCxEEgJ54okn6p9Hqu2GDRvUxx57TBfdp59+Wn388cf1
NFwILqKVN9xwgx6lhIDiswApuEi1Peecc3RR/uUvf6mLNuQV6cKQcSMKiv1Eu/uyn31Z0IfYVltb
m942SDHasW3btoEQVRJUggSVIAiCIAiC2D8FdaAWRFUhfhAzRDVRTAjRUaQNI0qLSCXmJ4UIQw4h
xhA54zNIlcW4VqTaQmQhrIlfIXqQX6TRYu7VSy+9VP3tb3/bFenFuE/IJ9aPisCGaO+hwkVp+wT7
BulGyjSEGqKKiOoupP6SoBIkqARBEARBEAQJal/TXiGikMV086OmisZifCcKDSGF1yiehLGkGMeK
MZ34uSGhuysCujv64rPPPlNvuukmXbghqqgK/Pnnn+v7TIJKkKASBEEQBEEQJKi07NEFoo7o6e23
366PUUVaMqLL7733nh79JUElSFAJgiAIgiAIElRa9nhEFQWVUDEYxaKQwrxixQr1ueee01OCe4k4
k6ASJKgEQRAEQRAECSotA7tgfCwip6iGjDG1GGOLglIorvTBBx/o6cwkqAQJKkEQBEEQBDEYBPXH
mqB+f4A52wG9fPnll+q9996rF4FCsShM+YP5ZZMW5ALn0HVCkKASBEEQBEEQe0xQH3744QZNUN/V
ZOQT4sBBO+affP3115+8+uqrn1xxxRWf1NfXf/LMM88kvucNjRF0nRAkqARBEARBEMQeY9OmTfzW
rVuHajJCHKCsXLlyKMMwQzdu3Jj4+hANE10jBAkqQRAEQRAEQRAEQYJKEARBEARBEARBECSoBEEQ
BEEQBEEQBAkqQRAEQRAEQRAEQZCgEgRBEARBEARBECSoBEEQBEEQBEEQBEGCShAEQRAEQRAEQZCg
EgRBEARBEARBEAQJKkEQBEEQBEEQBEGCShAEQRAEQRAEQRAkqARBEARBEARBEAQJKkEQBEEQBEEQ
BEGQoBIEQRAEQRAEQRAkqARBEARBEARBEARBgkoQBEEQBEEQBEGQoBIEQRAEQRAEQRAECSpBEARB
EARBEARBgkoQBEEQBEEQBEEQJKgEQRAEQRAEQRAEQYJKEARBEARBEARBkKASBEEQBEEQBEEQBAkq
QRAEQRAEQRAEQYJKEARBEARBEARBECSoBEEQBEEQBEEQBAkqQRAEQRAEQRAEQZCgEgRBEARBEARB
EIOd/w8bDnll52EwCwAAAABJRU5ErkJggk==

------=_NextPart_01D75918.E6EFEE90
Content-Location: file:///C:/8467A08E/Stalevo_clean_files/image005.emz
Content-Transfer-Encoding: base64
Content-Type: image/x-emz
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------=_NextPart_01D75918.E6EFEE90
Content-Location: file:///C:/8467A08E/Stalevo_clean_files/image006.png
Content-Transfer-Encoding: base64
Content-Type: image/png
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=

------=_NextPart_01D75918.E6EFEE90
Content-Location: file:///C:/8467A08E/Stalevo_clean_files/image007.emz
Content-Transfer-Encoding: base64
Content-Type: image/x-emz
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------=_NextPart_01D75918.E6EFEE90
Content-Location: file:///C:/8467A08E/Stalevo_clean_files/image008.png
Content-Transfer-Encoding: base64
Content-Type: image/png

iVBORw0KGgoAAAANSUhEUgAAA6gAAAC3CAYAAAAfKXP7AAAAAXNSR0ICQMB9xQAAAAlwSFlzAAAW
JQAAFiUBSVIk8AAAABl0RVh0U29mdHdhcmUATWljcm9zb2Z0IE9mZmljZX/tNXEAAISASURBVHja
7Z0LfFP1+f9Pci5JWm6hlJK2acuxRAxtoBxLLLE0lFiOGIoRjxhrBDvMWNV4YRjxRn/KsOq81Kkb
ikxlm9op80pBNnXeb3Pq/k5RmXedF0CnQzen538+pz0lDUmblgIFnvPi/WpJk3O+53suPe8+z/f5
Mv/3f//HEARBEARBEARBEMTehjqBIAiCIAiCIAiCIEElCIIgCIIgCIIgCBJUgiAIgiAIgiAIggSV
IAiCIAiCIAiCIEhQCYIgCIIgCIIgCBJUgiAIgiAIgiAIgiBBJQiCIAiCIAiCIEhQCYIgCIIgCIIg
CIIElSAIgiAIgiAIgiBBJQiCIAiCIAiCIAgSVIIgCIIgCIIgCIIElSAIgiAIgiAIgiBIUAmCIAiC
IAiCIAgSVIIgCIIgCIIgCIIgQSUIgiAIgiAIgiBIUAmCIAiCIAhi0D3oMowpIDLDrIwjx+WK8dQn
BEGCShAEQRAEQRC7RFsbY/Y5mFxNOAs18jrB904dh5grRldakz/XojC2eje7yio43/TIjYfvz30U
bYla3W6r3R6IZtE5Q5CgEgRBEARBEMRuollxj6zNZ26ysKZ3WYbZxjDmL0xm87uanL5lYk2brUVF
L4w6ZObVLo8sqqpqMj63MspY50xgr9cE9RVNUKv6s22sT5ZjFkRjB2PfxBXJFpL93qmVpS1Op/U5
Z03kDFdMpWgxQYJKEARBEARBELsDRFAlOzM06HUfXmZm3+JN+Z+LvllHadKY45fEErks/3KbIPzb
ZC7YPF5e4E+UyajIWBnGnq0oCtsvAWzyT/HKTceLgRbrYOsXVW0zx5SKGQcVFdzpFNh3eY77Lq+6
YancrnJ03hAkqARBEARBEASxG1kZD4ycnsdusPDO96RQzNslsAozRB7P3MJxgmoaU90uKfExA7G9
5qDVHpxkvdElLzxzsPZJq+wS7Hb7UKXKuYDjhW25VeHzSFAJElSCIAiCIAiC2M00R6RRfgfbbuEL
3/MEu48pbZLFYwQz+w1jLvrYG4p2pfO2BKQsN+OwpyuS1BIQrQ6Gye8YzyrmGWNZI2776LrykZdY
LfyX9vIjLrPmOscyojvPbdfHv+L9o+1Sx3jPVlnm3AwzRntNWxWTa7wO2ltlQZLsI+xK3BbV2mLX
PseIgeFMQipyp2hadrSDybcrLba+9E1ULj2GF4StJKgECSpBEARBEARB7AGWKVKuJqjrUwpqyFs1
xsR+zDL5/5RC0cM1aRSCNW6f9+D81UV88ZNeOXpY8vriirtArpYWF3HscybG9BbPF702evyRP5eV
cPmMAsfPsyzspwxjUk2csIUx829whRPuKS8Q7rWypo9NZm5LXnXkDIxRjSnuwgrW1G4zM5+Z2I7X
Y5s28dGAWFwjlVxU6BSeKakNL44EvSeINsvL7Ohp69zB2JgESR4anlURKea4Z0wM8xYnCO/nHHxE
qzu4zJlp3zQGSo8jQSVIUAmCIAiCIAhiEAjqIrlE4c3st4y56KOacMwbD/snFXOmp22c+RvW7PxY
Cka7vT8eFAsOzx+6dtjkOdc7PYGxViszqr4y73xblu3f5kPqbw0osdGK13ESzwvb7JOOWm4V3aMZ
URquSNacYMWoiwVB+DbXF74AMogxslGfWDzzYPMdgsD9L6d6fjwei4yuzWduHMKbt5k5Ts3z1N4Y
iUUnKlJxnLdIfxL9kdJOOR1SX1V2wfhZ806XAgqisNmhGnF+ts22xTSmCunKDhJUggSVIAiCIAiC
IAatoDrflUJNXRHRtqh9WGAc81uOs6im/Jp7JWVZLtJug+7c0qm57MMCV/h+otC2xhjLPMl5Xpat
4gWnL1xuvL447BInFFraWWft7YH4ypGxWaX1mqBuza2OxBPbEZVLlVQy2FCdc64mrv/SXl+qtLWx
mIO1fvLIZo4XvmHLZq+2x1+wtbfKHMOI2Uxbm1ltY9hoveeY7Al1tzK5rkkMg2xjJs/nzq2YnMO8
oG37B7Gu8Xg1KR2YBJUgQSUIgiAIgiCIwSKo3JgPx1cFZ2s2VyB5HIdMk0b93CYI/zFzhZs8cnSq
8f6V8cCIWge7LjniGvG7XZMstheF8XNWM0nzpyoSY2PsUhYEMp30aa/vJKhqu8w1+HLjhqAa751f
nbcEr+VUhc9XVLVbJWHM0xrysDfxFtsXmpi+iWlzDFgT84HJzH7oqGk4NRPhJEElSFAJgiAIgiAI
Yo8LKrNO4Phv8h2FGwpZ9lmzidnMseyHY/LL23xy46SUQpskqI0BT3Uxb9nsqApf6GpNP2doD4J6
XCpBDVfldkVQUQRJVRlTwmvnJotjLCCO8Rda1lnL5DWMw12IaXM6GakxXGOoS5YtmfQNCSpBgkoQ
BEEQBEEQe1xQEUHN/8DtnzvTwTD2TqEb4XLtLHI9CWqhYH2HL0MEdaN1DwnqTvOTNgbc4yZbLC8K
h8y5ldlFqSRBJUhQiV0GZcfdVutIlxyz7NZtuK12e2BHufO9RW9l3neFTTGG7yzNXsiIgRH76/HM
ZL+jAWaIlXHk7I5+3qWbDcOYMBZnMLaN7jv7532BSDzmzKA55gQxIIKqj0HdMZVM7+9PElRZmlrE
Wt5n86Y+7Iu1jO6r9C2oFedxHa8v3RVBjSvi6BoHt8EilP/NFVw8Pnn7bWqbWZLiNvwOJUElSFBT
EIu58DA8Sn8Y7pijydn5PeaDGpPwGihgGMcoV4weOna62bQx5kjANbbGU3KRkxdeLaudH8pk8Htf
ULUbWSzoLvZLJcucTutzzprIGa6YuleORUx2WUJ+9+E9lXnfpQfcuJIdqq2YjxLxPMu/x41xPzbe
Py+wp869PXE8M9lvdsyEh6VaefbMCext2i/iNyS50TeYznuMs6l3s6usgvNNj9y98iKx/56ne+u+
QGjHXFHYaDAwvqZc/D/tmP+/vX3MCWIg0OdBzcc8qJqgBnv/PacLaor3N8lecRLH/J0z898We8MR
NWls6CbtmTemPUckimji+NEFgVJFk84tOb7wBcbrkNEGX945kNG86vlLjPcmjktNFseVUcY6p4y9
ief4b0dOCjaLLRuzu90rG/3eqlmnKS65tdc/MCWMi11KgkocMILaGPJNKTLxr7Im83vGAG6TyfQ2
y5i2Mmbuc8Zk+kfXwG4z9yFnKnpduxl4qaNx01JNshyz4C9gzYp75IxC5uZs3vQ1y7LfuQILjxvo
hwZUpwtNZFqyBfPnZo77X15Nw7kDfbNK3KeeXm8KeStKePaZdGXed0l6AvbsWe6iy4eMPeJOUQqM
m1vjmu4UrP/g2ZL3tHOvan85npntt20TzxV8Wlhg+RvPF77skaPePXG8M32v/kt4Anu9JqivaIJa
RfeF/e++0xd2532B6HyQj0byZxQVtmbz7LbBcMwJYiC4bVnQPj2P3YAUX28o1qugtsaC9prRne9X
YlO7/04yX2/jTCrDFnxUVik3WK1WBFxGu0WmUKnxnty4OD5xQd34eZo8bs3xRc7D9RMNBKxtKJ4k
ew53cpb32YNnr3G1q0LHOqVhc715Fwk8/7W9fOZljBgchdfnd1b2TZTWRKJ1pXOsPPNvhhW+z62c
vkL0+UrRDpeY66mZMv5KfzhaxWRw7S7qqCy8DdJM5wpxQAgqHnCiwZqaEsvkdR5PYJoxiLvG7Zwy
gbO8wY+e+me7x3cIXtMu8FGzvBUniFbxiergQj919P8x8Sb/FK/cdLwYaLHqc2VJzKi6g5nfCgL7
VYm/ccAfGjrTKbNDXmcjxwtf7I50j8R96un1jjLvzpRl3ncV/IIotlrfcnjnXWS8Fq5yH8dzkx+W
At0LJezLxzPz/Z70iNsbrGIYe7aiKOyeON59eW9UZKy7o23E4DxPe3xo3I33BaIDPETHA+LwYMXI
S3iB3yb6F8wjQSX23fOZMfscTG6tp7TuEDPzDm/mVacncL7dITnTpa8jU0N2O6sOMeH9nOqsqj1b
UuLDu36uSAeV57PtVo793mw2q9qz03/NZvbfjsIhL1nH1t4WiLWMjgU9U7Tft5u5cTPucvlDEyNB
eXZ85cph0YBn7GReeN5qdm8uKautq5EDYsMsb+OUSQV3sjz7Aytkb2MLAquDAZ/3iHGm3/M894Pd
I19hdQQLZbm12/NYW9xumwVZ5s3fciyrmkym7xiG/Ya1ZH3CT5x9rT26ssdhWthPyWF1ziy3t/A8
r5rGTVmf65E8dik6lM4dYr8W1NYYwy9p8NVVhRYHE1McFoekkgrO8rLgqF3njraMNF5XW2P8afVV
s2saltQxsdYDOs23OWi1BydZb3TJC89MfL3Bl7tUEPiteGjYXdtukkuPMcYjMKpq3t37lO71dGXe
dxX8tVAQhG2OpL9KMoyUxTBt5v3tePa+3wHrntznXX0vsX/edzJld90XiO5EqpFy2HHMSVCJffae
prhH1uYzN1lY09tmhvmn9gvvU5OJe9/EFj0uhaKTUz4DhbwVRazpCa7j/Z+YeWGzo7rhlMTnWE1S
x0w9JO8a1sx8xjCmbSZz4eb8CUe1iMFYgf78q8nfUYfkLecE6/umwolrA+FoOa4jDKVaVCOGnCbz
K2Yz/7bZWXGHEo5IkVrnaZZi56NilXx2KBQqqy0wr7ayzIfYvslkec9kmrTOF4wV77R/ywI5Qa/r
jAIz87oJ7WAL3iytlJf4ostye33W69jPxzkT8z62w5jNH5k4/vXkfSWI/U5Q8ZfY5qaw2Hh+cwm+
N15H9bGJnOUVweFfr13MeYmfaVkWLVaiyw4y3t8SFTH7sKNjjKo4xq602PrS2Ew+r7a3cwHJPlyP
GCgK67YzozvGyYq5bWkuUtx8OgvNYOxsvpS0XhSYkCRmhEsT7dZWmetcp6O39mO/Iz5xdF35yEus
Fv5Le/kRl1lznWMZhy93U7ssdAya57eW1jYqrZrQd663x35JbmtvbegaMO+LxKMtLVld/eFw56hp
hLWnfk67T6I7LyA5HHXlI3baV8wjlq5IQX/3zfhrYZ3HvoLXU2mOaNG3x7jHMAnnZybnTMfxtY+w
K3FbNCBl2Rmtj8TA8OR0msFwPHvcb6ajvXFFsiUXnclkH3e0xVEgBpQh+AWsKIotIol5KY9rUhS0
p/4x2paqII7RNpfcKiRcX/lon/Een9tqN67jnn7Z9taf+At8QGRG6IWaMhyjTPedvp+nXX0X0Puu
83NiXvLnersvZPo7I925i2gL07H90Xapo1AcIrfujpoJWG+u8Xpf7gX97Y90BOz2ETvqN4i5sYQp
L/pzHrTG9PZh/wqDwYg9oo9/I0El9m1w/5bszNDO6VeGYfoVVO7F5ZAckdxxrcqcqL9nx/vtkmJL
cc3wnT/XEIe4XN0DK50/H87YxWGJ9wNcT9r6h+htskv6z7BNRpKylLaOe3/Arv98+I72SsPTZRGp
bQqrrS+7sx3Zxjp6A9vsrGY8onM72N7IVPtKEPuVoOpv7qxG1l2A0gsq3m+MQYsr7oK6qopzinju
LybG9JYgFP89Z1xdqzsYK8pk2719Xi8AokjF/oqyxZ4i659E/7yzw+GQt8JpvkNgze/yfMFmsTp4
Smt7u5D0ADU0PKsiUsxxz2iNfYsThPdzDj7iGrfSXNgxxsBdUiOVXFRYKDzlmdV4XCwaPGxSAfN7
m4X7cLQrcFVAactO/2CrjKgtKLgqy8J+qnWDauKELYxZ2Mzk194UicbytIeGJTzPbXX5IyfFm4Le
iQXMXdp7P8kdV3t1qvWmaavWB8ucPQkqx/NbcivnXLqgIThHa/udPK/1R0H+i+6aWeFYa/ebcPp+
juvbaE65T9wbXGH5H8oKitZkCezH3fd1+iopunJES9Q9sscH0T7um/HXQhtn2mIymb7Xt8fwmxP/
MhmPSPm9nTPhGpeoH1+n8ExJbXhxJOg9QbRZXmZHT1unvW/MYDue6fabMU160B+KuMKyp8o7rqPo
jE+OenVZqXGN7WEf9Wu2RQlkK5WenxSx/POcqfDZiprQqfNC1UFf3byfTHcWX5/Fm/+ZdFxvdivL
cjLrn+mrApG4Q/G7q4yCOEbbokF3sda2ZYVF/FOe+gXH4vqa7GTutPLsP5kxhzziCkUmNMejY2o9
BcsFln2HZQveFH0Lj1eUNrY//dlZLOMB7TzcnElxDbrv9O88NfpOrpYWo4iX3nd80Wu5B8+8Wus7
ZyaCmunvjJb4zueuop271XVzm/xF/Bqr2fSxycxtzauOnIGHyZjiLqxgTe02M/OZieW24PXYpk18
NCAWZ3Iv6G9/pAIPqWG/z1tWVNLGsmbt/mX6h4UveEOsmHt6IBrNikXczr6eB8uikqNOKltaxHF/
5cz8G+Mmz7p8trfoUoFnPydBJQiCIPY7QU0tQOkF1SCmiIW+/Kx7hpb413pqQlMwTnVWdWljVlbW
Z8yYqna3Ei/oaRu9fV6KtuatbBGHzphobtUetD5jWfaHMRMr766cFTlZCQYLgn6Ptyyfe9zCC1+U
+Bccb0R049qDRn1V2QXjZ807XQoo+It6dqhGnJ9ls31uGjP1ATkaOWTGZPM1WYJeVOT7ssmBK4Lh
xTXRoJg7u2Lk/wlW2xZnzfxwYkS521/CNJkP2O1DMA4Ug9btk45abhXdeYxdGtreLguo6mbhuS/d
E6dfKYcXT1N8dkfdweY1FovwZfJ607U122bbYkIfKHFHqjYsrCudy3Ls1+Zi8S+euY1zA6J9eKjG
PaXcyT1m4fltTq0/jD8iZHKc9LGtO+/TaEaUhot2cZj2+snJ+4o/VPT4INqPfdPHr4nWUcGKkRcL
gvDVyIrgJfr2GGkE+i2jcyYqDpteyNw8hDdvM3OcmuepvTESi07UfCPOWyRNNiKlg+14pt5vcTT+
ItsY9B7arehMqKlqZbMyYka+eVW6fXTVNIrtrQzXUF28eNi4mb9ziDUu/DU6HPBK3iFDHi6pjpwX
iURyQl7HSTsd16TzPnX/aG3T3hsNeaWd2taitU27ZrMFtI39zuMPNMuN8eqoT8ytl3LOswiWr9gy
/1q/XD8/Go3kBXyOSWUF1icFofxlTyA6vo/n0JiOP1qIo7Tz8C7tPPx/nmDPVWPpvtP/8zQeFAsO
zx+6dtjkOdc7PYGxViszqr4y73xblu3f5kOCtzKBlqyeBDXT3xntMiOkO3dFX2RpJBjIq6/IWaZd
K9/m+sIXYBy+PhbXJxbPPNh8hyBw/8upnh+PxyKja/OZG3u7F2hyOqQ//dHD78+aQotlk7X8qFty
vcGxAU+ueLiDa0dlUE9g7sLAoZZfDBFMX2V6Hmj3tCF1B2fdPNRW8YRHkqcGA+5i7aa/ZGzh6GdZ
jv+qNLBAIUElCIIgDnhBVdu1h9+qgni2teQNsbphRtfrm1x8SMq50CLYvsqpUC5wtXaPMPT98618
QGTwUHYyy1u+ZiccdYtdaelKEYzIrhonJ3zAOaZtEJWOfP5oveeY7Al1tzK5rkkMg0wyJs/nzq2Y
nMO8wPPC9yWBhcc1R6VRR7iYNQLPfi3WRBqMNJKoXHoMKrKZJ9TfwihtPaZQdI0DrY7Ed+yXPleW
PhastLrhxK711pUcC/FIXK/axrC9tPUHsa7x+FQPHp0pvttGVob+zx7f0c5IYEd/OCLNo/DQpvXz
Ob31M9PazqXbp55eT/cguiv7BuZX5y3pqIwXOaev54zc2sphXs76ySObOV74hi2bvdoef8HW3ipz
SK1h0gjA3jyePe03UkuTi85AVqKSfURP+xgLiGNmltjuKazEkMSE41JXMUesi57crqpc06ySOamO
a6b9k6ogjt62gL2jgAvPf1Hqj5xg9FuT7HaVccKrfL5/Y2LEbV5VzgUCb/mitHbHg3Zf+hNjhiQ7
Y2MY+5CeCjXRfaf/5ykqiM+TnOdl2SpecPrC5cbri8MucUKhpZ0vmn6nGIiP6rgviDvdF7DdTPpe
O3fZmM+R29u5G5WLj0k1L2BDZ1VNfeoIbV293QsG4rrtfo5px6I671yLYN1e7F9wgvH6IrlE4QX+
y5yq8PlRRRoz08Xclsl5AFGdX1Mazsoq+XuJV6kz1tesuMdMK2DXCRz7dWmgkQSVIAiCIEGNK25H
Tb61XSj0r3cn/TwW8nidLP8ez018VQpEx6Vaf6af98jRgzp+uYshPIxov9wvSCwK1ByRcmoc7AaL
UPCBOxit2rwyYA152Bt5i+0L7SHjTWN6HH2KHBPzgcnMfqg9/C/SfplzEV+OXmCi1N943I799lQX
CtZ3WPfsNb09KKaaOLnbg2LiemXP4cnrxfyRWltv6qmtjpqGU1NV6U3Y9rltafrDE2qqao4F8moK
rOsy7ecFtSVKqoe+dJNEpxPUXdm35Amxjfdkfs40ibrs1eT9FOvAA2EmxQT25vHsab9BuqIzhtCm
2kdIQm2h5UELP+HVkjLZL4qBrqp/GCuKqHlfJv9O9950bTMKuCT2W0T2HNRRfM2/3hHsEDtVVdiO
ueQ4VCPtEoFd7U+67wzseRrxu12TLLYXhfFzVjPRld2KdikSY2PsOwqYdbsvdM6Nuywo5vXa92at
74Pxsa0xt72nc7ezH5RU/ZA4L2Em18lAn2eq2mZWAu4TeN75tFuOVnb0j9021+v8ESdYvmLcR9+s
tLxgm+/L/WnP50HHWFScs9MKrA9q/bbO+GOIcd2EK3MuoDGoBEEQBAmq8fOgNLVYsLzL5vvXS0r3
SmR4OJmWxz5kYZ0fpCuck/Hn5ejUJHHq9uDeHmMs9WXmVRae/UqUo8csiwQc0wuEB6xl8hrG4S40
ps3pHHyvD2Z3uWTLDhnoXvWyUZZ8RYL1bXZC/a27+qCYfr0dDx6IcPkLLet6bKssW/oiC0Z/CDz7
L5ccVWJKja+IF97uRz/vkqDuyr4li5rxQJnpOQNhQKGohqqcczrXkdFcsXvzePYmqKn6GUUXEt6/
0z5uanXxDb68mI3nvuDM3H9z8w550F0j+xKniBkIQe2hbTv3W4r7Sro+3tX+pPvOwJ6nkKdi3rLZ
URW+0JVQ7CcVieeEW+4YE9wY9FRlev22tbWxDVV5p/f13E2+hoz6Cj1dJ7vjPEMUX5IUmyKJIzwe
ryvkl84ca+FeM5v575myo1cF4i1DI77cxT0er84/AuC1YsvO50byuUSCShAEQRzwghoNeg4vxETG
juk7PWw0RySMB2u3cAUQ1Gmp1p/p591yxyTv6cQJv6TneXMwefLW0lkL58ZCgXGTBeEF4ZA5tzI9
PHCnf6DzHL57HhQT19vxoIg+nmyxvNhbW/siC/r2vTkXYvJpXVDDvuoCVnh3V/u5r4K6K/uWTlAz
PWdccpMvSVCXDrygDuzxHABBTbmP7a2yJVwpnuLkzG9YeP4b7bz4Ntc15SYxEHPigXa+f/AK6q72
J913BvY8NaJ7fBkiqButfRXUqOzO7HeGHK3uPHeFvp67GQjqTtfJ7jjPOoW84jCPeINgHfuU5K+P
hWrE01le+Bfjnv1rXVCrOiKoaY+XIagBzzQ9qoq034R+Tz7mJKgEQRAECWpQmlrEWj5g86r/6IvE
R+/0cJKvPWwIxe9oD6xVqR8UM/u89qDoTXpQ7J76GGWsIQ9/k1V/OG6qaokHtAcdbr1FKP+bK7h4
fPJ229Q2syTFbYgu7e0Hxbgijq5xcBt6a6tR7CgTWUC62tFl/M0WoegfUjA2dbHiPcxpFt7rRz/v
kqDuyr6lF9TMzhlXsGnK3hDUXdnn3SWo+vu0B1et78bIXtdZhWbTZoET/mPKq75HibWMicriMTw/
OAV1V/uT7jsDe542ynrfvc/mTX3YF2sZ3WdBDXqqMvqdITdOzeTcXVgnzuX47semP4I60OcZttfg
d81wWrJftZbNusnhC5e4ZFnA+FJOsGiCOqdPghpBBJXHa5pApxFUpAmToBIEQRD7vaBG/J1jxfKn
t4tKfKeHkagsHVTB8y9zbOFH7mBTTbdf+BFx1HSH0G4tmv6gmDSlR18/bw90bNv4a3mOL3x+4liw
9pjLEhzH/8ZmnfyCKxAbq25i+Dll7E34a/vIScFmsWVjt3L9sUa/t3LWace0xOPZ2i/3JTuP2dIe
BgTrP9gMipUsqBXncZ0Pr4ZE6eOCjPkIe1kvHnJ7a2vVrNMUl9xqSbvt6oZ44oPJsqiUOy1f2GAt
1Po+2jIqrkjFkzj+pcz7eed9Srev3R4seee7idN77Mq+JY0j60rJy/ScMcY2Nvjy+iSoe/N49rTf
6foZEpg43i55H1FcRZZjXdvC+yOSw3n4GLZdYJ3v+5Sm6ugsl8JiuqKk45pp//TUtsR5ORMEtXSS
fl/xd91XElMV8V7jfN7V/qT7zsCep02yV5zEMX/nzPy3xd5wRE06XzbFXHyscw5aPSLaeU4YghoL
esZm+jsD50Bv525T/fhjeJ7/XDs2F+zoB00OO6/7vOr5S4zP93SdZNofjKtVyOQci2GsbZ7lQStX
/pqzJurece4lCGpLW3Zjde6ZPR+vroh3aYUgvMyPqfqjO9qct0OE28wNnfOglgYWHUcPPgRBEMR+
L6jxkDRuAmd5lc+r3ihFV45K/rkeCajMXZxlEbYz42bczkTbuipchiTnoR7bkBeLfeHFTJqxShl/
vnMyYxTE0AtMlB5xp/agNcx4ryI5Jk+0Zb1Y7J13jlGJNlpXOsfKM/9mWOH73MrpK0SfrxQTurvE
XE/NlPFX+cNNlZ0RNvz1eVviL/fFIamqQLC+q/+1elPP46zQJoEXtuX4Iufp8/DJskV7aGDDvpzz
M11vL2290h+OVjGpq/gqFp7/arinfoW8SbXs6I/io8bahrzmqAqfjQdqfU7QPvZz4j5FAwGrPn9j
itf1h7u4MqJmNLvBwuV/4FViU7vJQD/3TReDjkqcX2F7fT5nOtcZ8eH4dn9QHazHs6f9Bq3Lgvau
fg7Fuv4Q0NM+RiPBUXUVvjM93pAr8fUTpoxuFiziG75Qo29RcPxcpIMnH+9M+iflOdC9beeh38Ta
hcd33VcU79iJnOVvfJ7/ISnanNvTezPrz0a9P3GeB0RmhJVx5Lg6JYnuOwN7nuoiN8F8vY0zqQxb
8FFZpdxgtVrz8Dm3yBQqfu+PgtHFEzvOicBO9wVUzs3w+mWXRYL2ns5dKRStiineqYWs8B578Ow1
rnZV6GijNGyuNw+p11/by2dexojBUQnXVdp7QY/9cajWH5FoFaqDux2MnbEyua5Y+j+K4I8gk3j+
dd40QWvnMr1IYKvsEsLVYiMrWL5myuauamlrG1JfYb8ok+OFfp99CHuTTeD/7ZCUk9XOP5RsbJGy
5lbmLevY17pLrVJ0DNNDBWuCIAiC2GcFNSa7LKLVWlDrLT6DN3MqY87fKkq1IYZxjzFK4Rs0R9yj
D3eY1mZnWb8cM/HIixmrtcgrOsv8xUN/n+2cdqe7l7nj+vJ5fd5PM7vdbCl5p0IOL9AeHpySwzqx
umTIPdmF5es8SkfVTdAWt9tm4UGKN3/LsaxqMpm+Yxj2G9aS9Qk/cfa1gZaN1qZArniYy9TO85xq
n3hkCxOIjFIC4rBZUsEinhP+x4z2PpUrymXJ+9ztQVH2VJVYrZu5cTPuEv2hiZFgcHY46JnidZke
zHS9vbXVHl2ZlWrbTSHPFCfH/91mKXqv2Cufjv4IVJb5D80e+ueS8fKldqVlSH/6OXGfXNo+zQ/O
Cja3NI+Iym5vccLrkaA8u7k5PirgFg87xMS8g3PFWVV7tqTEh2d6HFLtG84/2e1wB8aZ7uZ5XjWV
1v4h1+0rt0vRoZnuC2Sl0Z9bOmOcaa3Acz/YPfIVVkewsKdjubePZ0/7DQHxu51VO/o5cJYYCIyI
+nMP6mkfY0H3mBklw+4ZVjL9Dp8c9uIcqfW4p08/aMS9lvL6X9iVtuyY7Dk08XhHZs2qj8Vi9t76
J/05sKNttS7T3Vrb1JGif5X28JwXDUhZtVLJ0fkmfgtrdr8nepWgpCi2qN+J96413msPxMYwTIcc
9dqf8Y4oU2cU9wELX7g5MZJP950BPk8V6aDyfLbdyrHfm81mVeuP/5rN7L8dhUNeso2tvQ3VeTvO
5cTztfZsMRAd1pe+jwXceT2cu9dhaq2Y4i6q4IUXrGb35pKy2roaOSA2zPI2TplUcCfLsz+wQvY2
tiCwOhjweY8YZ/o938O9oMf+8MxudbVusiyLSc7yAuZRnuP+PcxTf5EUTx3pjkekUTXaPmZZ+G+H
l81c7vAFihbNmzXz0KKCOwTtWJhcgbsrKz1hzsR8ZdL6J6di1orejlc06K4q5LjXbZbCD0ulwMkO
USqKhqqUKWOd93Ecq2r7+qXZWftrt7Ishx6ACIIgiP1OUJtC3ooi1vQYbza9pz0UfMowpk9MJuEd
k2nSOl8wVpz8/mURKS84PndFkcD/zcSY3mI553OeqllnBiLx0ZlsL9PPI9WO4/ktBZVHXFMvHXSJ
9sv9dZOZ/UdR2dRrpEh0JxFuXhbICXpdZxSYtfcxpm0mtuDN0kp5iS++cmRzVBoxvZBZZWWZj7R9
/IRhrW8Lk+dcofjF0yyc6XX9NZPlI5Np4vpU+7wjoiBajzokbzkrWN9jnJPagopSE3CyN1vMzId9
WW/atka7FxLp9kDV1maOKjXlPnfhL3iefYcxmd7iioo2lgXmnhhIUcAk03429okTrO+bCieuDYSj
5YjStGoPnV2vF3juDkXjE5qUmslO1vQ4xzD/xL6ZeWGzo7rhlMT0z77uW+f594R2fDv60MR+aOL4
1xPXm25fjHFtzYp7pHZ8b9aOr74Ok8nyXrrzd7Acz5T7beZfc9YuWNioBKY4TcxjRj+beGFTSY0c
n14k3Go1M++n28eoooyUJX+TEgrNmDax8FLObH7DxDlfcpbXX+KLNet91e24Jhzvnvqnp3MgZdtY
67tCxdyW+XWVcwTOpB0zvJf7p4krfsJfPzcwo5hdpb33A/29nPV9pjzUkjiNSSb9Ge8osnOXJqj/
zxOMHkb3nd1znnZK6piph+Rdw5qZzxh8zly4OX/CUS3uQIdcdp3Lae4LmfR9Jucu7oGLasSQ02R+
xWzm3zY7K+5QwhEpUus8zVLsfFSsks8OhUJltQXm1ZncC9L1hxRt1qOwsYiveFIhs441mbcKQsnr
vlDTlJS/fLVOiSIDyaG9l+M+YJxFG6Rw9OhIwF9WzjB/5szsB5oAv6u97zP8jjVlcLxwTUZkb8UE
B7ueN7PvMabip6pqIj8K+8WzLcWFj4jewBJfMFKQbo5ngiAIgtinBbVVljkHw9iZDoZqDOsoty+N
UNKkD7XGXLzYUY4/h2EcdiPlLeNtZvB5ozBIni+8VGvHkM4pAEYyCeOUksG4JW292R37IWYrnWl7
qvYAIdn1fRveuY8jGFEZgrnq9O8Z42fScKWXlCm0XX+vXRyG9wbszJD+rDddW3s/Xi6h81jlaG0Y
njhOrr/HKXGfEtP8kl/HuSJ27NcwY3/tkmLL9DikO/861zl8R38xI5PX29O+IIK60/HN4FjuzePZ
037HOvY1qZ8DWb3tIx6UjQhMQLJndfSVOCJ5LF26453JuZH6HNipbcO1fsuWNRlmdrxXwz4cxWNS
vTe5IE1v/dl5TWvHxT5EyTDNke47u3Df6dj+0M7PDXG5WvkU53La+0JvfZ/puQtx09bTcVzsUtc5
yUhSlrEvO/VND/3bU3+gTS6Gsfgcjvx6T+XSUGOj2FMfKfr5iGOhtbsz7TzAMFmdbbHv6L/Mj5c+
36z+WYdd63MB9wZtX22ZHjeCIAiC2CcFdbCSMCn7uXSACYKg+w6xJ4EMr4xGrcsWRybWzDrtmMQ5
WQmCIAiCOAAFdZGsPyhuQ8VGOsAEQdB9h9iTxKPK8IgcPDoYjs4QoySnBEEQBHHACirStYIOa+HM
cnuLXjxmnHe9Qwq6eyt4QxAEQfcdYqDAFDayLFvoHCAOBJBeHovFLK2trRZ83V0Y68dXg925PaL/
tLS0WPG1L3OPE8R+K6jRoK9oksm0zmLqKLjCmHsvIkIQBEH3HYIgiH48QGoCcvPNNx/69NNPNz/3
3HMrnn/++eW7i7/85S/LH3/88eXz589ffuihhy6fOnXq8lWrVi3fndsk+sczzzxzqXY+XLB161Yb
XSfEAS+o+Cue1FFUok9FRAiCIOi+QxAE0WdBNW/YsOFH//nPf776n7Z8//333+1O/vWvf3135JFH
fmc2m7/Lzs7+7t577834s6qq7sQPP/zw3e5u84HI/zqWz7Q+HknXCXHACypBEARBEASx5wT1T3/6
0ymajPxH3QPLN998o2qCinmVVavVqt5///19+vx///tffR2aUKuanKq07NblSxJUggSVIAiCIAiC
2NOCulAT1O17wni+/vprVZZlXVBtNpt67733ZvS5zz//XF2/fr36i1/8Ql2+fLl61VVXqbfffrv6
zDPPqB9//LH6xRdfqN9++y0p5cAuW0lQiUEhqO2tsuC2Wke6epj3j9grv0BMAZEZZmUcOS5XjKfj
uH+c03rb3Fa7PRDNor4dXLQEpCy3Pv9k79fbYLkPZNLmvt5L9qXzdl+/ngjiQBHUmTNn9klQ//rX
v6rz589Xf/SjH6mXX365unr1al1UzzvvPPXHP/6x2tjYqC5ZskRdtWqV+vzzz+syi+18//33pJgk
qMS+LKhtbYw5EnCNrfGUXOTkhVfLaueHtJPSRJ07SB6WFcZW72ZXWQXnmx658XA6jvv2Oa39ZjbF
gu5iv1SyzOm0PuesiZzhiqmDRoQO5PtFTHZZQn734d6D81cX8cVPeuXoYYP9PtCXNmd6L9mXztvB
0q6WAJPlYBjtH+PUvuTbpbheXERtlbm2tjYz/S4jSFD7HkF988031blz56q/+tWvuqKkSPNFiu/2
7dvVf/3rX+prr72mrl27VtX2RxdWsGLFCj3iiujql19+SdFVElRiXxFUPFDKckcJ6WbFPXJGIXNz
Nm/6mmXZ71yBhceRoA4eVkYZ65wJ7PXaQ+Ur2kNlFR3Hffucbo0xltBEpiVbMH9u5rj/5dU0nCu3
q4N6OosD5TxrCnkrSnj2GRtn/oY1Oz+WgtHD93Z/93Yf6EubM72X7Evn7WBoVzzodsou55XFPPeS
iTG9xXJFz3l8s87ySF5PsEYOR2KxHPpdRpCg9i2CCrE8/fTT1ZaWFv1zPS1a+/WxqRBWRFGvv/56
9bTTTlMXLlyoxuNxPer63HPPqZ999pn+HgguLSSoxCAU1HiTf4pXbjpeDLRYERGJSsyouoOZ3woC
+1WJv5EEdZARFRkrw9izkyuL0nHc9/qiM80yO+R1NnK88EVuVfi8wS6oB8p5ps+J6naWTs1lHxa4
wvc9wcbD93Z/93Yf6GubM7mX7Evn7d5uVywoFk4dIzww1FrxrOSVfVp7cgKSVFxfXnBJltX6MVvg
X+cOxvLo9xhBgpp5BBUFkBAVjUQiespuXxdEWb/66is9utrW1qY2NzerixYtUqPRqHr++eera9as
0VOHsW68D4JLCwkqsZcFtTlotQcnWW90yQvPTHy9wZe7VBD4raJ/wTzq2MEPHcd9uy+a5NJjeEHY
igdqRlUHbQrggXaerYwHRtQ62HUWvvC9vSGo6fp7d7a5L9scrOdtYrv2lKCq7TI3z5tzriaiW0qq
IuFuwi8xQ+u9xefZiurucfii+fQ7iyBBzTyCum3bNnXBggXqgw8+uMvbTIyuvvLKK7qcLl26VB+7
esopp6iXXHKJ3o7Nmzfr2/33v/9NwkqCSuxJQcU4mIhPHF1XPvISq4X/0l5+xGXWXOdYxuHL3dQu
C+Gq3HPxwFla26i0tsZ4t50Zrd1ExtiVlrQT9bbKLouDYfI7xt0w+VLSe1G4QpKYEa5YK9/aKnOd
63T0tM7uDwDtXECyD9cjN4rCdn6+kGHE3DZVZbtvxz7CrsRt0YCUZWe094mB4UxSZCe5vanaseM9
jgIxoAzRLlCznFAIJt3Pk1PjENlwM0we+pDRv9rH4H1RyY65Fgs6XtPaKSkjtHu1CZGpgIMZ1fn+
fLsUHWqsK7EAin4c3QN7HDvOj67tO/R2YR/dyki0TX/gUuw2pqPvtHa782S5teshsCUqWneMvxK7
bQvr9TmY3M7Pjtb2Kyuhf8Z0bi/XeL0vx3MgzuldaZ9LbhUSzut8tNF4j89ttRvnqpJwrho0BkqP
0x+ofZF4tKUlq+vcdrhz1Awf/Hvq9129BvfE/SLT+0Am11ym6w7Y7SM634M+y421dh+vuEyRcv0O
dn1Pspf5OdMxDjGTY9BTfxvXYLpCSJm0ua/3EibNPLB9OW8zuY4H6rh1tatTUDE2Nehm7J33U9xv
nYn31Ezv4z32pcLY5pSxtwlC/oeuwMJA8s8XN4bFQw868rJAIOLoz7XQ3+uFIAaroCK1dtasWV2C
um7dupTR0w0bNqgnnXSSLowDvXz33Xf6+NWtW7eqTz/9tHrDDTeosVhMF1Z8RYVgiDHGv2L7B3A6
MAkqsWcEtSWqjKgtKLgqy8J+qv0OVk2csIUxC5uZ/NqbItFYXsSXu4Tnua0uf+SkeFPQO7GAuUt7
7ye542qvDiht2Ts/6IhDw7MqIsUc94yJYd7iBOH9nIOPuMatNBfiwadRdpfUSCUXFRYKT3lmNR4X
iwYPm1TA/N5m4T4c7QpclWqdiQ+AEUUq9leULfYUWf8k+uedHQ6HvBVO8x0Ca36XZws2l1QHT5Fj
siUaEIv17TiFZ0pqw4sjQe8Jos3yMjt6GlKrxvTS3lZ3cJmz6z3xQLZS6flJEcs/z5kKn62oCZ0a
rq+pr5Sb5jGuVj4aDVjT/VyTlW7VTKNBX1EFa1pvMzHbTAy3zcQWPSEr0crGWuePLLz5DZZhvmRY
7gvzxNBVjPZAtVKRhk8vZG7OYpnPzIL1/YLq+QvxABiqcVehAEohX/ykL9hU2dIcHzHD4bhyoI5j
VxRFcY+sLWBWZ/PMVsbE/Msk2N5nyudcysjtAn6+UB4/U2v3JoYRvmDZij/6grFiXVwjUn5dVcU5
RTz3F4y/EoTiv+eMq9P6Ne401qvt1yoba/rYZOa25lVHztBueqaY4i7U+qfdZmY+M7HcFrwe27SJ
z/R47uo5LXb2RV/bFwuKTq19ywqL+Kc89QuOxXk92cncaeXZfzJjDnnEFYpMaI5Hx9R6CpYLLPsO
yxa8KfoWHq8obWzyAzXH81tyK+dcuqAhOEe7Nu7kee3cLsh/0V0zKxxrbe2x0EtccRek7vdYkXEN
NYb6fw3uoftFt+svZTvSXpOLjjeuuUzWjZTWsN/nLSsqaWNZ82aTyfQPC1/whlgRiinxHQ/+mche
JueMdm1/7vA1nBWJBEr9lSXnpzsGxnmYvr+nrwpE4g7F33EfSFUIKZM2JxZT6v1eMv1mt7IsJ52g
9nbe6uJb4xrbw3Wc13Hc7AN23BIFFUKvKgx7zCRmRRZv3mJm2Y9MHP+ao7rhFER9+3If74l2jH8t
N//KwgnfM6Or1jsDjaKaIN/RQMDaEJBDkUgkp6/XQn+vF4IYjIIK6YQUfvLJJztFUJFiC2k0FkQw
Fy9erLa2tu70s92xIB0Y23zvvff0wkoQ1DPPPFMXVoyBveWWW9R33nlHbz8JKkHsBkFVVcYUsNuH
YKyO9ot8m33SUcutojuPsUtD29tlocGXG7fw3JfuidOvlMOLpyk+u6PuYPMai0X40lkzP5xYiTCu
/fKsryq7YPyseadLAQV/oc4O1Yjzs2y2z01jpj4gRyOHzJhsviZL0AupfF82OXBFMLy4JhoUc2dX
jPw/wWrbkrzObg+AMbd9xkRzq/bg9Jn2+R/GTKy8u3JW5GQlGCwI+j3eMgf3uMALn7tq6puOKBZW
Z3PmbWaOU/M8tTdGYtGJmtvGeYukiW2ktPOX/ZBU7c222baYxlS1a1I9ur1V5hqqixcPGzfzdw6x
xoUARzjglbxDhjxSUj0/Ho1Gh2o/PzP1zyPnMa2bhMR90B+sPE7R5+A28tyYz0qr586WW1s5TcCs
QZ9nahln+jtv5r4vqW2M6MdHe0JUvA7XtMKsdWU18imBaEtWU8g7KbEAijfY5MMD0EAdx+Q/CsQC
DufMg8232Xjuf/aJc1rsSny4EVHAA+5cn7jIYpv8F5dHOVz7gDkedBT48rPuGVriX+upCU3B+KtZ
1aWNWVlZnzF6v8YL9CqbPqs9WDHqYkEQvs31hS9AhEMfy+gTi7Xt3SEI3P9ytD6OxyKja/OZG4fw
PR/PgTyn9f3OpH2++fFly6K5gUnM1dkC2sd+5/EHmuXGeLX2vtx6Kec8i2D5ii3zr/XL9fOj0Uhe
wOeYVFZgfVIQyl/2BKLjE9u+sK50LsuxX5uLxb945jbODYj24aEa95RyJ/eYhee3Of0Ljk93rGKK
WNhTv0vR1ryVLeLQ2grm2mxL/67BPXG/MK4/SYk7UkdOGUv6a1K75tra2JUBKavnazs+pkNgtEvL
YtlkLT/qllxvcGzAkyse7uDWW7R9Kw00zu1rBLWnc0Yeb75dk/f/5FcfeUXtodZfDhFMX/Z2DFL3
tzga/R0NeaWeCiFl0ubkYkq93UuYNOdFb+dtcW2jsmxZJEe7jm9Kdx27aqJjN7bguLkH7LglCmpb
ZyQ3WCNNrSgpvr2yWg5bHY5RdkmxtQQYa7incyrpPt4bUVmaWsyb32LNvMqMcT/l8YeOV6ItQxJ/
DyRGZXu7FtyR5tEboz33TbrrhSAGq6AiCnndddep2vWgOhwOXVC1e6Lq8/n0KWQ2bdrU9d5//OMf
6nHHHdc1ZcyWLVt0wd0TC7aDtkJYP/jgAz2Ses4556jHH3+8PsUNiiyRoBLEAAtq14OKMVanOhLv
ehhtl7lwVceYstLqhhON9M1oXcmx2gPYV+YJ9bcwSltH2fw2ho3We47JnlB3K5PrmsQwyDJk8nzu
3IrJOcwLPC98XxJYeFxzVBp1hItZI/Ds12JNpKFrndr2tXX+K3GdKR+ORQYPTiezvOVrdsJRt9iV
lq70yYjsqnFywvvcmGnrg8Hg+JBkv4jjhW/Ystmr7fEXbJBNhhGz8ZCVUXvlqBKPBBx1xZa1hZUY
UtfZDny2rmKOKDctCMm+krqS1D8vrYv+iElTXKTRX3Kcjbd9nutriCttHameeDAMV9qXadv+Oscb
Ps9IAY1GAt7SUvn6YLDj4aynAii7ehzTnx/iwRMtlhcFx+F4SBzd9aAlMtnHVQxpLa2JnIUHQByj
hqqCeLa15A2xumFGVxs2ufiQlHOhRbB9lVOhXMC0thvHXUk1RqyhOudcnA/a60sVTTgwT2P95JHN
6Y7n7jin+9Q+iRkarBh5Cc/zX5T6IycY622S3a4yTniVz/dvdAdjXVGOeVU5Fwi85YvS2gVKYnSl
84F628jK0P/Z4zvaEQno5/YHnGPaBndk5+IqajvDZdLveDCOB5gRejGjflyDe/B+8YNY13i8mqLQ
UiwgjplZYrsn5TVZt7BRUQLZi4IVR/e07uKOKsN8gy/vHItg3V7sX3CCsa5FdSXaMeD/leOdd5Fx
zPuSLtvbOZNT1RCPRqS8mS7mtkyPQar+7q0QUiZt7uu9JB0ZnLfrRaV5tGRnhqa7jltjLr63cyLT
42aMg00Q1HNxLoX8vgmVYtWKYFA5ONNzqqf7ePo//KrmBv/4EzRJ3cRzrGpmuf/mHXzYKikQOiwQ
XdltXb1dC1pffeeum98QVXzHZk044td9vV4IYrAKKsZ0QlCtVqsup4mUl5erH330kf4+REtvvfVW
9Sc/+Yk+Rcynn36qf+0tzRZiiXGmAz33KdaHyCkKKqEqMKKqiKaSoBLEbhDU5LE6Oz1w+huP63qv
7Dm8ULC+w7pnrzEeojDuJuRhb+Itti+0m8ubGm8ZsCbmA5OZ/TCvOrJIO7G5iC/nnJ3WGfBUJ6+z
t4fjnKrwBYkFOZojUk6Ng90g8AXv+MJN1Y21BYsFnv9Se9/5yeP9MmjvB3n+BYviUcUxo0C438JP
eLWkTPaLYqBrvBIeKuOKOLq20PJgqp9jPFe6sUtR2XPQREF4xQLh6ExRxXQP9WXmm7W++d6UN22D
FGkZpbYyXGNt6RmldQtPZxLGvKYrgLKrxzH9A5fCzqvMXWoVbFtKahaEd6xDPrjCdujtstyoP/DF
g+4xNfnWdqHQvz65SmUs5PE6Wf49npv4qkeOHoTXFtSWHJuqvYjEGQJofH5+dd6Sjgf8nY/n7jin
O9ehZNq+SHXeTud1RDvOFZzlZcHhX+8ILss1+rLj89w20b/g+BSCqj9Qt6U4ty1CwQceubE6eV/j
ituRWb83ibosVeWcuyvX4J64XzhqGk5NVdhmmSLm9nTNZXgv+skmVRXm1Y4/nuedT7vlaKX+BxfJ
bpvrdf6IEyxfMZDETpnoi6D2fs5ElkCy+nIfTNXfPd0H+tLmvtxLMjgf0p637mC0quM6zl2c6jrG
/W/AjpvcbulqF4+xseGlYUWeNLV06s8CgbDU13OqL2NQd9wz28wR2VsxwcG0C5zpW87MqiYz/+/c
ziEvmf4uYszsu6J/3k+PmZy1mhOsW/p6vRDEYBVULEihdblc3eSU53n15z//eVcaL1J6Iac33nij
LqcQ1/fff19/vacFEc9f/vKX6ssvv7zb2o95WJcvX66eeOKJ6ttvv02CShB7WlATq3I2ypKvSLC+
zU6ov5XpLNCAv0D7Cy3rrGXyGsbhLkR6YScjNZASOtTlki2d6zy353Vm/HC8NPEXMsb+aIK3SuDZ
L8rqFpzQUFN8riaomGJgpznwMmmvZqCWTa0u/LU+ZuO5Lzgz99/cvEMedNfIPmPahY4Hz/Q/Twce
Surd/CqLpfBdt9w4Da8tbpRLKg8qaisqEDabhYJ3pVCTtzmqjJHHitfL4e7zE6Z7+Oz/cWzrtdBG
NOipKrYK/+APPvI39s73L5pbMXfI5PA1jBjP7niPNLVYsLzL5vvXS0qHkCW2eVoe+5CFdWqSFZ3a
KahKmvZ2RShRPAWR2YTXMprTcCD6ood1pGrfzusNuMdN5CyvQFDFTnFMbkMaQT0v1bltSTOFS2OG
/Q5J0KM7VR0yPQDX4O67X2jXX6pt93ZNauvOy+RehPcijVaSFJsiiSM8Hq8r5JfOHGvhXjOb+e+Z
8jm/7qeg9njO5FQ1nLNx40ZrpCp3ya6ch721K9M29+Ve0pd9Tj5viwML5+rRzyqI+c7Xcaa/QzI6
bp2COt+PsbGWzwqmTPulvyj7Po8vfHKqKGNv59SugEJQc/2uEws582sCa/qBYS0qM2bqA1Iknp/p
fkcCUrHfae3X9UIQg1lQMdYTc5IitdcQ1KKiIvWNN97oes9bb72lp/c+++yzupxCaiGokNWeoqOI
cl544YW67CKSursWiDKq/iKSisguCSpB7DVB9Rye/MCJB/HJSAE9ZM6tTA8PM5mts+8Px8a653lz
LuJ5/vMkQV2a/ICVaXv1h6xW2RKuFE9xcuY3LDz/Dc/x3+a6ptykPewX4S/r7bGef55+P0oUG2/d
klMZPq+lZaV1SbhS9sxqPKO+ynmxheU+FesaG5oaw1UlJXW/8vm6V3wcGEHNvM87pNpum+3mVwsW
57vuYFPVyqg45NiJWddKcxeFmLaOqIkmsdWFnOV91jF9J1FqjkijtDa3W7iCD9xyx3i5fgrq0oEX
1NR9MVgEVf+MN+dCgRe2laYQVK3fD8+k312yPsZQE1RE8wb2Gtwd94u+XJOjXZU3uiPLCqJ+z0Ha
uv+S6bobg56KwzziDYJ17FOSvz4WqhFPZ3nhX8yE2bftTkHtELX+n4f7gqAmnrfFgcZkQe12Hff1
nOjxuHUK6oJaRLP5LfnuCfeNtdreNpsmvOzyx9z9uc/34eHeFNNkEbUFdkRTVVMsIOXPcuetsHLM
N5qkfp/nDZ/Tpt03mwIusbf91iS2uC/nNEHsK4KKBeJpt9t1OTWZTPo0L4ZQIg349ttv11Np3333
XV1MkU6L7zEetKciRUjxfeihh/S5ThHp3J0LpquBaJ966qn9mqOVBJUgQd1ND5xIda1xcBssQvnf
XMHF45PX36biL95xG/5SPYCC2u0BpyNFjL/Jwjrf9tU3To/UFJyDFN9UQpNpexMfMKJBaYzsdZ1V
aDZtFjjhP6Yxh99npFOm/XlnUY/U++EuRZqv4KhZ5wsqpfMqSy8INS2ubAz5fE5BeNPmnvXbcMi3
IHtK+HJG3DEVwt4SVLAwIM618ZbPHF7lovlhecZYm3S/zx85eIcoSVOLWMsHbF71H32RHWNVu9qc
r4mSUPyOJqjejghHyXFc0rEcTIK6oFac14f27TZBRcT96DL+Zqul+G23vLNsZNrvrmDTlMEgqJle
fz2JQcprzlGzVg4GPR0pq+nXHcAUVagqW+uqdVqyX7WWzbrJ4QuXuGRZwDhQTrD0W1B7O2cOJEHt
ft4a0fvUgprJOZHxcUtI8eV44XOnT7lont/dYLMIW5lxgd/aoyuHZ3xO9XIf3+kPeQHReppcOU+7
l1ckT4G1uSVgDVXmLrFy/HZT/vQNvujKkS1Rx8ie9rujTb7iGgf/UE/ndG/XC0EMVkHFPKizZ8/W
BTUrK0uXSmNBmm5TU5M+R+mHH36oiynmJkU6Lb6HDPZULAkSu6fGiGKKGqQiL1u2rNf0YxJUggQ1
QxIfqoxxQRgr1zWvYbcxZZKvWLD+g00o5AE5nFPG3oS/Oo+cFGwWWzZ2m1Ii1uj3Vs467ZiWeDw7
3Jna1ts6e3sYyvGFz08cg9oec1mC4/jfWK3Ss/5g4/j5NXmLte2kFNRM2ls16zQFc/Ulzneqtils
RHI4Dx+DiJTzQ+2BbpqcMAVBip8fnj4iydjmTOBvEiz571bU+c48aNysawLB+KjWmNs+Pd9yr9Vy
8HvjDxm+oUJZVM8kzSXYJR28810p2OgbqOPYG3HFPbq6QHjAZnG/WTFl3M22Q4+72kjv1UVJlg6q
4PmXObbwI3ewqabbZyPiqOkOod1aNP1Be6BDoubXlqKAzhbtWF6wo72MCUVQ8BCbVz1/ifH5xHGf
mQjqQPTFgrrM25c4B2jiHyEmYQxqvr9d7CwulZjmjvcmCmpXm6sb4omvL4tKudPyhQ3oOzFpWp2+
9LsxDrajL/t/PuyJ+wWuv1TTe0BQ0l2TAut8t7p+XmDuJPZGjuW/SbXuJqy7/qxQJOgr8ucJ91u5
8tecNVH3jr7cWXT0KHSK6y1l3/RyzuRWLzgbohapyv1pxudhiv7u6T7Q28/6ey/p9Xzo4bzdce7l
pRTU3s6JPh03V0fVXWM8cF5V5KdtbfHsow5hbsiyWr7KqQhd0Kru2HZP51Rv9/Gd7pESY1tU5zqt
MhSby6RIJz5fkUrLOOHvlvzp7Q6lZSQKnPV8LQQOrQ02RmaXC2s4ltve1+uFIAa7oEIwb7vtNn3s
6WGHHdYt2vnll1+qM2bMUKdPn66+9NJLupSioi+AdEJAv/3227TrxucRQX3hhRf2iL2hPfPmzdPH
vu6nc6WSoBJ7PIKqIA0rxxc5Dw8YSFFS1TY27Ms5X3uI2lYaWNT1ELU4JFUVCNZ32QlzbmU27ZgY
PVpXOsfKM/9mWOH73MrpK0SfrxQT1rvEXE/NlPFX+cNNlZ1/QV+a6TrTtVUvhlF6xJ3aQ9ww43VF
ckyeaMt60VkVPhuFNOb77DtJRLeH+p7be2UgEvVGo9HcugrfmR5vyJX42YbKvGWCVXyjQp579KxK
/xlub2hc4s9PmDK62WIV33IHIj0+zDbWiXOtLPtVnqP4mbLgWUd3PsyaG6o1uTZb/mviy1/1ybGD
kj/XGgvaa0azGyxc/gdeJTZ1II9jT0BCIr68syxm/jszX/SeO9TUbf/0CHll7uIsi7CdGTfjdiba
1hWpCEnOQz22IS8W+8KLjTQ1RIycSE09ePYaV7sqdDyoSsPmevMuEnj+a3v5zMsYMThKl9nOKqjp
jufuOKf70r6Ir+O8FmsXHr9D6L1jJ3KWv/F5/oekaHNX6q323vOS32u02cLzXw331K+QN6mWHed2
8VFjbUNec2jntqt152OVcb93PjDv6vmwB+4XV/rD0apUD/jRSHBUqmsS15xgEd/whRp9i+rd9VaO
+Srttd0Ym9Kk+EorOO413jThDSm0TL9+W2WXEK4WG1nB8jVTfvQtYrwlW25t51qXpb7eUvZNL+fM
8LIjfyYFIo55HX21NaPzMKm/MZemvt64MiJdu9LdI/p7L8E2000/lMl5axzLjusk9XXc6z05w+Mm
aXKPNi/qrKiMPxbo/RWxjvI52HuyLM63S32RI7oET1Fy6jy+s1KdU7iPewKNUxWFYd0Oxs443HZU
w07Xn+0yI0RqSpZYCg9vt7rlcrmzYrnBvOqSmUXWoW8WeOct6apm3sN+T/OOv0JpbKqKBscf3dM5
ne56IYjBLqhYIJ4olvSzn/2s2xynL774oj6dSygUUu+77z71n//8p57Wi2lm8BlEUnuq6IvU21gs
pj7zzDN7zOAg0vX19er9999PgkoQuyyosqeqxGrdzI2bcZfoD02MBIOzw0HPFK/L9CDPc6p94pEt
TCAySgmIw2ZJBYt4TvgfM9r7VK4olxlTJLTF7bZZE8zX23jztxzLYizBdwzDfsNasj7hJ86+NtCy
0doUyBUPc5naM11nKvQ598zsdrOl5J0KObxAu5k6JYd1YnXJkHuyC8sf9ETiBy2WnWLtOOZuged+
sHvkK6yOYGHyOntrr6t9k9AcceTMKBl2z7CS6Xf45LAX26r1uKf7x464x+KZ0yrL/oMCxUPvTv75
9ING3Gsrr7/OLsWH9tTviHxNFPjXLMLE16RAU+mO4+H2lVgt7/Hjd45mYe5R2e2sOsTEvMObOdVZ
VXu2XepIAR6I49i7+LnHTbTwLwn61BHd00k7ok3u0Yc7TGuzs6xfjpl45MWM1VrkFZ1l/uKhv892
TrvTnTBfX6PsFSfzwgtWs3tzSVltXY0cEBtmeRunTCq4k+XZH1ghextbEFgdDPi8R4wz/Z7v4Xju
jnO6MdCH9h1sbtPON3Wk6F9llaJ5KI5SK5UcnW/it7Bm93uiVwlKimKL+p0H1bpMa4332gOxMRh6
o0eJQp4pTo7/u81S9F6xVz4d51Ogssx/aPbQP5eMly+1KzvmUuxPv2NOzsaa3HGHHbxr1+CeuF/Y
oyuzUm07FnSPSXVNGtecGN1o1YRd6P3adttrtP7KsvDfDi+budzhCxQtmjdr5qFFBXcIWntNrro/
hBsjvnDTMsnvcVWPNzFvG9ebpMSHp78+ejxnvmd565e2ovFPuVzc8zzP/i+j8zChv116f8uzm5vj
owJu8bDE+4DRLghb8j0iVZszvZfo25w1q1570LOn2ucMztts/dzz55bOGKef+ymv48zuyb0et7Xh
xvDhDfUNM2d6Rv+c4/nvTeO86+2e0HhFaWMX1IrBPDP/BWs+5C0cH4Zxj9HOqYJ055QF9/HAyqx4
xF08sZh/hC8uf1RSogelO/74Y1GkuuAcwZb1MeectK46GD7Wql2LWKe/wjPDM3b4Hy2F1b93JNwH
e93v1k1Cb+d0uuuFIPYFQYV0rly5Uv1//+//daXsQjoxz+j555+vnnzyyerGjRu7xpyiOBLmHzUi
qSielCqSimgsUoSfe+65PWpxmCsVacuQVRJUgtgFQV0ZFa1HHZK3nBWs7zHOSW1BRakJONmbLWbm
Q+1m9QnDWt8WJs+5QvGLp1k40+v6aybLRybTxPW+YKy46yF5WSAn6HWdUWBmXjcxpm0mtuDN0kp5
iS++cmRzVBoxvZBZZWWZj/qyzmQ6KjPyWwoqj7imXjroEs6kbcvM/qOobOo17uiyvJXRwPDO7eht
N5ks75lMk9alWme69krRjnS0qKKMlCV/kxIKzZg2sfBSzmx+w8Q5X3KW118SiLeMikeVEbJU+5NU
P/fFmkf31u8tEpN19CTb1TZNdhmppesBIxoQxxzhFFZLwcajk9N7m0LeiiLW9ATHMP/E/pl5YbOj
uuEU/PV8U8zFD8Rx7FGqRWbIsRXWX7lqI2czcuoJ7JdFpLzg+NwVRQL/N61f32I553OeqllnBpLG
RyIis6hGDDlN5lfMZv5ts7PiDiUckSK1ztMsxc5HxSr57FAoVFZbYF6dyfEc6HNaZRhTn9vHWt8V
Kua2zK+rnCNwJm3/cZy4f5q44if89XMDM4rZVVYz84H+Xs76PlMeajHGOqI/okpNuc9d+AtNXt5h
TKa3uKKijWWBuScGNPHq7dik63djXGqz4h6pXRs37+o1uNvvF9HuhZ66nX89XJOJ11wm646GpHET
HMw6luM+YJxFG6Rw9OhIwFc2gTE9xnPFL3nmLpzbFA4c5mRNj7NJ11u6tNeez+miP433SpeWOS0P
cX04BhjXiP7mBOv7pgLP3aFofEKTUjMZ7Uq8DxT4Igu1hwc2FvJOTHWPSG5zJvcSfZuFE9cGwtFy
NU2ErqfzVo51pknvOPd6vI4H4Li9KM2qjwbGWm+zmk3v6f1ptnzEmCY9IMuK6zjJfIlFb4P5M5NJ
0No66UF/MDJ5ljcQVULB2hTnlL7dprBUMrFYaBeKPOu9oUYxbURak/4mufJYv6JMVRRZmj6p6DKe
M72h3UreMnPFfykom/0zKcWY1kz2uz/XC0HsC4KKBQWREseTIkKK8aMrVqxQzzzzTD16mrhs27ZN
H48KQQUQ1sTP43tEV6PRqD5nafICAR7oOVKNBdWJkeZ7wgkn6PtBgkoQ/RRU/Rer9kCil6y3i8OQ
whSwM0O6plxhmBGMqAzBfHP69x2vaT+ThienO2H8jsgw2R3vEbOVts5xWNpvaEzU3p91do9QdIxB
zfOFl2rvG9JZan+kMU9oyu30sM507e28UZuMv/AHJHtWR2l/cQTjahUy+XkmxGTGkjjHqbFeTQSt
qdrcKsuc2NFfw4z9s0uKbaCPY9r2KoHRdWMPWhlMmvom1fkkdmxX6xOHnUlKdevqf+2hV3tfx3G0
S8PwcIx9ZCQpyzgWO+1Dhu0diL7oR/uGa+vNlrUHVWbHcdKwD0cxl6RzU39vcnETRMC01+x639nF
4cl/pOhvvyOKNRDX4J64X/Tw8JTxNZfJuhU709FGUVtHLKan1QYYRluvfahL+z9SO3u63vp4Ttta
21s5ra+yEteXSV8l9rexvnTt6u0e0Z97SSbpoz2dtynPvTTn2S4fN1m2dJ6PO/VnQNL7fmjnPo/E
6zifejunOtufpR3PLCZNqnNivxrfSx3tzMnkd0Mm+93X64Ug9hVBTVxQHOnSSy9Vf/rTn+rR0/Xr
13eTSXwPYcUUNEYUFRV+EUWFmEIQEW3Fz1AVGF+T5RRFjSDFu3MfLrroInXBggX61DgkqATRT0Hd
VzAKX2AePTrYe6H/66XpoihfFwhE86g/CIIgCIIEdaAWCOaGDRv0saeIfmIuU1T6TZRTVO/dtGlT
N0FFpBIRU/wM0VSMP33yySfVyspKfSxr4vrxs56KKw3Ugu1ccMEF6kknnaSPlyVBJUhQ9+Od6yx8
sc0ofEHsXhAVcXREAEa7HdZJ/uLhd1XUNc7tS1SPIAiCIAgS1J4WyOfjjz+uF0U69thj1R//+Mf6
+FJjQcQT/8dY1b///e/qm2++qaf5AggqQLTyk08+0edSveyyy9TCwkJdEhFVNaKnEN6epqcZaElF
JPXEE0/U20mCSpCg7neiJHNBh7VwZrm9BeXIUfjCIQXdmRb3IfrHaXW+WqfZ/A8zw/zHzGdvFQqm
tblTFEciCIIgCIIEtb9yevfdd6uSJKnV1dV6ai4ipIk/xzQuiIa+/PLLuqC+9tprXZKKCCUiqZgv
FVL4t7/9Ta+mu3z5cnXWrFnqAw88oEsrfrY7U3tTLZgX9eKLL1bD4bD6xhtvkKASJKj7E9Ggr2iS
ybTOYmLeNwpf9KW4D9E/mkK+KU4T83fWzG4dPf6In7uV5jHULwRBEARBgjpQC6aCQTquz+dTW1pa
1E8//XQngYWQojIu5PT111/XZQ8Sa6T4QmAxthTfI/r6ox/9SK/ge9VVV6nTpk3Tv+JzWBBBhaju
rkJJyQuithhXi3lSsR8kqAQJ6n4CClxIHQU2+lXch+h/v9s7Cr4MdcVaeeoTgiAIgiBBHagFFXmR
hot5UBEB/fLLL/VUXEQ8UewIoOgQZPQvf/mLHkFFhPTVV1/VZQ+iiggqoqmY4mX+/Pl6ijCKK0F8
wTXXXKMeeeSRqvZMoz7//PP6OFWkA+PrnpJU7MMVV1yhtwHtJ0ElSFAJgiAIgiAIYhAJKsaTIrJ5
9NFH60WRrr76av3/GD+KiCOk1WDZsmXqkiVL1HPOOUeNx+Pq0qVLdVBIqbm5WV20aJFaU1OjnnHG
Gepjjz2mvvDCC+oTTzyhPvXUU/pUM3/+85/VSCSijwdFcSUUVELEdU8JKhbIdmtrqzp37txuxZtI
UAkSVIIgCIIgCILYC4IKSYMYIhoKYaytrVVjsZh61llnqU1NTeqpp57axWmnnaaefvrpOngP5DMR
zJF69tln6+C9kNw777xTj7I+++yz6tNPP60LKqKor7zyivrwww+rdXV16j333LPXLA+R4V/96lfq
Mccco7ePBJUgQR2Ym5cpIDLDrIwjx+WKUconQRAEQRAECWrKBeM9MQYTEUuI4rXXXquLKMaIIuqJ
YkZIecU0MUY1XsxrijGl+AowzhRTy+B9WMfGjRt1yfzNb36j3nDDDXrU9ZJLLlEbGhr0wkiQUwgw
0nmNNF98j5Tg6667Tp09e7a+rj0ZPU1ckMJ8yy23qHPmzFEfeeSRPVZVmASV2G8FtUVhbPVudpVV
cL7pkRsP3587MtoStbrdVrs9EM2iE4sgCIIgCBLU3hcUIELFXEz5oq1PL3yE6CZYsWKF+sc//lEf
e4oxp8Z0Mois4v0YU4r0V6Tntre3q3fddZd6xx13qL/+9a/VlStX6vziF7/QpRRjSy+//HJ9/fja
2NioBoNBPcUXEVNIKsanIqUXKb9I9UVa8fnnn69L6tq1a/V27o0FU98g2ov2rlu3bq/JMgkqsV8I
6sooY50zgb1eE9RXNEGt6s86tBPcJMsxC6Kxg7ED44pkC8l+79TK0han0/qcsyZyhiumUrSYIAiC
IAgS1DTC9cUXX+jRznvvvVcfM4ooKaKlEEpENVEA6dtvv+2qooto5lFHHaWL5vXXX6+Pz8T3P//5
z/WCQviK8ajgyiuv1P8PMf3lL3+pgyjk7bffrt53333q73//e106Ib+QUsgooq7YDrYHCUYVYBRX
ggTfeOON+hQ0SC1OnG91Ty5oGyLBaAem2fnuu+9IUAkS1P4SFRkrw9iz+1tBN97kn+KVm44XAy3W
wdZ5qtpmjikVMw4qKrjTKbDv8hz3XV51w1K5XaX5VgmCIAiCIEFNWBCBhAjedttt+ljQBQsW6OND
V69erafRYh5QpLQmL0jhxfQvqLqLtF8IJ75CVG+++WY9Yvq73/1Ol12k9CJNF1PMIAUY0VesE0IH
IHpbtmzRx6GiOi+EE+NQEaE1FkQoIa6IrCLV15BYtBljWfdWJBXyvGHDBj2SipTlVH1FgkqQoO5m
moNWe3CS9UaXvPDMwdrGVtkl2O32oUqVcwHHC9tyq8LnkaASBEEQBEGC2iFVkESMnzzvvPP0yrg/
/elP1ba2Nj2dFlOq9BYNxDqQ2oroIdKAEXnFtC/GZw0glqC3cZqI3iJaizGr+B6pvBjXmvg5FGeC
5CKKCkHFgrRiFGva21O/PPnkk2ooFNILKKEPSFCJA15Q1fZ2LiDZhyOi2aYorNvOjNZuUoUMI+a2
qepOUdKWgJTlZhz2VEWSWgKi1cEw+drnndrn8+xKiw2vt7Ux5ohPHF1XPvISq4X/0l5+xGXWXOdY
RnTnadvLYzo+M9oudYz3bJVlzs0wY7TXtNUxucbroL1VFiTJPsKuxG1RrS127XOMGBjOqKopQTIt
O9rB5Bvt6AtRufQYXhC2kqASBEEQBEGC2hExRRotopUQU0Q+N2/erI8hRSSzL+mtiGRizlJEOyGn
iHgCSCYioYkYBZQAZDYRRGMx3hTTt2CsKdKIkcaLSGqioCLFGK8j4gvBxgIZhNii2u/eXpCCjP5A
OjMKS5GgEgekoOrSqEjF/oqyxZ4i659E/7yzw+GQt8JpvkNgze/yfMFmsTp4Smt7u9ApfULI7z7c
e3D+6iK++EmvHD0scX1xxV0gV0uLizj2ORNjekvgi17LPXjm1WIknr8yqgyvLSi4KsvCfsowJtXE
CVsYM/8GVzjhnvIC4V4ra/rYZOa25FVHztAuAFNMcRdWsKZ2m5n5zMR2vB7btImPBsTiGqnkokKn
8ExJbXhxJOg9QbRZXmZHT1vnDsbyOiTZPjQ8qyJSzHHPmBjmLU4Q3s85+IhWd3CZsy8d2RgoPY4E
lSAIgiCIA11QIZSvv/66HimdN2+enoILqcTY074uWBeircYY1VWrVukpwlgnQHpwX8BY1Jtuuklf
F1KGkSJspPomSjNkFDKN6Ckk1pBWyDbEdjAskHZFUXRJxZQ0JKjEASeozTG3fcZEc6smjZ+xLPvD
mImVd1fOipysBIMFQb/HW5bPPW7hhS+cNfPnoaBRU8g7qYRnn7Fx5m9Ys/NjKRjtquIbD4oFh+cP
XTts8pzrnZ7AWKuVGVVfmXe+Lcv2b/MhwVvtgZVZAbt9SMjrbNSkb5t90lHLraJ7NCNKwxXJmhOs
GHWxIAjf5vrCF0AGIc9Rn1g882BNlgXufznV8+PxWGR0bT5z4xDevM3McWqep/bGSCw6UXPsOG+R
/uSqiY7d2CJl1Ve5Lxg/a97pUkBBBDY7VCPOz7bZtpjGVLVLStxBgkoQBEEQBJGZoEKUjIqz5557
rj6O89NPP+0xytdTVVpEW4877jh9/Oebb76pp9kmTivTV/BZY9wp5kw95ZRT9PbhtcSxpZBVI0Jr
iDUEFWKLCOxgWSCpiAajANQgmoKGBJXYM4KqqvqcppDGk1ne8jU74ahb7ErLcOPnEdlV4+SED7i8
aRsQnUTabdCdWzo1l31Y4Arf9wQ7ppnZFGP4eZLzvCxbxQtOX7jc+PzisEucUGhp54um3+kINOsn
dVfabHUkntgW7XUllQw2VOecq4nrv7TXlyptbSzmYK2fPLKZ44Vv2LLZq+3xF2ztrTLHMGJ2a8zF
R+s9x2RPqLuVyXVNYhhkGzN5PnduxeQc5gWeF34Q6xqPVxNSgUlQCYIgCIIgUgsqihyhoq4sy+pv
f/vbrvRbjDXFWM9UC8aOQviQfotUWoAiRpgLFTKKdaD4EaaFOfLII/WKuonTyBjg9VQgWmqA/yMC
iwrAPp9Pl020DQu29c9//rNrPCxkD0IKSU2MoA6WFN/E5fHHH9fnSYV0k6ASB5SgGjR1SmNOVfgC
zVrNxuvNESmnxsFusAgFH3gCjdV4rS0uDa91sOssfOF77s55UBv97tJJFtuLwvg5q5noym6VeRWJ
sTF2KYthOqQwnfRpr+8kqGq7zDX4cuOGoBrvnV+dtwSvae09X0kYI4spcEIe9ibeYvtCu8m+qfGW
AWtiPjCZ2Q8dNQ2nZiqbJKgEQRAEQRyogopI56WXXqpHTh9++GFd7N566y19DCeilunGnCI6iWI/
GKOKir6YygVptIhuAry2dOlSPdI5adIkXVYhsfgcorXYbiJIzU0Hfg7ZhGheeOGFetow5BZyjPUh
DTkxiorILoolGYWI8LNYLKZXCh5Mc5Gi7ZieB/sDsSdBJQ44QU0QsW7TqbTHGEt9mXmVRWC/KvE3
HqdLq+LO8TvY9Z2C6sNrEdntK+Ytmx1V4QtdrT3PF9qDoB6XSlDDVbldEVQUQULUN+G1cxPXEQuI
Y/yFlnXWMnkN43AXajfanE5GagzXGOqSZUs/+oUElSAIgiCIA0JQf/jhB11QETFFhBPVehE1hZii
Ai4ktbdKsxBHFP3BFCqIBqKqLj6H9FWM93z00Uf16r2YSuakk07S5z81UnYxThSpv9gexr2i8i7A
OhIx5jRF2xChBUg/vuiii/RiQ6gSjGlbIK+JVYUhooZcI005Ho/r86gOlnlIEelF5BpjZRctWqRH
sI2ILwkqcSAKajcRgyDO8+ZcpMng1lL//LSC2qgJaqFgfYcvQwR1o3UPCurS7utwj5tssbwoHDLn
VmYAhJIElSAIgiCIA01Q4ZeolnvUUUfpc3NClCCKhhBC+DJdIIKIAEJSIaEosoRo6qmnnqrPmbp+
/Xo9JRfRVqQRI203sVCSUTgJoPhRIsZ7UEkYKb433HCDHglF1PSBBx5Q6+vr1aefflqXO0RmU43n
NKLE+OwgkMCuBYIKKUeq9DHHHKPLNgkqcaAKajfh60iZ5W+y8s733J0pvs0RcVSyoEaDnqoi1vI+
mzf1YV+sZXR/pG9BrTiPS2pDXwU1roijaxzcBotQ/jdXcPH45G23qW1mSYrbUPCJBJUgCIIgCKK7
oD7xxBMLNWnbftVVV+ljM40oJiKWECakx/YlTRUCunDhQp1rr71WTxVGdBQS+dhjj+nyBYmEpCLq
CcFMTvHNBER00VaMSYVUQ/BQ3RfpxBgri+hoKkFFG/G+Cy64YFBN7YL2os+RSg05nT17tj5Oti9T
+ZCgEvuFoOb4wucnjkFtj7kswXH8b2zWyS+4/Y2leG2ZIub689l2C+981xDUWNA7dhLH/J0z898W
e8MRNWnu1E0xFx+LdcyZmiiiieNHFwRKFU06t2htuMB4HTLa4Ms7BzKaVz1/ifHexHGpyUI9p4y9
ief4b0dOCjaLLRuzE9sRa/R7q2adprjkVkuG/aKkEneCIAiCIIj9UVA1CVr4ySefbEfa7R133NEl
pwCR1EzHaRriFwqF9PRZRF2RbpsoiVjXXXfdpY9FRXruH/7wBxViDHnF/1HgCHz88cf6VxQ9Svwe
lXoRnYU0Q0Ihb/geU7TgZ+Dkk0/W5RfbTSWoeO3Pf/6znkqbrujT3krzRbtffPFFXcAxpleSJF2+
sY97QVRJUIk9LqgKJ1i+YkqPuJNR2oYZryuSY/JEW9aLxd555zCtmzrmQo357DWj2Q0WLv8DrxKb
qouszFjmTDBfb+NMKsMWfFRWKTdYrdY87UY32i0yhfP83kY5GvNoJ7Z5QW3JsQIvbMvxRc7T/m+K
BgLWtrY2c6PsOdzJWd5nD569xtWuCh3CKQ2b6827SOD5r+3lMy9jxOAovD6/s7JvorQaROtK51h5
5t8MK3yfWzl9hejzlaIdLjHXUzNl/JX+cLSKybCK76KOysLbIM2pfq4oCut2MHbG4bbjezr5CIIg
CILYlwX1kUceWfjCCy9sR8rtk08+qUdNMa4TQA4zmfYE78E406OPPlp9/vnne5RaSCEKAeF9EFMU
BsI2kUqM8aqJQJYTv0/8Pz4Dgcb6UCQJcgcpjkajemS1pwXjXiGySGseTAv6A/0IIQV+v1+tra3V
I9tr167Vf74H05JJUIk9K6gL60rnsmZ2u9lS8k6FHF6g3aCcksM6sbpkyD3ZheXrPEr0ILwvJrss
sttZdYiJeYc3c6qzqvZsMRDVhTamSAeV57PtVo793mw2q9o6/ms2s/92FA55yTa2dg2mqdEFUnYf
VmK1bubGzbjL5Q9NjATl2fGVK4dFA56xk3nheavZvbmkrLauRg6IDbO8jVMmFdzJ8uwPrJC9jS0I
rA4GfN4jxpl+z/PcD3aPfIXVESyU5dau6GZb3G6bBVnmzd9yLKuaTKbvGIb9hrVkfcJPnH2tPboy
q7f+wH5q+++cWW5v4XleNY2bsj7XI3nsUnRo4vuawl5xYjH/CF9c/qjU2UcEQRAEQRD7IggYbNy4
ceGGDRu2YwoYSCPGnUJO//a3v+lRy0wEFeM9Ma7z8ssv16OmPS2IDqKoEYolQS4xThXbRRowJNUA
kpkKSCq+QlLxPkg00nyNaXB+/OMf66/3tKCSL8bEIpV2MFXyRcox+h5pvkhh1o6RPvb27rvv1sUb
Ug0Zx/4hpXk3z5lKgkrsWUGd7y89juP5LQWVR1xTLx10CWdiXjeZ2X8UlU29RopEHV1CFvJWFLGm
JziG+acmoJ+YeWGzo7rhFCMlV5PUMVMPybuGNTOfMYxpm8lcuDl/wlEtmpwWGOtYGRWtRx2St5wT
rO+bCieuDYSj5YikakZrWlQjhpwm8ytmM/+22VlxhxKOSJFa52mWYuejYpV8digUKqstMK+2ssyH
2L7JZHnPZJq0zheMFSfuT/OyQE7Q6zqjwKztB9rBFrxZWikv8UWX5WbSH537+bjWD+9jO4zZ/JGJ
419P3FddthXv2InFQrtQ5FnvDTWKdPIRBEEQBLEvCyqKJD366KPbUcDo2Wef7SaoqJabicBB+M48
80xd+HqTJqNIEeYyRZTwkksu0SO3qOSbKKiGpCbKarK4QmqR/gtpw+chqEjdxes9LZBojI+9+OKL
dbkeLAvagsgwBBWRUhSK+tnPfqaLK8B43nPOOUcvMIUpdh566CE9qoo+JUEl9nlBNcag5vnCSxVF
GdI5LctIRo51G6vZKsucyDAjtJ8Nw5QtGiPskmLr9p6Yi+/8mYY4xOVq3Wnamc73DGfs4rDEdFuI
qrb+ju3bJf1n2CYjSVlKW4cYBuz6z4cb22cYaXiq9Fq1TWG1dWV3tiPb+HwmYJsOhrF3rF/fDrY3
Mnlf29oYs2RnsvR5XrWbOp18BEEQBEHssw+QnUWSNPHb3tDQoP7xj3/UBQlyijGoiFJCInuTVETz
Fi9erI8p7U1QIYcQQ4ythFyhWNFf//pXPQJqSGiinKaS1lSCiiltMo2gYkHUFuNuB8mco/qC9qPf
ERXGmNP29na96BP6N1Hwsd+oQoxUaQDZRvVfHKsBlFUSVGKPC6pRDOhc6kCCIAiCIIgDU1BRJEkT
m+0/+clP1Ouvv16XO0RRjblIkVL74Ycf9phSimjfddddp88v2lPhIVSqxbqQXou5VjU51oskIfqZ
GEFNjJami6qiXakENZMIqiGDkDtI+W5Olc1oQRsQOcUfB4zKyYho47ik6lMUpULkGn24fPlyFSna
KD6F6XdQJRnijajrLqQwk6ASe1ZQeysGRBAEQRAEQez/gvrYY48t/M9//rN9zZo1aiQS6Zr71Iig
AkghBBLilE7m8PPjjjtOn6MUY1dRsAgCBblChV6sBxV8kaIKmULE74orrtAr6iJ6CqlMldKbKnpq
CCqkFIKKird9jaBC8DB2dcmSJfp4z8GS3ov9MtKOcQwgqNu2bevxs/gDAfoYKb+IThuyumLFCj3t
+p133tHXkW5uWBJUYq8KKlJZgw5r4Y5iQN71DinoTiw6RBAEQRAEQRwYgooxqMgcRcQNc5QiEorq
uBBOoygRhA8CCdHpqQgSUnUhiBCkc889V0/f/elPf6pHNTEvKuT0t7/9rfr444/rcnr77bfr41wN
OU2V4pssqr0JKraViaBiwX5CqiHlqVKR91TFXEgjKgu/9NJLehTVkEjsK/Yn0zRkfA5tRj9gDlWk
/iJajVRmpArj2D766KP6tiCsiLAiqk2CSuxVQY0GfUWTTKZ1lq5iQJaPTKaJ65OLDhEEQRAEQRAH
hqBqYqMPXEQErq6uTh/fCOGDwAGIKf6PSGdvYxyRCgxRxXhUzKuKCB6KLiGaijGnjz32mF74B9FU
yBimeoEMY/29FUhKjqTuqqAioogoY3Nzc7diSRA9rBf7uyfmH0XfQE4hyonjTbGPEP7+jpOFZENC
0b/33nuv3u8QVvyx4PTTT1dbWlr0OWsx9+pHH32kR8ixfXzu+++/J0El9oygoriQ1FEAKKEYUOqi
QwRBEARBEMT+L6iahG03xAySOmfOHF1iHnzwQT3CCZGErEEmEwUqk4geZAfiiFReCNJll12mj5vE
OiG/EEsIlBG1xdfkdN/kSGqioH766ad6qi4+g6igkeKLbfcQHexa8F5EjjH2M3HBeiHWuzuKCgFG
GzD/KSQxMQUXKb8Q7t5SfDNZMBYV+wJhRR9v2LBBn4MWKc5G1Bvg/xD+P/zhD1s3btxIgkrsfkEl
CIIgCIIgiFSCaiyQ0mXLlqnHHnusXkjo6quv1mUNQgiJwphNjOEERiosIqt4HQILoYLgISKIar1I
MT300EP1Ma5XXnmlXsgH859CkACKM2FeVEiskUpsFE3qTVAx3tWYGxTbxZhNyDTa9PLLL/dYtMkY
vwlxRvoxxs0aCz6HyKJRsGh3LWizMf9scvo0xummK5I0EGnF2B6OGSK4kGGkX2MMa1NTk3r88cdv
VRSFBJUgQSUIgiAIgiD2rqAi2gZJxRjSsWPHquFwWJ+rFBJ58803q3fffbe6fv16PcK6du1ata2t
Tb3tttv0n2GcI8adIgILuYWcIq0UUgoBwvuR9qttVx+Lirk977nnHj1qBznCvKj4P+QTopquUJIx
BjVZUBENhORCwFBkCCnFieKZasG+Qsbvv//+rqq3EDekKkOUd1eaL9qIfUS1XrQhMXqK71Fh+LTT
Tuu1/QMZzYWwd/6hYes333xDgkqQoBIEQRAEQRB7T1AheatXr1YxLyrSPSGQkEC8jtRQFN+ByKHA
0a233qr++te/1r+HrOJniLQi8giJRGVZpJRifCfkByDt1pBASBh+jrGpSPlFmivWBVFFESWk3SKt
ONUYVGOaGURqDUFNHoOKCC+ikxBhbCdd6ivGm6L92LaR0ovoIvYFUUxMjbM7JBX7DzHFfiePM0U/
4Q8CS5cu7VNa9QAuNAaVIEElCIIgCIIg9rygGkWSEC2MRqNI79QlFPKH6B3SXAFSQSFuRmqvAf4P
gevLnJtYF+QREdezzz5bF0tEXLF9RA4hZ5jfE6mnEOPkSKoRQU0U1MQxqMYCOca8oCBVgSdjDCi2
kVgoCa9jG5BHSCq2szvmS0WbIeLoj8QFbbn88sv1SryJ7SJBJUhQCYIgCIIgiP1WUB955BF9mhnI
3ty5c9XFixfrEUpENT/++GMdRFDxf0gqIpGdVV77XawHwodpT5D+a8zVCUmEBCJdGFO/QAyRNozU
YKOYUmIkNTHF96abbuoqkpSqii9SVlGYCam0qeY8xeewvcSxnpBRRE4h0dhub9WL+22BWp9i/cnj
T/GHAaRGI7Lb374mQSVIUAmCIAiCIIh9SlA1cVv40UcfbZ8/f7563nnn6TKIdFuMjcR8mZA0SCBS
UI0IKoSpP9FEfAYyWl9fr0cGsV6k1CYKGKKxa9as0UUTEV2kuGLuThQ+So6gGim+EFRIXjpBNSK2
SPVFGjJSjxNTdrF9FFRCtDbxdUgpxrHi/bsjvRepu2g3+iG5P3EcTjjhBF3C99JCgkqQoBIEQRAE
QRB7Dk1AzHfdddfCFStWbD/llFN06TMKE0EIjSlmIKfJItkfIcP6Q6GQnj4MEU23IHqIeTrvu+8+
ddWqVXqVXyOKmirFF4KaLsU3WVKR6osUYlTNRcQUYz2NNF/IKyLFieIKSUeUc6DTe9Gf6GuMf03V
rxh7izlKd1fklgSVIEElCIIgCIIgBp2gLl++fOHRRx+9vb29XZdSIzJpCCoEKpP5RHtbMI4ShY8w
fU2qNNvEBcJ4xx136NO/IOJ64YUX6tFUtMlI800UVEhsYgQV7U+3IAKMn6MqMcD4T6wHhZ2QBoyv
iam+kFqkOQ90mi3Wh/1MJ774+V5K7SVBJUhQCYIgCIIgiD1PW1ubecGCBQtPPfXU7Yb0vfbaazsJ
6kCIEkQPYyofeuihXqOREDdMYwMxxXQ0SPNF+yCpifOiJo5BNQS1pwhqYjQXoorIMCKV2GeIKSKo
kNaXXnqpK2oKOcd7kseIHgALCSpBgkoQBEEQBEHswQdIhjHPnTt34WWXXaYXSYKoJQoqxAwpvumm
aOnLgrRdRDcRpcwkuoi5VhFBRZEgzI2K9hgRVANDUPsSQU0lq9geBPSjjz7SRRWSiqJJ+D/2HeKe
PA0MCSpBkKASBEEQBEEQAyyoiqIsvPrqq7dD6hIFFWM+jSJJSKNFWu6uRFLxeURCEe3sbT2Q2Usv
vVS9+eab1RtuuEEXUIzXNCr5JgoqxozifZDITCOoPckqChdhXc8884xewRcpwIioInq7l1NuSVAJ
ElSCIAiCIAhi/xdU7XtdUFOl+EJQkeYLEcTYzP6mukL+Nm7cqB577LHqX//6Vz0yiUJJSKHFOvF/
CCa2i+llwuGweu+996rnnnuuLouJc6FCTtFWSGOyoKar4tuXBSnG2HdEUxFJhaBCVLF+ElSCIEEl
CIIgCIIgdgOagJg1oVvY2Ni4HVVt0wmqMc0MxmViLGl/iyZBRH/5y1+qmhTrabsohLR27VpdSC+7
7DL1rLPOUqPRqD72FK+3tLToEVekGqeaB9WYZmb16tUDKqiGUGN6GUwzg3lbIdXY3gE0FpUElSBB
JQiCIAiCIPasoF5++eULQ6HQ9j/84Q96lBISmCioGIcJQYWsQQAhqJgipb8LoqYQvtbWVn3eVURI
IasrV65U//znP+vRWmz3uuuuU6+++mpdTBOr9xoRVCPFF4I6UCm+qRakJiNSi3lSEUk9gAomkaAS
JKgEQRAEQRDEnhXUe++9Vx+DeuKJJ+pRQow7hRBCyhJTfBFBRYovBBVzc+7qeExEKLEerBPyi+gs
CjJBlJcvX67+5je/0dtgpPYmC6oxzUyqFN++FEnKZEHKL6aaQZQZoortot0DPTcqCSpBgkoQBEEQ
BEEcuA+QDGN+4oknFmpyuP3MM89UTz755K7qtZBFAEGFnEFQIYAoIoQ5TREJ7Y+gIT0Y64CUogjR
rbfeqs+NGo/H9Ugq/g9RRhsSq/YmymniPKiI7u6OFN9UQo3iTdgm0n6xPYg7+oEElSBIUAmCIAiC
IIgBENQ//elPCzUR2Q75Ovvss9VQKKTeeeedeiQV0UlgjD81BBWRT4gZIou9LYi0ogASPo/xrW1t
bbqQnnbaaToYc9rQ0KCn5l5wwQXqtddeqxdHwnuRTpuY0pssqMYY1FtuuWW3RlATF6Q3Q57RDrQR
UeZdSXkmQSVIUAmCIAiCIAgiQVA10dwOI8F4yzVr1uhFjH7yk5+o99xzjy6qEFJETfFzfMUYzJ7k
FO+HkCICinlMUeyoqalJ/dGPfqSPOb399tv1dFkI6CuvvKKuW7dOH4Pa3NysXnzxxfr8pyiU9Nhj
j+nbTxRTQ1YNQYVA//rXv97tEdTkaCpEHRFmbAtT4CD1GX0CId9PUn9JUAkSVIIgCIIgCGLvCSoW
Y7wlhBFRTYglChqhgBGihUaKL4CIQlohZxiTCVnEGE1EQU899VQ9ZRhRUuPziHbiM0gbvvHGG7ui
qJDWFStWqFqb1JNOOkkXWExJs2TJEvXpp5/uKt6UKKiJ86DuaUFNFFVEh7FfkFWk/KIN2EcSVIIE
lTqBIAiCIAiC2EVBTUzNhXRBHJ1Op1pcXKwuXLhQl0dEPJGGi2liMP7z5z//uZ6ee9FFF+njSK+8
8kr9PYiQQuASq97+/e9/V0844QQ9nfjxxx/XxdaIzAIIKSK4mIP0vvvu06XVqOQ72AQ1UVQxthb7
gVRpfN0PoqgkqAQJKkEQBEEQBLH3BRVy9be//U2XyAULFnRV1f3jH/+oPvPMM7pYap/T///EE0/o
PPvss3o6LuQMYzJTVfnFWNb58+erv/jFL3SRS7UggosxpUuXLtXXh0gs1m8IanIVX6wT74f47i1B
Te47SvElCBJUgiAIgiAIYgAEFXK1fv169cgjj9THgWLuT1TKRfoqIqpI84UUItrZlzGXeN/999+v
R2FRwbenBdtB8SQIKtpw1113dU03kzwPKtpy22236ZV1Me4VY2d3Z5GkA2ghQSVIUAmCIAiCIIi9
K6iPPPKIesQRR+hjRFH8x5gTFV8BUmozqd6bvEBor7rqKvXqq6/ulvKbaoHAYuwrto/xq7/73e90
QYV4QkzxFeA1jH9FdBevIyq7tyOoJKgEQYJKEARBEARB7IKgfv/997qgIjqKaWYghZBDSCCmUoHw
4Xv8HGMt+7NAUDFWFQWUepuWBSKMCCqmc7nmmmvUu+++W5dRQ5YROcX/0R68hvVizCrkGWJLgkqC
SpCgEgRBEARBEPuooGoish1pupBHTAVjSCnSZvG9EbFE6m2qsaWZLBBbzK8ai8X0SsA9LZgr9ac/
/akuqCi89NRTT+kyCinF2FOMd8UUOBBTjJGdM2eOevrpp6u/+tWv9BRivI8WElSCBJUgCIIgCILY
RwUV1XZRwAgFh5Aui3lKUXgoMYKKaCWKIPV3gTiiQi8q/GJ7huziK6KqSNFFdLSxsVEvwISpaVAd
GFKKOVFvuukmXaJvuOEGfQoaiCnGymI6myuuuEKdN2+eOnnyZH0aG1pIUAkSVIIgCIIgCGIfFVTM
5YnpXzZs2KDLKar44ivkEIJqpNYiqtnbGNJ0C6K0KJR09NFHqz/72c/0bSE6+tBDD+lijIJISO29
/PLL1b/+9a/q3Llz9UrCWlvVZcuW6RHY5557To+qRiKRrullMPUNIqm//OUv9c9ArGkhQSVIUAmC
IAiCIIh9VFBRATccDusCCcFDem9iBNUolISxqZDUxAhoXxZ85pVXXtEl9IwzztCnkYGEXnrppXq1
Xggo5j+dOXOmWl1drc+piqlttm/frk8jg+lnkCaMdhjFmv773/+q7e3teoEkpAb/9re/7bdE00KC
SpCgEgRBEARBEHtZUJFie9ppp+niiHReyCkiqMYYVAgqePfdd/XxoEijxRQvEFUIYqbTzRgLBBKF
k7BdiCfGt9577736NDEQTYxDRdEjvM9YL8adIlKKKW+SF7TjrLPO0j9/ySWX9FqIiRYSVIIElSAI
giAIghiEgqoJoF7FF5HL+vp6vQgRoqXJKb54DYKK+UkhqIikIjUY0VeMH8X4VAilMT9qJgs+h2li
Ghoa9LGnqNiL15JlFwJ63nnn6Wm9qdaN11asWKEec8wxeqrwroyVpYUElSBBJQiCIAiCIPaSoBrz
oEICzzzzTD0KiQgq0mhRMAkkCyrk9OOPP9YFFZFUSCoioZiXFHKI6Cgq96aaMxUSi88gIor0Xow7
/f3vf6+LaTqxxTovvvhi9frrr9/pPYjgYswsiiWdeOKJ+j48/PDD/ZqvlRYSVIIElSAIgiAIghgE
gooFkVFEM5Hu+/LLL3dN7wJBxVcIKtJx8T6k2n7yySfqli1bdDmFYGKsKAQUcpocBYW04nMYa4qx
pABiCtntLeKKdW3cuFEfJwtxNlKEIbq33nqr/vrq1av16r5IA8ZYVAg3LSSoBAkqQRAEQRAEsY8K
KhYIKMaBYtoWjAs1pBQgagopxfhQiOkXX3yhR00hg0bUFBFNfA9ZReQT0VWkCiOVF+NDUfjogQce
0AUYEdhMF6wL1XwxV+uaNWu65j1FBBbVgDEtDSKo5557rj5HKra/Ly7oP+xrX8b0kqASJKgEQRAE
QRDEfimoWCCd1113nT4lDFJmUbTo6aef1lNpMSYV6b6IqqKAElKAUZkX1XYxfymiopizFJJ4yimn
6FO/oIARhPLxxx/XKwS/9NJL+jr6KmEQYYguJBQpv5iqBjKMNh177LH6diGxa9eu1WV5X1ywj4hc
7+X2k6ASJKgEQRAEQRDE4BBULBAkzH161VVX6VFKjPEERtQS8onvAb7/8Y9/rE8bE4/H9Sjp/Pnz
1TFjxqjnnHOOLrcouoSoKeY4feGFF/T03P4sGFsKKUWkEQskGdHe008/XY/yYgwtBHhPL5DtgYh6
InoK+cc+kqASJKgEQRAEQRAECWpSyulXX32lyx8iqH/5y1/U559/Xv+K/0MQkfqLMaiI/iG1FlFS
VNS94YYb9PRe/B9i+uKLL3Z9HqnCu7JAVJ988km98jDGnSLlGGKHFGB8vycX7DP2B+Nykfa8K9FP
9DUiwnt5DC0JKkGCShAEQRAEQQw+Qe3rgvRgSCLGmyL9FxKLiCnEFEBS8X9UCkaxo/6kwEJEr732
WnXatGl6QSQUWsJyxx136IWS9qTcYX8h4YgOY18h42gfRDXT6XYSo7CQfcw/i/WSoBIkqARBEARB
EAQJaj8XCNkf/vAHfTwooqTJcmoIqhFFNVJZU6XG4jVESY2fIZKLKW4wPU0kElFlWVZvvvlmvYKw
EcXEuNQbb7yxX+LbkzSmS93F/qK6McbgQkwTgYAj6oyIaOJ+9LQgvRfRUwgqItIkqAQJKkEQBEEQ
BEGC2s8FgoUxpz/72c/0MafGeFNIqSGmiTz33HO6zCECiojht99+qwsroo+o8ItpaSB5kEAURELB
prq6Oj1qis8b41CNSCaKMbW3t/c5cpluwfqNdqSapxXthUxiH7C/AGIK8L0hqmg/IqPYL2MqHkir
Af6Pn6FwFN6PiCzElgSVIEElCIIgCIIgSFB3Id0VBZNuueUWPapoSKkhqIn/T0z3RTQVhY3wGaTK
4ntDcDFvKsT0yCOP1IswPfjggynHr0Igm5qa9IJMA7FAPlEkCu0BkE2IJtKHEQ2FrKIdiBIbcpoo
qRBXQ1QNWcVXpD1jvViXAf6P9wPIKd4DYSVBJUhQCYIgCIIgCBLUfi6I+qGK7vXXX68LmSGgidHT
ZGmFhBo/w3vxfwgrpqVB1eDZs2erixcvVu+//35d+DAHa6oFQodKwlhnJum5vUVO33nnnS5pxr5A
RCGqkEhEQxFZhUwaQpoYPU0UVONr8nuSI65G5BRyis9AXBMjxCSoBAkqQRAEQRAEQYLax6jjNddc
o4sipA5Cl4mgJkZYIYKPPvqoetppp+mFlvA9pA0yh/GZ6SrkIoK6aNEiXW4NOYVIIj0XabW9iSp+
jnVDdDE21oiaJkdH0T6DdHLak6QakdLEiKkB9hNVkbGf+D+qAiNii9TpgUpbJkElSFAJgiAIgiCI
A0JQsUCsjjrqKL2iLoQrMUKaSlIRpQSJ4gcxhLxB1iB1RrowXoNEQiYhbZA3Q9yQXozo7cMPP6z/
fOvWrV1jYLEOpONCoPF+I0UXIEqJz0JmsT0jUppc9MiQVSOampjamyoqmiilxv+N9F4IMDC+x9hT
4zV8n/h/gGjqHk75JUElSFAJgiAIgiCIfV9QIZBIzw0Gg+rGjRt1KYPUGSJqpM0aIpoIXkfhJIwj
hSTis5A7vBefg3Ai9RZRUWNuVYglFgjrueeeq65du1YvtIQoJH6O9eArgDwbn0dFYIifMU8r3oft
p6rIm05WE4XU+N6IimL7EF5IqAFkE6/h80899ZTePwBS/cc//lG977771Ntuu00H+4Gf4X3Yd2Nu
1P6kLJOgEiSoBEEQBEEQxAEpqIYsXnjhhbqk/u53v+uSUUNM8RXCCBFdt26dunr1aj2dNxaLqQsW
LFAbGhr0uVSvuOIK9ZFHHukWoUwUTkRhsT6k96ISrhGhhYQmRjKNbRufTZRlQ0yTI7jJAp0cHYU8
GxKaTKKUQlaxTUjorbfeqp533nlqY2OjPlXO/Pnz9f3FV4B9Rmrz6aefrhebws/wPnzFa5j79c9/
/rOe+ovxvrtRVklQCRJUgiAIgiAIYv8QVCwY94l5So855hg1Go2ql19+uV48qaWlRV2yZIn+GkQU
AobU3IsuukhdtWqVHklEOi+q955xxhnq3Llz1Xg8rkcU8bohqpBEY0woXnv33Xf16Woghcb0LoZY
Jo71NF5PFNJUMppYtAgimgxeNwoaGZFfjJdFMac1a9aora2t6gUXXKALJ+QT+4kxsuiH9evX6yKL
tGOAiK4xDQ3k3khfxs+wrccee0wXfUg8+g3rW7ZsmS7vW7Zs2R3jU0lQCRJUgiAIgiAIYv8RVCyY
4xPRTERIkX6L6WIQQbz66qvVO++8U4+gQiohZEjLNcaXYoF0QXIRfcS8qvPmzdPFDN9DXvFZQ06N
FN1nn31WfeCBB3QRRgQX24MMX3bZZerdd9+tj0c1pDOxOJHxWiqwfnwO4gxJxhQ6kM/ly5fr4gwB
XbhwoXrSSSfpEoroKIQb+3nVVVfpY3GffPJJPaUY+4lIb38in+hL9BHGy2JfsY/YFiKt99xzjz7m
dgAjqiSoBAkqQRAEQRAEsX8JauK4VMgVhBNfUZgIwpXpAqlDhBEidv755+uiesIJJ+jzniLy2tzc
rKcHQxABIq8///nP1V//+tf6eFiIJATyxBNP1D+PVNsNGzaojz/+uC66zzzzjPrEE0/oabgQXEQr
b7jhBj1KCQHFZwFScJFqe8455+ii/Mtf/lIXbcgr0oUh40YUFPuJdvdlP/uyoA+xrba2Nr1tkGK0
Y9u2bQMhqiSoBAkqQRAEQRAEsX8K6kAtiKpC/CBmiGqimBCio0gbRpQWkUrMTwoRhhxCjCFyxmeQ
KotxrUi1hchCWBO/QvQgv0ijxdyrl156qfrb3/62K9KLcZ+QT6wfFYEN0d5DhYvS9gn2DdKNlGkI
NUQVEdVdSP0lQSVIUAmCIAiCIAgS1L6mvUJEIYvp5kdNFY3F+E4UGkIKr1E8CWNJMY4VYzrxc0NC
d1cEdHf0xWeffabedNNNunBDVFEV+PPPP9f3mQSVIEElCIIgCIIgSFBp2aMLRB3R09tvv10fo4q0
ZESX33vvPT36S4JKkKASBEEQBEEQJKi07PGIKgoqoWIwikUhhXnFihXq888/r6cE9xJxJkElSFAJ
giAIgiAIElRaBnbB+FhETlENGWNqMcYWBaVQXOmDDz7Q05lJUAkSVIIgCIIgCGIwCOqPNUH9/gBz
tgN6+fLLL9V7771XLwKFYlGY8gfzyyYtyAXOoeuEIEElCIIgCIIg9pigPvLIIw2aoL6rycgnxIGD
dsw/+frrrz959dVXP7niiis+qa+v/+TZZ59NfM8bGiPoOiFIUAmCIAiCIIg9xqZNm/itW7cO1WSE
OEBZuXLlUIZhhm7cuDHx9SEaJrpGCBJUgiAIgiAIgiAIggSVIAiCIAiCIAiCIEhQCYIgCIIgCIIg
CBJUgiAIgiAIgiAIgiBBJQiCIAiCIAiCIEhQCYIgCIIgCIIgCIIElSAIgiAIgiAIgiBBJQiCIAiC
IAiCIAgSVIIgCIIgCIIgCIIElSAIgiAIgiAIgiBIUAmCIAiCIAiCIAgSVIIgCIIgCIIgCIIgQSUI
giAIgiAIgiBIUAmCIAiCIAiCIAiCBJUgCIIgCIIgCIIgQSUIgiAIgiAIgiAIElSCIAiCIAiCIAiC
BJUgCIIgCIIgCIIgSFAJgiAIgiAIgiAIggSVIAiCIAiCIAiCIEElCIIgCIIgCIIgCBJUgiAIgiAI
giAIggSVIAiCIAiCIAiCIEhQCYIgCIIgCIIgCBJUgiAIgiAIgiAIgiBBJQiCIAiCIAiCIAY7/x+W
7nw0wjor6wAAAABJRU5ErkJggk==

------=_NextPart_01D75918.E6EFEE90
Content-Location: file:///C:/8467A08E/Stalevo_clean_files/image009.emz
Content-Transfer-Encoding: base64
Content-Type: image/x-emz
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------=_NextPart_01D75918.E6EFEE90
Content-Location: file:///C:/8467A08E/Stalevo_clean_files/image010.png
Content-Transfer-Encoding: base64
Content-Type: image/png
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------=_NextPart_01D75918.E6EFEE90
Content-Location: file:///C:/8467A08E/Stalevo_clean_files/image011.emz
Content-Transfer-Encoding: base64
Content-Type: image/x-emz
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------=_NextPart_01D75918.E6EFEE90
Content-Location: file:///C:/8467A08E/Stalevo_clean_files/image012.png
Content-Transfer-Encoding: base64
Content-Type: image/png
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=

------=_NextPart_01D75918.E6EFEE90
Content-Location: file:///C:/8467A08E/Stalevo_clean_files/image013.emz
Content-Transfer-Encoding: base64
Content-Type: image/x-emz

H4sIAAAAAAAEC9x5BzzWXfv4bWXvbAmRvWVvGWVmjyKZmXfIHlmJCj2yb1tmRrIlQklWJYTscSez
jJT1P1/cPer39D7v7/N//u/n/fwPl2ue61zf6zrnfM/5QoPBYI4AoIYBgJwQBvuOvs/u/wmQg8Ey
CGAwRiUNZRgMDWb0BA3WAzSYf5rsUwvkMNhLGhjsPeCo0H5WXlTDgNkpYsKAAxg3AEYAwB0Xmhwa
jB7QJADQSZqGAYIZgbEhgGwvAtAGANkyy2HCQBj7jUEO9wfNAnyg5Pxy6Pu+DmK7Icskh/1DhykH
+0FTAi9QH2oAOgDgIF4oZBIAR9uTwzygoaMz68K8YW4wd5g1zOmoyf+KlmM5f2YPDNRPPW22FwiD
QTw0BEp++f44JqSvIXc5JQzkKIwaBGWHwig5yu4Wr+6+fxT+CAoK+XOo0V2BbLPQcPZT437YEY70
OQ7pbezm9p80/3D8jEN8aAarKaIlQdFHcYxrNhnUvyMDY2n/eY4fxM1xGL/cIQ97AcOy8oDhQH1Z
AUC5B91+0EQw2A32I3I8QJMAQDVcQJAAkCKGwbZApDqA/k/VLIb355pBPJQslPxHzfAOa3aIgcl+
Q9mhMEpec2iXwdONDuUwBv+g/681S0cj3a9Z+mHHf7xmh+NyHMYjd8j/b2v2n6wJTPDnmkA8VBOU
HFUTMZyDnKIwKvcoux/4UHHEbm9fJHeggGoCrUfUOko7rEnZgRr2T9ek6TDuAuyD+FH8f3NNtE//
XBOIh2qCkqNq4oV+8EwofJjCH3Yoe5T8VzuUHKoJ1H6tybMD8T9eExjGQdxzaAcYxf831wT1nvi7
9w0qxyh8mMIf7yWUH5QcZXfHN+y1ZA4MNuTwyRza//f3LoD/rAnZ/t717r+8JkwgPujl9J/cw+Qk
fl4vEA+tF5T879YLyg6FD1MMQ9VmRbFYGHqvPFLRXfnr2nDu12bmsOM/vYeh1sf/7XphAPFB5zRU
8wWFigaJOlqrnL29g/360CgGPDfUwJmPTA92FZzYrMHZjRGmCbAnwDowFyCzgDkfmP3tX8a/tQDn
17+wyTQ9yP1fqH4rOmUBzjaH57IT+xX605RkJWG/pn9KUNTI/hkCxR1ijJOHhPqc8/55kviQ//Xc
xn+o/zZ7YIfiYfVrZP/q3Aal+eh5DlUTKBf/oibM8jBXUBWLH/eOw7D+OYQxCoX2o0E5/V07x/Bi
f++C9L90+6lLxmFuxof7zSFFjM2z/bN60U9WfzIoe63Ojn3/Qn+q/pL6tSbww/EKZg5qguJhL/9n
TaB8o+rwK00GdL+et3+tG6ovJIfW2uF9Cl0P0BDwAIBetwYA7AFAdrfCw+XeKIXLQTr9Q5k6wEen
LGqtagM5IwBOAEf9MwEeLGcYCv9urTMDGygmsMz3jtJH4/4dffT5j44NPRe4yu4/myOgrUEgvQAD
0U/P9hTw0gB+92wvgU4P7CeMAOBgf3EGlDvMDlCMsCtA5g5+HPc5G8C5HtHagDXgun+nhHoc7FIS
f+nHEnhwAZbXgb01uEEz7u9dVgDDYGIAeAEcP8QQzQEAqgskoz2kIRnKBtJBcnBd38fshzpov4B0
ECYHANmg/EE8JIf6QJjlkIZ8ovyoABoaB+JRY6H6/y4eaGzUOKcADdlD/iE/0D0d8gPZQHLIBxUA
agDQfAANnQn8wQGAwgyAhvSohpqDR+fNUfpfzY8KtIMx+4EzKzCINODB70/zgx0IpIDsd/OjFegO
5gM0M+D7FXTbfxt5gppDGkbwZcFlv7YHM+c6eDddAVKXn+aSG6g8tGMyAkvn/fkC0ZAHaJ5B88IC
5gD88gJeF3DQ/EPlFcollD+ohqj6QjIo3yyHcgWAIXtUH5Qt1A8CqCZQrlB6yI8qAEgHyVF2UD+U
DTQGxEPjQDQEkO6ob5pDGSRH+T9qg5oLUF9oTCheaA5APgQBoPxCcwWq+39iXtwC40CxyKLBYDcB
5AIAvz/Ni3tAgAdkv5sXl4EODupnCSp4sK4ZYQIgi1AeoednP8So3EM89NwQ/+uz6gEZBOFgTCim
MgC/xgTpoJjA729j0gY6RgCcAP5f5fJ3+/RR+dGxUc8G5bsABG8CMAn6/8z31r/5bFD+jvpnAjwO
ABRmONQDtN/+bv9gBlbQnIPeTToAw0EcGACTADja/ulviahvF6i7HcSDtPxj30CgPEBtXe3te9T9
QRjwf97taDEhPer8gzqzevxD3xJR3zz+nW8gUL5R84foyLdESP6frAnqGx+qJhAP1QQl/7s7HcoO
hUHX/Ya608Ws0pFAdzoYbH7/vP/rd6l0NL79mjw56PbjHvFP1eR/c6f7b6lJ2S/fCiEeqglK/nc1
Qdmh8GFqf9yz/+4bSDqa1H5Nev7La4La//5/Wi/8mv/6GwhqvYz/l9cG9U6C3kVQYyA++AaC2vOg
LeF3NBnQQe8nyOboe08P8F4A2PFhMFGAuYFRGsCQHepuB+kiAI8NQB0ANJF/jeEikGn/dI6BwYSA
DDrDQGczGgC8AFDnuF9jgOLgAWNDMSj8RQyQDooBiksdwF/FoA3kjLCnZ353LlI89O/yF/4h3b/j
XwCMAZ1B/ip++KH/pL/wD+n+Hf+MwPev567f1e53tT4qZwL+cAD8bu4oAx07AHoAKmfPKUJ74iM8
2P7/dpEg5hhIABpkN64Eg70DAP0fllPu4AwO5QG8amWhPwfwJ40jB8NSBfZSAKD/60K1+7VBsght
TRVCPFowKozwnOpZHVDlbgBOONDLo7bMpxkgNDcdFQVYSTf9HGAwbeU15EGc0fjbFljQOUtbXQ+M
AUNDA/+iRcfAwMDExMTCwjp27Bg2NjYODg4uLi4eHh4+Pj4BAQEhISERERExMTEJCQkpKSkZGRk5
Ofnx48cpKCgoKSmpqKioqalpaGhoaWnp6Ojo6elPnDjBwMBw8uRJRkZGJiYmZmbmU6dOsbCwsLKy
nj59mo2NjZ2dnYODg5OTk4uLi5ubm4eHh5eXl4+Pj5+fX0BAQFBQUEhISFhY+MyZMyIiIqKiomJi
YuLi4hISEpKSklJSUtLS0jIyMrKysnJycvLy8goKCoqKimfPnlVSUlJWVlZRUVFVVT137tz58+fV
1NTU1dU1NDQ0NTW1tLS0tbUvXLigo6Ojq6urp6enr69vYGBgaGhoZGRkbGxsYmJiamp68eLFS5cu
mZmZmZubX7582cLC4sqVK5aWllZWVtbW1jY2Nra2tnZ2dlevXrW3t3dwcHB0dHRycnJ2dnZxcYHD
4deuXXN1dXVzc3N3d79+/bqHh4enp6eXl5e3t7ePj4+vr6+fn5+/v39AQEBgYOCNGzeCgoKCg4ND
QkJCQ0PDwsJu3rwZHh5+69atiIiIyMjI27dv37lz5+7du1FRUdHR0TExMffu3fvjjz9iY2Pv378f
FxcXHx+fkJCQmJiYlJSUnJyckpKCQCBSU1PT0tLS09MzMjIyMzOzsrKys7NzcnIePHiQm5ubl5eX
n59fUFBQWFhYVFT08OHD4uLikpKS0tLSsrKyR48elZeXP378uKKiorKysqqqqrq6uqampra2tq6u
rr6+/smTJw0NDU+fPm1sbGxqanr27Flzc3NLS0tra+vz589fvHjR1tb28uXL9vb2V69edXR0dHZ2
dnV1dXd39/T0vH79+s2bN2/fvu3t7X337l1fX19/f//AwMD79+8HBweHhoaGh4c/fPgwMjIyOjo6
NjY2Pj4+MTExOTk5NTU1PT09MzMzOzuLRCI/fvw4Nzf36dOn+fn5hYWFxcXFpaWl5eXllZWVz58/
f/nyZXV1dW1tbX19fWNj4+vXr5ubm9++ffv+/fvW1tb29vbOzs7u7i64dUyWXfIHawAXrmrsBvba
UxCgeT2Q9QBCanclI3ddFxt3TwtXa5i8qzvc1YVRjFfkioAIo1DL++XTMJh82Lmz8npeZouXbgdN
ihGkUtoF/cXvxmislalHgKaqIL+KzbIH5Zdr2w8buXe2TdfEdkItqz+6PRUdoNk09mB+CueVbJwZ
aYSXSI7hyzpZiEWb29Tz3/i2SHVztcPRUGmVS3IgdelB+saD7ge2Xn1bfARIQ4+SyNmEwRLJETXZ
RbVUtZ6Vwq/m1N24yYtTHtKpUXmr6xtG10/vtraM4ncj18vuxn/q6fEIrJNJC7ySZugT4Rm86j1E
HZ+isUmYyND9lS8nrsPCQqzNrsqQbNbG88kHhmjkVEA9/dcgPVFz1fmVi9TdpOWr6PzVyItmMicH
ekdxrvvW+IXNkeTjtxhrpdpmeNufWFz1IIpZ0qzmG1sMcbcQKypYxRMuHcHwH8WIc356digEmdLk
jZ1cjab5pYZBI36p5ytTyarszq7G+IedbYQDSQ320/qd8pGqbybU3ecHI3qjzth9QaiUaQR9NBTl
tAE5mbdCEkosUlMgvSU5hkcWGs8mo9XxI/TffQvlEGQRo6vwlQ2S58oxF1VEpIZNPMzSRLxzziJY
GdtircGs3uowFJ90bEBDvLavrgx+LLWMO/Ly3cjixPewNcLxD1qXKxn6rWJ3F6IG9qo9KvgRFOXk
Pq8DOK+9mE+rntJMDUrZq0TaWYhxWSEnkLYMp3FFW/bMJEGcFp9Cp/1SxU7Fyfzh4b4t67NAddMt
UUIekX33fsCon+xJbpzVvan6RkKkpcEkgVhLD8nZuYlA6+ZtEQTjWJrcKy5OnS/vl3dlT3c2w4na
u5GUSw1Iauwx9tDstl1bbM5LCwLZLyo+tuO3iLNIks5KoXVj3VVK5o8PqhhJ3/NZ87UQC88n5w2V
fH0xSiaM0q450WOtLXsMWMul6oVids308p2sTrxesVd/unO5GbeCby+mqpq9XqM5ksEs823XNYae
51mu8FddVCG661F/DFIOvVyyVeSfsX31ke1iSKejvLvnzu3kNzpws2qp4NbJ7XbsYe4wzKWhbBK2
l24Wn5O+LfRk0TvxBRK/fjDulyPsUa2WyS8oX2/4SmMnSc4+lq8WP8KZStCbjXh+Bj8huPeRMbGt
QdQxY5x6NqHRgQs3v9T6vCSKPGexmsDmX0vHfYxNlydFpd1Bq1WwbHhmtHy9W6twZEs/qXnSpYYa
sRf8eUlgxCpWZdkX5ubkzEXuixG0tHs8reNZuzTbzLWXwmQTlUQ9zwecp9CIH9aOmEis05ZW0yN6
KMWEHIi9QgbIeiScfdPFY17M+TfzrCesXCTqprRmL+1ge9J/67FCdRj2VVylNZeJWkaEhvVHnZUh
aRyh17MZK62LgmbS5Mtk37eFvrjJi9G9en06VodMnZSfPLeBZHFCIRm3ZUEkELeHdYI7LtOPLnKu
Mk1iKwKz2jR4eNdX4aRJ8FKCkY/i14tkms4GKyq5r16HZ1RwTBcIVlBp4fRY2+wQT9SyIMIE73Mp
BA0cmzDOJFjMte34WvoJm2xu72ag3QUxN2t23VCc9b7W3PZueWucrUWqMv1bwtKd+ltq4YkjLoGN
7Igkwfu+obtOYQPKMkVVto0nGdASH8zSV5sp85feWS6H+1izJ/jeuUuDIOoNmMC9Jml587rMm1Y3
prfm5G+sJ9YsyqV2e0I7cfIGuUIsyndqLjVkz5Ii/Ggk7d6xm0l7G4vRDeJcq9F2WEqTCIkaLhq+
8ipBDe8ZOl0l1nZfkvn097AJ9VfaJTjXtPLCe+/EoZli0Qs0dj3URVf0EjCTmZfzda7iR1yg4aSm
UaLQzyR7u5uDaZSmNkQOZ9Oj+mCEn36vx5i2O4OAYpUFN4WqzSmWLxOJxRiZgHBJTlcr6D5lkeTz
/S38WI925pngR7jelO/EcwicEqzDjxPe3iTNyxL6XvdgQtg6384YK4Z4bbCqfDjN04i6OxCu71/l
Uy+GKCSgoCW4Tqs+MlPwrj3fFj4yOeAs5SmLXy0YsrT95tPiJDxSUM8rVLWceNxP5xOLX/vYQN7I
Urx1FXVbeFF1R8s563y9yx/Vw5PxGkleC+sKnSZcr/m+oaaLlC15ylqJfPMW/gFr34p/95mD1t6m
LP9wxfzb54/qNxcnOw0aPuPTVk+9pvHf+AIPfhyPTvxkQ7NyauFWL3XJC9n6zh6K8W0Vi0bE8lVh
uSleI7Ru36udQTAYv7qWXZWnyi35AI+Jb61mixTbIukPiYphyEbFZ5IC5pdtJyvX7RROfPH2v2sd
celcR5GCH2diW97ptlI02wkD7LvyvVhakrv1SLTucVZ7Nq0mXLfr9KtJHh5Oj6avepp/KTwzzv2i
p4KMKWi4kf5jPr4xw/WAE1cyV5qL0dkqq3vWiIqJ2SJW5bHKJ0hxAoZjqNOftZ/IWJQZxvL4rjA/
6pcjUSGD+NDB2DoojP2Hmtl7J1w2GvfbGontY0liNCGD6YmIMglEBn8cQsMzVVTq+WJCGZOTTHpx
u4K/5rO58Su1/sz+JURss7jy7FZpomG6yoikxQK7t6uvWebCCmVJe3qyeyonQhkwyzH5HD4Jz0Z7
zvmfTzue/AUZcZtO6AlmUVxbAEsaVwuuNM6tG30iU9oycyI5zxXXNS7LzHmzX/VBk2aH2918L3tX
xvAmufrGWnSiiBHPSLX1pFNhSgZm5Pz5LLNbfQGc/iX4bIncRjzB2oQGXIgqVjd2ymZtDZygyotj
l6y0krJ7umwH04uacemw1CkVCjL70NvPptLcM4mjlZhhPcVarUcpQiQbNVaCm2eTXD3Dhm8xuzan
W1AZdVwdwfO+OK8NizVPh/3zNsv3i6SaG+5PcJKxNDLjSmJs5NMf2QV/rCQ2825dq9PenLSLJNo9
t+0hLRYxm9Sry+up2NvU6TolnfUhzLshRKr3itGLkJgtBpNjUiPijzbjip61X63FWeW8H5hBw5LH
1kPdRvSJB3N5IqCF8MpLN0LhMBnZ8LESTGSsfadSubCaLhGCEptU/5ux4yVcii1VRMLwYlqwYQ/r
3eMqKnUkslNG2JrxlkN4eY5i3XrOYOt5z1nSSnf6emDjiPP0oBEpSd7XsL4hHMbYARnMHv1xFuud
helAQpxQEQqd3jDXLwSTsSXYGd71ISPOZQkxAw+VBNJDkJzwZqqctkePxpZpYhYw9fDtJyljEMFs
+G0Xw5RKsZCyk99I6w37b8RuX/BpqOxqzO6+WUn2LhP7tqkzljoD42qXMfWavVehye5uGy086+xm
scOSfGqOVpsLXR2JXSznO4pWjsCl1lXsRYlrs/YzdSAuivFQ0Ty2FpXMO5+0e9NX/P5o2EXE9eHV
N5yL8H6HbLuOefxawnPccN7ir1rR5mjdu9K996SyBe9LTqbrUPq4Mel/UVmpEGnHvnArn7JYLt+Q
YGrx80U0zZUCmeq8RI5XcLolTO3ZpIYYz4R6OY5bZDoI9ejQcZroMI77a7XTzhPiNxvREYu4pldX
7NPvj2Iol7kMbYRe1M+s2OMopOr3cPXi7YYve42nTNVyI75OTcAzpiUXHlsio3acqytlTbdzG+cz
aQW+b+FqxMsSn6vGcEJvO5ODbAxsXS3bLPQOO08Vthp6i/LZhda1FXgYcXnjqRqPZ7g3sNjxz9Zu
jT9KW7/q9VRwRM28ngURnd7ifXPKnXKI4HhyQGOvg5dZzyYmZaeLN3KHS63Ze0scTWPb89POI75v
CWmJvPc6tKarbuaR2W+OnRhNjvv61A2ruOy2EycFHy5yx9az+ZpUmk/gQke/W9ST7Rhyts/3pzwC
GbUflz9WTpZ8Urx9kaB7y5g2xkkkBvE9O3ByecJw69Veb2rNCH3PKPUF7rCz3k3UF+vfvTSdqsVB
LLCUmHCIdt4ezv0W/spu+0Ng6tUCFXc3bRjWM7nEjTc7aPNucRrWUVsCMhWX9K8MPB79NuFnFl2x
/bzoFeHquiWHDu/J6vmZ0PJqlU2S7QkmCie7RSOWFkmXSGQnXIZ36MSqra9VoLoeGw02W8hbQ3bZ
LSc7586UmQWRlg35sc1PtR5Nq9KiLF24tgsYJxUt4Dh9TRFy1Byfy8ac0COHRya86uQGvUej318f
848ZMZC2Yk6wayTgfG86KU6F6KmP6EjfGXwwtN4lvKronNB7rVF39qEPuVzopT/02tpO6Hp+fjrY
qYWvwtfCtVVpPZjirJqM1c3OOxHTMVt5VwKrVUiewF8cNpkJuyf8GbM92WfhVuxXqhl2hmghRV4H
oQ9V3FXGNE05KQ1EyCkf/j6VVmsPlsFzJKXIqWdBqgE+T0eXlNC8BM2yUpPLFpY/RFvJOzcEKmcS
R9iWamS4JDHuMSO+3q7yCW/JcFqmx98ce2Kz+ngwOL3qBjW1C8vgooEqZTKPl2j7BTRC/BdKKt/E
r1rrnsplK/62cXtUwGKVQizze37nsPi1OcIKy5yynMFp3Wx2HWzBzxx2t/Fy2Ews8m/YXJmJ76LR
fno+bbxuWCAC+UrNzu6MZtiqt9C86+NG93ymoVwL4q7ce28tkx2nn7wOCv0ssjpEoTnytanGzid9
5cJLtXtm/fPdS1usmxrBqzTPZzKZeHv93KbGnoeXxphe/iJkV844RH5hYSPIJLW0ydR/HT8BwdXO
Kvol8npLh7DPgP8kzDsqXCiyY3Gufz7SBj1dbDmYk+6MMcVtfW8vA2rO6dRN7E/xQtkmeAN502wE
n7ONGwOrQ2PvwWWyahw1krtyIwvHjn12sI3Ot73cGZq84JipWVg9SJyhXNf0iuGbqJo2NQZyKqtQ
q7qms6HEx6NC5UUGdQ8hfMhg6wNBOf2pLmGy5jCP8nK072Ze/S3ehiPYacGf7E5WLzewm6h7uC5j
nBPwFZ7naJU1qLB5wHzH2VhAfsIJPSMOLsNH9pk25IHRVgqVNU0kQnX7Nl104nxCac6x5DdlSa24
p81Y0F5fILOaDOHkLQpeZWov4edrI6KFP028Sp/fSyaKL6YrAi54rPXd1zXYMDK6iq9RxMrucVDA
ZVrpysTVy96YLwtSfFJ7nHzOHuPyasZJsl4xgfAHEisbGg2YcgOd7Av0nYwIvNkN4Xj+mYjHF5Cy
PJq6C9WaStv0COvY6G/nMmailsn46W7oitzaduTrG9LaLcxuGbibhIcVoXimS6HyjFxvXkZ3hKU/
ocekeJB/w8br2b4GuAyND3oi+clIanaEX7XDbkhg1GaIyQsknZhi/vuvJfCn55ReyIiRdl8+F1Jw
mbnHNtcy5NIwoYSwv2Gy2QOmktdieZYyo1kKRqKIToudwbS88pIUkwLVDz5z/Hw7yqb3KeLPL7y7
90z8eit5gtOThRMrC6Gxb04K455KmHfhH5XBJ8gjEL9eNEsc4Dv0BJvm1oCFUt/blpGPX/N1OZ/u
eKBfwEYQS3z0qI6fMQ8LepJs9b7bLQMZ6U7KnWDALjFd4CbZcyrvQxgF/WljmC5Dv4+GJIJAw7G7
nYia+M5aX+L8DRJs1eBLS1TlEndcFFKHtG1LEtLc00XEHpS3RjXotAgwaCqjf/VmeJ/zmek8865S
a8NDLJ2lKh6aFRevsPK+tUI6x0nuQWse+Fts3AKaDzmEWDlLQcy+gR7Y0x4NK26PKwTr8B4427xx
7C6kymPaiTRkl07jbPG7WOCcu2OsIUbzefBi5cqE+ydMfWOZ7fkXeCK9HTGmKzlnu0iOIRo5G0h6
dk/I3gweuqFbY/VQ/3LXnfr49uKBCxEniNaG3XTHpzFYIyy7FdmlFgeL393ybJEUkfgWZT7JdwlN
fv2K+kpcWwJcMGUuY/eNXkCWmjv6dxGpBw3Bb3uL0ATXSN0fsRUjDewVB7G1eQPjJGiyTCWDl1b4
xlmSP6oW3xHx0Pxowuc4HdBKiWmwUXuJN4/8k0nZdhD9+872ydd8x15+vCN2tu2+x8TLhcvFZ09E
95amBCyYbzhwcYbHIgy2bvu2D2rs6Dim+6rVYU3fruc787auUrWIzFY+jeapUXTjiYIrBf2G1LNc
Azbw8xPiDnZ/2GN9NeZIziGJIhRq8NiSLuzJ+HLnG/K0pP9iZUm5jQhtZu+Sfm0Kp4P1WD/OXNy3
JNdFvqq9NbhOh4jm/LzIeuMbjBRK7azgreO0PDPpom+cO5bqLPNUN46jaZdwOZjHjTU/GzYXcF6I
bUvvkXpuXmFAj3CUcb/TXvToWvOm4RfDlxsdCdWe0nw6r+46VoRJ7axyet5/uqEjbThG02WZXfk5
LUH8xfT4/Sw1g456BeJC/7qaQHO9WyvcaPclLsQO23TYrqZ4oD9cpFvkVJ+5LaG4uECJZBV7lJNT
XcPl/rIYPXaJa3ivhKpXdY5RIitS0sNoSpHBRIqTOvuh3tTejevm2s8b35cxj6Ad+xx6dc3BByfv
U1BdEP+7gA6TCLgrZnm7eH7lldw7yqvejWlvPeyF8l2kk13Se+3qQ2ju95MXs/u8pn0VY+7Kr8dW
3FTLm6VCfva72qNyHLYGGma+7C5jGw7iRv6q0uM0OMoc7vRLcnEsWrnxRvpDJZHYm7QGD/vqcZTx
aEp8XvtMbBdbMaWcWCisix2xX33SFw1j86WuTy6PnGMfujNsWHM3aKvZWV1TgFRBiq0ml7Qu15le
Et3IQFp4sDtGQvObfouu/Uk05Vs3zeEbWGLGhF3VwkyZUfKrJaZuoluxw6NtfntNLmz1uQV9yirp
6w85ubW0MDPGcedtZAR9yjIo3Pr4T+q6zeZGvxi3+io9/BLhnvm9/vx6TDwPcUXTQqoZR0+YQmFV
xWWD4NGt/MeVI947KU/8TtcWx7C1Ir970SISHVk18wb7G5NaRTydTO/lk1GTrcSpzwbn2c1d7mV/
YOvJE5izsYse6+bGiod2yajxQtOr8bMSRXHHIiKdzhRR4F8ZuNeYRJ/ImDJ3unWj7SaGGeeL89Ur
20598R8MJDe2FXgIwmIplIPvMZuQ7L4jY8OazjU9z5L1IbusVJJ7vY0WZvKRa9Pv/BdJrKD8sJkt
+7A9Vx9cbq1mjqJoZjtXG4fFbVskB2K8sky82DL4je3Mol3phlN4yzbdhSyTR0svO09QcFTQNrqH
7d5lL71mmbkgX26fUqwIhu+3N7rmiKCbRtfrnqbP40DEqL76MqU+UFj5gWBguQedy+B8oLMHbwr3
Lm1WYYl+yDHTGYze0mVNr0jpAR48xvL+AfYTx/uplY/l4+oK2eQTyZfAm4VsfJze3eRUYvPMXEvH
U3ZmGJ6KxnrOg6Ddi3zT1/SRx9X5xpUbX2ts9IQjJd4FSI3JUeGtP6ygJHa9yGXrhlP8bBlLk/8s
aeqotaTXA8QNrnDB1KZrnbKuO/LZL9yPp+r6NUnlKmBqTUkXFuXOufcQbz532bR865dExnySnmQg
NuoqFxonvDwS/rDOSlgXm01sbjyexcqSo9p/Ux0bq9dQdGWv+z1PiXPTYItz5g29+WvXXcSXuKeq
XEklpeZkpG43Rtf3fXyMpVm2qX1F+HxPoeSzl3QiMleetpFLWw+97D01Xy5PaLbdh2eLhHXFF/gE
sWqWl9M3yzZ9m9uIuVTO1OgeYXvT1wbuU/z4U2ZirUXlKVachaooRgwLZX4hEfoH7Bw1WN0MFmuU
UaFlF/xKne/nzUotzhc91esKnGIJIv/eyaNHrV+ZUx4fS1i196Z9sSrk1IVodeeb1JrntVzt+Xro
VVJV725fmpiborrsF79afFW/3jrMLkPTI+3zJeH5HC32s29u2xZ6PhLt629ybKKSrWalkDuJyxaK
TK4ym5qJa+fYW6lVE9W4IslLzXwLXleVL4ig7avrPq26zusRKsQ/EHp1heu0Qy/dAzFi39LUTEH2
4sDhLyzZ+G+eI1bHlG4xr5kK1eu+L27CJf2YZXme9gzxQy71YO174s89x+fSBl6oencHNehRvC44
jm2uFEbzZR73dJRE0ovla7jrVZTMF4Ji45/q2OIVvIMP11WI33CGOwefZBoWnNgljRg4Z+jX735q
rfQD5z0Z688Dl2Kf704o8Ja8ddSPses6PiAtkMYKDz5VplXs5ZTtYSqfdl0/g5lQVkTd6+WZTMzL
uR0SHHhWKjpstV1lzdKuWcqIkrqcLvMU/G8CxSxmz0kwNV3z5FJn4eQRZ9xZ6uYlhYIDQkpl7CqJ
niD0QtzYJSJCJVQETI3TFC3Nl3yHUq9+z7JPkV3JHaQbnpAozz5WKGO6meWq9pw4Hxmgn+xk1U41
nBIvVsBtaVvRai7U02wnthc0zNvUzsnWb9bTvbSwvVPhWn4ibI3rpAFiFsOqW6d9U+lrakpw5syH
TQVszL3OYqr/Aw0g8t/+CjpQxNWpvslEfTZc8AMv+6uOIVuhNsQ+/eJupZc6y+mPxlThxDObwlME
QD/Hpf9h8JExGWubNKGoyjrlx3uFSJ2JdMcyW+4SGTRnBsc98QTbshUmbkC/MKaLDgizsBOFE1EP
yfxKSdORIfYCyiyGwbeGVS/vdg0u20zpiY53Q8+x3oh5DmcNUNhIMcv0DL5c8wRbhxHOoV0W6JOg
YbQ5EE2pX5YCn1TbyBB73gmOq8FpC9kee8bHnGqblB7vl09RloR67kao8eCBwb++LWYClrjEXjGy
tVAksuduEdGX5ajBybys3E7xftVujgtGOkQsyJgWNTMSp7dVMndtU27aihprdwq7qUF9GmC9V4UF
G07CSIZmiKfGTpnorjhsUnSOIKRNQxe8Gp7OYRo4X/cDwNX6bAK0TGZ2hfBzKs+2SJyDL6dMR74O
3NGyU6IKg4HYBcCU7mjOTMEjKtxYOpDUneY4uSBTgBNkxoQE5xXKwh6db848vo5mbrFlsmSG7anW
Jg9fYrpp9SSbJQnQKU4+DpbK3SJwDdw0rNh02pgqganVom+bOeI94pYjwELTM4nOXCfpvCW7Ff80
jGHsybZecwggkLZPanPmXqE2tdYRcDx5AnVi+fxKWEWmUNzM4agy5tz0hr7hbDY9qJeUsEQ4QZ6w
VUJwQyc1TndWuqe4hWzHRYdAdhAjYGwRF1rhbBVLopmy+IKbL3FcT6DeRR9cSONlp/qhRyzrmU7V
YEoWjxoLJwXpOezEQ+PFUZBGOMHjGVZx3DYjzz7xHOtdbHwJk83+HG3So6FZyM4ijO18Cn4xSbmB
MREVhQaJ/W0z8YKeUQG5srcs53zaDsXnNXQr5jxWQ5rgZD0cKivBPjBL3lSV/lkIzejFfpKixGen
n6GRwc7dzajToC1EZyE1VQseb3di5sFuWsgTN6xAZeopYfr8bE2DkyOAtmvbZWVjXs2gEpxMADPP
rYm4NLVQYoZu9gCTPR1Rw+RSNvzD3mutI9aQnV6rzXDMTFKyrgnUCQuhpWkDuc/Qq0z+XrvG5sQJ
f/hQ6mrf8+7nUNoQNHIdtGEcnNxhug2WfuYZxwAn8yhWU2XlqSSIk+x0JlE8IcIaTFKZnTJtumbG
sTwb7QJlwmsunnSOoZlP+ss1PJ9oexs2te8O/ZzXw0k8IT8DxwiKiNLQpPeD8wDuw4tPxwxgRnJN
ROuQVCYb1KJJspNhvyZ5UvOcvDQH5sCIs7j/LFuguA09VORiff0u1pvBKXgeUDJc5FrGa6fByQ6p
B2wOs/vpHZPsTP+0j50314+BcAbXSrVVLunDDem5IJwBzWKqJmi27cvm+bgeXffMI+i0sTBzOKk/
IF87aikR0qIOXh2p3ln/VCrjOlJz1GlqV5Fp4kRsELcMsE+Ak9KzXIZiF9YNf+xZIYRRzPEYN8Lw
Ix8QprFw3ma7R0NUD2oB57+b7qjIjBSZ1dEc6srGXFZP3lNdoE7HTAOVZkzBXTOROtuUW5nz4Vmb
cEYHcdY7+eqfCSdNNO3Z8nZ/RK9iAaiEEyxKE/Bld1CGav3jmPWNZYFVkW1iSGQYuW5kvI4Pl9RK
ano2mW1PuYs4UquM4UYuG0hGL82aVw+JyuW5dS74mifk5zxvl6Ov+wNUD6cmnLahYn+BgRAoqCzR
PfRwCbNvL/EGOapqg9pS8fpPVG9tKQVu3Gp31qACrbpQbpeFky9VzE1lRGVoRtu+f4JKjztfyWnb
hJOkFYrKoN24HoJH5aLWnspowguHH0q5adk21ohidSg6wSK43g+f0WRhJmGzdZM679dhM4zKbT6/
ur1ryuQNXBNS58rTUpbxAg+VW9Lij4XWWh8S0pJQJwiS1gDN+x0BW6lQUGCsfes3B1SeRj3bZvG2
DWtIQXw75SjaI1EJyvxGsuBbNNsnlsog24RyWwRWhCdWLswRANguwOad61LLRzyp41QUwLmejm3U
qZhfVYG6/kPNQBbttpoUUoxCKnhb6Uqbmsf9Gnl5glHrFR9QQZHHARCbF/CkO3eDyCw5b4Kb57Rr
tg9WgxsCBi+RxT3BMkj6r09fyVNNdDbGU5eLPNd4OuG07HtMxkncS4aggJqABLISQtlvPSGSBI/w
9pGxNpjP/aLOZSRSeJskY7zRXaQwd2i25OVDeDYaYei0zzV98T7BSmnceN16yR1wahtWhL1ugO4m
ig15JPEBnbLuHGTi6ZhqYyrRQblCMb5hIYswLVnysdCDIrF6pVrWRIvsxMRJrcYB+iyrjVmMfm48
u/RaGkvDyY6zjaYVzrvWZGOwUguvR7chmGcmEQVAKDnn/fFMCq4fl4hn6XOWWS2Z4yjov51OPtbI
HRKERWlZ2yk3YqRV79TFa5nlsoyd2zqsFjif2u36fJe2QrG4M2TtGVwVjTVYvR/yUKi16l07TuJ+
R3qNModink2k7LjV7uRNn6DOHjyfJF1W43ADMK44tAjGvpclcjRXSawMMfaOk85vwKlWCnYgGpZe
UrY/oaneVo+EPijnOPKhVh937Y53Qh0Cnl3PQwEuDO6y87ZnTIialz51lbSs7tlctlWTWsJ5t7Ip
1iDKqbDthdOk/taEmQmtpmhJtCUlONcuJ6lddooC3oMnq1c2VTHhi3NbK+bia875Uk6hdnRzOJ/S
V+FszWd8nTyrm5YDp7XURoJpVu92o+WlkDqGhgI+Wbp02WtySZcLvhdPKxXsX133d+lP1YKvPEmy
IJtTsXLdjQxOyeJCgCw6DryBSZ0o46sy9nFY+hAPcx94Bzy0Wdwt5qAFQ6U7onIXZ1P7pMOKakyx
0ebcoRVZJs3ZWNdOyVzwVxoPGmvWRrZktcpugweopM7KpSunaQq1HFv0J8M/FE+kEpE+Y5aSheeC
m6HLKxQfTTw7UhifWmg/O9y+5DnJs4PcIUxWtFM8nIx17mO769BW2vt/gmNvDIh27pPxMjFlY3oE
Gbt6bHbsKlAeEdUur1CGZwd9stB+AZpWtBTiHMda+t9aNo79tmLr4OTsHoN7PLTKtB5RRp6j5WSY
Ae1SVCYCs56k8tvNzyXURo0arXMCMvWrL3wtjR9aSU08HgVLMSznRROmeatiu/JemSg7iabupjWP
uzLb3DvLiZmwpNmyoaVSvNQHFV54Y5sIh59pRiGSNpiNIO6hVvnZQp5qIs6rCOnGsRZNaGg74ARG
13dJgJNoCoUEMGMr2+CgLTWh6oFIcfH2CoPAU7MWD8Jug3USfX82nNxQadmQRXdCO57ErvADki3O
zGkxwJZQJ95r7RJHBiflps8/CF3gnV9oKqeVTSyxE0qxCEKzLrDbrDiqeYrMryClje3K9tQvRMuI
ZwvnoDJU8OElgiodmtC6Lr6QXAJ1WmjTkUVBnRNYrM4/1WVp7dd6sFi1qENHbM0W5Sc3UZQ8e9wI
UTorfTaHSepsSs/5WW0790ZaajUXm+NEoU7WLGeddpVVaqjIH202XZOV0zUWdhPp228PM1uSYfG3
i2kHOWoAD1Onum+pEJWASqX9FvKcvD7b3rTLiF3ZiWDUSZZXJFwlbvsKmP/YrKp/Ixc7uHCG9qHw
PxdUMj1ldXUFyLKZRW++NgIFnAC0qdzOQQt2D81EaFsf0A3W3TRM6mSI1+ggEafanVkj4gkzAGNz
YFseq2xwJs4/KHab6UCGqej/NXm2Rp8Fa4UnQbtI+aPVHzfh9eSSnvSjy0v7UyYMiHBSfql6kOYz
UueEe6ZLarp6WzEbcGW6MKJvyHsVKmSnzKvSZy5CBc6S3eJtX3ovfzEf0OmQqNv3NdtY6EaAMs2u
uq1ovvag1l0i5S2t4hqolNtLo/EZVSLNRhjQbPWmiKBEQAPvkw6MDWNlTv/7rFL4tQknnCBOreDm
ATWX7Wt3Z2HV4TuY6QFPH93FLh0hQjtod8aHsLmt/IF1onE7bTpUxsPmhHP4Ddc744eSM1T8ahgq
L44D3XYqvNyI13PiD2jIEh0Jzv8uM19HnQqf8lv+R+khB8kzU4cg796JqF6c53T5DxtlSQmaYKaQ
PCwN88U3rixcCeFJ0N2G+zic4KSqUoXCS9FPK4AKnSqvbdBnXf3l2aZ5rRv9oIbA1pyY3o0wdhtD
23grY33WmANNOr0uRiSDuj2GOkWGUtk0RIU0DVG3PP8ot/3RDkeePKMbYUrSiIe1o5RribzBKZaK
YJgZnpVeocZykgRSo81Anr5ew9/ktj+pJY7xW++Ff41HGBcdukmEk/Uwghc+8wvVarZtmAbKVAKN
opzxrKGBfeD3PxCdWq/Ea7Yh8eu1F0LR4xrpa0QcSg8ZoJ7zV9qd7aN9qF/IjoAhta7X3u4tr/7Z
iejUmFHulaFX6KUxm8o6dA/AqapQqdlG4TlWdhZPtI6auULU9OQOjfMTvv/RMvClN0b9e0PViQde
sBJOI+K9szsL6Ulmm7IRagpQFiOLxmc0QCXg8AkAjRsj4RTSbHrXBM9xd8vPrlSFLLGYXqFgLCU2
IcC+SJ3UdaMINUDllV96u1dmZrFrmYnpqDPqQSncOf3RdRXZ4QnkFkz6bIOfNiSVBL3odTilMKk7
jBtNf7c3vZLZe/qmzloJAU/NRZg8ctpAwxdrc3LstHJ2SvK/W4Ds37Y/G2H4MXTo2nsqN+L/p79b
xQN/4xSlzlJ0Jjxfil1XpbFZJiqyhWLiWRSdRp5zUCcm1xEoX/gvSs8fTLkyIW92hqzpuDd32kqr
KvmsHaZCslBDvRafI7pzv0ydDs+47ejPkacYKm3kGaPXIQt+AqLFXrzWO5hjV63OGCDL+cVM1Bki
zcpo/yR5wo0QGhx5P4LtaXCJtlPya+ne7y/h/eBGB+RfQB+6OEeQj11jWHNRp+RPBl4kK+avkWdw
8qWISkr9KjccjadP5pR1a0OociK58epDMJ97dL07121OnRPsTjfysEUl0P/f0oZ+QrPHIigVkkti
Kt+0bZxM/dq1ZT89QslzafCNQaTOnjFhKP6CKX9dsw2Qmo8osNs/Bic65LoOKsl+DzvI3Jaj8dQp
2zfZv8el5oDfXULlxw2KSVFF2SKNz7kYY16E/TKb7NQ3CEj+QXb7w256Mbck0EPcD5iIcxp1Aggp
m/GDMoCn8/l0RHGFULIGnQiMNHZhB3YIBGSycz7NNqzHsEtF3fx/iT5/uO9HSvpHB5vOZSMLXveo
TDism6zuB7Rjd0gEy1LxEb+QKpQiPJaYOYehEgdvxaKUPP+S6/aH+efqhPeANveoTEYTc4gyQqgj
JZU4t6xck6UrPpD65UAM5koUnEo/88lOwVQ13PDO05bphJW9+CXI5IN6Kdw2C19nWfBh+/VLr604
NW6BzYJ7mkUBvgRjItCZZacK0GCX/SnnkObZip8vKiCJ2cY9Ki/4EnpXJGtrsPB/cLYH955yinDM
Z3e6wdClGONILy3UxWmu/gHMgmddLGflmeC0XQ2pAN9U2dkzGGzK3rJOVHIIORDD8ioDZK/ZnWk0
gmd47xciDfWTvfyZaY+KyU5HEx3br+ca1JM1OY932SMcM0p0egvP7fyyU98hFaVR19PnH7IhELZE
qB1iTM7VRkiVS2YlTylIza4QBmZ013ol13juErIzaERRoUeZ1z8CJ31xxY7AFtV2Sk2o9glCxUaW
oUEJR89mjSRjdCw55BeRnTo0x3D/ggWqm+kRnpLGUsmNEOoKuZJ8Ujrz1QWM/i4naQWJBpWOMr3i
kzlv5QuwhW3YxTyij0rVWK3Ji7171SVvfJLVRqBvFTlDCVHz8RU1+SbUbHOqB5x72tRzy6Z3cR6V
uzq1xElS/YLq2lJwapGKtJDfGKuKoYXKJej79rO7xdIlyStkgLKO4iuyE/X+1bmHTi5XklsQkbne
U7rf9d9LqUI2P1pGwB79Mv+pmPTlTol1hdj1WKoF6wS2efm0JN/4941dkwnnhuXh2cclmSfBJ2Qz
mqY2fLEodVLDtbfW5y032cvfOZVYhOsUAjSTnlRqW6hzDKCsU61kuWFR491uG/p+bOG2VY7r/FHR
fWC/RCe5Sy6Zy+70k5tljC8/64s9wVfMZBGuDTQUK1tS+hHGlztlgUz1uW+Pl7AIcPcr2t2JBxfd
nXO7JIrRRLuY6aWpM6q4NpjFZnvxG2cFULU2sTQnioZKVIZUelYrtzE+jV4sqEPeOB5XGp4/ewJa
+GlNIzMNRR29s6R+9c6mM5o+1wItqk1b5fAYHvNgtnXBaZ8gcNjQE3YXmpm3nXln1Xnl78EZFNTc
RLUqzZbTbJ3qHR/6sXiWxcMfVtc/lohKgGZuhE75ycahJh4Rny71CrTNQsMONFVGMJvfscEHvLZO
oY3OhJDMo4bK8tRJxhP17U91+TU7NTys68bVKUISIYs1FqMUbOGgMW3E9aW308BefUe7n43kED1Q
gFGS+Ao/rSdPGiqL2Z35SzhAx2h8iwvFyge09VFRCmUbopgoFM3O9I4qR5PhkvSeDbvpFM9/BAVX
jRUc+FsrSMmGYQPUvAnR0RdNh1WoU4ajgEoJu8/jue1djqT9pnnitDWOryAekFKnnwAa8vKow7YU
8hYhqT4ENA5Vm5Z6tOLJrUnF3lKvHEmwYy3qVEQjjX4apB1NqwCQKTM7OHEiHbbzn+ed1XDFHGmt
yW7su5SkrKUZ8GSVizww5j01uexcwu4seZkY3DMVcKnkk7Oc1gknM3wM0c3+1F7zDBVC0GVQBSK9
Au0jklrT6LPT+JaOYs3BPUgAIPpmslwENVRWpU4daUD0k1huD5x8I+0sJw050aJK++0iZ+p2QT85
tAWMKuyl2zVGyt21dytAWotWT9Dyp5kyZJaLcN2cOkNO3yzLeeAmU3yaa4yr6xl9cN5PMScWzjk0
qg0qjEKsOO/bGWx8HtHsLJoZu6Wi5FekzVLHXV92/iYgrz27E05J/VD1Ba04aYbe2eTxLH1VkQF9
uRzR3HFwyw7UHO2W0n6wHiC/QW1/Jc/oI0qZQr9Jna9N7vpXd8EpAo8CEYFJMUBVcR8bJmOx6b62
MPhetphhBxm3Nag2lLn9xGr4Fdm5PhivP7EdzjujK5sDvbdJZw+dOMZUNMF9Lr2DxAkiPbXTUYAy
6LlGovj+F1Sh1yd3/Tu0windqywtK2mcKX2oepisxtl/cuhMcWYnlbC1wnuETBXahYpTcyeXVL/L
R5zYBie9fOhIn/E84bZCn2NeC7Q3UNYZWUoCOLcEGiNwUtPU25zZrmF3jnnJdzq3BU52sZGeYD6H
ZgqYlIiDc2/Uxr5VmamS/EKiCu20fQ6LKa9pqLwTVDVjacDJziYbZKYXucuqC9Xc0Z1T0+PnoNXv
0276aKekZLCvKlQ78SWcTDHZplriXoqNRpPO9cES+qHS246qbXS9x4h2cCN8ZWcVogWcgmYkTOem
GSk09dkQwoMEHeBkHxXn58u2lH2pswpLnFTACQBAmylM5aiz9o7uPGOkvVc6OLOMdDNCI3V+ZWcN
ADmc7NiHZFtPngboIJW1PaymKzvOMcMT7SaT6ZmlD32pswZKnpOnfkGnDWX+Y5KHTvEkOGuoM2iq
+7KwUJKjotl+7c4aSD2c3Hl0Zp2WkusBzpp7Nc6pKDcNjVYLD201ppK7bc1c4tcpuWTQ9pk01r9x
UZFnm8otOuKYSpz/KorBw30gnXMAa6h/apl9IcFP19JupVyhD0fVwQlLPqvn5g35SbyWWSNDbdlD
v9K71D8tOLyR6oWp8xsLqX7dCH0rzsEJPeiUakmGuTVQJ61aK1Xbdy0qPMpSuSQXvHHYgGXI2GWK
Ncn06xXqmU+3RwUZr66UZJ4nOY06wUEHPHLgtSo6zYuQO+Gxv4Vhut0+FJfaP75w9hJWgpMz64hT
tZLIcKfhCTO23y3Eth8cHxh9aq6rD73JDu0ddoJKd8bHVTqi31BTahKn+H9clODUXmSZXuuk5zQ4
sUR69VCgqOBoAzLjCHD2yQaWLTdEPC9Adcs6jP80CvuFs4rZai8y66iSmF6AdNrqHghfQxGS6DZg
DVtLWYGRuyJ2kj1414p+OA78J3Nzv3DWwMnAY3TuBU77Mnn2J5ewS7OMDf6GEJCTzUpb3XMGzsoM
l+OJaUsbAk88v8y2G8/IbLW1XEvPBvMKTfML0VbpaMkq1Us0z5ZtWxkbB10yD8Kyerl7heos+bwA
S6UJn33hrIATsUkUzhQm6/ZuORf8+PiYPFXoKVQ6tXE8H5ejpuhqJgKi3MjAlixt5LTYSRem+AqL
lYP/BJ7IyP3CWQ9nrCNpfDawWwlfT5KfTDySlEB189wup7BhEIWFeEckw+8eN8F3d47P0AwX90Tm
zIPfgjwHY6iTxvknLorMlt62wk7xbiFN45v0yrpFhdJP943pEXeZSc0U0Vnd1gnmRJQ5gMATfngW
O580jP/FRU3ZmcpIuhIUlp85FdBzTKcXWH3mvCirUUYGbkzjpEGEOBXsNviR/hfwjH3JCCf7mYjg
jMLTlSyQEJn+jH2Anf+4IYH+iD3XzMNO91B152db7GkCse5angTP7ZN+/S+37UIhuRFCu6NY2Db3
Cgmg0zlu6/O5lV7qlxTQgQzb0KQGfCG3lRjM92iZgcwrJG12XbQzE56uctQ8M3kXymzZKcjQTmuA
FV/sGUobSMWeZ3gfeZcEJywVNTwdolnRxcBu5yFRdRHs2rY8BF9Rc0IlHv6NqVQYKlz12o2sLRlB
Wa2r7DZVzbWR0BHbtEftS7gbOwYs3QRrMpA+krRmGLSLd4IoaKokJ0LM9TAwQ4PzWNltoqL7RM1w
6rItG7LFDu02RfDVBe76dlY8w2x8/C0cnOznp+SZ8s+9V6hZO0p3CI48HlLti/XbOi7syWGA+n0E
nCFJc+ST/wen+1whkKdGPN2OBu8V8pXdfKFbqzhUNVu6PX+DLdud66Andx7JaYcvdfZMtIeTNacl
LzPimaULtVVFdYXi++rdAjqtMiAhy+0JoeruMfVthSCcNemeVUvrD56U5dlCuXW9WUszxWlCqa+n
1I+yPdlCb4KcHgZiqrQp0UsEMh+9e/Axiq6EMfj5DlSFRnP4P4hc6yvlWfCwBFFC3BGnD3hmsjNj
ti01wVIV41iZUexMNAvE/Xvh6PYT0L17Rkbu4d/90NZF8v8CWo2hIufAfpCWDXkKlpoo0UwRwzMd
VspNybKo3JJqphLMDcudDvdw68ofYewUSFId+jLcdkiLLUfWsiHmfWXxMcNTwEwdHGL9C8dmI7NV
lqvhZ8TDpCjRIKdsj4FJ50gEU6Cw3UCh31z4NkDL/Z2MKqLCbAt9ttYsNrEpzT1bqhcbrV4JJvUf
Op2GOWJrRYUba9XDh/RgcQz0kO3uwTz8gL97RmP3NeUTW3DEzSL6i+O1GXU61TZqQTn5aSoe9R/x
INZMJS4oUBfS3OHDh2CN//UXRKl5yl88p1kbge2Nt1rSu4xftzsSSJZGm6VaC1Z7xu1E/6lHk2ht
Pe5PSTQ54u4PxsKvVdu6/yJag+/UUuoitODwAbKs2r/JThWfUh41aUP5AxkBi1y2ljZxC2C2i3g+
uCKkrB93t8Gz/IQmFPYHDr7g750wqCMsMLQWOCUfB3k61hQjZPLFgGcyOlMdsCZ1Yqw0M1Hj2Ahz
BJrSIhbNA/EkTQhDAwkSPtgFboloJ2KzC8zFzLd8VgmWeR/aCuc/VvjfsE1qp882d/LFstNuRVL/
2bO4jB3Aon7oT4mFblDXUf6WuvH/IHnp6Hgyy/r9NSEsvvXpsx3Of6EFR4QzlYlSARqOIDadvYny
/Zcr9R+1Mi2xvsZC8XBrCI1YhgA3b4QPoQPVFLipXzpLnYm5W+rWnfftgBP5sSSMnRZpD7qt6+rp
AbWbS7HiM6rcKkntdMeL7pLgMXat3s6Hw1FrXRttMrOI9mZNgZvVZ7J8INtPjH3llwfdCec/sQ2Y
P2klM2O00/VW4eNZGhUwHg8seRuPbVRmI6SvjZXeJMAooc79J2hCbJb+RnBCVlma3f50vrLUdMBR
0p9RchrVbVFyOkORO7xU2CUFaCJxFjoynk8nn5ibH6IJvRmcMPOsw4KoJTh2PLbY2+7ynwNBsu/f
+SZV/lGfMShASa99aaWyOE5sBYAg9idkTtPQe40jjb+6m9nqvZ630OgmMVL/24YoSjcNPV9qhRdC
U6EdPzZ3BdRi0uZRnsJGHS/dbZWLoTyO0eXnGdMQnAIpN5aAraJdoxz7/UESoMGBS2FPeWt7I5wa
VOmr7XwjGpx0DB1UGH1I4rT4RudBqfouNXBW34wTvSkV2sB36+9Snkk0SfWoyipfYVvD9JutdqX0
7P1oOKl5Xho60IuqkNRi1Rq7Spwr5U1rq6MJuW22YPTy1VaPPmhO6oTn3MorREeQ+2WaWsAGEY8b
XQrcbS9DXmVXg0g+C+JPw0Sunnbp9DUwI5xSA8759HInwng3Ak1aeiFEbAoP18mR3OmFjwCmIorW
euOfJ+bchOvGP8ldMSOcUIOwB63lGBUcS2MjYdKnREa74/YZm5sVnAgi9yToq5HfCSqqtrv/XDgl
67o4cnRHvZuB+ZCGLlCCInXXFJh/aYVr6Kb8GSsrxDE6YRm8NvT5qJPe8YzVeiz193o8A5hCmqpe
hYuxbBbeEBgL4Rt92l/1o6e+ZtH/19AZffVscLIiVBurpSoTaLaa91BmitSUbucynXEyK+o2jp6F
/ALlky5BNSRmjAA0ZHK8OJSxl88GJ8jo2iY4s88q8ZQl8HgwYooSQ5LLmWZy+UyEXA8yLDXVphZQ
5bS4YiweL54/F5ysppijSZqcwm+pzgqe4i9mVmGeMLZ8EryTm+Wvld1HtJ0ajxfhGXv5XHCy0lOX
AyFHtXOBM+1IYzUEUxOEJJshownZdbTowUBlzmydnltFokn41lLzXC80F5zgtYihpaMMqTioWzgW
cfQ5RXfJRUBlGiHNbE7mSiyx1O+WeTQrpVV8BuOlt01rTLL6XGYbCmXkiOb06iBOdrkgGXUlFZqa
WCJJ8w1LfCbFVh7cXQtgDFfbPitpkc3SCYsNjVuVorWhfIpqXFuKCgZRFl+JukWKxOVrXeuu2qlu
2CKi7qptXOveuLWoy36lVNVX0W6Qsi5FtVr9n/fMzO7sZneziUvze9mZM+f+zPOe95w5c+bk+wRT
fL3pJ6Y2kgZc/3xwdNdh5Tsuz6q09cDtg80XXF+cfO37Yh/VTVqUdp4tqxJZ9yVT5PVf/hvd+9HJ
nX5/O+1EVkzLsRP2Nf/rSMSBjvGrrj8ndn689tDqvef+st52ZvgjkQ1LfsSSl0dX/nlC9vKmto3/
Wrk3fOHudsKLiX/sv2FdNi2iz8pXCznPvt3jWqW988auuNjn+YlN3xk8YEOTozeWrRgT/0fxkhUe
6Vg3rfMXu8MTs15PObJ/5uFSl9/79a8W79ft0eivU1N/7bi96eoPTizZenb2Mwnl9sxNiRv++/zB
A8sWu1V6w9/L9MXNzRNKd01sLm5etaZr1cY/nWuaeqfkT3u+6L3y4J5BG0K7/xK7qlnLeR/tf7JB
i+2JbUcU3795zPTtfUY9/1Sdjkmh5e8cSWl3rcio7vNKXth58OqspuKoy1suJj9Z/0Lpyx0nDb3z
4e3SfTJrzOlbdGbGmw1ff6x/0c8OtS/Rtu775qsHoy/dajB7RerQyhOTQiMvr9lSufeT9W1XpK2/
zm9/vd7yP4pcn/rzyrdXVjF/dOibRRfF4e2yxRKtxrR8T9hy5eVdNaXXDlvqdO5e6UL/rpOWn2k8
53i3YQs3n5n5VtToPzcWEmdMruH4oc+JXsfqb7UdG5h4872FvecfO5HRrOy4ZR27sRsnPitfeZ6+
XXLvlY8tONzzsbS3End/HrGs6k+fbpj7cdO1H38RfzL7uUuvt/y4SvT+yaMHbmk/YZP12cXNk/Zs
XnV9vr5d5+s1rKnslW9GtXnmwx4RZZyOMkXqXP2x3cza4ku7PtrwxqwKppc7/xI3aN756//bMa7L
8uttnnlUHDSx3rFfjKt7vtus3+FHqg6rfeT5mfWqfn12z5mRI7ZtGvaD7bRp/c9hv/dJyOzc46uJ
Zeb2nZedfTLhzltLvq3wwuKfZ66xxg7qU2Tjp5f7TSwxK7R8xYHisBJi9dc2zG6z7MuxV78+/NvV
FkuaVvtk+NF/PVPvq8SORbOb/Ot29TXHmy88XObQjpvx/bqzoSc7vZf92TxDu4RxQ357Yqa51/u3
LvbZuOPApI4dboc30p8Y+eb3tgHHEsWnBu78fvzJJ1tW7l91e73RI3//ukh0z+KLXhjWuH5mq++G
79k3COtuzn43oH3z2t3a1rCJpj9rbpo6/ddm+y6OCK0faS7277iXvpw8fd74yEZNn049fX7Fuwm3
l16dX7ydM7R6RMS2Vd2mv9xv1OSeIdlNF/9x9sNCWa2O7G0Ysjvl10mjzkXXmDH5xV/6tU9Irt60
XVoDmy1k7u7s/XX29hqwYWP/JdM+jn97tvFM0x8/rldh4vr1m19ZPlL4sH3Vth9WjYrZW7rNySKP
dmzfydi+XHjXNcXeb5w2KmXRj0UTloVXeXv2m9cL/Xdst7CuE4/tPbpqw5WVIw8XrTrTuuzW8HLR
HXrvqtmk7LdLmg/UFRv/xI5e3yUuGd3+2u3qjU7GVor/7nqdU3+eGjmDrU38X8SeMj8O/+LtvcYm
Gy4vqyQmnZ6fOPS3qbvXrSxUpfbMBstOnpr+8rHk3UuL2W/VS9nf7/CWJasfbdBmwqHZ8U03dh6a
En48s8yGJ8an7A1N6FLu818MhcfsvLn/r4Tdn3xWzZm4udLu/6b9/PyqXrbR36xOXLvkpaxyQ6em
nJnee3LpF8oV6zfoZt1+g/cc2dO7z8z+kQmvLhuz32kd2WFC7cd66T78afPEiGNHe29qe9j8zqns
GvO7xxYpuTdiSt839qXGPxu65ZUhNTpNu7wtsfXYFzvvGTx7Qex7b5RK183Vf/e//wwcU/G11JOO
8foXlz72RbW50tH4mg1LpKT2qbzL9HgXYWDzutPaThr6Y1j53UW3Nls8KLRxI8ucup3jJ88+VPbr
pqWLdjc2XDF07YnkdyNKrCvae9oHbVqFdSp5MnHXup/TDyxd/EG7cd8PmRh6cnL/rfVqfJb2S3S9
Bj98ND/j96HPLTxStdy5Ops+NrXt8G2LrkNGZ166s63ckmG7Vz6yLLnPQunYz6V7L4+pvf27+K0v
LKpsWnu6rn5n9umsEy3+mrxvxTcDIjY2mWRo3ebDd3/a8NexaoXW7h3/2Aflm9W+sfqHxd+ONlTu
c2n1+umfn36r+oCE428dvpg4YIP+2NnK7Vc1PhOTWXHf3H22jCS2pOy3bV9e0rX/oSJd7eLiw92q
d2y358kByXvKTqxSbK/OMvC3opHi6MLv9/kyLnnQhsbOkc3v/HB0VJ8fnl63rvS4jqei025FLnlh
faOz58NeGv/Eq44px/d+8P7Mohg7tUyfPrT9uAlv1yu2wDxzU0qj5LcPDj8wa61x5URraBXLp+uK
H3ws8si869fiO14++fnjtXRVb24dOLrJmPc23xwAHFMNwz441WKR7eK3k//o2Kvs3n5Nn/nmsnlO
2wGD0mv0SupVt2m/YUMKtRplamutsufdGV9efDUy2/DJ5P9dnjO+xJ356zqO2Hh794VulV9zbglP
K9Wi+fbG2UWjuw3dOfTQwZSR8R312Uv+e75QmmnlHy93NgxcVyLuhZQvktv+3ezo4vRmzirs1xlz
JnRs0yyxW+fykdZaaY1KT50eHTkpfv3LoYY6SbNqJoV27GE40eYdQ/dRXeMfLflI80Uter763sVC
LQsndo95XHxHZ43vFzK8Sf3ls6ITsxdsfGFERrXbS/+dNHR9rYFvjt04+txgy/fljoZufWbGqRat
ok9GHOh24VjFmb+2TR7Wcn3FS/WSEhc26J98uuyuols2Hmu8ouOAA6GD1739ft9ClZ8e3Htx4QnJ
9V7vlFp7x8Ds5JonIie9tqr1v0p3eTzmpe/+u3Hxq2e7Dv8xot3QAXVais3id7ZLOd8mvkbjpeUW
TynS5vljhk6X3//q0Iz/vV5v2uDLRrFKi1GHB61dEzlt+QfF/nfkI8eOGvPnz7xdZW0ne/iB4ZFF
x8eXHS1eafHnoOLVTvXPlkYvmnCpxjfW1sXCl8fMtG/c2X5x6eWRE0a9cmzjtGHsj8OJ7780xNKs
VMVR2Wsj2v/QsfdHYa2NNX9u2fWDZjWL9WsQcauK42yZfXEvzrOGfNn9aLJz3u79FSfaOognd9dp
cD5jx7xJz6yo1HxS9W23esa+VfqJuPpLLQv2mj490c0+pXScs3DGc0M/dc7pXr1llSmlCp/ttOa6
c9/tZ8ZsqTdi7DtN/46a39JebdCY5jPDXux39fReXeRtljRje6Vmfz85/7VzVwcfHmu015o/JGRp
seZxTmeDQ9l/7fo9PrH2mIqNV7aaNQkhhZfXGzIv62t4T06sVKHKrEmH3lhd8Y9Jvz6duf7L5atv
R7eeOibzzY71dStSukYaE37f9fvGxA6Hvt0x50aj3/TnGu7ev7F354ErZ51DpCH1n2r+zrnjK1r0
rP/j4+1mXl7V6Ddz91ev6c8Vzmi1u8VIZ3K1T87rz72Ysf96+Cczks+3DUOZFRP/PXd88yOnO1zX
nzuX0apjp3WfFO9xGPVaGFr1y9Fdntry3Iasp9/M/NNc/6kWg5s1f/nOn6UPvztxdodnj814eoG+
Z/0XhHZX/37jteulDxef9NlzF8/1HVbzhb+Kr63RrvnxzrM/w6YNrFWLds0/bdprQpEYXZEncE17
raj7qNDWKFopG4M9o+HxLH60p4qybcsXcOJ3rhkbt7EZpVkZVaPFiuxXmnXo3Y6f6frvLyo3r4iw
Ivj9Gz9s+8LzeBnnx/AjwTYrzIgfhYV6uWNxPe5lHVuLHVzscDsQaRYqoF7Di8thVGwwfu1x9Tp+
m/Db1xoekArsIHsWab7AZTVcq3F1vDQexXV4zOXi++0xbErCsMkKw34mDNttMGzswbAfCMPOIwx7
aTBsjcKwbwvDrioMW74w7OLBsMUIuR9eWXhMxaZTHQ/jeYDdICm4HmI+jROx85KKU6fgffhOczKw
kXGsiuuh5fNsOjM8qaIUBJ3b+TC5TH9i59tRGkQPJ5/GGujIMjUwH04+55iZYZmkhSk8jHx2SGf6
Kh4oH8r2ORp/rOUNL5gPH58m9JqeTZND1nkD/39+bcQ4/SspJ4iHrH2WSmOGdjlRPmztc6GZ6af5
gvlwtc+56SxcOzjQINZp3P/fnR3s7FimHxAPUfv8mbFvYv3AfIjGQwMwPyH5g/nwtM9B2IbZP8yH
hs83GfvSL5kIeIDt03TuVvNVBw8uafpusiPAnQ9UW79hucF8cHxG/fG8e+bOsG7PFIffSuc9AEr7
aeBU957P1KFtGu2pesGr2LNmQnn61Knt20/LeA3bXunrFSm/l9n4ky65pNXlEp7X4JSZ6RyGfld/
TdIUjDoNjar9Fo8Z1qx+I65V383BGrZMjtXEyq+zW65s3uv2GfUnoTzVcDuOhtoqXcbh8N0y2SGK
Fgv9h1iyxlZviEjs1IFaY+LyC1BO9749sAnisXR3V4ZHahPhMTw7JcGZNbIZd96Mk0ypw9Ew9a84
RGxK7XA4sV+4BUfCOqQ6QiD6RkumJOQb7NxgYN5LezvnEyLxpkiARLFfTSBl+q0N7TitHwNfJ+Fz
YQVcbJ4+cjVRT3KqUdPfHJLHfQvqokx6oOGBKwudy3W3jgF2xhrcdBBfTosTUGWkgLBtCrSVIKo/
mVeCLIpZQ661aZiOWCTrDtRKiM1TRTCm3SQFkSJv9jZ17NTf+vvM1jQDW/xXdRAgJ8HEP2C41mY3
dBK+hAkwCS4Jd3IXKbBoiR87YTUnHlhPNaiV4LMIX2j62AOMabUJdNqLXNxG2ZZu+yg51jtmFHS2
dgJ0E0RyQASUMPAfZ9JJ8ChUFuLWJQrYJ3ZvtxOt7Oium8G0V3qzsClHXbzrxq/zwGcpYFHk1K4x
kja70hnMsBwqCxygk/MJHPw/gVPcnEXFVyZTeySsYtaICauf54Xo99z0KEJbnOLumYE/iZZbJCWu
TjnnfooClmffHXGruqxg2zRDga7pLGSWyAGCNY4WVAGuDFLGS5hUAuHjWwirc8Tbi+2E9eiLsQGq
lVIZZq5lgAgeQcHzWYGFTEbzQ0X6TeD10D97U64HGkn4HYDitSfNlRFz5ujAhbOKEILLBSFaEREL
udMPkjWyTTqQhrSUPGrrvuhS047pyyS3Ry4uXS7hruCfWMgYUGYBBtiVc2/Lvfyum2IXjHWO9QVz
PAyVh8MRZ7NacMKVihaYiGLZgzy9BRgVAViCeu1jIP3Bx4jJ1Pn61wjSL4911S5XR7B8lrIbJhFG
AkEH0SLfcXYaJdZWYFI9EWZxSijXpIEpo1WRAqxv4WzKrIoO2LAhhPTUnmp/T51QqdoUGjeZrLDh
DeHL9Psu5ApOE0GncQdyXmGHOUAOFZQCKe44H6ZirGMhH5lPnB28BpKJ+3E+nYAo/+hEeIlbOnoL
hUJE+KMEy9BDhEkRfQNX57PuxTyhDHp8W5qFcoTEpQIIZ1E8d23VijGihbwIKAfjcMbijpXaIgAo
oeGAnKg8/UjkWDkQEjYu4JJQwk1IF28HTINBBUsjp5duXgC3eRJdcLF7sSpagESdDAENiVACAzzI
Ew4L5RlpkIRUUEYoOVJUXQsRabRCqGQrRNHQLOBBZ4doxQNOcnI8nnLaPH+q0ZJaI3B7RYslNriK
q7GCa58meyGg4UJskIMfcCJkcHM0TpH8LQ7KvIQerQlXFB0YKAkEVedCPorT8wR4CpcglYBTQ1XF
AohWjJTpOlZFENxZF1S0EqwFKqlWloORESq+FpwhFyQj4Y6lPOeF4eDiExW02eJEBLq8LHBpRWGQ
YMsI1bMLL+kxQOIf4EvIPg8SHJ9XQmQgGqjwQK1lcolDkEZm1go/nAShRygOURRCceJs5AdzKZJH
QCGU2h/BlJETSgfc9C+v7bM4Lz+Xg5Edl3Fa6ET1xo+jpEsOBD5Orq/WOInndqYITkYeDd2pqwCT
VdZTSuQhgKDg4yAVpA4Vo+KJhikDlQtxZZurIyg+S8pWSAVJZ1UILgTVhtpqS+vF7yDdD4fTDRMx
TKIKEci0YhGdouuaKJVxE59QVXiQ+cEP/0SPorTF+nMHhfOMrLYyJI7LwtsotBIQ4aSTw5GpLSTx
UbpKBSZPmKS8pM1edHJuFZjEHUGCkhJABSh8ABDFUIC2pKDcQeGsUISD0x40mKljIbTOTG2JVzhO
I2CKWm/utlF1vYRqT9j4GW66UK7Jl7xVPmHTcmSZm0cwOE32DTJEIgeIQAZ/2CJOHc6eGA5xP4uH
Mo0rRkWbAFMih6fYwA3ScCFMHkK+HKILOECK5EVaa4kTTCbP3IK5CgZnKdZOxklHi4cTQC+xtX0t
3NdDm8Y9wou3KWbJqy4mDlE+EEhyifKJHHAq+ooL+T9Osr2VvLIK7rJwENFKsiQ3OO6ClhIy+jkv
Yp3uHdGJijokTWYVZJwaHw+nFUgUIYwcFl0TWqCW0alnuuIBUF2Pm+mRZcCLYPgsoSc8XGMBDRgh
8pnr62g70z8pkmespqhccNKYkO4NhOAROhmfcoK/SN4KYrg5n/DVlJEHZ+C7Lme0INxCKFyCGnKx
8KNDPG9mhhdF3ADtva5QNHAtjAAkCykCNVhFRMLLUbp4Jbi8fQJrbOBs/YUGw2f7MBmRDIsf0Y2A
UtSQdNdx7hNm+AqMWjSVkO2Qv2Lhr8AiPiUYLEIHiISRkAIXkUx0chd58vaJuPkRbhVzSdjLNYgn
VCQKoYrb4ej8MlbtAKhDcmWl2CHXdQ6H1aGIfHcUfIRHaYwKYDK1XIERAqg58gnOIxg+zyg4FX0l
kPhxKulEbgtmGI+ITk3XIvefASqB+QYSNU0UIdSICzBXGlwBNrqV2AA5BgoKhs8zoRbOHB04LLqk
nyyoL4D+yhl11yNXnIIVek8sytUzcresthyVgpubH5G45fdBCgQmQFgwfC7Qtk8VHJ1RByKX0DtF
GahDrUivXHssDHQJppKAGihHQpD4f7I8ohhns+Ev72JaDUAhavZCHiUYe1tWfSpzWmRYhAvg+OjL
JspALQS0pSjPDaES/HklcGWMsGSipMYhPgkjRHE4RZsrVLDxILe+qMmCPAfDZyRLICwKOuXsHp3T
oxYFQ3UNz7hG7fz5M5dK2KwaIKkulMBKVIuSGyUyMpEGO2JzydJfcDDtszybRDhUsXBHnDZHycZn
iWawkBvqqIjPJ2jj5OZOJWxuQnM+SVuJaCm3bPyEB8Onyd5YxsiNEJxQ2wve+ZlSYTrbsjDE4UHl
9JJ3lMDXRiisrLKkoT4eSUzoYPI7TBCCaZ9CWmEZp/vo8AECdrdLBtskyhpN8315EqNKJhlW0Vdi
qG2+9TYYPoVemoGfhdsgD61V4JhAdM90dlh0UCXLs9445kH4iIj0Fj9R8pXQCIsb6ysgCL+g+CzB
bhCVMI+cURwlX1lb0btkM8MNrtRRbLyvOP798KgGvmRSJZ/RKEasz5DcPYPiM4rt4ABVU5uzdcoF
EdD/sFCRboPJvjP30j1iWB2qxHr4uy/uYjwUFJ9CjGakQHrrryIAaklj9fDMLwgZJ90VDMoFxSWd
dfjvI1PR1wSVVc5IQfEpzJN7FiisrLp+S7OhidoNSUToOD5BlLNE/z4iB2q54Dd3o5jvfiWY/hMv
hVhhwiijVHsOnxXG6Pw1VoSaUS+awM2TYCAI8WXilGyM/BEuT3mqkYPjUxgH6+KWC2pqH2cYizTW
AjEWhPkIDeyF6Xpl4t53PJMfQ+w7todvcHwKEeyERbZC1DwzPbLwujBZOsAUyS+SvILu9hItWMpn
Hjn5NGVda30QX3o3OtC82m8JqhbFoIUCKf0sgXEKVsdf7FMJtyYzn3Xyn+ze8Wnq87z7jSq9YF23
p9aYWAG1podtIhOSCwBLTxYai4HCG/4rnL8QNOD8JczxPtvYllCe2rquTp11W0+riPWNXkqowL60
EEY6BGqfqEiq4y1WUTDid6/FgfaQP/Fsn1FpWI1XLRkPfjabFY8g/W613r1dRmtn6kKMXHEanT0Z
3iKlR+evSv5TmfL+/kjNzKN9mmJYyJN4gI/jAqySRCs8RraWl0bp7xCZRKma2s/Z4hhniM37QMFP
bhrv/ON8RJOL8A6eH/EwK8aJVqvVFmcFUoIqCLYsvoA0JImj9DO8RbzXVzVNwinK0Y3tFHKd2UTM
vIkpUOcaOCstnz8xvQKTA5Vh0uyMifKwDhlrDk+y8Bbqp4Fi5oQZaMWd02EuLiTyN6CBi89jaL6H
8drnzzJ2QxViE3ySWDGrwUWCCKi8IJTOCL8BoE4/7x8/hAWzM/ZdLAhN1EvBzJzkDacp38M+7Xrq
NPal1cFhYlUHB8phmkzAaZKBRsWEzCKgvgfyGaxdXCretnwnmSyd2PiyIXlDEURsaxBxfEdx29tX
2XciHuUB1KqoLZooJhXRQolQWYxPG/grI4eP3EqyuuSLxZv1hFSnfXOeZxR85OnlJXldB3/pap9R
6fokjKOJT5lO2QzR7KmLT9CKddNHaLQQm7OIXnrZc6GdtRLEmMJl7sOAKGepQfq4+BxMEx6YgcGk
RRxvoK72yQ0ROhg5R9OvbC2A+iDUrOb1AQvJNPYKK8WuBlmJBxBN5TPKHkYPRUAKgd662qck2YhQ
QeKVIdP7Jvumr48xbim2SK3vQPaj0J3ZWBPV458/P6JUoQdbimd5PM0DplWBSfZWoh6U7BAXnPB/
EK23dUpKSvUU6VZTjDcqRrDe6TvVsH/+rPJpDkPjdDVPGidgpKDYW5AoqWsfOLPZ7Icki8Or8o9r
zGt5FhbFmqRt9oryD14qbSoSy2tpbkZGSt2nu/+U7RDVUcKPQAvZtFA8jrzc4jF/MJiNT1+U/YY7
9J92KXwm6olNV/NUDBG6FbROWFwoK1ddYOQi/MxCnvHqtBO180FR9kUZBYhNQRkPGe2F6f05nyIm
OyQPcGW9BTAg1fBBYIWLtPZC44l5L9Xcct/0RQVJa9XnzwjWwsn1ll5hwNzKhkhpoDYtSBWa6Wms
vYhTr+jsgdOUvijmW23oP+1+hFfgDNQWo1bqPEmU9sn5lPzUEFsZGZbHagI9XmAbWZOYAqW3cvus
UMRCfJIhIpgaoBogXk7TbSxJkNyeZwq53UIUu1qw+NRR5Uz2Hbx5uviE4qJbsdo0NffhxGOY5lP+
slgo7pIyrHfGGtdVAXBwPkujeeKdPERpn1xxfa/M09YZn3+/4LqO0A7zMIY3R7uCCoBDR3Uoyfri
Ja2qtqS4RGcQtcMH4PRYzcVo1xieHuEm+yIloECcOJ+00AJAqXUq7VMMCqYg4DPT70cpQMaFSC5I
V4qXyut7QVfa++LQUa5Y2AY7BLXV2NsApRmHTGheTflAE9+665+R45Zjz7kSpZ+8H9PUruzz7uB8
0kIoUlw8lSn9Z6C22VWeyTbsSaLixmFO6CuJXCazPpPOkDKsSQm9xJ0F5KCjevQqgrfxaJ8cJe8/
JfL2LZ1osus05oHw/Vx/vEqzh2SwbzIp7mymznxdMki9tN2M75wepC/nMxHdJ9dbvDCW+0//VSht
Z1tuwi4PqZ4OvC0F4VIIVjGGTKMUMcpGBlH24kKaxzDQf34PKERH5QAnxkNuQgNp7ThXn2m9DqSL
QOh+TH4ZliGf8nZ5m5G/WBMji4ZHwRFX+6RhHx8N0bDPf/3KM83r26iJrLAgXClijbv8CdddWCW0
1UEsVIhk0f4z+QdCdFRmD9hbElFpoBJ5+pYznstlemEQFKmHtlum2/WzaKqBra/MDFdhnqJ9Z/AP
+cr9JxbA83E8ek/qQAPUJUM1NXIcGgQZ7ZOQxnr5Y1Y7Ew+mkE9hcFl0gFwefJCOiuQfNBCfsuIG
UNtSeG+iFaM9GuanLjokMc4yNF3fUlpo1rcT8G0+BRQg4XyWwviWD2+V8ZD/+pV0T3bJkWIwi9Dj
UfBJlrrzRHZ0siVT6JLGjmdE+8/lHwjRUZl4XoG5hRmSx0MS+fmWBSFe/r3w+WOJQlakdRDY8xks
5MBu7DMQa472ivnPXnI+hXGF+ECB1A/VjfVfJY+HTIpGw57y4QQRTRu3yfKHHQ00/A3BHE3BBUZ0
vCY9DH1lxeX1lfzXzmPSgKLRMDaKDK6s8g5RvNww/cdYoaDhlPksw5aS5sl0ihLq70dyfGVEjyUm
e19ik/dKACqUWIPU5mgcCo7oeFVM6UVSndzgosKB9DbtpFfVTfYmWInQlzpe9b9Qdg0imXfiUHBE
5lM4w5JkPskSBehXck5WmqOxZPEGUHKY1ESFEnQzyL8AiU6uSxm2MZXUlmAGwplz0idjM3BOo2Ty
YApLKmU+owsQSnX+Fn29Hron1zSQ4ubkMwbkZVThbZugcj4BvYDyKcxnO7jNJEIDjONjinqzxHE+
xfnk2lDA+TRl6NG1cLVFnW3eaNRrj0l37kk4zU/hHslKz/mEV0HlE5MBJ6zUQolP0e8DaKLnMB54
oMkm+w2korRcfQt0+0SFWQsongLUKgGCD1kQ7u1pjsYDyw0+jqKxFEQosRmR4F+QROeqTEkW3leF
iQlcyRWgdZTzHscb7ZhRYP0Bj5SB/jsUPndq0/3jbuauwVvse6oviRUT8j7bqGYRgpywNB5Ayxig
rw6ekA4Fuf+kSuOh8fsbVitqCjptQCrJUDyOXs/ZQjkmCeX4OB5c8p7JoYyHoj3S/dMXGj6F0ulM
/1lfWpGKN4Ier3bdtfSaNxHOhGElfCEr1BWai1sEKZB2SOeGIAj4uyVMv+fdOKtzxC38DbCpf7ee
ckEbDnd5dtzDx4zn7F7HCSL9p/YpCo9HI4qZDgVHtHxCdSvT02Od7YbT8kQ0Zmj38Fl3d4UreCyT
LoOJTSFtL1jkEHEWVTsU7U5TAFw6zzrgdTy2/6uV4MCGSFl/P7F6Ky633NDGiWAhvd3XiQZJMLK+
crcCrHzcdzd8SpI783vp8uSTb2G7K9NdgC1r6NdAesftI/yHhfyuXkbZC2NeM4xohNI66HRX4z5Y
P/9jMbXQfJ112lS0hW3tJCwR0hoh01lwut6tvcYY98IEWu8vXNkBQ0vNk7dP9Csynzu1OQfltllh
7YN8IRlUhppIGj7pL9GEz8J6Ib7UzUSR5IVg/zZ7II1qC2u16zdHXFxXhpdF5VkSH0QBJqACa37t
rY2S22yayt1Dp86VF33SUf8CQPJ1iwpMmVnjcCA10NsxLsaZdgDHX2u0E53jipOyyl0npzV/9tZE
3fb9Qul+/hRIHV/Epw4cKJYMSYSUoyVsRtpM27CvN7khXWqmE1J2QhDwZ7oB00FcKJIvPgETQCWe
+/046JRMwaZ+EswAB4pVix4oKU7qH4Dm3qLU2u/aE09Ui8WL+89TqYrUdRKnkPzwyXU2TqnL/Tip
7ZM+6YAZkGFiKaqLSXehqdPtOXak/RnLdolOB6AqrVTMx7jvfrPp+vtI9EmHlZaZKECxQNwN0OXq
XBm6+gNeiynSpQYLT1LMD1CS+oJWKc/9J2DiRtnUbO/HWeazDDPMsvGnFLl90qJMn6V1aQak639H
mEkci12Nv08CkRwg9S28upa88ynPY/gs8F556igjUwb7FJWkxxTiU16f6YtQRD1/CAap0cE6NFLS
f+awQm05QAfgwuFwqHzupJyDEiIz0ORbUJnkEonzSZ90QOipk/MJNrUjBc8sTLw7Zae3NnoliQgE
OG5vobGczzw/l1nldJ6l3OsrHTLEkpH+DhSG5snbp9d62xxFGv+EQdpWNY5bDzK0EAd+ClCpbDSS
mOkQjPANefA0F0zc/MchPi/hkw6qKH+8pv7Thn7Ft9oqBaVeh/ZumxyndJwOAusAtUCKfiVP89TY
hobuT1z+IQSVUidgGitMLooUFy0UvYpNkHJJbbqMjc33XaD7A4Cy4ExIpXlrkNgcjUMQYsUtQqIg
Yt5VFPA5D590EJ3Ep/JxTi50yiWmTmTH+ssay+sqVxjPn3npV4xcF0TprkAEkViHVw7hRAOAKs0z
V611ZXs2PYwDJSJxn4CZ+BQWRCOGmQ65Cm1Zgn+2XCPebQSGWckdeGXPq0l8xlH79Nd9epc2xxx6
AYrL75N8r5BPXuwQXl6hbd/vxolq64SyeCXI6eRfOSgoJW9Efq7Lp39ulVWX3yjUGZ/Ey3zu9JNE
623lWntB0vrdHzcTErFIiuoHIToVPoMt7X1WhfgUCaCiFcG3T2gtAX0AMMFnxqMW3qwUOyRrbeCi
jaL7Q+n/hMcBqMIpZaTyGZ37rcKtwfNNbO4R7z4GM7K9tASD6spn4TmfATvPOW3w12BObVvRl5du
NDeWuxNoBOHNQ/u08kWionT3KHLPQVeGTSKF41Ukg0ti8jOK59nRJJIsDfj02PwQAgeUxCURGqy9
lTeedMbmXsl7EIOVoyU1qB3Ulo+HwKcJ4wS/8gFNZVeb0BqLoTAROArxzEupb8C9UiTY9ikvVRcl
v0XdywDde+GyMaBKQnGJzkCzNFHp7EgmVcBkuU5TKcsl4dVCVrpNRCbnNEg+jWguuMMX7iUa/3kx
2vRV5pOPh0hzadznTy6xf7mCjPTkciyzFOtLeusAVI43uP4Tu8NxoJIru/vq0I0rTrad15LbocB8
mtLpzxm4JOpPxtYIMXs5QNBJ/9X2udMVy6cDpTpRsEPyGXrPPVnMcWVpn9KvxAGoyW8xJel9ila6
mgsLCzCzCa3FgSS48S1srfMBqq2gM++A1spapw77/MMUzmg/IuN424cJESEyn0QPNDeY9gmtJTPk
sdOz9vbdczdLb4wby8lwfd0aoJAKhb0Dyxkkoz0JQB2cTZyCsbf4vkI2Q5J3fvfpWievYOQGRLa3
AUtOj/auB74MFNJaUXpqnDgHMx4yAiaAoo16Z3e/rhmGQ9wegA55PiFQSfiI3js4Cu8ermxwtU8A
zd3emrJ44wTSB9Sr4HmFLcV95XTSLFicTfIGor32secXfRd4hi8cd8AWOaDAubdPC6eTyo3V5n4/
3cx+2EJ8cqQwRFLAwnxtWZKxRihbBM2S/lEPmrvepoJOiATtDVxcwLrkLVBn38v5pDrSU1nggksa
coannRTKhVoBUm6e0NsFO1EH/+tvjQkyTNobHxEfjDDzDvRjCp0Y4gYu1RdObIhfMtxKMGU6c+OT
BkIQapm+doMJXIF8h+piHqXek4BS84wNnJGvLYWwtBEdKMGk5gkR3tuJXMzROPgQY2eutcSk6cE1
T4Fh3EcWniqIfiXWR800XhEsZ4QrxYQyIXSfHMiB7pm0IBpJzHTIISarMwF/Wlrev8j0gJ7JqBY6
fOMK4VqH8a2Uo2YeHr7sEOHUywjlu+WfT5uYlZVFQOWdDk0PzgwJrKyejzOJTvSfkgesHBe+tk4C
zgg98UkS6Dnb5syK5zABlJdjfHBmSNDh2zJqV6gobQ+RC06j9zAedwKfepTk7ZPUgkSxt9EI04ol
Kz4hAUCpecrDA6N80ka6b25Wyj1QyLX7RKv7NkdNsKA6UrW3aJ3++s/O8fEJ8QkOC7XOBInnkvoA
ceoEM+b75HECjftywPD0uKL5ylUJMUcLJXj/yQ0RDkr73OmRsjOojHcg+84uOoUHaG6xf19iuCjD
5PN9HpXLebHAIHl5kirPK0IaCyr5DfNlb1PjIRcobWpCQpaSR3A4lchIejeiE0rgr1mRvinP2YEz
K+P1/Sd9YNYb41srNU7KA+LD3po4TJ51CobwchlGZ+Cy5FBTgkPSxOurcefFyd+vyITybWpy09wM
7+0C5uGDwXEbXOYWHZQgj/uiNdVIITbl6xRnVqzsMgbXraSq94VSlUdp+RId3pdhCzReT7RPmr8N
mM8lWgKmlQposRlPIQP6z4dFUo7xkNENU8BwSJLTpwbXrWCcGOcqsAx7w+XOk4O//3zKgbZFwyER
I/nAQKPwLb1WjOwkLUyFupKQ8voY34LOvpKSqrOLHotD9VOC/JyMrhQCimriJ1Yu3josT2DFU2W9
s3I+AwN9izXWZjkbN7hkWCrgQTjWnO0TrVPpSZDSmaUoMP5KsTajAG6LZnyYviZAxABB4FO4wpLQ
rPg0tbzuLdDiBExUt9LkFxOG77MLywABlgjN8Zydkqw2TiRMSIiVkxuDngQzQkdUqVBMdeXtrEP0
CBCKmlLz5O9XJMxUm/xm8yEzVHEFlmGbsW68BbSet06O17v/JDpdCYxOtVdJdf2JIVegHweWarhC
cn4Q5QoK6CA+hQpsGvFJBld5keR73Zuc03/42wbZPQ7f7ZQyOLj9IajUh3rb21LJ8ZlybByjEvoq
bgsm/FzegR2aPxeU382DdVRCBAuNA06ik4DSqjeJ/H0LbYC2JYmHlWG0rQC0QdZY5AHIUvudCDRH
48AFRkh14q/tuZsngMa5AwK5Uh2xanB+Nw/mfKKFfmlFJelJGx0LvTEL1ERNb+JVWYPJKLsCmXlz
CyTlwnXXm88oLZ1Cltp7orvAPIYkBCOp7htS0hAbTIoccXTcp7Td8DvxCZgACowqn1KOBNwDfyES
rwcbNaOPWebTchVSWW6zcRQ8+TwXL3PPE5oS1KYKM4Rxdazv/L18NfOCNF2cH5H5xG61Yf2tQEow
SYCUcpMEP/aIr6/Ga8HegjGjrkwmdBYCt9BjJ5Kao3GAeNJpVNVWiMJ4XtthyLF9H1MdF9QAX0/A
aligs04ONFVg38WhfXKg1Dwl2d/tkq/dR+OQmg237xeEX/BxGUhU6CSsnnx2iR/jTgQzlKlcpSKm
pr/QxMnp1Mxn53egoPApRJnZJgyG1PbpKgsrwyTXhZfDZKWdwJZyfSVO4eB8asd9xuR+mZpkqara
YqduiKQJ8u/EiMLhCk3f6XLmxaFTI8+1sxdsMLZxXGtVX5wDdKUYS5mLACAxQzaImim1z0VIZt6J
A74Y8KBT6HxB+HU8D6CXZUGaW8xnizwNHTLWuJx5cah8CsIHdrYpk8MUTFkTVuMPsBxcUksdvPjJ
slRayCigBFSiUibWoX0uM8X3czUtyiNFimJreGYWmFuJu3I9YIDrcEXN57adOncp2CLpWH+TTTKd
x6dWp5S/SnLqwLsjZr40xvedX5hhmESqChKBkdQWjKp8RlPOpZLHSHR2S1nlicOizhK5g/y5omCx
JDUwnwM/N598c8WQJ20pNdiWWgki/t5lwohrbRqiA4GcOjClr6sopUjTcLuhncykChNXFlH7XNYv
vr9aQeVcIUx2QG9jvYL8XRJOV9wcO8n4S+Xpr9NeLjQz9sbTz45BG6WulLoXGzaw+9pOUNmpBi/d
dK8DS71mZiGzQCHxSTrLx/B0pbG3UfHJkrYAejjaLHu4phU8w31doX26cfbK8cW/ryQ5/LR8Cl3M
wJlgs9HACFABlKBisDa2TTq+s+Jg1zVa0rRSpVXg2VA7CRBlpFBXVbTjoS79vOksoagtLZLKURk/
HjR0uqCGtfee0FADAp917mATFo+wH/pa+cBIIn8a/XEHuvs/7YaPqjfkWAmvYd1HNzkyB474kal1
2dudSGuOFoT/a+/ao+Qqynzd6ZCw6XTgzsydyR2ynUk2IuGhPQR8kLDbRDHiMw12YA6bYUCSiEqY
uBAMnJUBQeKK6BU6MAZmB3GPykNb4q66QZmIenDRQ688Fh+wM5ztkazHYYJiXDjK/r6qW/fV93bf
ut2T5A9qpm99VfXVV/XdX71u3aq65uZg7dSH7WKrx6+eOvQccPTckEDP0c3LXTzNz0LL11O2S6Gr
1S8YZ18pTW2+8lWYKzETSyN/u8RSQ8RVJS9P/cxe6WQPmpMx5eGxyHuB+8S5oM0akHx3+uczpHe0
vf7Fh8uMaZKBDtZ+rFpCPqNeP2RPYA+RclxBqEXwcSxBUv3kl2pVtrd7UQiCauqd8rRY6GnJpBva
WXQsBZtr14KG7C6Duf560ZCmHTwXVdgTV1COybicXur2XPrmEg/natna8dcNXGMR2dN/miPe6EQf
I8+ZUNTTbYiOUdDTvIzaFVSyB7+k2TnpwrivKnRAybM9g1b3ePoGoMaxo+pI/HQRja0M8bS3QQH6
jKxdaENrAiM9aOAnW62OVCRbIGD9P2EBIrqJHx5AsZJ4zrCfV6m3ryLbJSsQw3FmMf6xUeNqciwR
jxtejHEXgvMJTmxUz/KTtss7iedhiCAxeKpaImxxPD2N5+/mSv7APo9YE7F78FwGJUlLNEPCL+za
NT6/n/jACEUFloSnwFhIqIPnImf217DfmYUlUus3iofVgvBeXLMirZZdL9G2XJY55VP9MtDGc4zd
4NSzqOrJo3SXHyrRzSA1ycIFOnKyanvY4/g+mYTHdl/PqOlJBddu02J8x3n05Ry0fPz9Gz0pa5zu
Yd8GSKLgoUH1hNeQt2LhPy/epCiA5ZGgYpWU5hrrE3chVq4Pl6AZdl63jSp0K5ACPQcsLq2nEZ6j
N5WhJZ/W8SQv8By2F1VzRPpryu36F5cv+9xGkY5+KT8uASWXMxOmXEf0ofDAf9USz2V9nlRs0iz/
Qnoaanqi4BYLPG5P/TcsWdp0nDmlZnyiUeQu9hSVWqAiFOUCnUv3u3F/YB5/Jy865vjfcjYoSihy
RHEhfYWivudPRwoRS5zqqRtVX0gjh4GSI4pZXT0N2kSe+YG3wNqSOZ4d2AuAmi4KX7DcLslBx2cq
uNgb7sVbehvPKulHBrH5nSpWo+vnMZ7JOquRav5wFFxRzOroaX4sR3kM0dLenz3DzzMmPAkX/+Ia
Ayegvn5jsTj1IrYpMxxwi9nMU0kxUrRKGApEiYLBJbp+Dsre069DHNcASg6S1vXo9va8RwHFyaFa
2v1nee4AwQlIuCmQPGl+y9ombXo9nQ/xxCV6O2oobi9xV+0oguJVtA6e4wulVGUb/a2ooFF6dtEe
eXv6PES6Br8l8phfAYkoHzavUV5QsElYOyEsVRDnL0JRKEmqcUA9eEa1Q1l2lytKkTJwRwsUJ3yc
YF5e9p0EUCOd6ufizBWonjy3BI+vW1kcyBtmqJfqu56iIsvxFCWAkOV6V0FE1s92+9mzJhNxPJA/
nrHQcd9t96JKrS3UkaMhbFBsYUFOkc3A6HYmOGzGF5707vklDh/YKRLHFCTiFnHbI+vnrnhDtvDc
UuGhkJDnFeNl1KeTeWcQHhe+hGcvlvjhdsEQTAUfb+4InxOO8e/idwUvs1DRVk9oyCXgPdJdYMv1
4eI3Q8mbIR0dUbVoQd4x8kHdkU2HJqVudpzhhEaD6+/TOBlyqCSO+Pi62Bk+Nxz5v8IHBL4GPOmm
8H9eRUFzE5i/9cYer7ln3tAGtIHkLPAEXwyaVwHMxwoIqWuAZ5avCCNFq8WqX02+aiYQnybcjlnI
7wkvplLBIkXnpSsCT6OyNyBKxYlFyUULEQLzQ13vxaFJLzUWpNHbz5em0a3wUkuSvCakFR+ah6Oy
jiyhjHNAoStpJ8EFYU3cBRG5Plx8JmRxvS+8gQOJFMAy4QyRif85NLONwQQj8OyhwS0vuPbQigTY
JuTpnRJaQmNcKuVQj+NJdBFUlVqLCDwXe0ZDUr6CDfEFsNNtloZm7hrWTMGs4ZjBBTTPxDGxpARp
B2sD/KngdKVIK0QhJUk3XEHSz6mffVKGtLFzqRkzKjqWYXesQWX2gcl4MoEnvhqEPW1QNOS9TqA2
kEyaWDSegUpcPa6qUJhriRIchedMshlmqYch9uW77x0uyHkWSkiuKFtD90lfroeq7pyay+yvDdyf
Q1ypFklR4CfwtJGFK7r/HP+FKzcBlcUKYUQb/6YdF/uKUzEaIJsbeM6Ir8ygObFsT9cKmRXmE6i5
jaQRL6lVrhw5RXsUVT/Npppb3oHuQ8ZyfTx3+Hwue+JCTsa6aDiwbR7wJDirVk2Uz9fOCnPVc1Vo
ieIKTYuIyBWGAzbaW9EO7Q0IoxNkmzHGNOFpv8/OnuT5clocqcBzeB6piQparI0Q0t7yKjtO6gkM
hXqkNRCFH8Z9Z0BQrg8Xr6n51Ic3MAZt8CkisT6ha4x/milGLMmiYdiHBdXU4GIEXmOw6zHoN0gd
2CpSiH4cVYrLWyWOa4SeSVf+yPSzvH7yHRd4ryc+PCXDGtuEJw1vyYTguaS2sPEXc6vs6khVEiQ3
RFehqaOn6Ut+XW0V8IU3cmT5SzO68beX2YLtjdgD4ZrQU9TPQBicBtsb9JxBB2bSAwsMacgVRTEm
N8fY0dMfc8bTwftD4rlGeb/y+fn6F/CGZDJeHJcLeNJXvTAgCsVTH6vJHS0QMNpEdYRedpElG8pW
obarpw/Q/BFuqkmo0enqJA2Hbq+wnxeUBWgYMdJX97gJiT0RnEY0y3263m2vRK1yDKGzsOGsolGU
7ZBPTTOHeM0YIFHA2tCf40WQpS4HeP71Ag4nNA2J385+4hfaRXOTnfS8gghUqalakqZAk9REZuQ4
3rcix2Rn+AWpuvj6FAMPYU9bqlHBr+HTPxnqV2CKFjwCxswFRqU9rIAh8akCQFwJSgGnKLb9KCBL
ISTXp/vwbLb7pJfaFpZlsTYL0pUN8GxnL/F+xXlV4xOyi53qc08sgHMQC//J8O6kyp/KcJuqUBlq
6kPX4lLe6z9krNnvZELPaTrLbMEkhKsbjWbjz+TjhGK1EBLfKGf2e71z9Lww/hO+RqOEFZ5FXMTy
R2dRYO+F9PC+FIsbPCbG+x8Pdy2JXcD7MJnBPl0bFMcHeOrlZwWeRQiqNV9kqa2uL9+oE/xamxvM
qbJFc6Vbdd8xKaHzdIGI9ZzQcxLFNukzjwbZvfLznyEDBQQPs9R2JwcTGQs1Wr59d7y9RDtNd3Vk
AkuVmx8mTBf0ocQzo4TnhjQaXN4SFbz5lTQ/eNsSLqNCN7Q30DZJTmH3fhf24Hwdq7I9AXy46HGr
kqNbplEZksJJ7S2+YXnDNM0PFUMetCk7dPD2r4/tJ/J86h2cNV3kEzTmK6kC/MoLdf8qjITr1Rzx
66c36ney/Y5bkSA8jcqzfIQLTa3Q6MZNDPPdpx23bXOZkPxd9NptEx8CPQss7bgffjzdeYDQJBp6
TmOF8ljyIbJGCeTnFFFyqevfF5HeC/QuisxewFtJvXrgwJXbtm3ahLbeNZsue/G+7+GUaxIxk7ZM
/76mMSrNyY05NWUtYn2JBRCe6JVe4iMF9PcWuUOM+ZsTV0FNuqGXcoXDL7vXTlLkJWwuiu0IkdLk
+iSVzMYGgonMZLK4iKVRzG4cPUkG3X4/ucONObD5mq20UnzOpm3XYPnbn3bsuA5f9Vi+5u38f82O
VzfZDbY5hnYRPaxHTtOzJpv2meV5HoGKJMeTjhKd5kPUaEClXGOcLZV0lP0Km0dwWp5wo3KGx6VO
ZjdZNWdZqUjROPMudqbAM/gaqUaU0UuH49c12K+UmiQ4LQ9bVi7s8/ipkNmN+lDKK1AlMngFnkal
rYgOlI/HAwLWX7dsx7aqLM4772fzCwGOgNP4LMus0A2stLcDuJ1034kUni0YFbzYSWw0EXOIfZoG
4vR0ZQkf+4rpQzLP7Fn503vu+emqCktv9YXXOLoxRfU6neC09Sxxuzu6L6oREe7R0VSJEHiiJRIz
BHjiKHiT6SEduabycpc3uJZeVOY9i4lNPxYPRT0le0ndoSLnbHAZpgelxEazY86w16EhooLb75U1
lFk7XZy+7MXj71u5as+e3avXNGqEjmHzt0KAiWJrcUEjYvlKexN9ApfTxZ7kdsKLjSfuN16BUbEt
Fi2PqCH3rY1pAhizcq0nNITsSBXIlx7VyCbKwhUDpAJZyY3cD5JQgibjDeFwdWiJf0t6we6a9Dgw
QnyZvQVdZh1zUvoSxDBpIwGPiQLM7bATmnyiGznyycd8JFriidFcZjtKLowNREjC2ftlLa1jZ94H
PfHsbXEBI0VB9KQL3J30UvfZIYZQzeE5h7X111ZQJ5iIYayD3IYTZ+qYD5cZqvAI8BQxQVhENVxm
KdgjrxuabK8dPHUzz95EcEbj2Y2vkERmRAZkf8+O1LHLx9azVCrykGanTcbp4b0Jo7lxl1SwW6ye
np3x7unVaR1HWFpcsIndEZwIX8bFg+JcOmvfC8SJ5vK4eOrY1Ju6pJ6e7WyFGzGa6kiPoFBYnMGQ
FTVkQUe0hNqQ3iart655ZQ6ztkLJzqHX36aNSvpYK8Tf5zXyQm6+6ayxN3DfeHBzeLazZ32JqDu8
eOrGWP05/Y/QqnPajxRtfv89xp4sOZUcVNGiXC1OcYvIBKY3Xo2pI1nzheHLmN/2efgd5gl1+hMn
6AkLyhVETI+eflFKrnY8tjdpfHjqOl5GPVRHIr7B9+Ntwly5eVvY/9WZTxVMV09QQuU6y6DrpGcH
5bGvv0mjBeKfDUWtgJ/HaTR6aKBlhqSnLaMlevYEvjnqyU9sMoCnrn+gwh4oREY3Kksjw3hAB54q
DIyULcFGevKGKOzEyvqS3NCxZp8BIEpzxdkUFP3lhTW+toeBwU5dQws3DAyrLMGFAXNV6JmuG61e
ID7VXi84XlgNnrp+XpmlboiIHQvPUtUpt3zAXICw5OMhM5eajMiNgrcWwovlHHTOf5gxGj2X7UL9
LOGpx47OpyhoCBiyQCdMfojfOYEXkyEsMbxC8MRM9Lvx8drtYbEvavRWmuonVkzY9dOs0lxp0cKb
YeifyBjlFKI3bbRQCQYWfGYeK9SE3UGvH965bV9NgONBuNFTrPAwuJo0izY8z2FRI37HvqYWIZw7
FE+wnjfOWOoNwTi97Fe7KxgQPP7DqJMySE+aIrV4VAOTiGSsrNyXHZTYyJ2tzBeiGjE2CNeiwrHB
HqtbL/EH554y9dLUn95zOnTFZuADVcsfLpbpc814QBEkJsCn+//cqN8NypHuwUYVRTI2sKPwRDS+
KcTfHuVTf+HyzNHN199dhrK/wks0lErXUP108DShI5n+j/IXMy5XbKo7acRgClrQw+M2L4Yqv37J
47MBq9Gds06M9dccjwldlnn8yzduLNhcKLc4AsLeNm7g9fE03qw+V0kK50zSiJ5Mc7IOngjP0ovP
t0w6kcz3ws124xwbCWJp6sX7qBSnV+NQEEv0H6RdgeJARaJvy7E3kVPdLMLcRGuM1kDMCz9De3Ss
w9TF3nEdXnICxN0/vHHLiPA3By5b/mgFnnv+441XpyaxyVicX2FQRQWdZ087AtSIYbZfLUIkd308
Ec24qowvuG63BfBxPF4QXn+3UPbLjrLG+o/z5okt2AfV+KkBuMJUP8gWFCLTrxvQzpL2RjVitRqf
Go/bMGrIfKXA/d3XXgDx+oe5squ/dGDaErFKmz9ZYc9y9QriZKzp6fMqma0iVPmab/rx2kmyIZ7g
NJ/L0ZfSKU7guQyn9iyn00PYM6vX2MoOjNGB9DDiOl3Nsx85qakRnS14HpMpapKoa2dph+vJk2iY
Qtq/Etrdh5+Bsr86bc0fq6P575OWjjk7eVPSiucxqVYcPIn3gvvRpq61AnhKKRi7T3+cn8eUYexm
R0cQ1eRLmxY3PfnlZi/k+dMT6CX5jtl/vzIET5cLyJ6Qer+t5hZhl5MubTLH0wVXdLNUXDyRDm1a
zmAKF2cv2f+0IhO0cFkW5aVz7igdEM8/bjCN69nsLvJOYG5h/5ogVlQULSogzP/50zH4eRhm9Up+
Xc0Np6V71RM3Cxy3TPOT//8xUwiT1NjPyKWsxlyxORTwhMxsatmyty/3mzVrsLDGMWuWv2t6CwCF
mtB3qjqWdEBzDntrbCViMGoxeFyWrrYd1+04zm+uuw5ey+hC1I7jjv8EKQpN6ZsVL7DvurFVqGwZ
DwQtNGp4GvN3NDTHEZzQka7Tv2U3JMvs+cF1+cnEOLE0h4pF9O5ZtfLhVSthdvPrypVkSY/doE9G
vSQkhckvGIglN8iEx+ugV3NuNTz17LvuGWf3/ZSbh6EVTuEkjXfDcGVphEho2uY89hRWe4uWWCmf
LZotcdPUXDImNRF442qvl+Mz0v0f+hnLvG+Kf2eFyu6fsbKXjBVTtmTLVppbjSDluLYinog45H+G
MGhtPR6mMeOFadv+0c+w1F+moOmWqU3Tz7H5A1zPSTfBWFSrZkvcxDSXjEkN+gc4o3ja5M+Z0BKm
VDqJ/TeVWizOxWFA/4LjV2Kfc+tkoLsSKDNOSGJCHc8N/hYCgPG5LoEnITrObsZ3KzZtuRg7bqer
VoLqOdjo7Ya6uppylI7MlqobibYJ4d9TSftvZfOm6ENIORyTU7Vc1thUd/JHnMg01PHsRptKj2i2
Qf0jPHntRLHFvp3+3jTh+UH2dPwjbqU0bg/VfVjwscZ2aLE5HcZxPGrOsWwnn7rk9ROT8GSwouYO
9nUU2/HUFSpnLjrisQQv6VjRlVFDqeOp38JSOffjJBxPKGqriRUYpVJ53qZNz7H/Ksb+8ogvWzMt
m/zyiNU8dEzSyKU/UXbepA+IUstfABKYUHNkeMHUpiF2IT6yF1Okl21J8s04XjEBOgGe+hfZUZ3O
ygiD1096KyYMVO2/hf1xS44K36gVSC6Gc3g24Iw/n+DNIbLirHQx0dZ6WyFa8vbP7OsX8QVcRsEb
LRa9iPnHIbEiNWZKgidWXx/pZqfEexXZClHR7R/JzfutWD9dbJyDAMdw4q1yAUF+p+Z3xnQNsf3D
cnEEnagNRLmhRggrjAvDc3rFALUUU6DDtqjhdgqHVYlIhCd20s1d5Kzjppe5Ak6oSXD2j2xIl4/g
2TALSrnBVsTZgTNZ/cT+sUwhn5IqUAW18aTmFoBi+8BSETopmeLZLVj5FZ5QMjyx+aqvx5nJM2Xn
yYst1BzZyVhBpKdYcHsTv6MIV8/x1RxKjRhv82z3GiU8ASUfJEDN/hLfP0kSs5aK3Fa+afCnmxBP
bDG8cMKZsqSFbmTwfV8LnxHAlo5e2TmoVVCnt/JnsgUuLaGMbta3yCm4+ihXE4ha2IlEig45Cyyr
CgnMHpzufgeF7HDW/JH6uAQNK91g6PNnFIQdSJb7MK5ScFuwLjNKDS0qoJH/how14bS4VHBLeCbj
etLeskHnkUNhSNTZyhdHgfwnrZ94elrayfZLaYQnVU/hHrE8k2XxC+6w83AgxbbO1pKKwpH3RqXP
jg08S/RnCffIiOfcv9g9S9cswpm8fupDbXp+rikU4+UWJdeyndb5/kkk4d3geucsDYV4slqDxGuD
bdX0Xaigc7KiRmJJHxVb24E2N8myRf4kV5tea3zU62dPQaS8iO3vSFdF7TNpvNcvqyf0vEX9LVBn
i9+o+O+P5nfGcE1cK5hQO9vZxoECuajcit5ThJm71PUcTlsi8qxc1fHM99kZyS/sxrnzvKzS9ipP
scUxLk6XEzfXWbYwLmsSPk01klmR+Rls62IrxAkaJZrnK3pEqeu5we2kPHJaRirjucRZQdmRNtiZ
A0WLim2pVCLCMerbrHItf9XgZIYIzeeK4ehgGUuwdbIBfLujWuC1E3ja3jyQlqcqmZ5mNwQ2SE0Z
zwkmC1gXO8D+r4qTu1E5AWjBm5JyuZ3dVigBnnnG+oRGZuUefCAcisJgLORVU3l7Q7czC+MT0zqH
Kp5mhTlTt2MsJdXEpJAvT7RMXsVMzOZYiDKiqeQGvEuYOJyHovWyoziYVGzdMQIX6BnfcneDi1F2
nm8acCYNVsWzA3rKeYRBdqrEs1iyfDlYp9Z6drRotb8vDz6H7Ax9nnUcE9BTNkQT6SrHs4TG1tfa
4hg0/0vvOgJ50JhiMW8krzZcFc886dkn5GB4y/XkgyG/6GGl+9eedDWVP9F6LqX86DgyjfS0I7Wz
K0hPtLXBZoh/7KJesv6wYVkT/N6tdCniSc0QY/bDJQ6sJD05nJYvU2qnZGF23xd7NhyKeFIzhIbI
1qp8KrQs0fxX0faxs9il9OZ9cLY7FeRKEc8JrqdsiPLzSlCUVPX3npiuv9DWOIZlVGa7U0EmFPHM
Cz37RPaH2kjPUm317EjH0E+ynC/fxUiP2bDV8KTREBm7Pt2ZorpJvxF/3tYpTA/VnCTsF9Uilxqe
ohlyRkQ97BJ68KzpPfWZefGzd4s7rR8/kjKnGp6iGXJGRN1sBcCkkmv5Ex5/0u+u5xpPBSLXY04c
pobnBC+1uOznCZqVH9l4+tNX+VDZHa1dH+7PiOtSwzMv9ewTEsbmjoQ1Q4ZCRzGeKghZs3tVwtOU
asoR0Uwb7z3ts8DcnE65ZAPqjpbspm+QCIKV8JTNkDMiujPFO5XAQ1njVB0O7N4oOI7ZJJTwlM2Q
MyKiBrcEYyXN4qUHp3Yq4jnhlFt7XIeJTXSepZGken6BLUgaVfHOKuGZd/Xs4+mYlbeSmoFRX+ws
4HCcpbGZm2NUqZ/ioUzoag8E8vNGaJiQLA//W6l7qlMyoRGxVPDsxgmbFVIzvWfPd4S8wTkG8AyM
+iKSCnibn2R1jzoKsDfpVMFTt+jDAzB9OpFkOjIEZ4HTahf6yuObLbU4TXCrPuH22nraSbaz/f32
CZpKmRjFBmE6oPKgGSU8kauAngb7SYJmaP2JlXhfeWzdbThCUVSewfS5kcYXjgSm+tywCOrct0HL
zDcKEcGz490knlilMFJSytnOt+FGpR+5RClS88yaoog8csn63Ei70kqDBL5xP/WNfa6Ag0Q1i6fS
N5SNy8s4ReQrkwdJN28ymtcRg+4N4BnygbMoKeZFp1O9nIwKn1X/ZvHUx+L2TM+jw2QnH+x6KW+e
JomYdj6Ap86/C9U48gX3IuK3XmrMOEscTePZE+dg+HOpkf31zdYsKRFDrBaDx8tSg2eDb0JR3J3U
YT5+rOWVc7DppvHUxxtU0FEa/KTWFg62Zv70NL+zoauXwfR52Sbqzr2P3lTGsOCQdCXeTKrNDyFm
L9RkfV4R7XWelbPYuszSj016+Q8NrSkmm6/R06xEFlw6nynzyMEf/ITo1Hz91AcjFiDuxCnPmR8c
qg4zoGvzeOqdoYso+PlpD2wMJHfInC3AUw9bIPz8z1AxD21X4runqnj21tRPfO+z5q3uuTgijj0y
6Uvp0DpagWc3878G5D3mLw/dGC/sjmphnnX88iF44jseS90oO+lsuNRhVGR51lqBJxbDia/t6bp5
Lo1+0gd5UsS9yZGUFhkSHhCKp341y5zyx2Jp6g+PAu7MVw+LHtOf/5bgqZsnkX7P4MLSh6OW6us1
e0mXPv+9gsu8qkwB7MHX99eEHRYercETqhibl6258bAZFtTcW63Gp75HnlDrq89zOIa2DM/DUTlP
njQPHYd8Dc84d+nQ8WiKSfe+Vj8V79jBZVfF87X6eXDxUU1NFc/X6qfqHT64/NoyNKAL8KNPr70D
9mL8jsbvzPe+44Q5eREGJ6OwTvyOxG/t2896Wwq2N+7r4CY5Gn5R9CKbB1bbB3Ch3xQind7GWEcG
J3jDpvg7brwx/59n3pinsM/Zfu+B/xz8rqYMwGSPEmHrQPfi9wb8vPKXwk2s0s7a4cH4Xh2i6LMR
dwgZI52Pxs9rHkT+yGhtbcvOYdvZP7DL2UZ2qfBMcB1b9a5TX0VaTy36n4FXr2GM3JSE9B+8dWIO
hX9n/mV/cwr8pS2TknzSlv6Sr/ffclz+0TO3nUJynodSZH/kO+fMEO9nNINuM3snXWCGfnNVJ4Vv
+9A+rulX7fTHbFtwIR/39hwtaa/9+Y/d3U7xHx1LTZM++bTI9wo7/9LNfsyOuHgbh8wpP3S/ZVla
yNjwcXBTGSP/g4lJ/jQ/JuSmmyH9G2Ei+aSNqNxITHLr7udYfHPtOTN0jzgmsCUmN2lv4Zj02/EO
V0w89Y/RWmDCCs2Kt17G8j+Y2LLT/diSmxd0278RtjK+Y9sYSWxtp2MRtmRcbI/n2H5YeL9W33Af
ZNs1W22gfasdK9gG3qS9mWPy2dcwce7R0Kn+ekJuqifSX9aTp48Q7bu0pQDJJ23pL/nWt/89OwWe
D+y9/lrZBhJPsJ6M2hFb3QYOzhX5PsvOv3Sr9kvtyB+1e+jynL6rHu1pM50xEal4K27uCtgvw6b4
ckxEYVO2nxwTkR+Z1Ucx9grC1oHuxe94/Lzyl8J9JH7SlmMieHEj4y+Dy267X/XSZ8PfOw6aJ6Lx
q3ccdAb7GLuEXcg+6glXJbvsCGPfuncljR+kmfnwy3z8Q+NV6Ud27kevcP+8bcuwH59x2uVUngbP
6uTjmIdOfsP3yT2883bJwsc/Mr514mmXU8C6yx7ooHT/9tpHLyD+l9nDD26F/4ETRXziofI6fOzN
R3vzN3zbM0CAzKe4/wVvFPw146A/iPK2/ffCzttu9sgf2uuNg6j7oLE4pX0cfjROPz7P2HLQi/BD
jv6OLuLn0hLzixAgyyeVn4vxe2A+YxXYVQTQGFy6TwH9EO7BCnYPQqXhMm2Hl5bhfnsZnJQe4UX5
Xozf0fhRvtvyIgxOhvEdf74g+mib/n8//WVUWLwBAL==

------=_NextPart_01D75918.E6EFEE90
Content-Location: file:///C:/8467A08E/Stalevo_clean_files/image014.png
Content-Transfer-Encoding: base64
Content-Type: image/png
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------=_NextPart_01D75918.E6EFEE90
Content-Location: file:///C:/8467A08E/Stalevo_clean_files/header.htm
Content-Transfer-Encoding: quoted-printable
Content-Type: text/html; charset="windows-1252"

<html xmlns:v=3D"urn:schemas-microsoft-com:vml"
xmlns:o=3D"urn:schemas-microsoft-com:office:office"
xmlns:w=3D"urn:schemas-microsoft-com:office:word"
xmlns:m=3D"http://schemas.microsoft.com/office/2004/12/omml"
xmlns:st1=3D"urn:schemas-microsoft-com:office:smarttags"
xmlns=3D"http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=3DContent-Type content=3D"text/html; charset=3Dwindows-125=
2">
<meta name=3DProgId content=3DWord.Document>
<meta name=3DGenerator content=3D"Microsoft Word 15">
<meta name=3DOriginator content=3D"Microsoft Word 15">
<link id=3DMain-File rel=3DMain-File href=3D"../Stalevo_clean.htm">
<![if IE]>
<base href=3D"file:///C:/8467A08E/Stalevo_clean_files/header.htm"
id=3D"webarch_temp_base_tag">
<![endif]><o:SmartTagType
 namespaceuri=3D"urn:schemas-microsoft-com:office:smarttags" name=3D"Person=
Name"/>
<o:SmartTagType namespaceuri=3D"urn:schemas-microsoft-com:office:smarttags"
 name=3D"stockticker"/>
<!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext=3D"edit" spidmax=3D"3074"/>
</xml><![endif]-->
</head>

<body lang=3DEN-US link=3Dblue vlink=3Dpurple>

<div style=3D'mso-element:footnote-separator' id=3Dfs>

<p class=3DMsoNormal><span lang=3DEN-GB><span style=3D'mso-special-characte=
r:footnote-separator'><![if !supportFootnotes]>

<hr align=3Dleft size=3D1 width=3D"33%">

<![endif]></span></span></p>

</div>

<div style=3D'mso-element:footnote-continuation-separator' id=3Dfcs>

<p class=3DMsoNormal><span lang=3DEN-GB><span style=3D'mso-special-characte=
r:footnote-continuation-separator'><![if !supportFootnotes]>

<hr align=3Dleft size=3D1>

<![endif]></span></span></p>

</div>

<div style=3D'mso-element:endnote-separator' id=3Des>

<p class=3DMsoNormal><span lang=3DEN-GB><span style=3D'mso-special-characte=
r:footnote-separator'><![if !supportFootnotes]>

<hr align=3Dleft size=3D1 width=3D"33%">

<![endif]></span></span></p>

</div>

<div style=3D'mso-element:endnote-continuation-separator' id=3Decs>

<p class=3DMsoNormal><span lang=3DEN-GB><span style=3D'mso-special-characte=
r:footnote-continuation-separator'><![if !supportFootnotes]>

<hr align=3Dleft size=3D1>

<![endif]></span></span></p>

</div>

<div style=3D'mso-element:footer' id=3Df1>

<p class=3DMsoFooter align=3Dcenter style=3D'text-align:center'><!--[if sup=
portFields]><span
class=3DMsoPageNumber><span lang=3DEN-GB style=3D'font-family:"Arial",sans-=
serif;
mso-bidi-font-family:"Times New Roman"'><span style=3D'mso-element:field-be=
gin'></span><span
style=3D'mso-spacerun:yes'></span>PAGE <span style=3D'mso-element:field-se=
parator'></span></span></span><![endif]--><span
class=3DMsoPageNumber><span lang=3DEN-GB style=3D'font-family:"Arial",sans-=
serif;
mso-bidi-font-family:"Times New Roman"'><span style=3D'mso-no-proof:yes'>63=
</span></span></span><!--[if supportFields]><span
class=3DMsoPageNumber><span lang=3DEN-GB style=3D'font-family:"Arial",sans-=
serif;
mso-bidi-font-family:"Times New Roman"'><span style=3D'mso-element:field-en=
d'></span></span></span><![endif]--></p>

</div>

</body>

</html>

------=_NextPart_01D75918.E6EFEE90
Content-Location: file:///C:/8467A08E/Stalevo_clean_files/filelist.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml; charset="utf-8"

<xml xmlns:o=3D"urn:schemas-microsoft-com:office:office">
 <o:MainFile HRef=3D"../Stalevo_clean.htm"/>
 <o:File HRef=3D"item0001.xml"/>
 <o:File HRef=3D"props002.xml"/>
 <o:File HRef=3D"item0003.xml"/>
 <o:File HRef=3D"props004.xml"/>
 <o:File HRef=3D"item0005.xml"/>
 <o:File HRef=3D"props006.xml"/>
 <o:File HRef=3D"item0007.xml"/>
 <o:File HRef=3D"props008.xml"/>
 <o:File HRef=3D"themedata.thmx"/>
 <o:File HRef=3D"colorschememapping.xml"/>
 <o:File HRef=3D"image001.emz"/>
 <o:File HRef=3D"image002.png"/>
 <o:File HRef=3D"image003.emz"/>
 <o:File HRef=3D"image004.png"/>
 <o:File HRef=3D"image005.emz"/>
 <o:File HRef=3D"image006.png"/>
 <o:File HRef=3D"image007.emz"/>
 <o:File HRef=3D"image008.png"/>
 <o:File HRef=3D"image009.emz"/>
 <o:File HRef=3D"image010.png"/>
 <o:File HRef=3D"image011.emz"/>
 <o:File HRef=3D"image012.png"/>
 <o:File HRef=3D"image013.emz"/>
 <o:File HRef=3D"image014.png"/>
 <o:File HRef=3D"header.htm"/>
 <o:File HRef=3D"filelist.xml"/>
</xml>
------=_NextPart_01D75918.E6EFEE90--
